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Sepsis impairs the capillary response within hypoxic capillaries and
decreases erythrocyte oxygen-dependent ATP efflux
R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis
University of Western Ontario, London, Canada
Critical Care 2016, 20(Suppl 2):P001
Introduction: A hallmark of sepsis is early onset microvascular dys-
function. However, the mechanism responsible for maldistribution of
capillary blood flow is not understood. Evidence suggests red blood
cells (RBC) can sense local oxygen (O2) conditions and signal the vas-
culature, via adenosine triphosphate (ATP), to increase capillary flow.
We hypothesized that sepsis impaired microvascular autoregulation
over the entire capillary network, within a capillary and within the
RBC. Study objectives were to: 1) measure capillary response time
within hypoxic capillaries (capillaries with RBC hemoglobin oxygen
saturation (SO2) < 20 %), 2) test the null hypothesis that sepsis had
no effect on RBC O2-dependent ATP efflux and 3) develop a patho-
physiological model.
Methods: Hypotensive sepsis was studied in male Sprague-Dawley
rats using cecal ligation and perforation, with a 6-hour end point. Rat
hindlimb skeletal muscle microcirculation was imaged using a dual
wavelength spectrophotometric intravital microscopy system, and ca-
pillary RBC supply rate (SR = RBC/s), RBC SO2 and oxygen supply rate
(qO2 = pLO2/s) were quantified. Arterial NOx (nitrite + nitrate) and
RBC O2-dependent ATP efflux were measured using a nitric oxide
(NO) analyzer and gas exchanger, respectively.
Results: Compared to control, sepsis increased capillary stopped flow
and plasma lactate (p < 0.05). Increased plasma NOx (p < 0.001) was
related to increased capillary RBC SR (p = 0.027). Analysis of 30-
second capillary SR-SO2-qO2 profiles, revealed a shift towards de-
creased (p < 0.05) oxygen supply rates in some capillaries. Moreover,
capillary response time within hypoxic capillaries (time to restore ca-
pillary RBC SO2 > 20 %) increased 3-4 fold (p < 0.05). And, consistent
with impaired microvascular autoregulation, the RBC’s response to a
hypoxic environment, measured as RBC O2-dependent ATP efflux,
decreased by 62.5 % (p < 0.001).
Conclusions: Sepsis impaired microvascular autoregulation at the ca-
pillary and erythrocyte level. Impaired autoregulation was manifested
by increased capillary stopped-flow, increased capillary response time
within hypoxic capillaries, decreased capillary oxygen supply rate
and decreased RBC O2-dependent ATP efflux. This loss of local micro-
vascular control was partially off-set by increased capillary RBC sup-
ply rate, which correlated with increased plasma NOx.
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Introduction: IgG2 deficiency has been suggested to predispose to
severe H1N1 infection (1). However, contradictory findings have been
reported (2) and, therefore, further replication of these findings in
different cohorts need to be performed. The purpose of this study is
to assess the immunoglobulins and IgG subclasses levels, in a cohort
of patients with influenza.
Methods: We studied 137 Spanish patients who developed flu (80.3 %
by H1N1pdm virus). Diagnosis was confirmed by the detection of Influ-
enza virus in nasopharyngeal swabs using the Real-Time polymerase
chain reaction. Immmunoglobulins and IgG subclasses (Binding Site Hu-
man IgG Subclass kits) were measured in both acute and convalescent
phase and their correlation with severity was examined. We analyzed
genetic variants at IGHG2 in order to evaluated their role in the IgG2
levels. Clinical and immunological characteristics were compared using
the Chi-squared test or Fisher’s exact test when needed.
Results: Ninety-three patients were hospitalized and 49 required ad-
mission to intensive care unit. Sixty-four patients developed viral
pneumonia and 26 acute respiratory distress syndrome. No differ-
ences in the serum levels of IgG, IgA, IgM or IgG subclasses were ob-
served in the different subgroups according to severity of disease.
Genotype G2m n-/n- was associated with lower serum IgG2 levels in
the convalescent phase. Patients homozygous for the G2m(n-) allele
had significantly lower serum IgG2 levels (256.7 +/- 121.3 mg/dL, N =
16) than individuals carrying the G2m(n-) allele (n+/n- and n-/n- ge-
notypes, 334,5 +/- 120,4 mg/dL, N = 31) (p = 0.042). However no asso-
ciation of IgG2m genotypes and severity of flu was observed.
Conclusions: In our study we have not been able to replicate previ-
ously reported observations. IgG2 deficiency does not appear to be a
significant risk factor for severity of flu.
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Introduction: Intravenous(IV) immunoglobulin(Ig) treatment is known
to alleviate behavioral deficits in the experimentally induced model
of sepsis. To delineate the mechanisms by which IVIg treatment pre-
vents neuronal dysfunction, an array of immunological and apoptosis
markers was investigated.
Methods: Sepsis was induced by cecal ligation perforation(CLP) in
rats. The animals were divided into five groups; sham, control, CLP +
saline, CLP + immunoglobulin G IgG(250 mg/kg,iv), and CLP + immu-
noglobulins enriched with immunoglobulin M- IgGAM(250 mg/kg,iv).
Blood and brain samples were taken in two sets of experiments after
CLP to see the early(24 hrs) and late(10 days) effects of treatment.
Total complement activity, complement 3(C3) and soluble comple-
ment C5b-9 levels were measured in sera of rats using ELISA-based
methods. Cerebral complement content was analyzed by Western
Blot. Immune cell infiltration and gliosis were examined by immuno-
histochemistry using cluster of differentiation 3, CD4, CD8, CD11b,
CD19 and glial fibrillary acidic protein antibodies. Apoptotic neuronal
death was investigated by TUNEL staining and Western Blot-based
semi-quantitative evaluation of brain homogenates by bax and bcl-2
antibodies.
Results: IV IgG and IgGAM administration significantly reduced sys-
temic complement activity but increased serum C3 and soluble C5b-
9 levels. Likewise, Western Blot data showed slightly increased C5b-9
expression and significantly reduced C1q expression in brain samples
of IgGAM-treated but not IgG-treated septic rats especially in the first
day of administration. No cerebral cellular infiltrates were observed
in treated and non-treated septic rats. By contrast, IV IgG and IgGAM
treatment induced considerable amelioration in glial cell proliferation
which was increased in non-treated rats. IgG and IgGAM treated rats
exhibited significantly reduced numbers of apoptotic neurons and
cerebral expression levels of bax and bcl-2 as compared to non-
treated rats.
Conclusions: We suggest that IV IgG and IgGAM administration ame-
liorates neuronal dysfunction and behavioral deficits by reducing
apoptotic cell death and glial cell proliferation. IgGAM treatment
might be suppressing classical complement pathway by reducing
C1q expression.
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Introduction: Most patients survive the initial hyper-inflammatory
phase of severe sepsis and reach an intensive care unit with im-
munosuppression. Adenosine, a potent modulator of in fl;ammation
and immunity is strongly elevated in blood of septic patients. We
have previously shown that adenosine A1 receptor (A1R, Gi receptor)dominates the pro-inflammatory phase of bacterial peritonitis and
that activation of this receptor by a specific agonist induces A2AR
(Gs) expression and dominance during the resolution phase of inflam-
mation. In this study we aimed to elucidate the role of adenosine and
its receptors in sepsis-associated leukopenia. We hypothesized that ele-
vated adenosine levels in sepsis affects the normal development of
lymphocytes through down-regulation of A1R.
Methods: Polymicrobial severe sepsis was induced in C57BL/6 mice
by cecal ligation and puncture (CLP) with an 18G needle. Blood and
bone marrow (BM) cell counts, as well as flow cytometry were per-
formed at 24 h post sepsis induction.
Results: CLP-treated mice exhibited significantly lower number of
WBC compared to sham controls (9.15 ± 2.65 vs. 3.21 ± 1.58 cells x
10^3/μl). Sham A1R-/- mice showed lower WBC counts compared to
sham WT littermate (4.5 ± 3.24 cells x10^3/μl, p < .05). No significant
difference was observed in WBC count between the sham A1R-/- and
CLP WT groups. Similarly, desensitization of A1R by agonist (CCPA) or
elimination of A1R with A1R antagonist (DCPCX) were associated
with leukopenia. The T-cell was the main cell population affected by
CLP and A1R elimination. Apoptotic rate of nucleated BM cells in
sham A1R-/- mice was similar to the rate observed in WT CLP mice,
and almost 2-fold greater than the early apoptosis rate (Annexin V+,
7-ADD-) shown in WT sham group (3.64 ± 1.23 % vs. 1.86 ± 0.59 %, re-
spectively, p < .05). Interestingly, CLP-A1R-/- mice were shown to pro-
duce less interleukin (IL)-15 in lavage fluid compared to CLP-WT mice
(8.8 ± 6.0 vs. 35.3 ± 9.8 pg/ml, respectively p < .001).
Conclusions: The similarities in the phenotype induced by sepsis and
suppression of A1R support our hypothesis that dysfunction/down-
regulation of the Gi-A1R at the onset of sepsis changes the effect of
adenosine towards Gs-A2AR/A2BR-mediated leukopenia and immune
paralysis. Suppression of IL-15 might be a part of the mechanism of
leukopenia observed in CLP-treated mice and A1R-/- mice.
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Introduction: Neutrophil play an important role as the first line of
innate immune defense. Activated neutrophils become segmented
and cytoplasm grows larger including granules. However, some-
times it is difficult to diffentiate whether the segmented neutro-
phils are on the process to grow up or not, and to decide to stop
antibiotics or not. There are some reports that hyper spectral im-
aging (HSI) is available for analysis including diagnosis of malaria
infected cells and distinction of the cells to produce antibody. In
this study, we evaluated serial changes of HSI spectrum in patients
with infection, and examined whether we could distinguish acti-
vated neutrophils or not.
Methods: Sputum and urine samples were collected from the clin-
ically ill three patients with pulmonary infection(n = 2) and urinary
tract infection(UTI; n = 1). These samples were smeared on glass
slides and gram stain was conducted. We observed the slides with
HSI to get the hyper spectral data 10 times from each cytoplasm
of neutrophil, and analyzed hyper spectral data with the software
system, MultiSpec®.
Results: We could find that neutrophils have different spectrum in
each infectious stage, especially during from 400 to 700 nm wave-
length. Representative image of a patient with UTI was shown in
Fig. 1. When the neutrophils became segmented and had phagocyt-
osis, the cytoplasm of neutrophil enlarged and showed strong inten-
sity (black lines) compared to when microorganism disappeared and
the size of cytoplasm decreased (blue and red lines).
Conclusions: We could find the serial changes of spectrum of neutro-
phils during each infectious stage. HSI may be available to decide
start or termination of antibiotics. Further study is required to estab-
lish the cut off intensity level of the activated neutrophils.
Fig. 1 (Abstract P005).
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Introduction: Recent studies have demonstrated that the endotoxin
activity levels, which were analyzed using the Endotoxin Activity
Assay (EAA), correlated with the severity of sepsis in patients ad-
mitted to the ICU. On the other hand, there are several reports that
they dispute the clinical utility of the EAA. We focused on chemilu-
minescent intensity (CI) in response to lipopolysaccharide (LPS) by
EAA and evaluated the predictive value for the incidence of post-
operative infectious complications following elective gastroentero-
logical surgery.Methods: Forty eight patients who underwent elective surgery for
gastrointestinal cancer were enrolled in this study. Blood samples
were taken on the previous day (before surgery), and on the first
(POD1) and third postoperative days (POD3). All blood samples were
analyzed using the EAA system. We focused on CI max, which is max-
imally stimulated with LPS and the minimum CI, which is only stimu-
lated with opsonized zymosan.
Results: Postoperative infectious complications occurred in 23 of
the 48 patients. There were significant differences in the EA levels
between patients who developed postoperative infectious com-
plications and patients who did not on POD3. Minimum CI was
significantly higher in the patients who developed postoperative
infectious complications at all points compared to those from the
patients who did not. In addition, the ratio of maximal CI to mini-
mum CI, which reflects the neutrophil function against maximal
LPS, was significantly lower before surgery and on POD1 in patients
who developed postoperative infectious complications. Although a
significant positive correlation was observed between the neutro-
phil counts and maximal CI or minimum CI, no correlation was ob-
served between the neutrophil counts and the ratio of maximal CI
to minimum CI.
Conclusions: Chemiluminescent intensities, especially the ratio of
maximal CI to minimum CI, could be an early predictive marker for
the development of postoperative infectious complications.
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Introduction: C1 inhibitor (C1INH), belonging to the superfamily of
serin protease inhibitors, regulates not only complement system, but
also plasma kallikrein-kinin system, fibrinolytic system and coagula-
tion system. The biologic activities of C1INH can be divided into the
regulation of vascular permeability and anti-inflammatory functions.
The objective of this study was to clarify the serial change in C1INH
in patients with sepsis and evaluate the impact of C1INH on their
clinical course.
Methods: This study was a single center prospective observational
study. We serially examined C1INH activity values (normal range 70-
130 %) in patients with sepsis admitted into the intensive care unit
of the Trauma and Acute Critical Care Center at Osaka University
Hospital (Osaka, Japan) during the period between January 2014 and
August 2015. We defined refractory shock as septic shock unrespon-
sive to the conventional therapy such as adequate fluid resuscitation
and vasopressor therapy to maintain hemodynamics.
Results: The serial change of C1INH was evaluated in 40 patients with
sepsis (30 male and 10 female; 30 survivors and 10 non-survivor; mean
age, 70+/-13.5 years). We divided patients into three groups such
as (i) non-shock group (n = 14), (ii) non-refractory shock group
(n = 13), (iii) refractory shock group (n = 13, survivors; n = 3, non
survivors; n = 10). In non-shock group, C1INH were 107.3+/-26.5 %
at admission and 104.2+/-22.3 % at day1, and it increased after
day1 (128.1+/-26.4 % at day3, 138.3+/-21.2 % at day 7, 140.3+/-
12.5 % at day 14)(p = 0.0040). In non-refractory shock group,
C1INH were 113.9+/-19.2 % at admission and it increased after admis-
sion (120.2+/-23.0 % at day1, 135.7+/-19.9 % at day3, 138.8+/-17.2 % at
day 7, 137.7+/-10.7 % at day 14)(p = 0.0029). In refractory shock group,
C1INH were 96.7+/-15.9 % at admission and 88.9+/-22.3 % at day1 and
it increased after day1 (119.8+/-39.6 % at day3, 144.4+/-21.1 % at day 7,
140.5+/-24.5 % at day 14)(p < 0.0001). The difference between these
three groups was statistically significant (p = 0.0039). C1INH in non-
survivors did not increase significantly during their clinical course
(p = 0.0773).
Conclusions: In refractory shock patients with sepsis, the values of
C1INH were low (especially in non survivors) at admission and day 1.
The validity of C1INH replacement therapy in patients with septic
shock may lead to a new strategy for management in sepsis.
Fig. 2 (Abstract P009).
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Introduction: When septic patients progress to endotoxin shock,
they become subject to high mortality rate. The mortality rate of sep-
tic patients with multiple organ failure has been reported to be 30-
80 %. Recently, much sepsis related biomarkers have been measured
for diagnosis of sepsis.
Methods: We would like to clarify the difference of patient fs back-
ground and various biomarkers (Procalcitonin:, Presepsin., Interleukin-6,
Endotoxin activity assay:EAA,Angiopoietin-2) and 28-days mortality
rate in sepsis and bacteremia. Patients were classified as a group in
which blood culture was positive (BC-positive group: N = 31) or a
group in which blood culture was negative (BC-negative group:
N = 31).Blood cultures (blood samples were drown from different
two sites) were performed immediately after ICU admission due to
sepsis or septic shock. Results were expressed as mean+/-SD (median).
Statistical analysis was used with Mann-Whitney U-test and Chi square
test or Fisher’s test.
Results: Procalcitonin of BC-positive and BC-negative patients were
35.9}75.3 (7.8) and 17.1}30.9 (2.0) respectively. There are no signifi-
cant differences between the patients. Presepsin of BC-positive and
BC-negative patients were 2726}3208 i2147 jand 2733}2558 i2281 jre-
spectively, also, no significant difference between the groups.
EAA level of BC-positive patients was 0.54}0.20 (0.58), while that in
BC-negative patients was 0.37}0.26 (0.36), and the difference be-
tween the groups was statistically significant (p < 0.05). Angiopoietin-
2 of BC-positive and BC-negative patients were 16943}22793 i12000
jand 7457}7068 i5080 jrespectively. There is also a significant difference
(p < 0.05) between the groups. IL-6 of BC-positive and BC-negative pa-
tients were 2988}10602 i212 jand 516}1703 i107 jrespectively, but, no
difference between the groups. 28-days survival rate was 90.9 % in BC-
positive patient and 87.1 % in BC- negative patient. There were no sig-
nificant data in the two groups.
Conclusions: The values of EAA and Angiopooitin-2 of BC-positive
patients were significant higher than BC-negative patients. But, no
significant differences on 28-days mortality between the groups were
existed. These results showed discrepancy to our previous report1).
We shold be more evaluating about the patient’s basic disease.
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Introduction: Procalcitonin (PCT) is an early, sensitive and accurate
marker for sepsis. Especially, several studies indicated that PCT is an
important indicator to diagnose infection, predict outcomes or guide
treatment of abdominal sepsis. Recently, blood purification (BF) such
as endotoxin absorption therapy (polymyxin B [PMX] hemoperfusion)
and continuous renal replacement therapy (CRRT) has been carried
out for abdominal septic shock. However, there are few studies about
the changes of PCT levels in abdominal septic shock during BF.
Therefore, we retrospectively evaluated the changes of PCT levels in
critical patients with abdominal septic shock during BF.
Methods: Twenty-four patients (M/F 17/7, mean age 61 years) with
abdominal septic shock underwent BF (PMX and CRRT). PMX was
undergone twice and CRRT was undergone for 5 days. The changes
of PCT levels and other inflammatory mediators such as blood WBC
counts, CRP levels and lactate levels during BF were measured for5 days. Moreover, SOFA and survival rate 14 days after ICU admitted
were measured.
Results: Hemodynamics in all patients improved at 8 hrs after BF.
The PCT levels were improved (66.0 to 12.7 ng/mL; p < 0.05), but
WBC counts (8,420 to 10,380 /uL) and CRP levels (9.3 to 9.0 mg/dL)
were not improved 5 days after BF. SOFA scores decreased (12.5 to
7.0; p < 0.05) at 5 days after BF. All patients recovered and discharged
in ICU. There was significantly correlation between PCT and SOFA
scores (Y = 9.04 + 0.02X; R2 = 0.112, p < 0.0001), but there were no
correlation between PCT and other mediators.
Conclusions: In the present study, the PCT levels in critical patients
with abdominal septic shock improved after BF and there was signifi-
cantly correlation between PCT and SOFA scores.P010
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Introduction: Procalcitonin (PCT), a highly sensitive and specific bio-
marker for bacterial infections, is increasingly being used in the ED
and ICU for the diagnostic work up of patients with LRTI and sepsis.
Recently, Samsung IB BRAHMS PCT&#61650;, a new point of care
(POC) test, has been developed for a fast PCT measurement of whole
blood and EDTA samples with a measuring range of 0.08 - 10 μg/L.
The objective of this evaluation study was to determine the correl-
ation of the Samsung IB BRAHMS PCT test to established reference
methods.
Methods: This study was conducted to examine the correlation of
the Samsung IB BRAHMS PCT to the established reference methods
BRAHMS PCT sensitive Kryptor and BRAHMS PCT Elecsys at two
German Laboratories. The design was based on the related CLSI
Guidelines EP09-A3 (Measurement Procedure Comparison and Bias
Estimation Using Patient Samples). The study compared PCT values
using EDTA plasma determined with reference methods with results
determined with Samsung IB BRAHMS PCT using EDTA whole blood
and EDTA plasma over the whole measuring range of the assay in
patients undergoing routine care PCT measurement.
Results: 256 patients were included over a 6 weeks period. The cor-
relation between EDTA whole blood or plasma and the reference
method was r- = 0.97, the correlation of plasma and whole blood
samples, both determined on the Samsung analyzer, was r = 0,98.
The clinical concordance was 94 % related to a 0.5 μg/L threshold in
whole blood. No significant bias was observed (0.033 and 0.034 for
venous whole blood and plasma respectively, compared to the refer-
ence method). No difference was observed comparing imprecision of
whole blood and plasma. The total CV was < 14.5 % for concentra-
tions between 0.45 and 4.54 μg/L. The time to result of the Samsung
IB BRAHMS PCT was 20 min.
Conclusions: This study found an excellent correlation and diagnostic
accuracy of the new, sensitive POC device for rapid measurement of
procalcitonin. The Samsung IB BRAHMS PCT test allows an accurate
measurement of PCT at a point of care, where near patient testing is
Fig. 3 (Abstract P012).
Table 1 (Abstract P013).
Before CNS infection After CNS infection P value
WBC 13000 ± 6500 9700 ± 4200 0,12
CRP 18 ± 9.2 7.7 ± 4.7 0,06
PCT 13.4 ± 9.3 9 ± 2.2 0,2
Critical Care 2016, Volume 20 Suppl 2 Page 17 of 182practical, that is comparable to established lab based BRAHMS PCT
assays.
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Introduction: There is a lack of studies comparing the utility of C-
reactive protein (CRP) with procalcitonin (PCT) for the management
of patients with acute respiratory tract infections (ARI) in primary
care. Our aim was to study first the correlation between these
markers, and second to compare their predictive accuracy in regard
to clinical outcome prediction.
Methods: This is a secondary analysis using clinical and biomarker
data of 458 primary care patients with pneumonic and non-
pneumonic ARI. We used correlation statistics (spearman’s rank test)
and multivariable regression models to assess association of markers
with adverse outcome, namely days with restricted activities and on-
going discomfort at day 14.
Results: At baseline, CRP and PCT did not correlate well in the overall
population (r2 = 0.16 and r2 = 0.04) and particularly in the subgroup
of patients with non-pneumonic ARI. Low correlations were also
found comparing cut-off ranges, day seven levels and biomarker
changes from baseline to day seven. High admission levels of CRP
(>100 mg/dL, regression coefficient 1.7, 95%CI 0.6 to 2.8) as well as
PCT (>0.5ug/L regression coefficient 2.3, 95%CI 0.3 to 4.3) were sig-
nificantly associated with days with restricted activities. There were
no associations of both markers regarding ongoing discomfort at day
14.
Conclusions: CRP and PCT levels do not well correlate and have both
have moderate prognostic accuracy in primary care patients with ARI
to predict clinical outcomes. The low correlation between both
markers calls for interventional research comparing these markers
head to head in regard to their ability to guide antibiotic decisions.
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Introduction: Procalcitonin (PCT) has been proposed as a helpful tool
to guide treatment with antibiotics and to improve antibiotics stew-
ardship. [1,2,3] However the cut off for the PCT level has not been
agreed as different studies have suggested different thresholds to
predict the need for antibiotics, these cut off points ranged from
0.25 ng/mL – 1 ng/mL. In our hospital the reference range is set at
0.5 ng/mL. This study aimed at identifying the best PCT level to rule
out sepsis.
Methods: We have retrospectively reviewed 53 intensive care unit pa-
tients, who had serial PCT tests as part of their daily blood tests. Three
serial readings of PCT were collected in addition to microbiology cul-
ture results and whether the patient met the definition criteria for sep-
sis as set out in the 2001 International Sepsis Definition conference.
Results: Out of the 53 patients, 26 (49.05 %) patients had negative
microbiological cultures with no evidence of sepsis.
PCT test level of 0.13 ng/mL had 100 % sensitivity as no patient
below this cut off had evidence of sepsis or positive microbiology
culture. The Area under the ROC was 0.702 with 95 % Confidence
interval of 0.56-0.84 and a p value of 0.012 (Fig. 3).
Conclusions: Using lower PCT cut off would further enhance the abil-
ity of PCT to rule out sepsis in the critically ill patient.
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Introduction: Central Nervous System (CNS) infections after neuro-
surgical procedures with extensively drug resistant bacteria (XDR), in
intensive care unit (ICU) patients, is a life threatening complication
requiring early identification and immediate action. Increased num-
ber of white blood cells (WBC), high temperature and circulating
acute phase proteins are common in those patients making timely
diagnosis challenging. We sought to investigate the reliability of
serum C-Reactive protein (CRP) and procalcitonin (PCT) to early iden-
tify and monitor CNS infections.
Methods: From January 2013 to November 2015 all cases with CNS
infections were recorded. Inclusion criteria were the presence of
fever > 38.5oC and compatible lumbar puncture findings (increased
number of polymorphonuclear leukocytes, increased protein and low
glucose compared to serum levels). The WBC, CRP and PCT levels be-
fore (when the inclusion criteria were met) and after the infection
(last intrathecal administration of Collistin 300.000 IU, Amikacin
25 mg and Vancomycin 25 mg) were compared.
Results: Twelve patients (mean age 45.7 ± 18.1) were studied. WBC
remained high before and after infection. Conversely, CRP values
were statistically different before and after the infection whereas the
PCT ones were not (Table 1).
Conclusions: Based on our findings CRP carries a better predictive
value than PCT as biomarker for early diagnosis and monitoring of
CNS infections in ICU. The small number of patients is a limitation for
these results.
Table 2 (Abstract P015). Diagnostic Biomarkers in Severe Sepsis and
Septic Shock.
Parameters AUC;CI 95 % Cut-off Sens;CI95%
PCT, μg/L 0.989(0.96–0.998) 0.28 92(88.6–95.8)
PSP, pg/mL 0.948(0.9–0.98) 101.6 82(73.7–81.9)
PCT + PSP 0.998(0.973-1) 98(93.7-99.7)
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Changes in endotoxin activity assay and procalcitonin levels after
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Introduction: This study aimed to clarify changes in the endotoxin
activity assay( EAA )and (PCT) levels before and after direct hemoper-
fusion with polymyxin-B immobilized fiber(PMX-DHP).
Methods: We studied 212 patients [survival (S) group: 146; non-
survival (NS) group: 66] in whom PMX-DHP was performed for severe
sepsis and septic shock and who were admitted to the ICU. At the
same time, blood biochemistry and interleukin-6 (IL-6) levels were
measured before and after PMX-DHP. A double-lumen catheter was
inserted into the patient fs femoral vein, and PMX-DHP was per-
formed using a blood pump to remove endotoxins. The blood access
for hemoperfusion consisted of a venous-to-venous system. Nafamo-
stat mesilate was administered as a 40 mg bolus followed by 30-
40 mg/hour continuous intravenous infusion as an anticoagulant.
Extracorporeal circulation was performed for 2 hours. Results were
expressed as mean SD (median). The Mann-Whitney U-test and chi-
square test or Fisher fs test were used for statistical analysis.
Results: Regarding background factors, the APACHE2 scores in the
S-group and NS-group were 23.9 } 8.0 and 32.8 } 9.0, and the SOFA
scores were 10.0 } 9.0 and 12.9 } 3.4, respectively. The blood pressure
and PaO2/FIO2 ratio markedly improved immediately after PMX-DHP.
The IL-6 levels decreased immediately after PMX-DHP in the S-group,
but the levels showed no significant difference between the groups
before PMX-DHP. The PCT levels before PMX-DHP were 59.7 } 95.2
(24.7) in the S-group and 45.3 } 54.8 (24.0) in the NS-group. Imme
diately after PMX-DHP, these levels became 48.6 } 69.4 (25.5) in the
S-group and 51.9 } 67.5 (19.9) in the NS-group, respectively. The EAA
levels before PMX-DHP were 0.50 } 0.22 (0.46) in the S-group and
0.59 } 0.26 (0.59) in the NS-group. Immediately after PMX-DHP, these
levels became 0.50 } 0.21 (0.53) in the S-group and 0.53 } 0.27 in the
NS-group, respectively. These values showed no significant differ-
ences before and after PMX-DHP.
Conclusions: This study showed that the PCT and EAA levels had no
significant changes after PMX-DHP.
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Introduction: The purpose of the study was to determine the accur-
acy of CRP, PCT and presepsin (PSP) and the combination of them,
measured in the first 24 h after admission for diagnosis of severe
sepsis( SS) and septic shock (SSh).
Methods: Case/control study admitted in the Intensive Care Unit,
during 12 months. Criteria of SS or SSh was according to the Surviving
Sepsis Campaign and controls were enrolled in the Coronary Unit.
Biomarkers were measured within the first 24 h after admission. The
accuracy for diagnosis was determined using receiver operating char-
acteristic (ROC) and logistic regression was performed to assess the
combination of studied biomarkers could improve the diagnostic
value of each one separately.
Results: We analyzed 388 whom 142 were controls. 61.8 % of patients
were males, mean age: 63 years, interquartile range (IQR) (18–90) withAPACHE II of 26 (21-29) and SOFA of 9 (7-11); and in controls 67.8 %
were men, mean age: 63 years, IQR (39–91). The main sources of infec-
tion were respiratory tract 47.8 % and intra-abdomen 19.8 %.
AUC, cutoff value, sensitivity and specificity, positive predictive value
(PPV) and negative predictive value (NPV) of the biomarkers used in
the study are shown Table 2.
Comparisons between AUCs were significantly different (p <0.01) in
all cases except for PCT versus PCT + PSP (p < 0.163), however, the lo-
gistic regression showed that the combination of PCT and PSP im-
proved the diagnostic value of each one separately.
Conclusions: PCT and PSP levels measured on admission showed
high diagnosis efficacy to predict SS and SSh. Using both markers
simultaneously increases diagnostic accuracy in septic patients, im-
proving the classification of patients.P016
Platelet function analysis utilising the PFA-100 does not predict
infection, bacteraemia, sepsis or outcome in critically ill patients
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Introduction: Sepsis is known to be associated with impaired platelet
function (1). The PFA-100 (Siemens Healthcare, Dade International,
Miami, Fla., USA) is a device in which a citrated whole blood sample
is aspirated through an aperture coated with agonists inducing plate-
let activation. Platelet aggregation leads to occlusion of the aperture
and blood flow ceases over an interval termed the closure time (CT).
Aim:
The aim of the present study was to determine whether CT, mea-
sured by the PFA-100, could be used to determine the likelihood of
infection, sepsis, and bacteraemia or hospital mortality.
Methods: A single centre, prospective, observational cohort study.
Subjects were 101 pyrexial patients in a mixed adult ICU. Blood sam-
ples were drawn for cultures, full blood count, CRP and PFA analysis.
Admission diagnosis, demographic data, laboratory variables, APACHE II
scores and outcome data (infection, sepsis, bacteraemia and mortality)
were collected from the clinical records. Logistic regression analysis
was undertaken using Stata/IC (StataCorp, 4905 Lakeway Drive, College
Station, Texas 77845 USA)
Results: Median age was 60 (Interquartile Range = IQR 46-71), 57
patients (56.4 %) were male, median APACHE II score was 16 (IQR
10-19). Of the recruited patients, 78 (77.2 %) had an infective
process, and 70 (69.3 %) met SIRS criteria for sepsis; 12 patients
(11.9 %) had positive blood cultures, 19 patients (18.8 %) did not
survive to hospital discharge.
Logistic regression analysis, adjusted for age, gender and baseline
APACHE II score found that CT did not predict any of the outcomes.
Odd Ratios were 0.99 (95 % confidence interval = 95 % CI 0.98-1,
p = 0.2) for infection, 0.99 (95 % CI 0.98-1, p = 0.37) for sepsis,
0.99 (95 % CI 0.98-1, p = 0.64) for bacteraemia and 1.00 (95 % CI
0.99-1.01, p = 0.71) for mortality, respectively.
Conclusions: Platelet aggregation measured by closure time utilising
the PFA-100 system did not correlate with infection, sepsis, bacter-
aemia or mortality in our sample of febrile patients.
Reference
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Table 3 (Abstract P018). Inflammatory markers in different sepsis
groups.
Sepsis (n = 40) Severe Sepsis (n = 13) Septic Shock (n = 12)
IL-8 (pg/mL) 61 (21, 176) 71 (41, 104) 526 (136, 7998)**
CRP (mg/dL) 79 (40, 222) 193 (124, 422) 128 (21, 179)
PCT (pg/mL) 308 (108, 1038) 702 (385, 1637) 1258 (230, 17296)*
*p = 0.001, **p < 0.001
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Introduction: Extracellular histones are cytotoxic compounds capable
of mediating death in murine sepsis. Furthermore, circulating nucleo-
some levels predict mortality in human inflammation and sepsis.
Whether or not extracellular histone H3 correlates with other plasma
parameters and/or ICU scoring systems has not been completely estab-
lished, nor if levels of circulating extracellular histones can be used as
predictive markers for clinical outcome in sepsis.
Methods: Histone H3 (H3) plasma levels of 43 sepsis patients who
were admitted to the Intensive Care Unit were measured and we de-
termined the correlation of H3 levels with disease severity, organ fail-
ure, mortality and coagulation- and tissue homeostasis parameters
including LDH levels, thrombin potential (ETP), prothrombin levels,
antithrombin levels and platelet counts.
Results: For sepsis patients at the ICU we found that median H3
levels were significantly increased in non-survivors as compared to
survivors with levels found being 3.15 μ g/ml versus 0.57 μg/ml re-
spectively, P = 0.04. H3 levels are positively correlated with lactate
dehydrogenase (LDH) activity (Spearman’s rho = 0.49, P < 0.001), and
negatively correlated with antithrombin levels (rho = -0.34, P = 0.027)
and platelet counts (rho = -0.33, P = 0.031).
Conclusions: We conclude that circulating H3 levels correlate with
mortality in sepsis patients and inversely correlate with antithrombin
levels and platelet counts.
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Il-8: is this a more reliable biomarker for sepsis severity than CRP,
Procalcitonin, E-selectin, IL-6 and TNF-[alpha]
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Introduction: Sepsis is a systemic inflammatory response syndrome
(SIRS) with an evidence of infection. Numerous inflammatory markers
have been studied to assess the severity of sepsis. However, current
biomarkers are insufficient to accurately determine stage and prog-
nosis [1]. This study aimed to assess the cytokine Interleukin-8 (IL-8)
for determining the stage and severity of sepsis. A comparison was
made with C-reactive protein (CRP), Procalcitonin (PCT), E-selectin,
Interleukin-6 (IL-6) and Tumour Necrosis Factor-α (TNF-α ).
Methods: This study had full ethical approval from the South West
Wales Research Ethics Committee. Patients with a diagnosis of sepsis
were recruited from the Emergency Department and Intensive Care
Unit of a large teaching hospital in South Wales. Blood samples were
taken to determine IL-8, CRP, PCT, E-selectin, IL-6 and TNF-α.
Results: 65 patients were included in the study: 40 with sepsis, 13
with severe sepsis and 12 with septic shock. PCT concentration was
significantly increased in subjects with septic shock when compared
to sepsis (Table 3,*p = 0.001, Kruskal-Wallis test). IL-8 concentration
was significantly increased in septic shock compared to both sepsis
and severe sepsis groups (Table 3, **p < 0.001 and p = 0.013 respect-
ively, Kruskal-Wallis test). Using ROC analysis, IL-8 was found to be a
significant predictor of mortality (AUC 0.92, p < 0.001).
Conclusions: Both IL-8 and PCT significantly distinguished septic
shock from sepsis and severe sepsis. IL-8 was shown to be a promis-
ing inflammatory marker for assessing the severity and prognostica-
tion in patients across the sepsis spectrum.
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Introduction: Adrenomedullin (ADM) is a peptide with 52 amino
acids which has strong vasodilator activity. Elevated plasma ADM
levels have been detected in a wide variety of physiological and
pathological conditions, with the highest elevations observed in sep-
tic shock. Marino et al. demonstrated a strong association of admis-
sion ADM levels with the severity of sepsis, supporting an earlier
report describing elevated ADM levels in those with severe sepsis
and those with septic shock [1]. By using a novel assay specific for
bioactive ADM (bio-ADM) as Marino et al.the aim of the study was to
assess the relation between ADM measured at admission and in-ICU
mortality in consecutive patients regardless the cause of admission.
Methods: The French and euRopean Outcome reGistry in Intensive
Care Units (FROG-ICU) study was a multicenter observational study,
including 2087 consecutive patients followed up to one year for
those who survived to ICU stay. The protocol has previously been de-
scribed [2]. Plasma were collected at admission for all patients and at
discharge for in-ICU survivors. ADM was measured in all plasma using
a sandwich assay specific for bio-ADM. The association between in-
ICU mortality and the level of ADM was assessed by univariate ana-
lysis and adjusted analysis for severity at admission measured by the
SAPS-II. Improvement in area under the ROC curve and reclassifica-
tion indices were assessed.
Results: 2087 patients have been included, 65 % male with a median
age of 63 (51-74), a median Charlson score of 3 (1-5) and a median
SAPS-II 49 (36-63). Septic shock was present in 488 (23 %) patients.
Median (and interquartile range) of ADM in-ICU survivors and non-
survivors was 57 pg/mL [30-114] and 110 pg/mL [63-220], respect-
ively (p < 0.001). Hazard ratio of in-ICU death for patients with a level
of ADM higher than the median value was 2.12 (95%CI: 1.73-2.60)
and 1.68 (95%CI: 1.36-2.07) when adjusted for SAPS-II. Area under
the ROC curve of SAPS-II was significantly improved by the addition
of ADM (0.653 [0.624 - 0.682] to 0.702 [0.675 - 0.729], p = 0.01).
Conclusions: In the present study, ADM was independently associ-
ated with in-ICU mortality and improved prognostic prediction. The
clinical and therapeutic implication of these findings need to be fur-
ther investigated.
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Critical Care 2016, Volume 20 Suppl 2 Page 20 of 182Introduction: Prognostic biomarkers for sepsis are described irre-
spective of patient severity. Our objective was to describe the ability
of Heparin-Binding Protein (HBP) to predict the development of sep-
tic shock relative to the PIRO score.
Methods: Design: A secondary analysis of a multi-centered observa-
tional study. Inclusion: 1. adults >17 years with acute infection, 2.
hospital admission and 3. two measurements of HBP. Exclusion:
Hypotension within the first 12 hours. Initial PIRO scores calculated on
arrival. Outcome: The development of delayed hypotension (dShock) =
sBP <90 after initial assessment. Analysis: Subjects were grouped ac-
cording to PIRO score range using previously defined cutoffs, and out-
comes for each group were summarized. Average values and change
in HBP were described across each group.
Results: 367 subjects were identified from original 759 meeting all
study criteria. Frequency by disease severity: PIRO 0-4: 109 (30 %);
PIRO 5-9: 191 (52 %); PIRO 10-14: 67 (18 %). There was a progressive
increase in the frequency of dShock by increasing severity (37 %,
51 %, and 61 %). HBP was significantly elevated in dShock subjects
across all subgroups (0-4:66 v 25; 5-9:75 v 39; 10-14:87 v 36, p < 0.05).
The change in HBP was significant at the high-severity subgroup
(Fig. 4).
Conclusions: There is an increased predictive performance of HBP as-
sociated with worsening sepsis severity. Assessment of serial HBP
provided additional benefit at the high-severity subgroup.Fig. 4 (Abstract P020). Serial change in HBP in subjects who
develop delayed shock (dShock).
Fig. 5 (Abstract P022).P021
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Introduction: sCD14 represents a key receptor for Lipopolysaccharide -
Lipopolysaccharide binding protein complexes and activation of TLR-4
cascade. Our aim was to investigate the potential prognostic role of
this new marker on a cohort of patients with severe sepsis and sep-
tic shock.
Methods: We prospectively included 148 patients admitted to the
ICU with the suspected diagnosis of sepsis. Of these, 28 patients met
the inclusion criteria and were included in the final analysis. sCD14,
procalcitonin (PCT), C-reactive protein (CRP) were recorded at ad-
mission ICU day 1 and ICU day 3. Organ dysfunction, sepsis severity
scores (SOFA scores, Apache II score), vital parameters and manage-
ment were recorded during ICU stay.
Results: sCD14 at admission was associated with cardiovascular dys-
function: decreased mean arterial pressure (correlation coefficient = -
0.552, p = 0.048) and increased vasopressor support (correlation coeffi-
cient = 0.761, p = 0.035). Patients with increase sCD4 had a more severe
hepatocytolysis as demonstrated by increased levels of ALT (p = 0.019)and AST levels (p = 0.040). ICU length of stay correlated with sCD14
levels at admission (p = 0.011) and ICU day 1 (p = 0.012). Patients with
sCD14 levels < 2000 at admission had the lowest mortality rates and
patients with presepsin levels > 6000 had the highest mortality. Statisti-
cally significant differences were observed between sCD14 between
survival and non-survivals on admission (p = 0.042), ICU day 1 (p =
0.036) and ICU day 3 (p = 0.042).
Conclusions: Although sCD14 is associated with cardiovascular and
hepatic dysfunction, the exact dynamics of sCD14 are still unknown.
We observed a good correlation between presepsin levels at the
time of admission and ICU survival, demonstrating a good prognostic
role of this new inflammatory marker.P022
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Introduction: Differentiating patients who are infected or not in the
intensive care unit (ICU) can be very difficult. Present diagnostic tests
remain inadequate. CD64 has been found to be a potentially useful
marker to identify infected patients. Unfortunately, CD64 measured
by standard flow cytometers in a laboratory takes hours to perform.
The purpose of this study was to evaluate the Accellix CD64 ins-
trument which provides infection assessment in 30 minutes in ICU
patients.
Methods: Infected (ICUi) and non-infected ICU patients (ICU Control-
ICUc) and normal volunteers (C) had CD64 levels measured by the
Accellix CD64 instrument. Measurements were calculated as ‘CD64
index’, i.e. the ratio between the median fluorescence of the PMN
population and the median fluorescence of the control beads popu-
lation. Infection assessment was categorized per the CDC and ISF cri-
teria as having a DEFINITE, PROBABLE, POSSIBLE, or NO INFECTION.
Results: 92 subjects were studied (ICU- 54 and C-38). CD64 Index
levels were higher (mean ± SEM) in ICU definite and probable in-
fection patients than ICU no infection and normal control patients
(Definite Infection 2.24 ± 0.48, Probable Infection 1.54 ± 0.7, Possible
Infection 0.57 ± 0.37, No Infection 0.65 ± 0.17, Healthy 0.53 ± 0.02). Re-
sults can be seen in Fig. 5.
Conclusions: CD64 Index levels are higher in infected than non-
infected ICU patients. Accellix CD64 is a promising instrument to
differentiate infected from non-infected ICU patients in a timely
manner.P023
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Critical Care 2016, Volume 20 Suppl 2 Page 21 of 182Introduction: Current biomarkers for sepsis diagnosis are neither suf-
ficiently specific nor sensitive. Moreover, comprehensive diagnosis is
today delayed by the long time-to-result required for the quantitative
measurement of blood proteins in centralized laboratories. Therefore,
the need to combine a rapid, near-patient diagnostic platform with
the accurate measurement of proteins in complex matrices is the key
to improve sepsis patient outcome. We developed nanofluidic bio-
sensors that accelerate molecular interaction and thereby reduces
incubation time from hours to minutes. Biosensors are analyzed in
the abioSCOPE, a miniaturized automated fluorescence microscope.
Fluorescent antibodies specific for the tested protein are mixed with
50 μ l of blood collected at the patient’s fingertip. Complexes of de-
tecting antibodies and analytes are captured on the sensing area of
the biosensors and, upon excitation, emit a signal proportional to the
concentration of the analyte. As a proof-of-concept, we prepared bio-
sensors for the quantification of pancreatic stone protein (PSP/reg), a
promising biomarker that showed its superior ability to predict the
outcome of patients affected by sepsis in several clinical studies [1].
Methods: PSP/reg biosensors were analyzed in the abioSCOPE to de-
termine the analytical performances of the test. PSP/reg levels mea-
sured in a panel of serum samples from patients who underwent
surgery were measured in the abioSCOPE and compared to the con-
centration measured in a microtiter plate ELISA.
Results: High analytical specificity was showed in a competitive in-
hibition study. Analytical sensitivity of the test is inferior to the mean
PSP/reg value of a cohort of healthy individuals and the test is lin-
ear up to 1000 ng/ml of PSP/reg, thereby meeting clinical require-
ments. In a small-size comparison study, a good agreement was
observed for PSP/reg values measured in microtiter ELISA and in
the abioSCOPE.
Conclusions: The analytical performances of the PSP/reg test in
nanofluidic biosensors highlight that rapid and accurate quantitative
measurement of low abundance proteins can be achieved at no
quality costs. More data is however needed to better evaluate the
diagnostic performance of PSP/reg in various settings. Quantification
of PSP/reg in 5 minutes in the abioSCOPE, together with the evalu-
ation of other specific clinical signs performed at the bedside, will
hopefully improve the decision-making process of patient with sus-
pected sepsis and improve patient’s management in various clinical
scenarios.
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Introduction: Sepsis remains a major cause of mortality in intensive
care units and its incidence is increasing along with the antibiotic re-
sistance of the causing microorganisms. The management of sepsis
is technically demanding and costly with only few therapeutic op-
tions available. Prompt diagnosis and hence early treatment has a
major impact on patient survival. The advent of nanotechnology has
brought with it an astonishing number of novel tools enabling novel
technological solutions [1].
Methods: Here I will discuss how nanotechnology-enabled approa-
ches could contribute to the prevention, diagnosis and treatment of
bacterial infections.
Results: I will present nanoparticle-based approaches for ultrasen-
sitive detection of analytes in body fluids and the rapid removal of
pathogens from whole blood using magnetic nanoparticles [2]. Add-
itionally, potential hurdles encountered when translating nanomaterial-
based approaches into clinical settings will be illustrated.
Conclusions: This presentation will critically discuss the opportunities
and challenges of particle-enabled approaches for the diagnosis and
treatment of bacterial infections.References
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Introduction: Despite therapy improvement septic shock mortality is
still around 30 %. Better understanding of immunosuppression
mechanisms led to new therapeutics perspectives such as recombin-
ant IL-7 [1]. However it remains to better identify patients eligible for
such immunotherapy. The soluble form of IL-7 receptor seems to be
a promising candidate biomarker for this purpose since an associ-
ation between its plasmatic concentration and mortality has been re-
ported [2]. As we have no data on the transcriptional regulation of
IL7R gene expression in septic shock, the aim of this study was to de-
scribe, in this pathology, the expression of several mRNA splicing var-
iants of IL7R and to assess their association with mortality.
Methods: This retrospective study involved 30 ICU patients with sep-
tic shock. Whole blood sample was collected on the first (D1) and
the third day (D3) after septic shock diagnosis. Expression levels of
IL7R variants were measured using appropriate RT-qPCR designs: one
specific of the variant encoding the membrane form of IL-7R, one
specific of a variant corresponding to a potential soluble form and
one covering all known splicing variants, including the 2 mentioned
previously. Expression levels of these variants were described accord-
ing to time and compared to 19 healthy volunteers. The association
between our candidate biomarkers and day 28 status was assessed
by logistic regression analyses. ROC curves were performed in order
to evaluate performances.
Results: We noticed a decrease of expression levels of all IL7R spli-
cing variants in patients compared to controls. An association be-
tween mortality and IL7R decreased expression was found for
measurements at D3 and the ratio of expression D3/D1. This associ-
ation was observed whatever the transcription variant used, in par-
ticular at D3 for the membrane form and for the potential soluble
form of IL7R (OR = 0.28 [0.09–0.86], p = 0.026 and OR = 0.26 [0.07–
0.93], p = 0.039, respectively). The ROC AUC for these models were
0.81 [0.65–0.97] and 0.84 [0.69–0.98].
Conclusions: This work put in highlight a marked decreased expres-
sion level of all IL7R splicing variants studied during septic shock.
Persistence of lower expression on D3 was associated with higher
mortality. The quantification of the expression of IL7R could provide
an interesting biomarker to identify the most seriously ill patients
who could benefit from new immunotherapies.
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Introduction: Previously it was found in blood of septic patients a
high level of three phenylcarboxylic acids (PhCAs) - phenyllactic
(PLA), p-hydroxyphenyllactic (p-HPLA), p-hydroxyphenylacetic (p-HPAA).
These metabolites of aromatic acids have predominately microbial
origin in human body [1]. Experimentally demonstrated that PhCAs
affect the function of mitochondria [2]. It was shown prognostic
value of PhCAs at ICU admission [3]. In this study, we investigated
Critical Care 2016, Volume 20 Suppl 2 Page 22 of 182in different ICUs the relationship of disbalance of PhCAs with sever-
ity and mortality.
Methods: Blood samples (n = 147) were collected in two medical
centers from patients on the day of admission to ICU. Patients from
mixed ICU (M-ICU), n = 89, APACHE II 12 [8-16] were with docu-
mented infection of various localization, average age 58 (47-65)
years. Patients from surgical ICU (S-ICU), n = 58, APACHE II 8 [5-16])
were with intestine perforation (n = 35) and intestinal obstruction
(n = 23) after emergency surgery, the average age 64 (52-78) years.
Serum levels of PhCAs were measured using Gas-chromatography.
Healthy adult donors (n = 72) were used as a control [4]. Data were
compared by Mann–Whitney U-test, Chi-square test Pearson’s cor-
relation coefficient (IBM SPSS Statistics 22).
Results: It is noted that phenylpropionic acid (PPA) disappeared in
critical ill patients while always present in healthy. Levels of PLA, p-
HPLA and p-HPAA were significantly higher in critically ill patients of
both ICUs versus donors (p < 0,05). A positive correlation with total
serum levels of the 3 PhCAs and APACHE II were found (rM-ICU = 0.7
and rS-ICU = 0,8, p < 0.001). PLA and p-HPLA was significantly higher
in patients with arterial hypotension (MAP < 70 mm). Mortality was
31 % in ICUs. The total 3PhCAs serum level in died (n = 45) was
higher 6 times versus surviving (n = 102), p < 0,001. Area under the
prognostic ROC curve for APACHE II scale was 0,9 (p < 0,001), for ∑
3PhCAs 0,9 (p < 0,001), this confirms the high predictive value of ∑
3PhCAs.
Conclusions: We observed disbalance of aromatic acids metabolites
in critically ill patients. Absence of serum PPA and high level of PLA,
p-HPLA, p-HPAA are associated with severity and mortality. It is advis-
able intensify studies of the molecular mechanisms with participation
of PhCAs in critically state.
Supported by Russian Science Foundation Grant 115-15-00110.
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Introduction: We evaluated associations of copeptin levels with 10 year
mortality in otherwise healthy patients visiting their general practitioner
(GP) for a respiratory infection included in a previous trial (1).
Copeptin, the C-terminal part of the arginine vasopressin precursor
peptide, is secreted in response to stress and correlates with adverse
clinical outcomes in the acute-care hospital setting (2, 3). There are no
comprehensive data regarding its prognostic value in the community.
Methods: This is a secondary analysis including data from 359 patients
included in the PARTI trial. Copeptin was measured in batch-analysis on
admission and after 7 days. We calculated cox regression models and
area under the receiver operating characteristic curve (AUC) to assess
an association of copeptin with mortality. Mortality data were collected
through phone interviews 10 years after trial inclusion.
Results: After a median follow-up of 10.0 (interquartile range (IQR)
9.5-10.3) years, mortality was 9.8 %. Median admission copeptin
levels were significantly elevated in non-survivors compared to survi-
vors (13.8 pmol/l, IQR 5.9-27.8; vs. 6.3 pmol/l, IQR 4.1-11.5; p < 0.001),
Admission copeptin levels were associated with 10-year all-cause
mortality (age-adjusted hazard ratio 1.7 (95%CI, 1.2-2.5); p < 0.001,
AUC 0.68). Results were similar for discharge copeptin levels. Admis-
sion and day 7 copeptin levels were also strong predictors for ad-
verse outcome defined as death, pulmonary embolism and major
adverse cardiac and cerebrovascular events.
Conclusions: In a sample of otherwise healthy patients visiting their GP
for a respiratory infection, copeptin levels were strongly associatedwith 10-year all-cause mortality. In conjunction with traditional risk
factors, this marker may help to better direct preventive measures
in this population.
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Introduction: Sepsis is a systemic inflammatory response caused by
infection and leading cause of the death across the globe. Severity of
infection increase if untreated and lead to more lethal conditions,
such as severe sepsis and septic shock. There are several source of
infection for development of sepsis; however, half of the cases start
from lung and known as pneumonia. On the basis of infection site,
pneumonia can be categorised as community acquired pneumonia
(CAP) and hospital acquired pneumonia (HAP). To understand the re-
sponse of body under CAP and HAP, we compare the plasma prote-
ome of sepsis patients.
Methods: In the present study, we used quantitative proteomic ap-
proach (iTRAQ) to identify differential expression from survival and
non-survival septic patients secondary to CAP and HAP. In brief, the
plasma samples were depleted for high abundant proteins, trypsin
digested and labelled with iTRAQ 8plex system. The tryptic peptides
were separated by SCX chromatography and analysed with LC-MS.
The collected data processed and submitted to mascot search engine
with selection of swissprot database and 1 % FDR. The results from
mascot were further analysed by isobaric Q.
Results: The proteome profile unable us to indentify total 64 and 61
differentially expressed proteins in CAP and HAP survival patients,
while, 68 and 75 protein were identified in CAP and HAP non survival
patients. Total 26 proteins were common in survival patients,
whereas 38 and 35 proteins were specific for CAP and HAP, respect-
ively. Total 33 proteins were common in non survival patients, whereas
35 and 42 proteins were specific for CAP and HAP, respectively. On the
comparison of proteins across all groups, 21 proteins were common; 12
and 10 proteins were specific to CAP and HAP survival, while, 13 and
16 protein were unique to CAP and HAP non survival groups. These
proteins are key molecules for various biological functions including in-
flammatory response as well as signalling cascade like acute phase re-
sponse etc. The further analysis and validation is in progress.
Conclusions: This study provides the first molecular level evidence of
differential response in septic patients secondary to CAP and HAP.
The results show higher numbers of unique proteins to correspond-
ing groups. Underlying diseases, previous therapeutic interventions
and different etiology may underscore the differences observed at a
protein level.
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Critical Care 2016, Volume 20 Suppl 2 Page 23 of 182Introduction: Sepsis induced immunosuppression is an important
risk factor for unfavourable outcome in severe sepsis. The monocyte
HLA-DR expression (mHLA-DR) is suggested as a useful biomarker for
immunosuppression. In this prospective study of bacteremic sepsis
we aimed to; 1) assess the predictive value of mHLA-DR for second-
ary sepsis, and 2) compare mHLA-DR levels and dynamics of patients
with different bacteremic aetiology of sepsis.
Methods: Septic patients with positive blood cultures (n = 111), 1-2
days after admission, were included. Sampling was additionally pre-
formed on day 3, 7, 14, and 28. mHLA-DR was analysed by flow
cytometry, using a standardized protocol [1]. Data on events of sec-
ondary bacteraemic sepsis were collected retrospectively.
Results: Secondary sepsis occurred in 7 cases. The mHLA-DR levels
on day 1-2 were significantly lower for cases who developed second-
ary sepsis; median 8990 vs. 18200 AB/C (p = 0.009), AUC 0.798. The
negative predictive value (NPV) was 98 %, and the positive predictive
value (PPV) was 22 %. The three most prevalent pathogens demon-
strated differences in linear association over time, as shown in Fig. 6.
The mean mHLA-DR increased significantly to day 7 for [i]S.pneumo-
niae[/i]. A modest increase was seen for [i]S.aureus[/i].
Conclusions: In this clinical setting, a cut-off value of 12500 AB/C on
day 1-2 was associated with a high NPV for secondary sepsis. The
mHLA-DR levels were lower in patients who acquired secondary sepsis.
The aetiology of sepsis was associated with differences in mHLA-DR dy-
namics with the lowest initial values and greatest recovery demon-
strated for [i]S.pneumoniae[/i]
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Introduction: Upregulation of the expression of negative co-
stimulatory molecules on T-cells is one of the mechanisms behind
immunoparalysis in sepsis. We wanted to evaluate the prognostic
capacity of the soluble isoform of the negative co-stimulatory recep-
tor soluble B- and T-lymphocyte Attenuator (sBTLA) in severe sepsis
and septic shock.
Methods: A prospective observational study was conducted in the
mixed intensive care unit of Karolinska University Hospital, Huddinge,
Sweden. 101 patients with severe sepsis and septic shock (sepsiscohort) and 28 patients with non-infectious critical illness (ICU controls)
were included. 31 blood donors served as healthy controls. Blood sam-
ples taken on enrollment and at 24 and 48 hours were included in the
analysis. Plasma concentration of sBTLA was measured with Enzyme-
linked Immunosorbent Assay (ELISA). Patients were followed from inclu-
sion until day 28 or the day of death. Prognostic capacity of sBTLA was
evaluated on a categorical scale (the patients were divided into three
categories with the same number of subjects, based on the concentra-
tion of sBTLA) with Cox Regression and adjusted for age. Comparison
of plasma concentrations between survivors and non-survivors was
made with the Mann-Whitney U test.
Results: sBTLA levels were statistically significantly increased in the
sepsis cohort compared to ICU controls and blood donors. The over-
all 28 day mortality was 18 %. sBTLA levels were statistically signifi-
cantly higher at the time of study inclusion and until 48 hours in
28 day sepsis non-survivors than in survivors, and did not change
over time. 28 day mortality was 5-fold higher in patients with a base-
line plasma sBTLA > 21 ng/mL compared to those with a level lower
than 9 ng/mL (HR 5.0, 95 % CI 1.3-18, p = 0.02), but there was no in-
creased risk for death for patients with intermediate (10-21 ng/mL)
compared to low baseline sBTLA (HR 1.2, 95 % CI 0.2-5.8, p = 0.8).
Conclusions: Plasma concentrations of soluble BTLA were increased
in severe sepsis/septic shock compared to in patients with non-
infectious critical illness and healthy controls, and did not change
significantly over the first 48 hours after study inclusion. A baseline
sBTLA concentration >21 ng/mL was a negative prognostic indicator.
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Introduction: It is well recognised that coagulation is altered across
the sepsis spectrum (sepsis, severe sepsis and septic shock). This can
range from an increased thrombotic risk to disseminated intravascu-
lar coagulation (DIC) contributing to increased morbidity and mortal-
ity. Previous studies have attempted to investigate these changes in
coagulation using standard and global markers of coagulation [1];
however, clot microstructure has not been investigated. Recent re-
search has led to the development of a new biomarker of clot micro-
structure, Df, which quantifies the fibrin network of the incipient clot
[2]. This study aims to investigate the role of clot microstructure in sep-
sis, by using new quantitative biomarker of clot microstructure, Df.
Methods: This study had full ethical approval from the South West
Wales Research Ethics Committee. Patients with a diagnosis of sepsis
were recruited from the Emergency Department (ED) and Intensive
Care Unit (ICU) of a large teaching hospital in South Wales. Blood
samples were taken to determine Df, full blood count and standard
coagulation screen. A healthy control group matched for age and
gender was also recruited.
Results: 95 patients were included in the study: 49 with sepsis, 19 with
severe sepsis and 27 with septic shock. 44 healthy volunteers were re-
cruited as a matched control. Mean Df in the healthy control group
was 1.74 ± 0.03. Mean Df in patients with sepsis and severe sepsis was
significantly higher (1.78 ± 0.07 and 1.80 ± 0.05 respectively (p < 0.05,
One-way ANOVA Post-hoc Bonferroni correction)). Mean Df in patients
with septic shock was significantly lower compared to all other groups
(1.66 ± 0.10 (p < 0.001, One-way ANOVA Post-hoc Bonferroni correc-
tion)). Df was also significantly lower in non-survivors than survivors
at 28 days (1.66 ± 0.13 vs 1.76 ± 0.08, p = 0.006 (Students t-test)).
Conclusions: Our results indicate that patients with sepsis and severe
sepsis form tight highly branched fibrin clots (as indicated by high
Df). As the disease progresses to septic shock, much weaker clots are
formed (as indicated by low Df). This may help to explain the dichot-
omy of thrombogenicity and bleeding diathesis in patients across
the sepsis spectrum. The new functional biomarker, fractal dimension
(Df), therefore can be used to quantify clot microstructure across the
sepsis spectrum. It can also be used as an outcome measure, al-
though this study was not powered for outcome.
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Introduction: ROTEM is a viscoelastic test of coagulation, and has
been investigated as a tool for evaluating haemostasis in sepsis [1]. It
has been shown that a hypocoagulable viscoelastic profile is associ-
ated with poor outcomes in patients with severe sepsis [2]. ROTEM
measures several parameters that provide information on the kinetics
and structure of the developing clot. Clot microstructure (Df) on the
other hand evaluates a single parameter that quantifies microstruc-
tural properties of the clot. The aim of this study was to compare the
new biomarker, Df and ROTEM in patients across the sepsis spectrum
(sepsis, severe sepsis and septic shock).
Methods: This study had full ethical approval from the South West
Wales Research Ethics Committee. Patients with a diagnosis of sepsis
(SIRS with infection) were recruited from the Emergency Department
and Intensive Care Unit of a large teaching hospital in South Wales.
Blood samples were taken to determine Df, and ROTEM.
Results: 95 patients were included in the study: 49 with sepsis, 19
with severe sepsis and 27 with septic shock. 44 healthy volunteers
were recruited as a matched control. Df correlated significantly with
both structural and kinetic ROTEM parameters (p < 0.05), however
the correlations were weak (Pearson Correlation <0.4). The strongest
correlation was observed between Df and INTEM Clot Formation
Time (CFT), with a moderate correlation coefficient of -0.428. Df also
correlated significantly with ROTEM lysis parameters (LI45, LI60), but
these correlations were also weak.
Conclusions: Both Df and ROTEM appear to provide independent in-
formation about the coagulation system across the sepsis spectrum.
This could be due to the difference in the activation of the coagula-
tion pathway. Whereas whole unadulterated blood was used in de-
termining Df (immediately activated through contact after collection
of the sample), ROTEM utilises blood that is deactivated with sodium
citrate, and reactivated through tissue factor or contact activation.
This study concludes that ROTEM do not provide information about
the clot microstructure.
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Introduction: It is well recognised that coagulation is altered across
the sepsis spectrum (sepsis, severe sepsis and septic shock). Sepsis is
recognised to be a prothrombotic state, due to an increased pro-
coagulant activity and impairment of the natural anticoagulants and
fibrinolytic proteins [1]. Altered fibrinolysis could have a key role in
the accumulation of microthrombi leading to disseminated intravascu-
lar coagulation (DIC). The aim of this study was to assess the changes
in fibrinolysis across the sepsis spectrum using the Rotational Throm-
boelastometry (ROTEM) lysis index (LI60) and D-dimer concentration.
Methods: This study had full ethical approval from the South West
Wales Research Ethics Committee. Patients with a diagnosis of sepsis
were recruited from the Emergency Department and Intensive Care
Unit of a large teaching hospital in South Wales. Blood samples weretaken to determine ROTEM and D-Dimer concentration. Patients were
followed up for 28 days to assess 28-day mortality.
Results: 95 patients were included in the study: 49 with sepsis, 19 with
severe sepsis and 27 with septic shock. 44 healthy volunteers were re-
cruited as a matched control. D-Dimer concentration was 422 (297,
881) ng/mL in sepsis, 789 (374, 1586) ng/mL in severe sepsis and 3073
(765, 7279) ng/mL in septic shock (normal range <250 ng/mL). Median
EXTEM LI60 (%) in healthy volunteers was 92 (88.3, 94). ROTEM indi-
cated fibrinolytic function that was comparable to healthy volunteers in
the sepsis and severe sepsis groups (93 (90, 95) and 91 (87, 96) respect-
ively), but fibrinolytic function was significantly impaired in septic shock
compared to all other groups (97 (95, 98), p < 0.001, Kruskal-Wallis test
with Bonferroni correction). Impaired fibrinolytic function was also sig-
nificantly associated with mortality (INTEM LI60 of 94 (90.5, 96) in survi-
vors vs 96 (94.8, 96) in non-survivors, p = 0.006, Mann-Whitney U Test).
Conclusions: Fibrinolytic activity was increased in patients with sep-
tic shock. However there was an impairment of the fibrinolytic func-
tion as measured by ROTEM. The exact mechanisms leading to this
are not fully understood, however consumption of fibrinolytic factors
could contribute as evidenced by elevated D-Dimer concentration.
ROTEM lysis index (LI60) can potentially be used as a biomarker to
identify septic shock and as an outcome measure, although this study
was not powered for outcome.
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Introduction: The prediction of infection and its severity remains diffi-
cult in critically ill patients with suspected infection1. A novel, simple
biomarker derived from five blood-cell derived parameters that cha-
racterize the innate immune response in routine blood samples, the in-
tensive care infection score (ICIS), could be helpful in this respect 2,3.
We therefore compared the predictive value of the ICIS with that of the
white blood cell count (WBC), C-reactive protein (CRP) and procalcito-
nin (PCT) for infection and its severity in critically ill patients.
Methods: We performed a multi-center, cluster randomized, crossover
study in critically ill patients between January 2013 and September
2014. Patients with a suspected infection for which blood cultures were
taken by the attending intensivist were included. Blood was taken at
the same time for WBC, ICIS, CRP and PCT measurements in the study
periods. Patients were divided into groups of increasing likelihood of
infection and invasiveness: Group 1 without infection or with possible
infection irrespective of cultures, Group 2 with probable or microbio-
logically proven local infection without blood stream infection (BSI) and
Group 3 with BSI irrespective of local infection.
Results: In total, 301 patients were enrolled with 452 suspected in-
fection episodes (SIE), at more than 48 h intervals were analyzed.
CRP, PCT and ICIS were higher in Group 2 and 3 than 1. The AUROC
for the prediction of infection during the first SIE was 0.70 for CRP,
0.71 for PCT and 0.73 for ICIS (P < 0.001). For septic shock the AUROC
was 0.73 for CRP, 0.85 for PCT and 0.76 for ICIS.
Conclusions: The data suggest that the ICIS is useful for the predic-
tion of infection and its severity in critically ill patients. In contrast to
CRP and PCT, the ICIS can be determined routinely without extra
blood sampling or costs, yielding results within 15 minutes.
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Introduction: Distinguishing sepsis from infection-negative systemic
inflammation (SIRS) at admission based on clinical criteria poses a
diagnostic dilemma that can lead to delayed therapy or overly ag-
gressive treatment. This study quantified concordance of clinical im-
pressions of sepsis.
Methods: A prospective, observational study was conducted at an aca-
demic medical center and a community hospital in Utah. Adults admit-
ted to ICUs fulfilled SIRS criteria. The attending physician and a study
investigator classified patients at admission as sepsis, SIRS, or indeter-
minate. The reference diagnosis was determined through independent
review of all clinical data at discharge by two study physicians with ad-
judication by a third for discordant classifications. Inter-physician admis-
sion classifications at admission and discharge were compared.
Results: Of the 210 enrolled subjects, 58 (28 %) cases had at least one
physician classify the patient as indeterminate, and in 9 (4 %) there was
major disagreement with the classifications of SIRS and sepsis. At dis-
charge, in 46 (22 %) cases, at least one classification was indeterminate
and in 4 (2 %) there was major disagreement between classification of
SIRS and sepsis. When compared to discharge classification (Fig. 7), 142
(68 %) cases initially classed as SIRS or sepsis by the attending physician
remained unchanged. Of 89 patients initially diagnosed with sepsis on
admission, 66 (74 %) were deemed to be correct, 8 (9 %) were deemed
SIRS and 15 (17 %) indeterminate when compared to discharge classifi-
cation. Of the 40 (19 %) subjects indeterminate on admission, 12 (30 %)
remained so at discharge. 19 patients initially diagnosed with sepsis or
SIRS became indeterminate at discharge. One patient initially classed as
SIRS and 11 as indeterminate were ultimately discharged with a diag-
nosis of sepsis.
Conclusions: Considerable uncertainty exists with use of clinical criteria
for sepsis in ICU patients. Accurate tests that improve early diagnostic
accuracy are needed in the management of critically ill patients.Fig. 7 (Abstract P035). Classification of patients at admission and
revised at discharge.P036
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Introduction: Temperature measurement is an essential component
for decision making on intensive care both in the context of identify-
ing and treating sepsis and also in accurate calibration of blood gas
analysis. SpotOn™ a Zero Heat Flux Cutaneous thermometer has
been validated as a non-invasive, continuous and accurate method
of measuring temperature in patients undergoing cardiac surgery in
the operative and peri-operative period.1 We compared SpotOn™ with
Axilla thermometers, our current method of non-invasive temperature
monitoring, to establish how inaccurate our current practice was.
Methods: 25 acute patients were selected on admission to intensive
care at Lewisham Hospital, 17 male, 18 female, 16 medical and 9 sur-
gical. Temperatures were recorded for an average of 47 hours on
each patient using Covidien Fillac™ Axilla probes and SpotOn™ fore-
head probes as and when our current clinical practice indicated.
Results: A total of 435 comparative values were recorded over a
range of 34.4C to 38.5C. On average the SpotOn™ thermometer re-
corded temperatures 0.14C above the Axilla (95 % CI +/-0.04 with a
Wilcoxon matched-pairs signed rank test p < 0.0001). The average dif-
ference between SpotOn™ and Axilla over a normal range (36-37.4C)
was 0.07 (95 % CI +/- 0.04) p = 0.0028. The average difference between
SpotOn™ and Axilla at hypothermic temperatures (<36C) was -0.1
(95%CI +/-0.11 p = 0.13). The average difference between SpotOn™ and
Axilla at hyperthermic temperatures (> = 37.5C) was 0.53C (95%CI +/-
0.11 p < 0.0001). There were 12 occasions when the SpotOn™ therm-
ometer identified a SIRS defined temperature (<36 or > =38.3C) that
the Axilla temperature did not, affecting 10 of the 25 patients.
Conclusions: Zero Heat Flux Cutaneous thermometers have separ-
ately been shown to accurately record core temperatures. We have
highlighted that axilla probes are inaccurate in comparison to SpotOn™.
The Axilla probe appears to under-read at hyperthermic tempe-
ratures and over-read at hypothermic temperatures. The difference
between the two methods appears most marked at hyperthermic
temperatures.
As a consequence it is likely that axilla probes could fail to identify
sepsis in patients on intensive care.
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Introduction: AQ is based in the North West of England (population
9 M). The programme aims to improve sepsis care & clinical coding
within the region. In the first 12 months the care of over 9500 pa-
tients with infection was examined.
Methods: A panel of clinical experts developed a sepsis measure set
with the aid of BMJ evidence & identified a study population using
25 ICD10 sepsis codes. Patients with a sepsis code on discharge had
their initial care examined against a series of evidence-based inter-
ventions. An Appropriate Care Score (ACS) measured compliance
with the sepsis care measure set. The project is promoted by an on-
going series of collaborative events, where performance is published
& best practice is shared. A healthy sense of competition drives im-
provement in performance & commissioners are able to monitor per-
formance in their locality.
Results: Figure 8 shows the increase in ICD-10 coding in AQ partici-
pating trusts in the region vs Non AQ participating trusts. Figure 9
shows that at the start of the programme 23.6 % of septic patients
received antibiotics within 1 hour & in the last month this was up to
Critical Care 2016, Volume 20 Suppl 2 Page 26 of 18238.2 % of septic patients. ACSs have increased by 34 % when com-
paring the first 3 months & the last 3 months of the programme.
There is a downward trend in mortality when patients have achieved
all the measures within the measure set.
Conclusions: Use of the measure set and collaboration in the NW re-
gion of England appears to have improved early recognition & treat-
ment of patients with sepsis. Results have demonstrated improvements
in outcome measures, whilst recognising that improved coding & re-
cording of sepsis may change the studied population.Fig. 8 (Abstract P037).
Fig. 9 (Abstract P037). Graph showing monthly percentaghe of
septic patients who receive antibiotics within 1 hour of presentation.P038
Prehospital transport of acute septic patients
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Introduction: Sepsis is a systemic, potentially fatal host response to
infection, in which the speed and appropriateness of the therapy ad-
ministered in the initial hours are likely to influence outcome. Pa-
tients with sepsis are not always easily recognized prehospitally and
septic patients thus may be transported to hospital either on their
own accord, by ambulance or by physician assisted Mobile Emer-
gency Care Unit (MECU). We wanted to address to which degree the
type of transport from the prehospital scene and into the hospital is
related to severity of sepsis and 30 day mortality.
Methods: We included all adult patients (> = 15 years) presenting to
an emergency department between September 2010-August 2011
with a first-time admission of community-acquired sepsis of any se-
verity. Cases and type of transport to the hospital were identified by
manual chart review using predefined criteria.
Results: We included 1,713 patients. The median age was 72 years
(IQR 57-81) and 793 (46.3 %) were men. 621 patients (36.3 %) were
admitted with sepsis, 1,071 patients (62.5 %) with severe sepsis, and
21 patients (1.2 %) with septic shock.Among patients with sepsis, 390 (62.8 %, 95%CI 58.9-66.6 %) trans-
ported themselves, 197 (31.7 %, 95%CI 28.1-35.5 %) were transported
by ambulance, and 34 (5.5 %, 95%CI 3.8-7.7 %) by physician-assisted
ambulance (MECU). Their 30-day mortality was 6.2 %, 5.6 % and 8.8 %.
Among patients with severe sepsis, 673 (62.8 %, 95%CI 59.9-65.7 %)
transported themselves, 302 (28.2 %, 95%CI 25.5-31.0 %) were trans-
ported by ambulance and 96 (9.0 %, 95%CI 7.3-10.8 %) by the MECU.
Their 30-day mortality was 16.2 %, 23.2 %, and 22.9 %.
Among patients septic shock, 10 transported themselves (47.7 %,
95%CI 59.9-65.7 %), 7 (33.3 %, 95%CI 14.6-57.0 %) were transported
by ambulance, and 4 (19.0 %, 95%CI 5.4-41.9 %) by the MECU. Their
30-day mortality was 50.0 %, 12.5 %, and 37.5 %.
Conclusions: A substantial proportion of patients with sepsis arrive
to the hospital by themselves, but the proportion of patients with
ambulance or MECU transport increase by disease severity. This prob-
ably reflects the difficulty in diagnosing early sepsis.
P039
Vasodilatory plant extracts gel as an alternative treatment for
fever in critically ill patients
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Introduction: Fever is a sign that is commonly associated with syn-
dromes in intensive care. Hyperthermia is initiated by the action of
IL-1β at organum vasculosum laminae terminalis, where prostag-
landin E2 is released. Ortogel is a gel which contains plant extracts
(Capsicum, Arnica Montana, Symphytum Officinale, Juglans Regia,
Tannus Communis, Sambucus, Armoracia Rusticana, Lavandula Angu-
stifolia) with anti-inflammatory, analgesic and anti-pyretic effects,
producing cutaneous vasodilation. The purpose of this study was to
assess the anti-pyretic effects of Ortogel when compared to Acet-
aminophen administration in Intensive Care patients.
Methods: A randomized control trial was conducted in our Intensive
Care Unit of the Clinical Emergency Hospital in Bucharest from January
to June 2015. It included a total of 70 patients, divided in two equal
groups, suffering from fever of infectious cause (cutaneous temperature
of 38-39 degrees Celsius, measured using Nihon KOHDEN BSM 6000
monitor, in controlled room temperature). Hemodynamically unstable
patients were excluded. The study group received 30 ml gel (Ortogel)
with cutaneous administration while the control group received 1 g iv
acetaminophen. Primary outcomes were difference in cutaneous tem-
perature after 0.5, 1, 2 and 3 h from the baseline reading.
Results: Initially, the average temperature for the Ortogel group was
39.5 ± 0.11 degrees Celsius, with similar values in the control group
(39.0 ± 0.14). Ortogel was able to significantly decrease hyperthermia
at Δ T-max by 2.7 °C (p < 0.001), similar with paracetamol effects at Δ
T-max of 3.2 °C (p < 0.001). The gel showed significant suppression in
cutaneous temperature by 2.6 °C, from 39.5 ± 0.11 °C to 36.2 ± 0.32 °C
(p < 0.001), and the percentage inhibition of fever was 6.8 %. The anti-
pyretic effect started 45 min after administration (p < 0.01) and the re-
duction in rectal temperature was maintained for 3 h (p < 0.001).
Conclusions: The present study shows similar antipyretic effects of
Ortogel when compared to intravenous Acetaminophen. The antipyr-
etic effect installed in a similar time frame for the two groups. Orto-
gel may represent an alternative treatment provided for patients
with Acetaminophen contraindications.
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M. A. Wiewel1, M. B. Harmon1, L. A. Van Vught1, B. P. Scicluna1, A. J.
Hoogendijk1, J. Horn1, A. H. Zwinderman1, O. L. Cremer2, M. J. Bonten2,
M. J. Schultz1, T. Van der Poll1, N. P. Juffermans1, W. J. Wiersinga1
1Amsterdam Medical Center, Amsterdam, Netherlands; 2University
Medical Center Utrecht, Utrecht, Netherlands
Critical Care 2016, 20(Suppl 2):P040
Introduction: Hypothermia is associated with adverse outcome in pa-
tients with sepsis. Knowledge on the pathophysiology is highly limited.
Table 4 (Abstract P041).
Group I Group II Group III
No of patients 125 18 22
Age (yr) (mean ± SD) 56 ± 14 60 ± 16 44 ± 20
Female/Male (%) 25/75 37/63 33/67
First alert after admission (hr) (median) 5.65 10.23 4.26
SOFA (mean) 8.24 7.81 8.30
APACHE 2 (mean) 25.49 26.19 25.78
Mortality (%) 39.60 51.13 59.09
Critical Care 2016, Volume 20 Suppl 2 Page 27 of 182The objective of this study was to establish whether hypothermia was
associated with differences in the systemic host response to sepsis as
reflected by cytokine profile, endothelial activation markers and cellular
responsiveness towards lipopolysaccharide (LPS) during the first days
of intensive care unit (ICU) admission.
Methods: A prospective observational study in patients with sepsis
on ICUs of 2 tertiary hospitals in the Netherlands. Hypothermia was
defined as the lowest body temperature measurement below 36 °C
in the first 24 hours of ICU admission. Exclusion criteria were immu-
nodeficiency, active cooling, readmission or admission from operat-
ing theatre or other ICU. Logistic regression was used to investigate
the independent association of hypothermia with 90-day mortality.
Plasma levels of endothelial markers and cytokine levels were mea-
sured upon ICU admission and at days 2 and 4 thereafter in all
hypothermic and nonhypothermic patients with sepsis. Analyses
were performed in the entire cohort as well as a cohort matched for
disease severity. LPS ex vivo whole blood stimulation was performed
on day 1 of admission in a subset of patients.
Results: Hypothermia was identified in 186 of 525 patients and was
independently associated with increased mortality in multivariate
analysis. At baseline, patients with hypothermic sepsis were signifi-
cantly older, had a lower body mass index and increased incidence
of cardiovascular disease. Levels of pro- and anti-inflammatory cyto-
kines were not different between groups at all time points. Hypo-
thermia was also not associated with an altered response to ex vivo
stimulation with LPS in a subset of patients. Hypothermia was associ-
ated with sustained elevated levels of the endothelial activation
marker fractalkine during the first 4 days of ICU stay compared to
nonhypothermic patients in both the entire cohort and the cohort
matched for disease severity.
Conclusions: Hypothermic sepsis is associated with increased mortal-
ity. Patients with hypothermia showed increased levels of fractalkine,
irrespective of disease severity during the first 4 days of ICU stay.
This research was performed within the framework of CTMM, the
Center for Translational Molecular Medicine (http://www.ctmm.nl),
project MARS (grant 04I-201).
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Septic shock alert over SIRS criteria has an impact on outcome but
needs to be revised
G. Eren, Y. Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel
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Introduction: Clinical information systems(CIS) through protocol-
based alerts have long been used in intensive care units(ICU).They
can serve for early recognition and intervention of sepsis and septic
shock.We aimed to determine whether early response to “septic
shock alert” has any impact on the true diagnosis and patient out-
comes in septic shock.
Methods: 1384 patients admitted were reviewed over CIS(Metavision,
iMDsoft) in Bakirkoy Dr.Sadi Konuk.An early warning was protocolized
in the system relevant to international guidelines.Septic shock alert was
activated if the condition as per “> = 2 systemic inflamatory response
syndrome(SIRS) criteria together with SBP < 90 mmHg” was establish-
ed.Patients were categorized into 3 based on intervals between first
alert activation and initial response as per orders for diagnostics and in-
terventions. Group I assigned for “early acknowledgement and re-
sponse within 10 minutes after alert”, Group II as “response within 10-
60 minutes after” and Group III as “late response after >60 minutes”.
First acknowledgement of the alert, SOFA and APACHE 2 scores; and
patient outcomes were analysed.
Results: 165 patients recieved alert, however only 33 were diagnozed
with sepsis/septic shock on admission, on the other hand, later in
course of disease, 112 patients were confirmed to have sepsis. Group
I had the lowest mortality compared to others (Table 4).
Conclusions: CIS helps in early recognition and intervention of crit-
ical disease, thus has an impact in decreasing mortality.In order to
further decrease mortality, training is needed to increase compli-
ance to the alert systems.However, septic shock alert protocolized
over SIRS criteria seems to lead false positive diagnosis in one thirdof patients.This reveals the need for revising the sepsis and septic
shock definition.P042
Association between previous prescription of βblockers and
mortality rate among septic patients: A retrospective observational
study
S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi
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Introduction: Preclinical and clinical studies have investigated the
role of β -blockers in sepsis, especially in early sepsis, which charac-
terized by elevated sympathetic response. The purpose of this study
was to examine the association between a previous prescription for
β -blockers and mortality rate among septic patients.
Methods: We conducted a retrospective cohort study from January
1, 2003, to December 31, 2013, in a tertiary care academic medical
center. We included all patients admitted to the intensive care unit
(ICU) with severe sepsis and septic shock who were > =14 years of age.
Patients were defined to have a previous prescription of β -blockers
if the prescription was active for the 3 months prior to hospital
admission.
Results: We identified 4,629 patients with severe sepsis and septic
shock, 623 of whom had a previous prescription for β -blockers be-
fore hospital admission and 4006 of whom were not previously taking
β -blockers. Common medications used by patients were metoprolol
(77 %) and carvedilol (13 %). The overall mortality rate was 30 %.
Among patients who were previously taking β -blockers, 181 (29.1 %)
died in the ICU and 442 (70.9 %) were discharged alive. Of the patients
who did not have a previous prescription for β -blockers, 1,231 (30.7 %)
died in the ICU and 2,775 (69.3 %) were discharged alive. There was no
statistically significant association between patients having a previous
prescription for β -blockers and ICU mortality (risk ratio 0.94; 95 % con-
fidence interval [CI] 0.82 to 1.08; p = .39). We further stratified patients
on the basis of highest heart rate in the first 24 hours of ICU admission
into those with a heart rate >95 beats per minute and those with a
heart rate of < =95 beats per minute. There were no statistically signifi-
cant association between patients who had a previous prescription for
β -blockers and ICU mortality in either group (risk ratio 0.91; 95 % CI
0.77 to 1.06; p = 0.22) and (risk ratio 1.095; 95 % CI 0.78 to 0.1.54;
p = 0.60) respectively.
Conclusions: Our study demonstrated no significant association be-
tween previous prescription for β -blockers and ICU mortality. This
held true even after further stratification of patients on the basis of
highest heart rate in the first 24 hours of ICU admission. This result
may be due to lack of effect of β -blockers or short-term action of
medication use.
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Recognition and treatment of sepsis on labour ward– teaching &
information resources can improve knowledge
J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A.
Molokhia
Lewisham and Greenwich NHS Trust, London, UK
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Critical Care 2016, Volume 20 Suppl 2 Page 28 of 182Introduction: The UK Sepsis Trust aims to raise awareness of sepsis
and recommends an evidence based treatment bundle for severe
sepsis known as ‘The Sepsis Six’ [1, 2]. An audit was completed on
the Obstetric units of Lewisham and Greenwich NHS Trust, UK. We
wanted to assess the impact of teaching and posters on improving
knowledge.
Methods: We gave an anonymous questionnaire to maternity staff to
assess baseline knowledge. This tested respondent’s on the diagnos-
tic criteria for systemic inflammatory response syndrome (SIRS), sep-
sis, severe sepsis and their knowledge of the ‘Sepsis Six’ treatment
bundle for severe sepsis [1]. Our interventions consisted of 1:1 teach-
ing and the provision of an information poster. A re-audit was per-
formed in the same units a week later.
Results: We initially audited 33 maternity staff and re-audited 27.
Those re-audited reported that all staff had received 1:1 teaching
and 96 % had seen the leaflet or poster.
SIRS: Initially, 82 % had heard of SIRS, could name on average of only
1.5/6 criteria and only 58 % knew 2 criteria were needed for the
diagnosis. This improved to 100 %, 5.2/6 and 81 % respectively.
SEPSIS: 52 % could correctly define sepsis, only 3 % could define se-
vere sepsis with staff able to name on average only 0.8 of the severe
sepsis criteria. Their knowledge also improved to 70 %, 63 % and 2.4
respectively.
SEPSIS 6 MANAGEMENT: Staff knew 4.8/6 of the Sepsis Six steps for
management and 88 % knew it was required within an hour. There
was a slight improvement to 5.5/6 for management and a surprising
decrease in initiation of treatment to 85 %.
Conclusions: Our maternity staff were initially aware of SIRS and Sep-
sis and simple interventions required to diagnose and treat patients,
however their baseline knowledge of details in diagnosis and man-
agement was poor. We demonstrated that simple interventions such
as 1:1 teaching, a poster and readily available leaflet can dramatically
improve knowledge.
References
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Culture negative sepsis in the ICU – what is unique to this patient
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Introduction: There is paucity of data concerning the group of pa-
tients with a clinical syndrome of sepsis, suspected clinical infection
and negative cultures regarding disease severity, end organ failure
and outcomes. It is also not clear whether patients with only nega-
tive blood cultures (BCs) but other positive cultures have a different
disease entity than patients who have no growth in all of the cul-
tures taken. Our study attempts to further define true culture nega-
tivity and its effect on disease severity and outcomes.
Methods: All blood cultures results taken in the Detroit Medical Cen-
ter ICUs from December 2012 to March 2013 were collected. Any pa-
tient who had a negative BC was reviewed. All cultures taken within
10 days of the negative BCs were further reviewed. Patients were
then divided into 3 groups: 1.BC positive group- BCs within 10 days
of the negative BC were positive. 2. Non BC positive group - other
cultures within 10 days of the negative BC were positive. 3. All cul-
ture negative. The 3 groups were compared.
Results: During the study period, 300 patients had at least one nega-
tive blood culture. 132 had all cultures negative, 76 had positive BCs,
and 92 had other positive cultures. The BC positive group resembled
the negative group in all baseline characteristics. There was a signifi-
cant difference in the admission scores, with higher SOFA and APA-
CHE2 scores of the BC positive group. SOFA score was higher for the
positive group throughout the ICU stay. There was no difference inSIRS in both groups. However, there was more shock, need for vaso-
pressors, renal failure, respiratory failure and neurological alterations
in the BC positive group. The BC positive group was more frequently
started on antibiotics and had more antibiotic days then the negative
group. They also had worse outcomes with a higher mortality in the
ICU (40 % in the positive vs. 6.8 % in the negative, p < 0.0001) and
in the hospital (47.4 % vs. 9.9 % respectively, p < 0.0001). In a multi-
variate analysis of ICU death predictors, the only independent pre-
dictors were APACHE2 > 25 and positive BC group. Disease severity
was also worse in non-blood positive culture group when com-
pared with the negative group; scores were higher, there was more
end organ dysfunction, antibiotic treatment was longer and Out-
comes were worse.
Conclusions: We have shown that the culture negative patients have
lower disease severity, end organ failure and better outcomes, and
therefore should be considered for shorter antimicrobial treatments
and early de-escalation. Culture positivity indicate worse prognosis
even for non BCs.P045
Organ dysfunction in severe sepsis patients identified in
administrative data in Germany, 2007-2013
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Introduction: In administrative data, severe sepsis cases can be iden-
tified by different ICD code abstraction strategies. Comparing those
strategies, there is a substantial variability in incidence and mortal-
ity of severe sepsis depending on the codes used. To understand
which mechanisms depend the precision of case identification, we
aimed to investigate coding of organ dysfunction in patients with
severe sepsis hospitalized in Germany between 2007-2013 compar-
ing administrative coding with prospective data from a national co-
hort study.
Methods: Severe sepsis patients (>18 y) were identified in a nation-
wide database of hospital discharge data (DRG statistics) using ICD-
10 codes for I) sepsis + organ dysfunction (explicit coding strategy)
and II) infection + organ dysfunction (implicit coding strategy). Expli-
cit sepsis codes included 26 ICD-codes. Infection codes were adapted
from Angus et al. (2001, Crit Care Med). Organ dysfunctions were
identified by 27 organ failure codes. Septic shock was defined by
code R57.2, introduced in 2010. Comparative organ dysfunction data
was extracted from a German ICU cohort study (1).
Results: Between 2007-2013, we identified I) 941 957 severe sepsis
patients using explicit and II) 4 785 511 severe sepsis patients using
implicit coding strategies, including 18,2 % and 3,5 % of patients
with septic shock, respectively (112 787 patients 2010-2013). Respira-
tory failure was the leading organ dysfunction coded (56,4 % of ex-
plicitly vs. 59,6 % of implicitly identified cases). Renal failure was
identified more often when using explicit coding strategies (44,7 %
vs. 26,5 %). This was also true for coagulopathy (23,5 % vs. 12,5 %)
and metabolic alterations (13,1 vs. 6,1 %). Hypotension was coded in
18,7 % (explicit) and 5,1 % (implicit) of cases. Compared to a pro-
spective cohort of ICU patients with severe sepsis, distribution of
organ dysfunctions was similar to the one identified by explicit cod-
ing strategies (respiratory failure: 52 %, renal failure: 42,2 %, enceph-
alopathy: 27,7 %, coagulopathy: 22,2 %, metabolic acidosis: 17,8 %,
septic shock 50,8 %).
Conclusions: Pattern of organ dysfunctions in severe sepsis patients
differ depending on the coding strategy used. Hypotension and the
direct code for septic shock is coded in a similar percentage of pa-
tients, but in much fewer cases compared to a prospective cohort
study of ICU patients. The quality of organ dysfunction coding has
substantial influence on the accuracy of coding strategies for se-
vere sepsis in administrative data and therefore requires further
evaluation.
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Introduction: There were improvements in the knowledge about
sepsis care and also well-established guidelines. However, the mor-
bidity and mortality of septic patients remains unacceptably high.
Our objective is to evaluate the knowledge of residents in different
departments regarding the; Surviving Sepsis Campaign (SSC) 2012.
Methods: A cross-sectional descriptive study via a 15 question,
questionnaire which was distributed to residents in Songklnagarind
hospital, a-tertiary referral university teaching hospital in southern
Thailand. The interns as well as, the training residents in the Depart-
ment of Internal medicine, Surgery and Emergency medicine were in-
cluded in our study.
Results: The response rate was 136 (89 %) from 153 residents. The
residents included 46 (33 %) interns, 42 (30 %) internal medicine resi-
dents, 41 (30 %) surgical residents and 7 (5 %) emergency residents.
Regarding the definition of sepsis, severe sepsis and septic shock,
only 44 (32.3 %) residents were able to differentiate the severity of
sepsis. Internal medicine residents have a significantly higher rate of
correct answers than non-medicine and surgical residents (45.2 % vs.
26.6 %, P = 0.03 and 45.2 % vs. 12.2 %, P = 0.001). Only 77 (51 %) resi-
dents would measure blood lactate in sepsis patients, and there is
no difference in overall knowledge about lactate measurement and
interpretation between, internal medicine residents compared with
other residents. In fluid resuscitation, all residents (95.6 %) chose nor-
mal saline solution as their first choice. However, in respects to the
dose of fluid resuscitation, only 28 (20.5 %) residents gave the rec-
ommended fluid bolus (30 mL/kg) and internal medicine residents
had a higher percentage of correct answer than surgical residents
(28.6 % vs.7.32 %, P = 0.01). One hundred and fifteen (85 %) residents
and 123 (90 %) residents used appropriate target mean arterial pres-
sure and vasopressors, respectively. Most residents could give anti-
microbial agents (73.5 %) and steroid (93.4 %) appropriately in
patients with sepsis and septic shock. However, only half of the resi-
dents knew the target range of blood sugar control in sepsis pa-
tients, and internal medicine residents have a better knowledge than
the other residents
Conclusions: Our residents’ knowledge about SSC 2012 is not satisfac-
tory. Teaching couple with the learning process of sepsis management
should be further provided. Because, an improvement in knowledge
will surely decrease morbidity and mortality in sepsis patients.
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Effectiveness of a septic shock bundle to improve outcomes in the
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Introduction: The formation of the Surviving Sepsis Campaign in
2002 [1] led to the introduction of various sepsis management bun-
dles, with evidence of improved outcome [2]. In 2014 our ICU intro-
duced a quality improvement project to implement our septic shock
bundle, encompassing early central line insertion, dynamic fluid bo-
luses, mean arterial pressure >60 mmHg, measuring central venous
oxygen saturations, blood cultures and antibiotics. We aimed to in-
vestigate if the introduction of the bundle was associated with im-
proved patient outcomes.
Methods: A retrospective search of the WardWatcherTM database
identified patients admitted to our ICU with septic shock, from 2009-
2011 (Group 1) and after introduction of the quality improvement
bundle from 2014-2015 (Group 2). Patients with a significant under-
lying renal or vascular diagnosis were excluded. Acute physiology
and chronic health evaluation II scores (APACHE II) and outcome
measures including length of ICU stay, duration of cardiovascularsupport, need for renal replacement therapy (RRT) and ICU survival
were noted.
Results: A total of 171 patients were included; 88 patients in group 1
and 83 in group 2. Median compliance with all aspects of the bundle
was 60 % for group 2. Mortality was 43.6 % in group 1 compared to
38.6 % in group 2 (p = 0.64). Median APACHE II scores were similar
and duration of cardiovascular support was not significantly different
between the two groups. Length of ICU stay (median [interquartile
range]) was longer in group 2 at 6 days [3-12] compared to 3 [1-7]
(p < 0.001) however this significance was lost when non-survivors
were excluded. There was a significantly lower requirement for
RRT amongst ICU survivors in group 2 at 15.7 % compared to 34 %
(p = 0.0078).
Conclusions: We have shown a significant improvement in rate of
RRT associated with implementation of our sepsis resuscitation bun-
dle. Whilst implementation of care bundles has been associated with
improved patient outcome, the basis of this relationship remains un-
clear [2]. Our work fails to demonstrate a significant reduction in
mortality however we acknowledge the limitations of a small sample
size. Median bundle compliance is higher than in other published
work [2] however ongoing quality improvement work may increase
this further. We identified a longer length of stay in group 2. This
may represent either a longer period of treatment before deciding to
change the focus of care to palliation or a faster decline in patients
within group 1.
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Introduction: Vasopressor therapy is required to sustain life and main-
tain perfusion in the face of life-threatening hypotension occurring with
severe sepsis and septic shock, even when hypovolemia has not yet
been resolved. [1] We hypothesized that a dose of norepinephrine ad-
ministered in the first 24 hours correlates with the outcome of treat-
ment in patients with severe sepsis and septic shock.
Methods: We analysed a total of 632 consecutive patients with septic
shock (sepsis-induced hypotension persisting despite adequate fluid
resuscitation) from the EPOSS database (Data-based Evaluation and
Prediction of Outcome in Severe Sepsis), which was developed to
monitor and assess the treatment efficacy in patients with severe
sepsis and septic shock. Patients were admitted to participating in-
tensive care units (twelve hospitals – seventeen high-volume care
units) in the Czech Republic from 1st of January 2011 to 5th of No-
vember 2013. The patients were divided into two groups: survivors
(n = 316) and nonsurvivors (n = 316).
Results: The groups of survivors vs. nonsurvivors were similar in: age
66.0 (39.0; 84.0) vs. 68.0 (34.0;86.0) p = 0.162, men 184 (58.2 %) vs.
190 (60.1 %) p = 0.343, APACHE II score 26.0 (14.0; 39.0) vs. 28.0 (14.0;
40.0) p = 0.565 and the SOFA score 10.0 (4.0 – 16.0) vs. 10.0 (3.0 –
16.0) p = 0.912. Administration of the dose of 30 mL/kg of crystalloids
for hypotension or lactate 4 mmol/L (3 hours) and application of
vasopressors (6 hours) was performed in both groups, without statisti-
cally significant differences. Statistically significant differences between
survivors vs. nonsurvivors were found in the parameter “Dose of nor-
epinephrine in the first 24 hours”, 0.211 (0.022 - 1.104) vs. 0.333 (0.039 -
2.333), p < 0.001, OR (95 % IS) 2.009 (1.362; 2.965), p < 0.001
Conclusions: We found that a dose of norepinephrine affects the out-
come of human septic shock. Early administered and adequate dose of
vasopressors is an important predictor of survival, similarly to a suitable
initial fluid resuscitation and adequate antimicrobial therapy.
Fig. 10 (Abstract P050). MAP In The Two Groups.
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Introduction: Low-dose vasopressin (VP) recently emerged as a
promising therapy for septic shock[1]. The rationale for its use is the
relative VP deficiency in patients with septic shock and VP ability to
restore vascular tone and blood pressure, reducing the need for
cathecolamines[2]; however VP outcome effects in septic patients re-
main unclear[3-4].
Methods: We retrospectively analyzed patients admitted to our gen-
eral ICU for septic shock in the last 23 months (between 1/2014 and
11/2015) and treated with Norepinephrine (NE) or with the associ-
ation NE + VP.
Patients were treated with NE after adequate fluid expansion. VP was
added (0.02-0.03U/min) in case of MAP < 60 mmHg with NE dosage > =
0,4mcg/kg/min. We analyzed severity scores and plasma lactates at ICU
admission, mortality in ICU, urinary output during the first 24 hours of
vasopressor and need for RRT during ICU stay. Mann-Whitney and Chi-
Square tests were used for statistical analysis.
Results: 39 patients were enrolled, 15 patients received NE + VP (NV
group), 24 received NE (NE group). Overall mortality rate was 46.1 %:
53.3 % in NV and 42 % in NE group respectively (p = 0,47). The need
of RRT was greater in NV than in NE group (40vs20%, p = 0,19). Urin-
ary output in the first 24 hours of vasopressor was lower in NV group
(0,7vs1 ml/kg/h, p = 0,47). NV group patients had more severe
haemodynamic impairment and also worse severity score (SOFA =
11,8vs9,9; p = 0,03), worse renal function (AKIN 3vs2) at ICU admis-
sion and higher plasma lactates levels (3,9vs3,6; p = 0,39) NV group
had greater incidence of thrombocytopenia (105vs207, p = 0,03).
Conclusions: We didn’t find any statistically significant difference be-
tween NV and NE groups in ICU mortality, despite NV had a signifi-
cantly higher predicted mortality according to the SOFA. Renal
function impairment wasn’t significantly different in the two groups.
The greater incidence of thrombocytopenia (p = 0.03) observed in NV
group is in line with other studies.
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Introduction: Generalized vasodilation with nonresponding hypoten-
sion is present in half death cases due to septicaemia. Methylene
blue could be used as a valuable complement in refractory hypo-
tension treatment. The aim of this study was to determine the effect-
iveness of methylene blue as contributory treatment in patients with
septic shock
Methods: A controlled, randomized, double blinded, clinical trial was
performed. 60 patients were divided in two groups. A Group re-
ceived a single dose of methylene blue calculated 2 mg/kg per body
weight diluted in 100 cc of 5 % dextrose infused in 60 min. and CGroup, (control) received 100 cc of 5 % dextrose infused in 60 min.
Basal measurements of study variables were taken (MBP, lactate, base
deficit, central venous saturation and CO2 delta) prior blue methylene
administration and every hour afterwards, until MBP >65 mmHg with-
out vasopressor or 72 hours passed after shock began. Data about total
noradrenaline dose in mg, length of stay, mechanical ventilation length
and mortality was recorded
Results: MBP increased progressively first 6 hours after methylene
blue infusion in A Group 22 % and C Group 9.2 % (p:< 0.05), steadily
until 72 hour follow up. Noradrenaline dose decreased in the first
6 hours, on A Group an 86 %, C Group was 56 % (p:<0.05). Lactate
clearance first 6 hours was 62 % in A Group, in contrast with C Group
with 33 % clearance (p:<0.05). Mortality at ICU discharge on A Group
was 20.0 % and C Group was 36.6 % (p: <0.05) without variation at
21 days
Conclusions: Methylene blue is effective as contributory in septic
shock treatment.
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Introduction: Coagulation disorders are common in septic patients
and constitute a considerable diagnostic and therapeutic challenge
in the ICU. The excessive activation of coagulation involves consump-
tion of coagulation factors and platelets which may even lead to the
development of disseminated intravascular coagulation (DIC). In the
present study we investigated the usefulness of the thromboelasto-
metry method for bedside monitoring of coagulation abnormalities
in patients with DIC treated at the ICU.
Methods: In the observational study, patients with a diagnosis of se-
vere sepsis and overt DIC on admission to the ICU were included.
DIC was recognized using a scoring system based on the criteria pro-
posed by the International Society of Thrombosis and Hemostasis [1].
The results of thromboelastometry tests (ROTEM) performed on the
day of admission (day 1) and then daily for the next 3 days were
Critical Care 2016, Volume 20 Suppl 2 Page 31 of 182recorded. Clotting time (CT), clot formation time (CFT), maximum clot
firmness MCF), alpha angle, lysis index at 60 mi, and maximum lysis
index (ML) were measured in EXTEM and INTEM tests.
Results: Among 51 patients admitted with severe sepsis, 16 (31 %)
had a diagnosis of overt DIC. Out of 16 DIC patients, 5 patients died
(NS; DIC score 5 ± 0.4, 6 ± 1.0, 5 ± 0.0, and 6 ± 0.0 points on day 1, 2,
3, and 4 and 11 survived (S; DIC score 5 ± 0.4, 4 ± 1.2, 4 ± 2.1, and 3 ±
1.8 points). On admission, major coagulation abnormalities identified
by thromboelastometry, indicating a hypocoagulable pattern of ab-
normalities, were recorded for patients who did not survive: in-
creased CT (p = 0.005 in EXTEM; p = 0.51 in INTEM) and CFT (p = 0.02
in EXTEM; 0.05 in INTEM), a lower alpha angle (p = 0.008 in EXTEM;
p = 0.02 in INTEM), and decreased MCF (p = 0.03 in EXTEM; p = 0.31
in INTEM), in comparison to the results recorded for survivors. Differ-
ences in thromboelastometry parameters for groups of NS and S
were also observed on the 2nd, 3rd and 4th days. Fibrinolysis was
inhibited in nonsurvivors (LI 60 = 100 % and ML = 0 % in both EXTEM
and INTEM) during the entire time of observation.
Conclusions: Thromboelastometry used as a point-of-care assay
made it possible to accurately monitor patients with DIC. The pres-
ence of coagulation disorders indicated by thromboelastometry iden-
tifies a high-risk subpopulation of critically ill patients.
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Introduction: The frequency of early (within the first three days of
onset) sepsis-associated coagulopathy (SAC) and its association with
clinical outcomes varies depending on the definition(s) of coagulopa-
thy. Furthermore, the frequency of SAC may have decreased with
more effective use of sepsis bundles (early antibiotics, fluids, and va-
sopressors). Accordingly, we sought to determine the frequency and
outcome of early SAC.
Methods: We reviewed all patients admitted to the medical-surgical
ICU of St. Paul’s Hospital, a tertiary care hospital in Vancouver,
Canada from January 2011 to July 2013. We included patients who
met SAC inclusion criteria: sepsis and platelet count less than
150,000 (or a decrease of at least 30 %) and INR greater than 1.2
within the first three days of onset of sepsis. We assessed the pres-
ence and severity of SAC and the association of SAC with hospital
mortality and need for vasopressors, ventilation and renal replace-
ment therapy (RRT).
Results: Of 1,397 ICU admissions 517 had sepsis and of these, 373
(27 % of ICU admissions, 72 % of septic patients) had at least 1 INR
and platelet count at any point from day 1 to 3 of ICU admission. 20
to 35 % of septic patients met various criteria for SAC. Presence of
SAC at 12 hours or at 24 hours was associated with significantly in-
creased mortality (Odds Ratio (OR) = 2.3 & 1.94 at 12 and 24 hrs re-
spectively) and need for vasopressors (OR = 4.6 & 6.4), ventilation
(OR = 1.68 & 2.13) and RRT (OR = 1.71 & 2.94) in both unadjusted and
adjusted analyses. Increasing severity of the combination of abnor-
mal INR and platelets was associated with significantly higher mortal-
ity and greater need for vasopressors and RRT but not ventilation.
Increasingly abnormal INR was associated with increasing mortality in
a monotonic, increasing fashion whereas only severe thrombocyto-
penia (platelets (<80,000) was associated with significantly increased
mortality.
Conclusions: SAC is common (20 – 35 % of septic patients) and is as-
sociated with increased mortality and need for vasopressors, ventila-
tion and renal replacement therapy. Accordingly, there is a need for
therapies that decrease the severity of SAC to attempt to decrease
mortality and organ dysfunction in sepsis.P053
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Introduction: Hypercoagulability has been described both in cancer
patients and also in sepsis, leading to microcirculatory failure and
organ dysfunction in the latter. However, this is often overlooked by
standard coagulation tests (SCTs).The aim of this pilot study was to
compare hemostasis in cancer patients in the early stage of severe
sepsis/septic shock to cancer patients without sepsis
Methods: Adult patients operated for solid tumors (in the first 30 days
after surgery) admitted in the ICU with severe sepsis/septic shock
were included in the study group (SG). Patients scheduled for elect-
ive surgery due to intra-abdominal or pelvic malignancies were
included in the control group (CG). Exclusion criteria were: liver
diseases, chronic kidney failure, hematologic diseases, pregnancy,
chronic anticoagulant/antiplatelet therapy and blood derivates or
procoagulant treatments in the last 7 days. In both groups SCTs,
plasma levels of coagulation factors and rotation thromboelastome-
try (ROTEM®, Germany) were determined in the first 24-36 hours after
admission in the ICU (SG) and just before surgery in the CG. The fol-
lowing indices were calculated from the first derivative of the clot
firmness curve: Maximum Velocity (MaxVel), Time to Maximum Vel-
ocity of clot formation (t-MaxVel) and area under the curve (AUC) [1].
Results: After Ethics Committee approval, 32 patients in the SG and
26 patients in the CG were included. Patients in the SG had lower
platelet number (p = 0.001), prolonged SCTs (p < 0.001 for PT and
aPTT) and lower II,V, VII, X, protein C, S (p < 0.001) and antithrombin
III(p = 0.015) levels. In the SG, ROTEM showed delayed activation of
hemostasis, prolonged clotting times (p < 0.001) and increased t-
MaxVel (p = 0.001). But clot formation was similar in both groups
with non-significant differences in maximum clot firmness (MCF),
MaxVel and AUC. In the SG patients with APACHEII > =25 had higher
MCF (p = 0.026) and AUC (p = 0.003) as compared to patients with
APACHE < 25.
Conclusions: Our study showed that cancer patients with severe
sepsis/septic shock had similar hypercoagulability after a delayed clot
initiation as compared to cancer patients without sepsis, despite
thrombocytopenia and prolonged SCTs. These abnormalities were
only detected by dynamic hemostasis measurements but not with
SCTs. For firm conclusions the completion of this pilot study is
required.
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Introduction: DIC has a high prevalence among the critically ill, but a
specific diagnostic test is lacking. We aimed to assess whether ROTEM
is of additional value to discriminate patients with and without
DIC and whether it correlates with conventional and experimental
markers/tests of DIC.
Methods: In ICU patients with a coagulopathy (INR 1.5-3.0), DIC was
defined as a score of > = 5 points on the ISTH DIC score scale. Con-
comitantly with conventional coagulation tests (INR, aPTT, fibrinogen,
d-dimer and platelet count) ROTEM was performed. In addition,
levels of coagulation factors II, V and VII, antithrombin, protein C ac-
tivity and protein S were determined. Statistics by Mann Whitney
and Spearman’s rho.
Results: 23 patients were included of which 13 had overt DIC, the
majority was admitted to the ICU due to sepsis. Patients with DIC
Critical Care 2016, Volume 20 Suppl 2 Page 32 of 182had lower platelet count and lower levels of fibrinogen, factors II, VII
and VIII compared to patients without DIC. Endogenous anticoagu-
lants; antithrombin, protein C and S were also reduced in DIC pa-
tients. Thromboelastometry profiles were more hypocoagulable in
DIC patients compared to those without DIC: EXTEM CFT: 183 [142-
240] in DIC vs 72 [45-177] in non-DIC (p < 0.05), alpha: 60 [51-69] in
DIC vs 79 [66-81] in non-DIC(p < 0.01) and MCF: 49 [43-58] in DIC vs.
63 [58-73] in non-DIC patients (p < 0.05). ROTEM EXTEM variables in-
dicating hypocoagulability correlated with DIC scores and with low
levels of endogenous anticoagulants (Table 5).
Conclusions: In ICU patients with DIC, ROTEM showed hypocoagul-
able profiles and correlated with DIC score and low levels of en-
dogenous anticoagulants. Thereby, ROTEM may be a useful tool in
diagnosing DIC in the critically ill.Table 5 (Abstract P054). Correlation of EXTEM ROTEM with
coagulation tests/DIC markers.
CFT Alpha MCF
DIC score 0.731** -0.807** -0.705**
INR 0.159 -0.162 0.280
Platelet count -0.787** 0.755** 0.558**
Fibrinogen (g/L) -0.642** 0.648** 0.680**
Factor II (%) -0.527* 0.582** 0.497*
Antithrombin (%) -0.505* 0.497* 0.299
Protein C (%) -0.626** 0.631** 0.563*
Protein S (%) -0.390 0.468* 0.258
*p < 0.05,**p < 0.01
Fig. 11 (Abstract P056). NETs production under hypoxic condition.P055
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Introduction: A prior use of antiplatelet agents was associated with a
survival benefit in sepsis [1, 2]. But it remains unclear, if chronic anti-
platelet therapy should be continued or not during severe sepsis and
septic shock. In addition, the subsequent need of red blood cell
(RBC) transfusion in patients with continued chronic antiplatelet ther-
apy remains to be determined.
We hypothesized that the continuation of a preexisting antiplatelet
medication (aspirin, clopidogrel, dipyridamole) during sepsis therapy
reduces mortality rates of severe sepsis and septic shock without in-
creasing RBC transfusions.
Methods: We performed a retrospective, single-center cohort study
of intensive care (ICU) patients with severe sepsis or septic shock at
the University Hospital of Greifswald, Germany, from January 2010 to
December 2013. The local ethics committee approved the study
(Identifier: BB 133/10) and waived a written informed consent be-
cause of the anonymous data collection and the quality saving and
observing character of the study. The administration of antiplatelet
agents before and during ICU stay, the number of transfused RBC
concentrates and mortality rates up to 90 days were registered. Cat-
egorical data are represented as percentages and counts.
Results: Patients whose preexisting antiplatelet therapy was contin-
ued showed increased mortality rates in contrast to patients whose
medication was discontinued. The ICU mortality was significantly
reduced from 41.6 % (37/89) to 20.4 % (23/113)(OR 0.36; 95 % CI
0.19 – 0.67; p = 0.0013). The hospital mortality was as well reduced
from 51.7 % (46/89) to 25.7 % (29/113)(OR 0.32; 95 % CI 0.18 – 0.58;
p < 0.001). The mortality at 28 days was reduced from 46.1 % (41/89)
to 20.7 % (23/111)(OR 0.31; 95 % CI 0.17 – 0.57; p < 0.001). Theremarkable high mortality at 90 days was reduced from 63.6 % (56/
88) to 35.5 % (39/110)(OR 0.31; 95 % CI 0.18 – 0.56; p < 0.001).
The need of RBC transfusion was not affected by the administration
of antiplatelet agents (p > 0.05).
Conclusions: The continuation of a chronic antiplatelet therapy dur-
ing severe sepsis and septic shock was associated with an improved
ICU, hospital, 28- as well as 90-day mortality and did not increase the
need of transfusion in critical ill patients.
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Introduction: Neutrophil extracellular traps (NETs) are one of the im-
mune systems to suppress dissemination of infection by the netted
chromatin decorated with antibacterial molecules. We reported that
NETs were not observed in the abscess, but a lot of NETs appeared
after abscess drainage. Since closed wound area is known to be hyp-
oxic, we hypothesized that NETs production was affected by the con-
centration of oxygen.
Methods: Blood samples were obtained from healthy volunteers and
neutrophils were purified and stimulated with PMA. Incubation was
performed for 4 hours in a CO[sub]2[/sub] incubator or in a box with
oxygen scavenger. The specimens were stained with SYTOX Orange
and examined by immunohistochemistry. We counted the numbers
of NETs and analyzed its rate by Wilcoxon signed rank test.
Results: Five volunteers cooperated in this study. NETs were pro-
duced under both conditions. NETs amount decreased under hypoxia
in the four out of five cases and the average reduction rate was
57.8 % (Fig. 11), although it was not statistically significant (p = 0.13).
Conclusions: These results indicated that NETs production might de-
crease under low concentration of oxygen. Wound drainage may
promote NETs production by providing fresh oxygen to the infected
area. Further analysis has to be made to clarify the relations between
NETs production and oxygen.
Table 6 (Abstract P058). Frequency of source of infection depending







Respiratory 34 % 63 % 43 %
Abdominal 17 % 25 % 36 %
Genitourinary 26 % 7 % 12 %
Bones/soft tissue 6 % 9 % 7 %
Device related 8 % n.r. n.r.









2012 821 4.2 2.79 968
2013 1069 3.5 2.79 1203
2014 1158 2.4 2.79 1469
2015 1327 1.2 2.79 1692
Critical Care 2016, Volume 20 Suppl 2 Page 33 of 182P057
Impact of ultraviolet air sterilizer in intensive care unit room, and
clinical outcomes of patients
E. Gómez-Sánchez, M. Heredia-Rodríguez, E. Álvarez-Fuente, M. Lorenzo-
López, E. Gómez-Pesquera, M. Aragón-Camino, P. Liu-Zhu, A. Sánchez-
López, A. Hernández-Lozano, M. T. Peláez-Jareño, E. Tamayo
Hospital Clínico Universitario de Valladolid, Valladolid, Spain
Critical Care 2016, 20(Suppl 2):P057
Introduction: Scarce clinical trials have been conducted to evaluate
specifically the disinfectant activity of novel ultraviolet (UV) technol-
ogy in hospital rooms and intensive care units (ICUs). Our objective
was to evaluate the impact of an ultraviolet air sterilizer (UVAS) on
clinical outcomes of patients in the ICU.
Methods: Prospective, comparative, randomized, and non-interventional
study involving 1097 patients recovering in the ICU after cardiac surgery.
The UVAS (Medixair®) was placed in half of the ICU rooms; while the
remaining ones, identical to the others but without it, were used as
control.
Results: The number of patients presenting gram-positive cocci,
mainly S. aureus, was lower in patients with UVAS (12) than without
it (4). The incidence of sepsis was lower with UVAS (3.4 % versus
6.7 %). The 30-day in-hospital mortality rate was significantly lower in
patients with UVAS (3.8 %) than without it (6.4 %). Independent
factors associated with mortality were age (OR 1.046; 95 % CI
1.007–1.087), emergency surgery (OR 4.684, 95 % CI 2.107–10.415), and
the absence of the UVAS (OR 2.396; 95 % CI 1.132–5.074).
Conclusions: UV-C technology has demonstrated its effectiveness in
critical clinical variables of patients in the ICU, such as presence of S.
aureus in lungs, incidence of sepsis, or need of >48 hours of mechan-
ical ventilation. Moreover, the UVAS contributed to reduce the 30-
day mortality rate.
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Introduction: Administrative data is increasingly used in epidemio-
logical research, but needs to be validated for this purpose. We
therefore wanted to compare reported focus of infection in severe
sepsis between administrative data and prospective cohort studies
with chart review from Germany.
Methods: We identified hospital cases with severe sepsis between
2007-2013 from the “DRG-Statistik”, a database of nearly all German
inpatient cases, by the specific ICD-10 code R65.1 (sepsis with organ
dysfunction). Focus of infection was abstracted from documented
diagnoses for each case. For comparison data on focus of infection
was abstracted from a point prevalence study [1] and a prospective
cohort study [2] of severe sepsis in German ICU’s. Patients could have
more than one focus in all three groups.
Results: Relative frequency of the most important foci of infection is
reported in Table 6.Conclusions: There are striking differences in the reported foci of
infection depending on sampling techniques and method of data
abstraction. To improve the usefulness of administrative data for
epidemiological research, further evaluation is needed. The surpris-
ingly high incidence of device related severe sepsis warrants a
closer look.
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Introduction: CLABSI- a dreaded but preventable health care associ-
ated infection typically results in prolonged length of stay, morbidity,
mortality and economic burden both on the facility and the patient.
The aim post intervention was to achieve “Zero CLABSI” by imple-
menting simple evidence based practices using available standard
resources.
Methods: This Quasi experimental, interventional study enrolled pa-
tients (In house and Day Care) with Central Line devices in all units
of our 355 bedded hospital from Jan 2012 to Oct 2015. Data col-
lected prospectively by means of active surveillance (audits and HAI
tracking sheet) on practices pertaining to Central Lines showed fluc-
tuating CLABSI rates, above the NSHN benchmark 2.79 and conse-
quent Root Cause Analysis identified non conformities with standard
practices across all the units in the hospital. In response, a robust
program was devised and implemented in the month of Jan 2013,
targeting “Zero CLABSI”.
Results: see results
Conclusions: Achieving and sustaining “Zero CLABSI” is very challen-
ging in view of non modifiable risk factors of the population at risk
however strict compliance, continued surveillance and effective team
work will facilitate the journey to “Zero or Very Low CLABSI”.
References
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Fig. 12 (Abstract P059).
Fig. 13 (Abstract P062). Weighted estimates of practices and
attitudes reported by ICU doctors and nurses in high and middle
income countries, 2015.
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Introduction: Currently, CVC related BSIs are categorized as either
CRBSI or CLABSI. Both methods have major diagnostic limitations.
They both have low sensitivity, particularly among patients already
receiving antibiotics. Another limitation is the prolonged time that it
takes for diagnostic results to become available, which can adversely
impact therapy and clinical outcomes. Molecular techniques to diag-
nose CRBSI are less established. No study to date has attempted to
diagnose CVC related infections in septic ICU population using mo-
lecular techniques. Our study tested different molecular techniques
designed specifically to diagnose CVC associated infections and
compared them to standard CVC tip and blood cultures. We also
attempted a new culture method for CVC tips using saline vortexing.
Methods: ICU patients with a CVC suspected of having sepsis were
included. Blood was extracted for PCR and regular cultures. CVCs
were extracted and tips were cultured by the semiquantitive
method and also vortexed in saline which was subjected to PCR and
regular cultures. PCR was done both by Biofire commercial kit
(multiplex PCR) and by RT-PCR using unique primers targeting com-
mon ICU organisms. Organism load was quantified using threshold
cycle (Ct) with a cutoff of 35 used for a positive result. All methods
were compared.
Results: A total of 22 blood samples and CVC tips were tested. The
Biofire kit and the RT-PCR identified as positive 75 % of positive CVC
cultures.The Biofire kit failed to identify positive blood samples.The
RT-PCR identified 66 % of them. The Biofire kit did not identify false
positive samples. The RT-PCR had a false positive rate of 35 % of
negative CVC tips and 67 % of negative blood samples. Blood for
standard cultures was drawn prior to antibiotics in 41 % of patients,but almost all patients received antibiotics before blood was drawn
for PCR. CVC line tip vortex fluid cultures showed excellent concord-
ance with standard tip cultures.
Conclusions: These molecular systems show promise for rapid line
sepsis identification. False negativity is probably related to prior anti-
microbial treatment. The RT-PCR also had some false positivity pos-
sibly reflecting potential treatable organisms missed by standard
cultures. The commercial multiplex PCR kit showed lower sensitivity
than the RT-PCR.P062
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Introduction: Central line-associated bloodstream infection (CLABSI),
with a attributable mortality of 12 %-25%, is largely preventable.
Monitoring processes and outcomes and ensuring compliance with
clinical practice guidelines are important components of any inter-
vention aiming at prevention. We documented attitudes and prac-
tices in intensive care units in 2015 in order to assess compliance
with CLABSI prevention guidelines.
Methods: Between June and October 2015, we disseminated an on-
line questionnaire, available in 10 languages, to medical doctors and
nurses working in ICUs through national and international ICU soci-
eties. We investigated clinical practices related to central line (CL) in-
sertion, maintenance and measurement of CLABSI-related data.
Countries were categorized as high, middle, or low income according
to World Bank definitions. We computed weighted estimates (%
and standard error, SE) for countries providing at least 10 complete
responses.
Results: 3,407 complete questionnaires were received from 99 coun-
tries. Selected results for 13 middle and 27 high-income countries
are presented in Table 1. All low income countries provided less than
10 completed responses.
Conclusions: Adherence to international guidelines need to be rein-
forced at ICU level. Priorities in middle income countries should
focus on improving 1) full barrier precautions and 2) using chlor-
hexidine >0.5 % for skin preparation. Reduction of device exposure
through daily assessment of CL need remains a priority in both set-
tings. Almost all respondents consider measurement of CLABSI key
to quality improvement, however less than a quarter actually report
their CLABSI rate. Our study was limited by a non-random sample of
ICU doctors and nurses.
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Introduction: Central venous catheters (CVCs) are widely used in in-
tensive care but increase the incidence of adverse events, especially
catheter-related blood stream infections (CRBSIs). Coagulase-negative
staphylococci, such as S. epidermidis and Staphylococcus aureus,
are the most frequent cause of CRBSIs. These bacteria grow be-
cause a biofilm has developed. The inhibition of bacterial growth
by antimicrobial catheters helps to prevent surface colonization
and improve safety. Certofix® Protect is the third generation of
CVC, with non-leaching additives and antimicrobial activity from
the catheter tip to the connectors.
Methods: The antimicrobial performance (30 days) of non-leaching
anti-microbial CVCs on 7 typical CVC-associated infection bacteria
was tested with the “Roll-Out” method (Staphylococcus epidermidis,
Staphylococcus aureus MRSA and E. coli, Enterococcus faecalis,
Pseudomonas aerugionosa, Klebsiella pneumoniae and Candida albi-
cans). After inoculation, washing, incubation at 37 °C, immersion in a
minimum medium solution, and a second washing process, the cath-
eter sample was placed on an agar plate and rolled 3 times over the
agar plate to transfer surface bound bacteria to the agar medium.
After overnight incubation (37 °C), bacterial growth was recorded by
photography.
Results: The present in-vitro data demonstrate that non-leaching
antimicrobial CVCs (e.g. Certofix® Protect, B.BRAUN) exhibit antimicro-
bial efficacy and prevent biofilm formation from gram-positive,
gram-negative bacteria and fungi for up to 30 days. The study was
performed in direct comparison with a non-antimicrobial control
catheter, on which all 7 test strains were able to grow to an estab-
lished surface biofilm.
Conclusions: This is the first in-vitro study to demonstrate antibac-
terial surface activity and prevention of biofilm formation with anti-
microbial, non-leaching CVCs by using the “Roll-Out” method over a
period of 30 days. These results demonstrate that non-leaching anti-
microbial CVCs can prevent microbial colonization and infection.
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Introduction: Urinary tract infections are common problems in pa-
tients in ICU with increased mortality, costs and hospitalization. The
best way to treat urinary tract infections is to prevent them. The
mechanism of action for preventing bacterial adhesion for noble
metal alloy-coated urinary catheter is the generation of a galvanic ef-
fect. The aim of this study was to evaluate the benefits of noble
metal coated-catheter compared to silicone Foley catheter in patients
admitted to our Toxicology-Intensive Care Unit for drug poisoning,
with short-term catheterization.
Methods: We enrolled 120 patients which were randomly assigned
to one of the two groups: one group received noble metal alloy-
coated catheter (Group 1) and the other one received silicon Foley
catheter (Group 2). We excluded all patients with urinary tract pre-
contamination. Urine full examination and urine culture was taken at
admission and on day 3 of catheterization.
Results: The incidence of bacteriuria was 2 % with the noble metal
alloy-coated catheter and 6.6 % with the silicone catheter (p < 0.05)
after a mean period of 3 days’ catheterization time. Age over 65 years
(odds ratio 6.08) was significant risk factors for bacteriuria. The Gram
negative bacteria of Escherichia coli and Klebsiella pneumoniae werethe most uropathogenic bacteria. We observed significant association
between urinary tract infection caused by Escherichia coli and female
gender (p < 0.05).
Conclusions: Noble metal alloy-coated catheters may decrease the
incidence of urinary tract infections compared with silicon ones
and in the meantime may lower the need for antibiotics. Also, we
noticed that the incidence of bacteriuria increased with age in
both groups, but remained lower in noble metal alloy-coated cath-
eter group.P065
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Introduction: Urinary tract infection (UTI) is one of the most common
source of bacteremia in community setting. Predicting risk of
bacteremia can help the clinicians determine the appropriate site of
care and therapy. Previous studies were performed on factors associ-
ated with bacteremia, however, produced inconclusive results. The
aim of this study was to evaluate clinical characteristics to predict
bacteremia in community acquired UTI.
Methods: This prospective observational study was conducted at
Nakhonpathom hospital, a 670-bed tertiary care hospital in Thailand
during December 2014 and August 2015. Inclusion criteria were age
[>=] 18 years, fever, at least 1 symptom of UTI (dysuria, frequent or
urgent urination, flank pain or costovertebral tenderness) and pyuria
(defined by a presence of [>=] 5 WBC per high power field in a cen-
trifuged sediment). Patients were excluded if they: (1) had healthcare
associated infection; (2) had taken antibiotics during 72 h prior to
hospitalization; (3) presented with severe sepsis/septic shock. Clinical
factors associated with bacteremia were determined.
Results: There were 106 patients. The mean [SD] age was 44 [17]
years and 93 % were female. Twenty-two patients (20.8 %) had dia-
betes melliutus, while 9 (8.5 %) and 4 (3.7 %) had stone and struc-
tural abnormality of urinary system, respectively. Bacteremia was
found in 16 patients (15 %). [i]E.coli[/i] was the most common organ-
ism (13 cases), followed by MSSA (2 cases) and [i]Proteus mirabilis[/i]
(1 case). Surprisingly, 6 of 13 isolates (46.2 %) of [i]E.coli[/i] were ESBL
producer. Patients who had bacteremia were more likely to have
older age (mean [SD] age, 54.0 [12.6] vs 42.3 [16.9] years, p 0.004),
diabetes mellitus (40 % vs 16 %, p 0.04), chill (100 % vs 61 %, p 0.01),
higher body temperature (mean [SD] temperature, 101.3 [33.6] vs
100.0 [34.0] F, p 0.04), BUN/Cr ratio [>=] 16 (67 % vs 41 %, p 0.07)
and CRP [>=] 20 mg/L (92 % vs 61 %, p 0.05). Multivariate analysis of
factors with p < 0.1 in univariate analysis showed that BUN/Cr ratio
[>=] 16 (OR 4.5, 95%CI 1.1-18.7, p 0.04) and CRP [>=] 20 mg/L (OR
10.8, 95%CI 1.3-93.4, p 0.03) were associated with bacteremia.
Conclusions: BUN/Cr ratio and CRP level can be used to guide the
probability of bacteremia in community acquired UTI.
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Introduction: The aim of study was to analyze characteristics of
monobacteremia caused by Acinetobacter spp. and associating fac-
tors with mortality in surgical and medical intensive care units.





Number of cases 10 12
Number of organ failure (mean) 3.5 3.0
Invasive mechanical ventilation 90% 83.3%
Cardiovascular support 90% 100%
Renal replacement therapy 20% None
Length of stay in ICU in hours (median) 311 205.5
Length of stay in Hospital in hours (median) 869 480
APACHE II scores (median) 18.5 9
Probability of mortality (median) 25% 8%
Observed mortality 20% 16.6%
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cal and medical intensive care units with positive blood culture for
Gram-negative rod during 2005-2012 years was carried out.
Results: There were found 430 cases of Gram-negative rod monobac-
teremia, 77 (17.9 %) of them caused by Acinetobacter spp. There was
no difference in gender, age, comorbidities, source of bacteremia,
length of stay in intensive care unit for Acinetobacter spp. bac-
teremia (P > 0.05). Primary bacteremia was associated with surgical
procedures (OR = 4.677, P = 0.03) and previously treatment in other
hospital departments (OR = 1.02, P = 0.04). Acinetobacter spp. strain
was associated with high resistance to antibiotics (P > 0.05), as: cefo-
taxim (n = 75, 97,4 %), ampicillin (n = 74, 96.1 %), cefuroxim and cef-
tazidim (n = 66, 85.7 %), gentamicin (n = 65, 84.4 %), piperacillin (n =
65, 84.4 %), piperacillin with tazobactam (n = 62, 80.5 %), ciprofloxa-
cin (n = 59, 76.6 %), amikacin (n = 41, 53.2 %), ampicillin with sulbac-
tam (n = 33, 42.9 %). The low resistance to carbapenems (n = 6,
7.8 %, P = 0.03) was estimated. Acinetobacter spp. strains were found
to be mostly multi-drug-resistant, as resistant to > = 3 classes of anti-
biotics (n = 74, 96.1 %, P = 0.02), especially in postoperative patients
(n = 37, 92.5 %, OR = 4.042, P = 0.04) and previously treated in other
hospital departments (n = 41, 100 %, OR = 4.701, P = 0.03). Overall
mortality rate of Acinetobacter spp. bacteremia was 84.4 %. Lethal
outcome was associated with mechanical ventilation (n = 65, 100 %,
OR = 4.105, P = 0.05), multi-drug-resistant strain (n = 64, 98,5 %, OR =
1.182, P = 0.013), elderly (n = 36, 90 %, OR = 1.662, P = 0.016), resist-
ance to cefalosporins (n = 57, 86.4 %, OR = 2.367, P = 0.04), and alco-
hol abuse (n = 9, 81.8 %, OR = 3.926, P = 0.05).
Conclusions: Acinetobacter spp. monobacteremia usually appears as
caused by multi-drug-resistant > = 3 classes of antibiotics strain, but
with low resistance to carbapenems, especially in postoperative pa-
tients and previously treated in other hospital departments. It has ex-
tremely high overall mortality rate. Mortality was associated with
elderly, alcohol abuse, multi-drug-resistant strain and resistance to
cefalosporins also mechanical ventilation.
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Introduction: To describe the incidence, clinical features and outcome
of Group A and Group B streptococcal infections in our Intensive Care
Unit (ICU).
Methods: Retrospective analysis was conducted on all patients
admitted to ICU with Group A and Group B streptococcal infec-
tion from 2012 to 2015. Demographic and clinical information
were obtained from the Intensive Care National Audit & Research
Centre data.
Results: 22 cases were identified accounting for 0.8 % of all admis-
sions in our unit. The pathogen was mainly isolated from soft tissue
wounds and sputum. Median age of cases was 50 years. Organ sup-
port was as defined in the UK CCMDS [1] (Critical Care Minimum
Dataset definitions). The table lists the number of patients with re-
spiratory, cardiovascular and renal support, data on length of stay,
illness severity as assessed by APACHE 2 score [2] and mortality
rates.
Conclusions: Both Group A and Group B streptococcal infections
were associated with significant morbidity and mortality. The APA-
CHE 2 score appeared to predict the mortality reliably in patients
with Group A Streptococcal infections. In patients with Group B
Streptococcal infections however observed mortality was significantly
higher than the predicted mortality from the APACHE 2 score. ICU
and hospital length of stay were broadly comparable for those of the
general ICU population over that period (means 216 and 648 hours
respectively).
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Introduction: The diagnosis of spontaneous bacterial peritonitis (SBP)
is usually investigated by cytobacteriologic analysis.we purpose to
evaluate the effectiveness of the urinary strips URITOP + TM for rapid
diagnosis of SBP and emphasize the utility of inoculation of blood
culture bottles withascitic fluid for an accurate identification of
bacteria.
Methods: Our study included 44 patients with cirrhosis and tense as-
cites. Immediately, after paracentesis a urine test strips was per-
formed searching visually the presence of leukocytes and nit-
rites on the ascitic fluid. The reaction between this fluid and the
strip induced a color change. The color of the leukocyte reagent
area was then compared with the color chart of the bottle and the
result was scored in function of the number of crosses. Besides bio-
chemical and bacteriological analysis of the ascitic fluid was done
including bedside inoculation of five millimeters of this fluid into
aerobic and anaerobic blood culture bottles. Cultures of blood were
also obtained from all patients.
Results: SBP was diagnosed in 11 of the 44 samples. URITOP + TM
test was positive in 8 cases. The reading of leukocytes strips revealed
one cross, two crosses and three crosses in 15,4 %, 30,8 % and
15,4 % respectively. Nitrites were present in 69,5 % of cases. Blood
and ascitic inoculation were positive in 46,2 % and 53,8 % res-
pectively. The major bacteria isolated were gram-negative bacilli. We
found a significant correlation between SBP and visual detection of
white cells and nitrites (p < 10-3 for both parameters). A significant
correlation was also found between SBP and both ascitic (p = 0,02)
and blood (p = 0,006) inoculation. Both visual detection of leukocytes
and asitic inoculation in blood culture bottles had a sensibility and a
specificity of 100 %.
Conclusions: Our study showed that URITOP + TM is a rapid and ef-
fective method in the early diagnosis of SBP. Besides the inoculation of
blood culture bottles with ascitic fluid improves the detection of SBP
and ameliorate consequently the prognosis.
P069
Increased risk of cellulitis in patients with congestive heart failure:
a population based cohort study
J. Chen
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi
County, Taiwan
Critical Care 2016, 20(Suppl 2):P069
Introduction: Although it is well known that lymphedema of limbs
is associated with higher possibility of developing cellulitis, the
Critical Care 2016, Volume 20 Suppl 2 Page 37 of 182relation between congestive heart failure and cellulitis has never
been established.
We investigated the risks of cellulitis in patients hospitalized with
congestive heart failure in Taiwan to evaluate whether the risk is
higher compared to the general population.
Methods: The data from one million National Health Insurance (NHI)
beneficiaries were utilized. All adult beneficiaries were followed
from January 1, 2005 until December 31, 2012 to identify those
who developed cellulitis. Cox regression models were applied to
compare the hazards between patients with congestive heart
failure and the unexposed group after controlling for selected
covariates.
Results: We identified 4,842 patients hospitalized with congestive
heart failure and 748,701 patients without congestive heart failure.
After controlling for age, gender, urbanization level, socioeconomic
status, diabetes, hypertension, hyperlipidemia, malignancies, liver cir-
rhosis, atrial fibrillation, smoking, obesity, peripheral artery disease
and Charlson Comorbidity Index score, the adjusted hazard ratio was
1.65 (95 % confidence interval, 1.49¡X1.82) in patients with congestive
heart failure.
Conclusions: Congestive heart failure may be associated with in-
creased risk of cellulitis.
P070
Outcomes of severe cellulitis and necrotizing fasciitis in the
critically ill
D. R. Cranendonk1, L. A. Van Vught2, M. A. Wiewel2, O. L. Cremer3, J.
Horn4, M. J. Bonten5, M. J. Schultz4, T. Van der Poll2, W. J. Wiersinga2
1Academic Medical Center, University of Amsterdam, Amsterdam,
Netherlands; 2Academic Medical Center, University of Amsterdam,
Center for Experimental and Molecular Medicine, Amsterdam,
Netherlands; 3Department of Intensive Care Medicine, University Medical
Center Utrecht, Utrecht, Netherlands; 4Academic Medical Center,
University of Amsterdam, Department of Intensive Care Medicine,
Amsterdam, Netherlands; 5University Medical Center Utrecht, Dept. of
Medical Microbiology, Utrecht, Netherlands
Critical Care 2016, 20(Suppl 2):P070
Introduction: The skin is a common site of infection in intensive care
units (ICU’s). However, in contrast to necrotizing fasciitis (NF), limited
clinical data is available for severe cellulitis in the critically ill. The ob-
jective of this study was to describe the clinical presentation of pa-
tients admitted to the ICU for severe cellulitis, as compared to
patients with NF.
Methods: A prospective observational cohort study included all con-
secutive patients admitted to two tertiary ICU’s between January
2011 and January 2014. From this cohort, patients with possible,
probable or definite sepsis diagnosed within 24 h were selected. ICU
readmissions during the same hospital admissions and readmissions
within 30 days of the first hospital admission were excluded. Using
set criteria, sepsis admissions attributed to cellulitis or soft tissue in-
fections were retrospectively recategorized by an independent re-
searcher as admissions for NF, severe (i.e. ICU necessitating) cellulitis, or
another primary diagnosis but where cellulitis was present as a
comorbidity.
Results: Among 2562 ICU sepsis admissions, 31 (1.2 %) patients were
admitted for NF and 23 (0.9 %) for severe cellulitis. Cellulitis was diag-
nosed as a comorbidity in another 25 patients. Comparing severe cellu-
litis to NF, there were no differences in age, BMI, concurrent infections
or length of hospital stay prior to ICU admission. Patients with severe
cellulitis had lower rates of shock (30 % vs 61 %, p = 0.03) and need for
mechanical ventilation within 24 h after admission (52 % vs 94 %, p =
0.003), but had more chronic comorbidities (87 % vs 55 %, p = 0.02), es-
pecially of cardiovascular origin (44 % vs 13 %, p = 0.01). With causative
agents identified in 78 % of severe cellulitis patients, S. aureus was the
dominant organism (present in 44 %), while 44 % had a Gram-negative
infection and 26 % a polymicrobial infection. S. pyogenes was the pri-
mary organism in NF (61.3 %). Length of ICU stay was shorter for severe
cellulitis patients (3 [2-5] vs 5 [3-11] days, p = 0.01). Hospital- and
90 day mortality were similar in the two groups (26.1 % vs 22.6 %,
p > .99; 30.4 % vs 22.6 %, p = 0.54 respectively).Conclusions: Although patients with severe cellulitis were less critically
ill on ICU admission, when compared to patients with necrotizing fasci-
itis their mortality rates appear similar. This study is limited by
the relatively small sample size and retrospective diagnosis
recategorization.P071
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Introduction: Botulism is a rare paralytic illness caused by the action
of a potent neurotropic exotoxin produced by Clostridium bo-
tulinum. C. botulinum species produce seven serologically distinct
toxins, A-G. Human botulism is primarily caused by toxin types A, B
or E. In Europe, most wound botulism is now associated with inject-
able drug use. Symptoms are of descending paralysis, bulbar palsies
and respiratory failure.
Methods: This is a review of the clinical, microbiological and public
health aspects of an outbreak of botulism in Scotland from Decem-
ber 2014 to June 2015. Data was collected via prospective patient
interview and clinical data collation.
Results: 47 cases of wound botulism were reported: 23 probable, 17
confirmed, 5 discounted and two remain possible; Median age 42,
range 24-55 years, 65 % were male. 98 % of cases presented with
bulbar palsy but very few with descending limb weakness. 52 % of
patients required surgical drainage of wound-related abscesses and
65 % required mechanical ventilation. All patients received 3-doses
of trivalent anti-botulinum toxin therapy within 24 hours of clinical
diagnosis.
The diagnosis was microbiologically confirmed in 17 cases due to
presence of C. botulinum type B neurotoxin detected by molecular
assay in tissues and/or by serum bioassay. The C. botulinum strains
from 10 cases showed a common profile on fAFLP typing, thereby
confirming a link to a common source. All had a recent history of
injecting heroin which was obtained either in, or sourced, via Glasgow.
The source of infection remains unconfirmed but is thought to be due
to contaminated heroin, or cutting agent. There were four deaths, botu-
lism contributing to two.
Police Scotland was closely involved in risk management through in-
creased drug seizures throughout the region, reducing the supply of
potentially ‘contaminated’ heroin. Public health measures in-
cluded; risk communication via distributing postcards widely to
PWIDs via drug agencies and needle exchange centres to increase
awareness of signs and symptoms, advising smoking drugs as an al-
ternative form of administration and the avoidance of muscle
popping.
Conclusions: This is the largest outbreak of botulism among PWIDs
in Europe. Prompt identification of cases and appropriate clinical
management resulted in low mortality amongst the cases. Inter-
disciplinary cooperation was integral in management of the outbreak.P072
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Introduction: Extended-spectrum-beta-lactamase-producing Entero-
bacteriaceae (ESBL-E) strains are considered to be important, since
few antibiotics currently remain active against these bacteria. How-
ever, the implications associated with the surveillance of fecal carriers
of ESBL-E among ICU patients are unclear. The aim of this study was
to determine the efficacy of carrying out stool screening for ESBL-E.
Critical Care 2016, Volume 20 Suppl 2 Page 38 of 182Methods: We conducted a retrospective cohort study in the ICU of
Fukuoka University Hospital from April 2013 to September 2014. The
occurrence of infections or colonization with ESBL-E, the antimicro-
bial use density (AUD) values, and the clinical outcome were investi-
gated for the described periods, and those parameters were
compared between April-December 2013 (phase 1) and January-
September 2014 (phase 2). Moreover, we routinely performed stool
cultures for ESBL-E in phase 2.
Results: Of the 1,245 patients who were admitted to our ICU during
the study period, we identified 670 patients (phase 1) and 575 pa-
tients (phase 2) respectively. The rates of patients either infected or
colonized with ESBL-E were significantly higher in phase 2 than
phase 1 (3 % versus 12.3 %, p < 0.05). However, the AUD values for
fluoroquinolones (6.8 versus 10.4 defined daily doses/1,000 bed-days,
p = 0.27), third-generation cephalosporins (19.9 versus 33.3 defined
daily doses/1000 bed-days, p = 0.36), tazobactam/ piperacillin (48 ver-
sus 50.7 defined daily doses/1000 bed-days, p = 0.55), and carbapen-
ems (27.3 versus 60.3 defined daily doses/1,000 bed-days, p = 0.06)
were not significantly different in each subphase. Moreover ICU mor-
tality (17.9 % versus 16.1 %, p = 0.3) was also not found to differ sig-
nificantly in the different phases of the study.
Conclusions: The findings of this study suggest that the performance
of routine stool cultures for ESBL-E in ICU patients had no effective-
ness for improving the AUD values and clinical outcome.
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Introduction: ESBL and carbapenemase producing gram-negative
pathogens pose a major therapeutic challenge to the healthcare pro-
viders, both in hospital and in the community. Morbidity, mortality
and the cost of health care delivery are all increased by the emer-
gence of resistant pathogens. Therefore, it becomes important to
have a good knowledge of local microbial spectrum and sensitivity
profile, so appropriate prophylactic antibiotics could be administered.
This retrospective review was conducted to assess the prevalence of
both ESBL and carbapenemase producers among the uropathogens
in a newly opened tertiary care hospital in Chennai, India.
Methods: We retrospectively analysed the urine culture reports in
our hospital over a one-year period, from Sep 2014 to Oct 2015. Data
on the total requests and samples received, number of samples
tested positive, organisms isolated and their sensitivity pattern were
all collected.
Results: During this period, the microbiology lab received a total of
1991 urine samples, 77 % (1533) from outpatients and 23 % (458)
from inpatients. 18 % of the total samples received (358/1991) were
culture positive (19 % in outpatients and 13 % in in-patients). 21 %
of the outpatient and 63 % of the inpatient isolates were ESBL pro-
ducers. E coli and Klebsiella were the commonest organisms isolated
(290/358; 81 %). 92 % of the in-hospital and 73 % of the outpatient
ESBL isolate was E. coli. 5 % of the in-hospital isolates were carbape-
nemase producers.
Conclusions: The incidence of ESBL and carbapenemase production
among in-hospital uropathogens is very high at 63 % and 5 % re-
spectively. This confirms the global increase in the incidence of ESBLs
and carbapenemases. Although carbapenemase production in the
community is only 0.6 %, sepsis caused by these isolates is very dif-
ficult to treat with high mortality rates. Appropriate antibiotic use,
following a deescalation strategy and good antimicrobial steward-
ship are very important in improving outcomes and preventing
the spread of further resistance. Instead of following the generalantibiotic guidelines, developing robust local guidelines based on
the microbiological data on antibiotic sensitivity of the organisms
to guide prophylaxis will be helpful in achieving high rates of
clinical cure.
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staphylococcus aureus nasal colonization in critically ill patients
H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan,
B. Al Raiy, Y. Arabi
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi
Arabia
Critical Care 2016, 20(Suppl 2):P074
Introduction: The prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) has been increasing in the general population. In this
study, we examined the prevalence of MRSA nasal colonization in pa-
tients admitted to the intensive care unit (ICU), its risk factors and
the association with morbidity and mortality.
Methods: This was a retrospective cohort study of all patients who
were admitted to the ICU of a tertiary-care hospital in Riyadh, Saudi
Arabia in 2011, had nasal swab for MRSA colonization on admission
and stayed in the ICU for >48 hours. We calculated the MRSA col-
onization prevalence and studied the association between MRSA
colonization status and patient characteristics and outcomes, includ-
ing infections due to MRSA and mortality.
Results: The cohort included 464 patients with the following char-
acteristics: age = 51.7 ± 21.9 years, APACHE II score = 23.3 ± 8.7,
65.9 % males and mostly admitted from the emergency department
(40.7 %) and wards (30.2 %). Thirty-one (6.7 %) patients were MRSA
colonized and had similar age, gender distribution, chronic comor-
bidities and admission APACHE II score compared with the other
patients. Patients referred from other hospitals had the highest
prevalence (19.4 % versus 6.2 % for the other patients, p = 0.02). On
multivariate analysis with age, gender, APACHE II score and source of
admission (other hospitals versus other source) being the independ-
ent variables, only admission to the ICU from another hospital was
associated with MRSA colonization (odds ratio, 4.01; 95 % confidence
interval, 1.48-10.90; p = 0.006). Only 3 (0.6 %) patients in the cohort
had MRSA bacteremia during ICU stay and all were MRSA colonized
(p < 0.001). Furthermore, 14 patients had respiratory tract infection
due to MRSA, 9 (64.3 %) of whom were MRSA colonized (p < 0.001).
MRSA colonized patients had similar hospital mortality (38.7 % versus
41.8 %, p = 0.74) and length of stay (42 ± 43 versus 55 ± 97 days, p =
0.48) compared with the other patients.
Conclusions: MRSA nasal colonization was present in 6.7 % of ICU
patients and was associated with MRSA bacteremia and respiratory
tract infections, but not with mortality.P075
Multidrug-resistant Acinetobacter baumannii infection in intensive
care unit patients in a hospital with building construction: Is there
an association?
H. Talaie
Toxicological Research Center, Department of Clinical Toxicology,
Loghman-Hakim Hospital, Shahid Beheshti University of Medical
Sciences, Tehran, Iran
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Introduction: Here, we determined whether the Acinetobacter bau-
mannii (A. baumannii) class 2 integron is in the soil around our hos-
pital, and if the soil is the cause for increasing numbers of A.
baumannii infections in our intensive care unit (ICU) patients. A.
baumannii has emerged globally as a significant pathogen in hospi-
tals. It is also present in soil and water. In a previous study, we dis-
covered that the A. baumannii class 2 integron occurred most
frequently.
Critical Care 2016, Volume 20 Suppl 2 Page 39 of 182Methods: This cross-sectional prospective study was conducted in
two ICUs at Loghman-Hakim Hospital, Tehran, Iran, from November
2012 to March 2013. Patient, soil, and hospital environment samples
were collected. All isolates were identified using standard bacterio-
logic and biochemical methods. The phenotypes and genotypes
were characterized. The standard disc diffusion method was utilized
to test antimicrobial susceptibility. Integron identification was per-
formed by multiplex polymerase chain reaction.
Results: There were no A. baumannii bacteria isolated from the hos-
pital environment or soil, although the bacterium was detected
around the lip of one patient. Also, a total of 42 A. baumannii clinical
strains were isolated from the lower respiratory tract (n = 20), blood
(n = 6), urine (n = 8), and wound catheters and nasal swabs (n = 8).
65 % of the isolated species were classified as class 2 integrons. The
strains were 100 % resistant to piperacillin, piperacillin-tazobactam,
ceftazidime, ceftriaxone, cotrimoxazole, cefepime, ceropenem, and
cefotaxime. However, all of the strains were sensitive to polymyxin B
Conclusions: Further research is necessary to establish a relation-
ship between A. baumannii and soil, (especially in re¬gards to its
bioremediation), as well as to determine its importance in nosocomial
infections and outbreaks in the ICU.P076
Multidrug-resistant organisms in a Dutch ICU
J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos
St. Elisabeth Hospital, Tilburg, Netherlands
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Introduction: The objective of this study was to evaluate the dis-
tribution of multidrug-resistant organisms (MDROs) in a Dutch ICU
and compare outcome of MDRO-positive patients versus controls.
Methods: In a prospective single-centre study all patients, who
spent > 48 hours in the ICU, where screened for MDROs during a
6 month period from September 2014-February 2015. The clinical
setting was a 30-bed mixed ICU in the Netherlands. Baseline charac-
teristics were collected. Surveillance screening included rectal cul-
tures on admission and at dismissal and sputum cultures twice
weekly. Clinical cultures only on indication. Outcome measures in-
cluded ventilator time in days, median [range], VAP in patients, n
(%), sepsis in patients, n (%), length of stay (LOS) ICU in days, median
[range] and 30-day survival in patients, n (%). Statistics included the
α -test and Mann-Whitney U-test.
Results: 311 patients were included, 173 men, median age 64 years
[18-90], median APACHE II 18 [3-73]. A total of 27 MDROs were found
in 23 patients. Rectal cultures on admission revealed 17 MDROs in 14
patients, 10 MDROs were cultured in predominately sputum cultures in
9 patients during ICU stay. MDROs included 15 E. coli, 4 Klebsiella spp.,
E. cloacae, M. morganii, Citrobacter spp., Pseudomonas spp. all 1, 2 S.
Pneumoniae, 1 MRSA and 1 VRE. As only 1 patient had a MDRO posi-
tive blood culture colonisation appears more frequent than infection.
MDRO+ patients were placed in full contact isolation. Ventilator time,
VAP, sepsis and LOS ICU were significant higher in MDRO+ patients
(Table 9). There was no significant difference in 30-day survival 19
(83 %) versus 220 (76 %), p = 0.50.
Conclusions: MDROs were found in a small percentage of the pa-
tients. As MDRO+ patients had a longer ventilator time and LOS
ICU they may be more sensitive to VAP and sepsis. A large part of
MDROs was imported into the ICU. This underscores the impor-
tance of our MDRO Prevention program: surveillance cultures,
special attention to hand hygiene and washing with 2 % chlo-
rhexidine cloths.Table 9 (Abstract P076). Outcome.
MDRO+ MDRO- P
Ventilator time 8 (1-33) 3 (0-43) 0.001
VAP 5 (22) 20 (7) 0.012
Sepsis 10 (44) 46 (16) 0.01
LOS ICU 10 (3-54) 5 (2-64) 0.00P077
Epidemiology and risk factors of ICU acquired infections caused by
multidrug-resistant gram negative bacilli
Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji,
A. Ben Souissi, A. Riahi, M. S. Mebazaa
Mongi Slim University Hospital, La Marsa, Tunisia
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Introduction: Multi-drug resistant (MDR) Bacteria are a worldwide
threat especially for intensive care unit’s patients (ICU). In Gram
Negative Bacilli, the emergence and spread of Extended-spectrum
Beta-lactamase (ESBL) and carbapenemase-producing bacteria (CPB)
is one of the common causes of morbidity and mortality associated
with ICU-acquired infections (ICU AI).
The aim of this study was to determine the epidemiology and risk
factors for ESBL and CPB infections as well as the resistance patterns
of these bacteria isolated in a Tunisian multidisciplinary intensive
care unit.
Methods: We conducted a retrospective, case-control study including
all patients admitted between January and October 2015. ICU AI were
defined as those acquired no less than 48 h after ICU admission. We
did not include patients with no bacteriological evidence of infection.
Differences in ICU mortality, length of stay and duration of mechanical
ventilation (MV) were tested across patients with and without ICU ac-
quired MDR bacteria infections. We also assessed infected sites, most
frequent bacteria for each group (ESBL and CPB), and looked for risk
factors.
Results: In the study period, 184 patients were admitted to the ICU,
67 (34,41 %) had ICU AI. From these 67 patients, 35 had an ESBL in-
fection in 53 isolates, and 21 patients were infected with CPB iso-
lated from 30 cultures. Global mortality in the study period was
44,59 %, the mortality associated to MDR infection was 51,16 %. In
fact, mortality of ESBL infections was not so higher than the global
one (48,57 %) whereas CPB infection weighed down mortality to
reach 71,43 %. In the same way, length of stay was significantly lon-
ger in MDR infected patients (18,37 days ± 11.6 STD) than non-MDR
infected ones (8,66 ± 4.60 STD, p < 0,001). MV duration was respect-
ively 15,85 days (±12,51 STD) in MDR group and 6,62 days (±5,10
STD, p < 0,001) in the non-MDR infected group. Length of stay and
duration of MV were found to be risk factors for acquiring MDR infec-
tion in ICU. Ventilator associated pneumonia was the most frequent
acquired infection as well in non MDR infected patients as in both
ESBL and CPB. Acinetobacter Baumannii was the leading isolate from
CPB infection (60 %) followed by Klebsiella Pneumoniae (27 %). Con-
cerning bacilli producing ESBL, Klebsiella Pneumoniae was the most
frequently isolated (54,72 %) followed by Escherichia Coli and Entero-
bacter Cloacae (15,09 % each).
Conclusions: The prevalence of ESBL and CPB is increasing day by
day in nearly every center of different countries and is responsible
for large number of hospital-acquired and nosocomial infections,
with very few, if any, therapeutic options. Necessary steps to prevent
the spread and emergence of resistance should be taken.
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Introduction: The emergence of infections by multidrug-resistant
(MDR) Gram-negative bacteria which is accompanied by poor outcome
Critical Care 2016, Volume 20 Suppl 2 Page 40 of 182due to inappropriate therapy led to the investigation if adjunctive treat-
ment with Pentaglobin, one IgM-enriched immunoglobulin preparation,
may improve survival.
Methods: One hundred patients coming from the registry of the Hel-
lenic Sepsis Study Group with microbiologically confirmed severe in-
fections by MDR Gram-negative bacteria acquired after admission to
the Intensive Care Unit and treated with Pentaglobin were retro-
spectively analyzed. Another 100 comparators well-matched for stage
of sepsis, infection, appropriateness of antimicrobials and comorbidi-
ties coming from the same registry were selected. All-cause 28-day
mortality was the primary endpoint.
Results: 86/14 comparators and 86/14 Pentaglobin-treated cases had
severe sepsis/septic shock; 51 and 51 respectively were treated with
inappropriate antimicrobials; respective mean Charlson Comordibity
Index (CCI) was 2.86 and 2.67. 28-day mortality was 58 % and 39 %
respectively (p = 0.011). Post-hoc analysis of subgroups is shown in
Fig. 14.
Conclusions: Results favor the use of Pentaglobin as an adjunctive to
antimicrobial treatment for the management of severe infections
caused by MDR Gram-negative bacteria. Most of survival benefit was
shown in the subgroups of septic shock, age above 60 years, Charlson’s
Comorbidity Index above or equal to 3, APACHE II above or equal to 20
and SOFA score above 10.Fig. 14 (Abstract P078).P079
Must change the medical practice in ICU?
A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. López
Hospital Universitario La Paz, Madrid, Spain
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Introduction: The prevalence of carbapenems resistant bacteria has in-
creased since the first case reported, becoming a worldwide serious
concern. This problem specially affects the intensive care units (ICUs).
Usually at ICU, staff and residents develop an exercise of learning
and capture of decisions at the patient bedside. Probably this way of
work should change.
These are the changes developed in our ICU since January 2014,
when were identified the new generation of 11 cases of K.pneumonia
OXA 48.
Methods: On February, an operative strategic group (GEO) was
made and set up with the aim of eliminating and preventing new
cabapenems resistant infection cases. The compulsory use of barrier
methods was the keystone of all the process. A weekly meeting was
performed to talk about the outbreak situation. The main changes
carried out by the GEO were:
1) The disposable material (gloves and coats) were put outside of the
patient room, no worker could entry without disposable dressing
and had to leave it inside the room before exit. 2) Just one physician
worked at the patient bedside, dressed with a disposable coat. (The
discussions were made outside of the patients rooms) 3) Just one
nurse and one attendant worked with each patient. 4) Porters and
cleaners were specifically trained stable staff. 5) Colonized patients
were grouped on one side of the unit. 6) Microbiology: Rectal sam-
ples were collected at admission and on a weekly basis. Direct com-
munication among units with early notice of new cases. 7) Preventive
department: Global observation of the compliance (defense standards),
recommendation of caution at discharge for at least 7 days. 8) Develop-
ment of hospital OXA record book.Results: Since the formation of the GEO, number of new carbapenem-
resistant cases decreased drastically. Three new cases were reported on
February, two cases on March and one on April. Since May, the cases of
colonization by carbapenem resistant bacteria within the ICU have
been reduced to those cases imported from other units; there have
been exceptional cases generated on the unit. In these ones the failure
of defense was identified, reported, and measures were taken for
further occasions.
Conclusions: The growing emergence of multirresistant bacteria is a
real threat forcing us to adapt and change our way of working.
Good coordination among hospital workers is the most effective tool as
a firewall against these infections. The implementation of the techniques
previously described has proven to be an effective fighting technique
against carbapenemases producing bacteria.
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Mediterranean spotted fever in an infectious diseases intensive
care unit
A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos
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Introduction: Mediterranean Spotted Fever (MSF) is considered a be-
nign disease characterized by fever, rash and eschar. However, in
some cases it can have severe forms with purpuric rash and multior-
ganic failure. The objective of this study is to characterize and to de-
lineate predictors of bad outcome in patients hospitalized in an
Infectious Diseases Intensive/Intermediate Care Unit (ID-ICU).
Methods: We performed a cross-sectional study of adult patients ad-
mitted to the ID-ICU with the diagnosis of MSF between 1992 and
2014. The patients were identified in our department database and
subsequently the clinical records were consulted. The primary out-
come was death and secondary outcomes were its predictors. We
used the most appropriate measure of central tendency and distribu-
tion and statistical test (significance level 0.05).
Results: We include 30 patients. The ICU admission rate was 33 %
(comparing to MSF admissions to the Infectious Diseases Department
in the same period). There was predominance of women (53 %). The
patients were admitted to the ID-ICU with a median disease duration
time of 6 days (interquartile range 4). Seven patients (23 %) had comor-
bidities. At admission, the most common analytic abnormalities were
thrombocytopenia (93 %), transaminases elevation (90 %), elevation of
the urea and creatinine (73 %), lactate dehydrogenase elevation (73 %),
creatine phosphokinase elevation (60 %) and hyponatremia (53 %). The
median SAPS II score was 33. Reported MSF complications were con-
sciousness impairment (90 %), renal failure (70 %), pneumonitis (57 %),
respiratory failure (53 %) and gastrointestinal bleeding (13 %). Four pa-
tients (13 %) needed renal support and five patients (17 %) needed in-
vasive mechanic ventilation.
The mortality rate was 13 % (n = 4). We found a statistical significant
association between the SAPS II score and mortality: higher scores
are linked to death (Mann Whitney U test). We also found association
between higher leukocyte count and prolonged activated partial
thromboplastin time (aPTT) at admission with death (Mann Whitney
U test). We did not find association between any other analytical ab-
normality at admission and at death. We also did not find any bad
outcome association with patients’ symptoms, physical examination
abnormalities, renal or ventilation support (Person’s Qui Squared Test).
Conclusions: Although MSF is generally considered a benign
disease we had a high ICU admission rate and a considerable
mortality rate. We found that the SAPS II score, the leukocytes
count and aPTT are predictors of death in patients with MSF ad-
mitted to the ICU.
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Clinical features and outcomes of patients with Middle East
respiratory syndrome requiring admission to a saudi intensive care
unit: A retrospective analysis of 31 cases
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Critical Care 2016, Volume 20 Suppl 2 Page 41 of 182Introduction: We performed a retrospective study to describe the
clinical features and outcomes of a cohort of patients admitted to
our ICU with confirmed Middle East Respiratory Syndrome coronavirus
(MERS-CoV) infection.
Methods: All adult (>18 years old) patients admitted to our 20-bed
mixed medico-surgical ICU who were diagnosed with confirmed
MERS-CoV between Oct 1, 2012 and May 31, 2014 were included.
The diagnosis was confirmed using real-time reverse transcription
polymerase chain reaction (RT-PCR) on respiratory samples.
Results: During the observation period, 31 patients were identified
as having MERS-CoV infection (mean age 59 ± 20 years, 71 % males).
The median number of concomitant comorbid conditions was 3 (IQ:
2-4). The initial clinical manifestations of the MERS-CoV infections
had occurred at a median of 2 days (IQ: 2-4) prior to hospital admis-
sion. Cough and tachypnea were reported in all patients, and bilat-
eral pulmonary infiltrates were evident in 77.4 % of cases. Invasive
mechanical ventilation was required in 87.1 % of the patients during
the ICU stay, vasopressor therapy in 80.6 %, and renal replacement
therapy in 51.6 %. The overall ICU mortality rate was 74.2 %. The me-
dian ICU and hospital lengths of stay were 9 (IQ: 4-16) and 12 (IQ: 4-
16) days, respectively. Nonsurvivors were older (63 ± 19 vs. 46 ±
20 years, p = 0.48), had greater APACHE II and SOFA scores on admis-
sion to the ICU, and were more likely to require invasive mechanical
ventilation (95.7 vs. 62.5 %, p = 0.48) and vasopressor therapy (95.7
vs. 37.5 %, p = 0.002).
Conclusions: MERS-CoV infection requiring admission to the ICU is
associated with high morbidity and mortality rates. Possible risk fac-
tors for death include older age, greater severity scores and the need
for invasive mechanical ventilation and/or vasopressor therapy.
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Introduction: The Middle East Respiratory Syndrome coronavirus
(MERS-CoV) has caused several hospital outbreaks and frequently
leads to severe critical illness. To learn from our experience, we de-
scribed the response of our intensive care unit (ICU) to a MERS-CoV
hospital outbreak.
Methods: This observational study was conducted at a 1000-bed
tertiary-care hospital in Riyadh, Saudi Arabia which had a MERS-CoV
outbreak in Aug-Sep 2015. Our Intensive Care Department covered 5
ICUs with 60 single-bedded rooms. We described qualitatively and,
as applicable, quantitatively, the response of intensive care services
to the outbreak. The clinical course and outcomes of hospital
workers who had MERS were noted.
Results: A total of 62 critically ill MERS patients were cohorted in 3
ICUs during the outbreak with a peak census of 27 MERS patients on
Aug 25, 2015 and the last new case on Sep 13, 2015. Most patients
had multiorgan failure requiring support. Eight hospital employees
had MERS requiring ICU admission for a median stay of 28 days: 7
developed acute respiratory distress syndrome, 4 were treated with
proning, 4 needed continuous renal replacement therapy and one
had extracorporeal membrane oxygenation. The hospital mortality of
ICU MERS patients was 53 % (0 % for the hospital employees). All
MERS patients were admitted in single negative pressure rooms,
which were promptly increased from 14 to 38 rooms. The nurse-to-
patient ratio was ~1.2:1. Infection prevention practices were intensi-
fied. For example, the consumption of surface disinfectants and hand
hygiene gel increased by ~30 % and an average of 17 N95 masks
were used per patient/day. Family visits were restricted to 2 hours/
day and the ICU physicians communicated with the next of kin by
phone daily. During the outbreak, 2 ICU nurses and 1 physician
tested positive for MERS-CoV, had mild disease and recovered fully.
Although most ICU staff expressed concerns about acquiring MERS,
none refused to report to work. However, 27.0 % of nurses and18.4 % of physicians working in the MERS ICUs had upper respiratory
symptoms, but tested negative for MERS-CoV. The total sick leave
duration was 138 days for nurses and 30 days for physicians.
Conclusions: Our hospital outbreak of MERS-CoV resulted in many
patients requiring organ support and prolonged ICU stay. Their mor-
tality rate was high but lower than previously reported. The response
to the outbreak required facility and staff management and proper
implementation of infection control and prevention practices.
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Introduction: The Middle East Respiratory Syndrome coronavirus
(MERS-CoV) is one of the deadliest and least understood emerging
pathogens in the 21st century and continues to pose a threat to glo-
bal public health because of its high fatality rate. This abstract repre-
sents an attempt to analyze all publically available global surveillance
data of MERS-CoV cases reported by the WHO to date.
Methods: We analyzed all outbreak news archives of MERS-CoV be-
tween September 23, 2012 and October 1, 2015(1). We included all
cases containing data about age and gender (at minimum) and ex-
cluded cases reported as clusters. Data on age, gender, comorbidities,
healthcare worker, contact with camels, contact with a laboratory con-
firmed MERS-CoV case, date of symptom onset and date of laboratory
confirmation were retrieved and analyzed.
Results: A total of 219 outbreak news reports were released by the
WHO, 977 cases were include in our study; 68.8 % males: mean (SD)
age was 53.2 years (17.9), and 31.2 % females: mean (SD) age was
53.2 years (18.4), where the youngest patient reported was 10 month
and the oldest patient reported was 109 year old. Comorbidities
were reported in 46.9 %: mean (SD) age was 60.1 (15.4) and 71.8 %
male and 28.2 % female. Healthcare workers were reported to be
15.6 %, mean (SD) age was 38.6 (11.3) and 53.3 % male, 46.7 % fe-
male and 19.7 % of them had comorbidities. 12.1 % reported with
history of camel contact; mean (SD) age was 56.7 (15.1) and 91.7 %
male, 8.3 % female and 77.1 % of them had comorbidities. 25.3 %
were reported to have contact with a laboratory confirmed MERS
case: mean (SD) age was 43.9 (17.0), 63.0 % male 37.0 % female,
36.0 % reported to have comorbidities and 30.5 % were healthcare
workers. Date of symptoms onset and date of laboratory confirmation
were reported in 86.2 % and 56.5 % respectively. The overall mean (SD)
of time from symptoms onset to date of laboratory confirmation was
5.2 days (4.2) (95 % CI, 4.8–5.5).
Conclusions: Our study was based on publically available global sur-
veillance data and has the advantages of a large sample demo-
graphic description.
Reference
1. World Health Organization. Disease outbreak news (MERS-CoV)
[http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/].
Last accessed October 1, 2015.
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Introduction
Pneumonia remains a common cause of both admission to and de-
terioration in the intensive care unit. In many cases no organism is
identified, resulting in empiric treatment for the presumed causative
pathogen. Even when an organism is identified, the delay in
obtaining results is typically 48 to 72 hours. Both theses factors
Table 10 (Abstract P086). Tests requested within 24 hours of ICU
admission.
Test requested within





Blood cultures 48 (71%) 63 (97%)
Blood viral serology 37 (54%) 55 (85%)
Urinary antigens 43 (63%) 56 (86%)
Nasal +/- endotracheal viral swab 15 (22%) 57 (88%)
Sputum MC + S 20 (29%) 59 (91%)
All tests 19 (28%) 55 (85%)
Critical Care 2016, Volume 20 Suppl 2 Page 42 of 182can lead to unnecessary antibiotics, and of even greater concern,
inappropriate initial therapy. Molecular diagnostic techniques have
the potential to address both these problems. We present here
three cases which illustrate the utility of molecular diagnostics,
using a Taqman array card (TAC).
Methods
Three patients admitted to a university hospital general intensive care
unit with radiographically confirmed severe pneumonia underwent
bronchoscopy and lavage, with the samples being analysed by both
conventional microscopy and culture and nucleic acid extraction. The
nucleic extract was then placed on a TAC able to detect 48 microbial
genes using real time polymerase chain reaction (RT-PCR), directed to-
wards a range of established respiratory pathogens. Results are avail-
able with a time to threshold value which gives an indication of the
abundance of that gene in the sample.
Cases
The cases occurred amongst three adults (age range 19-49) who pre-
sented with clinical and radiographic evidence of pneumonia. Two
cases were community -acquired with the third being hospital-
acquired. The organisms identified by the TAC were Mycoplasma
pneumoniae, Aspergillus spp. Cryptosporidium parvum and Pneumocystis
jiroveci (PCJ), with one patient having two organisms detected. M.
pneumoniae and PCJ were not identified on standard cultures,
whilst Crytposporidum and Aspergillus spp and were both identi-
fied on conventional culture/microscopy 5 days after TAC identifi-
cation. In all three cases, the results of the TAC assay resulted in
change in management, with institution of new antimicrobials
targeting the organisms identified combined with rationalisation
of pre-existing antimicrobial treatments.
Discussion
These three cases illustrate how conventional cultures may miss im-
portant or unexpected pathogens, or return results late on in the
course of the disease. We believe that this technology has the poten-
tial to significantly impact on the management of critically ill patients
with lung infections, and are currently planning a larger scale evalu-
ation of its use in critical care.
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Introduction: Pneumonia is a major cause for ICU admission and
mortality. Prompt investigation facilitates tailored antimicrobial
strategy, guides management, and aids prognostication. The
British Thoracic Society (BTS)[1] suggest specific tests are per-
formed for patients with severe pneumonia: Legionella and
pneumococcal urinary antigens, sputum and blood cultures, respira-
tory viral PCR swabs, and atypical serology testing. We suspected
these tests were inconsistently undertaken or delayed in our ICU,
and introduced a computerised pneumonia screen, ‘BUNS’, (Blood
cultures and viral serology/Urinary antigens/Nasal +/- endotracheal
viral swab/Sputum sample) to consistently investigate this
condition.
Methods: All patients with a primary diagnosis of pneumonia ad-
mitted to a UK district hospital ICU over a one-year period up to 31/
10/14 were retrospectively reviewed to determine which investiga-
tions had been requested within 24 hours of admission. These were
compared to the BTS guideline [1]. We subsequently implemented
the ‘BUNS pneumonia screen’ within our electronic investigation sys-
tem. A single click auto-generated request labels for all tests in the
BTS guidelines. After implementation and staff education, we re-
peated the data collection between 1/2/15 and 1/11/15.
Results: See Table 10.
Conclusions: This study has shown that a computerised auto-
generated set of investigation requests, aided by an easily remem-
bered acronym, lead to increased proportion of patients (85 % vs
28 %) receiving prompt and consistent ‘gold standard’ investigations
for pneumonia. We believe this reduced duplication and delay inobtaining diagnostic results, thereby improving patient care. We sug-
gest the ‘Bundle of BUNS’ could be easily replicated in other ICUs,
and a similar system could be introduced for other presenting
conditions.
Reference
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Introduction: Despite the significant impact of nosocomial infections
on the morbidity and mortality of patients staying in the intensive
care unit (ICU), no study over the past 20 years has focused specifically
on pneumonia following secondary peritonitis. Our objective is to de-
termine epidemiological features and in-hospital mortality of pneumo-
nia in this kind of patients.
Methods: Prospective observational study involved 418 consecutive
patients admitted in the ICU, who had undergone a laparotomy be-
cause of a secondary peritonitis. Univariate and multivariate analyses
were performed to identify risk factors associated with mortality and
development of pneumonia.
Results: The incidence of pneumonia following secondary peritonitis
was 9.6 %. Risk factors associated with the development of pneumonia
were hospital-acquired peritonitis, >48 h of mechanical ventilation, and
SOFA score. The onset of pneumonia was late in majority of patients
(about 16.8 days after the initiation of the peritonitis), and the etio-
logical microorganisms responsible for it were different than for peri-
tonitis. The 90-day in-hospital mortality rate was 47.5 % of pneumonia
patients. Independent factors associated with 30–90-day in-hospital
mortality were pneumonia and SOFA score
Conclusions: Pneumonia in patients who had undergone a sur-
gery because of a secondary peritonitis, increases the 90-day
mortality.
The onset of pneumonia following secondary peritonitis usually is
late (16.8 days) and with etiological microorganisms different than
those responsable for secondary peritonitis
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The use of the “CURB-65 score” by emergency room clinicians in a
large teaching hospital
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Introduction: The “CURB-65 score” is a convenient, well validated
tool to assess disease severity and aid in the clinical management of
community acquired pneumonia (CAP) [1]. Recent literature however
demonstrates that its use is variable and often inaccurate. Failure
to use this tool may lead to over or under treatment and
may result in inappropriate patient admission thereby increasing
healthcare costs [2].
The aim of the initial audit was to determine the frequency of the
use of the score in emergency medical care and correlate this with
clinical decision-making. The data was analysed and common pitfalls
were identified. After the implementation of various tools designed
to address these issues a repeat audit was performed to assess for
any improvements.
Methods: 83 case notes of patients who presented with CAP were
retrospectively reviewed between March-May 2014. Based on the
data 3 key interventions were implemented. A teaching session re-
garding the calculation and practical application of the CURB-65
score was delivered to all emergency room clinicians. A CURB-65 pro
forma was created and implemented for use in the electronic patient
record system used at the hospital. Alongside this a pre-designed set
of electronic antibiotic prescription sets were created and incor-
porated into the electronic prescribing system in use at the audit
site. These accountated for allergies, patient weight and renal/
hepatic function. A further 50 case notes of patients presenting
with a CAP were then retrospectively reviewed during December
2014-Jan 2015 in order to assess the impact of the above
interventions.
Results: There was a significant increase in the number of case re-
cords containing a documented CURB-65 score after the implemen-
tation of the above interventions (43.4 % VS 92.0 %). There was an
associated improvement in the accuracy of calculated scores
(77.8 % VS 92.0 %). In turn, more patients received appropriate
antibiotic therapy (86.7 % VS 100 %). Of note, 6 patients prior to the
interventions were admitted despite their calculated CURB-65 score
being 0-1 without an alternate reason being documented. After the
implementation of these interventions no patients were admitted
with these scores.
Conclusions: Staff education, tools to aid accurate CURB 65 calculation
and pre-created antibiotic order sets lead to improvements in the
initial assessment and subsequent management of patients pre-
senting with CAP. These changes should be consider for use on a
wider scale.
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in mechanically ventilated patients in the medical intensive care
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Introduction: Community acquired pneumonia (CAP) guidelines ac-
knowledge respiratory viruses as a cause for CAP, but provide fewrecommendations regarding diagnosis or treatment due to lack of
data [1]. New technology to detect viral pathogens by highly sensi-
tive nucleic amplification tests has allowed for identification of add-
itional viruses through a small sample of respiratory secretions [2].
Our aim is to describe the incidence of viruses in mechanically venti-
lated patients with CAP in the ICU.
Methods: This retrospective chart review includes CAP patients ad-
mitted to the ICU and mechanically ventilated between January 2012
and September 2015. Type of virus and screening tool used for de-
tection, confirmed bacterial co-infection, length of stay (LOS) in the
ICU and hospital, mechanical ventilation days, and hospital mortality
are described.
Results: Evaluation of 55 patients with respiratory viral panel screens
resulted in 10 patients with positive findings. Seven patients had
positive nasopharyngeal swabs and 3 patients had positive BAL find-
ings. Influenza A was the most common and occurred in 3 patients.
Rhinovirus occurred in 2 patients, coronavirus occurred in 2 patients
with one of these patients also having parainfluenza virus 2. Influ-
enza B, respiratory syncytial virus A, and respiratory syncytial virus B
occurred in one patient each. 8 of these 10 patients had confirmed
bacterial co-infections. Overall, median ICU LOS was 12.5 days, me-
dian mechanical ventilation was 12 days, median hospital LOS was
15.8 days, and mortality was 25 %. Mortality occurred in a patient
with influenza A and in a patient with rhinovirus. Both had concomi-
tant bacterial infections.
Conclusions: This study demonstrates bacterial and viral co-infection
was common. Further research with larger sample size is needed to
better characterize respiratory viral infection in the setting of CAP in
the ICU.
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Introduction: Staphylococcus aureus pneumonia, especially within
the hospitalized or intensive care unit (ICU) population, is a clinically
significant and serious disease that contributes significantly to mor-
bidity and mortality. MEDI4893 is a novel mAb that targets, binds,
and functionally inhibits S aureus alpha toxin, a major determinant of
S aureus virulence. The use of MEDI4893 to prevent S aureus pneu-
monia offers a novel paradigm for managing specific high-risk pa-
tients. We describe the rationale and design of the SATTELLITE study
to investigate the use of MEDI4893 in mechanically-ventilated (MV)
subjects.
This study (EudraCT 2014-001097-34) is being conducted through
the Innovative Medicines Initiative Joint Undertaking in the EU
and is a joint collaboration between Medimmune and the
academic partners within the Combatting Bacterial Resistance in
Europe (COMBACTE), which is a consortium of experts in the
field of antibiotic-resistant bacteria and ventilator-associated
pneumonia.
Methods: SAATELLITE is a randomized, double-blind, placebo-
controlled, dose-ranging Phase 2 study to investigate the efficacy
and safety of MEDI4893 in MV subjects. The primary efficacy end-
Critical Care 2016, Volume 20 Suppl 2 Page 44 of 182point is the incidence of NP caused by S aureus through 30 days
postdose, proposed as a clinically meaningful, objective and repro-
duceable endpoint. Safety will be assessed through 360 days post-
dose. Subjects will be randomized in a 1:1:1 ratio to receive a single
intravenous infusion of Low-dose MEDI4893 or High-dose MEDI4893
or placebo and will be followed through 359 days post dose. Sub-
jects enrolled are ICU patients aged [>=] 18 yrs intubated and on
mechanical ventilator, whose lower respiratory tract samples are
positive for S aureus, but have not been diagnosed with new onset
of pneumonia prior to randomization.
Results: N/A
Conclusions: The SAATELLITE study represents an innovative pre-
emptive therapy approach to prevent S aureus nosocomial pneumo-
nia in MV patients, by utilizing the novel monoclonal antibody
MEDI4893, thereby offering a new paradigm in S aureus infection
management in high-risk patients.Table 12 (Abstract P092). Correlation between the percentage of
ventilated patients developed VAP and use.
Slope S. E. r r2 L. CI U.CI p value
Imipenem -0.02 0.04 -0.32 0.10 -0.17 0.12 0.388
Meropenem 0.08 0.10 0.43 0.19 -0.24 0.42 0.460
Tigecyclin 0.10 0.06 0.66 0.43 -0.11 0.31 0.223
Linezoline 0.00 0.01 0.13 0.01 -0.03 0.04 0.834
Colistin 0.32 0.20 0.67 0.45 -0.32 0.96 0.210P091
Risk factors and microbiological profile for nosocomial infections
in trauma patients
M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi,
Y. Boussarsar, A. Riahi, M.S. Mebazaa
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Introduction: Nosocomial infections (NI) were a major cause of mor-
bidity and mortality in trauma patients especially those hospitalized
in ICU. The systemic inflammatory response that follows the different
lesions is responsible of immune dysfunction promoting the emer-
gence of pathogens and the occurrence of infection. The aim of this
study is to identify risk factors for (NI), infection sites and microbio-
logical profile in trauma patients.
Methods: We conducted a retrospective study in the Intensive Care
Unit of Mongi Slim Hospital La Marsa from January 2015 to September
2015. All Trauma patients hospitalized for more than 48 hours at the
ICU were included. Demographic data, type and number of surgeries,
use of invasive devices, days under mechanical ventilation, site and
number of NI were recorded. We calculate simple frequencies and rela-
tive frequencies (percentage) for qualitative variables. We calculate
means and standard deviations for quantitative variables.
Results: A total of 42 trauma patients were admitted during this
9 month-period and 25 patients developed at least one NI. Infected
patients and non-infected one was comparable concerning gravity,
and mortality. Infected patients needed more transfusions than non-
infected ones (Table 11). Infected patients were mostly associated
with head trauma (73.8 %) and chest trauma (76.19 %). Ventilatory
acquired pneumonia was the most common NI (73.8 %). The most
common pathogens found were Klebsiella Pneumoniae 31 %, E Coli
17 % and Pseudomonas Aeroginosa 8.5 %. Patients with NI have had
more invasive devices.
Conclusions: The infectious complications are the second leading
cause of late mortality after brain injury. Injuries and invasive care
promote pathogens penetration in the organism. That’s why, all
trauma patients whose stay exceed 48 hours, should benefit from a
number of established early precautions to prevent infections espe-
cially pneumonia.Table 11 (Abstract P091). Summary of main results.
Infected patients (n = 25) Non-infected patients (n = 17)
ISS 33 29.9
APACHE II 11.5 7.4
Length of stay (days) 25.0 6.1
Transfusion (%) 70,5 34.9
Mortality (%) 34.1 30.2P092
Correlation between percentages of ventilated patients developed
vap and use of antimicrobial agents in ICU patients.
A. Vakalos, V. Avramidis
Xanthi General Hospital, Xanthi, Greece
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Introduction: The aim of our observation retrospective study was to
test the hypothesis that a correlation exists between the percentages
of ventilated patients developed VAP and the use of main end line
antimicrobial agents in ICU patients.
Methods: From 2008 to 2012 admitted to our ICU 384 patients.
We looked for the percentage of ventilated patients developed
VAP as well as the use of the following agents as items
per ventilation day per ventilated patient: Imipenem / cilastatin
(vial 500 + 500 mg), Meropenem (vial 1000 mg), Tigecyclin (vial
50 mg), Linezoline (bag, 2 mg / ml x 300 ml), Colistin IV (vial
106 IU). Using linear correlation, we looked for linear slope, cor-
relation coefficient (r), coefficient of determination (r2), r and p
value.
Results: Table 12
Conclusions: According to our data, there was no statistically signifi-
cant correlation detected between the percentage of ventilated pa-
tients developed VAP and use of any of the end line antimicrobial
agents studied. This may be due to late de-escalation, to use these
agents to treat other infections or to prevent spreading and
colonization.P093
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Introduction: Ventilator associated pneumonia (VAP) rates are a key
quality metric and the subjectivity of surveillance has been criticized.
The CDC introduced an objective algorithm to diagnose Possible VAP
(PVAP) [1]. Local practice uses HELICS methodology to diagnose
HVAP. We present preliminary results from a comparison of the tech-
niques, funded by Health Protection Scotland.
Methods: Algorithm relevant data were recorded prospectively on all
patients admitted to two ICUs for four months from June 2015. An
infection surveillance team conducted HELICS surveillance indepen-
dently. Ethics committee approval was not required. Information
guardian approval was received. Non-parametric comparisons were
used, p < 0.05 was considered significant.
Results: 266 patients were ventilated for more than two days. The
HVAP and PVAP rates per 1000 at risk ventilation days (total diagnoses)
were 5.0 (10) and 2.0 (4) respectively. Concordance between diagnoses
was poor (Cohen’s Kappa -0.02 (95 % CI: -0.04 to -0.01)). HVAP was sta-
tistically associated with longer stay and ventilation, in contrast to PVAP
Critical Care 2016, Volume 20 Suppl 2 Page 45 of 182(Fig. 15). Neither were associated with mortality (HVAP p = 0.22 and
PVAP p = 0.13).
Conclusions: Our preliminary data illustrate poor concordance be-
tween CDC and HELICS algorithms. In contrast to PVAP, HVAP may
reflect outcome. The lack of association with PVAP may be the result of
a low event rate.
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ventilator-associated events. Am J Crit Care 22: 469–73, 2013Fig. 16 (Abstract P094). LUS findings before (A,C) and after (B,D)
FBS (A-B patient 1, C-D patient 2).
Fig. 15 (Abstract P093). Tukey plot. VAP association with outcome.
(p values shown, Mann-Whitney U).P094
Lung ultrasound before and after fiberbronchoscopy -
modifications may improve ventilator-associated pneumonia
diagnosis
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Introduction: Lung Ultrasound (LUS) is a validated tool for
Ventilator-Associated Pneumonia (VAP) diagnosis [1] and monitor-
ing[2]. Dynamic linear/arborescent air-bronchogram is specific for
VAP.
Methods: 2 patients suspected for VAP were examined before
and after fiberbronchoscopy (FBS) by LUS, focusing on subpleural
consolidations, lobar/hemilobar consolidations and air-bronchogram.
Bronchoalveolar-lavage (BAL) was performed.
Results: Before FBS, LUS pattern wasn’t specific for VAP: both pa-
tients had only bilateral consolidations with no air-bronchogram
(Fig. 16a,c). After FBS, LUS pattern changed. In patient 1, the tissue-
like pattern turned into B-lines (Fig. 16b). BAL was negative. In pa-
tient 2, the same tissue-like pattern was visualized after FBS; a dy-
namic arborescent air-bronchogram appeared (Fig. 16d). BAL had
P.Aeruginosa 10(6) CFU/ml.
Conclusions: LUS allows early bedside VAP diagnosis. If the pattern is
non specific, changes after FBS may be useful: reaeration orients to
atelectasis; persistence of complete loss of aeration with dynamic air-
bronchogram appearance orients to VAP.
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Comparing the accuracy of predictors of mortality in ventilator-
associated pneumonia
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Introduction: Ventilator-associated pneumonia (VAP) remains an im-
portant cause of morbidity and mortality in critically ill patients.
Objective tools for prognose assessment may improve treatment
strategy. We sought to determine the prognostic value of procalcito-
nin (PCT), C-reactive protein (CRP), as well as clinical scores [ Sequen-
tial Organ Failure Assessment (SOFA), Acute Physiology And Chronic
Health Evaluation (APACHE II), Clinical Pulmonary Infection Score
(CPIS), Chest Echography and Procalcitonin Score (CEPPIS) ] in critic-
ally ill patients who developed VAP.
Methods: This retrospective study recruited patients admitted to the
Intensive Care Unit of the Anesthesiology Department, Marmara Uni-
versity Hospital (Istanbul, Turkey), from January 2014 to September
2015. Patients’ progress was followed until the 28th day after the diag-
nosis of VAP, when they were considered survivors. Patients who died
before the 28th day were non-survivors. Patients discharged from the
ICU before the 28th day were also considered survivors. APACHE II
score was assessed during first 24 h of admission; CPIS and CEPPIS
score were assessed at the onset of VAP (day 1). SOFA score, serum
CRP, serum PCT, pro-BNP were assessed on day 1,4, 7 of VAP diagnosis
and were correlated with 28-day survival and mortality.
Results: A total of 44 patients were enrolled. Of them, 23 (52.2 %)
died before day 28 after VAP diagnosis. The SOFA score in our study
was significantly lower in survivors at day 1, 4 and 7 compared with
nonsurvivors. In terms of APACHE II score, CPIS and cause of admis-
sion; the two groups were comparable. There were no significant dif-
ference between the nonsurvivors and survivors in terms of PCT,
CRP, leucocyte count at days 1 and 7. However, the leucocyte count,
PCT and CRP levels on day 4 were significantly higher in nonsurvivors
than survivors. Also pro-BNP levels at days 4 and 7 were significantly
higher in the nonsurvivors than survivors.
Conclusions: The biomarkers, PCT, CRP and pro-BNP, can predict
mortality in VAP, as can SOFA score. Although, CPIS and CEPPIS has
Critical Care 2016, Volume 20 Suppl 2 Page 46 of 182been described as useful scoring systems for diagnosis for VAP,
they did no differentiate between survivors and nonsurvivors. In
compare to CPIS, CEPPIS, a score based on chest ultrasonography
and procalcitonin levels, may be a better predictor of diagnosis
of VAP.
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Impact of pRBCs transfusion on percentage of ventilated patients
developed VAP in ICU patients
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Introductions: The aim of our observation retrospective study was to
test the hypothesis that a correlation exists between pRBCs transfusion
and the percentage of ventilated patients developed VAP (% VP) in our
both medical and surgical ICU served in community hospital.
Methods: From January 2006 to June 2014 admitted to our ICU 620 pa-
tients. We looked for the percentage of ventilated patients developed
VAP and the following indexes according pRBCs transfusion per year
from 2006 to 2014. Total, per patient, per hospitalization days (HD), per
patient ventilated (pts V), per ventilation days (VD) Using linear correl-
ation method, we looked for linear slope, correlation coefficient (r), and
coefficient of determination (r2), and by linear regression method using
ANOVA test we looked for p value, according % VP and pRBCs
transfusion.
Results:
Conclusions: According to our data, there was no statistically significant
correlation detected between the percentage of ventilated patients de-
veloped VAP and pRBC transfusion. Our data suggest that even though
pRBC transfusion may have an impact on immunosuppression and in-
fection disease developing, the impact on the percentage of ventilated
patients developed VAP is not statistically significant.Table 13 (Abstract P096). Correlation between the percentages of
ventilated patients developed VAP and pRB.
pRBCs Slope r r2 St
Error
L. CI U.CI p
value
Total transfusions 2.487 0.139 0.019 0.685 -13.323 18.296 0.7209
Transfusions per pt -0.084 -0.375 0.14 0.079 -0.272 0.102 0.3197
Transfusions per H.D. -0.003 -0.265 0.07 0.005 -0.016 0.008 0.4902
Transfusions per Pt V. -0.085 -0.33 0.123 0.085 -0.288 0.118 0.3546
Transfusions per V. Day -0.008 -0.409 0.167 0.007 -0.025 0.008 0.2737
Fig. 17 (Abstract P097). U chart: monthly VAP rates.P097
The impact of a series of interventions on the rate of ventilator
associated pneumonia in a large teaching hospital
H. E. Ellis, K. Bauchmuller, D. Miller, A. Temple
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Introductions: Ventilator associated pneumonia (VAP) has a reported
incidence of between 9 – 27 % and a strong association with in-
creased ICU length of stay and mortality[1]. Current evidence sug-
gests that the application of a care ‘bundle’ may reduce the rate of
VAP [2]. We aimed to assess the effects of a sequential multi-
faceted care bundle and audit program on VAP rates in our
institution.
Methods: The existing care bundle (head up positioning, daily sed-
ation holds) was supplemented by a 3-step process of interventions
between December 2008 and October 2015, each accompanied by adedicated staff education initiative: 1) Guidance on stress ulcer
prophylaxis, changing of respiratory circuitry and sedation holds; 2)
Introduction of a new endotracheal tube with continuous subglottic
suction and cuff pressure monitoring; 3) New oral hygiene guidance.
Data was analysed using MS excel and a statistical process control
chart designed for non-conformity attribute data with an unequal
area of opportunity. Values are expressed as mean and upper control
limits (UCLu).
Results: A total number of 26480 consecutive ventilator days were
assessed. Monthly VAP rates remained stable around a constant mean
of 16.45 per 1000 ventilator days between December 2008 and Sep-
tember 2013. Following introduction of oral hygiene guidance, a statis-
tically significant shift in process occurred identifying a special cause.
This represents a reduction of monthly VAP rate to 7.44 per 1000 venti-
lator days (Fig. 17).
Conclusions: Introduction of a multidisciplinary stepwise VAP preven-
tion initiative led to a significant reduction in mean monthly VAP
rates over time.
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Introductions: Pseudomonas aeruginosa is one of the leading causes
of nosocomial infections in critically ill patients. The organism pro-
duces an array of factors that contribute to its virulence. Two such
virulence factors are the Psl exopolysaccharide, which contributes to
bacterial persistence, and the PcrV protein which contributes to the
virulence of the organism. MEDI3902 is a novel bivalent, bispecific
mAb that selectively binds to both factors, thereby inhibiting the
cytotoxicity and immune evasion properties of the pathogen. Psl and
PcrV target expression is independent of antibiotic susceptibility sta-
tus; therefore, MEDI3902 also has the potential to be active against
multi-drug resistant strains of P aeruginosa. MEDI3902 is being devel-
oped for the prevention of P aeruginosa pneumonia. We describe
the rationale and design of the EVADE study to investigate the use
of MEDI3902 in mechanically-ventilated (MV) subjects.
Table 14 (Abstract P100). Outcome’s variables in both groups.
AS colistin
group (n = 66)
IV colistin
group (n = 67)
P
value
Length of stay; days: mean+/- SD
(median)
26+/-18 (20) 27+/-19 (21) 0.84
Duration of MV : mean+/-SD (median) 14.28+/-7 (13) 17+/-11 (15) 0.08
Duration of MV in survivors: mean+/-SD
(median)
13.8+/-8 (12) 19+/-11 (17) 0.01
All-cause 28-day Mortality (%) 24.20% 26.80% 0.8
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Initiative Joint Undertaking in the EU and is a joint collaboration
between Medimmune and the academic partners within the Com-
batting Bacterial Resistance in Europe – Molecules against Gram
Negative Infections (COMBACTE-MAGNET), which is a consortium of ex-
perts in the field of antibiotic-resistant bacteria and ventilator-
associated pneumonia.
Methods: EVADE is a randomized, double-blind, placebo-controlled,
dose-ranging study to determine the efficacy, safety, and pharmaco-
kinetic responses to MEDI3902 in adult ICU patients requiring MV
and who are colonised with P aeruginosa in the lower respiratory
tract (LRT). The primary efficacy endpoint is the incidence of NP
caused by P aeruginosa, proposed as a clinically meaningful, object-
ive and reproducible endpoint. The safety of MEDI3902 will be
assessed through 49 days postdose. Subjects included in the study
are ICU patients aged ≥18 yrs, intubated and on MV; have LRT sam-
ple positive for P aeruginosa, but have not been diagnosed with new
onset of pneumonia prior to randomization.
Conclusions: The EVADE study represents an innovative pre-emptive
therapy approach to prevent P aeruginosa nosocomial pneumonia in
MV patients by utilizing the novel mAb, MEDI3902, thereby offering a
new paradigm in P aeruginosa infection management in high-risk
patients.
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Short-term inhaled colistin adjunctive therapy for ventilator-
associated pneumonia
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Introductions: Ventilator-associated pneumonia (VAP) is an import-
ant cause of prolonged intensive-care stay and mortality, particu-
larly with the emergence of multi-drug resistant gram-negative
bacteria.
The aim of this study is to investigate the role of inhaled colistin on
the outcome of patients diagnosed with gram-negative VAP.
Methods: We recruited all patients with a confirmed gram-negative
culture and sensitivity taken from Endotracheal (ETT) aspirates
after > = 48 hrs of mechanical ventilation and pneumonia clinical
criteria: radiological infiltrates, fever, leucocutosis or leucopenia,
purulent secretions. Eighty five were randomized to enter either
the study group of inhaled colistin (3x 106 IU/day, for 5 days) as
an adjunctive therapy to conventional treatment of VAP (n = 52
pts) or enter the control group of conventional therapy only (n =
33 pts). Comparison included microbiological outcome (Day 6 ETT
aspirate culture and sensitivity) as well as clinical outcome, clin-
ical pulmonary infection score- CPIS.
Results: There was a higher organism clearance rate in the colistin
compared to the control group (p = 0.02). Multi-drug resistant or-
ganisms were observed in [26 (50 %) vs 13 (39.4 %), p = 0.79 ] of the
Colistin and Control groups respectively. There was a higher clear-
ance rate of MDR organisms [21/26(81 %) vs 3/13(23 %), p = 0.0005]
in Colistin vs. Control groups respectively.
There was statistically significant difference in (CPIS) between both
groups. A score >6 represented ( 21.2 % vs 45.5 % , p = 0.01) in Colis-
tin vs control group respectively. A smaller number of patients re-
quired mechanical ventilation > 15 days in the Colistin vs control
group, (p = 0.013). The ICU mortality was (40 % vs 69.7 %, p = 0.008)
in Colistin vs control group respectively. No significant change of
renal function or occurrence of bronchospasm were observed be-
tween both groups.
Conclusions: Short duration of adjunctive inhaled colistin shows a
significant clearance of the initial organisms, including multi-drug re-
sistant groups, in patients with gram negative ventilator-associated
pneumonia. This line of treatment shows a significant decrease in
the duration of mechanical ventilation and ICU mortality when com-
pared with conventional therapy, with no significant added adverse
drug reactions. Adjunctive inhaled colistin is safe and effective as an
additive therapy in patients with gram-negative ventilator-associated
pneumonia.P100
Effect of aerosolised colistin on weaning from mechanical ventilation
A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal
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Critical Care 2016, 20(Suppl 2):P100
Introductions: Ventilator-associated pneumonia (VAP) due to
multidrug-resistant (MDR), gram-negative bacteria (GNB) is respon-
sible for a prolongation of ventilation days. Several recent studies fo-
cused in Aerosolized polymyxin emphasize the potential benefit of
this modality. Indeed, by increasing bactericidal activity in situ, this
modality led to faster resolution of clinical signs, and perhaps, accel-
erated weaning from mechanical ventilation (MV). The purpose was
to determine whether aerosolized colistin (AS) would accelerate
weaning from MV in VAP due to MDR GNB.
Methods: Prospective randomized trial from April 2013-April 2015.
Included were patients who have MV over 48 h and developed a
VAP defined as a CPIS (Clinical Pulmonary Infection Score) > 6. Ex-
clusion criteria were septic shock and / or bacteremia. Included pa-
tients were divided into two randomized groups. The first group
received colistin in AS as 4 million units (MU) by nebulisation 3
times per 24 h. The second group received colistin in IV as a load-
ing dose of 9 MU followed by 4.5MU two times per 24 h. Colistin
was given for 14 days or until extubation. Patients were followed
for 28 days.
Outcome Measures: primary: clinical cure defined as pathogen eradi-
cation and improvement in oxygenation but mainly weaning from
MV. Secondary: length of stay and 28-day mortality.
Ethical approval of the protocol was obtained from the institutional
review board
Results: a total of 133 patients were analyzed. The cure rates were
similar (71.2 % vs 68.6 %, p = 0.85). AS administration was superior in
improvement of the PaO2/FiO2 ratio during evolution. Also, it was
faster in pathogen eradication (p = 0.04). In survivors, weaning of
ventilation was significantly earlier in AS group: 13.8 vs 19 d (p =
0.01). No difference for secondary outcome measures (Table 14)
Conclusions: In critically ill patients with VAP due to MDR GNB, AS
colistin facilitate weaning from MV. This modality was superior in im-
provement of oxygenation and the time required for pathogen
eradication.P101
Septic shock is an independent risk factor for colistin-induced
severe acute kidney injury: a retrospective cohort study
B. Bilgili, M. Haliloglu, F. Gul, I. Cinel
Marmara University Pendik Teaching and Research Hospital, Istanbul,
Turkey
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Introductions: Colistin, a last-line therapeutic agent for the treatment
of multidrug-resistance gram-negative infections, is limited in its use
due to nephrotoxicity. This retrospective cohort study evaluates risk
factors for colistin-induced severe acute kidney injury (AKI) in critic-
ally ill patients.
Methods: Patients admitted to a university hospital ICU, were with-
out pre-existing kidney injury, and received colistin therapy 72 or
more hours were included. Patient demographics, the source of in-
fection and outcome were collected. AKI was evaluated by using the
Fig. 19 (Abstract P103). Performance of PDDS vs. CVMN.
Fig. 18 (Abstract P103). Amikacin Inhale, an integrated
drug-device combination.
Critical Care 2016, Volume 20 Suppl 2 Page 48 of 182RIFLE criteria. Risk factors for the development of AKI were analyzed
via logistic regression analysis.
Results: One-hundred and two patients were included in the study.
The overall incidence of AKI was 77,5 % (n = 79), and that of severe
AKI was 34,3 % (n = 35). On univariate analysis, age and septic shock
correlated significantly with severe AKI patients (p = 0,042, p = 0,001,
respectively). By multivariate logistic regression analysis, septic shock
was the only independent risk factor for colistin-induced severe AKI
(OR 8,580 [1,868 – 39,417]; p = 0,006).
Conclusions: A high incidence of colistin-induced AKI defined by RI-
FLE criteria is observed in critically ill patients. Septic shock is the
only variable independently associated with severe AKI induced by
colistin therapy.
References
1) Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K: Evaluation of colistin
as an agent against multi-resistant Gram-negative bacteria. International
journal of antimicrobial agents 2005, 25(1):11-25.
2) Kim J, Lee KH, Yoo S, Pai H: Clinical characteristics and risk factors of
colistin-induced nephrotoxicity. International journal of antimicrobial
agents 2009, 34(5):434-438.
3) Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Pascale G,
Raponi G, Vitale M, Pietropaoli P, Antonelli M: Risk factors for acute
kidney injury in critically ill patients receiving high intravenous doses of
colistin methanesulfonate and/or other nephrotoxic antibiotics: a
retrospective cohort study. Critical care (London, England) 2013,
17(4):R174.
P102
Nosocomial pneumonia - emphasis on inhaled tobramycin
A. Kuzovlev1, A. Shabanov2, S. Polovnikov3, V. Moroz1
1V.A. Negovsky Research Institute of General Reanimatology, Moscow,
Russia; 2N.V. Sklifosofsky Institute of Emergency Medicine, Moscow,
Russia;3NN Burdenko Main Military Hospital, Moscow, Russia
Critical Care 2016, 20(Suppl 2):P102
Introductions: Inhaled antibiotics as an adjunct to systemic an-
tibiotics present as a significant treatment modality in ICU patients
with nosocomial pneumonia (NP). The aim of this study was to inves-
tigate into the efficacy of inhaled tobramycin (IT) as an adjunct to
systemic antibiotics in the treatment of NP in sepsis.
Methods: Sixty ICU ventilated septic patients with NP were enrolled
in the retrospective study (all male, 58.4 ± 6.3 years old; primary rea-
son for ICU stay - intraabdominal infections (80 %), mediastinitis
(13 %), other (9 %)). Diagnosis of NP was made according to the
standard clinical and CPIS criteria. Associations of multiresistant
gram-negative bacteria (sensitive to tobramycin) were detected in
bronchoalveolar lavage (BAL) of all patients. Patients were random-
ized into two groups: IT (n = 30), addition of IT to systemic antibiotics
(carbapenems, aminoglycosides, protected penicillins); and no IT (n =
30), shift of systemic antibiotics according to sensitivity. Groups were
comparable in APACHE II and CPIS scores. Inhaled tobramycin was
administered 300 mg twice daily via nebulizer. NP resolution on day
5 after IT initiation was assessed as a primary outcome. The data
were statistically analyzed by STATISTICA 7.0 (M, &#963;, Newman-
Keuls test; p < 0.05).
Results: Administration of IT as an adjunct to systemic antibiotics was
associated with a higher incidence of NP resolution (84 % vs. 52 %, p =
0,0322, χ criterion). The decrease of microbial titer to 103 to 104 CFU/
ml was detected in both groups by days 5 to 7, but it was reliable in
73,6 % of the patients of group 1 (p < 0.02). Eradication of microbes in
BAL on day 7 was achieved in 72 % of IT-treated patients and in 48 %
of antibiotic shift patients. Treatment with IT made it possible to wean
patients earlier: by day 8.2 ± 1.5 vs. 11.1 ± 2.8 in the other group (p =
0.001). Hearing loss and tinnitus were detected only in three patients
treated with IT. There were no cases of bronchospasm during inhal-
ation of IT. The mortality rates did not differ between the groups (16 %
in IT-group vs. 12 % in antibiotic shift group).
Conclusions: Administration of IT as an adjunct to systemic antibiotics
is efficient in the treatment of NP – it leads to a higher rate of NP reso-
lution and an earlier weaning from ventilator.P103
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Introductions: Amikacin Inhale is an integrated drug-device combin-
ation of: Pulmonary Drug Delivery System (PDDS), vibrating mesh
nebulizer & specially formulated Amikacin Inhalation Solution (AIS) in
development for Gram-negative pneumonia in intubated & mechan-
ically ventilated patients (Fig. 18). This in vitro study compared the
delivered dose of AIS from the PDDS vs commercially available
nebulizers.1
Methods: Delivery of AIS (400 mg; 3.2 mL of 125 mg/mL) was com-
pared for the PDDS vs commercially available jet, ultrasonic or con-
ventional vibrating mesh nebulizers (CVMN). Each was tested at the
ventilator location specified in its Instructions for Use (IFU). The
CVMN was tested at 4 further positions. Except for the CVMN pre-
humidifier, tests were performed without humidification.
Results: Vibrating mesh nebulizers (PDDS, CVMN) achieved higher
delivered doses than ultrasonic (4 %) and jet (11 %) nebulizers. The
delivered dose of AIS post-ET tube was higher with the PDDS vs
CVMN (57 % vs 19 % of nominal). Up to 60 % of AIS was collected in
the expiratory filter with the CVMN vs 3 % for the PDDS. The CVMN
had improved deposition (up to 29 %) at the extra locations relative
to IFU position but this was still lower than with the PDDS (Fig. 19).
Delivered dose with the CVMN was affected by humidity, which has
previously been shown not to affect PDDS performance.2
Conclusions: Amikacin Inhale (AIS delivered by PDDS) provided a
higher delivered dose of AIS vs commercially available nebulizers.
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Introductions: Nebulization of antibiotics is a promising strategy for
the treatment of severe pulmonary infections. We tested, in an ani-
mal model of severe pneumonia, short-term therapeutic efficacy of
nebulized and systemic antibiotics.
Methods: Seventeen pigs (31.8 ± 1.9 Kg) were anesthetized and on
MV for 78 hours. Multi-lobar pneumonia was developed by P. aerugi-
nosa (1), resistant to amikacin (A), fosfomycin (F) and susceptible to
meropenem (Mero). Following clinical diagnosis of pneumonia, ani-
mals were randomized to receive the following treatments: nebulized
saline (control); nebulized AF; nebulized A; nebulized F; nebulized AF
with Mero administered IV; Mero alone. Nebulization was performed
through an in-line vibrating mesh nebulizer (PARI GmbH, Germany).
Upon autopsy, lungs were weighed and the lobes biopsied for
P.aeruginosa quantification.
Results: Upon autopsy, lungs weighed 732 ± 320gr in the control
group, 546 ± 89gr in the AF, 560 ± 83gr in the A group, 519 ± 53gr
in the F, 480 ± 85gr in AF + Mero and 537 ± 80gr in the Mero group
(p = 0.591). As depicted in Fig. 20, P.aeruginosa concentration in
lung tissue varied among groups (p < 0.001). In particular, in the AF +
Merop group, the highest bactericidal efficacy was achieved.
Conclusions: In an animal model of amikacin-resistant P.aeruginosa
pneumonia, the adjunctive use of nebulized AF and systemic mero-
penem achieves higher bactericidal efficacy vs. nebulized or systemic
antibiotics alone.
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Optimization of gentamicin peak concentrations in critically ill
patients
C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman,
R. A. Mathôt, M. D. De Jong, R. M. Van Hest
Academic Medical Center, Amsterdam, Netherlands
Critical Care 2016, 20(Suppl 2):P105
Introductions: Despite the administration of body-weight standard-
ized starting doses of gentamicin, a wide range in peak concentra-
tion (Cpeak) is generally observed in critically ill patients resulting
from variable pharmacokinetics of gentamicin between patients and
within a patient over time. This may hamper the efficacy of gentami-
cin treatment. The aims of this study were 1) to determine thepercentage of patients that reached a target Cpeak level of 15-
20 mg/L after the first dose as well as after subsequent doses during
which therapeutic drug monitoring (TDM) was applied and 2) to
quantify the impact of several patient parameters on the volume of
distribution (Vd) of gentamicin, which is correlated with Cpeak.
Methods: Blood samples were prospectively collected and analysed by
nonlinear mixed-effects modelling (NONMEM) to estimate Vd and
Cpeak for every administration during a course of gentamicin therapy.
Clinical data and routinely collected serum gentamicin levels from crit-
ically ill patients were analysed retrospectively with NONMEM to quan-
tify the impact of patient parameters on gentamicin Vd and Cpeak.
Results: With a median starting dose of 4.9 mg/kg, 39 % of Cpeak
were subtherapeutic after the first dose (n = 59 patients). In total,
52 % of 131 Cpeak were not within the therapeutic range of 15-
20 mg/L during the course of therapy. Of the 20 cases with subse-
quent Cpeak values and no dose adjustment, 6 (30 %) changed from
non-therapeutic to therapeutic and 3 (15 %) changed from the-
rapeutic to non-therapeutic Cpeak. Even after performing TDM, 24 % of
subsequent doses resulted in subtherapeutic and 24 % in suprathera-
peutic levels. Analysis was performed retrospectively on 303 gentami-
cin concentration measurements from 44 critically ill patients receiving
174 doses. Albumin serum level was significantly (p < 0.001) associated
with Vd and with Cpeak. Most patients with albumin levels below
15 mg/L did not obtain therapeutic Cpeak.
Conclusions: 39 % of gentamicin Cpeak were below the therapeutic
range after a first median dose of 4.9 mg/kg in critically ill patients, sug-
gesting that higher doses are indicated. Patients with hypoal-
buminaemia are at increased risk for achieving suboptimal gentamicin
Cpeak, suggesting that gentamicin dose should be increased for pa-
tients with hypoalbuminaemia. Since gross fluctuations in Cpeak were
observed over time within patients, Cpeak should be measured repeat-
edly when patients receive gentamicin treatment for more than 2 days.
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Introductions: Cefepime is a widely used antibiotic with the potential
for significant, but under-appreciated neurotoxicity due to its ability to
cross the blood brain barrier and antagonize GABA activity in a concen-
tration dependent fashion. Data suggest that 15 % of ICU patients
treated with cefepime will experience neurotoxicity with symptoms
that range from encephalopathy, myoclonus, seizures and coma. Rec-
ognition of this adverse event is difficult since these symptoms are
commonly experienced by the critically ill. We reviewed published lit-
erature to further characterize this adverse drug event.
Methods: A librarian-assisted search was conducted to create a list of
all publications associated with cefepime associated neurotoxicity
patients from 1980-2015. Our search employed the CINAHL and
MEDLINE databases for article identification and the PRISMA-P proto-
col was followed to promote robust reporting of data. To determine
eligibility for study inclusion, identified articles were independently
assessed by two reviewers.
Results: Thirty-five identified publications described cefepime in-
duced neurotoxicity in 137 patients. Patient characteristics included
both ICU (17 %) and non-ICU patients (4 %), but patient location was
unspecified in most cases (79 %). Symptoms included encephalop-
athy (75 %), myoclonus (41 %), seizures (11 %), and coma (1 %).
Renal dysfunction was present in 93 (68 %) patients and cefepime
dosing was appropriate, excessive, or unable to be assessed for
20 %, 41 %, 39 % respectively. Symptom onset was between 1-15
days (median 4) after initiation of therapy with resolution within
3 days (median 2) of cessation of cefepime. Emergent hemodialysis
was employed in one case, and 55 patients (40 %) required treat-
ment with an antiepileptic medication. Serum levels were collected
in 12 patients and were exceeding toxic thresholds (<20 mcg/ml) in
11 patients (mean 64 ug/mL). Ninety-one patients (66 %) survived,
13 patients died (9 %), and the individual outcomes of the remaining
patients were unreported. Complete neurologic recovery was
Critical Care 2016, Volume 20 Suppl 2 Page 50 of 182reported in 62 patients (45 %) and symptom improvement in 27
(20 %). All patients with reported neurologic recovery did not im-
prove until cefepime was discontinued.
Conclusions: Cefepime associated neurotoxicity is an under-
appreciated adverse drug event that is difficult to recognize in the
critically ill. Early recognition of cefepime neurotoxicity is critical and
may prevent potentially devastating consequences that occur with
continued drug administration.P107
Unasyn® causes QT prolongation during treatment of intensive
care patients
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Introductions: Patients admitted to an intensive care unit have a multi-
factorial disorder based on diseases in which cascades of immu-
nomodulation mediators may be released as response to pathogenic
organisms. To treat the inflammatory reaction an antibiotic therapy is
fundamental [1]. Effects of disease pattern and intensive care measures
(e.g. sepsis) on heart rate and variability are poorly understood.
Haran B described that with a high resolution ECG even in patients
without prior heart pathologies an electrical instability could be de-
tected during repolarisation shortly before cardiac arrest, not record-
able with a conventional ECG [2].
Therefore we analysed changes of beat-to-beat cardiac activity dur-
ing antibiotic therapy of intensive care patients with a high reso-
lution electrocardiogram. Obtained results may offer new insights in
the development of alterations in cardiac electrical activity of critical
ill patients due to antibiotic therapy.
Methods: Administrated at 1000 Hz sampling rate the cardiac electric
activity of 14 patients of the intensive care unit were analysed during
their antibiotic therapy. The patients received a Unasyn®-infusion,
which contains 1 g Sulbactam, 2 g Ampicillin and 230 mg sodium.
Obtaining continuous ten-minute recordings (Lab SystemTh Pro - Bard
electrophysiology U.S.A.) ten electrodes were fixed on the prepared
skin for recording the leads I, II, III and V1 to V6 and reconstruct pursu-
ant to Einthoven’s equation aVR, aVL, aVF.
Results: Results obtained from 14 treatments with Unasyn® demon-
strate that from the onset of the infusion the QT-interval increases
additionally up to 39 ms (p < 0,05). This variation persisted for the
first three minutes of therapy and returns during the next two mi-
nutes to their pre-values. Other ECG data remained unchanged dur-
ing the time of treatment.
Conclusions: Haemodynamic alterations – QT-interval prolongation -
could be detected with onset of antibiotic treatment with Unasyn®.
The similar antibiotic Tazonam® showed in another study of us no
significant beat-to-beat changes. With regard to comorbidities of ICU
patients, it seems reasonable that changes in cardiac electric activity
might be observed even earlier during their ICU stay.
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Introductions: Our objective is to compare efficacy and safety of
vancomycin versus teicoplanin in Methicillin-resistant staphylococcus
aureus (MRSA) infections among poisoned patients of toxicological
ICU of Loghman Hakim hospital.Methods: Safety and efficacy of vancomycin versus teicoplanin has
been assessed in 104 patients consisted of 54 patients treated by tei-
coplanin and 50 patients treated by vancomycin. Based on the man-
ufacturer’s instruction and kidney function in each patient, drug dose
was adjusted. Teicoplanin was administered at a loading dose of
6 mg/kg (400 mg maximum dose) for three loading doses every
12 hrs and then every 24 hrs for 7 to 10 days. Vancomycin was adminis-
tered at a loading dose of 20 mg/kg every 12 hrs (maximum dose 2gr/
day). Blood, urine and tracheal samples were cultured. Chest X-ray and
routine Para clinical studies have been done in all cases. The study
populations were assessed during 3 visits and one month follow up. Pa-
tients with fever and positive tracheal cultures (TC) ± abnormal WBC at
the end of treatment, have been reported as failure of treatment.
Results: Seventy eight (75 %) out of the 104 eligible patients, were
male. The mean age ± SD of patients was 36.1 ± 16.8 and 39 ± 13.4 in
teicoplanin and vancomycin groups, respectively. Most common drug
toxicities were opium, TCA (tricyclic antidepressant), methadone. Mor-
tality rate in teicoplanin group was 16.6 % but in vancomycin was
22 %.Complications during respiratory infection process were seen in
5/50 and 9/54 in vancomycin and teicoplanin groups respectively, in-
cluding ARDS 2 (40 %) in vancomycin group and 7 (77.8 %) in teicopla-
nin group, pleural effusion in 2 (40 %) in vancomycin group versus 1
patient (11.1 %) in teicoplanin group. One patient in teicoplanin group
had empyema and 1 (20 %) in vancomycin group had chronic obstruct-
ive pulmonary disease (COPD). Treatment failure in vancomycin group
was 5/50 (10 %) and in teicoplanin group was 4/47(8.5 %) (P value >
0.05) and all positive TC in both groups were polymicrobial. Nephrotox-
icity and bicytopenia, as the adverse effects had significant differences
between two groups.
Conclusions: Teicoplanin should be considered as an effective alterna-
tive to vancomycin in Methicillin-resistant staphylococcus aureus
(MRSA) infections treatment. Adverse effects such as nephrotoxicity
and bicytopeniasignificantly were decreased in teicoplanin therapy.
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Introductions: Bacteriophages are environmental viruses. Lytic phages
have proprieties to penetrate and multiply inside their targeted bac-
teria until the release of new virions. Many clinical empirical data are
available from Georgia and Poland, but no control randomized clinical
trial is available. The phagoburn study assess efficacy and tolerance of
two cocktails of bacteriophages against Escherichia coli and Pseudo-
monas aeruginosa.
Methods: Natural phages were isolated from hospital and Paris sew-
ages. They were featured by phenotype and genotype to exclude
transfer of antibiotic resistance genes and lysogenic proprieties by
Pherecydes-Pharma. PP0121 is a cocktail of 12 phages against E coli,
and PP1131 was performed against P. aeruginosa.
Cocktails are applied by a topical way in burn patients infected by E.
coli or P. aeruginosa applied through an alginate gauze (Algosteril)
onto infected wounds. The control arm is treated by Silver Sulfadiazine
(standard treatment).
The main goal is the comparison of time to reduce bacterial load of
2 quadrants on plate by daily eSwabs.
220 patients are expected. All patients are hospitalized in a burn unit
to ensure a safety environment.
Results: Phagoburn was funded by European Commission (FP7) in 2013
for 3,8 million Euros. After transfer from research and development to a
Master Phage Bank, bioproduction of phages was performed in GMP-
like conditions by Clean Cells (Nantes-France). As a systemic absorption
of phages is supposed, an isolator was necessary to ensure a sterile and
apyrogenic solution. The 3 european regulators (French agency ANSM,
AFMPS for Belgium, and Swiss-Medic for Switzerland) allowed the first
Critical Care 2016, Volume 20 Suppl 2 Page 51 of 182inclusion in July 2015. In December, 15 patients were already included
in 11 investigators centers.
Conclusions: One century after phages discovery, Phagoburn is the
first mutlicentric control randomized trial ever done in the world
about phage therapy in humans. Results will be available in 2016.
Phages could be an old but innovative way in the war against anti-
microbial resistance. Antimicrobial resistance could be the leading
cause of mortality in 2050.
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Introductions: Effective antibiotic therapy, which can be defined as
the timely administration of the antibiotic to which the causative
microorganism is susceptible using the right dose, has been associated
with improved outcomes in severe sepsis or septic shock. However,
antibiotic dosing errors are not uncommon. This study evaluated the
frequency and the risk factors of antibiotic dosing errors in patients
with severe sepsis or septic shock.
Methods: This was a prospective observational study of all adult pa-
tients with severe sepsis or septic shock who were admitted to the
ICU between 01/10/2013 and 30/04/2014. Using Micromedex as the
reference, the doses of administered intravenous antibiotics on the
first ICU day were compared to the recommended doses and were
classified as under-dosed, over-dosed or appropriate. We excluded
antibiotics which usually does not need dose adjustment. Multivariate
logistic regression analysis was performed to assess predictors of anti-
biotic dosing error (under- or over-dosing). Age, gender, height, weight,
chronic cardiovascular and renal diseases, estimated glomerular filtra-
tion rate and presence of shock were the independent variables.
Results: During the study period, 189 patients had severe sepsis
(62 %) or septic shock (38 %). We evaluated 263 antibiotic prescriptions.
Most (62 %) patients received appropriate antibiotic doses. However, 39
(21 %) patients were under-dosed, 30 (16 %) were over-dosed, and 3
(2 %) had combination of over-dosing and under-dosing. Septic patients
with chronic cardiovascular disease (p = 0.035) and chronic renal failure
(p = 0.021) were more likely to have antibiotic dosing errors. However,
respiratory failure, liver failure, immunodeficiency state and diabetes
mellitus were not clearly associated with dposing errors. Vancomycin
was associated with the highest dosing error rate (43 %). The other anti-
biotics (pipercillin/tazobactam, meropenem, imipenem, ceftriaxone, cip-
rofloxacin, colistin and gentamicin) were dosed appropriately in >70 %
of prescriptions. The multivariate analysis showed that the estimated
glomerular filtration rate was the only variable associated with dosing
error (odds ratio, 0.98 per 1 ml/min increment; 95 % confidence interval,
0.97-0.99).
Conclusions: Antibiotic dosing errors, which include under- and
over-dosing, were common in patients with severe sepsis or septic
shock. Vancomycin had the highest rate of inappropriate dosing.
Lower glomerular filtration rate was a significant predictor of dosing
error and should be routinely considered for antibiotic dosing.
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Critical Care 2016, 20(Suppl 2):P111Introductions: The management of invasive candidiasis (IC) remains
a major challenge. Delayed antifungal therapy is known as an inde-
pendent mortality factor in Septic shock attributed to IC [1]. Thus,
empiric antifungal therapy (EAFT) can be indicated in septic patients
at risk of IC. However, the unreasonable administration of antifungal
is implicated in emergence of resistant candida strains [2]. The pur-
pose was to evaluate the impact of an EAFT on 28-day survival in
septic patients without documented Candida infection.
Methods: a retrospective cohort study. Two groups of septic patients
without a documented fungal infection were compared according to
whether they were treated or not by an EAFT. Included were hospi-
talized patients more than seven days that developed a sepsis and
even the sepsis origin has not been determined. Excluded were pa-
tients treated with an antifungal adapted to documented fungal in-
fection and immunocompromised. The analysis consisted in
evaluating the impact of an EAFT on 28-day survival. The analysis
was adjusted on the following confounding factors: the Acute
Physiology And Chronic Health Evaluation II (APACHE II) score, the
candida score, invasive ventilation and central catheterisation.
Results: 83 patients were included. 48 in the EAFT + group and 35
in the EAFT- group. The patient’s baseline characteristics were com-
parable in severity illness, underlying diseases and risk factors for
IC. Moreover, the EAFT + group had a younger age (48 vs 58, p =
0.03) and higher candida score (3.08 vs 2.31, p = 0.01). It has not
been demonstrated an improvement of 28-day survival of an EAFT
when administered to septic patients without documented fungal
infection. These results were in accordance both in crude analysis
and after adjusting on APACHE II score, candida score, invasive ven-
tilation and central catheterisation with OR = 0.73 ; CI 95 % [0.28;
1.91]; p value = 0.53. However, improved survival by an EAFT was
showed in patients with an APACHEII score < 16: OR = 0.62; CI95%
[0.39; 0.97]; p =0.036. Similar results were objectified by the Kaplan-
Meier survival curves.
Conclusions: no beneficial impact of an EAFT on at 28-day survival
apart moderately ill patients with APACHE II <16.
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Introductions: Neurocysticercosis (NCC) is the most common parasitic
disease of the central nervous system. Every newly diagnosed patient
with NCC has probably been infected by someone harboring tape-
worm in patient’s immediate environment. On the basis of an incor-
rect assumption that human NCC does not occur in countries in
which law prohibit swine breeding and consumption of pork, the
disease is has been considered nonexistent in Arab world.
Methods: A retrospective study was carried out in the Emergency de-
partment, Alkhor hospital, HMC from April 2014 to May 2015 (14170/
14). All patients above age of 18 yrs diagnosed to have Neurocysticer-
cosis from August 2005 to December 2013 were included in the study.
Data were retrieved from medical record department and electronic
data base. This included baseline demography, clinical presentation
and radiological findings.
Results: Out of total 137 subjects enrolled 9 were excluded. All the
128 subjects were male Majority of the subjects was in the age
group 21-30 yrs (n = 86)-. Majority were from Nepal 76 (58.1 %). 30
(20.3 %) patients gave history of previous episodes of seizure, how-
ever only 8 of them were on regular antiepileptic medication. 107
patients presented to A &E with seizures (83.5 %). Among which
GTCS was the most common form 85 %. Use of tobacco was seen
in 20 subjects (13.6 %) and Alchohol in 10 (6.8 %). 9 subjects re-
ported to use both. Radiological examination, CT scan revealed
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39.8 %. Perilesional edema was noted in 100 subjects.
114 patients were admitted to the hospital out of which 5 required
ICU care. Anti-epileptic medication was initiated in all patients except
10 patients. Reason could not be identified. Except for 13 patients all
other patients received short course of oral steroids.
Conclusions: 1) Majority of the patients are young males from Asian
countries.
2) GTCS is the most common mode of presentation.
3) Solitary lesion is the most common radiological findings.
The increased ease of international travel and increasing number of
immigration from developing countries have led to widespread rec-
ognition of NCC developed countries.
Reference
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Early indicators in acute haemorrhagic shock
A. Kleinsasser
MUI, Innsbruck, Austria
Critical Care 2016, 20(Suppl 2):P113
Introductions: Acute haemorrhage in the CCU may be hard to per-
ceive. Variables other than blood pressure or haemoglobin are
sought after.
Methods: In this study we examined how acute haemorrhage affected
cardiovascular, blood gas, laboratory and pulmonary gas exchange vari-
ables before, right after and 60 minutes after a 65 % blood loss in a
model with anesthetized pigs. Blood pressure, lactate concentration,
base deficit and blood glucose may all act as indicators for acute
haemorrhage.
Results: All animals had comparable variables at baseline. Right
after exsanguination animals expectedly showed depression of
cardiovascular variables. In addition, lactate and blood glucose
were increased directly after blood loss. The drop in haemoglo-
bin concentration still remained insignificant at 60 minutes after
blood loss. Base deficit was only different 60 minutes post
bleed.
Conclusions: Glucose and lactate are earlier indicators than Hb or
BE.Fig. 21 (Abstract P113).P114
Filtering of red blood cells reduces the inflammatory response of
pulmonary cells in an in vitro model of mechanical ventilation
M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings,
N. P. Juffermans
Academic Medical Centre, Amsterdam, Netherlands
Critical Care 2016, 20(Suppl 2):P114
Introductions: Red blood cell (RBC) transfusion is associated with
acute lung injury, but the causative factor is not known. Possibly,
mechanical ventilation and red blood cell (RBC) transfusion are syner-
gistic in the induction of lung injury. We hypothesize that filtering of
RBCs or depletion of RBCs from microvesicles decreases the pulmon-
ary inflammatory reaction during mechanical ventilation.
The objective of this study is to investigate the effects of filtering of
RBCs or depletion of RBCs from microvesicles on the production of
IL-8 in an in vitro model of mechanical ventilation.
Methods: Alveolar epithelial type II A549 cells were cultured on an
elastic membrane and incubated with cells or supernatant from
stored (35-42 days) RBC products. RBCs were optimized by filtering
of the supernatant using a 0.2micron filter, or by depletion of the
supernatant from microvesicles using high-speed centrifugation (N =
4 per group). Cyclic stretch of 25 % was applied to the cells for
24 hours using a cell-stretcher at 37&#730;C in the presence of 5 %
CO2. IL-8 production was measured using ELISA. Controls are un-
treated products and non-stretched cells.
Results: Stretched cells showed higher levels of IL-8 compared to
non-stretched cells (198.2 ± 11.7 vs 62.0 ± 1.9 pg/ml, p < 0.05). Incuba-
tion with untreated RBC products further spiked IL-8 production
compared to cells that were only stretched (892.8 ± 235.8 vs 198.2 ±
11.7 pg/ml, p = 0.027). Both filtering of supernatant and depletion of
microvesicles resulted in reduction in levels of IL-8, compared to
samples to which untreated RBCs were added (respectively 306.6 ±
73.1 vs 340.2 ± 24.4 vs 892.8 ± 235.8 pg/ml, p = 0.02).
Conclusions: Stretching of alveolar cells and RBC transfusion have a
synergistic effect on the production of IL-8. Furthermore, our experi-
ments indicate that supernatant of RBCs contain causative agents for
IL-8 production. Possibly, microvesicles are responsible for this reac-
tion. Filtering of RBCs might be a reasonable and feasible procedure
to remove microvesicles from the products.
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Microparticles from red blood cell transfusion induce a
pro-coagulant and pro-inflammatory endothelial cell response
M. Van Hezel1, M. Straat1, A. Boing1, R. Van Bruggen2, N. Juffermans1
1Academic Medical Center Amsterdam, Amsterdam, Netherlands;
2Sanquin, Amsterdam, Netherlands
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Introductions: Red blood cell (RBC) transfusion is associated with in-
creased morbidity and mortality in the critically ill. We hypothesized
that MPs from stored RBC bags can induce endothelial activation, either
directly or mediated by immune cells.
Methods: MPs were isolated by high speed centrifugation from RBC
transfusion bags. Human umbilical vascular endothelial cells (HUVECS)
were incubated for 6 hours with supernatant from RBC bags either con-
taining MPs or depleted from MPs, with or without addition of mon-
ocytes or granulocytes. Controls were incubated with PBS as a negative
and TNF as a positive control. Expression of adhesion markers were mea-
sured on flow cytometry and markers of coagulation and inflamma-
tion were measured in the culture medium. Monocytes were cultured
with stained MPs and adherence was studied using confocal microscopy.
Results: Supernatant from RBCs containing MPs up-regulate endo-
thelial expression of ICAM and E-selectin with 7.8 [2.8 – 22.9]% and
2.6 [-1 – 7.7]% resp. compared to baseline. Up-regulation was absent
when stimulated with RBC supernatant depleted from MPs. Also, up-
regulation depended on the presence of monocytes. MPs adhere to
Critical Care 2016, Volume 20 Suppl 2 Page 53 of 182monocytes, which was partly abrogated after co-incubation with
antiCD11b or anti-CD18 antibodies (from 100 to 67[57-72]% and to
56[47-67]% of positive cells resp.). RBC-derived EVs also strongly in-
duce endothelial shedding of vWF.
Conclusions: Up-regulation of endothelial cell adhesion markers and
shedding of vWF antigen following RBC transfusion is caused by MP,
and requires the presence of monocytes. Thereby, MPs from RBC units
induce a pro-inflammatory and pro-coagulant endothelial cell response.P116
The contribution of cytokines on thrombosis development during
hospitalization in ICU
D. Markopoulou1, K. Venetsanou1, V. Kaldis1, D. Koutete1, D. Chroni1,
I. Alamanos2
1KAT Hospital Athens, Kifisia, Greece; 2ICU-B, KAT Hospital Kifisia, Athens,
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Introductions: The development of thrombosis in ICU patients is one
of the most frequent causes for unfavourable outcome. The different
types severe illness are accompanied by activation of cellular and
biochemical processes. The aim of the study is to investigate the pos-
sible effect of cytokines on thrombosis in trauma and neurosurgical pa-
tients in ICU.
Methods: Eighty-four patients, 46 with trauma and 38neurosurgical
included in the study, divided into two groups according to throm-
bosis incidence. Demographic and clinical data were recorded and a
single blood sample collected on admission. Interleukins (IL-) -6,-8,-10
and Tumor necrosis factor (TNF)-a, were determined in serum by
ELISA. Statistics performed with Graphpad 5.0.
Results: Patients with thrombosis showed statistically significant ele-
vated proinflammatory cytokines (TNF-a, p < 0.01, IL-6, p < 0.05) and
lower anti-inflammatory IL-10 release (p < 0.05) on admission, compared
to those without thrombosis. IL-8 admission levels, had no difference be-
tween groups (p > 0.05), due to later expression. There were no signifi-
cant differences between age and hospitalization days in both groups.
Thrombosis found to be correlated with poor outcome (p < 0.05).
Conclusions: The early activation of cytokines in trauma and neuro-
surgical patients seems to play an important role on thrombosis de-
velopment and further patient’s outcome.
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Prophylactic enoxaparin dosing and adjustment through anti-xa
monitoring in an inpatient burn unit
L. Koch, J. Jancik, H. Rhodes, E. Walter
Hennepin County Medical Center, Minneapolis, USA
Critical Care 2016, 20(Suppl 2):P117
Introductions: The incidence of venous thromboembolism (VTE) in
acute burn patients has been reported to range from 0.4 %-23%.
[1] Standard enoxaparin prophylaxis dosing has been shown to pro-
vide anti-Xa levels below goal in a significant proportion of burn
patients, resulting in a potential increase in thrombotic risk. [2] The
objectives of this study were to evaluate the effectiveness of
standard prophylaxis enoxaparin dosing within an inpatient burn
unit and identify patient characteristics associated with lower initial
anti-Xa levels.
Methods: Patients admitted to the burn unit between November
2009 and July 2015 with an appropriately measured anti-Xa level
were examined through retrospective chart review. Levels were con-
sidered appropriate if drawn 3-5 hours after at least three consecu-
tive enoxaparin doses. Anti-Xa levels ranging from 0.1-0.4U/mL were
considered to be within the goal prophylactic range. Patient demo-
graphics and injury data including age, sex, admission weight, and
burn percentage of total body surface area (%TBSA) weredocumented. The incidence of VTE and adverse events, including
bleeding events attributed to enoxaparin, were also recorded.
Results: Thirty-three acute burn injury patients treated with enoxa-
parin had at least one measured anti-Xa level during admission. Only
21 of these patients (63.6 %) had an initial anti-Xa level within the
specified goal range. An additional 6 patients (18.2 %) were initially
subtherapeutic, but achieved therapeutic levels with dose adjust-
ment, while 4 patients (12.1 %) never had a measured anti-Xa within
goal range prior to the discontinuation of enoxaparin or before
discharge. The median enoxaparin dose required to achieve goal
anti-Xa levels was 40 mg every 12 hours. Patients with an initial
therapeutic level had an average burn size of 23.2 % TBSA and mean
admission weight of 106.7 kg, while those with an initial subthera-
peutic level had an average burn size of 40 % TBSA and mean admis-
sion weight of 114.1 kg. There was one VTE event among the study
population, occurring in a patient with therapeutic anti-Xa levels.
There were no documented bleeding events leading to the discon-
tinuation of enoxaparin in any of the study participants.
Conclusions: Standard enoxaparin dosing was shown to provide
initial subtherapeutic anti-Xa levels in many patients with acute
burn injury. In the overall study population, the enoxaparin dosing
strategy was associated with a low incidence of VTE and bleeding
complications.
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Determination of optimal cut-off values of haemoglobin, platelet
count and fibrinogen at 24 hours after injury associated with
mortality in trauma patients
K. Maekawa1, M. Hayakawa1, S. Kushimoto2, A. Shiraishi3, H. Kato4,
J. Sasaki5, H. Ogura6, T. Matauoka7, T. Uejima8, N. Morimura9,
H. Ishikura10, A. Hagiwara11, M. Takeda12
1Hokkaido University Hospital, Sapporo, Japan; 2Tohoku University
Graduate School of Medicine, Sendai, Japan; 3Tokyo Medical and Dental
University Hospital of Medicine, Tokyo, Japan; 4National Hospital
Organization Disaster Medical Center, Tokyo, Japan; 5Keio University
School of Medicine, Tokyo, Japan; 6Osaka University Graduate School of
Medicine, Osaka, Japan; 7Rinku General Medical Center, Osaka, Japan;
8Kinki University Faculty of Medicine, Osaka, Japan; 9Yokohama City
University Graduate School of Medicine, Yokohama, Japan; 10Faculty of
Medicine, Fukuoka University, Fukuoka, Japan; 11National Center For
Global Health and Medicine, Tokyo, Japan; 12Tokyo Women’s Medical
University, Tokyo, Japan
Critical Care 2016, 20(Suppl 2):P118
Introductions: The purpose of this study was to determine optimal
cut-off values of haemoglobin, platelet count and fibrinogen at
24 hours after injury associated with mortality in trauma patients.
Methods: We performed a retrospective analysis of patients survived
over 24 hours after injury from J-OCTET (Japanese Observational
study for Coagulation and Thrombolysis in Early Trauma) database. J-
OCTET was a retrospective multicenter study to investigate disorders
of coagulation and thrombolysis in patients with severe trauma. Mul-
tivariable logistic regression models were developed to determine
optimal cut-off values of hemoglobin, platelet count and fibrinogen
at 24 hours after injury. We validated the models internally with
bootstrapping to assess potential overfitting.
Results: There were 722 trauma patients included, with median age
of 57 years, median injury severity score of 22, median revised trauma
score of 7.84, and an overall mortality of 6.5 %. The optimal models asso-
ciated with mortality were hemoglobin < 10.0 g/dL (c-statistic 0.77,
95%CI&#12288;0.69-0.85), platelet count < 10.0x104 /μ L (0.80, 0.72-0.87),
fibrinogen < 200 mg/dL (0.82, 0.72-0.92). After 200 cycles of bootstrap-
ping, the average optimisms were 0.03, 0.03 and 0.01, respectively.
Conclusions: A hemoglobin < 10.0 g/dL, platelet count < 10.0x104 /μ L
and fibrinogen < 200 mg/dL at 24 hours after injury were associated
with mortality. The impact of correction of these values with blood
products warrants further validation.
Fig. 22 (Abstract P120).
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Trauma-induced coagulopathy - prothrombin complex concentrate
vs fresh frozen plasma
O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova,
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Introductions: The mortality in the in patients with traumatic injuries
in a case of bleeding is the most frequent cause of preventable
death after severe injury.
Methods: The study involved 91 patients who entered the Odessa
Regional Hospital with traumatic injuries: concomitant skeletal trauma,
fractures of femur and humerus. Patients were divided into 2 groups:
1st group (n = 46) as a treatment was received PCC in a dose of 1 ml/
kg (25 IU/kg) and TXA in a loading dose of 1 g during 10 minutes
followed by an infusion of 1 g during 8 hours at time of admission to
the intensive care unit (ICU); 2nd group (n = 45) received FFP in a dose
of 15 ml/kg and TXA in a loading dose of 1 g during 10 minutes
followed by an infusion of 1 g during 8 hours. Evaluation of the func-
tional state of the hemostasis system was carried out using low-
frequency piezoelectric thromboelastography (LPTEG) on admission to
hospital and 24 hours after the patient’s admission to the ICU.
Results: According to LPTEG indicators traumatic injuries patients has
a statistically significant abnormalities in all parts of hemostatic sys-
tem: platelet aggregation - Intensity of contact coagulation (ICC), the
coagulation - Intensity of coagulation drive (ICD), clot maximum
density (MA) and fibrinolytic activity - Index of retraction and clot
lysis (IRCL). ICC in patients with traumatic injuries was reduced by
29.59 %, ICD was less than normal at 37.59 %, MA was reduced by
74.71 %, which showed coagulopathy, IRCL was 90,78 % above the
norm, which stands expressed hyperfibrinolysis. Patients of 1st group
according to LPTEG had significant changes in all parts of coagulation
24 hours after the intensive care. Indicators of platelet hemostasis char-
acterized by persistence of hypoagregation: ICC was reduced by
24.71 %, compared to the norm; parameters of coagulation and fibrin-
olysis have reliable trend toward normal and decreasing the activity of
fibrinolysis index reaches normal reference values. Patients of 2nd
group have hypoagregation and hypocoagulation state with decreased
active of fibrinolysis: ICC was reduced by 24.72 %, ICD reduced by
20.76 %, MA was reduced by 23.54 %, IRCL was in the normal range.
Clinically, patients of the 1st group had reducing the volume of blood
transfusions as opposed to the 2nd group.
Conclusions: Patients with trauma-induced coagulopathy have viola-
tion in all parts of hemostatic system. The use of prothrombin complex
concentrate and tranexamic acid can reduce the severity of patho-
logical changes in the hemostasis in patients with traumatic injuries.
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First study to prove the superiority of prothrombin complex
concentrates on mortality rate over fresh frozen plasma in patients
with acute bleeding
C. Plourde, J. Lessard, J. Chauny, R. Daoust
Hopital Sacré-Coeur de Montréal, Montreal, Canada
Critical Care 2016, 20(Suppl 2):P120
Introductions: Prothrombin complex concentrates (PCC) proved its
efficiency over fresh frozen plasma (FFP) in achieving faster coagulopa-
thy reversal and many other factors. However, a recent Cochrane re-
view/analysis found no superiority of PCC over FFP on mortality. Ad-
ditional research is needed to determine the impact of PCC on mortality.
Methods: This retrospective cohort study enrolled adults presenting
to the emergency department of a tertiary-care center betweenMarch 2008 and February 2015. All patients had evidence of acute
bleeding from any source, were anticoagulated with vitamin K-
antagonist and received vitamin K upon arrival. We compared mor-
tality rates between FFP and PCC using the Kaplan Meier survival
curve and a Cox multivariate regression.
Results: We identified 633 patients: 289 (45.7 %) received FFP and
344 (54.3 %) received PCC. Subjects treated with the FFP compare to
PCC increase their probability of mortality during the follow up
period (HR = 1.6 (95%CI: 1.2-2.1); p = 0.002) after controlling for con-
founding variables.
Conclusions: This study confirms the decrease in mortality over a
3 years follow up associated with PCC use compared to FFP in patients
presenting for any type of acute bleeding. PCC should be used as a first
line therapy for anticoagulation reversal of vitamin k antagonist.
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Prothrombin complex concentrate vs fresh frozen plasma in
obstetric massive bleeding
S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov
Odessa National Medical University, Odessa, Ukraine
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Introductions: In the developing world about 1.2 % of deliveries are
associated with postpartum haemorrhage (PPH) and when PPH oc-
curred about 3 % of women died.
Methods: Our research involved 51 patients with massive post-
partum bleeding after Ñesarean section that were divided into 2
groups: 1st group contained 10 patients as a treatment of massive
bleeding with coagulopathy was scheduled PCC in a dose of 1 ml/kg
(25 IU/kg), packed red blood cells (PRBC), 2nd group (41 patients) re-
ceived fresh frozen plasma(FFP) in a dose of 20 ml/kg and PRBC. The
functional state of the hemostasis system was carried out using low-
frequency pyezoelectric thromboelastography(LPTEG) on admission
to hospital and every 2 hours after admission.
Results: According to LPTEG indicators patients with massive post-
partum bleeding had abnormality in all parts of hemostatic system:












ADP A P-selectin 5342 ± 1836 5582 ± 1830 4574 ± 1677 0,035
CRP A P-selectin 6184 ± 2049 6455 ± 2020 5283 ± 1931 0,028
TRAP P-selectin 7366 ± 1942 7623 ± 1813 6513 ± 2158 0,028
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duced by 45.64 %, the coagulation - Intensity of coagulation dri-
ve(ICD) was less than normal at 59.32 %, clot maximum density (MA)
was reduced by 88.15 % and fibrinolytic activity - Index of retraction
and clot lysis(IRCL) was 86,16 % above the norm. Indicators of plate-
let hemostasis in patients of 1st group characterized by persistence
of hypoagregation: ICC was reduced by 18.69 %, compared to the
norm; parameters of coagulation and fibrinolysis have reliable trend
toward normal and decreasing the activity of fibrinolysis index
reaches normal reference values (ICD was less than normal at
10.65 %, MA was reduced by 19.31 %, IRCL was 15,21 % above the
norm) 2 hours after, and became to the normal 4 hours after infusion
of PCC. Patients of 2nd group had hypoagregation and mild hypo-
coagulation state with increased active of fibrinolysis: ICC was re-
duced by 22.79 %, ICD reduced by 20.79 %, MA was reduced by
30.54 %, IRCL was above the norm to 25.46 % 4 hours after, and be-
came to the normal 6 hours after infusion of FFP. Clinically patients
of the 1st group had reducing signs blood loss, decreased volume of
transfusion PRBC for 11 % and decreasing volume of infusion therapy
for 19 % compared to patients of 2 ng group. There was 1 case of
transfusion related lung injury in 2nd group.
Conclusions: Obstetric patients with massive postpartum bleeding
have violation in all parts of hemostatic system. The use of prothrom-
bin complex concentrate can reduce the level of blood loss decrease
volume of transfusion packed red blood cells and infusion therapy.
Reducing the use of blood components in the intensive care unit of
massive bleeding can be a method of preventing the development
of TRALI-syndrome.
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Impact of FFP transfusion on VAP in ICU patients
A. Vakalos , V. Avramidis
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Introductions: The aim of our observation retrospective study was to
test the hypothesis that a correlation exists between FFP transfusion
and incidence of VAP in our both medical and surgical ICU served in
community hospital.
Methods: From January 2006 to June 2014 admitted to our ICU 620
patients. From our database we looked for incidence of VAP (% ven-
tilation days) and the following values and indexes according FFP
transfusion per year from 2006 to 2014 (mean values). Total, per pa-
tient, per hospitalization days (HD), per patient under mechanical
ventilation (pts V) and per ventilation days (VD) Using linear correl-
ation method, we looked for linear slope, correlation coefficient (r),
and coefficient of determination (r2), and by linear regression
method using ANOVA test we looked for p value, according VAP and
FFP transfusion.
Results:
Conclusions: According to our data, there was no statistically signifi-
cant correlation detected between VAP and FFP transfusion indexes.
Our data suggest that even though FFP transfusion may have an im-
pact on immunosuppression and infection disease developing, the
impact on VAP is not statistically significant.Table 15 (Abstract P122). Correlation between VAP and FFP
transfusion indexes.
FFP Slope r r2 St.
Error
L. CI U.CI p
value
Total transfusions -0.236 -0.0151 0.0002 5.624 -13.527 13.075 0.9691
Transfusions per pt -0.077 -0.3074 0.0944 0.0906 -0.2917 0.1368 0.421
Transfusions per
H.D.
-0.001 -0.0802 0.0064 0.0073 -0.0088 0.0157 0.8574
Transfusions per Pt
V.
-0.072 -0.2749 0.0755 0.0964 -0.301 0.1551 0.4741
Transfusions per V.
Day
-0.005 -0.2188 0.0078 0.0095 -0.0283 0.017 0.5716P123
Preoperative platelet function test and the thrombin generation
assay are predictive for blood loss after cardiac surgery
L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M.
Roest, B. De Laat, M. Lance
Maastricht UMC, Maastricht, Netherlands
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Introductions: Peri- and postoperative bleeding is a major cause of
morbidity and mortality in cardiac surgery. This study evaluates the
value of thrombin generation (TG) and a new platelet function ana-
lysis in the prediction of haemostatic problems.
Methods: We studied 82 patients undergoing cardiac surgery in
2015.
Blood samples were collected before surgery (T1) (n = 82) and upon
arrival at the ICU (T2) (n = 67).
TG was measured by Calibrated Automated Thrombography (CAT).
Blood loss was recorded until 24 hours after surgery.
Platelet function was assessed by a platelet activation test (PAC-t-UB)
which estimates P-selectin expression and binding of fibrinogen
to activated alphaIIbbeta3 after platelet activation of GPVI, PAR-1
and P2Y12 receptors, by specific agonists: P1Y12-ADP, PAR-1-
TRAP, GPVI-CRP.
Patients were divided in a high and low blood loss group, with a cut-
off value of 1 liter during ICU stay.
Results: TG parameters lagtime and time-to-peak in pre-operatively
sampled whole blood, showed significant prolonging in the high
blood loss group. (2.53 ± 0,52 vs 2.88 ± 0,87: p = 0.027 and 4,67 ± 0,61
vs 5,12 ± 1,00: p = 0.017 respectively).
The PAC-t-UB test showed significant differences between groups in
P-selectin expression by GPVI, PAR-1 and P2Y12 agonists at T1
(Table 16) but not in fibrinogen binding.
Conclusions: Preoperative assessment of TG measured by CAT was
predictive for blood loss following cardiac surgery.
These findings may help in identifying patients at risk for postoperative
bleeding complications.P124
Rotational thromboelastometry versus standard coagulation tests
before surgical interventions
M. Durila, P. Lukas, M. Astraverkhava, J. Jonas
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Introductions: Prolonged value of prothrombin time/activated partial
thromboplastin time (PT/APTT) are often found in patients under-
going surgical procedure. Thromboelastometry as a global test using
whole blood might yield different results. The aim of our study was
to compare coagulation profile as shown by conventional coa-
gulation tests versus thromboelastometry before surgical procedures
and to find out which test better reflects patient’s clinical condition
in perioperative period.
Methods: In patients undergoing surgical procedures with prolonged
PT/APTT blood sample was obtained for thromboelastometry-
ROTEM-EXTEM. In case of normal result the patient underwent the
procedure without administration of clotting factors and bleeding
complication was observed in perioperative period.
Results: In 65 patients with PT-INR 1.46 ± 0.19 (min-1.22, max-2.22)
and APTT 1.17 ± 0.18 (min-0.83, max-1.52) the procedure was
Fig. 23 (Abstract P126).
Critical Care 2016, Volume 20 Suppl 2 Page 56 of 182performed without bleeding complication when ROTEM-EXTEM was
in normal values for all parameters.
Conclusions: Our data suggest that surgical procedures can be done
without bleeding complication despite prolonged PT/APTT in case of
normal ROTEM-EXTEM. This approach can reduce FFP administration
in daily practice.
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Correction of impaired clot quality and stability by fibrinogen and
activated prothrombin complex concentrate in a model of severe
thrombocytopenia
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Introductions: Bleedings in severe thrombocytopenia (TCP) vary from
mild to severe and may be even life-threatening when accompanied
with hemodilution as a result of trauma and subsequent fluid resusci-
tation. The aim of this study was to evaluate the effect of fibrinogen
and activated prothrombin complex concentrate (FEIBA) on clot
quality and resistance to fibrinolysis in a model of TCP and
hemodilution.
Methods: Blood was obtained from healthy volunteers who signed
an informed consent form approved by the local research ethics
committee. TCP [(16 ± 4) x 106 mL-1] was created by mixing platelet-
poor plasma with packed cells. The samples were diluted or not to
60 % with TRIS/saline buffer and subjected to clotting in the pres-
ence of tPA. Blood was spiked with fibrinogen (3.0 mg/mL) and/or
FEIBA (1 U/mL). Maximum clot firmness (MCF, mm) and lysis onset
time (LOT, min) were evaluated using rotational thromboelastometry
and presented as Mean ± SD.
Results: MCF in nondiluted TCP blood was 18 ± 5. Spiking the blood
with fibrinogen and FEIBA increased it to 29 ± 4 and 27 ± 7, respect-
ively (P < 0.001). Combined use of these agents increased MCF to
34 ± 4 (P < 0.01). Dilution of TCP blood reduced MCF to 9 ± 5 (P <
0.001). Spiking diluted blood with fibrinogen increased MCF to 15
± 4 (P < 0.01), spiking with FEIBA increased it to 22 ± 4 (P < 0.01),
and combination of both agents had the greatest effect on MCF
that reached 30 ± 6 (P < 0.01) and did not differ from its level in
nondiluted blood following combined spiking. LOT in nondiluted
TCP blood was 13.1 ± 5.1. Spiking the blood with fibrinogen had no
effect on LOT while spiking with FEIBA prolonged it to 21.5 ± 7.3
(P < 0.05). Combined use of both agents further increased LOT to
33.0 ± 4.6 (P < 0.01). Dilution of blood as well as spiking diluted
blood with fibrinogen had no significant effect on LOT while spik-
ing with FEIBA prolonged it to the same extent as in non-diluted
blood (P < 0.05). Compared to FEIBA, combination of both agents
slightly prolonged LOT, but the difference did not reach statistical
significance.
Conclusions: Both in nondiluted and diluted TCP blood: (1) fib-
rinogen and FEIBA synergistically improve clot quality (firmness); (2)
fibrinogen alone does not increase clot resistance to fibrinolysis butpotentiates such effect of FEIBA if added in combination. Both agents
could serve as alternative therapeutic approach to bleeding patients
with severe TCP.
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Assessment of point-of-care prothrombin time analyzer as a
monitor after cardiopulmonary bypass
H. Hayami1, Y. Koide2, T. Goto3
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Introductions: Activated clotting time (ACT) is currently used for dose
adjustment of heparin during CPB, and has been thought as gold
standard in this field. However, in difficult case, such as prolonged car-
diopulmonary bypass, consumption coagulopathy might also occur,
and there might be need for blood components. Monitoring ACT only
is not adequate in such case. The CoaguChek XS system is a portable
instrument for monitoring oral anticoagulation therapy. It determines
the PTINR value from a drop of capillary blood specimen, and it has
been reported that accuracy seems to be better for hematocrit (Ht)
>30 %. We compared PTINR measured by CoaguChek XS (CCINR) with
PTINR analyzed by laboratory test (LabINR) after CPB.
Methods: 34 patients who underwent CPB were enrolled. After
weaning from CPB and heparin reversal by protamine adminis-
tration, CCINR, LabINR, ACT, aPTT and Ht were measured. The
correlations between CCINR and LabINR, ACT and aPTT, were
assessed.
Results: CCINR correlated well with labINR (r = 0.81, Y = -0.163 +
1.191 X). Moreover, evaluating subgroup whose Ht <30 % (N = 27,
mean Ht 24.6 %), correlation was thought to be acceptable (r =
0.706, Y =0.047 + 1.058 X). On the other hand, correlation between
ACT and aPTT, widely considered as “the Gold standard h was infer-
ior (r = 0.567, Y =0.047 + 1.058 X).
Conclusions: CCINR is an useful alternative to labINR for guiding
blood component therapy after CPB.P127
Disseminated intravascular coagulation (dic) is underdiagnosed in
critically ill patients: do we need d-dimer measurements?
V. B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis,
J. P. Paquet
1Institute of Ageing and Chronic Disease, Liverpool, UK; 2Institute of
Infection and Global Health, Liverpool, UK; 3Department of
Haematology, Royal Liverpool University Hospital (RLUH), Liverpool, UK
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Fig. 24 (Abstract P129).
Critical Care 2016, Volume 20 Suppl 2 Page 57 of 182Introductions: The International Society of Thrombosis and Hae-
mostasis (ISTH) DIC scoring system has been developed as a simple
tool to diagnose DIC. It is based on platelet count, prothrombin time
(PT), fibrinogen level and fibrin degradation products (FDP) or D-
Dimer results. However, the score is less useful in critical illness as D-
Dimers and FDP are usually elevated due to the underlying disease.
Hence neither DIC scoring nor FDP or D-Dimer measurements are
routinely performed in ICU. Triggers to request D-Dimer measure-
ments have not been established.
Methods: This retrospective study included ICU patients admitted to the
RLUH over a 4-year period. Demographic details were collected at admis-
sion along with routine blood results for the first 7 days. A truncated DIC
score was calculated for all patients who had coagulation tests done for
7 days: Platelet count >100x109/L = 0 points, >50 to <100x109/L = 1 point,
< 50x109/L = 2 points, PT <3 s prolonged= 0 points, >3 s but <6 s = 1
point, >6 s = 2 points, fibrinogen >1.5 g/L = 0 points, <1.5 g/L = 1 point.
Patients with a truncated DIC score of ≥2 were considered high risk for
DIC. In this patient cohort, highly elevated D-Dimers would establish a
diagnosis of overt DIC. Patients admitted after elective surgery and those
who stayed on ICU <7 days were excluded.
Results: 464 patients were included in the analysis. ICU mortality was
25.4 %. Mean APACHE II was 19.8 ± 7.1. 272 patients had a maximum
DIC score of 0 (167 patients) or 1 (105 patients) and were not at risk for
overt DIC. However, 192 patients had a maximum DIC score of ≥2, with
14 patients displaying a DIC score of 5 even without D-Dimer results
available. In none of the patients with a DIC score of ≥2, D-Dimer or
FDPs were analysed. Only one patient with a DIC score of ≥2 had nor-
mal platelet counts and two patients showed mild thrombocytopenia.
All patients with severe thrombocytopenia and 73 of 122 patients with
moderate thrombocytopenia had a DIC score of ≥2.
Conclusions: DIC, although associated with outcome, remains under-
diagnosed in critically ill patients. In patients with moderate or severe
thrombocytopenia a truncated DIC score should be calculated. If the
score is between 2 and 4, measurement of D-Dimers or FDP should
be requested to fully establish the diagnosis of DIC.
P128
Validity of the age-adjusted d-dimer cutoff in patients with COPD
B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis,
J. P. Paquet
Hôpital du Sacré-Coeur de Montréal, Montreal, Canada
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Introductions: Diagnosing thromboembolic disease represents a
challenge in older patients with COPD. The ADJUST-PE study has
recently validated a new age-adjusted D-dimer cutoff (age x 10) in
patients older than 50 years old. When the results of this study are
cautiously analyzed, it seems that the validity of this cutoff in pa-
tients with COPD is unreliable. The objective of the current study
was to specifically validate or invalidate the use of the age-adjusted
D-dimer cutoff in patients with COPD aged 50 or older.
Methods: Files from patients who visited the emergency department
of Hôpital Sacré-Coeur de Montréal between March 2008 and May
2014 were retrospectively reviewed. Patients aged 50 and older with
COPD and with a non-high pretest probability of thromboembolic
disease were included. These patients all had a D-dimer measure-
ment and a radiologic exam (pulmonary angioscan, ventilation/perfu-
sion lung scan or a lower extremity doppler). The results are
presented in proportions with 95 % confidence intervals without
continuity correction and with sensitivity measurements.
Results: 195 patients were included according to those criteria. 5
were excluded from analysis because of a non-confirmed diagnosis.
Among the 190 patients analyzed, 15 had a diagnosis of thrombo-
embolic disease, resulting in a prevalence of 7,89 % (IC95% = 4,49 %-
12,69 %). 4 had a negative D-dimer level with the conventional cutoff
(<500 μg/L) and 15 (all of them) had a negative d-dimer level with
the age-adjusted cutoff. The sensitivity of the conventional cutoff
was 73,33 % (IC95% = 44,90 %-92,21 %) and the sensitivity of the
age-adjusted cutoff was 0 % (IC95% = 0,00 %-21,80 %).
Conclusions: In conclusion, the new age-adjusted D-dimer cutoff
cannot be used safely in patient with COPD older than 50 years old
who have a non-high pretest probability of thromboembolic disease.References
Righini, JAMA 2014. 311 (11) : 1117-1124.
Schouten, BMJ 2013. 346:f2492.P129
A scoping review of strategies for prevention and management of
bleeding following paediatric cardiopulmonary bypass surgery
K. Siemens1, D. Sangaran1, B. J. Hunt2, A. Durward1, A. Nyman1,
I. A. Murdoch1, S. M. Tibby1
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Introductions: To systematically review literature reporting strategies
for prevention and management of mediastinal bleeding post paed-
iatric cardiopulmonary bypass (CPB) surgery.
Methods: Scoping review of publications (1980-2015) reporting
the effect of any intervention on outcomes for postoperative
bleeding (mediastinal drain loss, transfusion requirement, coagula-
tion parameter). Inclusions: <18 years, cardiac surgery on CPB. Exclusions:
haematological disorders. Databases included MEDLINE and EMBASE.
Results: 548/2794 screened articles were included: 466 (85.0 %) original
research, predominantly retrospective 175 (37.6 %) and prospective 119
(25.5 %) observational studies, a smaller proportion of randomised con-
trolled trials (RCTs) of 85 (18.2 %) and non-randomised controlled trials 24
(5.2 %) (Fig. 24). Study sizes ranged 5 - 22,258 (median 62). Most fre-
quently evaluated interventions: blood products (17.3 %), CPB circuit
modification (13.6 %), antifibrinolytics (13.2 %) (Fig. 24). Publication num-
bers increased at a mean rate of 6 per year from 14 (1980-85) to 229
(2010-15). Within this group the raise of increase of RCTs was 0 (1980-85)
to 35 (2010-15).
Conclusions: A variety of interventions for bleeding prevention/treat-
ment are available. Trial sizes are often small, quality of evidence
low. There is a trend towards studies of higher quality (RCTs) in
recent years.
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Nadir hemoglobulin during cardiopulmonary bypass: impact on
postoperative morbidity and mortality
F. Ampatzidou , D. Moisidou , E. Dalampini, M. Nastou, E. Vasilarou,
V. Kalaizi, H. Chatzikostenoglou, G. Drossos
G.Papanikolaou General Hospital, Thessaloniki, Greece
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Introductions: Aim of this study was to evaluate the impact of
low hemoglobulin (<7 g/dl) during cardiopulmonary bypass
(CPB) because of hemodilution, on postoperative mortality and
morbidity.
Methods: A total of 667 patients who underwent elective cardiac sur-
gery procedures under the use of CPB in our department during a
2 years period were retrospectively studied. The lowest value of
hemoglobulin (Nadir Hb) throughout CPB was recorded. Group A
consisted of patients with Hb < 7 g/dl, while group B was the control
group. The following perioperative outcome indices were compared
between 2 groups: Increase of Lactate (Lac) value at the end of CPB,
acute kidney injury (AKI) defined by RIFLE criteria, postoperative use
of non invasive ventilation (NIV), prolonged mechanical ventilation
(>48 hours), perioperative infarction (PMI), stroke, total red blood
transfusion > 3units, atrial fibrillation(AF) and mortality. Statistical ana-
lysis was based on chi-square test.
Results: 162 patients consist group A and 505 control group.
Results are shown on Table 17.
Conclusions: Optimal hemoglobulin during CPB has not been de-
fined. Severe hemodilutional anemia (Hb < 7 g/dl) has statistical sig-
nificant correlation with increase of Lac value at the end of CPB,
postoperative AKI, use of NIV, prolonged mechanical ventilation,
transfusion with >3 red blood cell units and has strong correlation
with mortality.Table 17 (Abstract P130).
Group A No of pts
(%)




Lac increase 63 (38.9) 134 (26.5) 0.03
AKI 35 (21.6) 63 (12.5) 0.04
NIV 30 (18.5) 54 (10.7) 0.026
Prolonged
ventilation
17 (10.7) 19 (3.8 ) 0.01
PMI 3 (1.9) 4(0.8) 0.29
Stroke 3(1.9) 6(1.2) 0.46
RBC >3 86 (53.1) 105(20.8) <0.01
AF 60(37) 156(30.9) 0.14
Deaths 9(5.6) 5(1) <0.01
Fig. 25 (Abstract P131). ‡ = p < 0,05 compared to the other group
§ = p < 0,05 compared the same group.
Fig. 26 (Abstract P131).P131
Red blood cell transfusion does not influence the prognostic value
of RDW in critically ill patients
S. Spadaro1, A. Fogagnolo1, T. Fiore1, A. Schiavi1, V. Fontana1, F.
Taccone2, C. Volta1
1Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy;
2Department of Intensive Care, Erasme Hospital, Université Libre de
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Introduction: Some studies have found a correlation between in-
creased RDW and mortality in ICU patients. However, RDW values
can be increased by transfusion (RBCT), erythropoiesis or hemolysis.
In this study we investigated whether the prognostic value of RDW
was influenced by RBCT in ICU patients.
Methods: All patients admitted to ICU over 8 months were en-
rolled in the study. Patients were analyzed in two groups (A ifno RBCT was given and B receiving RBCT before ICU admission).
We measured RDW, reticulocyte index (RI) and haptoglobin on
admission and 48 h thereafter. RDW was categorized in tertiles:
<14 %; 14,1-15,8 %; >15,8 %. We collected 28-day mortality,
changes in SOFA score and length of stay in ICU
Results: 102 patients were enrolled(64 in group A and 38 in
group B).Clinical variables are shown in Fig. 25. Cox-regression
analysis shows that high RDW values were significantly associ-
ated with 28-day mortality (Fig. 26). Patients in Group B had
higher level of RDW on admission (16.7 ± 2 % vs. 15.1 ± 2.2 %;
p = 0.03). Nevertheless, the accuracy of RDW to predict mortality
was similar in the two groups (ROC curve 0.697 for group A
and 0.711 for group B). Patients with higher RDW had also a
lower RI but similar levels of haptoglobin when compared to
others.
Conclusions: Among critically ill patients RBCT were associated with
higher RDW but this did not influence the prognostic value of RDW.
High RDW values could not be secondary to an increased erythro-
poiesis, as suggested by low RI.P132
Reasons for admission in the paediatric intensive care unit and the
need for blood and blood products transfusions
E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis,
V. Panagiotidou, M. Sdougka
Hippokration General Hospital Thessaloniki, Thessaloniki, Greece
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Critical Care 2016, Volume 20 Suppl 2 Page 59 of 182Introductions: An important part in the puzzle of treatment of
Pediatric Intensive Care Unit (PICU) patients (pts) is the transfusions
of blood and blood products in order to stabilize the critically ill chil-
dren, and improve their outcome. The purpose of the present study
is to investigate the reasons for admission and the need for blood
products transfusions in a cohort of PICU pts, and in specific diagnos-
tic categories (sepsis, traumatic brain injuries, etc)
Methods: We studied retrospectively all consecutive admissions in
the PICU during a two years period (from 01.01.2012 to 31.12.2013).
Data were collected through chart reviews for the following para-
meters: Demographics, reason for admission, underlying diseases,
treatment characteristics, blood and blood products transfusions, and
outcome of the patients. The criterion for transfusions followed the
Sepsis Surviving Campaign 2012 guidelines for the pediatric popula-
tion and the 2013 European guidelines for the Management of
Bleeding and Coagulopathy following major trauma. In special cases
the criterion for transfusion was clinically significant hemorrhage. The
definitions of transfusion units were equivalent to 10 ml/kg for Red
Packed Cells (RPC) and Fresh Frosen Plasma (FFP), and 0.1 unit/kg for
Platelets (PLT) and Cryoprecipitate (CP).
Results: A total of 233 PICU patients (124 boys and 109 girls) were re-
corded. There were 53 children with respiratory failure, 39 children with
pathology of the nervous system, 31 with sepsis, mainly admitted from
the pediatric oncology department, 24 with traumatic brain injuries, and
others with miscellaneous reasons for admission. Almost 25 % of the chil-
dren with respiratory and neurologic failure suffered from underlying dis-
eases. A total of 1795 units (U) of transfusions were given which were
grouped as follow: RPC (385 U), FFP (453 U), PLT (804 U), CP (153 U).
Conclusions: The most common reasons for admission in the
pediatric intensive care unit were respiratory failure and pathology of
the nervous system. These critically ill children presented in many oc-
casions with anemia and thrombocytopenia, hemodynamic instabil-
ity, clotting and bleeding disorders (while they were in infection)
and the administration of blood and blood product derivatives were
paramount to them. The immediate recognition of transfusion indi-
cations, and the early prompt interventions lead to better and faster
recovery of small patients.
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The implementation of a massive haemorrhage protocol (mhp) for
the management of major trauma: a ten year, single-centre study
R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans
Morriston Hospital, Swansea, UK
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Introductions: Massive haemorrhage is a leading cause of death in
major trauma. About one-third of all bleeding trauma patients
present with a coagulopathy as a result of physiologic derangements
such as acidosis, hypothermia, or haemodilution related to fluid ad-
ministration.(1) In 2011, Morriston Hospital introduced a Massive
Haemorrhage Protocol (MHP) in the Emergency Department (ED).
The aim of this study was to evaluate the impact of the MHP.
Methods: All adult trauma patients admitted to the ED (2005 to 2015)
were studied, using the data collated for the Trauma Audit and
Research Network. Variables included sex, age, Injury Severity
score (ISS), PS14 code (injury severity score), injury mechanism,
use of Tranexamic acid (TXA), volume of fluids/blood components
given at the scene or in the ED, in-hospital mortality hospital and
ICU and hospital length of stay. Patients were divided into two
groups; patients admitted pre-MHP and patients admitted post-
MHP introduction. Differences were analysed using the Fisher
Exact test and Mann-Whitney U tests.
Results: A total of 731 patients were included, 376 in the pre-MHP
and 355 in the post-MHP group. There were no significant differ-
ences in age, sex, ISS, PS14 code, injury mechanism and mortality
between the two groups. The use of TXA was significantly higher in
the post-MHP group (p < 0.001). The median amount of fluids given
at the scene and in the ED was significantly higher (1.5 litres versus
1.0 litre) in the pre-MHP group (p < 0.001). A significantly higher
number of units of prothrombin complex concentrate (PCC) andfresh frozen plasma (FFP) were given in the post-MHP group in the
ED (both p < 0.05). There was no significant difference in the num-
ber of units of blood / plasma reduced cells given in the ED be-
tween the two groups. Hospital and ICU length of stay were
significantly reduced following the introduction of the MHP (both
p < 0.001).
Conclusions: The results of this study have demonstrated that a
well-defined MHP may contribute to reducing both ICU and hos-
pital length of stay. In the post-MHP group, patients received sig-
nificantly lower amounts of fluids at the scene and in the ED and
there was a significant increase in the use of TXA. A significant
increase in the amount of PCC and FFP given to patients in the
ED was reported, with no associated increase in blood/plasma re-
duced cells.
Reference
1) Spahn D, Bouillon B, Cerny V et al. Management of bleeding and
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An integrated major haemorrhage protocol for pre-hospital and
retrieval medical teams
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Introductions: Irrespective of aetiology, major haemorrhage is associ-
ated with poor patient outcome and its management presents con-
siderable clinical and logistic challenges. The introduction of in-
hospital major haemorrhage protocols, following damage control re-
suscitation (DCR) principles, has demonstrated improved patient out-
come and blood product delivery with reduced wastage of blood
products.1,2 However, simple adaptation of hospital-derived protocols
is inadequate for use by retrieval teams and a tailored approach is re-
quired to address the specific challenges encountered.
Methods: A protocol for major haemorrhage management by retrieval
services was developed, based on the best available evidence. Within
the protocol integrated guidance was provided for retrieval teams and
clinical coordinators.
Results: The clinical challenge of inter-mission variability of blood prod-
uct availability was addressed by the use of two regimes within one re-
trieval team algorithm. The “Primary” regime is based upon the resources
carried by the retrieval team and represents a minimum standard of
major haemorrhage management for all patients. The “Inter-Facility
Transfer” (IFT) regime provides guidance on delivering hospital-standard
DCR, where possible, using locally available resources.
The logistic challenges encountered by retrieval teams are extensive.
The retrieval clinical coordinator is instrumental in reducing delays,
maximising use of resources and maintaining handover of information.
Their role was clearly defined and a checklist developed in order to
avoid omissions.
The protocol was adopted by Retrieval Services Queensland for
state-wide use by fixed and rotary wing retrieval teams.
Conclusions: This novel protocol addresses many of the specific clin-
ical and logistic challenges faced by retrieval teams. The protocol
contains specific guidance yet provides flexibility to encompass the
variety of major haemorrhage scenarios encountered, which may
range from roadside polytrauma to the inter-facility transfer of an in-
tensive care unit patient. The goal is seamless transition of care with
ongoing damage control resuscitation from point of referral, during
transfer, and upon arrival at the receiving centre.
References
1) Khan S. A major haemorrhage protocol improves the delivery of blood
component therapy and reduces waste in trauma massive transfusion.
Injury. 2013, 44(5):587-92
2) Pham HP and Shaz BH. Update on massive transfusion. Br J Anaesth.
2013 111(Suppl 1):i71-i82
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The impact of transfusion thresholds on mortality and
cardiovascular events in patients with cardiovascular disease
(non-cardiac surgery): a systematic review and meta-analysis
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Introductions: Restrictive red cell transfusion policies are recommen-
ded as safe for the majority of hospital patients with anaemia. Uncer-
tainty exists for patients with cardiovascular disease, in whom the
heart may be more susceptible to limited coronary oxygen supply.
Methods: We performed a systematic review with meta-analyses
of in-hospital randomised controlled trials that evaluated a restric-
tive vs liberal transfusion threshold and that included patients
with cardiovascular disease. A comprehensive search of databases
(including CENTRAL, MEDLINE and Embase) was performed on
02/11/2015. Data extraction was completed in duplicate. Risk of
bias was assessed using Cochrane methodology. Mantel-Haenzel
random effects models were used with relative risk ratios (95 % CI).
Outcome measures were thirty-day mortality, and cardiovascular
events.
Results: We identified 41 trials of which 11 trials enrolling cardio-
vascular patients (n = 3033) were included for meta-analysis (restrict-
ive n = 1514 patients; liberal n = 1519). There was no association be-
tween transfusion thresholds and 30 day mortality RR 1.10 (95 % CI
0.88-1.50, P = 0.30, I2 = 14 %). There was an increased risk of acute
coronary syndrome (ACS) in patients in the restrictive transfusion
threshold (9 trials; RR 1.71, 95 % CI 1.11-2.65, P = 0.01, I2 = 0 %)
(Fig. 27).
Conclusions: Restrictive transfusion practice is associated with higher
rates of ACS in patients with cardiovascular disease. This supports
the uncertainty highlighted in current guidelines, and indicates the
need for further research into best practice for this group.Fig. 27 (Abstract P135).
Fig. 28 (Abstract P136).P136
The relationship between poor pre-operative immune status and
outcome from cardiac surgery is specific to the peri-operative
antigenic threat
S. Moravcova1, J. Mansell2, A. Rogers2, R. A. Smith2, C. Hamilton-Davies2
1Royal Brompton & Harefield NHS Trust, London, UK; 2Barts Heart Centre,
London, UK
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Introductions: We have previously demonstrated that there is an in-
verse relationship between pre-operative levels of endotoxin core
antibodies (EndoCAb) and the development of complications follow-
ing cardiac surgery[1,2]. It is not known whether this relationship is
due to a specific protective effect against specific antigens or if it is a
reflection of a generalised hypoimmunity. During the peri-operativeperiod patients are at risk of exposure to endotoxin and staphy-
lococcus with an incidence of surgical site infection of approxi-
mately 1-3 %.
Methods: 62 patients scheduled to undergo first time aortic valve re-
placement had serum analysed for levels of EndoCAb, antibodies to
staphylococcus (teichoic acid, á-toxin) and also to varicella as a non-
specific immune measure. The primary outcome variable was post-
operative length of stay with secondary measures of incidence of
post-operative infection. All patients were risk scored by means of
Euroscore.
Results:
Conclusions: An inverse relationship is observed as previously be-
tween pre-operative EndoCAb levels and outcome. A similar relation-
ship can be seen also between the anti-staphylococcal antibody
levels and outcome with a more pronounced infective component.
The absence of a relationship between the varicella antibody levels
may imply from this study that low pre-operative immunity relating
to post-operative morbidity is specific to the peri-operative threat.
References
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Impact of simple clinical practice guidelines for reducing post-
operative atrial fibrillation after cardiac surgery
A. Omar , M. Allam, O. Bilala, A. Kindawi, H. Ewila
Hamad medical corporation, Doha, Qatar
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Introductions: In view the adverse consequence of post-operative
atrial fibrillation (POAF) encompassing hemodynamic deterioration,
thromboembolic hazards beside the intolerable fast rate, and mortal-
ity; preventing POAF seems to be an ideal goal. The POAF events in-
cidence reported to be 30 and 40 % in coronary artery bypass and
valvular surgeries respectively. [1, 2]. We aim to assess the impact of
a simple clinical practice guideline for POAF events prevention and
highlighting the incidence in Asian population.
Methods: Single center retrospective study conducted over one year,
we enrolled all patients subjected to cardiac surgery (267), and patients
with existing or prior AF were excluded. Patients were divided into two
groups (group I) before and (group II) after implementing the CPG.
Results: Both groups were matched regarding the age, gender,
smoking history, preoperative ejection fraction, EuroSCORE, urgency
of surgery and underlying surgery type valvular or coronary. There
was a statically significant difference in POAF events was14.9 % in
group I and vs 8.3 % in group II (P = 0.05). The overall total rate of
Critical Care 2016, Volume 20 Suppl 2 Page 61 of 182POAF in all patients was 11.4 % that is below the rate in European
centers. [1] Patients with POAF significantly required more inotropic
support (p = 0.04), in addition they were associated with prolonged
length of mechanical ventilation and ICU stay (p = 0.001 and 0.02
respectively).
Conclusions: The argument of rhythm control in POAF would favor
preventive measures that reduce post-operative transition from sinus
rhythm with expected favorable effects of lessening the blood stasis
and left atrial thrombosis chances.
References
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Dexamethasone administration during cardiopulmonary bypass
has no beneficial effects on elective postoperative cardiac surgery
patients
F. Ampatzidou , D. Moisidou , M. Nastou, E. Dalampini, A. Malamas,
E. Vasilarou, G. Drossos
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Introductions: Aim of this study was to investigate any beneficial ef-
fect on postoperative mortality and morbidity when a single dose of
dexamethasone is administered during cardiopulmonary bypass
(CPB) in cardiac surgery patients.
Methods: A total of 782 patients who underwent elective cardiac sur-
gery procedures under the use of CPB in our department during
28 months period were retrospectively studied. In 499 patients a sin-
gle dose of 8 mg dexamethasone was given during CPB( group A)
while it was not administered in 283 patients (group B). The follow-
ing factors were compared between 2 groups: Low cardiac output
syndrome (LCOS), prolonged mechanical ventilation (>48 hours), septi-
caemia, postoperative stroke, acute kidney injury (AKI) defined by RIFLE
criteria, AKI requiring dialysis treatment, atrial fibrillation(AF), sternal
wound infections and mortality. Statistical analysis was based on chi-
square test
Results: Group A consist of 499 pts, mean age 65.38 ± 9.8, mean
EURO score II,1.86 ± 1.9. Group b consist of 283 pts, mean age 65.33
± 11.7, mean EURO score II 1.7 ± 1.4.
Results are shown on Table 18.
Conclusions: Dexamethasone administration during CPB, has no
protective impact on postoperative LCOS, septicemia, stroke, AKI,
atrial fibrillation, sternal infections and mortality. There is a ten-
dency for correlation with prolonged mechanical ventilation pro-
tection and the severe form of AKI requiring dialysis but not
statistical significant.Table 18 (Abstract P138).
Group A No of pts
(%)




LCOS 21(4.2) 17(6) 0.263
Prolonged
ventilation
17 (3.4) 18(6.4) 0.055
Septicemia 9(1.8) 6(2.1) 0.756
Stroke 5(1) 5(1.8) 0.36
AKI 68(13.6) 46(16.3) 0.317
Dialysis 12(2.4) 14(4.89) 0.057
AF 159 (31.7) 89(31.4) 0.951
Sternal infections 9(1.8) 6(2.1) 0.756
Deaths 9(1.8) 6(2.1) 0.756P139
Intra-aortic balloon counterpulsation in patients undergoing
cardiac surgery (IABCS): preliminary results
G. Ferreira, J. Caldas, J. Fukushima , E. A. Osawa , E. Arita , L. Camara ,
S. Zeferino, J. Jardim, F. Gaioto, L. Dallan , F. B. Jatene , R. Kalil Filho ,
F. Galas, L. A. Hajjar
University of Sao Paulo, Brazi, Sao Paulo, Brazil
Critical Care 2016, 20(Suppl 2):P139
Introductions: The intra-aortic balloon pump (IABP) is used in a var-
iety of clinical settings in which myocardial function is reduced. In
cardiac surgery, its role on clinical outcomes is debated due to con-
flicting results of retrospective analysis and limitations of a recent
prospective study. The IABCS study aims to evaluate the effective-
ness of prophylactic IABP in high-risk patients undergoing cardiac
surgery.
Methods: The IABCS study is a prospective, single-center, random-
ized controlled trial in high-risk patients scheduled to elective cardiac
surgery at the Heart Institute/University of São Paulo. Inclusion cri-
teria were additive EuroSCORE > = 6 or left ventricular ejection frac-
tion (LVEF) < = 40 %. Eligible patients were randomly assigned, in a
1:1 ratio, to IABP group or control group. Removal of IABP catheter
was accomplished after 24 hours of the procedure under the follow-
ing circumstances: cardiac index > = 2.2 L/min/m2 and dobutamine
infusion dose < = 5 μg/kg/min. The catheter was immediately re-
moved if a severe adverse event related to the procedure was
detected. The primary outcome was the composite endpoint of mortal-
ity and major morbidity in 30 days after cardiac surgery, according to
the modified Society of Thoracic Surgeons definition, which included:
prolonged mechanical ventilation (>24 hours), stroke, mediastinitis,
need for reoperation, cardiogenic shock, and acute renal failure.
Results: A total of 116 patients were enrolled from April 2014 to Sep-
tember 2015. Fifty-two patients were assigned to IABP group and 64
patients to control group. The mean age was 64 ± 8 years in the IABP
group and 67 ± 9 years in the control group (P = 0.06). The median
LVEF was 40 % (31-45) in the IABP group and 40 % (35-55) in the
control group (P = 0.873) and the median EuroSCORE was 6 (4-7) vs.
6 (4-7), P = 0.873, respectively. The primary outcome was observed in
40.4 % in the IABP group and 37.5 % in the control group (P = 0.751).
Mortality rate was similar in both groups (15.4 % in the IABP group
vs. 10.9 % in the control group, P = 0.478). Patients from the IABP
group had a greater duration of inotrope use (3215 minutes [2003-
5670] vs. 2110 minutes [1521-3355], P = 0.006) and longer ICU length
of stay (5 [4-9] vs. 4 [3-6], P = 0.008).
Conclusions: Preliminary data demonstrated a similar occurrence of
the primary outcome in both groups, with greater use of inotropes
and longer ICU stay in the IABP group. Our results suggest that a tai-
lored approach for IABP placement should be incorporated in future
cardiac surgery studies.
P140
Effects of low-dose atrial natriuretic peptide infusion on cardiac
surgery-associated acute kidney injury
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Introductions: Acute kidney injury (AKI) after cardiovascular surgery
is associated with an increase in morbidity and mortality. Atrial natri-
uretic peptide (ANP) is a potent endogenous natriuretic, diuretic, and
vasorelaxant peptide. However, its effectiveness on AKI is uncertain.
The objective of this study was to evaluate the effects of ANP on
renal function and medical costs in patients with AKI undergoing car-
diovascular surgery.
Methods: We conducted a multicenter prospective randomized
placebo-controlled study in patients with AKI who underwent
Table 19 (Abstract P142). The data is presented as Me (Q25 – Q75).
Parameter Group I (n = 5) Group II (n = 25)
ET-1, before surgery, fmol/ml 9.01 (5.86 – 12.48) 1.83 (0.87 – 3.12)
ET-1, the end of surgery, fmol/ml 9.23 (6.03 – 12.96) 1.53 (0.79 – 2.96)
ET-1, 24 h after surgery, fmol/ml 8.68 (5.64 – 12.06) 1.57 (0.81 – 3.07
NO3.endo, before surgery, μmol/l 9.23 (6.48 – 12.53) 13,98 (10.96 – 18.45)
NO3.endo, the end of surgery, μmol/l 3.98 (1.96 – 5.82) 10.53 (7.39 – 14.15)
NO3.endo, 24 h after surgery, μmol/l 25.9 (22.85 – 29.93) 11.28 (8.08 – 14.96)
NO2.endo, before surgery, μmol/l 1.28 (1.04 – 1.46) 1.32 (1.04 – 1.61)
NO2.endo, the end of surgery, μmol/l 0.34 (0.18 – 0.53) 1.12 (0.85 – 1.40)
NO2.endo, 24 h after surgery, μmol/l 0.86 (0.67 – 1.02) 1.37 (1.10 – 1.66)
Critical Care 2016, Volume 20 Suppl 2 Page 62 of 182cardiovascular surgery including coronary-artery bypass grafting,
valve replacement, and thoracic aorta replacement. This trial was
conducted at eleven centers in Japan from May 2012 to March 2015.
Definition of AKI used in this study was an increase in serum cre-
atinine level > =0.3 mg/dl from preoperative level within 48 h after
surgery. The patients were randomly assigned to receive a con-
tinuous infusion of low-dose ANP (0.02microg/kg/min) or placebo.
The infusion of ANP or placebo continued until the serum creatin-
ine level decreased to preoperative level. The primary endpoints
were 1) changes in renal function during 90 days measured by serum
levels of creatinine and cystatin C, and creatinine clearance or esti-
mated glomerular filtration rate, and 2) need for renal replacement
therapy during 90 days. The secondary endpoints were 1) length of
ICU, 2) length of hospital stay, and 3) medical costs during 90 days.
Results: Of the 77 enrolled patients, 37 were assigned to the ANP group
(median age 72 yrs, male:female 24:13) and 40 to the placebo group
(median age 74 yrs, male:female 31:9). ANP infusion did not significantly
increase creatinine clearance or estimated glomerular infiltration rate
compared to placebo. There was no significant difference in serum levels
of creatinine and cystatin C, renal replacement therapy rate (1 of 37 pa-
tients in the ANP group vs 3 of 40 patients in the placebo group), length
of ICU and hospital stay, or medical costs for 90 days.
Conclusions: Low-dose ANP infusion did not show renoprotective ef-
fect nor cost-saving effect in the treatment of cardiac surgery-
associated AKI.
Clinical trial registration number (UMIN 000006812).
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Acute kidney injury influence on high sensitive troponin
measurements after cardiac surgery
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Introductions: The risk assessment of cardiac troponin and other car-
diac biomarkers in end-stage renal disease is not equivalent where
clinical decision making in patients with renal diseases based on car-
diac biomarkers needs justification in relation to patient manage-
ment or outcomes [1]. Long-term outcome could be influenced by
acute kidney injury (AKI) in cardiac surgery [2], but cardiac troponins
need exploration in theses settings. We aim at assessing the diagnos-
tic performance of high sensitive troponin T (hsTnT) in the settings
of cardiac surgery-induced AKI.
Methods: Single center observational retrospective study. A database
was available for all patients. Based on the AKI Network definition pa-
tients were divided into 2 groups, group I without AKI (259 patients)
and group II with AKI (100 patients) where serial of hsTnT and creat-
ine kinase (CK)-MB followed. Both groups compared and statistically
analyzed. We enrolled 359 patients, patients with ESRD were
excluded.
Results: A total of 359 patients were enrolled with mean age of 55.1 ±
10.2 years. Both groups were matched regarding the age, gender, body
mass index, the association of diabetes or hypertension, and Euro score.
AKI group had significantly higher mortality 6 % vs group I 1.7 % (p =
0.026). The hsTnT significant changes between both groups remain all
over the course, which unparalleled to those of CK-MB. The AKI group
with more associated with heart failure 17.9 % vs 4.9 % (p = .000); and
post-operative atrial fibrillation, 12.4 % vs 2.9 % (p = 0.005).
Lengths of ventilation, stays in ICU and in hospital were signifi-
cantly higher in the AKI group.
Conclusions: Unlike the CK-MB profile, the hsTnT showed significant
changes between both groups all over the course denoting possible
delayed clearance in patients with AKI that needs to put in consider-
ation in interpreting post-operative myocardial events.
References
1) Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiology-
Renal Physiology 2003; 285(2), F167-F177.
2) Prowle JR & Kirwan CJ. Acute Kidney Injury After Cardiac Surgery: The
Injury That Keeps on Hurting?*. Critical Care Med. 2014; 42(9), 2142-2143.P142
Complex evaluation of endothelial dysfunction markers for
prognosis of outcomes in patients undergoing cardiac surgery
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Introductions: The specific role of endothelin include vasocons-
triction, cardiac hypertrophy and remodeling [1]. Endothelial dys-
function is reasonable to believe that there is diagnostic and prog-
nostic value in its evaluation for outcome [2].
Methods: In a prospective trial (30 male of 54 ± 5) the method
of prognosis of outcomes was examined. The dynamics of
endothelin-1 (ET-1) level, metabolites of nitric oxide were analyzed
in perioperative period; we studied it’s correlations with clinical
and laboratory data. Statistical analysis was carried out in SPSS
17.0.
Results: Group I included 5 patients with multiple organ dysfunction
syndrome in the early postoperative period. Group II included 25 pa-
tients with uncomplicated postoperative course (Table 19). The high
concentration of ET-1 and low level of nitric oxide metabolites in
perioperative period indicates the predominance of vasoconstrictor
effect, which in its turn leads to vascular wall damage and hypoper-
fusion of organs and tissues.
Conclusions: High levels of ET-1 and nitric oxide metabolites
imbalance, which characterize the functional state of the endo-
thelium, are predictors of postoperative morbidity in cardiac
surgery.
References
1. Rodríguez-Pascual F. et al. Pharmacol. Research.–2011.-63.-463–472.
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New-onset atrial fibrillation in intensive care: incidence,
management and outcome
S. A. Jenkins, R. Griffin
The Hillingdon Hospitals NHS Foundation Trust, Middlesex, UK
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Introductions: Atrial fibrillation (AF) is a common arrhythmia in
critically ill patients. However, data evaluating AF in the non-
cardiac intensive care setting are limited. The objective of this
study was to describe the incidence, management and outcome
of new-onset AF in patients admitted to non-cardiac intensive
care.
Methods: We performed a retrospective review of consecutive pa-
tients admitted to the intensive care unit (ICU) of a district gen-
eral hospital over a 10-month period. Patients with pre-existing
Fig. 29 (Abstract P144). Changes in the Sublingual Microcirculation
during Acute Pulmonary Hypertension.
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excluded.
Results: The study population consisted of 330 critically ill pa-
tients admitted to the ICU during the 10-month period. The inci-
dence of new-onset AF was 10 % (n = 33). 55 % of patients with
new-onset AF were male and mean age was 73 ± 11 years. The
medical notes were available for review for 26/33 patients. Pa-
tients with new-onset AF frequently had evidence of sepsis
(81 %), respiratory failure (62 %), circulatory shock (38 %) and
acute kidney injury (31 %). Mean ICU day when AF occurred was
2.6 (range 1 - 10). Rhythm control strategy was used as first-line
therapy for the majority of patients: 81 % received intravenous
amiodarone and 12 % underwent electrical cardioversion for
haemodynamic instability. 23 % received beta-blockers and 23 %
digoxin as second-line therapy. 69 % of patients were anticoagu-
lated with heparin infusion or therapeutic-dose low-molecular-
weight-heparin. 31 % remained in AF at time of ICU discharge.
New-onset AF was associated with longer ICU length of stay (me-
dian 6 days versus 3 days, p = 0.04) but not hospital mortality.
Conclusions: New-onset AF occurs in 10 % of patients admitted to
non-cardiac intensive care and is associated with longer ICU length
of stay. Further multicentre studies are needed to determine the op-
timal management and anticoagulation strategies for new-onset AF
in critically ill patients.P144
One single spot measurement of the sublingual microcirculation
during acute pulmonary hypertension in a pig model of shock
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Introductions: The effect of pulmonary hypertension in the sub-
lingual microcirculation (mci) remains unclear. We described in
a pig model of shock the effects of the hemodynamic changes
during acute pulmonary hypertension in conjunction with
sublingual mci alterations measured with the Cytocam-IDF
(Indident dark-field illumination) imaging fixed in one sublin-
gual spot.
Methods: Pulmonary hypertension was unexpectedly observed as a
complication after intravenous infusion of contrast agent through
the central venous catheter. This contrast agent can induce allergic
reactions leading to massive blockage of the pulmonary arteries and
increase pressure in the pulmonary capillaries. A similar response
was observed in three other animals. Mean arterial pressure (MAP),
right atrial pressure (RAP), and pulmonary artery pressure (mPAP)
were recorded continuously. One single spot measurement of the
sublingual mci was performed with the Cytocam-IDF imaging fixed
on a metal arm support.
Results: Acute pulmonary hypertension was characterized by an in-
crease in the mPAP, followed by high RAP and low MAP. The time
course of the sublingual mci alterations was recorded simultaneously
with the hemodynamic changes (Fig. 29). The progressive raise in
RAP induced blood to flow backward to the large veins, inducing
venous stasis and reducing microcirculatory perfusion. Despite the
adrenergic response with normalization of MAP, no recovery in sub-
lingual mci was observed.
Conclusions: Abnormalities in the sublingual mci during severe
pulmonary hypertension were mainly associated with decrease
perfusion pressure due to high RAP and hypotension. These
different phases of acute hemodynamic changes could be de-
tected with Cytocam-IDF imaging fixed in one sublingual spot.
This study was supported in part by an Innovation grant from the
Dutch Kidney Foundation (grant nr. 14OIP11).P145
Assessment of levosimendan as a therapeutic option to recruit the
microcirculation in cardiogenic shock – initial experience in cardiac
ICU
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Introductions: The presences of microcirculatory inadequacy despite
resuscitation of hemodynamics strongly correlate with microcircula-
tory failure and poor outcome. (1) We sought to evaluate the re-
sponse of the levosimendan, as an inotrope and vasodilator, that can
improve perfused capillary density in previous studies.(2) and
whether these beneficial effect can be utilized during cardiogenic
shock state. Recruitment of microcirculation can be detected by
veno- arterial pCO2 difference (Δ pCO2) which increases earlier as
the intracapillary blood velocity falls and could reflect the adequacy
of microvascular blood flow. (2)
Methods:
Retrospective observational study including 40 patients with car-
diogenic shock admitted to our cardiac ICU were enrolled between
January 2013 and March 2015. Arterial and mixed-venousblood gases
and hemodynamic variables were obtained at admission and every
2 hours for intial 6 hours. dPCO2, Ca-CvO2, dPCO2/Ca-CvO2 and Cv-
aCO2/Da-vO2 quotients was calculated.
Results: Completed data sets were obtained from 40 patients , CI,
cardiac output (CO), systemic vascular resistance (SVR), serum lactate,
mixed venous saturation, arterio venous oxygen content difference and
dPCO2. Subsequently, Ca-CvO2, (Cv-aCO2/Da-vO2) and the CI was ex-
amined and both found to be statistically significant different after start-
ing levosimendan in cardiogenic shock patients (p < 0.001), comparing
the serial measurements show statistical significant difference between
initial samples and after 6 hrs. From starting levosimendan (P < 0.05)
Conclusions: In our clinical series, dPCO2, Ca-CvO2 in patients with car-
diogenic shock was significantly improved after starting levosimendan
in cardiogenic shock patients, within 6 hours of initial resuscitation;
therefore, it might be reasonable to consider levosimendan as a poten-
tial therapeutic option for microcirculatory recruitment during cardio-
genic shock state. Further studies needed to confirm these findings
References
1] De Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, Vincent JL
(2010) Monitoring the microcirculation in the critically ill patient: current
methods and future approaches. Intensive Care Med 36:1813–1825.
2] Gustavo A, Ospina-Tascon, Umaña M, et al. (2015) Can venous-to-arterial
carbon dioxide differences reflect microcirculatory alterations in patients
with septic shock? Intensive Care Med. 17 November 2015.
Critical Care 2016, Volume 20 Suppl 2 Page 64 of 182P146
Terlipressin vs. norepinephrine in the Potential Multiorgan
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Introductions: Brain death is a serious disease that affects brain
parenchyma but also all other organs. Intensivist’s task is to
maintain organic homeostasis to allow PMD to reach withdrawal
multiorgan in the best conditions, protecting from possible
damage post neurovegetative storm (NS). NS causes severe
hemodynamic instability resulting in peripheral hypoperfusion,
hypotension, high values of lactates (LA), polyuria, depletion
of catecholamine and stunning heart. Aim of our prospective
study was to evaluate efficacy of terlipressin vs. norepinephrine
in maintaining hemodynamic stability after NS [1].
Methods: 10 adult patients hospitalized in intensive care with
acute brain injury, diagnosis of brain death, post NS, mean arter-
ial pressure less than 65 mmHg. The patients were divided into
two groups: 5 patients, group norepinephrine (infusion at 0.1
mcg/kg/min for 6 hours) and 5 patients, group terlipressin (infu-
sion at 1.5 mcg/kg/h for 6 hours). These parameters were col-
lected for each patients: mean arterial pressure (MAP), values of
LA. The results were expressed as mean with standard deviation.
For the comparison between the groups was used the Fisher test,
considering significant for a p < =0.05.
Results: After 6 hours of treatment group norepinephrine: MAP
85 ± 4mmgh, LA 4.1 ± 0.5mMol/L while the group terlipressin:
MAP 108 ± 4mmhg, LA 2.1 ± 0.2mMol/L. Comparing the two
groups the p-value for each variable was: MAP p = 0.034, LA p =
0.021.
Conclusions: We have shown that the use of terlipressin has im-
proved patient’s hemodynamic stability in brain death after NS,
with an increased mean arterial pressure and decrease of lactates,
compared to the use of norepinephrine. This has allowed an im-
provement in peripheral perfusion. Comparing the two groups
we have reached statistical significance for each variable
calculated.
Reference
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Echocardiography in the potential heart donor exposed to
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Introductions: The brain death is a serious disease that affects the
brain parenchyma and also the other organs. Intensivist’s task is to
maintain a normal organic homeostasis for the potential donor. In
this way, it is possible to reach multiorgan withdrawal optimally pro-
tecting from possible damage. The aim of this prospective random-
ized study was the evaluation of cardiac function of potential heart
donor underwent substitution hormonotherapy by serial echocardi-
ography [1].
Methods: 40 adult patients(pts), admitted to the intensive care
unit with acute brain injury, bilateral non reactive mydriasis,
Glasgow Coma Scale 3, absence of any reflection and potential
progression to brain death. Pts were divided randomly into two
groups: Hormonotherapy group (20 pts) treated with substitu-
tion hormonotherapy (triiodothyronine, vasopressin, methylpred-
nisolone, insulin) and Control group (20 pts) with standard
treatment. In all pts serial transesofageal echocardiography
evaluations were performed with focus on systolic function,evaluated with ejection fraction of the left ventricle with Simp-
son’s method. The echocardiographic exams were performed at
entrance of the pts, post neurovegetative storm and within
12 hours after diagnosis brain death. The results were expressed
as mean with standard deviation. For the comparison between
the two groups was used the Fisher test considered significant
with p ≤ 0.05.
Results: Pts in the two groups were statistically matched for sex
(p = 0.28) and age (p = 0.37). All patients have evolved in brain
death. In Hormonotherapy group baseline ejection fraction was
54 % ± 3%, 28 % ± 8% post neurovegetative storm, and 43 % ±
6% within 12 hours after brain death. In the control group the
baseline ejection fraction was 49 % ± 7%, post neurovegetative
storm 25 % ± 6%, and 34 % ± 5% within 12 hours after brain death.
Comparing the two groups we have reached statistical significance
(p = 0.028).
Conclusions: Comparing the two groups, we noticed both starting
from a similar baseline cardiac function. During the neurovegeta-
tive storm, we recorded a similar myocardial stunning. However,
in group who used substitution hormonotherapy is shown a re-
covery of systolic function to almost basal level within 12 hours
after brain death while in the control group remains a dysfunction
in systolic function. Considering these pts as potential heart
donors we have shown that substitution hormonotherapy im-
proves systolic function, despite the stunning post neurovegeta-
tive storm.
Reference
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Machine learning can reduce rate of monitor alarms
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Introductions: Bedside alarms sound when vital sign (VS) exceed
thresholds due to real instability (alerts) or artifact, leading to alarm
fatigue. We used machine-learning (ML) algorithms to classify
alarms as alerts or artifacts in VS data streams to assess impact of
such a filter on alert rate.
Methods: Patients had VS monitoring data (heart rate [HR], re-
spiratory rate [RR], oximetry [SpO2]) recorded at 1/20Hz. We par-
titioned data into training/validation (294 admissions; 22,980 hrs)
and test sets (2,057 admissions; 156,177 hrs). Alarms are VS devi-
ations beyond stability thresholds, and annotated as real alerts
or artifact. We trained a random forest ML algorithm to discrim-
inate alerts from artifact for long alarms (>3 min) and evaluated
performance in the test set on both long and short alarms
(<3 min) according to how many artifact alarms can be reduced
among the total number of alarms (M1); and how many artifact
alarms can be correctly filtered from the total artifact alarms
(M2).
Results: Figure 30 shows calculation of M1 (overall alarm duration
reduction = 31 %) and M2 (artifact alarm duration reduction = 94 %)
The number of artifact alarms in the complete data set is estimated
from artifact prevalence in the annotated sample. Figure 31 is the
ROC diagram for ML algorithm for both short and long alarms. The
vertical line indicates proportion of artifact alarms correctly identi-
fied at a false negative rate of 30 % (i.e. % of real alerts incorrectly
filtered out).
Conclusions: This ML filter algorithm can reduce about 94 %
of artifact alarms and 31 % of overall alarms, potentially redu-
cing alarm fatigue if applied clinically. FUNDING NIH RO1
R01NR013912.
Fig. 31 (Abstract P148). ROC diagram for ML algorithm for short
(A) and long (B) alarms.
Fig. 30 (Abstract P148). Calculation of M1 (total alarm reduction)
and M2 (artifact alarm reduction).
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Introductions: The use of peripherally-inserted central catheters
(PICCs) has notably increased in hospitalized, critically ill and ambula-
tory patients. However, it is important to understand the rationale
and risks associated with this new technology. The aim of this study
was to describe patterns of use and complications of PICCs, which
were placed in the ICU setting.
Methods: Prospective observational study carried out in a 500-bed
general hospital with a 14-bed ICU, in which a specialized unit for
catheter insertion is available. PICCs were implanted always in the
middle third of the arm, following a protocol that includes strict ster-
ile insertion procedure and echo-radiological control. Data of patients
with PICCs inserted from January 2013 to April 2015 were collected,
including demographics, characteristics of insertion, complications
and outcomes. Descriptive data included frequencies and percent-
ages for categorical variables and mean and standard deviation (SD)
or median and interquartile range (IQR) (25th-75th percentile) for
quantitative variables.Results: A total of 677 PICCs were placed. The mean age of the pa-
tients was 59 (15) years, with a 50.2 % of males. Patients came from
a hospital ward (n = 402, 59.4 %) and the remaining from home (n =
275, 40.6 %). More than half of the patients (n = 351, 51.8 %)
belonged to the Haemato-Oncology Service, 79 (11.7 %), to Internal
Medicine and 46 (6.8 %) to ICU. 293 (43.3 %) patients had solid
tumours, 128 (18.8 %) haematological neoplasms and 43 (6.4 %) in-
flammatory bowel disease. PICCs were mainly used for chemotherapy
and parenteral nutrition in 347 (51.3 %) and 156 (23 %) patients, re-
spectively. No major complication related to insertion was registered.
The mean length of use was 70 (19-188) days with a sum of
79,537 days of catheter placement. Reasons for withdrawal included
end of treatment in 334 (49.3 %), death in 160 (23.6 %), catheter-
related bloodstream infection (CRBSI) 41 (6.1 %), and deep venous
thrombosis (DVT) in 5 (0.7 %). A total of 57 CRBSI were recorded with
incidence density rates of 0.71‰ catheter-days. A total of 15 symp-
tomatic DVT (2.21 %) were recorded.
Conclusions: Many patients in non-intensive care unit settings re-
ceive PICCs; most of them were haemato-oncological patients, mainly
for the administration of chemotherapy. There were no relevant com-
plications related to catheter insertion. The mean time of use was
70 days, and the reason for withdrawal was the end of treatment or
death. An incidence density of CRBSI of 0.7‰ catheter-days was re-
corded with few symptomatic DVT.P150
Recordings of abnormal central venous pressure waveform
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M. S. Tovar Doncel1, C. Ince2, C. Aldecoa1, A. Lima2
1University Hospital Rio Hortega, Valladolid, Spain; 2Erasmus MC,
Rotterdam, Netherlands
Critical Care 2016, 20(Suppl 2):P150
Introductions: A normal central venous pressure (CVP) waveform
contains five components. These components include three peaks
(a, c, v) and two descents (x, y). The characteristics and am-
plitude of the CVP waveform components change significantly
during cardiovascular distress and its visualization can provide in-
valuable additional hemodynamic information. We described CVP
tracings recorded during an episode of pulmonary hyper-
tension in a porcine model of shock, aiming to characterize the
CVP waveform morphology in conjunction with the simultaneous
hemodynamic alterations.
Methods: This is an animal case-report in which the CVP waveform
was recorded during an ongoing experimental porcine shock model
monitored with Swan-Ganz catheter. Pulmonary hypertension was un-
expectedly observed as a complication after intravenous infusion of a
contrast agent through the central venous catheter. A similar response
was observed in three other animals. Together with the CVP tracings,
recordings also included cardiac output, systolic/diastolic arterial pres-
sure, heart rate, and systolic/diastolic arterial pulmonary pressures.
Results: The episode of pulmonary hypertension lasted for 3-5 min
with spontaneous recovery. The CVP changed from a baseline value
of 4-6 mmHg to 16-18 mmHg. The CVP waveform tracings showed
abnormal large ‘a’ wave complex resembling a cannon ‘a’ wave of
CVP. Figure 32 shows the different patterns of the CVP morphology
with the different components of the tracing recorded during the en-
tire episode of pulmonary hypertension. A simultaneous ECG is
shown to demonstrate the timing of the different components.
Conclusions: The abnormal CVP waveform morphology during an
episode of pulmonary hypertension shows a series of waves that can
provide invaluable additional hemodynamic information.
This study was supported in part by an Innovation grant from the
Dutch Kidney Foundation (grant nr. 14OIP11).
Fig. 32 (Abstract P150). Central venous pressure waveform tracings.
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Ultrasound guided central venous access technique among French
intensivists
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Introductions: The use of ultrasound is recommended to secure cen-
tral venous catheter placement in the ICU. However several surveys
showed that only 50 % of the CVC procedures are performed using
the ultrasound guided technique. The reason why physicians con-
tinue to use landmarks were the lack of formation and the absence
of ultrasound device. We designed a survey to elicit information on
physician’s characteristics, experience in CVC placement, training on
ultrasound technique, the use of ultrasound for CVC placement,
reasons for non-use of ultrasound and their opinion on the neces-
sity to continue to teach the landmark technique to residents.
Methods: This survey (14 questions) has been electronically ad-
dressed by Email to every physician belonging to the BoReal group
of research (8 university’s and 20 community’s ICU in the North-west
of France). The survey was sent to the 289 physicians (166 seniors
and 121 residents) working in those ICUs.
Results: We received 190 responses (response rate 66 %). Among the
respondents, 66 % were less than 40 years old, 34 % were residents,
41 % presented an experience in CVC placement < =5 years and
53 % declared putting more than 1 CVC per week. 71 % of the resi-
dents declared having learned both landmark and ultrasound guided
techniques during their residency. Only 18 % reported using always
the ultrasound to put CVC. The main reasons why they don’t use
ultrasound were 1) they think they don’t need it (36 %), 2) the ultra-
sound was not available (33 %) while 3 % declare the absence
of ultrasound device in their setting and 3) 11 % reported the
absence of formation on ultrasound technique. Coagulation ab-
normalities (64 %), obesity (54 %) and anatomical difficulties (52 %)
were the main motivations to use ultrasound reported. 53 % of
the respondents declared having been confronted during the last
12 months to an urgent situation where the ultrasound was not
available quickly enough. Finally 91 % think that the landmark
technique should still be taught to the residents.
Conclusions: Our survey shows that a large majority of the intensivists
still perform landmark procedures while almost every physician re-
ceived a formation on the ultrasound technique. Ultrasound device is
present in the large majority of the institution however their availability
is still scarce. Despite the several guidelines, physicians still don’t useultrasound for every procedure and think that landmark technique
should still be taught to residents.
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Predictive ability of the Pv-aCO2 gap in patients with shock
M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila,
A. AlHussain
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
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Introductions: Central venous-to-arterial carbon dioxide difference
(Pv-aCO2 or CO2 gap) is recognized as an index of global tissue per-
fusion. Additionally, the ratio of Pv-aCO2 by arterial-to-central venous
O2 content difference (Ca-vO2), has been described as indicative of
¡®anerobiosis¡¯ in shock. The aim of this study was to demonstrate
the predictive abilities of the Pv-aCO2 gap and Pv-aCO2/Ca-vO2 ratio
in patients undergoing resuscitation from shock.
Methods: Critically ill patients with shock who required vasopressors
or inotropes were included in a prospective, observational study. Ser-
ial measurements of Pv-aCO2 gap, lactate, and Ca-vO2 were obtained
at the time of starting the vasopressor/inotrope (time 0), then at
times 3, 6 and 12 hours. The Study protocol was approved by the
Hospital Research Ethics Committee (RAC No. 2151 048).
Results: Fifty patients were enrolled. The mean APACHE II score was
26.9 ¡À 7.3. Thirty patients (60 %) had septic shock, 15 patients
(30 %) had combined septic and cardiogenic shock, 3 patients (6 %)
had hemorrhagic shock, and two patients (4 %) had cardiogenic
shock. 28-day mortality rate was 62 % (31 patients). Fifteen patients
(30 %) developed acute kidney injury.
Patients surviving to day-28 had a lower Pv-aCO2 gap at time 0 (7.5,
IQR 7 vs. 4.8, IQR 5, p = 0.007), and demonstrated greater clearance
of the Pv-aCO2 gap during resuscitation (-0.75 IQR 4.8 vs. +0.75 IQR
5.2, p =0.024). A cut-off value of ¡Ý 6 mmHg significantly predicted
28 day mortality (75 % vs. 45.5 %, p =0.033). In a subgroup of pa-
tients in whom a resuscitative target of ScvO2 70 % was achieved, a
higher Pv-aCO2 gap was significantly associated with lower 28-day
survival (6.7 IQR 6 vs. 3.7 IQR 4, p =0.009).
Pv-aCO2/Ca-vO2 ratios were significantly lower in patients surviving
the ICU and until day-28 of follow up; this relationship was observed
both at time 0 (0.21,IQR 0.17 vs. 0.27, IQR 0.22, p =0.042) and at time
3 (0.19, IQR 0.1 vs. 0.24,IQR 0.07, p =0.047) for ICU mortality, and
(0.27, IQR 0.19 vs. 0.18,IQR 0.12, p =0.013) and (0.27, IQR 0.08 vs. 0.19,
IQR 0.10,p = 0.011) for 28-day survival.
Conclusions: This study suggests that Pv-aCO2 gap and Pv-aCO2/
Ca-vO2 ratio can be used to predict mortality in shock, especially in
patients for whom the usual goals of resuscitation have been
achieved. A Pv-aCO2 gap value of 6 mmHg may be used as a reason-
able cut-off point.
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Comparison of echocardiography and pulmonary artery catheter
measurements of hemodynamic parameters in critical ill patients
P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris,
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Introductions: Measurements of cardiac output (CO), pulmonary ar-
tery occlusion pressure (PAOP) and systolic pulmonary artery pres-
sure (SPAP) remain important parameters for the management of
critically ill patients. Pulmonary artery catheter (PAC) with ther-
modilution technique has been considered the clinical standard in
measurements of CO. However, it is an invasive technique that can
be associated with complications. Transthoracic echocardiography
(TTE) is a non-invasive technique allowing to calculate the CO and
the PAPS. We decided to compare the CO and SPAP measured by
TTE and by PAC.
Methods: We prospectively included all patients monitored with
PAC, sedated and under mechanical ventilation in our ICU. We ex-
cluded patients with arrhythmias, severe valvulophathy and poor
echogenicity.
Critical Care 2016, Volume 20 Suppl 2 Page 67 of 182The CO, PAOP, right auricular pressure (RAP) and SPAP were mea-
sured using the PAC (-PAC). CO-PAC was an average of three thermo-
dilutions. The TTE CO (COTTE) was derived from the Doppler stroke
volume, the E/A ratio from the transvalvular mitral flow and the Ea
from the mitral annular TDI. SPAP was estimated from tricuspid gra-
dient (SPAPecho) plus RAP (estimated by inferior vena cava diam-
eter). Measurements made with TTE and PAC were performed
simultaneously by two experienced operators. A linear regression
and a Bland-Altman analysis were performed.
Results: 22 patients (36 measurements) were monitored with PAC,
age 64y/o(60-70), SAPS 61(60-79), ejection fraction (EF) 58 %(46-61).
The linear regression between COTTE and COPAC was R2 = 0.78 (P <
0.001). The Bland and Altman analysis showed a bias of -0.4 l/min
and limits of agreement from -2.8 to 1.9 l/min. The linear regression
between SPAPecho and SPAP-PAC was R2 = 0.52 (P < 0.001), the lin-
ear regression improves when SPAPecho was calculated from tricus-
pid gradient plus RAP measured by PAC R2 = 0.62 (P < 0.001). The
Bland and Altman analysis showed a bias of -3.7 mmHg and limits of
agreement from -18.1 to 10.7 mmHg. Linear regression between E/A
and PAOP, E/Ea and PAOP were weak, R2 = 0.33 (P < 0.001) and R2 =
0.42 (P < 0.001) respectively.
Conclusions: This study confirms that COTTE correlates well with the
measurement of COPAC in critical care patients sedated under mech-
anical ventilation. The TTE estimation of SPAP appears also reliable.
But the TTE estimation of PAOP (E/Ea and E/A) in this population of
patient with unselected EF is not consistent.
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The volume clamp method for noninvasive cardiac output
measurement in postoperative cardiothoracic surgery patients: a
comparison with intermittent pulmonary artery thermodilution
J. Wagner, A. Körner, M. Kubik, S. Kluge, D. Reuter, B. Saugel
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
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Introductions: The CNAP technology (CNSystems Medizintechnik
AG, Graz, Austria) enables noninvasive continuous recording of the
arterial pressure waveform based on the volume clamp method. Re-
cently, the manufacturer released a novel algorithm for measuring
cardiac output (CO) using pulse contour analysis of the arterial
waveform. In this study, we compared CO measurements with CNAP
(CNCO) with invasive CO measurements using intermittent pul-
monary artery thermodilution (pulmonary artery catheter (PAC); PAC-
CO) in postoperative cardiothoracic surgery patients.
Methods: In this interim analysis, simultaneously obtained CNCO and
PAC-CO measurements were analyzed in 30 patients during the first
hours after cardiothoracic surgery. We performed 3 independent sets
of 5 consecutive thermodilution measurements each per patient. The
average of the 3 closest of the 5 PAC-CO measurements was used for
comparison with the average of the corresponding CNCO values.
Three pairs of measurements were excluded due to artifacts resulting
in 87 paired measurements for analysis. In addition, 25 cardiac out-
put–modifying maneuvers were analyzed to evaluate trending ability.
We conducted 2 separate comparative analyses: 1) CNCO calibrated to
the first simultaneously measured PAC-CO value (CNCOcal) vs. PAC-CO
and 2) CNCO auto-calibrated to biometric patient data (CNCObio)
vs. PAC-CO. Agreement between the two methods was statisti-
cally assessed by Bland-Altman analysis and by calculating the
percentage error (PE). For evaluating trending ability, the con-
cordance rate (CCR) was calculated. An exclusion zone of 0.5 L/
min was applied.
Results: For CNCOcal, the Bland-Altman analysis resulted in a mean
difference of -0.2 L/min, a standard deviation of ±0.5 L/min and limits
of agreement of -1.1 to +0.7 L/min. The PE and CCR were 18 % and
100 %, respectively. For CNCObio, the Bland-Altman analysis resulted
in a mean difference of +0.5 L/min, a standard deviation of ±1.1 L/
min and limits of agreement of -1.6 to +2.6 L/min. The PE and CCR
were 43 % and 94 %, respectively.
Conclusions: In this clinical study in patients after cardiothoracic sur-
gery, CNCOcal showed good agreement (PE 18 %) and good trend-
ing ability (CCR 100 %) when compared with intermittent pulmonaryartery thermodilution. For CNCObio, we observed a higher PE (43 %)
but acceptable trending ability (CCR 94 %).
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Hemodynamic monitoring in patients with septic shock (SS) –
CPCCO (continuous pulse contour cardiac output) vs. TEE
(transesophageal echocardiography)
E. Colombaroli, F. Righetti, G. Castellano
Intensive Care Unit, St. Boniface Hospital, Verona, Italy
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Introductions: A reliable hemodynamic monitoring and a correct in-
terpretation of the data are of crucial importance in the patient (pts)
with SS to choose the strategy of treatment in the Intensive Care
Unit (ICU). The aim of this prospective study was to compare two
techniques of hemodynamic monitoring to assess which is more reli-
able in the management of pts in SS[1].
Methods: 20 adult pts in ICU for SS. All pts were monitored with
CPCCO Pulsion Medical Systems and serial TEE have been performed.
The cardiac output(CO;L/min) was measured continuously with the
method CPCCO(triple injection of 15 ml of 0.9 % saline solution at
4 °C in the CVC, thermo dilution curve measured in the femoral artery
through the catheter thermistor dedicated) and simultaneously with
TEE(LVOT area multiplied the integral speed/time of aortic flow multi-
plied by the heart rate) at the entrance, after fluid challenge with
500 ml of crystalloid and during the use of vasopressors and/or ino-
tropic drug(VId). Same operator measured echocardiographic CO with-
out being aware of the CO supplied by CPCCO. The results were
expressed as mean with standard deviation. For comparison and correl-
ation between measurements were used linear regressions according
to the Bland-Altman method. Statistical significance was considered at
p ≤ 0.05.
Results: 120 measurements were performed. 60 with CPCCO and 60
with the TEE. 40 measurements were realized at the entrance, 20
with CPCCO(1.8 ± 0.2) and 20 with TEE(1.75 ± 0.3), 40 after fluid chal-
lenge, 20 with CPCCO(2.5 ± 0.3) and 20 with TEE(2.7 ± 0.2), 40 during
the use of vasopressors and/or inotropic drug including 20 with
CPCCO(4.5 ± 0.3) and 20 with TEE(4.4 ± 0.2). There is a good correl-
ation and a limited bias between measurements provided by CPCCO
and by TEE, both at the entrance(r = 0.992,bias = 0.15), after fluid
challenge (r = 0.954,bias = 0.24), both during the use of VId (r =
0.967,bias = 0.33). These values were statistically significant (p = 0.026).
Conclusions: This study showed that there is a good correlation be-
tween the data provided by CPCCO and TEE. Both methods can be
used reliably for hemodynamic monitoring in SS.
Reference
1. V. De Castro et al. Comparison of stroke volume and stroke volume
respiratory variation measured by the axillary artery pulse-contour
method and aortic Doppler echocardiography in patients undergoing
aortic surgery. Br J Anaesth 2006; 97:605-10
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Cardiac output measurement with transthoracic echocardiography
in critically ill patients: a pragmatic clinical study
T. Tran, D. De Bels, A. Cudia, M. Strachinaru , P. Ghottignies, J. Devriendt,
C. Pierrakos
Brugmann Hospital, Brussels, Belgium
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Introductions: The assessment of cardiac output by echocardiography
is a frequent clinical practice. However, this method shares important
limitations which can lead to inappropriate therapies.
Methods: We retrospectively evaluated transthoracic echocardio-
graphy examinations of critically ill patients performed between
2013-2014. The stroke volume (SV) was calculated using left ventricu-
lar outflow tract diameter and flow velocity time integral (DT) and
was compared to stroke volume estimated from the difference be-
tween the end diastolic and end systolic volume measured by Simpson
biplane method (S2D). We excluded patients with atrial fibrillation and
any significant valvulopathy. Low end diastolic value (EDV) was
Critical Care 2016, Volume 20 Suppl 2 Page 68 of 182considered as a volume <70 cc and low ejection fraction (EF) was
defined <45 %.
Results: We evaluated 147 exams. Twenty patients were excluded
because of atrial fibrillation and 41 because of a significant valvu-
lopathy. A total 86 pairs of stroke volumes measured by the two
methods were evaluated. The r value was 0.51, r^2 = 0.25 and p <
0.01 by regression analysis. The mean bias of stroke volume mea-
sured with DT over that estimated with S2D was 29 % (95 % CI 21.4-
37.5, p < 0.01). There was a negative correlation of this bias with
mean SV (r^2 = 0.09, p < 0.01). A negative linear correlation was
found between the bias and the end-diastolic volume and EF but
not with end-systolic volume (r^2 = 0.21 p < 0.01, r^2 = 0.15 p < 0.01
and r^2 = 0.01 p = 0.93, respectively). A higher bias was observed in
patients with low EF (46 % ± 33 vs 25 % ± 36 p0.03) and in patients
with low end-diastolic volume (64 % ± 33 vs 20 % ± 31 p < 0.01).
Conclusions: A significant overestimation of stroke volume measured
with Doppler ultrasound by transthoracic echocardiography com-
pared to S2D was observed in critically ill patients. This overestima-
tion was more prominent between the patients with low end-
diastolic volume and/or low EF. Given that none of the two methods
that we used can be considered as gold standard a further evalu-
ation of DT should be made in this group of patients. Conversely, in
every day clinical practice, the combination of these two methods
may be an easy way to identify possible errors in cardiac output
measurements.
P157
Left ventricular outflow tract velocity time integral correlates with
stroke volume index in mechanically ventilated patients
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Introductions: Ultrasound is a non invasive and bedside accessible
method of cardiac function monitoring. Left ventricular outflow tract
(LVOT) velocity time integral (VTI) can be measured in most critical
care patient and is an useful tool for this purpose. Calculations of car-
diac output needing aortic valve area are strongly dependent on
skills and observers. We hypothesize that LVOT-VTI is an accurate es-
timation of stroke volume index (SVI). The objective of the study was
to assess the correlation between SVI and LVOT-VTI.
Methods: Three ICU from different university hospitals participated
in the study. Consecutive patients with haemodynamic monitoring
on mechanical ventilation were included. Patient with aortic valve re-
gurgitation or dynamic stenosis on the LVOT were excluded from the
study. LVOT-VTI was measured by pulsatile doppler echocardiog-
raphy. Five measurements of LVOT-VTI were obtained on each pa-
tient. Mean and maximum values were recorded. Simultaneously,
five measurement of SVI by floating pulmonary artery catheter (PAC)
or Pulse Induced Contour Cardiac Output (PiCCO) thermodilution
methods were obtained and the mean was recorded. Mean and max-
imum LVOT-VTI were correlated with mean invasive SVI. Statistical
analysis: correlation was assessed by Pearson correlation index and
intraclass correlation coefficient (ICC).
Results: One hundred and two paired measurements were recorded
in thirty two patients. One patient was excluded from the study due
to the difficulty to obtain an adequate acoustic window. Twenty one
patients were monitorized by PiCCO and eleven by PAC. The Pearson
correlation index between LVOT-VTI en SVI was r = 0,770 (p < 0,001).
This correlations was similar for measurements taken by PiCCO (r =
0,736, p < 0,001) but worsened when PAC was used to calculate SVI
(r = 0,470, p = 0,004). Correlation was acceptable for patients on atrial
fibrillation (r = 0,619, p < 0,001).
Conclusions: LVOT-VTI could be useful as a non-invasive simple
method to estimate SVI in most of mechanically ventilated patients.
Larger studies are needed to assess factors influencing on this corre-
lations, such as the measurements performed by PAC.Reference
Evangelista A, et al. Cardiac index quantification by Doppler ultrasound in
patients without left ventricular outflow tractabnormalities. J Am Coll
Cardiol 1995&#894; 25: 7106
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Transpulmonary thermodilution (TPTD) derived from femoral vs.
jugular central venous catheter: validation of a previously
published correction formula and a proprietary correction formula
for global end-diastolic volume index (GEDVI)
W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, RM Schmid,
T. Lahmer
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Introductions: Usually TPTD for measurement of global end-diastolic
volume index (GEDVI) is performed by indicator injection via the
jugular or subclavian vein. If this access is not feasible, femoral access
can be used. However, several studies demonstrated significant over-
estimation of GEDVI due to the additional volume of V. cava inferior.
One of these studies provided a correction formula (1). As a conse-
quence, one of the manufacturers of commercially available TPTD-
devices requires information about the venous catheter position, and
correction of GEDVI in case of femoral access can be assumed.
Methods: It was the aim of our study to compare GEDVI derived
from TPTD using jugular venous access (GEDVI-jug) to uncorrected
(GEDVI-fem-uncor) and corrected (GEDVI-fem-cor) GEDVI as calcula-
ted by the PiCCO device and to GEDVI-form calculated from the pre-
viously suggested formula (1).
We recorded 31 datasets in 15 patients equipped with both jugular
and femoral venous access. Each dataset consisted of three triplicate
TPTDs using the jugular venous access as the gold standard and the
femoral access with and without the information about the femoral
indicator injection. (Bland-Altman analysis; Wilcoxon-test for unpaired
samples; SPSS 23.0).
Results: 15 patients, 9 male, 6 female, age 60 ± 15 years, 174 ± 9 cm,
83 ± 17 kg. GEDVI-fem-uncor was significantly higher compared to
GEDVI-jug (1026 ± 263 vs. 765 ± 145 ml/m2; p < 0.001) with a bias of
+260 ± 182 ml/m2 and a percentage error (PE) of 40.6 %. GEDVI-fem-
cor was slightly different to GEDVI-jug (811 ± 159 vs. 765 ± 145 ml/m2;
p = 0.025) with a PE of 29.6 % and a bias of 46 ± 117 ml/m2 which was
significantly lower (p < 0.001) than the bias for GEDVI-fem-uncor.
GEDVI-form was not significantly different from GEDVI-jug (797 ± 162
vs. 765 ± 145 ml/m2; p = 0.063) with a PE of 26.1 % and a bias of 31 ±
108 ml/m2 which was significantly lower (p < 0.001) than the bias for
GEDVI-fem-uncor, but not than the bias for GEDVI-fem-cor (p = 0.557).
Conclusions: This study confirms that GEDVI derived from uncor-
rected femoral indicator injection TPTD markedly overestimates
GEDVI and also results in inacceptable imprecision. Correction by
the PiCCO-device and by the formula recently suggested (1) re-
sult in acceptable accuracy and precision of GDVII derived from
femoral TPTD. The recently suggested formula provided the low-
est bias and PE values.
Reference
(1) Saugel, Huber et al., Crit Care 2010; 14:R95
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Venous return driving pressure and resistance in acute blood
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Introductions: Guyton’s venous return model helps to interpret circu-
latory response to blood volume changes. The model implies that
Critical Care 2016, Volume 20 Suppl 2 Page 69 of 182venous return depends on the venous return driving pressure (VRdp),
i.e. the difference between mean systemic filling pressure (MSFP) and
right atrial pressure (RAP), and resistance to venous return (RVR). We
studied VRdp and RVR response to hypo- and hypervolemia in pigs
with intact circulation.
Methods: We measured in anesthetized pigs (n = 10; 2 early
deaths) pulmonary artery blood flow (QPA; ultrasonic flow probe),
RAP and MSFP (venous pressure at zero flow during right atrial
balloon occlusion; MSFPRAO) at baseline, after bleeding of 9 mL/
kg body weight (hypovolemia) and after retransfusion of the shed
blood and an equal amount of hydroxyethyl starch (hypervole-
mia). Blood volume (BV; indocyanine green dye dilution) was
measured at baseline and hypervolemia and calculated for hypovolemia
as BVbaseline minus shed volume. Stressed volume (Vs) was defined from
systemic vascular compliance (Cvasc = Δ BV/Δ MSFPRAO) at MSFPRAO = 0.
Statistics: analysis of variance for repeated measures.
Results: [mean (SD); n = 8]. BV (mL/kg) was 98 (16) at baseline, 89
(15) in hypovolemia and 113 (21) in hypervolemia (p = .001). The re-
spective MSFPRAO (mmHg) was 13.0 (2.8), 10.8 (2.2) and 16.4 (3.0),
VRdp 7.0 (2.4), 5.7 (1.7) and 8.2 (2.2); QPA changed in parallel
(p < .001 for all). RVR did not change (p = .49). Cvasc was 3.2 (.8)
mL ×mmHg-1 × kg-1; linear regression r2 = .96 (.04). The respective
Vs before bleeding was 42 (9) mL × kg
-1, or 43 (10)% of the total
blood volume.
Conclusions: The parallel changes in BV, VRdp and QPA, estimated by
mutually independent methods, support the Guytonian model and
stress the importance of RAP as backpressure to venous return. The
linear relationship between changes in BV and MSFPRAO indicate
a constant Cvasc and that changes in BV translated fully into
change in Vs.
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Dynamic arterial elastance calculated with lidcoplus monitor does
not predict changes in arterial pressure after a fluid challenge in
postsurgical patients
D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi
St George’s Healthcare NHS Trust, London, UK
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Introductions: Dynamic elastance (EaDyn), calculated as the ratio be-
tween Pulse Pressure Variation (PPV) on Stroke Volume Variation
(SSV) has been proposed as a predictor of change in arterial pressure
in response to a fluid challenge. We want to assess the predictive
value of EaDyn calculated with LiDCOplus cardiac output monitor in
post-operative patients.
Methods: In this prospective observational study 38 fluid responsive pa-
tients were monitored with an arterial catheter, cardiac output (CO) moni-
tor (LiDCOplus). Haemodynamic data was recorded one minute before
the fluid challenge and one minute after. 250 mL of crystalloids were in-
fused intravenously over 5 minutes. Changes in mean arterial pressure
(ΔMAP) systolic arterial pressure (ΔSys) and diastolic arterial pressure
(ΔDias) were analysed in a regression models against the values of EaDyn
, at baseline, adjusted by baseline values of the haemodynamic of inter-
est (i.e. MAP) and the presence of mechanical ventilation.
Results: There is no evidence that EaDyn at baseline predicts the
ΔMAP (p = 0.17), ΔSys (p = 0.21) or ΔDias (p = 0.17). The mechanical
ventilation was a significant predictor of changes in MAP (p = 0.003),
Systolic (p = 0.001) and Diastolic (p = 0.001).
Conclusions: EaDyn calculated with LiDCOplus and adjusted by
baseline arterial pressure does not predict changes in arterial
pressure after a fluid challenge in post-operative patients.
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Analysis of duration of post-operative goal-directed therapy
protocol
C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson,
A. Rhodes, M. Cecconi
St George’s Healthcare NHS Trust, London, UK
Critical Care 2016, 20(Suppl 2):P161Introductions: The purpose of this study is to describe the timing for
achieving targets of the post-operative goal-directed therapy (GDT)
protocol in postoperative patients admitted to ICU in St George’s
Hospital, in order to explore if the duration of this intervention can
be reduced.
Methods: This is a retrospective study of the post-operative GDT
protocol, which basically consist of administration of fluids and ino-
tropes in order to achieve an oxygen delivery index of 700 mL/min/
m2. Data from a randomly selected month were collected and com-
pared with the data from the audit in 2009. Data was graphically and
analytically explored. Continuous variables are presented as means
and standard deviation, categorical data is presented as number and
proportions. Means are compared with student t test. Statistical sig-
nificance is considered with p < 0.05.
Results: 83 patients (74.1 %) were considered suitable for GDT. The sur-
gery name or type of surgery was not documented in 55.4 %. Oxygen
delivery index (DO2I) significantly increased from baseline to the max-
imal level (559.27 ± 182.31 to 679.91 ± 216.27, p = < 0.0001), but did
not change significantly from baseline to the value at the end of the
protocol (559.3 ± 21.05 vs 548.4 ± 22.37, p = 0.7243). Maximal DO2I was
spontaneously achieved by 21.5 % of cases. 13.9 % of patients achieved
the maximal DO2I in the 8th hour. In general, the maximal DO2I was
achieved at the 4th hour, which is the same timing observed in 2009.
Conclusions: The current post-operative optimisation protocol is safe
and effective. At the current stage, duration of the protocol cannot
be safely reduced.
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Hemodynamic optimization – back to square one?
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Introductions: The aim of the study was to assess whether hemo-
dynamic optimization by protocols based on hemodynamic moni-
toring reduces mortality in critically ill patients.
Methods: We performed a systematic review and meta-analysis
according to the Cochrane Handbook for Systematic Reviews of
Interventions. The study was registered in the PROSPERO database
(2015:CRD42015019539). We searched the PubMed, Embase and
CENTRAL databases for articles in English. Inclusion criteria were RCTs
studying adult patients with critical illness, treated in an intensive care
unit. The intervention should be protocolized and based on results from
hemodynamic measurements, defined as cardiac output, stroke volume,
stroke volume variation, oxygen delivery, central venous oxygenation
(ScvO2) or mixed venous oxygenation (SvO2). The control group should
be treated without any structured intervention mentioned above. Exclu-
sion criteria were pediatric, animal and perioperative studies. Primary out-
come was mortality; secondary outcomes were weight gain or fluid
balance. Risk of bias was assessed independently of each other by two in-
vestigators. Statistical analysis was performed by RevMan 5.3 software.
Results: Preliminary results: Out of 575 screened papers, eight RCTs
meeting the inclusion criteria were found. None of the eight studies
were completely blinded. A total of 5323 patients were enrolled in the
included studies. There was no statistically significant difference in mor-
tality between the groups. Mortality in the hemodynamic intervention
group was 23.6 % (630/2664 patients) vs. 24.1 % (641/2659 patients) in
the control group, OR 0.96 (95 % CI 0.82-1.11) P = 0.95. I2 = 19 %.
Conclusions: There is no evidence in the literature that hemo-
dynamic monitoring combined with a structured intervention re-
duces mortality in critically ill patients. To investigate if mortality
can be reduced by individualized hemodynamic management the
monitoring has to be reliable, the intervention must be directed
towards a meaningful treatment goal and the controls should re-
ceive standard of care.
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Effectiveness of fluid thoracic content measurement by
bioimpedance guiding intravascular volume optimization in
patients with septic shock
M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina
Hospital O’horan, Mérida, Mexico
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Introductions: Appropriate resuscitation and intravascular volume
optimization are treatment cornerstone in septic shock. Optimization
requires invasive monitoring and static measurements, due to it, is
necessary a non invasive, fast and dynamic method. Thoracic fluid
content (TFC) by thoracic bioimpedance surge as a monitoring sys-
tem that fulfils the requirements: non invasive, easy placement and
dynamic.
Methods: Sixty patients were enrolled, divided in two groups with
30 subjects each, admitted at ICU with septic shock diagnosis. F
Group was formed by patients in whom TFC was measured by thor-
acic bioimpedance, in order to guide intravascular volume
optimization; C Group patients were optimized following “Surviving
Sepsis Campaign Guidelines”, recording mortality at ICU discharge
and at 28 days, mechanical ventilation length and ICU length of
stay.
Results: Based on TFC F Group obtained a faster and higher Mean
Arterial Pressure (MAP) increasing up to 42.5 % at 6 hours, compared
to C Group where MAP arise only 19.5 % at 6 hours (p:<0.05). Due to
lactate clearance F Group, obtained a total clearance of 54.4 % and
66.6 % at 6 and 12 hours, on C Group clearance just came up to
25.3 % and 35.8 % at 6 and 12 hours (p: 0.001). A higher mortality at
ICU discharge was reach on C Group with 33.4 % vs 26.7 % (p: 0.001)
from F Group, 28 day mortality was 36.5 % and 27.8 % (p:0.003) on C
and F Group respectively.
Conclusions: Measurement of thoracic fluid content by thoracic
bioimpedance is effective while optimizing intravascular volume in
septic shock.
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A systematic review on the role of internal jugular vein ultrasound
measurements in assessment of volume status in critical shock
patients
N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T.
Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L. Luciani
Policlinico Modena, Bologna, Italy
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Introductions: Previous studies tested the role of the internal jugular
vein ultrasound exam (IJVUE) in the prediction of volume status but
there are divergent conclusions on the its effectiveness in shock pa-
tients. For this reason we conducted a systematic review to check
the level of reliability, validity and correlation with Central Venous
Pressure (CVP) of the IJV ultrasound measures and the quality of
reporting of literature on this topic.
Methods: This review was based on the PRISMA guideline. The sys-
tematic search of the literature published from 1941 through 30 June
2015 explored the PubMed, Cochrane Library, Web of Know-
ledge, and Scopus databases. Inclusion criteria were studies who in-
vestigated the reliability, the accuracy in predicting low CVP and the
correlation with CVP of the IJV ultrasound measures in adult
(>18 yrs) spontaneously breathing patients in shock. Three resear-
chers selected studies using inclusion criteria and then assessed their
quality using the STARD and QUADAS guidelines. The key words for
literature search were: internal jugular veins, ultrasonography, volume
status, central venous pressure, shock.
Results: We collected 219 studies: 20 excluded with reasons, 194 be-
cause duplicates. Five studies were included for the final analysis: 3
on reliability , 4 on correlation with CVP , 5 on validity. The IJV ultra-
sound measures (IJV ratio, anterior-posterior IJV diameter [AP-IJVD],
IJV area) showed an inter-rater agreement range from moderate to
excellent . The AP-IJVD had a significant high correlation with CVP;
there were divergent conclusions on IJV area and poorly correlation
for IJV ratio. The IJV ratio showed a moderate-good validity in pre-
dicting low CVP; the AP-IJV showed an high sensitivity and specificity
for hyper and hypovolemia; an increase of IJV area effectively ruled
out elevated CVP. Two studies respected more than 80 % of the
STARD items and four more than 80 % of QUADAS items.
Conclusions: Because few reports have been published on this topic
the conclusions of this review should be confirmed. Anyway the
quality of reporting and methodology of the studies collected were
good. The IJVUE seems to have a good reliability and accuracy in
predicting low or high CVP . The AP-IJVD shows the best correlation
with CVP.P165
Importance of recognizing dehydration in medical Intensive Care
Unit
M. Mackovic, N. Maric, M. Bakula
Clinical Hospital Sveti Duh, Zagreb, Croatia
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Introductions: Dehydration is a relatively unrecognized disorder in
medical ICU especially among older patients. Our aim was to deter-
mine the incidence of dehydration upon admission as well as the risk
of developing dehydration during hospitalization and its effect on
patient outcome. Moreover, several lab parameters were studied in
order to assess the correlation to the diagnosis.
Methods: All patients entering ICU in a 6 month period in 2015 were
enrolled and screened for dehydration on day 1 and day 3 using clin-
ical and lab parameters (BUN, Cr, BUN/Cr ratio, Hct, serum Na, urine
specific gravity). BUN/Cr >20 was used as a diagnostic criteria. Serum
osmolality was not used due to unconsistent eligibility. In total of
332 patients, 38 were excluded due to GI haemorrhage. Finally, 294
patients were included, M/F 152/142, median age 74. Statistical
methods used were McNemar test (differences in dehydration
on day 1 and day 3), binary logistic analysis (association of lab
Fig. 34 (Abstract P167). Fluid type.
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tic regression model (outcome).
Results: Of 294 patients 126 (42.9 %) were dehydrated upon ad-
mission. Dehydration clinically diagnosed at admission and defined
by BUN/Cr >20 were significantly associated (McNemar test; χ 2 =
42.01; n = 246; p < 0.001; ϕ =0.24). Dehydration was correctly clinic-
ally recognised in 45/126 (35.7 %). Patients with BUN/Cr >20 had 3
times higher odds to be accurately clinically diagnosed. No correl-
ation could be found between dehydration and values of Hct, serum
Na and urine specific gravity. Statistically significant positive associ-
ation was demonstrated for BUN (OR = 1.08; 95 % CI 1.04-1.11; p <
0.001) and Cr (OR = 1.00; 95 % CI 1.00-1.00; p = 0.048). On day 3 133/
249 (54.1 %) patients were dehydrated which represents sig-
nificant increase (McNemar test, χ 2 with continuity correction = 7.01;
n = 246; p = 0.008; ϕ = 0.45). Overall, dehydration at any point of stay
was associated with adverse outcome (death) (ORadj = 2.45, 95%CI
1.38-4.34, p = 0.002).
Conclusions: Dehydration is a common finding in ICU and can be
clinically easily overlooked due to insensitivity of clinicians for milder
forms of dehydration which could explain a relatively high rate of
misclassification. Clinical and lab parameters are insufficient for diag-
nosis which is consistent with previous observations. According to
these data, hydration status changes during ICU stay and it’s fluctua-
tions are associated with increased mortality suggesting that main-
taining an adequate hydration status is of core interest for patient
outcome.
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Effect of volume for a fluid challenge in septic patients
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Introductions: An effective fluid challenge should increase the mean
systemic filling pressure (Pmsf) in order to increase the venous return.
The object of this study was to test the effect of several doses of intra-
venous fluids on the change of Pmsf in septic patients.
Methods: Patients were randomly allocated to receive 2, 3, 4 or 5 ml
/kg (body weight) of intravenous crystalloid over five minutes. Pmsf
was measured using the arterial pressure after stopping blood flow
in the arm with a pneumatic tourniquet inflated for one minute.
Mean arterial pressure (MAP), central venous pressure (CVP), cardiac
output (CO) and stroke volume (SV) were recorded at baseline and
immediately after the fluid infusion. CO was measured with LiDCO-
plus monitor. A positive response was defined as an increase of
10 % from baseline. From previous data, the least significant
change (LSC) for Pmsf was 14 %. Medians were compared using
the independent samples media test, and proportions were com-
pared using an exact fisher test. Statistical significance was consid-
ered when p < 0.05
Results: 40 patients were included, 40 % of them were responders.
The changes (Δ ) of Pmsf and CO in each group are described in
Table 20. There is marginal evidence of Δ Pmsf is related to the dose
of fluids, but the Δ CO and the proportion of responders are not af-
fected by the dose of fluids infused
Conclusions: The dose of fluids does not affect the change in CO or
the proportion of responders to a fluid challenge in septic patients.Table 20 (Abstract P166). Changes of Pmsf-arm, cardiac output and
percentage of responders in each group. Data presented as median
(interquartile range).
2 ml / Kg (n =
10)
3 ml / Kg (n
= 12)
4 ml / Kg (n
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Fluid bolus practices in a large Australian intensive care unit
B. Avard1, P. Zhang2
1The Canberra Hospital, Hughes, ACT, Australia; 2Australian National
University Medical School, Canberra, Australia
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Introductions: Fluid bolus administration is a ubiquitous therapy
within Intensive Care, however recent evidence has suggested a
more judicious approach may improve patient outcome. We
aimed to describe the fluid bolus practices within our large
Australian Intensive Care Unit to inform future focus of educa-
tion of staff.
Methods: We conducted a retrospective audit of 234 critically ill pa-
tients who received fluid boluses and collected information on fluid
type, volume, time administered, patient severity and prescriber de-
tails. Ethics approval was obtained. Data was analysed using IBM
SPSS Stat 21.
Results: We found that a balanced salt solution was the most
commonly used for fluid bolus therapy in our unit, independent
of patient disease or severity. The majority of fluid was pre-
scribed by junior doctors between 4 pm and 8 am, within
48 hours of ICU admission, though there was an additional peak
of bolus administration at day 5 for those who remained in the
unit at this time. Patients received on average 1.3 L of fluid in
boluses.
Conclusions: Fluid bolus use in the clinical environment is highly
variable and does not always align with theoretical principles.
References
MyburghFig. 35 (Abstract P167). When bolused.
Table 21 (Abstract P170). Comparative cumulated fluid balance in mL.
Survivors (n = 108) Non-survivors (n = 75) p
48 hours 1923 ± 1575 3038 ± 1235 0.02
Day 7 5663 ± 2401 6947 ± 3005 0.02
Day 14 4024 ± 1986 4673 ± 2265 0.03
Day 21 5042 ± 1967 7243 ± 3480 0.02
Total fluid balance 4982 ± 3087 9949 ± 3665 0.02
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Liberal late fluid management is associated with longer ventilation
duration and worst outcome in severe trauma patients: a
retrospective cohort of 294 patients
M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez,
X. Capdevila
Lapeyronie University Hospital, Montpellier, France
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Introductions: Liberal late fluid management (LFM) was associated
with a higher morbi-mortality in different critically ill populations. In
trauma, restrictive fluid strategy is largely recommended early resus-
citation phase, however LFM has not been really studied. The main
goal of present study was to assess in a severe trauma population
the impact of liberal LFM on mechanical ventilation duration.
Methods: A retrospective analysis of all consecutive severe trauma pa-
tients admitted to our regional trauma center from 2010 to 2013 was
performed. All patients with an ISS ≥16 and a length of ICU stay ≥7 days
were included. Main admission characteristics, injuries, transfusions and
management were collected, as well as fluid therapy and mechanical
ventilation during ICU stay. Patients were classified in conservative LFM
group if they had at least two consecutive days with a negative fluid bal-
ance between Day 3 and Day 7; the other patients belonged in liberal
LFM group. These two groups were compared, especially in terms of fluid
balance and mechanical ventilation requirements.
Results: During study period, 294 patients were included: median
age 40 (IQR 25–58), ISS 29 (21–58), SAPS II 34(25–45), 76 % of male,
15 % of massive transfusion and 52 % of severe trauma head injury.
After analysis of LFM,157 patients (53 %) were classified as conservative
LFM and 137 (47 %) as liberal LFM. These two groups did not signifi-
cantly differ in term of baseline characteristics, severe injuries, severity
criteria or transfusion needs. Daily and cumulative fluid balances were
also identical between these groups from Day 0 to Day 2. Conversely,
liberal LFM was significantly associated with more ventilation days (11
vs 8.5 days; P = 0.02), less ventilator-free days at Day 30 (19 vs 21 days;
P = 0.03), longer ICU stay (19 vs 16 days; P = 0.03) and hospital stay (30
vs 25 days; P = 0.04). Mortality rates were comparable between both
groups (6 %). Multivariate analysis also highlighted that liberal LFM was
independent risk factor for a reduced ventilator-free days at Day 30
(B = -2.1 [95%CI -4.1–-0.1], P = 0.042), as well as ISS score, severe
trauma head injury and massive transfusion needs.
Conclusions: Liberal LFM was associated in our series with higher
morbidity in the severe trauma patient; longer ventilation durations,
and longer ICU and hospital stay. These results were observed des-
pite a similar admission severity and early fluid management.
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Introductions: Emergency department (ED) patients admitted to the
hospital with community-acquired pneumonia (CAP) may be at par-
ticular risk for volume overload related complications due to their in-
fected lungs. This study used the Premier administrative database
containing 17 % of US hospital discharges in 2013 to examine the as-
sociation between a higher amount of fluids administered on day 1,
hospital mortality and ventilator free days (VFD).
Methods: CAP was defined as a bacterial pneumonia diagnosis present
on admission in ED patients receiving chest x-ray and parenteral antibi-
otics on Day 1. Day 1 total fluid volume was stratified into quartiles. The
primary outcome was hospital mortality, and secondary outcome was
VFDs over a 30 day period. To adjust for potential confounds, patients
were stratified into 5 severity groups based on their modelled predicted
mortality, and a propensity model for giving fluids was built using clinical
characteristics, severity of illness scores, and ICD-9-CM codes present on
admission for important acute and chronic conditions. Patients were thengrouped by severity of illness quintiles of predicted risk of death for the
CAP population. The association of fluid administration with outcome was
assessed within each quintile of mortality risk using chi-square analysis.
Results: 192,806 adult ED patients with CAP were analyzed. Patients
were 51.3 % female with a mean age of 69. Overall mortality rate
was 7.4 % with an average of 24.6 VFDs. After propensity adjustment
by severity of illness, mean amount of fluid administered on day 1
ranged from 842 ml to 2,189 ml. Within the fifth severity quintile we
found a significant difference in the hospital (22.5 %) vs. predicted
(18.3 %) mortality rate in the highest fluid quartile. Similarly, within
the fifth severity quintile, we found a significant difference in the
number of VFDs in the highest fluid quartile (16.1) compared to the
rest of the quartiles (19.3-20.3).
Conclusions: For adult ED patients with CAP, we found significant as-
sociations between day 1 fluids and increased mortality and de-
creased VFDs in the highest fluid quartile and severity group, after
adjusting for severity of illness and acuity level. This study may have
identified the subset of ED patients who may benefit from a more re-
strictive fluid strategy when presenting to the hospital with CAP.
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Introductions: Administration of fluids is routine in management of ICU
patients. However, controversies still exist with regard to the ideal type,
dose and timing of iv fluid and a large amounts of evidence has shown
that fluids can have deleterious effects on several organ functions, both
from excessive amounts and from their non-physiological electrolyte
composition (1). The aim of our study was to assess the negative impact
of positive fluid balance on outcome in critically ill patients.
Methods: Retrospective study for one year (July 2014 to June 2015),
including all patients admitted in medico-surgical ICU for more than
48 hours. Demographic data, SAPS II and APACHE II scores were reg-
istered at the first day. Length of stay, duration of mechanical venti-
lation, use of extra renal therapy, RIFLE score and mortality were
noted. Daily and cumulative fluid balance was registered at 48 h, 7th,
14th, 21st days and at discharge.
Results: A total of 183 patients were included. Mortality rate was
41 %. Severity scores were 49 ± 17 and 19 ± 9 points respectively in
SAPS II and APACHE II. Table 21 resume cumulative fluid balance. We
noted a higher rate of septic shock, longer length of stay and mech-
anical ventilation duration in non-survivors group. The use of extra
renal therapy was higher in non-survivors group (1 vs 11 p = 0.01). RI-
FLE score and diuretics use were also higher in non-survivors group
(1 vs 2 p = 0.03 end 7 vs 16 p = 0.041). Non-survivors also showed
higher accumulated positive fluid balance.
Conclusions: Fluid accumulation is very common throughout the
course of a patient’s ICU stay with the evidence of the potentially
deleterious effects of fluids and electrolytes on many organ systems.
A more conservative approach regarding fluid management strategy
in ICU patient seems to be less deleterious, but randomized con-
trolled trials addressing this issue were needed.
Reference
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Fig. 36 (Abstract P173). Box plots depicting daily cumulative fluid
balance between groups.
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Impact of fluid balance to organ dysfunction in critically ill
patients
C. Pereira, R. Marinho, R. Antunes, A. Marinho
Centro Hospitalar do Porto, Porto, Portugal
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Introductions: Fluids are a cornerstone of the management of critic-
ally ill patients with systemic inflammatory response syndrome who
are at risk of multiple organ dysfunction syndrome. However, as with
any therapy, fluids can be associated with harm, such as added or
worsening organ dysfunctions. This study aimed to determine the
impact of fluid balance (FB) in the respiratory, cardiovascular, renal
systems.
Methods: Single-center prospective and observational study between
June and December of 2014. All patients staying in ICU for more
than 8 days were collected. Data on demographics, clinical character-
istics, the total amount of fluids administered and excreted, blood
creatinine and urea, the need and dose of vasopressors, PaO2, FiO2,
MAP were collected regarding the first 8 days in the ICU. SPSS was
used for statistical analysis.
Results: 122 patients were enrolled, where 64,3 % were men, with an
average age of 58 ± 16, mortality rate was 22,3 %. The average daily
FB in the eight days was 520.3 ± 1549.3 ml. There was a lower daily
FB among survivors compared to nonsurvivors (433.8 ± 1483.7 ml vs
876.9 ± 1755.8 ml, p0.005). The cumulative fluid balance (cFB) dif-
ference between survivor / nonsurvivors was significant at the 8th
day of ICU (p = 0.037). Regarding the cFB and the respiratory system,
it was found that patients with a ratio PO2/FiO2 < =200 had a higher
cFB between the 4th and 8th day. In the group of patients who re-
quired vasopressor support, cFB was higher in the 2nd and 3rd days
(p = 0.04 and p = 0.036, respectively). The group of patients with a
GFR <75 ml/min/1.73 m2 presented cFB slightly higher than the
group with higher GFR (2nd and 4th days p = 0.049 e p = 0.041,
respectively).
Conclusions: This study demonstrated that the cumulative fluid bal-
ance was higher in patients who had more severe dysfunctions of
the systems reviewed, and these were associated with increased
mortality rate. What remains to be established is whether fluid over-
load is only a biomarker that puts patients under an increased risk of
death or an iatrogenic condition from critical care that should be
considered in daily care and actively treated and avoided.
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Volume bolus in ICU patients: do we need to balance our
crystalloids?
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Introductions: Normal saline contains 154 mmol of Na and Cl, and
may therefore induce hypernatremia, hyperchloremia and acidosis.
Observational studies showed that resuscitation with normal saline
when compared to balanced crystalloids, is associated with acute
kidney injury and death. In these studies a large volume of saline
was administered. A 1 liter (L) fluid bolus is often administered in ICU
patients, e.g. for hypotension or oliguria. It remains uncertain if this
limited volume is also associated with adverse effects. The aim of this
study was to evaluate the effects of a fluid bolus of saline (S) and
Plasma-Lyte (PL), a balanced crystalloid, on electrolytes, acid-base sta-
tus, hemodynamics and urine output (UO).
Methods: We conducted a prospective randomized single blinded
study comparing a 1 L fluid bolus of S and PL administered over
60 min, on a ICU cohort of 51 patients between 21th July 2015 and
3rd November 2015.
We included adult patients, who were prescribed a 1 L fluid bolus,
and who had an arterial line and bladder catheter. Patients on dialy-
sis were excluded. Data were recorded right before fluid infusion
(T0), directly after (T1) and three hours (T2) after.
Results: The data of one patient was excluded from analysis because
of a lack of informed consent. The remaining 50 patients wereincluded, 23 (46 %) received S, 27 PL (54 %). There were no sig-
nificant differences in baseline characteristics (T0) between both
groups. S patients had higher Cl at T1 and T2 (110 vs. 109 mmol/L;
p = 0.032 , resp. 110 vs. 108 ; p = 0.038), and higher Na at T1 (138
vs. 135 mmol/L; p = 0.034). Otherwise, no differences were noted. In
addition, S patients had immediately after infusion an increase of Na
(+0.4 vs. -0.8 mmol/L) , Cl (+3 vs. -1 mmol/L) (both p < 0.001), and a de-
crease of Strong Ion Difference (SIDa) (-2.3 vs. -0.1; p < 0.001), Strong
Ion Gap (SIG) (-0.7 vs. +0.4; p = 0.015), and anion gap (AG) (-1.5 vs. -0.4;
p = 0.018). This persisted at T2 for Cl (+2 vs. -1 mmol/L; p < 0.001) and
SIDa (-2.1 vs. 0.4; p = 0.018). We found no difference in UO and blood
pressure.
Conclusions: Compared to Plasma-Lyte, a 1 L fluid bolus of saline
was at short term associated with a small increase of Na and Cl, and
decrease in SID, SIG, and AG. These changes were statistically signifi-
cant, but limited and were not associated with differences in
hemodynamics or UO.P173
The use of 6 % HES solution do not reduce total fluid requirement
in the therapy of patients with burn shock
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Introductions: Burn injury is included in the list of contraindica-
tion to HES use, but there is no convincing evidence base to
such statement because of the small population of burn patients
and absence of high-quality studies. Aim of this study was to ac-
cess the efficacy and safety of HES in the therapy of patients
with burn shock.
Methods: Design: retrospective cohort controlled study. Inclusion cri-
teria: age > 18 years, TBSA burned 20 %-80%, absence of AKI at the
admission. Patients were divided in two groups: HES group: 24 pa-
tients received 6%HES 130/0,4 in addition to base fluid therapy with
Ringer solution and control group: 25 patients received only Ringer
solution.
Results: Baseline characteristics were well balanced between
groups. Hospital mortality was not significantly different: 45,8 %
and 28,0 % in HES group and control group, respectively, p =
0,31. Rate of AKI was 29,2 % in HES group and 20,5 % in control
group, p = 0,5201. 2 patients in HES group and 1 patient in con-
trol group required RRT. Independent risk factors for AKI were
TBSA burned (OR 1,09 (1,01-1,19), p = 0,04), index Baux (OR 1,09
(1,01-1,19), p = 0,02) and need for catecholamines (OR 12,7 (1,2-
144,9), p = 0,04). There wasn’t significant difference between
groups in total volume of fluids administered in the first 3 days
(Image 1).
Conclusions: This study did not show any negative influence of 6 %
HES solution on mortality, incidence of AKI and need for RRT.
Addition of HES solution in the early infusion therapy is not associ-
ated with the reduce of total fluid requirement.
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Electron microscopic assessment of acute kidney injury in septic
sheep resuscitated with crystalloids or different colloids
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Introductions: The influence of intravenous fluids on kidney function
and injury, especially in septic patients, is still being controversially
discussed. We investigated the impact of different intravenous pre-
parations on ultrastructural kidney damage (USKD) in a clinical rele-
vant model of ovine peritoneal septic shock.
Methods: After approval by the local veterinary authorities, 20
healthy, female sheep underwent induction of peritoneal septic
shock following an established model and consecutive randomi-
zation to one of the study groups: 1) control (no fluid therapy),
2) balanced crystalloids (Jonosteril©), 3) 5 % human albumin (Huma-
nalbin©), 4) balanced 6 % HES 130/0.4 (Volulyte©) [each n = 5]. For
dynamic detection of USKD, sequential sonography-guided kidney
needle biopsies were performed at both healthy and septic baseline
(BL1, BL2), as well as 6 h, 12 h and 24 h after the start of resuscita-
tion. Analyses of the n = 1000 electronic microscopy pictures (10 pic-
tures per time point (n = 5) and animal (n = 20)) were performed by
two blinded, independent investigators following the “electron
microscopic tubular injury“ (EMTI) score. The score contains the pa-
rameters 1) vacuolar alterations, 2) dissociation of epithelium and basal
membrane, 3) epithelial cell injury, 4) intratubular precipitation and 5)
intact microvilli cuticular layer. Each component of the score was quan-
tified from 0 (no damage) to 3 (severe damage).
Results: All groups developed USKD over time with consecutive in-
creases of EMTI scores. At BL2 + 6 h, the EMTI score of the HES-group
was significantly lower as compared to crystalloid- and control-group
(each p < 0.05) and at BL2 + 12 h the EMTI scores of albumin- and
HES-groups were significantly lower as compared to the control
group (each p < 0.01). 24 h after BL2, the EMTI score of the human
albumin-group was significantly lower as compared to the control-
and crystalloid-group (each p < 0.05). There were no significant differ-
ences between albumin- and HES-group at any time.
Conclusions: In the present ovine model of septic shock, all groups
developed sepsis-associated USKD. Animals of the colloid-groups
(albumin and 6 % HES 130/0.4) showed significantly decreased injury
scores as compared to the animals of the control- and crystalloid-
group. Ultrastructural kidney damage was most pronounced within
crystalloid- and control-group in this study.
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haemorrhagic shock and resuscitation with 0.9 % saline or
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Introductions: The present study was designed to compare the im-
pact of resuscitation with either 0.9 % sodium chloride (0.9 % NaCl)
or a balanced hydroxyethylstarch (HES) solution (6 % HES 130/0.4,
Volulyte®, Fresenius Kabi, Bad Homburg, Germany) on the conjunc-
tival microcirculation in a sheep model of haemorrhagic shock.
Methods: After approval by the local veterinary authorities, 10 female
sheep were anaesthetized. After Baseline measurements 3x 10 ml
blood per kg body weight were withdrawn to establish haemor-
rhagic Shock. Sheep were randomized to receive either 0,9 % NaCl
(Saline group, n = 5) or Volulyte® (HES group, n = 5) for Resuscitation
until Baseline values of mean arterial pressure (MAP) were reachedagain. At Baseline, Shock and after Resuscitation haemodynamic vari-
ables and 5 videos of conjunctival microcirculation were recorded
(CytoCam®, Braedius, Huizen, The Netherlands). The perfused vessel
density (PVD) and microvascular flow index (MFI) were calculated
using a dedicated software (AVA Software v3.2, MicroVisionMedical,
Amsterdam, The Netherlands). All values are presented as Median
[IQR]. Mann-Whitney-U-Test was used for comparisons between
groups. A p-value < 0.05 was considered statistically significant.
Results: MAP decreased in both groups from Baseline to Shock and
increased after Resuscitation (Saline: from 89 mmHg [82;92] to
34 mmHg [32;46] to 72 mmHg [72;78]; HES: from 86 mmHg [71;97]
to 43 mmHg [36;46] to 83 mmHg [67;92]; non-significant (ns) be-
tween groups). In the Saline group 4980 ml [3312;5700] and in the
HES group 610 ml [489;615] of the respective fluid was needed (p =
0.009). In both groups, PVD decreased from Baseline to Shock (Saline:
from 100 % to 83 % of Baseline value [49;86]; HES: from 100 % to
74 % [61;80]; ns between groups). While PVD increased after Resusci-
tation in the HES group to 125 % [120;147] it decreased in the Saline
group to 64 % [62;79] (p = 0.009). MFI decreased from Baseline to
Shock in both groups (Saline: from 3.1 [2.5;3.3] to 2.0 [1.6;2.3]; HES:
from 2.9 [2.9;3.1] to 2.5 [2.3;2.7]; ns between groups). After Resuscita-
tion MFI increased significantly higher in the HES (3.4 [3.2;3.5]) than
in the Saline (2.7 [2.4;2.8]) group (p = 0.012).
Conclusions: Balanced 6 % HES 130/0.4 recruited more perfused ves-
sels and improved microvascular blood flow in the conjunctival
microcirculation better than 0.9 % saline, while sparing considerable
amounts of intravenous fluids.
P176
A single centre nested pilot study investigating the effect of using
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Introductions: Early clinical trials and experimental data have re-
ported that the use of unbuffered fluids may adversely influence
gastrointestinal (GI) function when compared to buffered fluids. GI
dysfunction and nutritional feeding intolerance is common amongst
critical unwell patients. No previous studies have assessed the GI ef-
fects of different crystalloid fluids in critically ill patients.
Objective: To evaluate the effect of Plasma-Lyte 148 (PL-148) com-
pared with 0.9 % saline (saline) on gastrointestinal (GI) feeding in-
tolerance in mechanically ventilated ICU patients receiving nasogastric
(NG) feeding.
Methods: We conducted a single centre pilot study nested within a
multicentre, double-blind, cluster-randomised, double crossover trial.
All adult patients who required crystalloid fluid as part of the SPLIT
trial [1], expected to require mechanical ventilation for >48 hours
and receiving enteral nutrition exclusively by a NG tube were eligible.
The study ICU used either blinded saline or PL-148 for four alternat-
ing seven week blocks. The primary outcome was the proportion of
patients with GI feeding intolerance, defined as high gastric residual
volumes (GRV), diarrhoea or vomiting while receiving NG feeding in
the ICU. The proportion of patients with each of high GRV, diarrhoea,
and vomiting were secondary outcomes.
Results: 69 patients were enrolled, 35 assigned to PL-148 and 34 to sa-
line. In the PL-148 group, 21 of 35 patients (60.0 %) developed GI feeding
intolerance as compared to 22 of 34 patients (64.7 %) in the saline group
(OR,0.82; 95 % CI, 0.31 to 2.17; P = 0.69). A high GRV was observed in 4 of
35 patients (11.4 %) and 11 of 34 patients (32.4 %) in the PL-148 and sa-
line groups respectively (OR,0.27; 95 % CI, 0.08 to 0.96; P = 0.04).
Conclusions: Among mechanical ventilated patients receiving NG
feeding, the use of PL-148 compared to saline did not reduce the
proportion of patients developing GI feeding intolerance but was as-
sociated with a decreased incidence of high GRV.
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A single centre nested pilot study investigating the effect on post-
operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as
crystalloid fluid therapy in adults in ICU after heart surgery
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Introductions: Using buffered crystalloid fluids, such as Plasma-Lyte
148 (PL-148), may reduce post-operative blood loss and transfusion
requirements compared to 0.9 % saline (saline) [2,3]. However, no
studies have assessed the effect on postoperative blood loss of using
different crystalloid fluids after heart surgery.
Objective: To evaluate the effect of PL-148 compared with saline on
bleeding following heart surgery.
Methods: We conducted a single centre pilot study nested within a
multicentre, double-blind, cluster-randomised, double crossover trial.
All adult heart surgery patients who required crystalloid fluid ther-
apy in ICU as part of the SPLIT trial [1] were eligible. The primary
outcome was chest drain output from time of arrival to ICU until
12 hours post operatively. The key secondary outcomes were total
volume of fluid in chest drains from arrival to ICU until 24 hours if
still in ICU and proportions of patients requiring any of the following
blood products (packed red blood cells, platelets, fresh frozen
plasma or cryoprecipitate).
Results: 251 patients were enrolled, with 131 assigned to PL-148 and
120 to saline. There was no difference in postoperative chest drain
output at 12 hours (ratio of geometric means, 1.06; 95 % CI, 0.93 to
1.20; P-value = 0.42) or at 24 hours. In the PL-148 group, 28 of 131
patients (30.5 %) required blood products in ICU compared with 22
of 120 patients (18.3 %) in the saline group (OR, 1.96; 95 % CI, 1.08
to 3.54; P = 0.03).
Conclusions: Among patients admitted to ICU following heart sur-
gery, the use of PL-148 compared to saline did not reduce the
amount of post-operative blood loss but was associated with in-
creased use of bloods products.
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Introductions: Approximately 1 to 2 % of patients attending the
Emergency Department have hypernatremia(1). Hypernatremia over
160 mmol/L is considered to be very severe and as such needs to be
treated with caution(2). Extreme cases of hypernatraemia are rare
(where sodium levels are exceptionally high), especially in adults and
the most common pathophysiology in such cases would be related
to severe dehydration. We see this more in the elderly population,
children, the institutionalised and patients with dementia.Methods: We report a unique case of extreme hypernatremia of
196 mmol/L and severe sepsis in a young 39-year-old adult with
Huntington’s dementia, which presented a challenge in fluid
management.
Results: The hypernatraemia was thought to be caused by chronic
severe dehydration from poor intake and the sepsis was thought to
have started as an inadequately treated urinary tract infection. The
patient was initially treated aggressively with hypotonic saline and
intravenous antibiotics, but was subsequently managed using a
slower correction rate after identifying the chronic nature of the
natremia. To our knowledge, this is the first reported case of extreme
hypernatremia and severe sepsis manifesting concomitantly in such
a young patient.
Conclusions: We highlight the difficulties of balancing the risks and
benefits of rapid versus slow fluid resuscitation in such complex clin-
ical situations. We highlight the difficulty of balancing the risks and
benefits of rapid fluid resuscitation, necessitated by severe sepsis and
acute kidney injury, against the complexities of fluid resuscitation in
correcting such an extreme hypernatremia.
We advocate early identification of chronic hypernatremia and ef-
fective administration of intravenous fluids in the Emergency De-
partment that is decided on a case-by-case basis. In cases of
severe and extreme hypernatraemia in particular, accurate calcula-
tion of free water deficit is essential to manage the patient ef-
fectively. In line with this, we must ensure that such patients are
always weighed on admission.
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Introductions: The development of hypernatraemia leads to hyper-
tonic stress within the cells. Previous studies have shown that the
presence of hypernatraemia on admission to Intensive Care is an in-
dependent risk factor for poor prognosis. While rapid correction of
hypernatraemia can have devastating neurological consequences; a
correction speed too slow is associated with an increased risk of
death. The primary objective was to assess the frequency of severe
hypernatraemia in patients admitted to our Critical Care Unit, located
in a tertiary referral centre and university hospital. Time to sodium
normalisation, presence/absence of neurological symptoms and pa-
tient outcome was also evaluated. Severe hypernatraemia was classi-
fied as plasma sodium ≥160 mmol per litre.
Methods: We retrospectively searched the Critical Care database for
laboratory sodium values ≥160 mmol/L occurring between November
2013 and November 2015. Where appropriate, sodium was corrected
for glucose. This identified all patients in whom severe hypernatremia
was present on admission and those in whom it developed during their
Critical Care stay.
Results: We identified 14 patients with severe hypernatraemia over
the past two years in our Critical Care Unit. The plasma sodium range
was 160 to 196 mmol/L. All values > 170 mmol/L occurred in patients
with hyperglycaemic hyperosmolar syndrome (HHS). The underlying
aetiology was as follows: 4 (28.6 %) patients HHS, 1 (7.1 %) patient
diabetic ketoacidosis, 1 (7.1 %) patient lithium-induced diabetes insi-
pidus and 8 (57.1 %) patients with dehydration secondary to unre-
placed water loses. In no case was the rate of correction greater than
10 mmol/L per day. The average length of time for correction to nor-
mal sodium level of 145 mmol/L was 6 days. Three patients (21.4 %)
died in Critical Care. Two patients (14.3 %) died following discharge
to the ward. The remaining 9 patients (64.3 %) were discharged
Critical Care 2016, Volume 20 Suppl 2 Page 76 of 182home to their primary residence. All patients had neurological symp-
toms on presentation, primarily confusion. One patient presented
with seizures. All patients were treated with 5 % dextrose. One pa-
tient developed hypernatraemia in Critical Care. Moderately elevated
sodium levels were untreated in this patient prior to the diagnosis of
severe hypernatraemia. The remaining patients all presented with
hypernatraemia.
Conclusions: Severe hypernatraemia is associated with a high mortal-
ity rate of 35.7 %. Physicians should be aware of the excessive risk
associated with this condition and diagnosis should be fol-
lowed by prompt rehydration and intensive clinical and biochemical
monitoring.
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Correlation between arterial blood gas and electrolyte
disturbances during hospitalization and outcome in critically ill
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Introductions: Critical illness is a life-threatening multisystem process
that can result in significant morbidity or mortality. In most patients,
critical illness is preceded by a period of physiological deterioration;
but evidence suggests that the early signs of this are frequently
missed.
Methods: In this cross-sectional study, the medical data of all critic-
ally ill patients admitted to the Albert Schweitzer Hospital were
reviewed between January 2013 and September 2015. Data including
age, gender, SAPS III score upon admission, arrival and 24 hour ABG
and electrolytes values, as well as length of stay and in-hospital
mortality rate were collected. A logistic regression model was used
to determine the association between acid-base and electrolyte dis-
turbances and in-hospital mortality after adjustment for potential
confounding factors.
Results: Of the 4732 patients, 57 % were male; mean age of 58 years
old, mean SAPS III score of 58 points and 33,8 % of them died in the
hospital. Univariate analysis showed a significantly higher risk of mor-
tality in patients who developed mixed metabolic acidosis plus re-
spiratory acidosis on their admission day (OR = 3.45, p-value < 0.001).
Multiple logistic regression analysis demonstrated that mixed meta-
bolic acidosis plus respiratory acidosis (OR = 3.91, 95 % CI = 1.37-
10.21, p-value = 0.003) and hyponatremia (OR = 0.58, 95 % CI = 0.31-
0.65, p-value 0.01), patients with hyperkalemia had higher mortality
(serum potassium over 5,1 mEq/L 43,4 % died and serum potassium
over 6,0 mEq/L 76,5 % died; p 0.01 and p 0,002 respectively), were
three significant predictors of mortality, regardless of other con-
founding variables.
Conclusions: The results show that in critically ill patients initial mixed
metabolic acidosis plus respiratory acidosis, hyponatremia and hyperka-
lemia are significant predictors of mortality, but other factors after ad-
justment for potential confounding factors had no prognostic effect.
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Introductions: HAGMA is a commonly encountered acid-base dis-
order in clinic practice. Multiple mnemonics were proposed to coverthe common underlying causes – “GOLDMARK(1)”, “KUSMALE”, “KAR-
MEL” and, of course, “MUDPILES”. The “I” in “MUDPILES” represents
some rare causes of HAGMA including “I”ron, “I”soniazid and “I”nborn
errors of metabolism. We present a rare case of HAGMA secondary
to isoniazid (INH) overdose.
Methods: A 41 year old male was intubated for status epilepticus. He
had a medical history of pulmonary tuberculosis (pTB) and had been
treated with a course of rifampicin, INH and ethambutol since
6 months ago.
Results: Arterial blood gas in the Emergency Department showed se-
vere metabolic and respiratory acidosis; pH 6.76, pCO2 80, pO2 62,
HCO3 11, BE -24. The initial anion gap was 26. Physical examination
was unremarkable except for fever and hypotension. Neurological
examination did not reveal any lateralising signs. CT scan of the brain
was normal. Mild renal impairment, and lactate acidosis resolved
rapidly with initial fluid resuscitation. Serum and urine toxicology
for commonly encountered drugs were also negative. Patient
regained orientation on day 3 of intubation and was promptly extu-
bated. Further history revealed that he had consumed a bottle of iso-
niazid tablets after an altercation with his wife the same night.
Conclusions: Tuberculosis is endemic is South East Asia. INH is one
of the four drugs used in the treatment of this disease. Side effects
of isoniazid range from mild hepatotoxicity to the potentially fatal
INH hepatitis. HAGMA refractory to conventional therapy is one of
the hallmarks of INH toxicity. Though it is one of the rare causes of
HAGMA, prompt diagnosis and treatment with high dose pyridoxine
(2) reduces mortality and morbidity.
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Introductions: Acute kidney injury (AKI) is independently associated
with increased mortality in the critically ill, especially when renal re-
placement therapy (RRT) is required. “Early initiation” of RRT and its
possible beneficial effect on mortality, has been the focus of many
research protocols. However, published papers show no uniformity in
the definition of early initiation. The main problem to determine this
best moment of initiation is the lack of a distinctive parameter that can
predict RRT requirement. The question rises if differences between pa-
tients with any stage of AKI and patients with RRT-requiring AKIN stage
III can be identified looking at the “classical parameters” (serum creatin-
ine (SCr), urea, potassium, bicarbonate, pH, cumulative fluid balance),
plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) and urinary
output (UO) at the time of first rise in SCr (first AKI).
Methods: This is a retrospective subset-analysis performed on the
NGAL-study database [1] in adult critically ill patients with develop-
ing AKI. Data were collected and analyzed at the time of first AKI and
at the highest level of serum creatinine (peak AKI). Mann-Whitney-U
test was used to detect differences between both groups.
Results: A total of 59 patients developed any stage of AKI during the
first 7 days after ICU admission, 15 patients required RRT eventually.
At the time of first AKI, pNGAL and UO were the only parameters
that differed significantly (P = 0.02 and P = 0.04 respectively) between
the two groups. The “classical parameters” showed a significant dif-
ference between groups later on at the time of peak AKI (=time of
RRT initiation) (Fig. 37).
Conclusions: Critically ill patients with RRT requiring AKI have a sig-
nificant lower urinary production and significant higher pNGAL con-
centration compared to patients with non-RRT requiring AKI at the
time of first rise in SCr. The “classical parameters” fail to make this
distinction at this very early stage of AKI. Therefore, plasma NGAL
Critical Care 2016, Volume 20 Suppl 2 Page 77 of 182and UO might have the potential (perhaps in combination with the
Furosemide stress test) to become valuable parameters in future pro-
spective protocols that intend to study the value of early RRT initi-
ation on hard outcome measures in critically ill patients.
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Introductions: The choice for the right renal replacement therapy
(RRT) for severe acute kidney injury in critically ill patients has been
investigated many times in the last two decades.
Although some questions have been answered, in current practice
many different approaches are still used in the ICU. The authors
review the treatment of Acute Kidney Injury (AKI) in critically ill
patients, indications for SLED and continuous renal replacement
therapy (CRRT) in critically ill patients in four Portuguese ICUs.
Methods: Prospective observational study conducted in 4 ICUs in 3
Portuguese hospitals for seven months. All patients with AKI who
needed a renal replacement therapy were enrolled. Data on de-
mographics and clinical characteristics of patients were collected at
baseline.
Results: 127 patients were enrolled, with an average age of 61,3 ±
15,26, and mortality rate was 46 %. 42 patients performed SLED
(33,07 %), and 85 % performed CRRT (63,97 %). The most common
indications for CRRT was fluid overload (47,76 %). Most of the pa-
tients start the both procedures in the first two days in ICU. Most of
the patients (59 Ð 60 %) were in organ failure, using the RIFLE cri-
teria when they started RRT. Patients in CRRT were more hemody-
namically unstable (norepinephrine in CRRT Ð 1,99 ± 5,36 and in
SLED - 1,49 ± 4,56). Mortality rate Ð 52,94 % in CRRT and 30,95
in SLED.
Conclusions: CRRT seems to be the ideal mode of renal replacement
therapy for hemodynamically unstable with fluid overloaded. However,
in expert hands, the two treatments provide similar outcomes and can
be complementary.
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Critical Care 2016, 20(Suppl 2):P184Introductions: The North of England Critical Care Network does not
currently have an up- to- date guideline regarding the use of renal
replacement therapy (RRT) within intensive care.
We wished to evaluate current practice in the region and consider
the need for regional guidance on the management of acute kidney
injury in our units.
Methods: An electronic survey was sent to all the consultants in in-
tensive care within the region. Responses were anonymously collect-
ing using internet-based survey software.
Questions were based upon the currently available guidance and
evidence.
Results: Invitations were sent to 139 consultants who have some in-
tensive care commitment. There were 55 responses giving a re-
sponse rate of 39.6 %. Unit size varied greatly, from under 10 beds,
to over 20. The majority (43.6 %) had between 10 and 20 beds.
46.3 % of respondents had less than 10 patients receiving RRT per
month, 40.7 % had between 10 and 25 patients per month and 13 %
had more than 25 patients per month. 43 % gave positive comments
regarding the support they receive from renal services. Some areas
where interactions between renal physicians and critical care could
be improved were identified. Only 67 % of respondents were aware
of an up to date guideline for the use of RRT in their unit.
1.9 % of respondents preferentially use the subclavian vein for siting
renal access lines. 9.3 % preferentially used the femoral veins. 31 %
never have visits from a nephrologist.
Conclusions: There is a wide variety in practice, with some areas
where practices could be improved , notably awareness of guidelines
available, choice of renal access line site, and working relationships
between renal and critical care.
As part of a quality improvement programme, we plan to create a re-
gional best practice recommendations document that is relevant to
the systems in which we work and specific to critical care. By doing
this, we hope to improve outcomes for those receiving renal replace-
ment therapy in our units.
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therapy
S. Stads1, A. J. Groeneveld2
1Ikazia Hospital, Rotterdam, Netherlands, 2Erasmus MC, Rotterdam,
Netherlands
Critical Care 2016, 20(Suppl 2):P185
Introductions: Acute kidney injury necessitating continuous renal re-
placement therapy (CRRT) in critically ill patients is associated with
high mortality. Timing of CRRT remains a matter of debate. We inves-
tigated the effect of timing of CRRT on 28-day mortality.
Methods: A post-hoc analysis is performed on the multicenter data
from the earlier published CASH study. In critically ill patients receiv-
ing CRRT, between 2005 and 2011, the effect of variables at initiation
of CRRT on 28-day mortality were evaluated. Univariate and multi-
variate cox regression analysis were performed to determine renal
and patient-specific variables associated with 28-day mortality.
Results: Of the 139 patients evaluated for inclusion, 13 patients were
excluded because of a history of chronic kidney disease, 5 patients
were excluded because no creatinine at CRRT initiation was available,
and 5 patients were excluded because an admission creatinine below
50 μmol/L. In the 116 included patients, 28-day mortality was 37
(32 %). In univariate proportional hazards cox regression analysis, ICU
admission after cardiopulmonary resuscitation ( HR 4.403, p = 0.043),
SOFA score ( HR 1.117, p = 0.024) and creatinine at CRRT initiation
(HR 0.997, p = 0.020) were associated with 28-day mortality. Multivari-
ate analysis demonstrated that age (HR 1.092, p = 0.050), admission
weight ( HR 1.036, p = 0.016) ICU admission because of respiratory
failure (HR 9.275, p = 0.29) and creatinine at CRRT initiation (HR 0.990,
p = 0.022) were associated with 28-day mortality. After correction for
disease severity scores, such as APACHE 2 score and SOFA score, and
markers for fluid overload, such as hematocrit and cumulative fluid
Fig. 38 (Abstract P187). Hypophosphatemia during CRRT with
PO4-supplementation via infusion or dialysate.
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mortality. Even after correction for admission creatinine, only creatin-
ine at initiation remained associated with 28-day mortality. In ROC
curve analysis a CRRT initiation creatinin of 318 μmol/L was the best
predictor for 28-day mortality.
Conclusions: In this multicenter cohort, creatinine at CRRT initiation is
an independent predictor of 28-day mortality, even after correction for
admission creatinine, disease severity and hemodilution. Therefore
these data argue in favour of a time-dependent effect of CRRT on 28-
day mortality. These data suggest that late CRRT initiation may have
better outcome then earlier CRRT initiation. However further research is
needed to confirm this hypothesis and reveal underlying mechanisms.
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intensive care unit
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Introductions: Karnofsky performance scale (KPS) [1] is being widely to
describe patients’ functional status. Correlation between poor func-
tional levels and adverse outcomes has been found. KPS is used in deci-
sion making surrounding starting aggressive therapy. We evaluated the
impact of KPS on long term renal & patient survival in AKI patients, re-
ceiving renal replacement therapy (RRT) in intensive care (ICU).
Methods: We prospectively enrolled AKI ICU patients between Octo-
ber 2011 & October 2013. Demographics, APACHE II and SOFA
scores, modality & dose of RRT, ICU length of stay (LOS) and KPS
were collected. Data on renal and patient survival at ICU discharge,
at 28 and 90 days and also 12 months were collected. Analysis used
was multivariate logistic regression (Stata 14.1)
Results: 155 patients were recruited. 97 (62.6 %) were males. Median
age was 62 (IQR 47-72). Median APACHE II score was 23 (IQR 18-27).
Median SOFA score on admission was 10 (IQR 7-13). 101 (66 %) were
mechanically ventilated, median LOS was 6.8 (IQR 2.7-14.9) days, me-
dian KPS was 80 (IQR 70-90), 79 (51 %) patients were dependent on
RRT at ICU discharge, with 61 (39.4 %), 56 (36.1 %) and 56 (36.1 %) at
28 & 90 days and 12 months respectively. 105 (66.7 %) patients sur-
vived to ICU discharge, with 94 (61.4 %), 88 (57.5 %) and 80 (52.3 %)
patients being alive at 28 & 90 days and 12 months respectively.
Adjusting for age and sex, APACHE II was the only factor associated
with patient need for RRT at ICU discharge, 28 days, 90 days and
12 months (OR 1.09, 95 % CI: 1.03-1.15, p = 0.003; OR 1.1, 95%CI 1.04-
1.16, p = 0.001; OR 1.1, 95%CI 1.04-1.17, p = 0.001 and OR 1.1, 95%CI
1.04-1.17, p = 0.001, respectively). After adjusting for age and sex, ad-
mission SOFA (OR 0.88, 95%CI 0.8-0.97, p = 0.008), APACHE II (OR
0.89, 95%CI 0.84-0.95, <0.001) and KPS (OR 1.03, 95%CI 1-1.06, p =
0.049) were associated with ICU survival. However at multivariate re-
gression analysis, only APACHE II was independently associated with
ICU survival (OR 0.91, 95%CI 0.85-0.97, p = 0.003).
Conclusions: Disease severity remains the main determinant of out-
come in AKI patients receiving RRT on ICU. Despite the apparent rele-
vance of KPS to outcomes on critical care, we could not in this instance
show that KPS independently affected renal or patient survival. More
studies on larger numbers of patients are required to clarify this issue.
Reference
[1] Oken M et al. Am J Clin Oncol. 1982;6:649-655
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Critical Care 2016, 20(Suppl 2):P187Introductions: CRRT with regional citrate anticoagulation (RCA) pro-
vides long filter running times and effective dialysis doses. Thus, the
risk of hypophosphatemia (hypoPO4) is high and PO4 substitution is
required. We investigated whether separate infusion of PO4 or a
PO4-containing dialysis fluid is more effective to avoid severe
hypoPO4.
Methods: Retrospective-prospective observational study in a univer-
sity hospital. CRRT with RCA-CVVHD (30 ml/kg/h). PO4 substitution
via a separate infusion (PO4-I; retrospective data); use of a PO4-
containing dialysate (CiCa dialysate K4, Fres. Medical Care)(PO4-D,
prospective data). Primary outcome: incidence of severe hypoPO4.
Secondary outcome: maintenance of normal PO4-levels, duration of
mechan. ventilation and length stay in the ICU (with approval of local
ethics committee, NCT01946113).
Results: We recruited 100 pts. for each group. Epidemiological data
were not different in PO-I vs PO-D (mean age 69 ± 11 vs 68 ± 12 y;
BW 81 ± 19 vs 86 ± 22 kg; male 66 vs 71 %). Major cause of AKI was
sepsis (41 %). Incidence of severe hypophoph: PO-I 66 vs PO-D 12 pts.
(p < 0.05). Duration of mechan. vent.:PO-I 592 ± 508 vs PO-D 428 ±
466 h(n.s.), ICU days PO-I 33 ± 30 d vs PO-D 26 ± 25 d (n.s.).
Conclusions: Despite rigorous efforts to maintain normal PO4-
levels via PO4-infusion, severe hypophosphatemia occured in
66 % of all pts. In contrast, a PO4-containing dialysis fluid en-
sured normal PO4-levels in most pts. and significantly reduced
the risk of severe hypoPO4. There was a trend towards reduced
length of mech. ventilat. and ICU stay. Thus, a PO4-containg di-
alysate can be recommended to increase safety of CRRT in ICU
patients.P188
Citrate regional anticoagulation for post dilution continuous renal
replacement therapy
S. Ghabina
Royal London Hospital, London, UK
Critical Care 2016, 20(Suppl 2):P188
Introductions: S Schwarze, A Beane, S Ramsay, C J Kirwan, J R Prowle
Regional citrate administration (RCA) is an effective anticoagulation
technique for continuous renal replacement therapy (CRRT). Com-
monly, RCA protocols incorporate citrate within the replacement fluid
adding calcium post filter. Following modification of the Aquarius hae-
mofilter (Nikkiso), we designed and implemented a protocol for RCA
with standalone citrate administration pre filter and post dilution
CVVHF using calcium containing replacement fluid.
Methods: A prospective audit of the first 10 critically ill patients re-
ceiving RCA with post dilution CVVHF. Inclusion criteria: Adult critic-













R 25 ± 3,2 11 ± 3 7,1 ± 2* 325 ± 22 7,8 ± 2 539 ± 25#
K 11 ± 2 3 ± 1 2,2 ± 0,9 7,4 ± 3 2,6 ± 2,1 0,1 ± 0,01
angle 33 ± 4 32 ± 3 62 ± 6 19 ± 2 69 ± 7 0,2 ± 0,01
MA 42 ± 3,2 34 ± 2,8 66 ± 9,8** 24 ± 4 57 ± 6 1,6 ± 0.3#
* p < 0,05 vs group A ** p < 0,01 vs Group A. #P < 0,01 vs. Group B and A
Critical Care 2016, Volume 20 Suppl 2 Page 79 of 182ally ill patients requiring CRRT but contraindicated for heparin. Exclu-
sion criteria:liver disease, liver injury, noradrenaline >0.5mcg/kg/min,
ideal body weight >90 kg, receiving >6 u/hr of insulin, sodium <120
or >160 mmol/l, pH >7.5 or bicarbonate > 40 mmol/l. Primary
outcome measure-filter time Secondary outcome measures:cal-
cium replacement; Post filter ionised calcium (iCa); acid base
status and serum sodium levels. A dose choice of 25 or 35 mls/
kg/min with parallel changes to the filtration fraction from 20
to 25 % as required to manage metabolic alkalosis. If metabolic
alkalosis persisted, RCA was stopped. Acid Citrate Dextrose
Forumula-A (ACD-A) (113 mmol/L of citrate) is administered at a
weight related rate aiming for a citrate concentration of 2.5-
3 %. Replacement fluid is Accusol 35 (1.75 mmol/l calcium). A
post filter solution of 10 mmol/l calcium chloride is adminis-
tered according to post filter ionized calcium (iCa).Bicarbonate,
iCa and sodium measured at 3 to 6 hourly intervals during
therapy.
Results: 10 patients (6 male) aged 31-82, received RCA across 49
filters. Median filter lifespan 21 hours (1-72). Post filter iCa
(mmol/L) 0.38 (0.28-0.64); Filter time (hr) 21 (1-72); Ca:iCa 1.83
(1.01-2.59) pH 7.37 - 7.45; Bicarbonate mmol/L 28.3 - 33.2; So-
dium (mmol/L) 138 – 141. 8 of 49 filters (16 %) in 6 patients re-
quired calcium replacement (median 13.5 mmols (0.25-32.75)).
Filter cessation: Planned 4;Set life expired (72 hours) 2;Clotted cir-
cuit 19; Pressure 12; Balance 2; Access 3; liver failure 1; Not docu-
mented 6.
Conclusions: CRRT and RCA with standalone citrate administration
and post dilution is an effective and safe alternative where hep-
arin anticoagulation is contraindicated. Standard calcium contain-
ing replacement fluid dramatically reduces the need for
additional post filter calcium infusions which adds to potential
cost saving.Fig. 39 (Abstract P190). Systemic iCa and Ca substitution.P189
Citrate 18 mmol/l improves anticoagulation during RRT with
adsorbing filters
F. Turani , A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano,
R. Barchetta, M. Falco
Aurelia and European Hospital, Rome ,Italy
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Introductions: Adsorbing filters with an anti-inflammatory action -
Coupled plasma filtration and adsorption -(CPFA) and Cytosorb may
be clinically useful during sepsis.
The aim of this study in a cohort of septic patients during RRT with
CPFA or Cytosorb is to evaluate with tromboelastography monitoring
(TEG) three different methods of anticoagulation 1-Heparin anticoa-
gulation. 2-Citrate anticoagulation with 10 mmol / L Citrate. 3-Citrate
anticoagulation with18 mmol/ L Citrate.
Methods: Thirty patients submitted to CPFA or Cytosorb had
three different methods of anticoagulation :1-Unfractioned Hep-
arin (group A). 2 – 10 mmol/L Citrate (group B) 3- 18 mmol/ Cit-
rate. (Group C). All patients had monitoring of coagulation, ACT,
and TEG at basal time (T0) and after 6 hours (T1). Blood samples
for TEG were collected from the patient’s artery (site 1) and post
hemofilter (CPFA) or post cartridge (Cytosorb) (site 2). All data
are expressed as mean ± SD. ANOVA test was used for the statis-
tical study.
Results: the TEG data is show in Table 22. Statistical comparison was
made for the same site.
Conclusions: 1- During CPFA or Cytosorb RRT Heparine increased R
(delay in activation of coagulation ) and decreased MA ( less cloth
strength ) in patients , increasing the risk of bleeding. 2- 18 mmol/L
citrate anticoagulation decreased MA and increased R in circuits
better then in Group A and B, achieving an optimal extracorporeal
anticoagulation. (1)
Reference
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Calcium gluconate instead of calcium chloride in citrate-
anticoagulated CVVHD
O. Demirkiran, M. Kosuk, S. Bozbay
Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
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Introductions: The Ci-Ca CVVHD is a successfully implemented pro-
tocol in several European countries to conduct CRRT in patients
with AKI [1]. This protocol recommends a calcium chloride solu-
tion (CaCl-S) for calcium supplementation. Due to non-availability
of CaCl-S, we modified this approach and used a calcium gluco-
nate solution (CaGl-S) instead.
Methods: The Ci-Ca CVVHD protocol [1] relies on modifying the
calcium substitution to control s-iCa, which we applied analo-
gously in our modified protocol. Further in the Ci-Ca CVVHD proto-
col, the ratio between dialysate flow (Qd) and blood flow (Qb) is
linked to the effect on the acid-base status and typically set to
33 %, which we essentially applied throughout the study using
3 l/h dialysate flow at 150 ml/min blood flow. Systemic ionized
Ca (s-iCa)and acid-base parameters were closely monitored to en-
sure safe application of our modified protocol. We retrospectively
analyzed 14 critically ill patients.
Results: With respect to systemic iCa, our patients group had low
values at start of Ci-Ca CVVHD, which might already explain the
higher required amount of CaGl-S compared to literature data as-
suming that a calcium deficit in the patients is filled up, see Fig. 39.
Concerning acid-base results, we did see a slight tendency to alkal-
osis after prolonged Ci-Ca CVVHD with CaGl-S, see Fig. 40. This
might well be attributed to gluconate metabolism yielding some
additional bicarbonate.
Conclusions: We successfully established use of a CaGl-S with the
Ci-Ca CVVHD protocol. Noting the slight trend to alkalosis, we
have decided to slightly reduce the blood flow to 130 ml/min.
This will reduce citrate needs and less citrate will be metabolized
by the patient to bicarbonate.
Reference
1 Slowinski et al. Crit Care 19:349
Fig. 40 (Abstract P190). Serum bicarbonate and Qd/Qb ratio.
Table 23 (Abstract P192).
I° II° III°
Bilirubin, mmol/lt 0,4 0,8 0,8
Albumin, mmol/lt 0,4 0,8 0,4
Bilirubin Mass Balance, mg 572 1.020 2.499
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Enhanced clearance of interleukin-6 with continuous veno-venous
haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux
AV1000S
V. Weber 1, J. Hartmann1, S. Harm 1, I. Linsberger 1, T. Eichhorn 1,
G. Valicek2, G. Miestinger 2, C. Hoermann2
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Introduction: We aimed to compare the clearance of inflamma-
tory mediators, specifically interleukin-6 (IL-6), in CVVHD using
the high cut-off filter Ultraflux EMiC2 vs. the standard haemofilter
AV1000S.
Methods: Clearance of IL-6 was compared for the two filters in an
in vitro set-up using spiked human plasma (800 pg/ml IL-6) as well
as in a controlled randomized clinical trial including 30 patients with
sepsis and acute renal dysfuncion. The protocol was approved by the
local Ethics Committee and CVVHD was performed using the multiFil-
trate Acute Therapy System with Ci-Ca anticoagulation (Fresenius
Medical Care). Plasma samples were taken at the start of CVVHD
(0 h) and after 1, 24, and 48 h. A panel of 27 cytokines was de-
termined in the plasma samples using a cytokine bead array. In
addition, IL-6 and albumin were quantified in dialysate samples
at the indicated time points.
Results: The in vitro clearance was significantly higher for EMiC2
as compared to AV1000S (5.00 vs. 0.03 ml/min). In clinical samples,
IL-6 concentrations in the dialysate were 44.7 % vs. 30.5 %; 49.1 %
vs. 14.3 %; 31.4 % vs. 7.1 %; and 29.9 % vs. 5.6 % relative to the
levels in plasma at 0, 1, 24, and 48 h for EMiC2 and AV1000S, re-
spectively. The filters did not differ significantly with respect to al-
bumin removal.
Conclusions: Both in vitro and in vivo data show significantly higher
clearance of IL-6 for the high cut-off filter Ultraflux EMiC2 vs. the
standard haemofilter AV1000S.
P192
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Introduction: A new sorbent (Cytosorb, Cytosorbents USA), based on
blood-compatible porous polymer-beads able to adsorb hydrophobic
molecules, could be a valid artificial support in many conditions of
organ failure removing cytokines and toxic molecules directly from
blood. At present, extracorporeal systems are based on plasma-adsorption. We performed an in vitro study on bilirubin kinetics re-
moval to verify the system’s adsorption capacity and the ability to
remove protein-bound solutes.
Methods: We performed 3 in vitro tests. Experiments 1&2 were
done with equimolar solution of Albumin (Alb.)-Bilirubin (Bil.), with
only Unconjugated Bil., strongly Alb.-bound [1], to verify the re-
moval of protein-bound solutes. In the test 3, 24 h long, we tried to
reproduce clinical conditions, with higher concentration of Bil. and
lower of Alb. to study kinetics & mass balance. Solutions were recir-
culated in a circuit including a peristaltic pump and CytoSorb at a
flow rate of 100 ml/min. Samples were collected pre and post cart-
ridge at different times: 0, 15, 30 min and then every 30 min until
the end.
Results: All of the experiments showed the adsorption capacity of
the system concerning Bil. (Table 23) with a minimal loss of Alb. Ex-
periments 1&2 demonstrated the capacity to adsorb protein-bound
solutes. In this condition the removal of Bil. is possible only breaking
the Alb.-Bil. complex. Test 3 showed a Bil. adsorption of 2.499 mg,
equivalent to the removal of blood Bil. in a 70 kg patient with an ini-
tial concentration of 49,98 mg/dl. The major reduction was in the
first 8 h but the cartridge maintained an adsorption capacity until
the end. We could not demonstrate any release of the adsorbed Bil.
in 24 h.
Conclusions: This in vitro study shows the effectiveness in remov-
ing Bil., any significant loss of Alb., the resin ability to break the
Alb.-Bil complex and to adsorb irreversibly Bil. Cytosorb might
represent a valid and simple aid in organ dysfunctions, without
need of plasma separation. In vivo studies are ongoing to con-
firm the in vitro results.
Reference
[1] Weber et al. Biomacromolecules 2008, 9 1322-1328.P193
Case series of patients with severe sepsis and septic shock treated
with a new extracorporeal sorbent
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Introduction: Clinical studies have shown that the reduction of toxic
levels of cytokines from blood with the use of a new sorbent, Cyto-
Sorb (CytoSorbents), could be useful to regain control during a com-
plicated inflammatory condition in patients with severe sepsis/septic
shock [1]. In this case series, we evaluated patients admitted to our
ICU from Jan. to Nov. 2015 treated with CytoSorb. The aim was to
analyse its influence in clinical outcomes, as mean arterial pressure
(MAP), vasopressors need and inflammatory markers, like procalcito-
nin (PCT).
Methods: We included 8 patients (4 f, 4 m): 2 severe sepsis and 6
septic shock. Patients’ data are reported in Table 24 as median (lower
and upper quartiles). All patients were non-responding to the
Standard of Care for the treatment of severe sepsis/septic shock.
Therefore, CytoSorb was used as adjunctive therapy in combin-
ation with continuous renal replace therapy (CRRT), in order to
control the cytokines storm and improve the hemodynamic sta-
bility. It was installed in series connection after the dialyser in
the CRRT circuit for 24 h (median duration of the treatment:
48 h). Clinical parameters were collected before and after every
treatment with CytoSorb.
Table 25 (Abstract P194).
Initial Conc. (ng/ml) % Removed at 5 hours
C5a 25 98 ± 1.3
Procalcitonin 16 96 ± 0.7
S100A8 50 93 ± 0.5
HMGB-1 100 83 ± 7.4
Aflatoxin 10000 98 ± 0.1
TSST-1 2000 97 ± 4.5
alpha-toxin 1500 83 ± 3.2
Critical Care 2016, Volume 20 Suppl 2 Page 81 of 182Results: 6 treated patients survived and during the treatment
there was an overall improvement of MAP from 83 (73,5-89) to 88
(82-89,5) mmHg, with a rapid reduction in vasopressors dosages:
noradrenaline decreased from 0,33 (0,15-0,46) to 0,13 (0,10-0,18)
while dopamine from 7,5 (6-8) to 3 (1,5-5) Y/kg/min. Moreover,
there was a markedly decrease of PCT levels from 14,53 (7,64-67,5)
to 3,90 (1,62-23,05) ng/dl and an improvement in renal function,
thanks to the combination of CytoSorb with CRRT. In non-survivors,
MAP was hard to stabilize and decreased from 89,5 (77,75-101,25) to
69,5 (63,25-73,75) mmHg and there was an aggravation in overall
patients’ conditions.
Conclusions: To our experience, a timely use of CytoSorb in com-
bination with the standard therapy could have benefits in impro-
ving patients hemodynamic and helping a more rapid stabilization.
However, more in vivo studies are
needed to confirm these results.
Reference
[1] Schadler et al. Critical Care 2013 17 (Suppl 2):P62Table 24 (Abstract P193).
Age, years 65,5 (52,25-67,25)
Type of Patient 6 Surgical /2 Medical
ICU Stay, days 17 (9,5- 27,5)
Vasopressors need, days 5 (3,25-10,5)P194
In vitro adsorption of a broad spectrum of inflammatory mediators
with CytoSorb® hemoadsorbent polymer beads
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Introduction: This study quantifies the ability of CytoSorb® hemoad-
sorbent polymer beads to adsorb a broad selection of inflammatory
pathogen- and damage-associated molecular pattern molecules
(PAMPs & DAMPS) and cytokines from whole blood in an in vitro re-
circulation system. PAMPS cause either direct damage or trigger an
immune response in the host to fight infection leading to the
production of high levels of cytokines and the release of DAMPS
into the bloodstream, which can trigger a maladaptive systemic
inflammatory response syndrome (SIRS) that can contribute to
organ injury. The benefits of cytokine reduction using extracor-
poreal blood filtration with hemoadsorbant porous polymer beads
has been demonstrated in septic animals, yet the adsorption of
other toxins and inflammatory factors may also contribute to the
observed benefits.
Methods: Purified proteins were added to whole blood and recircu-
lated through a CytoSorb® device or control device for 5 hours.
Plasma was analyzed by ELISA.
Results: Hemoperfusion of whole blood through porous polymer
bead devices for 5 hours removed substantial quantities of a broad
spectrum of DAMPS, PAMPS (Table 25) and cytokines (ns). Levels of
the inflammatory proteins were reduced by <20 % during the five
hour hemoperfusion through a control device (ns).
Conclusions: This study demonstrates that CytoSorb® hemoad-
sorbent polymer beads are capable of reducing a broad range of
toxic DAMPS and PAMPS from blood providing a means, in addition
to cytokine reduction, of reducing the uncontrolled immune res-
ponse that contributes to a maladaptive SIRS response, organ injury
and death in patients with a broad range of life-threatening inflam-
matory conditions such as sepsis, trauma, lung injury and many
others. Further study to elucidate the potential clinical impact is
warranted.P195
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Introduction: In several studies and in vitro data is demonstrated
that the additional treatment with an extracorporal cytokine ad-
sorption filter (Cytosorb, Cytosorbents corp.) may be helpful in pa-
tients with multiorgan failure due to increased cytokine levels [1].
CytoSorb is used as adjunctive therapy not only in septic multiorgan
failure as well as in severe pancreatitis and other critical ill patients
and is well tolerated and safe.
Methods: We collected data from 14 Patients treated additional with
cytokine-haemadsorption filter (Cytosorb) as adjunctive therapy in
septic shock or severe SIRS. The focus was abdominal (28.6 %), pneu-
monia (50 %) and pancreatitis (14.3 %). Aim of our case study was to
show the effectiveness of Cytosorb treatment used as adjunctive
therapy in critically ill patients. If there was no decrease of catechol-
amine demand and kidney injury persistent after initial therapy fol-
lowing actual guidelines [2], Cytosorb therapy was initiated. We
collected data before, during and after treatment and calculated de-
mand of norepinephrine (μg/h vs. thereby achieved mm Hg MAP).
Results: 42.8 % patients were female, mean age was 56,4 years, APA-
CHE II Score was 37, overall survival was 35,7 %. In contrast, survival
in Cytosorb therapy start delay 24 h was 66.7 %. Poor outcome in-
creased in patients with late start of Cytosorb (survivors: therapy start
delay < 48 h: 50 %, delay > 48 h: none). Cytosorb therapy start in non-
survivors was by far later than in survivors (61,3 h vs 28,8 h). After
Cytosorb therapy we observed pronounced decrease of catechol-
amine demand (Norepinephrine μg/h vs thereby achieved MAP): Cat-
echolamine demand decreased 10-fold (84,81 vs 8,84). Blood lactate
level was divided into halves (mg/dl: 42,7 vs 20,2).
Conclusions: In this case study the effects we could observe were
pronounced decrease in catecholamine demand and blood lactate
level. We could see increased survival if treatment with CytoSorb
haemadsorption filter started between 24 – 48 h, patients who had a
greater delay had poor outcome. Reasons for delay has been late
acute renal failure or late admission to ICU. This implicates a therapy
start not later than 24 – 48 hours.
References
[1] Hetz H, et al. Septic shock secondary to ß-hemolytic streptococcus-
induced necrotizing fasciitis treated with a novel cytokine adsorption
therapy. Int J Artif Organs 2014;37:422-6.
[2] Dellinger RP, et al. Surviving sepsis campaign guidelines for management
of severe sepsis and septic shock. Intensive Care Med (2004) 30:536–555
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Oxiris membrane decreases endotoxin during rrt in septic patients
with basal EAA>0,6
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Critical Care 2016, Volume 20 Suppl 2 Page 82 of 182Introduction: Endotoxin > 0.6 is associated with mortality in critical
care patients but few clinical studies evaluate whether Renal
Replacement Therapy (RRT) with an adsorbing membrane may
decrease endotoxin and modulate pro inflammatory mediators
[1].
The aim of this study in a cohort of septic patients during CRRT is to
evaluate. 1- The changes of endotoxin during RRT. 2- The changes of
IL6 and Procalcitonin
Methods: Patients with renal failure and sepsis / septic shock sub-
mitted to RRT with an adsorbing membrane (oXiris , Gambro) were
stratified in three groups according to basal EAA levels: Group A
(EAA > 0,6 ) Group B (0,40-0,59) and Group C (0- 0,39).
All patients had monitoring of endotoxin -chemiluminiscent based
endotoxin activity assay (EAA - Spectral Diagnostic, Ontario, Canada)
IL6 (Elisa), procalcitonin (LUMI test PCT Braun Diagnostic Berlin,
Germany) , and inotropic support at basal time (T0) , at 24 hours (T1)
and 48 hours (T2).
All data are expressed as Mean Sd. ANOVA test was used to compare
the changes of EAA , IL6 and Procalcitonin.
Results: 53 septic patients with renal failure and sepsis /septic shock
were enrolled. Group A included 33 patients (62 %), Group B 14 pa-
tients (26 %) and group C 6 patients (11 %). At Table 26 are shown
the changes of EAA. In Group A also IL6 decreased from to 357 ±
100 pg/mL to 143 ± 43 (p < 0,05) and Procalcitonin from 30 ± 5 to 8
± ng/mL (p < 0,05). In Group B and C ,too, IL6 and Procalcitonin de-
creased significantly . 33 patients survived and 20 deceased. Survi-
vors had at T2 lower EAA then non survivors (EAA 0,5 ± 0,2 vs .0,66 ±
0,13 . p < 0,01).
Conclusions: 1 The adsorbing membrane oXiris may decrease
endotoxin in patients with EAA > 0,6. -2 This is accompanied by a
reduction of Il6 and Pro calcitonin. 3- Endotoxin decrease to < 0,6
may increase survival. These data confirm, in part, a very recent
study on liver failure treatment with a new extracorporeal liver
device combining Septex filter with Oxiris.
Reference
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T0 T2 p value
Group A 0,7 ± 0,16 0,56 ± 0,16 0,001
Group B 0,5 ± 0,07 0,52 ± 0,18 ns
Group C 0,21 ± 0,05 0,37 ± 0,06 nsP197
An observational prospective study on the onset of augmented
renal clearance: the first report
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Introduction: The phenomenon of augmented renal clearance (ARC)
is increasingly reported in intensive care unit (ICU) patients. However,
there have been few reports on ARC in Japan. The aim of this obser-
vational study was to describe the prevalence and the patient char-
acteristics of ARC in a cohort of patients with normal serum
creatinine level at a Japanese ICU.
Methods: We conducted a prospective cohort study from May to
September, 2015 at the emergency ICU of a tertiary university hos-
pital in Japan. The creatinine clearance (CLCR) rate of all patients was
measured on admission. ARC was defined as a body surface adjusted
CLCR rate of †130 mL/min/1.73 m2. We sought to study the inci-
dence of ARC and to record the patient characteristics that were as-
sociated with ARC prospectively.
Results: Two hundred ninety-five patients were admitted to our ICU
over the study period; 33 of whom were recruited into the present
study. We identified 13 patients (39.4 %) with ARC. Patients with ARCwere younger (46.5 vs. 70.7 years; p < 0.05), were less frequently male
(23.1 % vs. 70 %; p < 0.05), had a lower APACHE II score (12.6 vs.
17.6; p < 0.05), and were less frequently diagnosed with sepsis (0 %
vs. 40 %; p < 0.05) than patients without ARC.
Conclusions: ARC was a common finding in Japanese ICU patients
with normal serum creatinine levels. Further multicenter studies are
needed to gain a better understanding of the precise epidemiology
of ARC in the Japanese population.
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Introduction: Acute Kidney Injury (AKI) is frequent in severe sepsis;
44 % in our ICU [1]. We developed a goal-directed, diagnostic ultra-
sonographic algorithm to assist in the evaluation in AKI. Our aims
were to determine the effects on the incidence rate of AKI.
Methods: A prospective, observational study of patients with severe
sepsis and acute oliguria (met the definition of AKI by reduced urine
output of RIFLE criteria) was performed. Inferior vena cava (IVC)
diameter, collapsibility, and renal perfusion with color Doppler were
incorporated into an algorithm that was used by primary intensivists
for volume assessment and management. The effects of the
algorithm-directed interventions were assessed by serum creatinine
and urine output (in ml/kg/hour) twenty-four hours later and by 28-
day outcomes. The proposal was approved by the Research Ethics
Committee (RAC no.2141039)
Results: Fifty-three patients were studied; mean APACHE II score
21 ± 7.6,mean SOFA score 9 ± 3.8. Twenty-four (45 %) patients were
diabetic, 23(43 %) hypertensive, 17(32 %) cirrhotic, 34(64 %) patients
were on vasopressors. Mean creatinine at time of evaluation was
147 ± 75.4, serum lactate 3.2 (1,17).Ultrasound evaluation revealed
intravascular dehydration in 18 (34 %), euvolumia in 23(43 %) and
fluid repletion in 9 (17 %). Based on ultrasound results, 21(39 %) pa-
tients were given loop diuretics, 10(19 %) started on continuous
renal replacement therapy (CRRT), fluid boluses to 21(39 %). In 1
(2 %) patient CRRT was stopped. Serum creatinine increased by 1.5
times in 5 (9 %) patients, urine output was 0.9 ml/kg/hour (IQR 1.6).
68 % patients recovered from AKI, with 6 (12 %) either on chronic
dialysis or with chronic kidney disease. At follow-up, 32 % (17 pa-
tients) had renal injury.
Conclusions: Incorporation of a standardized, diagnostic algorithm
using bedside ultrasonographic assessment helped us to significantly
reduce our rates of acute kidney injury.
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Introduction: AKI is characterised by an abrupt loss of kidney function.
Due to its worldwide increasing prevalence and mortality, the disease
has become an important health care challenge to be treated in inten-
sive care units (ICU)1,2]. AKI causes are numerous,~10 % of cases are
postrenal obstruction with urineaccumulation. Ultrasound(US) is the
procedure of choice diagnosing this cause of AKI and hence choosing
the best therapy. A survey in UK revealed more than 40 % ICUs do not
contact a nephrologist within 48 h in AKI. Moreover, not even 40 % of
ICUs were provided with a US option for 24 h a day[3]. This is the
Fig. 41 (Abstract P200). ROC Curve “Angina Index Score”.
Critical Care 2016, Volume 20 Suppl 2 Page 83 of 182reason, why we developed FARIUS (focused on acute renal injury with
US) a programme for the education of students and physicians in diag-
nosing obstruction via US in an expert like manner.
Methods: FARIUS was approved by the ethic commission and devel-
oped as a 4 h programme for a training in renal US. To validate FAR-
IUS, we compared US results of 22 trainees (15 students, 7
physicians) with those of 10 experts (2 ICU physician, 3 urologist, 1
nephrologist, 4 internal specialist). We present the results of two
quality parameter, i.e.(i) defining the length(cm) of the right kidney
of a female volunteer,(ii) diagnosing postrenal obstruction by evalu-
ating images from US examinations. FARIUS participants voted if pre-
sented images deveal postrenal obstruction or not. Answers analyzed
for correctness, specificity and sensitivity. Statistical analysis (Wil-
coxon Test) were realized with INSTANT+.
Results: (i) FARIUS:n = 22;mean = 10,25;SD = 1,013;min = 7,5;max = 12,3;
Expert:n = 10;mean = 10,15; SD = 0,463;min = 9,7;max = 11,3. Statistical
analysis did NOT reveal a significant difference between groups (p =
0,823; p > 0,05). (ii) Evaluation of US images reveal 81,2 %(12,2 of 15)
correct answers (mean:12,2; min = 8; max = 15; SDE = 1,84), sensitivity
(98,2 %), specificity (73,2 %).
Conclusions: We could demonstrate, that absolvents for FARIUS are
able to provide US examination to detect and evaluate postrenal ob-
struction at similar quality like experts. Identification of patho-
logical results had a high sensitifity. However, the variance for the re-
sults indicates some amendment. Thereby the treatment of ICU pa-
tients with AKI could be more independent from external con-
ditions offering an equal diagnostic quality. Economic interests and
human resources could be positive affected also. Further investigations
are in planning.
Reference
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Effectiveness of renal angina index score predicting acute kidney
injury on critically ill patients
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Introduction: Until two thirds of critically ill patients develop Acute
Kidney Injury (AKI) and it is associated with an increased risk of
death. Renal Angina Index is a score that evaluates the risk of pre-
senting AKI. This study was used to determine the effectiveness of
the Renal Angina Index as a developing predictor of AKI in 3 days.
Methods: The study was based on a prospective cohort of critically
ill patients in whom Renal Angina Index score was completed with a
72 hour follow up of serum creatinine levels, water balance and urin-
ary output, establishing after patients that develop AKI. Afterwards a re-
lationship was established between Renal Angina Index score and its
predictive capacity of developing AKI, determining sensibility, specifi-
city, positive predictive value and negative predictive value for the
score.
Results: A final sample of 206 patients was obtained at the end of
the study. The incidence of AKI in the studied population was 27.2 %
(n = 56), and the average scores of Renal Angina Index were 20.52 in
those who develop AKI and 4.35 in those who didn’t develop AKI.
This score offers a 90.7 % sensibility, 95.4 % specificity with an area
under de curve of 0.963 (0.934-0.991). A positive predictive value of
0.88 was obtained and a negative predictive value 0.97.
Conclusions: Renal Angina Index score is effective predicting AKI in
critically ill adult patients.
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Introduction: There is still uncertainty about whether interventions
for blood pressure is effective to treat new-onset acute kidney injury
(AKI) in critically ill patients. Moreover, little things are known about
the significance of blood pressure in AKI without sepsis. The pur-
poses of this study are to explore which parameter of blood pressure
after the onset of AKI is associated with AKI stage progression, and
to investigate whether the meaning of blood pressure in new-onset
oliguric AKI is different between patients with or without sepsis.
Methods: This is a retrospective cohort study including adult pa-
tients whose stay in the ICU (Jikei University Hospital, Tokyo,
Japan) for 24 hours or more after the new onset of oliguric AKI.
Oliguric AKI was defined as urine output less than 0.5 mL/kg/h
for 6 hours according to the Kidney Disease Improving Global
Outcomes (KDIGO) definition. The primary outcome was AKI Stage 3
progression in the KDIGO criteria. In a 24-hour time frame, we analyzed
mean arterial pressure (MAP) parameters (time-averaged MAP; lowest
MAP; and time length below MAP 70 mmHg), considering stratification
by sepsis.
Results: We analyzed 576 patients with oliguric AKI. Stage 3 pro-
gression occurred in 16.0 % of them. In 158 patients with sepsis on
ICU admission, Stage 3 progression occurred in 29.6 % of them.
When the patients were stratified by sepsis, time length below MAP
70 mmHg was significantly associated with Stage 3 progression in
multivariable analyses: OR 1.09 (95 % CI: 1.02-1.16) each hour with
sepsis, OR 1.07 (1.03-1.12) each hour without sepsis. In the multivari-
able analysis of all patients, categorized time length below MAP
70 mmHg showed increasing trends of ORs: 1.58 (0.73-3.41) for 0-6
hours, 1.71 (0.74-3.98) for 6-12 hours, 3.19 (1.24-8.24) for 12-18 hours,
6.42 (2.41-17.10) for 18-24 hours.
Critical Care 2016, Volume 20 Suppl 2 Page 84 of 182Conclusions: In a 24-hour time frame after the new-onset of oliguric
AKI, time length below MAP 70 mmHg was associated with Stage 3
progression in oliguric AKI with or without sepsis. The results suggest
that the recognition and treatment of AKI should be early regardless
of sepsis. Urine output as a continuous monitor might be more use-
ful for this purpose than serum creatinine. Further studies should be
needed to investigate the meaning of interventions for blood pres-
sure as treatment of AKI.
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Introduction: In hospitalized patients anaemia increases the risk of
developing acute kidney injury (AKI). Our aim was to determine
whether anaemia also has an impact on the risk of progression from
early AKI to more severe AKI in critically ill patients.
Methods: We retrospectively analysed the data of patients admitted
to an ICU between 2007 – 2009 who had AKI stage I, as per AKI Net-
work classification, and had undergone haemodynamic monitoring
within 12 h of diagnosis. We collected baseline characteristics and
differentiated between patients who progressed to AKI stage III and
those who did not. Univariate and multivariate logistic regression
analyses were used to identify risk factors for progression.
Results: 210 patients were included in the analysis. 85 patients
(41 %) progressed to AKI III, 120 did not. Five patients with AKI I died
before their renal function recovered or progressed. Patients with
AKI I who progressed to AKI III were sicker on the day of AKI I with
a higher SOFA score (9 vs 8; p < 0.001), higher arterial lactate (2 vs
1.6 mmol/L; p < 0.001), lower MAP (median 71 vs 74 mmHg; p =
0.01), lower cardiac index (median 2.6 vs 3.3 L/min/m2; p < 0.001)
and increased need for respiratory and cardiovascular support.
There was no difference in Hb concentration (96 g/L). Risk factors
for progression from AKI I to AKI III are shown in Table 27.
Conclusions: In critically ill patients with AKI stage I, anaemia was
not associated with an increased risk of progression to more se-
vere AKI.Table 27 (Abstract P202). Multivariable logistic regression models for
progression to AKI stage III.
Parameters on day of AKI OR 95% CI p-Value
Mechanical ventilation 22.12 2.40-205.52 0.006
CAD/CCF 3.17 1.55-6.49 0.002
Arterial lactate 1.57 1.15-2.13 0.004
SOFA score 1.21 1.04-1.39 0.01
CVP 1.07 1.01-1.14 0.02
Cardiac Index 0.69 0.50-0.96 0.03
MAP 0.97 0.92-1.02 0.18
Hb 0.82 0.65-1.03 0.09
SaO2 0.97 0.79-1.20 0.79P203
Estimated glomerular filtration rate based on serum creatinine:
actual practice in Dutch ICU’s
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Introduction: Glomerular filtration rate (GFR) describes the flow rate
of filtered fluid through the kidneys. Creatinine clearance (CrCl) is the
volume of blood plasma that is cleared of serum creatinine (SCr) per
time unit and is an important measure to approximate “true” GFR.CrCl can be estimated either by population based mathematical
equations or it can be measured using serum and urine creatinine
concentration after collection of urine over a certain period of time.
Deterioration of CrCl/GFR identifies patients with acute kidney injury
and is important for appropriate drug dosing. In our ICU practice the
MDRD-eGFR equation is standard of care for a “reliable” estimation of
GFR. Recently, the CKD-EPI-SCr equation was introduced as a more
accurate measure especially in patients with higher GFRs. However,
in critical ill patients there is no steady state of SCr, which is a pre-
requisite in order to estimate GFR irrespective of the mathematical
formula used. We regularly treat patients with demonstrably highly
impaired kidney function in spite of “normal” estimated GFR leading
to toxic levels of renally cleared drugs. We investigated the actual
practice of GFR approximation in Dutch ICUs.
Methods: Structured questionnaire via telephone.
Results: In June 2015 35 hospitals in the Netherlands (27 hospitals in
southern Holland and 8 academic hospitals) were approached and the
on-call intensive care doctor and clinical chemist were queried. At the
moment of our query 15 hospitals used the CKD-EPI-SCr equation in
order to estimate GFR, 20 hospitals used MDRD-equation with 5 plan-
ning to soon introduce CKD-EPI-SCr equation. In all intensive care units,
ours included, eGFR on admission was used to define patient’s GFR and
determine drug dosing. Intensive care doctors were conscious that
eGFR might overestimate their patient’s “true” GFR. Protocols for drug
level analysis (i.e. Vancomycine) exist. However, standardized measure-
ments of patients CrCl were not performed in none of the ICU’s.
Conclusions: In current clinical practice mathematical equations are
used to estimate GFR even in critically ill patients. Apparently, there
is a shift from MDRD- toward CKD-EPI-SCr-equation. However, when
applied in the critically ill both formulae provide completely incom-
parable values (data to be published). Therefore it is highly debatable
if CKD-EPI-Scr eGFR will be a better estimate in comparison to
MDRD-eGFR. Recent literature suggests that the only method that
approximates Inulin-based-GFR during critical illness is a measured
GFR, which we support to become clinical practice in all ICU’s.
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critically ill patients
H. R. De Geus, A. Hana
ErasmusMC, Rotterdam, Netherlands
Critical Care 2016, 20(Suppl 2):P204
Introduction: The serum-creatinine based estimation of Glomerular
Filtration Rate (eGFR) using the MDRD-equation is inaccurate in critic-
ally ill patients and tends to severely overestimate the “real time
clearance capacity” especially in catabolic states. Recently, CKD-EPI-
Serum-Creatinine and CKD-EPI-Cystatin-C equations were introduced
as more precise alternatives for eGFR. Originally, all these equations
have been validated in patients with stable chronic kidney disease.
Most Dutch hospital laboratories, ours included, still report MDRD-
eGFR in their electronic patient data system, however many intend
to, or already have switched to CKD-EPI-Serum-Creatinine-eGFR. To
date, (e)GFR is a key element in clinical decision making, even in the
ICU setting. However, indiscriminate application of these mathemat-
ical equations may be questionable in the critically ill.
Methods: In order to calculate GFR applying MDRD, CKD-EPI-Serum-
Creatinine and CKD-EPI-Cystatin-C formulae and assess their mutual
comparability in an all-comer adult academic ICU cohort we performed
a post-hoc analysis from the NGAL-study. MDRD-eGFR, CKD-EPI-Serum-
Creatinine-eGFR and CKD-EPI-Cystatin-C-eGFR were calculated using
admission-day data. Man-Whitney U test was used for comparison be-
tween groups.
Results: Out of 663 consecutive admissions, 47 cases were excluded
due to missing data. Patient characteristics comprise median (95 %
CI) age of 59 years (57-60), SOFA score 5 (5-5), APACHE II score 18
(17-19), male:female ratio 358:257. Analysis of eGFR by MDRD-, CKD-
EPI-Serum-Creatinine en CKD-EPI-Cystatin-C resulted in significantly
different outcomes. In comparison to the MDRD-equation, CKD-EPI-
Serum-Creatinine-eGFR values are higher (P[<=]0.05), whereas CKD-
Fig. 42 (Abstract P206). Baseline Characteristic of the
study population.
Fig. 43 (Abstract P206). Baseline Characteristic of the
study population.
Critical Care 2016, Volume 20 Suppl 2 Page 85 of 182EPI-Cystatin-C values are lower (P[<=]0.002). In direct comparison the
CKD-EPI-Serum-Creatinine-eGFR is higher than the CKD-EPI-Cystatin-
C-eGFR. This difference is significant for the entire cohort and persists
throughout KDIGO stages 1-4 subgroups (p[<=]0.003). In KDIGO
stage 5 small sample size limits interpretation of results.
Conclusions: In our cohort the use of the abovementioned mathe-
matical equations results in completely different eGFR values. Par-
ticularly, the new CKD-EPI-Serum-Creatinine and CKD-EPI-Cystatin-C
equations provide incomparable eGFR values. Although these formu-
lae are supposed to be more precise, it remains questionable
whether they are sufficiently reliable in the ICU-setting.
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Introduction: An ideal biomarker for early diagnosis of septic acute
kidney injury (AKI) should reflect renal damage at cellular level. The
aim of this study is to assess and compare the role of a urinary cell
cycle arrest marker, insulin like growth factor binding protein-7 (IGFBP-7)
in early diagnosis of septic AKI in adult critical care patients. Besides, its
role in mortality prediction was also evaluated.
Methods: Single center prospective cohort study. Patients without AKI,
admitted to a medical intensive care unit (ICU) between January 2010
and March 2013, were included. According to their ICU followup char-
acteristics they were grouped as sepsis-non AKI, sepsis-AKI and non-
sepsis-non AKI [control]. IGFBP-7 was studied with Human ELISA Kit/96
Test/USCNK® from admission and daily collected serial urine samples.
Results: One hundred and eighteen patients formed the cohort; 52 in
sepsis-non AKI, 43 in sepsis-AKI, 23 in control group. Admission urine
IGFBP-7 predicted septic AKI development with 72 % sensitivity and
70 % specificity for a threshold level of 2.5 ng/ml with an area under
the receiver operating characteristics curve (AUC) of 0.79 (95 % CI:0.70-
0.88). No impact of sepsis was observed on urine IGFBP-7 levels in the
absence of AKI. In septic AKI group Urine IGFBP-7 levels continuously
increased upto the day of AKI development and high levels suspended
for 10 days further. If it continued to be > = 4.7 ng/ml after 7 days of
AKI than it predicted mortality with 83 % sensitivity and 82 % specificity
(p = 0.009,AUC:0.894,95%CI: 0.742-1.046). But it was not one of the sig-
nificant predictors of mortality in multivariate analysis.
Conclusions: Admission urine IGFBP-7 levels and following its course
in ICUs can be used for early diagnosis of septic AKI development
without being affected by sepsis itself. But, its role in predicting mor-
tality needs further clarification.
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Introduction: Establish categories of risk for development of severe
acute kidney injury based on the combination of levels uNGAL with
various clinical variables.
Methods: A clinical, retrospective, observational, descriptive and ana-
lytical study in the ICU of the Medica Sur Clinic Foundation in under-
stood period of January 1, 2013 to December 31, 2014.Results: 82 patients included in the study, 37 (45.1 %) were male and
45 female (54.9 %) with a mean age of 57 ± 20 years. The main cause
of admission was septic shock in 57.3 %. Creatinine levels and time
uresis uNGAL significant differences with a probability less than 0.05.
The cutoff for the diagnosis of acute kidney injury admission was
166.8 ng / ml, and the outcome of severe acute kidney injury, the in-
come cutoff was 306.35 ng / ml.
Conclusions: There was no statistically significant difference between
variables except for the creatinine levels and urinary lipocalin uresis
time. Cutting uNGAL admission to the outcome of severe AKI was
306.35 ng / ml.
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Shrunken pore syndrome is associated with a sharp rise in
mortality in patients undergoing elective coronary artery bypass
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Introduction: Shrunken Pore Syndrome(SPS) is suggested as a an eGFR
based on cystatin C, which is lower than 61 % of their eGFR based on
creatinine, i.e. when eGFRcystatin C <61 % of eGFR-creatinine.
Methods: The preop. plasma levels of cystatin C and creatinine were
measured in 1638 patients undergoing CABG. eGFRcystatin-C and
eGFRcreatinine were calculated using two pairs of estimating equa-
tions, CAPA-LMrev, and CKD-EPIcystatin C and CKD-EPIcreatinine, re-
spectively. The patients were studied over a median follow-up time
of 3.5 years (2.0-5.0 y) and the mortality determined.
Results: The Cox multivariate analysis demonstrated that the preop
presence of SPS independently predicts poorer survival in addition to
previously known risk factors. The five year survival for all patients
was (mean ± 95 % CI) 90.0 ± 1.2 %,. Survival for patients with SPS de-
fined by the equation pair CAPA-LMrev was 58.8 ± 9.0 %. Survival for
patients with SPS by the equation pair CKD-EPIcystatin C-creatinine was
65.1 ± 0.6 %.
Conclusions: SPS is a strong, independent, predictor of mortality.
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Fig. 44 (Abstract P207). Risk of mortality after CABG by Kaplan
Meier for Shrunken pore syndrom.P208
The biomarker nephrocheck™ can discriminate the septic shock
patients with an akin 1 or 2 acute renal failure who will not
progress toward the akin 3 level
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Critical Care 2016, 20(Suppl 2):P208Introduction: Patients hospitalized for septic shock have an in-
creased risk to develop acute renal failure (ARF) and require a renal
replacement therapy (RRT). The best delay to start RRT is a matter of
debate. A new urine test, the NephrocheckTM has been validated. It
corresponds to the urine concentration product of 2 tubular suf-
fering markers (TIMP2 and IGFBP7) associated with a risk of develo-
ping an ARF within 12 hours. The aim of our study was to analyze
the capacity of the urine TIMP2*IGFBP7 to predict the absence of
evolution toward the AKIN 3 in patients hospitalized for a septic
shock who present an ARF AKIN 1 or 2.
Methods: Every patient admitted for a septic shock in our medical
ICU who presented an ARF AKIN 1 or 2 within the first 6 hours fol-
lowing the start of catecholamines was prospectively included. Exclu-
sions criteria were pre-terminal chronic renal failure or chronic
dialysis, anuria, patients AKIN 0 or AKIN 3. TIMP2*IGFBP7 urine assay
was performed at baseline (H0) and H12. Clinical and biological pa-
rameters were collected at H0, H12 and H24. The performance of the
NephrocheckTM to predict the absence of evolution toward the AKIN
3 level within the first 24 hours was tested for the baseline measure-
ment and for the evolution of the NephrocheckTM between baseline
and H12 (delta H0-H12).
Results: Fifty-seven patients were included, 20 (35 %) patients devel-
oped an AKIN 3 ARF (group AKIN = 3) and 37 patients did not reach
this level (AKIN < 3). At H0, the urine output was lower n the AKIN < 3
(0.69 (0.47-0.99)) versus AKIN = 3 (0.33 (0.16-0.58)ml/h/kg, p = 0.007).
There was no difference for the other variables at baseline including
creatininemia. The TIMP2*IGFBP7 was different between the two
groups at H0 (AKIN < 3 versus AKIN = 3, respectively 0.96 (0.68-1.34) ver-
sus 5.96 (2.33-10.37) p = 0.0002) and at H12 (0.46 (0.28-0.93) and 3.65
(0.95-9.98); p = 0.0008). The median delta H0-H12 was not different be-
tween the groups. A TIMP2*IGFBP7 at H0 ¡Ü1.85 predict the absence of
progression toward AKIN3 with a sensibility of 80 % and a specificity of
73 %. Compared to the creatininemia at baseline (AUC 0.61, 0.47-0.74),
the AUC of TIMP2*IGFBP7 (0.80, 0.67-0.89; p = 0.05) urine test was su-
perior for assessing the risk of AKIN3. But there was no difference with
the diuresis at baseline (AUC 0.72, 0.58-0.83; p = 0.33).
Conclusions: The NephrocheckTM and the urine output at admission
predict the absence of progression from AKIN 1 or 2 toward the AKIN
3 level of septic shock patients.
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Introduction: Acute Kidney Injury (AKI) is a serious complication
in hospitalized patients, particularly in the critically ill, in whom
AKI is independently associated with poor prognosis and out-
come. Sepsis is the most important cause of AKI and its patho-
genesis is clearly distinct from non-septic AKI. Here, we compared
the clinical course and outcome in septic and non-septic critically
ill patients worldwide.
Methods: Intensive Care Units (ICUs) were invited to participate vol-
untarily in the Intensive Care Over Nations (ICON) audit. In par-
ticipating centers, data was prospectively collected from all adult pa-
tients (>16 years) admitted to the ICU during a 10-day period. Pa-
tients admitted for less than 24 h for routine postoperative
surveillance were excluded. Data was collected daily during the ICU
stay up to 28 days, with a follow-up for outcome data until hospital
discharge or death. AKI was defined according to the Risk, Injury,
Failure, Loss and End-Stage (RIFLE) classification and was diagnosed
during the first 48 h after ICU admission. Patients with pre-existent
chronic renal failure (CRF) were analyzed as a separate subgroup.
Results: The study population comprised 9579 patients. At admis-
sion, 30 % of patients fulfilled sepsis criteria of which 67 % devel-
oped AKI, compared to 57 % in the non-septic population (p <
0.0001). AKI was more severe in septic patients and these patients
Critical Care 2016, Volume 20 Suppl 2 Page 87 of 182were less likely to recover to a lower RILFE category compared to
non-septic patients (improvement between day 3 and day 7 in 22 vs.
32 %, p < 0.0001). Dialysis incidence was higher in septic patients
compared to non-septic patients (21 % vs. 5 %, p < 0.0001). Also
in-hospital mortality rates were higher (33 % vs. 14 %, p <
0.0001), which increased to 51 % in septic and 35 % in non-
septic AKI-F patients. Hospital mortality of septic AKI-F patients
was similar compared to septic patients with pre-existent CRF (HR
1.6, 95%CI 1.3-2.0 compared to 1.8, 95%CI 1.5-2.1 in septic AKI-F
patients). Septic patients with AKI-R or AKI-I that improved be-
tween day 3 and day 7 after admission showed a similar mortal-
ity compared to septic patients who did not develop AKI, while
mortality remained elevated in AKI-F patients that improved be-
tween day 3 and 7.
Conclusions: AKI in sepsis is more severe, less likely to recover and
associated with a higher mortality, compared to non-septic AKI.
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Does enhanced recovery after surgery reduce the incidence of
acute kidney injury in those undergoing major gynae-oncological
surgery?
M. Waraich , J. Doyle, T. Samuels, L. Forni
The Royal Surrey County Hospital, Guildford , UK
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Introduction: Gynae-oncological surgery involves a patient popula-
tion that is elderly, undergoing intra-abdominal surgery sometimes
with tumour extension to the ureters; long anaesthetic and surgical
times with extensive blood loss. All of these factors have been
highlighted in the Kidney Disease: Improving Global Outcomes
(KDIGO) as factors for developing acute kidney injury (AKI) [1]. The in-
cidence of AKI in the gynaecological population is thought to be
about 13 % [2]. Enhanced recovery after surgery (ERAS) pathways in-
corporate the use of goal directed fluid therapy with cardiac output
monitoring perioperatively. Our study aim was to look at the inci-
dence of AKI before and after the introduction of an ERAS pathway
in our centre.
Methods: We retrospectively looked at patients undergoing major
gynae-oncological surgery before and after the introduction of an
ERAS pathway. There was no patient exclusion in our cohort. We
used the KDIGO definition of AKI using the patient’s preoperative
serum creatinine as baseline. Serum creatinine on admission to the
critical care unit was taken as day 1. Data was collected for day 1, 3,
7 and 30. The main outcome of the study was the incidence of AKI
pre and post ERAS introduction. Contingency analysis using Yates
Chi-squared was performed.
Results: Our single centre cohort included 459 patients, of which 127
were in the group before the introduction of ERAS (pre ERAS) and
332 were post introduction group (post ERAS). The overall incidence
of AKI was 10.24 % in the pre ERAS group and 9.04 % in the post
ERAS group which was not statistically different. At day 1 the inci-
dence of AKI was 3.94 % in the pre ERAS group and 1.52 % in the
post ERAS group (p-value 0.22). At day 3 it was 8.2 % in the pre
group and 6.48 % in the post group (p-value 0.67). Analysis showed
there was no statistical difference between the incidence of AKI in
the pre and post ERAS groups at day 1,3,7 or 30.
Conclusions: The incidence of AKI in our cohort of patients was
lower than cited at about 10 %. There was no statistical difference in
the incidence of AKI after the introduction of an ERAS pathway. Thus,
we observed no reduction in the incidence of AKI with the in-
troduction of an ERAS pathway.
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Identification of risk factors for the development of acute kidney
injury after lower limb arthroplasty
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Introduction: Acute kidney injury (AKI) is an independent contributor
to morbidity and mortality [1]. In view of this we evaluated factors
that may be associated with the development of AKI after hip and
knee arthroplasty and studied the subsequent effect AKI had on
length of stay (LOS) and mortality.
Methods: On a retrospective basis, a clinical database of information
on all lower limb arthroplasties at an elective tertiary orthopaedic
hospital was analysed for the time period between 1st January 2009
and 31st October 2015. AKI was defined by the Kidney Disease: Im-
proving Global Outcomes (KDIGO) classification.
Results: Incidence of AKI between 2009 and 2015 was 2.99 % in
8033 patient episodes. All factors other than gender were noticeably
associated with AKI. Rate of AKI was 2.7 % in elective cases compared
to 10.5 % in urgent cases. Revision surgery was associated with an in-
creased rate of AKI when compared to primary surgery. AKI increased
with age and the rate of AKI in patients over the age of 80 was 9.9 %.
Development of AKI progressively increased from 0.88 % in ASA 1 to
13.3 % in ASA 4 patients. Pre-operative anaemia and blood transfusion
increased the risk of AKI from 2 % to 4.6 % and 2.2 % to 8.9 % respect-
ively. All patients who developed AKI had post-operative anaemia. AKI
affected 6.9 % of those patients who were admitted to the HDU while
patients not admitted to HDU demonstrated a rate of AKI of 1.7 %. Pa-
tients with AKI had a mean LOS of 28.6 days compared to 9.4 days in
those without AKI. Patients with no AKI had a mortality of 1.8 % at one
year compared with 5.8 %, 6.5 % and 7.7 % in patients with Stage 1,
Stage 2 and Stage 3 AKI respectively.
Conclusions: Our incidence of AKI is much lower than that reported
in the literature and a retrospective study demonstrated the rate of
AKI to be 14.8 % after elective orthopaedic surgery [2]. It is possible
that this may be secondary to the routine post-operative admission
of patients with risk factors to the HDU environment. Risk factors
found to be associated with AKI were consistent with the results of
previous studies [3]. Even Stage 1 AKI resulted in an increased mor-
tality at one year. Interpretation of our findings is limited by con-
founding. Early recognition of risk factors will aid identification of
patients at increased risk of AKI. Subsequent pre-optimisation and
normalisation of reversible risk factors where possible as well as
planning of appropriate post-operative care may reduce the burden
of AKI.
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Incidences and associations of acute kidney injury after major
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Introduction: Acute Kidney Injury (AKI) has been identified as a com-
mon and clinically significant complication after major trauma requir-
ing ICU admission [1].
Methods: We performed a retrospective, single centre observatory
study of major trauma admissions to the Royal London Hospital
Adult Critical Care Unit over a 30-month period to assess the inci-
dence and associations of AKI in this population. AKI was defined by
the related KDIGO definitions using creatinine criteria. Trauma-
related AKI was defined as AKI by the KDIGO creatinine criteria occur-
ring in the seven days after admission. In the absence of known
baseline creatinine the admission value was used.
Critical Care 2016, Volume 20 Suppl 2 Page 88 of 182Results: 858 patients admitted to the ICU after major trauma were in-
cluded in the study, 81 % were male. Median Age was 41 (IQR: 27-
56), median New Injury Severity Score was 34 (22-50) and median
ICU admission APACHE-2 was 12 (8-16). Overall, AKI incidence was
16 %. AKI was associated with greater hospital mortality (33 % vs.
16 % p < 0.001) and hospital length of stay (Fig. 45). In multivariable
logistic regression, accounting for illness severity scoring AKI
remained associated with increased in-hospital mortality (OR = 1.9,
1.2-3.2) however when broken down by AKI category only AKI-3 was
significantly associated (OR = 3.4, 1.6-7.3).
Conclusions: Acute Kidney Injury is a common finding in critically ill
patients after major trauma and is associated with greater illness se-
verity, rates of death and length of stay.
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Fig. 46 (Abstract P214). Trajectory of serum creatinine in patients
with post-op LOS > 5d. Mean, SEM.P213
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Introduction: Major trauma patients have more chance to reduce
kidney function due to hemorrhagic shock or direct injury. This study
aimed to evaluate the clinical characteristics and risk factors of acute
kidney injury (AKI) in patients after major trauma.
Methods: We performed a retrospective cohort study in a single cen-
ter. Among 386 patients who visited emergency department from
January 2012 to December 2013, 322 patients with trauma were en-
rolled. Patients were divided into two groups, patients who devel-
oped AKI (n = 301) or not (n = 21), to compare the clinical data. We
conducted multivariable logistic regression to independent predic-
tors for AKI and mortality.
Results: The overall incidence of AKI was 6 % (n = 21). The mean age
was 70.9 ¡¾ 12.5 years and 80.9 % were males. Also initial in-
tervention was done embolization (n = 5, 23 %, P < 0.01), and oper-
ation (n = 7, 33 %, P < 0.45). 10 AKI patients were need to receive
renal replace therapy. (47 %) Independent risk factors associated
with traumatic AKI were injury severity score (ISS) [odds ratio
(OR) = 1.084, P < 0.01], presence of shock (OR = 3.78, P = 0.018),
and increasing of the serum creatine kinase (CK) (OR = 1.123, P <
0.01) level. Hospital mortality was higher in AKI group (23 %)
than not (1 %).
Conclusions: The development of AKI was associated with severity of
damage and organ perfusion. Furthermore, the AKI patients after
trauma was refer to increase mortality.P214
Trajectory of serum creatinine after major surgery and the
diagnosis of acute kidney injury
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Introduction: We have demonstrated that even mild and transient
perioperative acute kidney injury is associated with significantly
worse survival in the year after major surgery (see accompanying ab-
stract). However, confounding effects of major illness on serum cre-
atinine levels may cause severity of AKI to be underestimated and
recovery from AKI over-estimated [1].
Methods: From a population of 1897 patients undergoing major sur-
gery we examined of which 128 had AKI we examined baseline and
hospital discharge creatinine-base estimated GFR (CKDEpi formula)
and the trajectory of serum creatinine in patients who were hospital-
ized for > =5 days after surgery.
Results: In 1836 patients who survived to hospital discharge median
duration of hospitalization was 7 days (IQR: 4-11) and 11 days (6-25)
in those patients who had post-operative AKI. In all hospital survivors
mean eGFR rose significantly from baseline to discharge: 88.4 to
94.7 ml/min/1.73 m2 (p < 0.001). However in those with AKI discharge
eGFR was similar to baseline 76.4 to 74.5 (p = 0.6). 1225 patients
stayed > =5 days after surgery in those with AKI mean creatinine rose
rapidly and eventually settled to near baseline however overall cre-
atinine fell progressively in the five days after surgery and was
~10 % below baseline at discharge (Fig. 46). In a regression analysis
a higher discharge eGFR significantly correlated with longer hospital
length of stay (p < 0.001), however no such relationship existed for
baseline eGFR (p = 0.79).
Conclusions: Baseline reduction in serum creatinine after major sur-
gery may confound our ability to identify AKI and to assess its sever-
ity and recovery. Importantly, these effects may be more pronounced
in patients with longer hospital admissions who are at higher risk of
complications including AKI.
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Epidemiology of acute kidney injury after cardiac surgery. A single
center retrospective study
S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud,
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Fig. 47 (Abstract P216). Unadjusted Kaplan-Meier plot for post-
operative survival by AKI status.
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and treatment, the incidence of acute kidney injury (AKI) remains
high. In cardiac surgery AKI is reported to be around 30 % with need
for renal replacement therapy up to 1 %. [1] We aim to characterize
the differences in premorbid status, etiology, intraoperative and post-
operative influencing factors for AKI development and the patients’ sec-
ondary outcomes.
Methods: Single center retrospective observational sturdy, AKI was
determined from Acute Kidney Injury Network as an acute (within
48 h) deterioration in renal functions when serum creatinine con-
centration entirely increase to value of greater than 0.3 mg/dL
(26.4 μmol/L) from baseline or 1.5-fold increment from baseline) [2].
Patients divided into 2 groups, group I without AKI (544 patients)
and group II with AKI (181 patients). The patients admission database
were recorded as well as the secondary outcome measures.
Results: The mean age was 52.7 ± 11.6 years. We reported high AKI
association in our settings (25 %). The AKI group match the other
group with respect to age, gender, body mass index, the association
of diabetes or hypertension. AKI group had significantly higher addi-
tive Euro Score 6 ± 4 vs 4 ± 2, lower ejection fraction 47 ± 11 vs 50 ±
9 ( P = 0.00 and 0.00 respectively. Lengths of ventilation, stays in ICU
and in hospital were significantly higher in the AKI group. The AKI
group with post-operative atrial fibrillation 29.8 % vs 10.5 % (p =
0.001). AKI group had significantly higher mortality 6 % vs group I
1.7 % (p = 0.026). Interestingly, AKI was more prominent in Asian
group than Arab 92(50.8 %) vs 77(42.5 %) P = 0.04 The independent
risk factors for AKI in our population were additive Euro Score, car-
diopulmonary bypass time, post-operative low hemoglobin, post-
operative white cell count and total blood loss.
Conclusions: Cardiac surgery induced AKI is highly predominant and
prognostically substantial. Therapies targeting preoperative anemia,
cardiopulmonary bypass time, and perioperative red blood cell trans-
fusions, may display guard against this complication.
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Post-operative acute kidney injury after major non-cardiac surgery
and its association with death in the following year
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Introduction: Acute kidney injury is a common complication after
major surgery that has been associated with adverse outcomes.
Methods: A retrospective study of major non-cardiac surgery in a
teaching hospital over an 18 month examining the incidence of AKI
with one-year follow-up. AKI was defined by KDIGO creatinine cri-
teria. Major surgery was defined as inpatient procedures of >1 h dur-
ation. To assess the independent effect of AKI on survival, a multi-
variable Cox proportional-hazard survival model was developed.
Results: 1897 patients were included, post-operative AKI occurred
in 128 (6.8 %), of these 101 had KDIGO stage 1 (5.4 %), 19 stage 2
(1 %) and 8 stage 3 (0.4 %). Patients who developed AKI were sig-
nificantly older, had a lower baseline eGFR, were in a higher ASA
class and spent longer in hospital post-operatively compared to
those without AKI. Hospital Mortality occurred in 17/128 (13.3 %) of
patients that developed AKI post-operatively compared to only 16/
1741 (0.9 %) of those that did not (p < 0.001). However by a year of
surgery 34/94 (27 %) of patients who developed post-operative AKI
had died compared to only 106/1741 (6 %) who had not had AKI
(Fig. 47), p < 0.001. In the multi-variable model accenting for mul-
tiple confounders AKI was associated with a hazard ratio for death
of 3.0 (1.91-4.72) in the year after surgery. Importantly AKI definedby only a 26 μmol/L creatinine rise and AKI with recovery remained
associated with on-going ibcreased risk of death to one year.
Conclusions: In major surgery patients we have demonstrated an as-
sociation between even mild acute kidney injury and increased risk
of death in the next year.P217
Factors affecting acute renal failure in intensive care unit and
effect of these factors on mortality
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Introduction: Early detecting acute renal failure in intensive care
units is important by the aspect of determination of the disease’s se-
verity and grade of the organ dysfuncion, discharging the patient
from the intensive care units and decreasing mortality rate. The
Acute Dialysis Quality Initiative workgroup proposed a classification
system for acute kidney injury (AKI) identified by the RIFLE (Risk, In-
jury, Failure, Loss of kidney function, and End-stage kidney disease).
The purpose of our study is to assess acute renal failure development
in intensive care units patients, factors affecting it and the effect of
the factors over mortality via using RIFLE score.
Methods: The age, height, weight, gender, diagnosis, comorbid dis-
eases, admission reason to the intensive care and intensive care stay
were recorded. Also in the first day, in the seventh day and in the
14.day after admission to the intensive care, the APACHE II score,
SOFA score, RIFLE score, biochemical parameters (albumin, preal-
bumin, urea, creatinin, cholesterol, HCO3- level), triceps thickness
and waist circumference measurement were all recorded. Patients
was grouped into AKI and non-AKI. Patients in non-AKI group had no
oliguria and obvious creatinine rise, while patients in AKI group had
oliguria and obvious creatinine rise. The AKI group was assessed by
RIFLE score due to hourly urine output, creatinin rise and seperated
into three groups as R = Risk, I = Injury, F = Failure.
Results: Our study was carried out with 502 patients. 39,2 % of the
patients was in the acute kidney ýnjury group while %60.8 was in
non- acute kidney ýnjury group. acute kidney ýnjury group was con-
sisting of % 21,3 (n = 107) R group, % 12,4 (n = 62) I group and % 5,6
(n = 28) F group. The renal failure development is related with high
age, short body height, excessive weight, existence of chronic dis-
ease and long intensive care units hospitalization period. As a result
of our study renal failure was also related with high urea, creatinine,
HCO3- levels, low cholesterol, albumine and prealbumine levels.
Renal failure was not related with triceps thickness mea-
surement. Intensive care units hospitalization stay and mortality were
higher in patients who develop renal failure.
Critical Care 2016, Volume 20 Suppl 2 Page 90 of 182Conclusions: we think that patients especially in intensive care units
with high age, excessive weight, chronic diseases, high urea, creatin-
ine, HCO3- levels, low cholesterol, albumine and prealbumine levels
are prone to renal failure. Those patients should be carefully followed
for renal failure.
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Introduction: Although there are differences in criteria of live-kidney
transplantation in organ transplantation programmes in the World,
it is still performed widespread. Even though there are develop-
ments in tissue matching and immunesupressive protocols, graft
loss is still an important problem after live-kidney transplantations
because of acute and chronic allograft nephropathy. We aimed to
assess the survival rates of patients and grafts after live-kidney
transplantation.
Methods: The results of live-kidney transplantations between years
2011-2014 were reviewed. Patients’ age, gender and tissue antigen
integration were determined. The chronic rejection and primary graft
failure rates were recorded. Survival rates of the grafts and patients
during 3,6,9,12,24,36 and 48 months were determined.
Results: The number of kidney transplantations was 11755 between
2011-2014. The source of organ in 80.8 % of the transplantations was
live-donors. The mean age of the patients who had live-kidney trans-
plantation was 40.8 ± 11.6(mean ± SD), and 65.1 %(6182) were male
and 34.9 %(3314) were female. Chronic rejection and primary graft
failure were determined in 2.4 %(224). Patient and graft follow-up
periods were 26.20 ± 14.4(mean ± SD) and 24.8 ± 14.1(mean ± SD)
months, respectively. Mean survival time of the patients was 49.42 ±
0.086 months, and survival rates for 3,6,9,12,24,36 and 48 months
were 98.5 ± 0.001 %; 97.7 ± 0.02 %; 97.3 ± 0.002 %; 97.1 ± 0.002 %;
96.9 ± 0.002 % and 96.7 ± 0.002 %, respectively. Mean survival time
of the graft was 47.87 ± 0.07 months in these patients and survival
rates of the graft for 3,6,9,12,24,36 and 48 months were 99.2 ±
0.001 %; 99 ± 0.001 %; 98.7 ± 0.001 %; 98.5 ± 0.001 %; 97.6 ± 0.002 %;
96.7 ± 0.002 % and 96.3 ± 0.003 %, respectively.
Conclusions: In recent years, there is a significant increase in live-
kidney transplantations in our country, due to inadequte obtaining
of organ from cadaver. We observed a quite high patient and graft
survival times and a low chronic rejection incidence in our live-
kidney transplantation patients. Although there is a high life quality
and better graft function in live-kidney transplantations compared
to cadaver-kidney transplantations, cadaver-kidney transplantations
should be increased.
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Introduction: Difficult intubation and extubations remains the most
important problem in anaesthesia of patients with neck phlegmon
[1,3]. Old guidelines for airway flow [2,3] does not fully satisfy the
anesthesia procedures in patients with the neck phlegmon. We
should create safe algorithm for intubation and extubation in that
patients.Methods: Uncontrolled prospective cohort clinical study was made
in 75pts. with neck phlegmon. In main group (n = 38) intubation was
performed using fibrobronhoskope or Flaplight laryngoscope with
video-adapter. Tracheostomy was not performed. Sedation was by
deksmedetomidine infusion. In control group (n = 37) intubation was
made by conventional laryngoscope and early tracheostomy followed
by surgery. Sedation by thiopental Na or propofol.
Results: The laryngoscope Flap-Flight upgraded with video-adapter
was more efficient in case of difficult intubation. Early tracheostomy
was associated with absolutely risk of mediastenitis (28,0 %) (95%CI:
0,14-0,47) in comparison with patients without tracheostomy. Dex-
medetomidine was more effectiveness method for sedation which
reduced reaction of cardiovascular system from 86 % to 9,5 %
(χ =24,44; Ð < 0,01). In control group was 13,5 % of postextubation
ARF in comparison with 0.3 % in main group. Postponed extuba-
tion was performed from 10 to 72 hours after decreasing inflam-
matory, larynges edema, and trizm.
Intubation algorithm: 1. Evaluate risk difficult intubation, trizm and
stridor; 2. Perform laryngoscopy and classify by Kormack-Lehane: III-
IV grade - use fibrobronchoscope; 3. In case of opening mouse to
1,5 cm, unable to use fibrobronchoscope - perform tracheostomy
under LA. 4. In case cannot ventilate-cannot intubate surgery airway.
Exctubation algorithm:1. Postponed extubation (10-72 hrs) is recom-
mended; 2. For sedation use dexmedetomidin infusion rate 1,5-3
mqg/kg/hrs.
Conclusions: The algorithm of anesthesiologist’s actions was created
to provide the safe airway flow in intra- and postoperative period
of patients with neck phlegmon, which reduced the incidence of
serious intubations from 51,4 % to 7,9 %, failed intubations from
19 % to 0,3 %, mediastinitis from 27 % to 2,6 %, deaths from
32,4 % to 2,6 % and mortality due to traheostomy from 32 % to
6,3 %.
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Introduction: Nasal high flow oxygen (NHFO) is an attractive therapy
for acute hypoxemic respiratory failure (AHRF), with reported comfort,
and theoretical wash-out of CO2 and generation of PEEP. However, its
clinical efficacy is uncertain. We undertook a systematic review of
current evidence to support its use in adults.
Methods: Medline and EMBASE were searched using the terms: nasal
AND (high-flow OR high flow) AND (oxygen OR oxygen therapy. RCTs
were included if comparison was made between NHFO and standard
O2 therapy, or NHFO and CPAP or NIV, for AHRF in adults, and pri-
mary outcomes (intubation and mortality) reported on.
Results: We identified 468 potentially relevant studies. 4 RCTs met in-
clusion criteria. There were important differences in patient groups,
interventions and outcome measurements, precluding meta-analysis.
There were no significant differences in intubation rate or mortality
between intervention groups, with the exception of Frat (2015), who
demonstrated significantly reduced 90d mortality in NHFO compared
with standard O2 and NIV groups, and lower intubation rate on post
hoc analysis of patients with lowest PF ratio.
Conclusions: There is only limited evidence from RCTs at present to
support use of NHFO rather than conventional therapy for acute
Critical Care 2016, Volume 20 Suppl 2 Page 91 of 182hypoxemic respiratory failure in adults, and further study of patients
at risk of requiring invasive ventilation is needed.
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Study Setting Participants NHFO Standard O2
Jones 2015 ED Tachypnoea, hypoxia 1/165 3/138 p = 0.23
Bell 2015 ED Tachypnoea, hypoxia 0/48 1/52 p = 0.33
Frat 2015 ICU Respiratory failure 40/106 44/94 p = 0.19
Lemiale 2015 ICU Immunocompromise/
respiratory failure
5/52 4/48 p = 0.82
Fig. 48 (Abstract P221).P221
Setting optimal flow rate during high flow nasal cannula support:
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Introduction: High Flow Nasal Cannula (HFNC) is a non-invasive re-
spiratory support that might impact major clinical outcomes of acute
respiratory failure patients [1]. We present preliminary data from a
clinical study that aims to describe physiological effects of HFNC at
different flow rates.
Methods: We performed a prospective randomized cross-over
study on 4 acute respiratory failure patients admitted to the ICU
with PaO[sub]2[/sub]/FiO[sub]2[/sub] < =300 mmHg. FiO[sub]2[/
sub] was set to obtain SpO[sub]2[/sub] of 90-95 % by facial mask
and left unchanged during the study. All patients underwent 4
randomized steps (20 min): 1. Facial mask at 12 L/min; 2. HFNC
at 30 L/min; 3. HFNC at 45 L/min; 4. HFNC at 60 L/min. During
all phases, continuous recordings of Electrical Impedance Tomog-
raphy (EIT) data calibrated by spirometry and esophageal pres-
sure (Pes) tracings were obtained.
Results: At higher flow rates, PaO[sub]2[/sub]/FiO[sub]2[/sub] im-
proved (mask: 162 ± 78 vs. HFNC 30: 187 ± 82 vs. HFNC 45: 199 ± 79
vs. HFNC 60: 198 ± 68 mmHg; p < 0.005) and Borg dyspnea score de-
creased (6.2 ± 3.0 vs. 5.0 ± 2.4 vs. 5.0 ± 2.4 vs. 4.2 ± 1.7; p < 0.05). Pes
swings, a measure of patients’ inspiratory effort, decreased with
HFNC (10.9 ± 5.5 vs. 7.9 ± 2.9 vs. 8.1 ± 4.1 vs. 7.4 ± 2.8 cmH[sub]2[/
sub]O; p < 0.05). Peak inspiratory flow (PIF), as assessed by EIT [2], de-
creased at higher flow rates (60.6 ± 27.5 vs. 53.2 ± 22.5 vs. 53.9 ± 24.1
vs. 50.0 ± 21.4 L/min; p < 0.05), suggesting decreased respiratory
drive. Interestingly, when patient’s PIF exceeded the flow delivered
by each external source, oxygenation was lower, likely indicating
higher discrepancy between externally set and alveolar FiO[sub]2[/
sub]’s (Fig. 48).
Conclusions: HFNC improves oxygenation and reduces inspiratory
drive and effort, thus decreasing the risk of respiratory decompen-
sation. Optimal flow rate during HFNC might be titrated based on pa-
tient’s inspiratory flow.
Reference
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Dose to dose consistency across two different gas flow rates using
cystic fibrosis and normal adult breathing profiles during nasal
high flow oxygen therapy
L. Sweeney, A. O’ Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin
Aerogen, Galway, Ireland
Critical Care 2016, 20(Suppl 2):P222
Introduction: This study investigated the dose to dose consistency
by aerosol delivery during nasal high flow therapy (NHF). We sought
to investigate the efficiency of dosing across two different gas flow
rates during simulated normal and cystic fibrosis (CF) breathing. Sal-
butamol was used as a tracer aerosol. The efficient and reliable deliv-
ery of aerosol to CF sufferers by a non-invasive, comfortable means
of delivery could have considerable effects on patient care.
Methods: Two adult breathing patterns were evaluated using a
breathing apparatus to simulate both a normal adult (15 BPM, Vt
500ML, I/E 1:1) [1] and a Cystic Fibrosis adult (22 BPM, Vt 525ML, I/E
1:4) [2] Adult high flow nasal cannula (OptiflowTM Fisher and Paykel)
were attached to a humidifier (MR850TM, Fisher and Paykel) set at
37 °C. 2.0 ml of Salbutamol (2 mg/ml) was nebulized using a vibrat-
ing mesh nebuliser (VMN) (Aerogen Solo, Aerogen, Ireland) with an
average mass median aerodynamic diameter (MMAD) of 4.8 μm
(measured using the Apparatus E/5 impactor). Tracheal Dose (dose
delivered beyond the trachea) at each gas flow rate under test (10
and 30 LPM) was captured using an absolute filter (Respirgard 303,
Baxter) distal to the airway model (n = 10), see Fig. 49. The mass of
drug eluted from the filters was determined using UV spectroscopy
(at 276 nm) and interpolation on a standard curve of Salbutamol
concentrations (200 μg/mL to 3.125 μg/mL).
Results: The results of testing are presented in Table 30. Time to deliv-
ery of the 2.0 ml dose of Salbutamol was recorded at approximately
4.25 minutes for each run. Results are expressed as a percentage of the
nominal dose placed in the nebuliser medication cup.
Conclusions: From the results of testing performed for both normal
and CF simulated adults at gas flow rates of 10 and 30 LPM, the p-
values for each respectively are >0.05 (0.891, 0.744, 0.188 and 0.589).
This indicates that each set of data (n = 10) are normally distributed
and therefore dosing is consistent. It may be concluded from this
study that delivery of aerosol to adults at both high and low gas flow
rates via NHF therapy is an efficient and highly reproducible means
of administration.
References
1 Hart N et al. Am J Respir Crit Care Med 2002; 166:61-66.
2 Tiddens et al. Eur Respir J 2000; 15:735-742.
Fig. 49 (Abstract P222). Tracheal Dose Test Setup.




Normal Normal Normal CF CF CF
Mean Tracheal
Dose (%)
SD P-value Mean Tracheal
Dose (%)
SD P-value
10 20.46 1.6940 0.891 13.84 0.3471 0.188
30 13.85 0.4200 0.744 9.38 0.2563 0.589
Fig. 50 (Abstract P222). Illustration of CF and Normal adult data
distributions (n = 10).
Table 31 (Abstract P223). CPIS Results.
Device Mean CPIS Number of patients with CPIS > 7
Control (KimVent) 5.9 9/36 (25%)
Study (AMCSS) 4.9 1/29 (3.5)
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Final results of an evaluation of airway medix closed suction
system compared to a standard closed suction system
M. Pfeffer1, J. T. Thomas2, G. B. Bregman1, G. K. Karp1, E. K. Kishinevsky1,
D. S. Stavi1, N. A. Adi1
1Kaplan Medical Centre, Rehovot, Israel; 2West Virginia University,
Morgantown, West Virginia, USA
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Introduction: Endotracheal Tube (ETT) begins to be colonized with
oral bacteria and respiratory pathogens that adhere to its inner sur-
face. The use of Airway Medix Closed Suction System (AMCSS) could
effectively reduce ETT resistance, bacterial burden, biofilm develop-
ment and the Clinical Pulmonary Infection Score (CPIS). The goal of
this study was to evaluate the efficiency of the AMCSS com-
pared to a standard closed suction system.Methods: 80 critically ill patients were randomized into two groups.
40 patients (Control) were suctioned using KIMVENT* Closed Suction
System (Kimberly Clark, USA) and 40 patients (Study) were suctioned
using AMCSS (AMCSS, Biovo Technologies, Israel). 15 patients were
withdrawn from the trial. CPIS calculations were performed daily.
Post extubation, resistance through the ETT was measured using a
Mass flow meter and pressure transducer. The ETTs were then cut
open longitudinally. Two 1 cm-long hemi-sections of the distal part
of the ETT were dissected for qualitative and quantitative analysis of
representative biofilm accumulations using Scanning Electron Micros-
copy (SEM). During the analysis, investigators were blind to treat-
ment allocation.
Results: Mean resistance at flow rate of 60[l/min] was lower in
the Study group compared to the Control group – 11.85 vs.
14.33 [cmH2O/l/s]. This difference was significant according to
Mann-Whitney test. CPIS was found to be lower in the Study
group compared to the Control group (4.9 vs. 5.9). The propor-
tion of subjects with CPIS above 7 was lower in the Study arm
(3.5 %) compared to the Control (25 %). This difference was sig-
nificant according to Mann-Whitney test [Table 31]. Biofilm stage
was lower in the Study group compared to the Control—2.26 vs.
2.72. In addition, patients that were treated with AMCSS had
2.933 times higher probability for a lower biofilm stage in com-
parison to Control group.
Conclusions: The results conclude that the use of AMCSS reduces
the resistance, CPIS and biofilm formation and can be effective in
limiting the biofilm development to the early stages.P224
Different cuff materials and different leak tests - one size does not
fit all
T. Poropat, R. Knafelj
Rihard Knafelj, Ljubljana, Slovenia
Critical Care 2016, 20(Suppl 2):P224
Introduction: Once inflated endotracheal tube cuffs can form micro-
folds enabling microaspiratoins. We tested adequacy of methylen
blue visual test.
Methods: 10 porcine tracheas were intubated with different cuff
shape/materials. Barrel and tappered shaped cuffs made of polyvinyl
chloride (PVC) and polyurethane (POLY) were tested. Following intub-
ation cuffs were filled with air (25 cmH2O cuff pressure). 3 mL of
methylene blue (1%water solution) with iodine contrast (Iomeron
300) was instiled in trachea. Same protocol was applied using 20 mL
syringes instead of tracheas. After 1 and 24 h visual confirmation
and CT 3D reconstruction was performed to evaluate distal tracheal
leakage.
Results: No CT or visual leakage was detected in POLY. No visual
leakage was confirmed in tubes with supraglotic suctioning, while
some leakage was visible on CT, POLY performed better. PVC leaked
visually and on CT within the first hour. All cuffs had superior seal in
cylindrical model of trachea, POLY performing better.
Conclusions: POLY cuffs offered superior seal to PVC cuffs regardless
of shape, adequate seal was maintained through 24 h. Methylene
blue compared can not confirm micro leakage. Syringe is not satis-
factory surrogate to actual trachea.
Reference
Optimal care and design of the tracheal cuff in the critically ill patient.
Jailette et all Ann Int Care 2014;4:7
Fig. 51 (Abstract P224).
Fig. 52 (Abstract P226). A device for Emergency Transtracheal
Lung Ventilation.
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Observational study on the value of the cuff-leak test and the
onset of upper airway obstruction after extubation
E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas
Corporació Sanitària i Universitària Parc Taulí, Universitat Autònoma de
Barcelona, CIBER Enfermedades Respiratorias, Sabadell (Barcelona), Spain
Critical Care 2016, 20(Suppl 2):P225
Introduction: The cuff-leak (CL) test has been postulated as a useful tool
in order to assess the risk of upper airway obstruction (UAO) after extu-
bation. However, current evidence is still limited, and systematic exclu-
sion of patients receiving corticosteroids in prospective trials further
limits our knowledge. Our objective was to evaluate the association of
the value of the CL test and the appearance of UAO, including patients
receiving corticosteroids, and to detect other associated risk factors.
Methods: Prospective observational study in a general mixed ICU
(May-December 2014). Daily screening of patients considered ready
to wean by their medical team was performed. Only those patients
who succeeded a spontaneous breathing trial and were eligible for
extubation, according to the local protocol, were included.Demographic and clinical data were collected. We recorded the CL
value (%) at the end of the successful spontaneous breathing trial,
prior to extubation. The appearance of UAO, the need for reintuba-
tion, and reinstitution of MV were recorded.
Results: Thirty-three patients were studied. The mean age was
65 ± 12 years old, 64 % were males, 10 patients (30 %) were re-
ceiving corticosteroids, and the total duration of MV at inclusion
was 13 ± 7 days. After extubation, four patients (12 %) developed
UAO, requiring reintubation in two cases. The CL test values were
significantly lower in those patients who developed UAO (35 ±
22 % vs 61 ± 25 %; p = 0.05). The ROC curve analysis of the value
of CL test in predicting UAO showed an AUC of 0.8 (95 % CI 0.61
to 0.98; p = 0.06). Other factors associated with the appearance of
UAO were a difficult intubation (75 % vs 8 %, p = 0.001.), number
of attempts in the initial intubation (2 vs 1, p = 0.001), and prehos-
pital intubation (50 % vs 3 %, p <0.01). No differences in Cormack,
MV days or diameter of the endotracheal tube were found. None
of the patients receiving corticosteroids prior to extubation devel-
oped UAO, whereas among the remaining 23 patients, 4 (17 %)
developed UAO (p =0.1).
Conclusions: In our sample, the appearance of UAO after extubation
was associated with significantly lower CL test values. Further studies
are required in order to evaluate the usefulness of the CL test and
corticosteroid therapy in the prevention of UAO.
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A device for emergency transtracheal lung ventilation
D. Pavlovic1, L. Lewerentz2, A. Spassov2, R. Schneider2
1Dalhousie University, Halifax, Canada; 2Ernst-Moritz-Arndt-Universität,
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Introduction: Here we present an improved theoretical version of a
valve for transtracheal ventilation as a bi-directional manual respiratory
pump where a combination of low flow during inspiration, by reducing
gas supply to the valve, and increased flow during expiration, by in-
creasing gas supply to the valve, permits more effective venturi effect
and efficient expiration, with low total gas consumption.
Methods: The theoretical performance of the valve was modeled
mathematically and the model was tested in vitro with a standard
valve but by variable flow rates (Fig. 52).
Results: It was shown that, by increasing flow during expiration, the
valve would permit to shorten the expiratory time and achieve
higher minute volumes (i.e. volumes of 7 L/min of gas or higher), as
compared with the ventilation with the similar transtracheal cannula
without variable flows (volumes achieved were about 4 L/min). Vari-
able flow would provide shortening of the inspiratory time and effi-
cient expiratory aid, and permit I:E ratios of 1:1, or even the inverse
ratio ventilation.
Conclusions: Satisfactory lung ventilation can be assured with trans-
tracheal ventilation with a bidirectional manual respiration valve with
variable gas flow.
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Long-term outcome and health-related quality of life in patients
discharged from the intensive care unit with a tracheostomy and
with or without prolonged mechanical ventilation
S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit,
J. Decruyenaere
Ghent University Hospital, Gent, Belgium
Critical Care 2016, 20(Suppl 2):P227
Introduction: Long-term outcome and quality-of-life (QoL) in patients
requiring prolonged mechanical ventilation (PMV) after failure to
wean is scarcely documented. However, due to improvements of re-
spiratory care in the ICU, an increasing amount of patients requires
PMV. This study evaluates long-term survival and QoL in patients
treated by tracheostomy for difficult weaning, with or without need
for PMV at ICU discharge.
Methods: We retrospectively investigated post-ICU trajectories and
survival in patients admitted at the medical ICU of a tertiary center
between 1999 and 2013. Only patients requiring tracheostomy for re-
spiratory failure of varying etiology and difficult weaning were in-
cluded. Patients were discriminated between those who did or did
not require ventilation at ICU discharge. Patient characteristics affect-
ing survival rates were examined. QoL assessment was done in survi-
vors using the Short Form Health Survey (SF-36) and the Severe
Respiratory Insufficiency (SRI) questionnaire in 2014.
Results: A total of 114 patients was included, of whom 59 required
mechanical ventilation at ICU discharge and 55 were weaned from
ventilation at that point. One-year survival rates were 73 % and
69 %, respectively. In patients with a follow-up of at least five years,
5-years survival rates were 40 % (16/40) for ventilated and 42 %
(14/33) for weaned patients. In the ventilated group, survival rates
were significantly lower in the elderly (p = 0.001) and in patients with
a high Charlson Comorbidity Index (p = 0.02) or chronic kidney dis-
ease (p < 0.001). QoL was assessed in 21 ventilated and 22 weaned
patients after a median of 58 and 52 months. Response rates were
84 % and 81 %, respectively. Overall, QoL scores for physical func-
tioning were low in both groups. QoL for physical functioning,
assessed with SF-36, was lower in the ventilated (8/100) than in the
weaned group (20/100). Scores for social functioning and mental
health were less below norm and similar between both groups (62
and 52/100 vs. 62 and 48/100, respectively). A similar trend was ob-
served with the SRI questionnaire.
Conclusions: Long-term survival in patients selected for PMV with
tracheostomy after failure to wean was not significantly different
from that of weaned patients with tracheostomy. This suggests that
survival of these patients depends more on the underlying disease(s)
than on the ventilation itself. Despite the physical QoL scores being
low in both groups, mental QoL was still acceptable.
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Ultrasound-guided percutaneous dilational tracheostomy versus
bronchoscopy-guided percutaneous dilational tracheostomy in
critically ill patients (trachus): a randomized clinical trial
A. Gobatto, B. Besen, P. Tierno, L. Melro, P. Mendes, F. Cadamuro,
M. Park, L. M. Malbouisson
Universidade de São Paulo, São Paulo, Brazil
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Introduction: Percutaneous dilational tracheostomy (PDT) is routinely
performed in the intensive care unit (ICU) with bronchoscopy guid-
ance. Recently, ultrasound has emerged as a potentially useful tool
to assist PDT as it helps to identify the most appropriate location for
the tracheal puncture site, guide needle insertion into the trachea,
and may significantly reduce procedure-related complications.
Methods: An open-label, parallel, noninferiority, randomized con-
trolled trial was conducted comparing ultrasound-guided PDT with
bronchoscopy-guided PDT in mechanically ventilated critically ill pa-
tients indicated for a tracheostomy. The primary outcome was pro-
cedure failure defined as a composite end-point of conversion tosurgical tracheostomy; associated use of bronchoscopy in the case
of ultrasound-guided PDT; associated use of ultrasound in case of
bronchoscopy-guided PDT; or occurrence of a major complication.
Results: A total of 4965 patients were screened, of whom 118 under-
went the procedure, 60 patients in the ultrasound group and 58 pa-
tients in the bronchoscopy group. Procedure failure occurred in one
(1.67 %) patient in the ultrasound group and one (1.72 %) patient in
the bronchoscopy group, with an absolute risk difference of 0.06 %
between groups (90 % confidence interval, -5.57 to 5.85) in favor of
the ultrasound group in the as treated analysis, not including the
prespecified margin of 6 % for noninferiority. No other patient had
any major complication in both groups. Procedure-related minor
complications occurred in 20 (33.3 %) patients in the ultrasound
group and 12 (20.7 %) patients in the bronchoscopy group, (P =
0.122). The median procedure length was 11 [7-19] vs. 13 [8-20] mi-
nutes (P = 0.468), respectively and clinical outcomes were also not
different between groups.
Conclusions: Ultrasound-guided PDT is noninferior to bronchoscopy-
guided PDT in mechanically ventilated critically ill patients.P229
Is it safe to discharge patients with tracheostomy from the ICU to
the ward?
B. C. Civantos, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia
Hospital La Paz, Madrid, Spain
Critical Care 2016, 20(Suppl 2):P229
Introduction: Many of the patients admitted to the ICU receive a
tracheostomy and are discharged whit it to the general ward. Insuffi-
cient skills and experience of staff caring for tracheostomy patients
may lead to suboptimal care and increased morbidity and mortality.
Tracheostomy outreach teams and an appropriate training to the
staff are the key to improve quality of care, decrease adverse events
and make decannulation with safety in these patients.
Methods: We conducted a retrospective study in a medical ICU in a
tertiary care hospital that doesn’t have a step-down unit. A two
intensivists team followed up daily the patients discharged with
tracheostomy from the ICU to the general ward until they were dis-
charged from the hospital. Training sessions to the ward,s staff (doc-
tors, nurses and nursing assistants) were made about tracheostomy
cares every week. We analized clinical and epidemiologic variables,
time to decannulation, complications related to the tracheostomy,
decannulation failures, readmissions and mortality.
Results: From February 2012 to October 2015, a total of 2568 pa-
tients were admitted to our ICU; during this period, 100 patients
were discharged to the regular ward with tracheostomy tube in
place. Of these, 68 % had neurological damages (due to head in-
jury, ischemic and hemorrhagic events), 14 % chronic obstructive
pulmonary disease, 8 % severe miopathy, 6 % postanoxic en-
cephalopathy, 2 % Guillain Barre and 2 % amyotrophic lateral
sclerosis. 10 % of the patients with a high length of stay had
complications because of the tracheostomy (tracheal stenosis,
granuloma and malacia), and all of them were solved. There were
2 readmissions to the ICU due to cannula obstruction. Decannula-
tion at the ward was possible in 36 % of the patients, none of
them had to be recannulated and all survived. Global mortality
was 23 %, but excluding the patients under palliative cares, the
mortality decreased to 5 % and the causes of death were not dir-
ectly related to the tracheostomy.
Conclusions: In hospitals without a step-down unit and a high
healthcare demand the monitoring of the tracheostomized patients
by a skilled team let to decannulate the patients at the ward with
safety. It would allow discharge sooner this kind of patients from the
ICU and therefore decrease the length of stay, the complications as-
sociated to the ICU admission and accordingly the costs. On the
other hand, once at the ward, the team can detect early the compli-
cations, solve them and create a safety atmosphere for the patient,
the family and the staff in charge.
Fig. 54 (Abstract P231). Comparison of the Aerosol delivery to
lung filter (n = 3).
Fig. 53 (Abstract P231). A)dry side of HH B)inspiratory limb
C)between Wye & ETT D)between HMEF and ETT.
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The application of tracheostomy in children in ICU
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1Institute of Mother and Child, Chisinau mun., Moldova; 2Institute of
Emergency Medicine, Chisinau mun., Moldova,3State University of
Medicine and Pharmacy, Chisinau mun., Moldova
Critical Care 2016, 20(Suppl 2):P230
Introduction: The study arises from the need to implement some
therapeutic conducts by applying tracheostomy in children who have
been in prolonged artificial pulmonary ventilation over the last 8 years.
Methods: The patients included the study groups are 96 children from
the pediatric ICU of the Institute of Mother and Child. Children submit-
ted to study were divided into 2 groups. 1st group - 61 children (63.5 %)
on prolonged artificial pulmonary ventilation without tracheotomy ap-
plication and 2nd group - 35 children (36.4 %) to whom during pro-
longed artificial ventilation management the tracheotomy was applied.
Results: After a retrospective study, we have noted the following:
children on prolonged artificial ventilation spent on avg. 24.7 ± 3.3
bed/days. The classification by disease of children requiring intub-
ation with prolonged ventilation was the following: Multiple develop-
ment abnormalities - 31 cs (32.2 %); Brain and neuromuscular
disorders - 25 cs (26.0 %); Bronchopulmonary Chronic diseases - 16
cs (16.6 %); Genetic diseases - 12 cs (12.5 %); septic conditions - 10
cs (10.4 %); Development abnormalities of diaphragm - 2 (2.0 %). In
the 2nd group, our study revealed the following complications: com-
plication of subcutaneous emphysema - 6 cs (17.1 %), but pneumo-
mediastinum - 2 cs (5.7 %), lobar emphysema - 1 cs (2.8 %),
suppurations - 2 cs (5.7 %), situations that were resolved. All children
received a special critical care under the Protocol of pneumonia
prophylaxis associated with artificial ventilation: gentle suctioning of
secretions with closed suction systems after cuffinflation. Placing on
30° and oral hygiene for 2-3 times/day being mandatory for each
one. Also, a daily hydroelectrolitic rebalancing, calculation of individ-
ual energy need and symptomatic therapy was performed. Along
with the improvement of general condition, appearance or improve-
ment of the deglutition reflex, the oral nutrition with semi-solid
preparations recommenced in 5 children (22.5 %) from the first day
of tracheostomy application, in 7 cs the nutrition recommenced on
3-5 day together with partial parenteral nutrition until the full re-
sumption of oral nutrition. It is worth noticing also the significant
decrease in length of stay on artificial respiration in the 2ndgroup
of children (22 ± 0.9 days) compared to the 1stgroup (37 ± 1.7 days).
Despite the complex therapeutic effort, due to severity of basic dis-
ease in the 1 group 15 (24.5 %) children died and in the 2nd group
3 children (8.5 %) died.
Conclusions: 1.The application of tracheotomy in patients with endo-
tracheal intubation and prolonged artificial ventilation reduces the
infant mortality rate.
2. In the 2 group we have noticed the decrease of the duration of
treatment, which leads to a reduction in the prime cost of the child
treated in the intensive care unit.
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The impact of passive humidifiers on aerosol drug delivery during
mechanical ventilation
P. Kelly, A. O’Sullivan, L. Sweeney, R. MacLoughlin
Aerogen, Galway, Ireland
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Introduction: The purpose of this study was to determine the impact
passive humidifiers (PH) on delivered aerosol dose.
The prevalence of PH usage during invasive mechanical ventilation
where the upper airway is bypassed is on the increase due to their
low cost and ease of use [1-2]. However PH are not without their lim-
itations. These include blockages and aerosol therapy (AT) associated
issues [3-4]. PH manufacturers have identified the restraint of use
with AT as a major area for development. Bypass PH for use with AT
have been developed by Smiths-Medical, Hudson RCI and Carefusion.
Other companies have developed non-bypass PH that are compat-
ible with AT, such as Pall and Intersurgical.Methods: The nebulizer positions are shown Fig. 53. A ventilator
(SERVO-i®, Maquet) was operated with the conditions- Vt 500 mL,
15BPM, I:E 1:2 and PEEP 5 cm.H2O, with a heated pass-over humidi-
fier (Fisher & Paykel) with heated-wire circuit attached to an 6.5-mm
inner-diameter endotracheal tube (ETT)(Flexicare). The absolute filter
(Respirgard 303, Baxter) was positioned elevated to the distal tip of
the ETT. The HH conditions were 38 ± 1 °C. For Passive humidification
conditions, the PH were pre-conditioned for 4 hours under heated
and humidified conditions. A vibrating-mesh nebulizer (Aerogen
Solo, Aerogen) was used. A nominal dose of 2.5 mL of Salbutamol
(2 mg/mL) was used. The mass of drug eluted from the filters was
determined using UV spectroscopy. 3 commercially available PH
were used, Ultipor100 (Pall) and Filta-Therm (Intersurgical) compat-
ible with AT, while the Airlife (Carefusion) was not approved for use
with AT.
Results: The results of testing are presented in Fig. 54. Results are
expressed as a percentage of the nominal dose recovered from the
filter. The values used for Circuit A and B were reported in [5].
Conclusions: The largest aerosol dose delivered was at position B.
Position A, C and D aerosol dose delivered were comparable. When
the PH was placed between the Wye and the Nebulizer (position D),
the delivered dose was unchanged when compared to position C
(p-value between 0.298 - 0.488), suggesting that the inclusion of
a PH has minimal effect on aerosol delivery.
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Fig. 56 (Abstract P232) Tracheal dose (%). (P-values included from
paired t-test analysis).
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Evaluation of vibrating mesh and jet nebuliser performance at two
different attachment setups in line with a humidifier nebuliser
system
A. O’Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin
Aerogen, Galway, Ireland
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Introduction: This study investigated emitted and tracheal dose de-
livery for a vibrating mesh nebuliser (VMN) and jet nebuliser (JN) in
line with a humidifier nebuliser system with two different nebuliser
positions relative to the patient. Selection of nebuliser type can
have a significant impact when treating a patient, previous studies
have shown that the VMN delivers more aerosol than the conven-
tional JN [1].
Methods: Aerosol delivery performance was evaluated by character-
ising the Emitted dose [drug that exits the mouthpiece or T-piece of
a nebuliser] and Tracheal dose [drug delivered beyond the trachea].
A 2.0 mL dose of Salbutamol (1 mg/mL) was nebulised as a tracer
aerosol using both a VMN (Aerogen Solo, Aerogen, Ireland), and a JN
(Cirrus 2, Intersurgical). Both nebulisers were put in-line with the hu-
midifier nebuliser (Aquamist, Intersurgical) system. Two nebuliser po-
sitions (distal and proximal to the patient) were assessed for their
effect on both emitted and tracheal dose delivery at supplemental
gas flow rates of 5 and 11 LPM (n = 3). For tracheal dose the ne-
buliser was connected to the head model via facemask. The head
model was connected to a breathing simulator (BPM 15, Vt 500 mL,
I:E 1:1,) and drug collected on an absolute filter (RespirGard II 303,
Baxter). The drug was extracted and quantified using UV spectropho-
tometry. Finally, a paired t-test analysis was carried out to evaluate
the different test setups.
Results: Based on the results presented, the VMN delivered the high-
est emitted dose (70.49 ± 1.86 %, distal at 5 LPM), (67.84 ± 0.98 %,
distal at 11 LPM) and (101.03 ± 5.45 %, proximal at 5 LPM), (107.40 ±
5.51 %, proximal at 11 LPM) at both attachment setups and supple-
mental gas flow rates compared with the JN (48.43 ± 6.92 %, distal at
5 LPM) & (47.94 ± 3.48 %, distal at 11 LPM) and (56.86 ± 1.12 %, prox-
imal at 5 LPM), (53.48 ± 5.22 %, proximal at 11 LPM).
The VMN also delivered the highest tracheal dose (10.00 ± 0.67 %, distal
at 5 LPM), (9.66 ± 1.51 %, distal at 11 LPM) and (12.06 ± 0.39 %, prox-
imal at 5 LPM), (14.36 ± 1.25 %, proximal at 11 LPM) at both attachment
setups and supplemental gas flow rates compared with the JN (3.73 ±
0.22 %, distal at 5 LPM) & (3.19 ± 0.69 %, distal at 11 LPM) and (7.79 ±
1.03 %, proximal at 5 LPM), (8.68 ± 0.39 %, proximal at 11 LPM).
Conclusions: Results demonstrate that the VMN delivered signifi-
cantly larger fractions of aerosol (P-values <0.05) for both emitted
and tracheal dose at both positions in the humidifier nebuliser pa-
tient circuit.
Reference
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Psv-niv versus cpap in the treatment of acute cardiogenic
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Introductions: Acute cardiogenic pulmonary edema (ACPE) is a com-
mon cause of acute respiratory failure. Non invasive continuous airway
positive pressure (CPAP) has been validated as effective treatment in
addition to pharmacological therapy. The aim of study is to compare
non invasive pressure support ventilation (PSV-NIV) and CPAP in this
setting of patients.
Methods: From 1 september 2015 to 15 november 2015, 24 patients
were admitted to emergency department (ED) for ACPE. All patients
were treated with standard medical therapy. In addition, 12 patients
were treated with CPAP (group A) and 12 were treated with NIV-PSV
(group B). Arterial hemogasanalysis was performed at admission (t0)
and after 30 minutes from the beginning of ventilation treatment
(t30′) to evaluate pH, pO2/FiO2, pCO2 and lactate cleareance (lactate
t0-lactate t30′/lactate t0).
Results: We enrolled 24 patients (10 men and 14 women). The
median (o average) age was 74 years. Baseline characteristics of
patientes were: sistolic blood pressure 180 mmhg, diastolic blood
pressure 102 mmhg, pO2/FiO2 181, Ph 7,21, pCO2 53 mmhg, lactate
3,4 meq/l. After 30 minutes of CPAP, we noticed in group A patients
an improvement of 52 % in pO2/FiO2 ratio, an increase of 0,02 points
in pH value, a reduction of 10 % in pCO2, a lactate cleareance of
28 %, in group B an improvement of 120 % in pO2/FiO2 ratio, an
increase of 0,13 points in pH value, a reduction of 20%in pCO2, a lac-
tate cleareance of 35 %. No patients required endotracheal intub-
ation. Two patients in A group, after 30 minutes of CPAP, shifted in
PSV-NIV because of increase of pCO2.
Conclusions: The preliminary results of our ongoing trial have
shown a better outcome at t30′ in patients affected by ACPE
treated with PSV-NIV compared to those treated with CPAP in
lactate clearance, improvement of pO2/FiO2 ratio, pH and pCO2
value. No differences in side effects between two groups were
shown.
References
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Introduction: Non-invasive ventilation (NIV) is commonly used as a
first line therapy for immunocompromised patients with acute re-
spiratory failure, although it may not be appropriate for every pa-
tient. Failure of NIV is an independent predictor of mortality and
delayed endotracheal intubation may worsen prognosis. We report
our center’s experience and outcomes for patients with active haem-
atologic malignancy treated with NIV.
Methods: We conducted a retrospective chart review of consecutive
patients with haematologic malignancy admitted to Mount Sinai
Hospital ICU for acute respiratory failure between January 1, 2010
and May 31, 2015, and were initially treated with NIV (BiPAP or CPAP).
We compared characteristics of patients who were successfully treated
with NIV and avoided endotracheal intubation (ETI), and those who
failed NIV.
Results: 79 patients (32 females, 56 ± 14 yrs, APACHE II 27.6 ± 4.6)
with haematologic malignancy were treated with NIV for acute re-
spiratory failure. 76 % of patients had acute leukaemia, 10 % had
lymphoma, and 14 % had chronic leukaemia, multiple myeloma or
myelodysplastic syndrome. Aetiology of respiratory failure was multi-
factorial in 39 % patients, with features of pneumonia in 77 % pa-
tients, severe sepsis or septic shock in 42 %, and pulmonary oedema
in 30 %. 57 % of patients failed NIV and required ETI, 8 % had a do-
not-intubate (DNI) order and died following NIV failure, and 35 %
avoided ETI. Compared with patients who avoided ETI, those who
failed NIV were more likely to have acute leukaemia (84 % vs 61 %,
p = 0.019) and at baseline had higher PaCO2 (39 vs 30, p = 0.038),
higher FIO2 (0.6 vs 0.4, p = 0.002), and more vasopressor use (31 %
vs 11 %, p = 0.059). Only one patient had a diagnostic bronchoscopy
while treated with NIV and 25 (55 %) had bronchoscopy within 1 day
following ETI. Of the 44 patients who failed NIV and required ETI,
(68 %) died in the ICU. Overall ICU mortality of this cohort was 41 %
and 3-month mortality was 57 %.
Conclusions: Two thirds of patients with haematologic malignancy
and acute respiratory failure required ETI following NIV failure and
had a high subsequent mortality. Patients who fail NIV have higher
PaCO2, higher FiO2 and more vasopressor use. Use of NIV may be as-
sociated with delayed diagnostic bronchoscopy.P235
Use of non-invasive ventilation in infectious diseases besides
classical indications
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Introduction: Non-invasive ventilation (NIV) is used with well-defined
scientific evidence in acutely decompensated chronic pulmonary dis-
ease and acute pulmonary edema. NIV has been also successful in
immunosuppressed patients with pulmonary infiltrates, especially in
hematological and pharmacological immunosuppressed patients. The
use of NIV remains controversial in pneumonia, tuberculosis, flu,
acute respiratory distress syndrome (ARDS)… The aim of this study is
to analyse the use of NIV in an Infectious Diseases Intensive/Inter-
mediate Care Unit (ID-ICU).
Methods: We performed a cross-sectional study of adult patients
needing NIV, admitted to the ID-ICU between 2010 and 2014. We ex-
cluded patients who need NIV with chronic pulmonary disease, acute
pulmonary edema or during weaning of mechanic ventilation. The
patients were identified by our hospital database and subsequently
the clinical records were consulted. The primary outcome was the re-
sult of NIV and secondary outcomes were death and its predictors.We used the most appropriate measure of central tendency and dis-
tribution and statistical test (significance level 0.05).
Results: We included 50 patients (34 male) with a median age of 52.
The majority (27) were immunosuppressed: 21 patients had human
immunodeficiency virus (HIV) infection with CD4 count less than 350/
mm3, 3 had hematological neoplasia under chemotherapy, 2 were
under immunosuppressant drugs, and 2 had solid neoplasia under
chemotherapy. The median APACHE II score was 19 and SAPSII score
was 43. Eight patients had a “do not intubate” status due to their co-
morbidities. The most frequent reason to perform NIV was bacterial
pneumonia (44 %) followed by pneumocystosis (30 %), ARDS (16 %),
flu (6 %) and tuberculosis (2 %). Median time of NIV was 3,5 days. We
had a NIV success rate of 60 % (14 patients were intubated, 5 did not
have intubation indication and 1 patient died from another cause). The
mortality rate was 28 %. We found statistically significant association
between the severity scores SAPSII and APACHE and the NIV result and
death (higher scores were associated with failure of NIV and death). We
also found that patients with hematological neoplasia under chemo-
therapy had higher rates of failure of NIV and death. HIV infection was
associated with death but not with NIV failure.
Conclusions: The use of NIV is nowadays more frequent apart from
its classical indications. We found that higher severity scores and
hematological neoplasia under chemotherapy were associated with
unsuccessful NIV. However NIV can be used in these patients as a
comfort measure.
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Introduction: Many factors affecting noninvasive ventilation (NIV)
success had been investigated up to now but there is no any data
about the affect of fragility on NIV outcomes in critically ill patients.
In this prospective and observational study, we aimed to investigate
the effect of fragility on the application and results of NIV in the in-
tensive care unit (ICU).
Methods: We included in the patients over 50 years old who were
admitted to Medical ICUs of our hospital. For detection of patients
fragility Clinical Fragility Score (CFS) and comprehensive geriatric
assesment were used. Patients who have CFS > =5 were considered
as fragile. The successful NIV group (NSG) is defined as achieving suc-
cess in at least two of the followings: PaO2 > 60 mmHg, PaCO2 <
50 mmHg, pH = 7,35-7,45, improvement of respiratory effort, recovery
of consciousness. The relationship between entubation and fragility
was also assessed. Application problems were defined as; cooperation
problems, hearing problems, delirium/agitation (Richmond agitation
sedation scale > 1) , claustrophobia, alzheimer, problems related with
chin, mouth tooth and leak (>35 L/min).
Results: We included in 85 patients who were underwent to NIV in
two ICUs. Mean age of patients was 72,5 ± 10,6, 60 % of them were
male and mean APACHE II score was 20,6 ± 5,7 (8-34). Mean CFS of
the patients was 4,6 ± 1,6 and 42 % of them were fragile (CFS > =5).
There were 63 (75 %) patients in NSG and 22 (25 %) in NIV failure
group (NFG). APACHE II and SOFA scores of NFG were higher and
NSG had more non-fragile patients (CFS < 5) (41 vs 22, p = 0.011).
Fifty-three (62,4 %) patients had NIV application problems and mean
CFS of this group was higher (4,9 ± 1,6 vs 4,0 ± 1,7, p = 0,028).
Using NIV previously at home (p = 0,025), APACHE II (p = 0,001), SOFA
(P = 0,012) were detected as factors affecting the NIV success in uni-
variate analysis. While fragile patients(CFS > =5) had significantly
higher application problems(80 % vs 57 % p:0,038), entubation (31 %
vs 8 %, p:0,007) and mortality rates (30 % vs 4 %, p:0,001), significantly
lower NIV succes rates (61 % vs 85 %, p: 0,011). In logistic regression
Critical Care 2016, Volume 20 Suppl 2 Page 98 of 182analyses fragility was only independent risk factor for NIV failure
(OR:3.5, p:0,02).
Conclusions: These results showed that fragility is associated with
NIV application problems and failure in the ICU and increases NIV
failure risk more than 3 times.
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Introduction: Metabolic alkalosis (MA) represents up to half of all
acid-base disturbances in hospitalized patients and it is important to
know that if it is interact with the noninvasive ventilation (NIV) ther-
apy in hypercapnic respiratory failure. Because of the frequent diur-
etic and steroid usage lots of hypercapnic patients with COPD and
heart failure requiring NIV are also at risk for MA and it may cause
hypoventilation. While many reasons of NIV failure have been stud-
ied and defined extensively MA as a reason of NIV failure has not
been investigated in hypercapnic respiratory failure yet. The aim of
this study is to assess if MA influence NIV success and intensive care
unit (ICU) outcome in patients with hypercapnic respiratory failure
and receiving NIV therapy.
Methods: Data of 206 patients with hypercapnic respiratory failure
and treated with NIV screened retrospectively. Patients who received
asetozolamid during the NIV therapy excluded from the study. We in-
vestigated frequency, risk factors for the development of MA and if
MA effects PaCO2 reduction rate, NIV, ICU and hospital stay and
mortality.
Results: Sixty one of 206 (30 %) patients developed MA at 3rd day
and this group were older, more obese, had heart failure and used
loop diuretics more often than the other group Lenght of NIV, ICU,
hospital stay were longer in MA group than the non-MA group
(p:0.024, 0.006, 0.001 respectively). Arterial blood gas values at the
day of MA was pH: 7.45 PaO2: 71 mmHg, PaCO2: 58 mmHg
HCO3:41 meq. Admission diagnosis of heart failure increased devel-
opment of MA risk 3.4 times (OR:3,4 (CI 95 %:1,6-7) p:0,001). 190 mg
of furosemid dose determined as cutt of point for the development
of MA (AUC = 0,782 p < 0,001, sensitivity 68 %, specifity 80 %). Dur-
ation of NIV was significantly longer in patients with MA but it was
independent risk factor for only hospital stay longer than 10 days
(OR:3.4, CI95%:1,7-6,8), p < 0.0001).
Conclusions: MA may be seen as high as 30 % in patients with hy-
percapnic respiratory failure and requiring NIV and may cause to in-
crease in risk of longer hospital stay in these patients .
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Introduction: Noninvasive ventilation(NIV) is practically used for pa-
tients with acute exacerbation of COPD(AECOPD) with acute respira-
tory failure(ARF). Several new modes of NIV are currently pro-
vided for ventilatory assistance, however it is not known what the
best one is. Theoretically, neurally adjusted ventilatory assist(NAVA)
improves asynchrony and preserves natural breathing [1], which
might benefit to dynamic hyperinflation.
Methods: A pilot crossover study comparing asynchrony index and
breathing patterns between AECOPD patients assisted with NIV-PS
and those assisted with NIV-NAVA was conducted. AECOPD patients
with ARF using NIV-PS were recruited. The clinically stable patients
were randomly ventilated with NIV-PS or NIV-NAVA for 30 minutes,
and then switched to the other mode after a wash-out period. Onepatient could be enrolled more than 1 comparative sequences. Breath-
ing patterns, 6 types of asynchrony and electrical diaphragmatic activi-
ty(EAdi) were continuously recorded during the 20 last-minute periods.
Continuous data were reported as medians (IQR) or means (SD) and
compared by using unpaired t-test or Mann-Whitney U test.
Results: Three AECOPD patients were allocated to seven comparative
sequences. NIV-NAVA tended to decrease % asynchrony index:
12.88(3.33, 21.95)% in PS VS 2.62(0.85, 11.57)% in NAVA, p = 0.13.
NIV-NAVA significantly reduced trigger-delay(Td) : Td in PS 9 (6.75,
20.75) ms VS Td in NAVA 3 (1,6.5) ms, p = 0.017,and improved inef-
fective triggering: 1.03(1.8) events/minute in PS VS 0(0) event/minute
in NAVA, p = 0.026. Moreover, assistance with NIV-NAVA tended to
deliver lower tidal volume(Vt) with higher Vt variability: mean Vt
8.91(2.7) ml/Kg with CV 28.42 during PS VS mean Vt 6.81(1.85) ml/Kg
with CV 38.45 during NAVA. In contrast, the similarity of respiratory
rate (RR) and EAdi variability was observed: RR 21.44(2.75) /minute
with CV13.25 in PS VS 22.7(4.11) /minute with CV10.04 in NAVA and
EAdi 22.17(14.42) μV. with CV 46.40 in PS VS 17.02(11.02) μV. with CV
45.87 in NAVA, respectively.
Conclusions: Compared with NIV-PS, NIV-NAVA attenuated asyn-
chrony, especially ineffective triggering, in AECOPD patients. It also
promoted physiologic breathing pattern, including matched neural
triggering and low Vt with high variability.
Reference
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Introduction: High frequency ventilation has theoretical advantages
for the management of ARDS, however, high frequency oscillatory
ventilation (HFOV) did not improve outcome [1]. High frequency jet
ventilation (HFJV), unlike HFOV allows for spontaneous ventilatory ef-
forts. We report our experience with HFJV in patients with severe
hypoxemia over a 10 year period.
Methods: HFJV (Monsoon, Acutronic Medical Systems, Hirzel,
Switzerland) was superimposed upon low rate (6/min) low volume
(100-200 ml) SIMV. Patients who required FiO[sub]2[/sub] > 0.5 and
PEEP > 10 cmH[sub]2[/sub]O or those with bronchopleural fistula
were candidates for HFJV. Patients were excluded if air trapping was
evident on expiratory flow curve or the machine was unavailable (1
unit only). In all patients intratracheal mean airway pressure (MAWP)
was measured continuously. Parameters were compared over time
using ANOVA (p < 0.01 significant).
Results: 47 patients received HFJV (35 males, age 58 ± 18, BMI 26.4 ±
4.2, APACHE II 24.4 ± 8.8). Baseline (BL) Vt, PEEP and peak pressure
were 7.4 ± 1.5 ml/kgpbw, 12 ± 3 and 32 ± 6 cmH[sub]2[/sub]O Re-
spectively. At BL 8 were in prone position and 10 received NO. Dur-
ing HFJV 3 remained in prone position and 8 received NO. One
patient was converted to ECMO and 2 patients were weaned from
ECMO to HFJV (data not shown). Over the first 24 hours of HFJV oxy-
genation improved significantly at all time points (Fig. 57) while
PaCO[sub]2[/sub] decreased from 52 ± 11 to 41 ± 10 (P < 0.001). pH
increased (7.30 ± 0.1 to 7.40 ± 0.1, P < 0.001) while MAWP (22 ± 5 to
19 ± 5 cmH[sub]2[/sub]O P = 0.03) and lactate (1.9 ± 1.2 to 1.8 ±
1.0 mM/L, p = 0.6) did not change. During the first 24 hours oxygen-
ation improved in 41 patients. HFJV was continued for a median of 5
(IQR 2,7) days. 30 of the patients survived to hospital discharge.
Conclusions: This report suggests that HFJV improves oxygenation
without increasing airway pressures, reducing ventilation, or affecting
the general condition as manifested by lactate levels. Further, pros-
pective trials are required.
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Fig. 57 (Abstract P239).
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HFOV revisited: a 7 year retrospective analysis of patients
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Introduction: High Frequency Oscillatory Ventilation (HFOV) offers at-
tractive lung protective features by providing mean airway pressures
but minimal tidal alveolar pressure/volume swings. Small trials have
suggested benefit to HFOV but two recent large trials (OSCAR
and OSCILLATE) suggested either no benefit or even harm [1,2].
Questions of generalizability have been raised. In OSCILLATE, en-
rolled subjects were often in shock and mandated unusually high
mean airway pressures. This combination can be difficult to man-
age in centers with variable expertise in HFOV management. Be-
cause our institution has considerable HFOV experience, we
retrospectively reviewed all of the patients who received HFOV
with us over the last 7 years.
Methods: We evaluated 219 patients who received HFOV from 2007-
2014 at Duke University. Forty-six ARDS patients met the OSCILLATE
inclusion criteria and data was collected via retrospective chart review.
Results: Our results compared with OSCILLATE and OSCAR results are
summarized in the Table 32.
Conclusions: Despite limitations to our study (retrospective, ob-
servational and with limited data availability), we think our lower
HFOV mortality despite worse baseline oxygenation when compared
to OSCILLATE and OSCAR is notable. This may reflect lower HFOV
mean airway pressures in shock patients as well as having experi-
enced personnel available 24 hours a day in our institution. We con-
clude there may still be a role for HFOV in severe ARDS if patients
are properly selected and careful attention is paid to mean airway
pressures.
References
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Parameter Current Review OSCILLATE OSCAR
Number of Subjects 46 275 398
Age 50 +/- 12 55 +/-16 55 +/-19
Gender (%Male sex) 61 61 64
Pre HFOV PaO2/FiO2 77 +/- 25 121 +/- 46 113 +/-37
HFOV mean Paw (cm H20) day 1 28 +/-2.1 31 +/-2.6 26.9 +/- 6.2
Apache II 24.1 +/- 5.9 29 +/- 8 21.8 +/- 6.0
Mortality (%) 39 47 41.7P241
Implementation of a goal-directed mechanical ventilation order set
driven by respiratory therapists can improve compliance with best
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Introduction: Multiple studies have shown that low tidal volume,
lung protective ventilation strategies may reduce pulmonary compli-
cations in non-ARDS ICU patients. In busy ICUs, discrepancies may
arise between ventilator management goals and actual practice. We
developed a goal-directed mechanical ventilation order set that
included physician-specified lung-protective ventilation and oxygen-
ation goals to be implemented by our respiratory therapists (RTs).
Our primary outcomes were to determine if a simple respiratory
therapist-driven order set with predefined goals regarding oxy-
genation and ventilation could be implemented with good com-
pliance and to determine compliance with the ARDSNet PEEP/
FiO2 table. As secondary outcomes, we evaluated duration of
mechanical ventilation, ICU length of stay, and both in-hospital
and ICU mortality.
Methods: We evaluated 1302 patients undergoing invasive mechanical
ventilation prior to and after institution of a standardized, goal-directed
mechanical ventilation order set. Specific goals for oxygenation (SpO2,
PaO2, PEEP/FiO2 table use) and ventilation (pH, PaCO2) were selected
by providers and were subsequently implemented by our RTs as they
saw fit.
Results: A total of 1693 unique episodes of invasive mechanical ven-
tilation and 1302 individual patients were analyzed. Compliance with
the new mechanical ventilation order set was found to be high with
a mean of 86.9 % of ventilator settings compliant with orders. The
difference in order compliance before and after implementation was
statistically significant (mean 1.3 % vs. 86.9 %, p <0.0001). Compli-
ance with the ARDSNet PEEP/FiO2 table after implementation of the
order set was significantly greater (median of 82.9 % vs. 86 %, p =
0.02). There was no difference in duration of mechanical ventilation,
ICU length of stay, in-hospital or ICU mortality.
Conclusions: A standardized mechanical ventilation order set with
physician-specified oxygenation and ventilation goals to be imple-
mented by RTs who routinely practice lung-protective ventilation can
be implemented with good compliance and improve adherence to
the ARDSNet PEEP/FiO2 table.P242
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Introductions: Over 60 % of patients admitted to an Intensive Care
Unit (ICU) will require Endotracheal Tube (ETT) intubation and mecha-
nical ventilation[1]. The aim was to perform an audit of ventilation re-
gimes in critically ill patients admitted to Whiston Hospital. Its main ob-
jectives were to evaluate the current management of ventilated
patients on ICU at Whiston hospital in comparison to the current local
standards of best practice, with the main emphasis surrounding IBW
(Ideal Body Weight) documentation and reduction in initial tidal vol-
ume (TV) from traditional guidelines.
Methods: A retrospective study looking at a sample cohort of 182
patients admitted to the ICU at Whiston from January 2014 to the
end of June 2014 who was managed with either Pressure Regulated
Volume Control (PRVC) or Synchronised Intermittent Mandatory
Ventilation (SIMV). Of those 182 candidates, 107 matched the ventila-
tion inclusion criteria. The data sources used were under the ICU
Table 33 (Abstract P243). Patients’ characteristics.
Patients’ characteristics Group F (n = 27) Group S (n = 23) P value
Male: Female in % 51.9:48.1 60.9:39.1 0.52
Age 51.89 ± 14.58 47.52 ± 14.60 0.29
LUS score 20.47 ± 2.75 12.52 ± 4.61 <0.05
Critical Care 2016, Volume 20 Suppl 2 Page 100 of 182subcategory on the trust electronic data management system and ICU
electronic charting system. A data collection proforma was completed
for each patient.
Results: All patients initiated on PRVC or SIMV should have their an-
thropometric measurement of ulnar length or actual height recorded. It
was found only 35.5 % of patients admitted had these recorded as op-
posed to the local guideline of 100 %. 50 % had documented IBW with
16.9 % of those not having a recorded optimal TV based on 6 ml/
kg. Of the 45 patients who had documented IBW appropriate TV
calculated, 62 % were commenced on TV greater than their calcu-
lated optimal TV. Every patient’s arterial oxygen saturations were to
be maintained between 88-92 %. Only 10.3 % of patients met this
standard, although 95.4 % of patients maintained saturations
greater than 88 %.
Conclusions: To summarise it is clear that documentation relating to
ventilation care is lacking despite a clear section outlined on the ICU
admission proforma. A proposal to resolve this issue would be to use
a laminated sheet including patient’s ulnar length/actual height, IBW
and optimal TV.
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Predictive value of lung aeration scoring using lung ultrasound in
weaning failure
M. Shoaeir1, K. Noeam1, A. Mahrous1, R. Matsa2, A. Ali1
1Alexandria Universitry General Hospital , Alexandria, Egypt; 2 University
Hospital North Middlands, Stoke On Trent, UK
Critical Care 2016, 20(Suppl 2):P243
Introduction: Optimal time to wean from mechanical ventilation
(MV) remains a challenge in most critically ill patients [1]. There have
been studies looking at the factors that aid weaning from MV, how-
ever the results have been variable. Recent evidence suggests lung
ultrasound (LUS) can predict successful weaning from MV [2]. This
study assesses the ability of the lung aeration scoring [3] using LUS
to predict successful weaning in critically ill patients.
Methods: This prospective, observational and non-interventional study
was performed in a general ICU in a large university hospital over a
period of 6 months. We included all patients who needed MV for >
48 hours (n = 50), and were eligible for Spontaneous Breathing Trial
(SBT). LUS was performed during SBT and lung aeration scoring was
calculated in 12 lung regions. Points were allocated according to the
worst ultrasound pattern observed: N (normal lung pattern) = 0, B1
lines ( multiple well-defined B lines) =1, B2 lines (multiple coalescent B
lines) = 2, c (consolidation or atelectasis) = 3.
Relevant data were collected from patients, including demographic
and LUS aeration scoring, in a standardized case report form (Table 33).
Patients were divided into two groups: Group F and Group S based on
the failure and success in weaning, respectively. The LUS aeration scor-
ing was applied to both groups to assess the predictability of weaning
failure.
Results: Lung aeration scores were significantly higher in patients in
Group F compared to Group S (p < 0.01). The sensitivity, specificity
for failed extubation for a LUS score of > 18 is 88.89 and 86.96
respectively.
Conclusions: Lung aeration score using lung ultrasound can predict
weaning failure in critically ill patients. Our study showed that a LUS
score of >18 has a good prediction value. However larger randomised
controlled trials are required to validate this pilot study.References
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Introduction: Clinicians are routinely faced with the challenges of
managing the ventilatory care and weaning process during the clin-
ical course of the illness. Almost 40 % of mechanical ventilation time
is spent on weaning [1] and in the last decade, automatic ventilator
control and ventilation modes were designed to help weaning from
mechanical ventilation. In many studies automated weaning signifi-
cantly decreased weaning time in critically ill patients when compared
with physician controlled weaning process [2,3]. We conducted a pro-
spective randomized trial comparing automated weaning with a stan-
dardized weaning protocol in a multidisciplinary ICU.
Methods: From April 2014 to Mars 2015, we enrolled critically ill
adults requiring more than 48 hours of mechanical ventilation.
Patients were randomized since admission considering availability
of SmartCare equipped ventilators (8 Evita XL in our unit: 4 with
SmartCare and 4 without). We included patients who tolerated at
least 24 hours of pressure support with PEP equal or less than 5
cmH2O and were not ready to undergo a spontaneous breathing
trial, they were assigned to be weaned either by SmartCare (SC
Group) or by the physician controlled weaning according to local
guidelines (PCW Group). Weaning duration, total duration of me-
chanical ventilation and the success of weaning were the primary
endpoints.
Results: Forty-four patients were enrolled, 22 in each group. There
was no difference between the two groups concerning age, sex,
neurological or respiratory history, diagnosis or severity at study
entry. Weaning duration and total mechanical ventilation were simi-
lar between the two groups and were respectively 6 +/- 7 days in
PCW Group vs 5 +/- 4 days in SC Group (p = 0.63) and 11 [3-37] days
vs 10 [3-23] days in SC Group. In the PCW Group, we noted only one
extubation failure and there were no reintubation in SC Group.
Conclusions: Although automated weaning using SmartCare did not
show significant benefit for patients concerning duration of mechanical
ventilation and duration of weaning when compared to physician-
controlled weaning according to local protocols; it has certainly offer a
gain of time for the medical staff in an ICU where there is no respiratory
physiotherapist neither critical care specialty nurses.
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Fig. 59 (Abstract P245). Algorithm based in GMEMI score.
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Ultrasonographic evaluation protocol for weaning from
mechanichal ventilation
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Introduction: Mechanical ventilation (MV) is a therapy for vital sup-
port used in a significant proportion of critically ill patients. The
right time to succesfully discontinue this therapy is a challenge for
the intensivist The ecocardiographic evaluation of the diastolic dys-
function, the diaphragm and the lung have become an invaluable tool
for weaning from MV protocols, especially in pacients with dificult or
prolong weaning from MV. We propose a mathematichal model of an
ultrasound protocol for weaning from MV that integrates the three
modalities
Methods: Based on current literature, we develop a score justified by
a mathematical model based on inequations
Results: When the risk of failure in the weaning process rises, for
these reason the weaning process should be suspended. When
the risk of failure is low and the weaning process should be
continued.
Conclusions: The use of math models for decision making is of
great importance, it sets an objective parameter within the exist-
ing evaluations. We proposed the use of inequations, to set inter-
vals of solution with the three points of care for ultrasound
guided weaning from MV. With this the inequations propose gen-
erate an area of certainty within the proposed values an the solution
intervals.
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Diaphragm ultrasonography: a method for weaning patients from
mechanical ventilation
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Introduction: Our aim was to assess diaphragm ultrasonography as a
tool to predict the outcome of weaning.
Methods: We enrolled 5 intubated patients who were admitted to
our Intensive Care Unit at the Saint Antony Hospital of Padua; a
Nutrivent nasogastric tube was placed in each to measure the dia-
phragm contractility as the transdiaphragmatic pressure (ÄPdi) with
the following formula: ÄPdi = gastric pressure-esophageal pressure.
We performed a diaphragmatic sonography with the M-mode tech-
nique. We calculated the diaphragm contraction speed as the slope
(Scdi) of the curve provided by the diaphragm contraction during the
inspiratory phase of the spontaneous breathing trials. The correlation
between the mean ÄPdi and the mean Scdi was evaluated using the
Pearson’s method according with a linear regression analysis.
Results: We found a significant correlation between the ÄPdi and the
Scdi with a Pearson coefficient ñ = -0.851 and a linear determination
index R = 0.718 as shown in Fig. 60.
Conclusions: the Scdi calculated during trials of spontaneous breathing
represented a bedside, standardized and reproducible tool to predict
the outcome of weaning.
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Fig. 60 (Abstract P246). Relationship between ÄPdi and Scdi.
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Dorsal diaphragmatic excursion tracks transpulmonary pressure in
ventilated ARDS patients: a potential non-invasive indicator of
lung recruitment?
R. Cho1, A. Adams 1, S. Lunos2, S. Ambur1, R. Shapiro1, M. Prekker1
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Introduction: Optimizing positive end-expiratory pressure (PEEP) in
acute respiratory distress syndrome (ARDS) patients to attain lung
recruitment while avoiding over-distension is a clinical challenge.
Methods of titrating PEEP to safely recruit the lungs have included
achieving adequate SpO2, attaining best compliance, or increasing
PEEP while monitoring esophageal manometry to establish a posi-
tive end-expiratory transpulmonary pressure (Ptp). Bedside ultra-
sonography is available and useful as a diagnostic tool in the care
of critically ill patients. Preliminary work identified marked differ-
ences in excursions between the dorsal and ventral diaphragms
during lung-protective tidal ventilation in ARDS patients. We
hypothesize that lung recruitment in the supine patient may be de-
tected non-invasively by increased dorsal diaphragmatic excursions,
indicating that dependent lung regions may be recruiting with ad-
equate PEEP.
Methods: In this proof-of-concept study, we enrolled 7 ARDS patients
treated with invasive mechanical ventilation and neuromuscular
blockade in the supine position. We measured Ptp using esophageal
manometry and ventral/dorsal diaphragm excursions using anatomic
M-mode ultrasonography as the applied PEEP was changed (set by
the treating physician) as follows: +3,+6, -3, and -6 cmH2O. A stand-
ard lung history was established by recruitment maneuvers between
each PEEP change, and the sequence of PEEP changes was random-
ized for each subject. We used linear mixed effects models to evalu-
ate for an association between applied PEEP and Ptp and dorsal
diaphragmatic excursion (DDE).
Results: Acceptable ultrasound images of diaphragm excursion were
obtained in 6 of 7 patients; one patient had a large hepatic cyst pre-
cluding diaphragm ultrasound, data from this subject was excluded
from the analysis. At enrollment, the mean(+/-SD) P/F ratio was 156
+/-61 mmHg, mean baseline PEEP was 12.7+/-2.2 cmH2O, and the
mean SpO2 was 94+/-2.2 %. Ventral diaphragmatic excursions were un-
changed by PEEP. Increasing PEEP resulted in corresponding increases
in Ptp and DDE (p = .0006, p = .005). The transition from a negative to
positive Ptp with increasing PEEP occurred as DDE was observed to
markedly increase.
Conclusions: This exploratory study suggests an association between
Ptp and DDE as dorsal lung is recruited by increasing PEEP. If vali-
dated in a larger sample, ultrasound evaluation of dorsal diaphra-
gmatic movement may be a non-invasive method for estimating
lung recruitment in ARDS.P248
Pulse oximetry in the icu patient: is the perfusion index of any
value?
M. Thijssen, L. Janssen, N. Foudraine
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Introduction: Pulse oximetry (SpO2) is intensively used as a surrogate
for arterial oxygenation (SaO2) however, little is known about its ac-
curacy in daily ICU practice. Disturbed perfusion may lead to a poor
signal as indicated by a lower perfusion index value (PFI) and so
compromise its accuracy. We studied SpO2 accuracy in its relation-
ship to the PFI.
Methods: In a 5 month period, 281 patients were retrospectively
studied resulting in 1281 concomitantly measured values of SpO2
(Philips M1191BL/M1194A), SaO2 and PFI. Inotropic use, pH, MAP,
mechanical ventilation and body temperature were studied as inde-
pendent variables. PFI values were categorized as low or poor with
PFI < 1.0, intermediate or moderate with 1.0 < PFI < 2.5 and as reliable
or high with PFI > 2.5. Data collection: All SaO2, SpO2 and PFI mea-
surements during the first 3 days after admittance were collec-
ted unless the patient was invasively ventilated, then all measurements
were collected until extubation. Statistical analysis: A linear correlation
of the SpO2 and SaO2 values was assessed by Pearson’s method and
the mean SpO2-SaO2 difference (Δ ) was assessed by using the Bland
and Altman method.
Results: Statistical analysis showed an overall correlation (r = 0.685;
p < 0.01) between SaO2 and SpO2. The Bland and Altman analysis
revealed that the limit of agreement within the general mean
and ±2SD showed a Δ of ±6 % (Fig. 61). Of all values SpO2 over-
estimated the SaO2 value in 48.2 % of all cases and underestimated
SaO2 in 31.4 %.
Over a wide range of PFI values (median 1.4, range 0.1-19.2) we
found moderate agreement between SpO2 and SaO2 with slightly
better agreement for higher PFI values (Fig. 62). Even with a PFI > 2.5,
15.9 % of all measurements showed a difference between SpO2 and
SaO2 of more than ±2 %. The other independent variables showed
only very weak associations (r < 0.2) with the Δ SpO2-SaO2, except
for mechanical ventilation (ANOVA p = 0.002).
Conclusions: We found a clinical relevant lack of agreement between
SpO2 and SaO2 measurements. In contrast to general expectations
SpO2 exceeds SaO2 in 48.2 % of all measurements. PFI is of little
value as differences may be great as even with a high (good) PFI
value, 15.9 % of concurrent measurements of SpO2 and SaO2 differ >
±2 %. These findings may influence daily practice on how to adjust
mechanical ventilation by SpO2 measurements.
Fig. 62 (Abstract P248).
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Ventilation is a better assessment of respiratory status than EtCO2
C. J. Voscopoulos1, J. Freeman2
1University of Hawaii, John A. Burns School of Medicine, Honolulu, USA;
2Respiratory Motion Inc., Waltham, USA
Critical Care 2016, 20(Suppl 2):P249
Introduction: ICU patients require multiple monitoring inputs to op-
timize care & are subjected to many discomfort-causing interventions..
Direct measurement of respiratory effort in non-intubated patients is dif-
ficult, so clinicians rely on secondary indicators of respiratory sufficiency,
such as pulse oximetry & capnography (EtCO2), which have significant
limitations. Clinicians often resort to using respiratory rate (RR) measure-
ments from the capnograph. We used a novel non-invasive respiratory
volume monitor (RVM), which measures minute ventilation (MV), tidal
volume (TV) & respiratory rate (RR), to assess the ability of EtCO2-
generated RR to quantify respiratory status in non-intubated patients.
Methods: Continuous RVM & capnography data were collected from
50 subjects (age:46 ± 14 yrs) using an impedance-based RVM (ExSpiron)
& capnograph (Capnostream 20) with a sampling oral/nasal cannula
(Smart Capnoline Plus). Each subject performed 6 2.5-min breathing
trials at various RRs. The correlations between EtCO2 measurements
(low: <35 mmHg, normal: 35-45 mmHg, high: >35 mmHg), capnography-
based RR (low: <6 b/min, adequate: > = 6 b/min), & RVM-based
MV (low: <2 L/min, adequate: > = 2 L/min) were evaluated.
Results: Comparison of MV & EtCO2 measurements revealed that in
only 24.6 % of the 9324 analyzed epochs did adequate MV coincide
with normal EtCO2. 68.7 % of the time adequate MV coincided with
low EtCO2, & 100 % of low MV corresponded to either normal or low
EtCO2 (Fig. 63a). Correlation was poor between the capnograph’s RR &
EtCO2 measurements: normal EtCO2 coincided with adequate RR just
24.9 % of the time & none of the low RR measurements were revealing
of a high EtCO2 (Fig. 63b). When using RR as a proxy for MV it was also
noted that low MV is observed at a wide range of RRs, with only 15.5 %
of all low MV events captured by a low EtCO2-based RR (Fig. 63c).
Conclusions: This study confirmed that EtCO2 is an inadequate proxy
for MV in non-intubated patients. EtCO2-based RR is a poor proxy for
EtCO2 & an even worse proxy for MV.Fig. 63 (Abstract P249).
Fig. 64 (Abstract P250).P250
Evaluation of the relationship between non-invasive minute
ventilation and end-tidal CO2 in patients undergoing general vs
spinal anesthesia
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Critical Care 2016, 20(Suppl 2):P250Introduction: Capnography (EtCO2) is unreliable for monitoring re-
spiratory status in non-intubated patients. We used a noninvasive re-
spiratory volume monitor (RVM), which provides accurate
measurements of minute ventilation (MV), tidal volume & respiratory
rate (RR) in non-intubated patients, to compare the relationship be-
tween EtCO2 & MV in intubated patients with general anesthesia
(GA), non-intubated patients with spinal anesthesia (SA) & awake
volunteers.
Methods: RVM data (ExSpiron, Respiratory Motion Inc., Waltham MA)
were collected from 153 patients in 3 groups: Group 1, 54 patients,
age:65.2 ± 12.1 yrs, BMI:31.2 ± 6.3 kg/m2, surgery with GA; Group 2,
60 patients, 68.9 ± 9.0 yrs, 30.5 ± 5.8 kg/m2, surgery with SA; Group
3, 39 volunteers, 48.5 ± 13.8 yrs, 27.9 ± 8.6 kg/m2, coached to
breathe at varied RRs. Groups 1&2 EtCO2 data were collected via
ventilator (Draeger Apollo), with an ET tube in Group 1 & sampling
nasal cannula in Group 2. Group 3 EtCO2 data were collected via
capnograph (Capnostream20, Covidien) with nasal cannula. Deming
regression quantified the relationship between EtCO2&MV. EtCO2
sensitivity&mean EtCO2 were compared across cohorts by un-
paired t-tests.
Results: The EtCO2 sensitivity was significantly higher in intuba-
ted patients vs volunteers (-83.5° ± 9.7°vs-30.1° ± 16.1°, p < 0.001,
Fig. 64a). In non-intubated patients the sensitivity was not nor-
mally distributed & spanned the range of intubated patients &
volunteers. Measured EtCO2 values were higher in Group1 than
Groups 2&3 (37.2 ± 4.4 mmHg vs 23.0 ± 5.2 mmHg vs 31.0 ± 4.0 mmHg,
respectively, p < 0.001, Fig. 64b). EtCO2 measurements were normally
distributed in all groups.
Conclusions: Our results show that EtCO2 lacks adequate sensitivity
to changes in MV&introduces measurement bias with the nasal
cannula.P251
Respiratory volume monitoring provides early warning of
respiratory depression and can be used to reduce false alarms in
non-intubated patients
C. J. Voscopoulos1, D. Eversole2, J. Freeman2, E. George3
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Introduction: Pulse oximetry (SpO2) is associated with significant
false alarms, & gives late notice of respiratory depression. In this ob-
servational study, we assessed the ability of a respiratory volume
monitor (RVM) that non-invasively measures minute ventilation (MV),
tidal volume & respiratory rate to capture respiratory depression in
advance of low SpO2 & with fewer false alarms.
Fig. 66 (Abstract P252). Results (median, Q1, Q3).
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66.8¡À10.3 yrs, BMI:29.6¡À5.7 kg/m2) at 1-min intervals. ¡°Predicted¡ ±
MV (MVPRED) was calculated for each patient, based on body surface
area. ¡°Low SpO2¡ ± (alarm condition) was an SpO2 < 90 %; ¡°desatur-
ation event¡ ± was ¡°Low SpO2¡ ± for ¡Ý2min; and ¡°false alarm¡ ± was
¡°Low SpO2¡ ± for <2 min. ¡°Un-Safe MV¡ ± was defined as MV <
40%MVPRED. MFANOVA was used to evaluate differences in the clin-
ical populations, & unpaired one-sided t-tests were used to compare
measurements across groups.
Results: Of 80 alarm conditions, 62 (78 %) were false alarms. The
other 18 events (¡Ý 2 min) occurred in 15 patients (Fig. 65a). The
RVM showed that 11/18 desaturation events were from patient mo-
tion & high MV & only 7 events were ¡°true desaturation¡ ± events,
(Fig. 65b). Each true desaturation event was preceded by ¡°Un-Safe
MV¡ ± by 16.7¡À4.6 min (mean¡ÀSEM) & the severity of ¡°Un-Safe
MV¡ ± was strongly correlated with the time delay (r = 0.77, p <
0.05). While MFANOVA found no difference in the demographics
of the populations with true desaturation events vs. false alarms
(p > 0.2 for ht, wt, age, BMI, sex), the length of stay in the PACU
for true desaturations group was significantly longer (176¡À9min
vs. 134¡À18min, p < 0.05).
Conclusions: This study showed that >90 % of SpO2 alarms in the
PACU were likely false. MV monitoring gives advanced warning of re-
spiratory depression with fewer false alarms.Fig. 65 (Abstract P251).P252
P/i index: a predictive edi-derived weaning index during nava
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Introduction: Edi-derived indices provide reliable predictors of suc-
cessful separation from the ventilator only during the SBT [1-3]. Their
performance is not better than the performance of RSBI [3].
We previously investigated in a physiological study the relationship
between Edi peak and Edi area under the curve (P/I Index); we con-
cluded that P/I Index can give important information on the balance
between respiratory drive and respiratory demand, and may predict
weanability at clinical support level [4].
The aims of the study are: 1) to validate P/I Index as weaning pre-
dictor at clinical ventilatory support and 2) to compare P/I Index sen-
sitivity during NAVA in predict SBT success respect to: Edi peak,
Neuro-ventilatory efficiency (NVE) and RSBI.
Methods: We prospectively enrolled 54 patients ventilated with
NAVA meeting criteria for SBT.
For each patient, we identified 2 step: 1) enrollment, T[sub]0[/sub]; 2)
end of SBT. We recorded RSBI, Edi peak, and two Edi-derived wean-
ing indices: NVE , P/I Index.
SBT failure and success were defined according to clinical protocol
in use.
Results: 34 patient completed SBT and were successfully extubated;
11 patients failed SBT ; 9 patients failed the first weaning step before
the trial (subgroup A).At T[sub]0[/sub] differences between success (S) and failure (F) group
were statistically significant for P/I only.
At the end of SBT differences between S and F group were statistically
significant for RSBI and P/I.
Conclusions: P/I Index predict ability to sustain SBT under ventilator
assistance and during SBT. Subgroup A may represent a group of pa-
tients not adequately assisted, where classic indices and NVE are not
able to predict the inability to start SBT. Further investigations are
needed to understand whether P/I Index may provide information on
adequacy of assistance during NAVA ventilation.
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Adequacy of ventilation in patients receiving opioids in the post
anesthesia care unit: minute ventilation versus respiratory rate
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Introduction: Opioid use decreases respiratory drive and can cause
opioid-induced respiratory depression (OIRD), which is challenging to
recognize in non-intubated patients from respiratory rate (RR) alone.
Using a non-invasive respiratory volume monitor (RVM) that mea-
sures minute ventilation (MV), tidal volume (TV) and RR, we examined
whether RR alone can identify LowMV episodes (used to define OIRD)
in the post-anesthesia care unit (PACU).
Methods: After written informed consent, MV, TV and RR mea-
surements were collected via RVM (ExSpiron, Respiratory Motion,
Waltham MA) from 358 patients (age: 67.1, 19-91 yrs; BMI:
29.8,19-49 kg/m2) undergoing elective joint replacement surgery.
205 patients received PCA opioids in the PACU: 96 received
hydromorphone (0.2 mg) and 109 received morphine (1 mg per
dose). RVM measurements were calculated from 30-second seg-
ments in the 30 minutes before and after first dose. Predicted
MV (MVPRED) was calculated from each patient’s BSA. LowMV
was defined as MV < 40%MVPRED for >1 min. LowRR was defined
as RR < 6breaths/min. Sensitivity and specificity analysis correlated
LowRR with LowMV.
Results: For patients receiving opioids, LowMV occurred 13.7 % of
the time before and 17.8 % of the time after a dose. Importantly,
LowRR coincided with less than 12.5 % of all LowMV episodes. On
average, patients experienced 1.5 ± 0.2 LowMV episodes before opi-
oid (range: 0-9episodes; duration: 2.17 ± 0.13 min) and 1.8 ± 0.2
LowMV episodes (0-9episodes; 2.40 ± 0.12 min) after opioid dosage
(p > 0.5). In both groups, a low RR alarm set to below 6 breaths/min
would miss 88.3 % of LowMV episodes, yielding a sensitivity of
12.4 %, specificity 98.5 %, positive predictive value 60.5 %, and nega-
tive predictive value 85.8 %. Figure 67 shows a plot of paired MV
and RR measurements.
Conclusions: LowRR measurements alone provide an insufficient as-
sessment of respiratory status. Our data suggest that LowMV is pri-
marily related to a decrease in TV and not RR.
Fig. 67 (Abstract P253).
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Comparison of regional and global expiratory time constants
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Introduction: Although regional compliance (C) and resistance (R)
can vary considerably between different lung regions, traditional pul-
monary function tests can measure global values, only. To overcome
this drawback we recently proposed a novel EIT-based method to es-
timate regional expiratory time constants (τ = tau). In this abstract re-
gional values were compared with global ones.
Methods: In ten intubated patients with hypoxemic and hypercapnia
lung failure time constants (τ = R·C) were estimated from global and re-
gional volume EIT signals obtained by Swisstom BB2 (Swisstom,
Switzerland). A first order exponential decay model was fitted to each
regional and global impedance curve using MATLAB (The MathWorks,
USA). The spread and mean of regional τ values is depicted in Fig. 68
and compared with the one τ value derived from the global signal.
Results: ARDS lungs exhaled “faster” whereas COPD lungs were
“slower”, the latter reflecting the predominance of airway obstruc-
tion. ARDS patients show only minor regional differences and global
τ corresponded perfectly with the mean τ derived from different lung
regionals. In contrast, COPD patients showed a large spread of their
regional τ values. Nonetheless, the mean of the regional τ values cor-
responded well with global τ .
Conclusions: Mean expiratory time constant derived from regional
EIT signals was similar to the one value calculated from the global
EIT signal in both, patients with short (ARDS) and long expiration
time requirements (COPD). As a sign of heterogeneous disease, the
latter showed a wide spread of regional τ values.Fig. 68 (Abstract P254).P255
Electrical impedance tomography: robustness of a new pixel wise
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Introduction: Passive exhalation shows a characteristic exponential
course with asymptotic approximation of the end expiratory lung
volume. It can be described as V(t) = Vinsp · e^(-t/(R · C)) where V is
the lung volume at time t, Vinsp the volume at end inspiration, R the
resistance and C the compliance of the lungs. The product of R · C is
called τ (tau). Although R and C can vary considerably between dif-
ferent lung regions, traditional pulmonary function tests provide glo-
bal values, only. Therefore, we recently proposed a novel method to
obtain regional τ values using electrical impedance tomography (EIT).
As this approach can be challenging in presence of small ventilation
amplitudes, noisy signals and heterogeneity we determined in this
study its robustness.
Methods: In 8 intubated patients, with hypoxemic or hypercapnic re-
spiratory failure, we measured EIT signals at 50 images per second
using Swisstom BB2 recording 30 consecutive breaths during steady
state conditions. Regional breath by breath τ values (Fig. 69) were es-
timated by fitting an exponential model to each regional curve. Only
τ values within the range of 0.05 and 3 s stemming from ap-
propriately fitted curves (R2 > 0.6) were considered thereby excluding
poorly ventilated and poorly fitted lung areas. To estimate the ro-
bustness of τ , we calculated the regional coefficient of variation (CV)
for all breaths as standard deviation divided by mean.
Results: Mean and median CV values of each patient were below
5 %, however some pixels showed values of up to 25 % mainly at
the lung boundaries or close to poorly ventilated areas.
Conclusions: The suggested approach for calculating regional ex-
piratory τ values provided robust results with low coefficients of vari-
ation. However, certain lung regions at the lungs’ boundary showed
high variability. Therefore, to increase reliability such pixels should be
excluded from future calculations.Fig. 69 (Abstract P255).P256
Validation of regional and global expiratory time constant
measurement by electrical impedance tomography in ards and
obstructive pulmonary diseases
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Introduction: Obstructive airway diseases such as asthma or COPD
are increasing in numbers and frequently lead to severe exa-
cerbations with the need of non-invasive or invasive mechanical ven-
tilation. Severe COPD in particular is often characterized by inhomo-
geneous ventilation. In case of mechanical ventilation in obstructive
pulmonary diseases or ARDS, modern ICU ventilators provide accur-
ate measurements of pressure-volume curves on a global, but not on
a regional level. Electrical impedance tomography (EIT) in contrast is
an established non-invasive tool to measure regional ventilation. The
Fig. 70 (Abstract P257).
Critical Care 2016, Volume 20 Suppl 2 Page 106 of 182aim of our study was to calculate an EIT-based (32x32 pixel, 50
frames per second) expiratory time constant τ (tau) for each image
pixel and a global one for the entire lung and to validate it against a
global volume signal measured at the airway opening.
Methods: In 12 intubated patients with hypoxemic and/or hyper-
capnic respiratory failure we performed EIT and pneumatic volume
measurements (Swisstom BB2, Switzerland) on different PEEP level
recording 100 consecutive breaths during steady state conditions
with breathing frequencies between 14 and 16/min. Regional breath
by breath τ values were obtained by fitting in a nonlinear least square
manner an exponential function to the EIT curve of each pixel. The
same algorithm was applied to the pneumatic volume curve and corre-
lated with the mean τ of all regional EIT measurements.
Results: The mean τ calculated from the regional EIT signals showed
a strong correlation with the global τ calculated from the pneu-
matic volume signal. In 2773 breaths Pearson r was 0.8752 (0.8662
to 0.8836) and r2 0.7660. Patients with severe COPD typically
showed longer time constants than those with ARDS. The mean τ
calculated from the global EIT signals showed a strong correlation
with the global τ calculated from the pneumatic volume signal as
well (Pearson r: 0.8978).
Conclusions: The mean τ calculated from the regional EIT signals
shows a very strong correlation with the global pneumatic volume
signal reflecting EIT as a valid method to calculate global and re-
gional expiratory time constants. EIT therefore provides for the first
time a regional breath by breath measurement of airflow obstruction
and may help to guide mechanical ventilation especially in obstructive
pulmonary diseases.Fig. 71 (Abstract P257). Airway, transpulmonary and pleural
pressure during a PEEP change 0-8-0 cmH2O.P257
Transpulmonary pressure in a model with elastic recoiling lung
and expanding chest wall
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Introduction: We have shown in pigs and ARDS patients that lung
elastance can be determined without esophageal pressure as the
change in PEEP divided by the change in end-expiratory lung vol-
ume, deltaPEEP/deltaEELV [1,2]. The hypothesis is that this is an ef-
fect of contra-directional forces of the expanding rib cage and recoil
of the lung that creates negative pleural pressure, which persists also
at an increased PEEP/EELV. Esophageal pressure, used as a surrogate
for pleural pressure (PPL) is unreliable for determining absolute end-
expiratory esophageal pressure, because of extra-pleural effects on
measurements. The aim of the present study was to evaluate the ef-
fect of an expanding rib cage on absolute pleural pressure changes
during PEEP steps in a respiratory system model.
Methods: A model with a recoiling elastic lung and expansive chest
wall complex was built (Fig. 70). Lung elastance could be varied be-
tween 46, 24, and 17 cmH2O/L. In volume control, PEEP was in-
creased from 0 to 4, 8, and 12 cmH2O, while airway and pleural
pressure was measured and deltaEELV obtained by spirometry.
Results: When PEEP was increased endexpiratory pleural pressure in-
creased during the first expiration, but then declined back to base-
line, while end-expiratory transpulmonary pressure (PTPEE) increased
until it equaled the change in end-expiratory airway pressure (delta-
PEEP = deltaPTPEE) (Fig. 71). There was an good correlation between
transpulmonary pressure at all lung volume levels derived from PAW-
PPL (pleural pressure) and transpulmonary pressure derived from
lung elastance calculated as deltaPEEP/deltaEELV, r2 = 0.99, y = 1.01x.
Conclusions: As end-expiratory pleural pressure remains unchanged
when increasing PEEP, end-expiratory transpulmonary pressure
changes as much as PEEP and lung compliance can be determined
as deltaEELV/deltaPEEP.
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Introduction: The aim of this study is to evaluate whether the in-
crease in lactate in pleural and abdominal effusion can be used as a
criterion for the differential diagnosis of the nature of the fluid
Table 34 (Abstract P259). Discharges from unit.
Unit outcome Died Alive Total
Pulmonary fibrosis 43 35 78
Control 1484 6446 7930
Total 1527 6841 8008
Table 35 (Abstract P259). Discharges from hospital.
Died Alive Total Pulmonary fibrosis
50 27 77 Control
2093 5695 7788 Total
2143 5722 7865
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fusion is a frequent finding in patients in the ICU and Internal Medi-
cine Department.It is possible to distinguish between transudate and
exudate by Light’s criteria[1,2].Pursuing an acid-base assessment of
the fluid,we have noticed an increase in the value of lactate,beyond
the blood range,in the cases that were diagnosed like exudate to the
calculation of Light criteria[4].The advantages of this test is that it is
a simple test,executable by the physician and his result is available
within few minutes.
Methods: We collected data of 30 patients who had clinical indi-
cation for thoracentesis or paracentesis.For each patient we per-
formed arterial blood gas with lactate,total protein and serum LDH
dosage,acid-base assessment with lactate,total protein and LDH
dosage,cytology and bacterial culture on the fluid.Of every patient
we calculated “liquid/serum” lactate ratio in order to measure the
eventually present increase in pleural or abdominal effusion.The
diagnosis of the liquid effusion nature (exudate or transudate) was
performed by Light’s criteria.A statistical analysis was carried out by
performing a ROC curve in order to find the best cut-off for liquid/
serum lactate ratio predicting the presence of an exudate.
Results: Of the 30 patients (13 [43 %] males and 17 [57 %] females,
mean age 65,53 ± 13,271 years) 15 had peritoneal effusion and 15
had pleural effusion,15 patients had a exudate and 15 a transu-
date by Light’s criteria.We performed a ROC curve to predict the
presence of exudate by the liquid serum lactate ratio and we ob-
tained an AuROC of 0.69 with the best cut-off value of 2,02 (Sensi-
tivity 0,73 and Specificity 0,73). When we performed the same
analysis only on pleural effusion patients we obtanined a an
AuROC of 0,78 with the best cut-off value of 2,13 (Sensitivity 0,7,
Specificity 1,0).
Conclusions: Liquid/Serum lactate ratio seems to be a promising tool
to predict the presence of an exudate,in particular in pleural effusions.
Further studies are needed to warrant these statements.
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Introduction: The objective of this study was to evaluate the out-
comes of patients admitted to the intensive care with pulmonary fi-
brosis. Numerous studies have demonstrated a poor outcome with
patients admitted to the intensive care unit (ICU) with pulmonary fi-
brosis [1-2].
Methods: A computerised hospital database was used to search for
all patients admitted to the ICU at East Surrey Hospital with pulmon-
ary fibrosis between 2003-2015. Data was analysed using Microsoft
Excel 2007 and GraphPad software. The primary endpoint was sur-
vival at unit and hospital discharge.
Results: 8048 records were reviewed and 79 met the inclusion cri-
teria. A control group of patients without a diagnosis of pul-
monary fibrosis was used for comparison (7954). Results showed
54 % of patients with pulmonary fibrosis died before discharge from
the unit compared to 18.8 % in the control group p = 0.0001
(Table 34). Similarly, 63.3 % of patients with pulmonary fibrosis died
before hospital discharge compared to 26.3 % of the control group
p = 0.0001 (Table 35).
Conclusions: The results from this study are consistent with previous
findings. The risk of death prior to discharge from our intensive care
unit is almost 30 % higher for patients with pulmonary fibrosis. From
the data presented above, it may be prudent to consider that pa-
tients with pulmonary fibrosis presenting with no reversible causesof acute respiratory failure may be less likely to benefit from admission
to the ICU.
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Introduction: For patients with ARDS supported on ECMO, the opti-
mal sedation and analgesia strategy is unknown. Our objective was
to characterize pharmacological practice in a high-volume ECMO
center and describe sedation depth, incidence of delirium and
mobilization in this population.
Methods: We conducted a retrospective study to describe medi-
cation (sedative, analgesic, paralytic, antipsychotic) administration in
60 patients treated with VV-ECMO for ARDS at Toronto General Hos-
pital. We recorded Sedation-Agitation Scale scores (SAS), medications
administered, routes and doses, CAM-ICU scores, and mobilization
while on ECMO.
Results: (INTERIM) 23 adults (19 males, 48 ± 11 years, APACHE II 31 ±
5) with severe ARDS (P/F 72 ± 19), mainly from pulmonary sepsis
(91 %), were treated with VV-ECMO from Jan 2012-July 2014. Median
duration of VV-ECMO was 9 days (IQR 5-11). At 48 hr post ECMO initi-
ation all patients were deeply sedated (SAS[<=]3), with 96 % and
100 % receiving a sedative (midazolam 87 %, propofol 26 %) and
opioid (fentanyl 91 %) infusion respectively. Within 24 hr prior to
ECMO discontinuation, in patients who survived ECMO (78 %), 44 %
of patients were still deeply sedated. At this time, 89 % were receiv-
ing sedatives (67 % infusion vs 22 % intermittent) and 83 % were re-
ceiving opioids (72 % infusion vs 11 % intermittent). At 48 hr post
ECMO discontinuation 83 % of patients reached light levels of sed-
ation (SAS > 3). At this time point only 61 % were still receiving seda-
tives (33 % infusion vs 29 % intermittent) and 50 % were receiving
opioids (33 % infusion vs 17 % intermittent); 22 % were not receiving
any sedative or opioid. While on ECMO 57 % of patients had cisatra-
curium infusions for a median duration of 16 hrs (IQR 10-76). 88 %
had [>=]1 positive CAM-ICU score for delirium. Haloperidol and que-
tiapine were the primary antipsychotics used throughout ECMO
(30 % and 57 % respectively). 57 % of patients underwent physical
Critical Care 2016, Volume 20 Suppl 2 Page 108 of 182therapy within a median of 5 days of starting ECMO (IQR 3-7), yet
the majority (62 %) achieved only passive range of motion in bed
during ECMO.
Conclusions: Patients with ARDS were deeply sedated with mida-
zolam and fentanyl infusions after VV-ECMO initiation. Patients transi-
tioned from deep to light levels of sedation around the time of
ECMO discontinuation with many receiving sedation and analgesia
via intermittent bolus or not at all. Few patients were actively mobi-
lized during ECMO treatment.
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Introduction: Veno-venous ECMO is a well-established life-saving
measure in patients with severe acute respiratory failure refractory to
conventional therapies. There are currently no accepted definite
guidelines defining the suitability of patients nor studies outlining
the outcomes of all patients referred. Criteria for acceptance and re-
fusal are defined according to international standards and clinical
judgement. We aimed to characterise the patient population based
on whether they were refused or accepted into the ECMO service,
and compare the outcomes in each category.
Methods: We reviewed all patients referred for veno-venous ECMO
to one national centre over 44 months. Clinical parameters include
gender, age, working diagnoses; referral centres, ventilator require-
ments, respiratory investigations and survival information. All refer-
rals were categorized according to whether they were accepted or
refused. The refused cohort was substratified based on whether they
were ¡®too well¡¯ or ¡®futile¡¯. Patients were followed up to 180 days
after referral.
Results: Of 451 referrals, 276 (61 %) were refused whilst 125 (28 %)
were accepted into the service. The remaining 50 (11 %) were trans-
ferred to another national centre due to the lack of ECMO beds at
the studied centre. The mean age and duration of mechanical venti-
lation before referral were significantly higher in the futile group
(56.1 years, 5.1 days) compared to those who were accepted
(42.9 years, 3.1 days) or ¡®too well¡¯ (46.5 years, 3.3 days) (p <0.05).
The futile group had higher rates of multi-organ failure and severe
immunosuppression. Gender, body mass index, lung injury scores
and degree of hypoxaemia were similar in all 3 groups. Interestingly,
60 % of patients who were too well had higher lung injury scores
(Murray score ¡Ý3) compared to 45 % and 41 % in those who were
futile and accepted respectively. The survival of the ¡®futile¡¯ group
was poor; whilst those who were too well and accepted had similar
outcomes. At 180 days, 44 % of those who were too well had died,
whilst 15 % of those who were futile survived.
Conclusions: We present the first report on the outcomes of patients
who referred but not accepted for vv-ECMO in the context of a na-
tional centralised referral system. Identical survival at 30, 60 and
180 days between the accepted patients and the ones deemed too
well warrant further investigations.
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Introduction: The international Extracorporeal Life Support Organi-
sation (ELSO) publishes ECMO outcome scores. In 2015, Schmidt et al
validated the SAVE score which uses 12 pre-ECMO variables derived
from the ELSO dataset to assist in predicting survival after veno-
arterial ECMO and to allow comparison between centres - we have
evaluated our outcomes against this.Methods: All patients receiving ECLS had data prospectively collated
and where possible, a SAVE score was calculated - actual outcomes
were compared to provide quality assurance information and a stan-
dardised mortality ratio which we describe as our ‘SAVE SMR’.
Results: There have been 57 ECLS runs in 53 patients and 33 patients
who received peripheral VA ECMO – all of these cases were moribund
by conventional intensive care standards, and included 17 true eCPR
cases. Overall, 21 weaned (64 %) and 17 survived (52 %) – 3 who were
weaned but died, were refused transfer for destination VAD/transplant
assessment.
Within the VA ECMO group who were not eCPR at initiation, 13/17
(76 %) weaned and 11 survived (65 %). The SAVE-score was calcu-
lated for 13 cases, with 4 patients excluded as they were post planned
procedures (cardiac surgery or emergency VT ablation where 3/4
(75 %) survived).
The mean age was 37 years (15-64), mean SOFA score in the 6 hours
prior to ECMO cannulation being 17 (12-24) and the mean SAVE
Score was – ve 13 (-2 to- 20).
11/13 (85 %) patients were in the most severe category (V) as com-
pared to 6.7 % & 20.4 % in the derivation and validation cohorts in
the study. The predicted survival from our SAVE scores was 20.8 %,
whilst our observed survival to discharge was 61.5 %.
The standardized mortality ratio (SMR) for our service was 0.49.
Conclusions: King’s College Hospital ECLS service, which recently
won an international award from ELSO, performs excellently.
We recommend ensuring that centres undertake benchmarking for
governance purposes.
We recommend supporting centres that do not impose restrictive cri-
teria in regard of the initiation of ECLS – moribund patients (INTER-
MACS classification 0 or 1) can do well with mechanical circula-
tory support.
Destination therapy & commissioning remains a problem within
the UK.
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Introductions: Patient selection for veno-arterial extracorporeal mem-
brane oxygenation (VA-ECMO) in refractory cardiogenic shock, in par-
ticular the early recognition of futility, remains a significant clinical
challenge. Previous case series and the SAVE score [1] have focussed
on variables that predict in-hospital mortality. The early identification
of those patients who are likely to deteriorate and die within 48 hours
despite VA-ECMO is an attractive paradigm to guide clinical decision
making and improve appropriate resource utilization.
Methods: Data were retrospectively collected from the records of
consecutive patients supported with VA-ECMO at Spectrum Health
between January 2010 and October 2015. Based on a review of the
current literature, 8 candidate predictors of 48 h-mortality were ex-
pertly selected (Image 1); the ‘worst’ value within the 24 hours prior
to ECMO cannulation was considered for modeling. Ridge regression
[2] was used to develop a risk prediction model and cross validation
applied to select the optimal tuning parameter. Model discrimination
was assessed using the area under the receiver operating curve
(AUC) and calibration was assessed using several common indices.
Results: 141 patients were included. 48 h-mortality was 16 % (22 pa-
tients) with an in-hospital mortality of 43 %. The model demon-
strated good discriminatory power AUC = 0.79 (Bootstrap 95 % CI =
0.68 to 0.88) and good calibration. Arterial pH shows the strongest
association with mortality in our model (Fig. 72).
Conclusions: In a small retrospective cohort study, an 8-parameter
score of pre-ECMO variables predicted mortality with an AUC of
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quired, the use of pre-ECMO variables corresponds with medical
decision-making in real-time, enhancing clinical utility in the acute-
setting.
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Introduction: Our aim was to assess spirometry values 6 months post
ECMO. ECMO is used in severe acute respiratory failure ref-
ractory to conventional management. Support entails gas exchange
through an extracorporeal oxygenator allowing lung rest as the
underlying pathology resolves whilst preventing further damage
from ventilator associated lung injury. Knowledge and experience in
ECMO is growing however the significant costs and potential compli-
cations associated with the technique mean it is imperative to evalu-
ate the longer term outcomes.
Methods: Glenfield hospital is one of five centres in the UK com-
missioned by NHSEngland to provide respiratory ECMO support. All
adult ECMO survivors are invited to a follow up clinic 6mths post
ECMO decannulation and undertake spirometry by rolling seal. FEV1
(Forced Expiratory Volume in 1 sec), FVC (Forced Vital Capacity) and
PEF (Peak Expiratory Flowrate) are measured and compared to nor-
mal values indexed to patient’s age, gender and Body Mass Index.
Results: Between January 2011 and June 2015 100 patients attended
follow-up clinic. Average age 42.4 years (SD 12.9) with 48 % males.
Average number of days on ECMO was 8.5 (SD 6.3).
Six patients were unable/unwilling to undertake spirometry leaving
94 patients’ data for analysis. Mean FEV1, FVC and PEF, presented as
a % of that predicted (standard deviation) were 84.5 % (SD 21.4 %),
87.9 % (SD 21.5) and 97.6 % (SD 27.9) respectively. Normal values
are > =80 % predicted. 19 patients (20 %) had a FEV1 < 70 % pre-
dicted, of which 7 patients (39 %) had a diagnosis of asthma. 19 pa-
tients (20 %) had FVC values <70 % predicted, indicating a moderate
or severe restrictive defect. Patients with FVC or FEV1 < 70 % had a
significantly longer time on ECMO than patients with values > 70 %
(11.3 vs 6.2 days, p < 0.001).
Conclusions: 20 % of our ECMO survivors demonstrated a moderate/
severe obstructive, restrictive or mixed defect. These patients had a
significantly longer ECMO run than those with normal values. Thisis comparable to a smaller study in ECMO patients and 2 studies
assessing spirometry in conventionally treated ARDS patients at
6 months (1-3).
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Introduction: Low tidal volume ventilation improves outcomes in the
acute respiratory distress syndrome, but may impair carbon dioxide
(CO[sub]2[/sub]) clearance. Extracorporeal carbon dioxide removal
(ECCO[sub]2[/sub]R) can control CO[sub]2[/sub], but existing devices
are expensive and require considerable expertise to operate. Since
CO[sub]2[/sub] is transported predominantly as bicarbonate, using
dialysis to remove bicarbonate offers several advantages, but this ap-
proach has been limited by bicarbonate replacement problems. How-
ever, contemporary understanding of acid-base balance treats
bicarbonate as an anion whose concentration is dependent on the
strong ion difference (SID). We hypothesised that a novel dialysate
designed to remove bicarbonate, but maintain SID, would lower
CO[sub]2[/sub] with no change in pH. We tested this hypothesis in a
rodent dialysis model, comparing our dialysate to a conventional so-
lution (Prismasol™).
Methods: 14 Sprague-Dawley rats (400-600 g) were anaesthetised with
ketamine, xylazine and butorphanol, then intubated and placed on
mechanical ventilation. A femoral and jugular vein were cannulated to
provide dialysis access. Ventilation rate was adjusted to create hyper-
capnia and dialysis commenced. Dialysis was provided using a M10 fil-
ter (Baxter, France), and the dialysate was constructed such that no
bicarbonate is present, but SID was maintained. Blood gases were
tested hourly (iStat, Abbott). Control dialysis experiments were per-
formed with Primal™ (Baxter, France). Data is reported as mean and
standard deviation and differences compared using Students t-test.
Results: Using a blood flow and dialysate flow rate of 1 ml/min,
mean pre-filter partial pressure of CO[sub]2[/sub] (PCO[sub]2[/sub])
was 78 mmHg (±14) whereas mean post-filter PCO[sub]2[/sub] was
70 mmHg (±14) using Prismasol and 12 mmHg (±5) using our bicar-
bonate free dialysate (p < 0.001). Removal of bicarbonate did not sig-
nificantly affect pH across the dialysis filter (0.003, p = 0.49). This
translates to the removal of 0.041 ml/min (±0.0019) of CO[sub]2[/
sub]. When scaled up to an adult dialysis filter of 0.9 m2, with a blood
flow of 200 ml/min, it’s the equivalent of removing 175 ml/min
(±8.25) of CO[sub]2[/sub].
Conclusions: A bicarbonate free dialysis solution designed to main-
tain the SID, lowers PCO[sub]2[/sub] in post-filter blood, when com-
pared to conventional dialysate, while maintaining pH. We estimate
we could remove 175 ml/min of CO[sub]2[/sub] in adults, existing low-
flow ECCO[sub]2[/sub]R devices only remove 90 ml/min.P266
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Introductions: The purpose of this study was to evaluate the as-
sociation of procalcitonin, interleukin-6, interleukin-8 and interleukin-
10 plasma levels during the first 72 hours after lung transplantation
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(PGD), ICU mortality and graft function one year after LT
Methods: Prospective observational study in a 32-bed mixed ICU.
Procalcitonin, Interleukin-6, 8, 10 plasma levels were measured at
24 h, 48 h, 72 h after LT from 100 LT-recipients included prospect-
ively. Patients were followed until one year after LT. Time and cause
of death were recorded.
Results: Procalcitonin at 24 h were associated with PaO2/FIO2 over
the first 72 h and the severity of PGD at 72 h after LT (procalcitonin
at 24 h of patients with grade 0-2 PGD were different from those pa-
tients with grade 3 PGD) (p < 0.01). PCT levels at 24 h was higher
from the 9 patients who died, (p = 0.02), AUC = 0.74 predict ICU-
mortality. Procalcitonin and interleukin-10 at 24 h, 48 h, 72 h were
correlated with the FEV1 one year after LT. Interleukin-10 at 48 h,
also were correlated with the FVC one year after LT
Conclusions: Higher levels of procalcitonin at 24 h following LT are
associated with grade 3 PGD at 72 h and ICU mortality. Interleukin-
10 and Procalcitonin levels during 72 h posttransplantation were as-
sociated with patients with worse graft function after one year.Table 36 (Abstract P266). Characteristics of the population and global
outcomes.
Age, median (IQR) years 55 (48–60)
Male, no. 59
Bilateral lung transplant, no. 51
Unilateral of lung transplant, no. 49
APACHE II score, median (IQR) 19 (16-23)
Respiratory infection, no. 39
Rejection, no. 29
T0 Grade 3 PGD, no. 50
T24 Grade 3 PGD, no. 33
T48 Grade 3 PGD, no. 25
T72 Grade 3 PGD, no. 22
ICU mortality, no. 9P267
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Introductions: Acute respiratory distress syndrome (ARDS) is a com-
mon complication of nosocomial pneumonia (NP) in patients with
abdominal sepsis. The aim of this study was to investigate into new
molecular biomarkers of ARDS in abdominal sepsis.
Methods: The observational study in ICU ventilated septic patients
with peritonitis (76 %) and pancreonecrosis (24 %) was performed in
2010 and 2015. ARDS was diagnosed and staged according to the
V.A. Negovsky Research Institute criteria and the Berlin definition.
Plasma surfactant protein A and D (SPD, SPA) were measured on day
0, 3, 5 by the immunoenzyme essay (BioVendor, USA). Patients
were treated according to the international guidelines. Data were
statistically analyzed by STATISTICA 7.0, ANOVA and presented as
median and 25-75th percentiles (ng/ml); p < 0.05 was considered
statistically significant. Areas under the receiver operating curves
were calculated.
Results: One hundred patients (out of 783 screened) were enrolled
in the study according to the inclusion/exclusion criteria. Patients
were assigned into groups: NP + ARDS (n = 55, 45 ± 5.1 years old, M/F
50/5, mortality 29,0 %) and NP (n = 45, 42 ± 5.8 years old, M/F 41/4,
mortality 26,6 %). Groups were comparable in APACHE II and SOFA
scores on the baseline. In the NP + ARDS group SPD was higher at allpoints than in the NP group. Plasma SPD on day 0 > 111.2 ng/ml
yielded a sensitivity of 68.2 % and specificity of 92.3 % (AUC 0.85;
95 % CI 0.684-0.945; p < 0.0001) for diagnosing ARDS in NP. A com-
plex ROC analysis (SPD + P/F ratio <280 + EVLWI >8.3 ml/kg) yielded
a better diagnostic accuracy of SPD: cutoff >93.7 ng/ml, sensitivity
81.0 %, specificity 100.0 % (AUC 0.96; 95 % CI 0.817-0.998; p <
0.0001). SPA on day 0 is not informative for ARDS diagnosis (SPA >
36.2 ng/ml, sensitivity of 51.2 %, specificity of 92.3 %, AUC 0.61; 95 %
CI 0.474-0.745; p < 0.1168). Plasma SPA was significantly lower in sur-
vived versus died patients with ARDS. Plasma SPA on day 0 >
=18,6 ng/ml yielded a sensitivity of 88,9 % and specificity of 72 > 7 %
for prediction of mortality in ARDS patients on day 5-6 of ICU stay
(AUC 0.86; 95 % CI 0.685-0.962; p < 0,0001).
Conclusions: Thus, in abdominal sepsis patients with NP and ARDS
new molecular biomarkers can be used for ARDS diagnosis (SPD) and
prognostification of outcomes (SPA).
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Introduction: Acute Lung Injury and acute respiratory distress syn-
drome (ALI/ARDS) is characterized by tight junction’s (TJ’s) barrier dis-
ruption and changes in the composition and integrity of Claudins
(CLDN) which are components of TJ’s. CLDN5 is highly expressed and
augment permeability in lung parenchyma, although the regulation
by inflammatory stimuli remains elusive. This study aims to in-
vestigate CLDN5 expression and regulation by TNF, in LPS-induced
ALI/ARDS in mice.
Methods: Lung injury was induced by intratracheal LPS admi-
nistration in adult male C57BL/6, and TNF-/- mice. Mice underwent
bronchoalveolar lavage (BAL) and sacrificed at 6 h and 24 h after LPS
administration. Histological score of ALI was assessed in lung tissues.
CLDN5 cellular localization was evaluated by immunohistochemistry,
while its expression levels were verified by Western blotting.
Results: In mice lung tissue, following LPS administration, CLDN5 im-
munoreactivity was distributed along the alveolar epithelium and
vascular endothelium. CLDN5 protein expression levels was increased
by 3 fold along with ALI characteristics (augmented in BALF cellularity,
protein content and ALI score). In TNF-/- mice, CLDN5 expression is sta-
tistically reduced as early as 6 h after LPS administration with conse-
quently increased in BALF protein content. In addition increased
CLDN5 expression was observed upon 24 h LPS administration. TNF bi-
phasic action on CLDN5 expression was dependent on ERK1/2 expres-
sion levels.
Conclusions: In LPS induced ALI/ARDS in mice, CLDN5 was increased
associated with ALI severity. Moreover, TNF regulates CLDN5 ex-
pression, and TJs permeability dependent in part on ERK1/2 pathway.
Our findings emerge the role of Claudins and especially CLDN5 to eluci-
date the pathophysiology of this form of injury.
P269
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Introductions: Adult respiratory distress syndrome (ARDS) is cha-
racterized by a breakdown of capillary integrity, leading to the leak-
age of protein-rich fluid and the accumulation of inflammatory cells
within the airspaces. Bronchoalveolar lavage (BAL) is the commonly
used method to obtain lower respiratory tracts samples and to define
the role of cells in the inflammatory response in ARDS. However,
there is the need to assess the feasibility of using relatively non-
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ies of the lower respiratory tract in ARDS patients.
Methods: EASP samples were taken from 25 ICU mechanically venti-
lated ARDS patients, at <36 h, <6d, and >6d from admission. Total
cell counts/ml were determined in a Neubauer chamber and differ-
ential cell counts were performed on a cytospin preparation stained
with Diff-Quick.
Results: The total number of cells in all ARDS EASP samples was 89
± 25x104/ml; median cell viability 89 [80–95]%. A correlation was
found between neutrophil counts in blood and in the EASP speci-
mens (ρ =0.42 p = 0.04).
Total cell counting tended to be lower within 36 h samples, but not
statistically different from sampling at other times. In subjects with
bacterial infection and ARDS, high neutrophil percentage was found
up to 6d (95[82–98]%); the percentage slightly decreased at >6d
(85[74–97]%).
Macrophage percentage had a trend for being higher in ARDS pa-
tients with a positive bacterial culture compared to those with a
negative one (15[5–27]vs5[3–12];p = 0.066).
Macrophage and neutrophil percentage according to ARDS etiology
are reported in Fig. 73.
Conclusions: EASP analysis found an increase in neutrophils in bac-
terial infection vs non-infective ARDS patients. In addition, different
risk factors for ARDS were associated with different percentage of
macrophages and neutrophils in EASP. Following our preliminary
findings, further studies are required to assess if monitoring EASP cel-
lularity over time could be useful to evaluate prognosis in ARDS.Fig. 73 (Abstract P269).P270
Epidemiological and clinical profile of patients with acute
respiratory distress syndrome in the surgical intensive care unit
surgical, hospital JRA, Antananarivo
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Introduction: Acute respiratory distress syndrome (ARDS) is a very
common situation for patients hospitalized in intensive care. It is as-
sociated with a high morbidity and mortality rates and the manage-
ment is always a great challenge for intensive care. The objective of this
study is to describe the epidemiological and clinical profile of patients
with ARDS in the surgical ICU of the University Hospital Joseph Ravoa-
hangy Andrianavalona JRA Antananarivo Madagascar
Methods: This study of twelve months was led from January to De-
cember 2014 in the surgical ICU of JRA Hospital Antananarivo. It in-
cluded all patients with clinical and radiological signs of ARDS. Age,
gender, clinical and radiological signs, treatment and outcome of the
patients were considered.Results: Twenty-six patients were identified, that means 1.74 % of
patients hospitalized in intensive care during the study period. The
average age was 56 years with a sex ratio M / F 1.16. Of these pa-
tients, 62 % had a history of ethyl and smoking, 8 % had asthma and
30 % had no particular experience. In 69 % of cases, ARDS was
present at intake and is a reason for hospitalization. In ARDS, 31 % of
patients had hemodynamic shock with failure and 15 % of them
were associated with liver failure. All patients were put on antibiotics
treatment and 85 % of them were on mechanical ventilation. The
mortality rate was high 81.61 % in a context of multiple visceral
failure.
Conclusions: In this study, ARDS affects mainly young patients with
respiratory history. The management is very heavy especially in a
country like ours because of the lack of materials and particularly
monitoring. The mortality rate from ARDS remains high. Currently
the development of the prone technique and body extra support
may improve the ARDS mortality rate.
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Effect of high PEEP after recruitment maneuver on right
ventricular function in ARDS. Is it good for the lung and for the
heart?
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Introduction: Protective ventilatory strategies for ARDS with lower
tidal volumes and higher PEEPs may benefit the lung. But high PEEP
may induce right ventricular (RV) dysfunction which may severely im-
pair hemodynamic. We hypothesized that opening the lung with re-
cruitment maneuver, followed by maintaining high PEEP may be
good for the lung and for the heart.
Methods: We included ARDS patients (P/F < 200) under mechanical
ventilation sedated and paralyzed. An open-lung protocol consisting
of a 4-step recruitment maneuver (from 25 to 40 cm of PEEP) and a
decremental PEEP titration (to find the best PEEP named open-lung
PEEP) was performed after ruling out hypovolemia. We recorded
mean arterial pressure (MAP), cardiac output (CO), right-to-left ven-
tricle diameter ratio (RV/LV) using echocardiography, tricuspid annu-
lar plane systolic excursion (TAPSE), aortic velocity time integral (VTI),
systolic lateral RV annulus velocity (S) during the recruitment maneu-
ver at 40 cmH2O and 1 hour and 24 hours after this maneuver at the
chosen best PEEP (open-lung PEEP).
Results: 10 patients with ARDS (age 55 ± 13, SAPS 70 ± 15) were in-
cluded. The median PEEP increased from 9 (6.0 – 13.5) cmH2O at
baseline to 21.0 cmH2O (16.0 – 23.0) (p < 0.01) at openlung PEEP.
PO2/FiO2 increased from 70.6 (40.6 – 89.6) to 209 (141 – 229),
p < 0.01. RV/LV increased from 0.70 [0.58 – 0.75] to 0.80 [0.73 – 0.83],
p = 0.02, during PEEP of 40cmH2O and returned to baseline values
(0.75 [0.63 – 0.89], p = 0.10) at open-lung PEEP. The TAPSE decreased
from 18 [17 – 21]mm to 16 [15 – 17]mm (p = 0.02) at a peep of 40
cmH2O, returned to baseline 18 [17 – 19]mm at open-lung and
remained stable 24 hours later. S presented the same pattern. MAP
dropped from 89 [73– 95]mmHg at baseline to 70[60– 81]mmHg
(p = 0,01 vs baseline) during the last step of recruitment, was 70
[69–77]mmHg at open-lung PEEP, and was 79[67– 84]mmHg 24 hours
later. CO decreased from 5.9 l.min-1 (IQR 4.6 – 7.3) to 4.4 l.min-1 (IQR
3.5 – 6.4) during recruitment but returned to baseline value at open-
lung PEEP (5.6 l.min-1 (IQR 4.4 – 7.1)) and remained stable at
24 hours. Ejection fraction was unchanged at open-lung PEEP and at
24 hours, compared with baseline value.
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to open the lung with an increase of P/F and apply high PEEP of 21
cmH20 to maintain the lung open. The right ventricular function was
not impaired, confirming that what is good for the lung may be not
deleterious for the heart.P272
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Introduction: In ARDS patients under mechanical ventilation recruit-
ment maneuver may open the lung and improve blood oxygenation.
During this maneuver cardiac dysfunction may occur. We decided to
analyze using speckle tracking, the effect of recruitment maneuver
on the left ventricular longitudinal strain (LVLS).
Methods: We included ARDS patients under mechanical ventilation
sedated and paralyzed with P/F < 200. An open-lung protocol con-
sisting of a 4-step recruitment maneuver (from 25 to 40 cm of PEEP)
and a decremental PEEP titration (to find the best PEEP) was per-
formed after ruling out hypovolemia and severe acidosis. We re-
corded clinical parameters (mean arterial pressure (MAP), heart rate
(HR)) as well as ejection fraction (EF) using 2D echocardiography, mi-
tral annular plane systolic excursion (MAPSE) with M-Mode echocar-
diography, aortic velocity time integral (using pulsed Doppler)(VTI),
systolic lateral LV annulus velocity using spectral tissue Doppler im-
aging (S) and left ventricular longitudinal stress (LVLS) using speckle
tracking at baseline, during the recruitment maneuver at 40 cmH2O
and 2 minutes after this maneuver at the chosen best PEEP.
Results: 9 patients with ARDS (age 55 ± 13y/o) with SAPS 70 ± 15, P/F
130 ± 19, lung compliance 26 ± 8 ml/mmHg, PEEP 9 ± 3 cm H2O, re-
spiratory rate 25 ± 5/mn, MAP 78 ± 12 mmHg, HR 85 ± 12/mn, EF 60
± 18 %,VTI 22 ± 6 cm, MAPSE 1,3 ± 0,5 cm, S 8,4 ± 4,5 cm/s, were in-
cluded. During recruitment at a PEEP of 40 cmH2O, HR 90 ± 14/mn
and P/F176 ± 85 increased; MAP 62 ± 22 mmHg, MAPSE 1,3 ± 0,5 cm;
S 8,4 ± 4,6 cm/s; EF 49 ± 22 %, VTI17 ± 8 cm all decreased. At the
best PEEP of 12 ± 5cmH2O, P/F dramatically increase to 242 ± 80
and all hemodynamical and echocardiographic and Doppler pa-
rameters returned to the baseline values. LVLS was at -15,6 ±
5,6 % at baseline and dramatically increased to -8,1 ± 5,6 at a
PEEP of 40cmH2O and returned to the baseline value of -13,8 ±
5 % immediately after the recruitment maneuver. This left longitudinal
strain impairment during the maneuver was more severe at the apex
(-19 ± 8 % vs -7 ± 8 %).
Conclusions: Recruitment maneuver induces transient LV systolic
dysfunction particularly at the apex of the LV. This dysfunction maybe
due to a transient myocardial ischemia and disappears immediately
after this maneuver.P273
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Introduction: Updating equipment in Critical Care is important to im-
prove practice but changing to a new service involves a significant
amount of effort from initial planning to final launch. This study was
designed to evaluate the stages of implementation, quantify the time
spent and the cost of updating our nitric oxide delivery service. Nitric
Oxide is one of the most expensive therapies currently used in
our Hospital accounting for over 700,000 Euros (€) per annum.
Estimated cost savings (€350,000) have to be weighed against
clinical risk and the cost of implementing a new device.
Methods: Updating the nitric oxide delivery system was relevant to
Adult (AICU) and Paediatric Intensive Care Units (PICU), Catheter La-
boratories and Theatres. The implementation plan was studied to es-
tablish the number of hours and cost of each stage using meetingminutes, email correspondence, training records and working time
equivalent calculations.
Results: 1. Testing equipment and trial of the new device on AICU
and PICU: carried out by Clinical Engineering. Six months was spent
testing and modifying the equipment so it was safe to use in a clin-
ical setting and a further six months to find a suitable patient. Time
spent 35 hours and cost = €5320.
2. Approval to switch: approved at a Clinical Practice Committee
meeting and with Divisional Directors. Time spent = 7 hours and
cost = €408.
3. Develop a costing model: data from our electronic prescribing sys-
tem was used to establish the number of patients, hours of treat-
ment and the volume of gas used in the financial year of 2014/15.
This information was essential to calculate the number of cylinder re-
fills, number of consumables required, and the cost of the rental for
the machines and cylinders. These data were presented to Finance
to highlight potential cost savings for switching delivery systems.
Time spent = 36 hours and cost = €2,100.
4. Contract: a service level agreement for the new service was agreed
between Pharmacy, Clinical Engineering, Procurement and the com-
pany. An agreement was made on number of machines and cylin-
ders to be held on site, timescale for urgent deliveries of back-up
machines and cylinders and annual service requirements. This was
signed by the Director of Operations and the Director of Phar-
macy. Time spent = 14 hours and cost = €532.
5. Training of staff: Training sessions to nurses and doctors of all
grades for AICU amounted to 20 hours of time spent at a cost of
€582. Training for PICU was 30 hours and cost €620. Training for Cath
Labs and Theatres was 3.5 hours and cost €100.
Conclusions: This evaluation has shown that switching to a new ni-
tric oxide delivery system was cost effective (€9662) but the time
(145.5 hours), effort and clinical risk involved was huge. A carefully
considered implementation plan was essential for a safe and successful
switchover.
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Introduction: Acute pancreatitis is known to have a variety of causes,
but the specific death rate and severity for each cause remains un-
known. Epidemiological studies of acute pancreatitis have been re-
ported in China and Europe, but these have not included statistical
analysis of factors affecting the outcomes of patients; thus, there is a
need for examination.
Methods: The present study was a retrospective study. We studied
cases of severe acute pancreatitis in 20 Japanese facilities from Janu-
ary 2009 to December 2013. The target cases were divided into four
groups: gallstone, alcoholic, idiopathic, and other cases. We exam-
ined the relationship between patient outcomes by cause and vari-
ous types of factors using statistical techniques.
Results: The total cases of severe acute pancreatitis (n = 1159) were
divided into gallstone cases (n = 456), alcoholic cases (n = 456), idio-
pathic cases (n = 240), and other cases (n = 222). According to the
comparison regarding the background of patients, young men were
prone to be more in the alcoholic group. A comparison of patient
outcomes revealed significant statistical differences for rates of admi-
nistration of early enteral nutrition (gallstone 22.8 %, alcoholic 30.9 %,
idiopathic 26.2 %, other 20.2 %, p = 0.014), mechanical ventilation man-
agement (31.5 %, 27.6 %, 37.9 %, 29.2 %, p = 0.043), and mortality
(14.1 %, 8.1 %, 16.6 %, 17.5 %, p = 0.001) among the four groups.
We performed a multivariate analysis for death at the time of dis-
charge from hospital and development of infection. The odds ratio
for death at the time of discharge from hospital for patients who re-
ceived early enteral nutrition was 0.48 (95 % CI 0.28 to 0.81). These
Critical Care 2016, Volume 20 Suppl 2 Page 113 of 182results showed the different relationship among the groups. In the
group of cause-specific cases, a similar trend was observed only in
patients with gallstones.
The odds ratio for the development of infection for patients in the al-
coholic group who received early enteral nutrition was 0.26 (95 % CI
0.10 to 0.63). In the other group, we couldn ft indicate the same ten-
dency statistically.
Conclusions: The results of the present study suggest that the factors
contributing to an improvement in outcome may differ according to
the cause of severe acute pancreatitis. There might be a need to
examine tailor-made treatments for severe acute pancreatitis accord-
ing to cause.
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Introduction: Severe liver failure is common and carries a high mor-
tality risk in patients with both acute and acute-on-chronic liver fail-
ure. Extracorporeal liver support therapy (ECLST) could be one of the
treatment option. But despite proven biochemical efficacy, there are
little data regarding clinical end points. We show our experience for
more than six years in our ICU.
Methods: Single-center retrospective observational study that en-
rolled patients with hepatic failure treated with ECLST, between No-
vember of 2006 and December of 2012. Data on demographics,
clinical characteristics, SOFA and MELD were evaluated. Excel and
GraphPad Prism were used for statistical analysis.
Results: 15 patients were enrolled, that underwent in total 22 sessions.
8 (53 %) were men, with an average age of 46 ± 14, mortality rate
53 %. 2 patients (13 %) were admitted due to acute liver failure (ACF)
and the other 13 (87 %) due to acute-on-chronic liver failure (ACLF).
The length of stay (LOS) was 12.40 ± 11.54 in the ICU and 35.13 ±
31.04 days in the hospital. SOFA and MELD score at admission
were respectively 9.47 ± 3.66 and 30.13 ± 8.55; before the session
9.77 ± 4.29 and 31.2 ± 9.1; after the session 9.14 ± 3.91 (p = 0.14)
and 30.91 ± 5.81 (p = 0.514). After ECLST there was a decrease in
total bilirubin (24.99 ± 5.61 mg/dL to 15.15 ± 4.38 mg/dL, p <
0.0001), creatinine (1.01 ± 1.044 mg/dL to 0.63 ± 0.732 mg/dL, p <
0.001), BUN (49.59 ± 40.95 mg/dL to 25.14 ± 20.89 mg/dL, p <0.0001)
and platelets (69.000 ± 50.800/mm3 to 54.000 ± 34.800/mm3, p <0.005).
The global mortality rate was 60 %. 33 % of the patients (5) were
submitted to a liver transplante, with a mortality rate of 0 %,
wether the mortality rate in the patients without liver transplant
was 90 %.
Conclusions: ACF and ACFL have high mortality rate without liver
transplant, although extracorporeal liver support therapy improved
total bilirubin, creatinine and BUN. Nevertheless, the value of extra-
corporeal liver support remains to be corroborated by further clinical
studies that include the optimal timing, mode, intensity and duration
of this treatment.
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Introduction: Acute-on-chronic liver failure (ACLF) is a distinct syn-
drome from acute liver failure (ALF) characterised by acute decom-
pensation, organ failure and high short-term mortality (50 %) [1].
Several novel measures (Consortium Liver Failure-SOFA (CLIF-SOFA)
and Royal Free Hospital (RFH) scores) have been specifically devel-
oped to predict mortality in ACLF, however their validity has not
been assessed in ALF [1]. The aim of this study is to compare theperformance of mortality prediction models in ALF and ACLF in the
intensive care unit (ICU) setting.
Methods: Retrospective data were collected on patients admitted
with liver failure to ICU between 2008 and 2014. Demographic,
clinical and biochemical parameters were recorded on admission
to ICU. The main outcome was death in ICU. The scores were
calculated for CLIF-Organ failure (CLIF-C OF, a shortened version
of CLIF-SOFA), CLIF-ACLF (includes age and white cell count),
RFH, Model for End-Stage Liver Disease (MELD) and Acute Physi-
ology and Chronic Health Evaluation (APACHE II). Accuracy and
calibration of the scoring systems were assessed using area
under the receiver operator curve (AUROC) and goodness-of-fit χ
respectively.
Results: 220 patients were included in the study (ACLF = 118, ALF =
102). The main aetiology of cirrhosis in ACLF group was alcohol
(91.5 %). The leading causes of ALF were paracetamol overdose
(48 %), alcoholic hepatitis (31.4 %) and viral hepatitis (11.8 %). ACLF
patients were significantly more likely to have longer stay (median 6
vs. 3 days, p < 0.005) and higher risk of dying (54.2 % vs. 33.7 %,
χ <0.05). In general, the scoring systems performed better in ALF
(AUROC values: CLIF-OF 0.77; CLIF-ACLF 0.79; RFH 0.80; MELD 0.80;
APACHEII 0.76) compared to ACLF (AUROC values: CLIF-OF 0.68; CLIF-
ACLF 0.68; RFH 0.72; APACHEII 0.65; MELD 0.71). Calibration of the
models was acceptable across the both groups, except for APACHEII
in ALF patients (χ =14.2, p < 0.05).
Conclusions: Mortality and morbidity is higher in ACLF compared to
ALF. Prediction models developed in ACLF populations perform even
better in ALF. This could be possibly explained by relatively few co-
morbidities in ALF. In our patient cohort, the highest accuracy was
achieved using RHF and MELD scores rather than CLIF-SOFA based
measures.
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Introduction: It is known that the risk of hemorrhage in patients with
chronic liver disease is higher compared with general popu-
lation. However, the evidences between chronic liver disease and
coronary artery disease are inconclusive. We investigated the diag-
nosis of coronary artery disease in patients with chronic liver disease
in Taiwan to evaluate if there is a higher risk compared to the gen-
eral population.
Methods: We utilized a sampled National Health Insurance claims
database containing one million beneficiaries. We followed all adult
beneficiaries older than 18 years from January 1, 2007 till December
31, 2010 to see if they were diagnosed with coronary artery disease.
We further identified patients with liver disease and compared their
risk of coronary artery disease with the general population.
Results: We identified 28,511 patients with chronic liver disease and
728,285 patients without. After controlling for age, gender, urbanization
level, socioeconomic status, diabetes, hypertension, hyperlipidemia, ma-
lignancies, heart failure, atrial fibrillation, smoking, obesity, peri-
pheral artery disease and Charlson Comorbidity Index score, the ad-
justed hazard ratio was 0.74 (95 % confidence interval, 0.65¡X0.84) in
patients with chronic liver disease. In subgroup analyses of cirrhotic pa-
tients with severe complications, the hazard ratio of coronary artery dis-
ease is much lower compared with general population, but the result is
not statistically significant. (hazard ratio, 0.30; 95 % confidence interval,
0.04¡X2.14)
Conclusions: Chronic liver disease may be associated with decreased
risk of coronary artery disease. However, no severity-effects associa-
tions can be observed.
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Introduction: 809 Liver Trasplantations (LT) were made at Hospital
Clínico Universitario de Santiago de Compostela (Spain) in the period
1994-2014, accounting 4.25 % of all LT performed in Spain (19005
cases, according to the Spanish Liver Transplant Registry- RETH).
20 years of experience review and comparison of Acumulated Sur-
veillance Rates of our experience respect to the Spanish data pro-
vided by RETH.
Methods: Retrospective and descriptive study of 809 cases of LT per-
formed from 1994 to 2014 at Hospital Clínico Universitario de
Santiago de Compostela (Spain) based in our local LT Registration
and in the National Spanish Registration- RETH.
Results: 809 LT cases, 12 of which were Hepatorenal Transplantations,
3 required a Re-Transplantation. Media of LT: 36 LT/year. Gender:
79.35 % were Male and 20.64 % Female with a Mean Age of 51 years
old. Blood Group Predominancy: A positive (49 %) followed by the
group 0 positive (39 %). The most frequent indication of TL was:
Alcohol-related Cirrhosis (43 %), followed by Idiopathic (43.01 %) and
Fulminant Hepatic Failure (6.18 %). The most common indication for
Re-Transplantation was Hepatic Artery Thrombosis (34 %) followed by
Primary Allograft Dysfunction (28.57 %). Mortality at 20 years: 34.86 %,
the most frequent cause of Death was: Recurrence of Underlying Dis-
ease (28 % with a 80 % rate in Hepatitis C Virus Cirrhosis) followed by
Bacterial/Fungal infections (20 %). The Acumulated Surveillance Rate at
20 years is 47 % in our series, higher in comparison with the overall
data provided by RETH (37 % using Kaplan-Meier Curve p <0.01) and in
the last five years (2008- 2013) is 77 %, higher compared with RETH
data for the same period of time (70 % p <0.05). The Acumulated Sur-
veillance Rate at 20 years based on LT Indication: 70 % in Fulminant
Hepatic Failure group, 50 % in the Alcoholic Cirrhosis group and 35 %
in Hepatitis C Virus Cirrhosis. In Re-transplantation group, Acumulated
Surveillance Rate at five years (2008-2013) is just 23 %.
Conclusions: Alcohol-related Liver Disease, Hepatitis C Virus and
Hepatocellular Carcinoma are the most frequent Indications of LT in
the current Transplantation Program. Acumulated Sirveillance Rates
are similar to the ones found in other Transplantation Programs. The
main Cause of Death is Recurrence of the Underlying Disease,
followed by Infectious and Cardiovascular Diseases. High Mortality
Rates in Re-transplantation Group leads to a more careful selection
of cases.
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Introduction: We hypothesize that diarrhea can lead to intestinal fail-
ure associated liver disease (IFALD) in critical illness. Risk factors for
liver injury in the ICU include toxicity of drugs and TPN, but etiology
often remains unknown. Currently, there is emerging interest in the
relation between intestinal failure and liver injury. The oc-
currence of IFALD is mostly attributed to the use of TPN in patients
with intestinal failure, but recent data suggest that interruption of the
enterohepatic cycle also may be an important cause. Diarrhea induces
nutrient malabsorption but may also impair reabsorption of bile acids
and disturbance of the gut-liver axis. Along this line of reasoning diar-
rhea may be a hitherto unidentified risk factor for liver injury through
the development of IFALD.
Methods: We retrospectively analyzed patients admitted to our ICU
from September 2014 until February 2015. Markers of liver injury and
other clinical and biochemical parameters were recorded on the daydiarrhea (>250 ml/day) developed (median at the 2d day of ICU admis-
sion) and 2 days thereafter. In patients without diarrhea data were re-
corded at the day of ICU admission and 2 days later. Patients with liver
injury (defined as an elevation of serum y-glutamyltransferase or alka-
line phosphatase levels above reference values) on admission or at the
moment diarrhea occurred were excluded. 79 patients remained for
analysis (19 with liver injury). Uni- and multivariate analyses were per-
formed to identify risk factors for liver injury.
Results: In patients who developed liver injury the incidence of diar-
rhea (58 %) was higher than in control patients (22 %) p = 0.003, X2-
test. Multivariate logistic regression analysis showed that diarrhea is
an independent risk factor for the development of liver injury. (OR
4.1 (95 % CI 1.2-14.5), p = 0.028)
Conclusions: Diarrhea is an independent risk factor for the deve-
lopment of liver injury in the ICU. This supports the hypothesis that
disturbance of the liver-gut axis due to diarrhea and bile salt malab-
sorption in ICU patients should be regarded as a manifestation of in-
testinal failure, potentially leading to intestinal failure associated liver
disease. Future research should be aimed at unraveling mechanisms
of IFALD in ICU patients and at interventions limiting malabsorption
or its consequences for intestinal-hepatic bile salt signaling.P280
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Introduction: Constipation in critically ill patients is a common prob-
lem and has been associated with a number of significant complica-
tions including prolonged mechanical ventilation, increased length of
stay, compromise of intenstinal protective barrier and difficulty estab-
lishing enteral feeding [1].
Our intensive care unit (ICU) bowel care guideline specifies initiation
of treatment for constipation, defined as a patient not opening their
bowels for three consecutive days.
Methods: We retrospectively audited consecutive ICU patients over a
two-months to establish the incidence of constipation as well as ad-
herence to bowel care guideline. Patients were excluded if they had
stayed on the ICU for less than three days, had undergone recent
bowel surgery or were on an alternative bowel care protocol (e.g. en-
cephalopathy, spinal or brain injury patients).
Data collected included bowel care prescriptions, rectal examinations,
episodes of bowel opening and stool type.
Results: Of the 37 patients included, 43 % suffered a period of con-
stipation during their ICU stay. Treatment for patients who had not
had their bowels opened for three consecutive days was initia-
ted in only 44 % of patients. Treatment strategies for constipation
varied and were partially or fully compliant with guidelines in only
37.5 % of constipated patients. Despite similar APACHE II scores and
ages across the two groups, the incidence of a patient having at least
one episode of failure to feed via the enteral route occurred in a
higher proportion of constipated patients (69 %) compared with
non-constipated patients (35 %).
Conclusions: The incidence of constipation on our unit is decreasing,
however it remains a common problem, which seems to impact on
establishing enteral feeding. As it can cause potentially serious com-
plications in critical care patients, compliance with the guideline
should be improved. We have changed policy to include starting
prophylactic laxatives [2], unless contraindicated, in all new admis-
sions with earlier escalation of treatment. Continued education and
promotion of the new guideline is ongoing in our unit.
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Introduction: Phase angle (PA), obtained from bioelectrical impedance
analysis (BIA), is a non-invasive method, for measuring altered electrical
properties of biological tissues. It has been recognised as an objective
prognostic marker of disease severity and frailty. The aim of this study
is to determine, whether phase angle is a marker of malnutrition and
postoperative morbidity in low operative risk patients undergoing car-
diac surgery.
Methods: A prospective study was conducted in a tertiary hospital.
The nutrition state of cardiac surgery patients was evaluated using
BIA the day before scheduled surgery. After applying selection cri-
teria, 342 low operative risk patients were selected and classified into
two groups in accordance to PA value: a low PA group and normal
PA group. The correlation between low phase angle and low fat free
mass index (FFMI), a marker of malnutrition, was assessed. Associa-
tions between low phase angle and adverse postoperative outcomes,
defined by STS postoperative risk evaluation model, were analysed.
The impact of low PA on length of stay in ICU and hospital was
evaluated.
Results: Low PA was detected in 61 (17,8 %) patients in the selected
group, which consisted of low operative risk patients with median
Euroscore II value of 1,46 [IQR:0,97-2,03] and was associated with
FFMI with Pearson’s R of 0,515 (p < 0,001). Low PA was associated
with higher rates (13 (21,3 %) vs. 30 (10,7 %) p = 0,023) and risk of
postoperative morbidity in univariate regression analysis (OR =
2,27,Cl95% = 1,10-4,66, p = 0,026). Furthermore, low PA persisted as
an independent factor in multivariate regression analysis (OR = 2,50,
CI95% 1,18-5,29, p = 0,016) adjusted for preoperative risk factors of
postoperative morbidity. Evaluation of hospitalization length revealed
tendency of a prolonged hospitalization (>14 days) rate (31 (50,8 %) vs.
105 (37,8 %), p = 0,063) in the group with low PA.
Conclusions: A low preoperative phase angle is an indicator of mal-
nutrition and determines adverse outcomes after cardiac surgery.
Further research is needed to evaluate clinical applications of the
phase angle, such as a more accurate identification of malnourished
cardiac surgery patients.P282
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Introduction: Perioperative fasting reduces the risk of aspiration of
gastric contents. This risk is weighed against the risk of intraoperative
hypotension and insulin resistance postoperatively. Guidelines have
varied from the “nil-by-mouth-from-midnight” regime to the more lib-
eral “2-4-6” regime, as per the Association of Anaesthetists of Great Brit-
ain and Ireland (AAGBI) and ESA guidelines, whereby unlimited clear
fluids are allowed up to 2 hours preoperatively.
Methods: Adult patients were recruited prior to theatre on their day
of surgery. Fasting times were calculated using a verbal questionnaire
and noting the anaesthetic start time.
Results: All patients (100 %) exceeded the ESA fasting guidelines for
solids, with some fasting for greater than 24 hours before an elective
procedure. Fasting times for liquids were shorter, but on average
were in excess of 2 hours.
Conclusions: Patients, irrespective of whether they arrive on the day
of surgery or are inpatients fast for similar times, all longer than the
ESA guidelines. Patients and their families, as well as hospital staff
should be aware of current guidelines. Current protocols should be
adjusted to improve compliance.References
-ESA Guideline on Pre-operative fasting, European Journal of Anaesthesiology
2011
-Audit on preoperative fasting of elective surgical patients in an African
academic medical center. World J Surg 2014
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Introduction: ICU is a local where there is a great concern with cost-
benefit ratio. Early enteral nutritional is recommended in cases of
critically patients and started within 48 h of initial treatment, after
hemodynamic stabilization. Early Feeding (EF) improves nutritional
outcomes, reduces ICU and hospital death, while Delayed Feeding
(DF) reduces feeding complications and ICU length stay. Patients sur-
vival improves total costs of care and reduces meaningfully in Early
Feeding. Our study objectives is if the EF would have influence on
costs, length stay, and final outcome in ICU and hospital when com-
pared with the DF.
Methods: This study was in a 50 particular hospital ICU beds in ES-
Brazil. 151 critically patients with nutritional therapy indication were
enrolled. This retrospective study (nov13-nov14) we grouped as EF,
until 48 h admission, and DF, after 48 h. We compared SAPS3, lenght
stay, direct costs (materials, medicines, gas and hospital fees), and
outcome. Medical records were extracted from the MVsystem and
Epimed Software. Differences between the groups was studied using
the Student-t for independent samples and the Ztest for two propor-
tions was used to assess the outcome. Significance level was 5 %
and 95 % confidence interval.
Results: We evaluated 151 patients, 56.1 % male, age 59.9yo ± 19,
SAPS3 44.1 ± 13.7. EF ICU and hospital length stay: 7.3d ± 11.2 and
21.0d ± 40.5; EF ICU and hospital daily cost: US$4,758 ± 22,006 and
US$863 ± 620; EF ICU and hospital discharge: 75.2 % and 64.8 %; EF
ICU and hospital death: 24.8 % and 35.2 %. DF ICU and hospital
length stay: 8.1d ± 6.3 and 17.9d ± 11.7; DF ICU and hospital daily
cost: US$2,024 ± 3,363 and US$893 ± 500; DF ICU and hospital dis-
charge: 45.7 % and 54.3 %; DF ICU and hospital death: 54.3 % and
45.7 %. SAPS3, lenght stay, costs and hospital death had no statis-
tical difference. EF received more discharge from the ICU and hos-
pital (p < 0.001). EF showed less ICU deaths (p < 0.001).
Conclusions: The cost and length stay (ICU and hospital) showed no
statistical difference. There were improvement in the ICU mortality and
length stay in ICU and hospital. Although the ICU mortality showed dif-
ference, the hospital death had no considerable variations.
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indirect calorimetry?
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Introduction: A recent paper suggests that energy expenditure (EE)
can be calculated from ventilator derived CO2 measurements
EEVCO2 and a fixed respiratory quotient (RQfixed) [1]. However, this
method can introduce clinically significant errors when applied to in-
dividual patient measurements.
Critical Care 2016, Volume 20 Suppl 2 Page 116 of 182Methods: 261 unselected mechanically ventilated patients with EE
measured by indirect calorimetry were analyzed. EE was compared
with calculated EEVCO2 using measured VCO2 and RQfixed = 0.85.
The clinically acceptable accuracy level for EEVCO2 was set at ±5 %.
Equations for the calculation of EE and EEVCO2 are shown on
Table 37. Since 5 % variation of EEVCO2 corresponded to ±0.05
of RQfixed, we compared the EEVCO2 and EE among patients
with measured RQ lower, matching, or higher than this range.
Statistical analysis was conducted by paired t-test of EEVCO2 and
EE, and bias was determined from the mean difference (kcal/d).
Actual 5 % accuracy rates of EEVCO2 for each group were also
calculated. All analyses were conducted on SPSS statistics version
22 (IBM, USA).
Results: Overall bias for EEVCO2 was +24 (kcal/d), but only 40 % pre-
sented 5 % accuracy compared to EE. 46 % of the patients had
matching level RQ, but 5 % accuracy rate was 57 %. The level of bias
was clinically unacceptable for patients with lower or higher RQ
[Table 38].
Conclusions: Energy expenditure calculated from ventilator derived
measurements is acceptable for only 40 % of the patient population,
and large bias can be overlooked if results are not verified by indirect
calorimetry. EE derived from ventilator measurements should not be
considered equal to EE measured by indirect calorimetry.
Reference
1. Stapel et al.: Critical Care 2015; 19: 370Table 37 (Abstract P284). Equations for calculating energy expenditure
(EE) and EEVCO2.
EE = 1.44 × [3.941 × VO2(ml/min) + 1.11 × VCO2(ml/min)]
Respiratory quotient (RQ) = VCO2/VO2
EEVCO2 = 1.44 × [3.941 × VCO2/RQfixed + 1.11 × VCO2]
Table 38 (Abstract P284). EEVCO2 bias vs. measured EE (Matching RQ :
RQ fixed ±0.05 (0.80 ~ 0.90)).
N (%) EEVCO2 Bias (kcal/day) p value Overall
261 (100) +24 .029 Lower RQ
78 (30) -166 .000 Matching RQ
119 (46) +51 .000 Higher RQ
64 (24) +203 .000P285
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Introduction: Although described more than 70 years ago, the refee-
ding syndrome remains understudied with lack of a standardized defin-
ition and treatment recommendations. The aim of this systematic re-
view was to provide evidence in regard to a standardized definition,
incidence rate and time course of occurrence, association with adverse
clinical outcomes, risk factors and therapeutic strategies to prevent or
treat this condition.
Methods: We searched MEDLINE and EMBASE for interventional and
observational clinical trials focusing on refeeding syndrome, excluding
case reports and reviews. We extracted data based on a predefined
case report form including bias assessment.Results: Out of 2206 potential abstracts, 44 records with a total of 6269
patients were included in the final analysis including 2 interventional
studies and 16 studies including anorexic patients. Definitions for
refeeding syndrome were highly heterogenous with most studies rely-
ing on electrolyte disturbances only and others also including clinical
symptoms. Incidence rates varied between 0 % and 80 % depending
on the definition and patient population. Occurrence was mostly within
the first 72 hours of start of therapy. Most of the risk factors are in ac-
cordance with the NICE guidelines, but older age and enteral feeding
were additionally described. Associations of refeeding syndrome and
adverse outcomes remain unclear, as does the effect of preventive
measures and treatment algorithms.
Conclusions: Although there is consensus in regard to risk factors
and timing of the occurrence of refeeding syndrome, there is wide
variation in definition, reported incidence rates and management
recommendations (preventive measures and treatment). Further re-
search is warranted to fill this gap.P286
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Introduction
After participating in the EPaNIC trial, we changed the protocol for
the administration of parenteral nutrition (PN) in our ICU [1]. The ad-
ministration of PN supplementing enteral nutrition (EN) in case of in-
sufficient caloric intake, was postponed from day 3 after ICU
admission to day 8, compared to the “late-PN-group” in the EPaNIC
trial. One of the exceptions is patients with a BMI less than 18, where
starting PN depends on the individual decision of the attending in-
tensive care physician. The protocol for the administration of EN and
glycaemic control remained unchanged. Micro-nutrients intraven-
ously are prescribed for all patients as from day 3 after ICU admission
in case of inadequate caloric intake. Two years after implementing
the new protocol, we conducted a survey investigating the compli-
ance with the new protocol.
Methods
We conducted a retrospective analysis of all patients admitted to a
6-bed medical unit of our ICU from 01/04/2013 to 30/11/2013. From
220 admitted patients, 123 were considered critically ill since they re-
ceived tight glycaemic control. The other patients were excluded
from the analysis since they stayed for less than 24 hrs in the ICU,
mostly for monitoring purposes.
Results
Only 6 out of 123 patients received PN (4.88 %). In 4 cases PN was
started at day 8 after ICU admission in accordance to the new proto-
col. PN was started earlier in 2 patients suffering from an
haematological-oncological disease complicated with neutropenic
sepsis and a BMI less than 18 and already receiving PN on the ward.
Since a caloric intake less than ¾ of the caloric target at day 3 after
ICU-admission was considered a cut-off for starting PN in the old
protocol, 88.62 % of the patients would have met the criteria for re-
ceiving PN according to that protocol.
Conclusions
There is a good compliance to the revised protocol where PN is only
started at day 8 after ICU admission in our medical ICU unit, besides
some predefined exceptions.
This significantly reduces the number of patients receiving PN com-
pared to the old protocol.
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Critical Care 2016, Volume 20 Suppl 2 Page 117 of 182P287
Nutrition may be another treatment in the intensive care unit
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Introduction
Several studies have shown that exclusive enteral nutrition is mostly
ineffective in providing adequate energy intake in critically ill patients.
For this reason, ESPEN reviewed its guidelines in 2009 in an attempt to
improve this practice by recommending that all patients, who are re-
ceiving less than their targeted enteral feeding after 2 days should be
considered for parenteral nutrition.
The aim of this study is to evaluate whether Portuguese ICUs changed
their nutritional strategy according to ESPENs guidelines.
Methods
Observational prospective study, conducted in eleven Portuguese
ICUs of nine general hospitals. Patients with 18 years of age or older
were eligible if they were ventilated and had a length of stay (LOS)
in ICU greater than 7 days. Demographic data, along with the ener-
getic intake in the first 7 to 10 days and type of nutritional support
used were collected from the selected patients.
Results
130 patients were enrolled, 63.8 % were male, the median age - 64 ±
16 (19Ð91), median BMI Ð 27.9 ± 5.9 (18.8Ð49), ICU LOS Ð 15.4 ±
6,1 days, mortality rate of 26.9 % (35). 70 % of patients were admitted
for medical reasons, 31.5 % had normal weight, and the remaining pa-
tients were either overweight or obese. Energy intake in the first 10 days
was 12.4 ± 6.6 Kcal/Kg/day (0Ð34.1); excluding the first 3 days it rose to
15.6 ± 7.4Kcal/Kg/day (0Ð34.1). Nutritional support was evaluated over
a period of 1,223 days in which 80 % of the days patients received nu-
tritional support, 66 % by enteral route and 14 % by parenteral route.
Conclusions
Energy needs in a critically ill patient can vary between 20-25 Kcal/
kg/day. In our study a large proportion of Portuguese ICUs patients
receive inadequate nutrition. Recent randomized clinical trials sup-
port the recommendation that “less nutrition is better”. However, it is
not uncommon for critically ill patients to be starved and this is dele-
terious and should be avoided.P288
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Introduction
Appropriate nutrition delivery in the ICU is a topical issue. Most stud-
ies have focused on energy supply by enteral or parenteral nutrition.
A few studies now also focused on protein supply. Studies also agreeon the importance of adequate protein supply, 1.2-2.0 g/kg/day, for
the outcome.
The aim of this study is to evaluate the amount of protein supply
given to critically ill patients in Portuguese ICUs
Methods
Observational prospective study, conducted in eleven Portuguese
ICUs of nine general hospitals. Patients with 18 years of age or older
were eligible if they were ventilated and had a length of stay (LOS)
in ICU greater than 7 days. Demographic data, along with the energetic
intake in the first 7 to 10 days and type of nutritional support used
were collected.
Results
130 patients were enrolled, 63.8 % were male, the median age -
64 ± 16 (19Ð91), median BMI Ð 27.9 ± 5,9 (18.8Ð49), ICU LOS Ð
15.4 ± 6,1 days, mortality rate of 26.9 % (35). 70 % of patients
were admitted for medical reasons, 31.5 % had normal weight,
and the remaining patients were either overweight or obese.
The energy supply in the first 10 days was 12,4 ± 6,6 Kcal/Kg/day
(0Ð34,1); Carbohydrates are the main source of calories - 1,5 ±
0,93 g/kg/day (0Ð4,2), lipids - 0,4 ± 0,3 g/kg/day (0Ð1.37), protein/
amino acid administration were - 0,32 ± 0,27 g/kg/day (0Ð1.11). Re-
garding additional supplements besides artificial nutrition, the impact
on overall energetic intake of propofol was 1 ± 0.6 Kcal /Kg/day (0-
9.7), while the amount for glucose solution was 1.3 ± 1 Kcal /Kg/day
(0Ð8).
Conclusions
We may safely conclude that less calories is better in the ICU but sci-
entific recognition of the importance of protein is growing, and al-
though optimal protein dosing studies are not available, expert
opinion supports administering in excess of 1.2 g/kg/day. At present,
in most of the Portuguese ICUs, the majority of critically ill patients
receive less than half of the recommended protein intake.
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Introduction
An audit was carried out to determine the amount of protein, in
grams per kilogram body weight per day (g/kgBW/d), being provided
to adult, Level 3, critically ill patients. International evidence based
guidelines recommend 1.2 g/kgBW/d [1]. Protein is an integral com-
ponent of nutritional therapy in critically ill patients which aims to
minimise muscle wasting [2].
Methods
A prospective Audit was carried out in 2015 in a 21 bedded, Level 3,
Adult Intensive Care Unit within a University Teaching Hospital and
Major Trauma Centre. Inclusion criteria included all patients who
were enterally fed. Exclusion criteria included parenteral nutrition,
less than 4 days of enteral nutrition and incomplete data. Protein
provision was measured against 1.2 g/kgBW/d. Propofol was not re-
corded which was a limitation of the Audit. The Audit was not sub-
ject to ethical approval according to Trust standards.
Results
Of 308 admissions, 111 patients were audited, 27 excluded and 84
patients included within data analysis (n = 84). Mean protein
provision was 0.87 g/kgBW/d. Mean protein percentage delivery was
78 %. Protein deficits became more pronounced when measuring
against ‘higher’ disease specific recommendations. Feeding protocols
were adhered to in 6 % of patients. At initial assessment the nutri-
tional products met protein in 55 % of patients. On average, patients
experienced 20 hours of enteral nutrition stoppages.
Conclusions
Patients received a mean of 0.87 g/kgBW/d of protein compared to
the minimum of 1.2 g recommended by international guidelines.
There were wide variations of protein delivery between patient
groups. Reasons for not meeting protein provision were multi-
factorial. Dietitians are expertly skilled within the MDT to improve nu-
tritional care within the ICU.
Table 39 (Abstract P290). Clinical characteristics between 25(OH)-
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compared to 1.2g.
Vitamin D status.
Variable Sufficient ( > = 20
ng/ml) n = 41
Deficient ( <20 ng/
ml) n = 75
p-
value
Age (years), mean &#177;
SD
61.44 &#177; 15.79 58.76 &#177; 21.10 0.018
Male gender (n,%) 31 (75.6%) 35 (46.6%) 0.003
Body mass index, mean
&#177; SD
21.95 &#177; 4.29 22.04 &#177; 3.61 0.535
APACHE II, mean &#177; SD 16.73 &#177; 7.45 18.52 &#177; 8.68 0.124
Respiratory arrest 24 h prior
to ICU (n,%)
19 (46.3%) 49 (65.3%) 0.047
Ventilator dependent (n,%) 20 (48.8%) 51 (68.0%) 0.042
Serum 25(OH)D (ng/ml),
mean &#177; SD
34.97 &#177; 11.63 10.90 &#177; 4.90 <0.001
Table 40 (Abstract P290). Clinical outcomes between 25(OH)-Vitamin
D status.
Sufficient ( > = 20 ng/
ml) n = 41
Deficient ( <20 ng/




19.5% 21.3% 0.817 Total MICU length of stay
(day+/-SD)
7.07 &#177; 7.62 6.97 &#177; 6.94 0.861 Hospital mortality (%)
21.9% 29.3% 0.368 28-day mortality (%)
17.0% 20.0% 0.701 Total Hospital length of
stay (day+/-SD)
19.85 &#177; 20.43 26.78 &#177; 26.90 0.087 Vasopressor therapy (%)
63.4% 80.0% 0.051 Duration of ventilator (day
+/-SD)
14.19 &#177; 15.27 11.37 &#177; 13.57 0.181 Rate of ICU infection (%)
19.5% 25.3% 0.478P290
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Introduction
Vitamin D deficiency is commonly found in hospitalized patients, and
associated to the multiple adverse clinical events, including in-
creased in morbidity and mortality. Although, this condition is also
frequently found in the critically ill patients, the correlation to clinical
outcomes remains unclear. This report will demonstrate the preva-
lence of vitamin D deficiency in medical and the associated clinical
outcomes among the medical critically ill patients in Thailand.
Methods
Prospective observational study was conducted during 6 months in
the medical ICU in Songklanakarind hospital. Demographic data and
clinical outcomes, including 28-days mortality, ventilator days, ICU
and hospital length of stay, were collected. Serum 25-hydroxy-
vitamin D (25(OH)D was measured within 24 hours after ICU admis-
sion. The 25(OH)D level less than 20 ng/ml is generally defined as a
deficiency state. The correlation of 25(OH)D status on admission and
clinical outcomes were then analyzed with chi-square test or student
T-test. The p-value less than 0.05 defined as clinically significant.
Results
Of the 116 critically ill patients, the prevalence of 25(OH)D deficiency
was 64.65 %. Patients with 25(OH)D deficiency were statistically sig-
nificantly younger, had female gender, had higher blood glucose
levels, higher rate of respiratory arrest 24 h prior to ICU admission
and higher requirement of mechanical ventilator support. The 25(OH)D
deficiency was not significantly correlated to the 28-day all-cause mor-
tality. However, there was a trend toward increased in the vasopressor
used, higher rate of ICU infection and longer hospital length of stay,
among the deficiency group.Conclusions
Our study demonstrated that the prevalence of vitamin D deficiency
in Thai critically ill population was high (64.65 %). We also found the
significantly higher rate of respiratory arrest and mechanical ventilator
dependent in the deficiency group. However, the vitamin D deficiency
in Thai critically illness was not significantly associated to the ICU mor-
bidity and mortality.P291
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Introduction
Vitamin D deficiency has been associated with several adverse out-
comes mainly in the outpatient setting. The objective of this study
was to examine the prevalence of vitamin D deficiency and its asso-
ciation with risk of adverse clinical outcomes in a large prospective co-
hort of medical inpatients.
Methods
We collected clinical data on measured 25(OH)D levels in adult med-
ical patients upon hospital admission and followed them for 30 days.
Regression analyses adjusted for age, gender, comorbidities and
Fig. 75 (Abstract P292). Atrial Fibrillation: subgroup analysis.
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min D deficiency on several hospital outcomes.
Results
Of 4257 included patients, 1,510 (35.47 %) had 25(OH)D levels of
25-50 nmol/l (Vitamin D insufficiency) and 797 (18.72 %) had
levels <25 nmol/l (severe deficiency). Vitamin D insufficiency and
severe deficiency were associated (OR/HR, 95%CI) with an increased
risk of 30-day mortality (OR 1.70, 1.22 to 2.36 and 2.70, 1.22 to 2.36)
and increased length of stay (HR 0.88, 0.81 to 0.97 and 0.72, 0.65 to
0.81). Severe deficiency was associated with risk of falls (OR 1.77, 1.18
to 2.63), impaired Barthel index (OR 1.80, 1.42 to 2.28) and impairment
in of quality of life. Most associations remained robust after multivariate
adjustment and in subgroups based on gender, age, comorbidities and
main diagnoses (P for interaction >0.05).
Conclusions
In this comprehensive and large medical inpatient cohort, Vitamin D
deficiency was highly prevalent and strongly associated with adverse
clinical outcome. Interventional research is needed to proof the ef-
fect of vitamin D supplementation on these outcomes.P292
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Introduction
Over the last few years, supplementation with omega-3 polyunsatur-
ated fatty acids (n-3 PUFA) has emerged as a therapeutic option for
patients undergoing cardiac surgery due to their immunomodulatory
properties and anti-arrhythmic action. Nonetheless, there is a paucity
of data supporting the effectiveness of n-3 PUFA in the treatment of
cardiac surgery patients. So far, several randomized controlled trials
(RCTs) have assessed the effect of perioperative n-3 PUFA preventing
postoperative atrial fibrillation (POAF), although their efficacy still re-
mains controversial. Therefore, we conducted an updated systematic
review and meta-analysis evaluating the effects of perioperative oral/
enteral n-3 PUFA and intravenous (IV) fish oil lipid emulsions on rele-
vant clinical outcomes for cardiac surgery patients.
Methods
We included RCTs enrolling adult patients undergoing cardiac surgery,
which evaluated oral/enteral and parenteral n-3 PUFA compared to a
placebo and reported clinically important outcomes. According to eligi-
bility criteria, original studies were abstracted in duplicate. Intensive
care unit (ICU) length of stay (LOS) was the primary outcome; secondary
outcomes were incidence of POAF, duration of mechanical ventilation
(MV) and hospital LOS. Hypothesis-generating subgroup analysis was
performed to identify potentially more beneficial treatment strategies.
Results
A total of 11 RCTs (n = 2846 patients) met inclusion criteria. When
the data from 4 trials were aggregated, n-3 PUFA had no effect on
ICU LOS (WMD -4.43, 95 % CI -13.43, 4.48, P = 0.34, heterogeneity I2 =
43 %). However, n-3 PUFA were associated with a trend in the reduc-
tion of POAF (RR 0.89, 95 % CI 0.76, 1.05, P = 0.17; I2 = 34 %, P = 0.13).
In addition, in those oral/enteral based trials, n-3 PUFA showed a ten-
dency towards a reduction in POAF (RR 0.87, 95 % CI 0.74, 1.03, P =
0.11; I2 = 47 %, P = 0.07; Fig. 75). The test for subgroup differences on
overall POAF showed a trend (P = 0.16). There was no effect of n-3
PUFA on MV days and hospital LOS.
Conclusions
In patients undergoing cardiac surgery, supplementation with omega-3
fatty acids does not improve any clinical outcome in the postoperative
period.P293
Can 5-hydroxytriptophan prevent post-traumatic stress disorder in
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Introduction
Long-term hospitalized patients in Intensive Care Units (ICUs) are at
high risk of developing major depressive syndrome or Post-traumatic
Stress Disorder (PSD). There are correlations between the degree of
depression and survival in these patients. The incidence of depres-
sion and PSD is three times higher in patients in intensive care com-
pared with the general population. 5-hydroxytryptophan, a precursor
of serotonin, can be used for the prevention of depression in these
patients.
Methods
We conducted a randomized controlled trial on 30 patients, hos-
pitalized in our ICU for non-surgery causes. We dosed serotonin
levels on admission day, at 7 and at 14 days. Patients with psychiatric
disorders and malignancies were excluded as those who were in
treatment with drugs that interfere with the metabolism of serotonin.
Selected patients were randomly assigned either to receive placebo
treatment (first group, N = 30) or to received 300 mg of 5-
hydroxytryptophan (5-HTP) (second group, N = 30). Psychiatric
evaluation was performed using the Clinician-Administered Post-
traumatic Stress Disorder Scale.
Results
At baseline, no significant differences were recorded regarding sero-
tonin plasma levels (243 ± 47.75 and 252.6 ± 38.59 μ g/l, P > 0.05) or
age (55 ± 12.38 and 54.66 ± 12.11, P > 0.05), in both groups. After the
first determination we observed a decrease in serotonin levels in the
placebo group (184.46 ± 37.57) and in 5-HTP group (229.26 ± 39.35)
(p < 0.001, T-value is 3.18). Delirium was present in 3 patients in the
placebo group and 1 patient in 5-HTP group. After 14 days, serotonin
levels were lower in the placebo group when compared to treatment
group (P < 0.001), and delirium was absent in the latter. Mean end
points for Clinician-Administered Posttraumatic Stress Disorder Scale
were higher in placebo group when compared to treatment group
(P = 0.006), at the same time.
Conclusions
Several studies suggest that depression can increase mortality in crit-
ically ill patients. The use of antidepressants in these patients may be
contraindicated, therefore 5-HTP can become an alternative therapy
in depression of patients in ICU.
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Introduction
Selenium is an essential trace element with antioxidant and immu-
nomodulatory effects. Several randomized controlled trials (RCT) and
meta-analyses have demonstrated that parenteral selenium may be
able to improve clinical outcomes in intensive care unit (ICU) patients
and new trials have been published since our last update. Thus, we
updated our data with this systematic review on parenteral selenium
as single strategy or in combination with other antioxidant micronu-
trients in the critically ill.
Methods
We included RCTs that evaluated clinical outcomes associated with
intravenous selenium as single or combined strategy in parenterally
or enterally fed patients. Overall mortality was the primary outcome;
secondary outcomes were infections, ICU length of stay (LOS), hospital
LOS, and ventilator days. Subgroup analyses were done to elucidate
the effects of selenium on mortality and infections (Table 41).
Results
21 trials met our inclusion criteria (n = 4129). When the results of the
20 trials reporting mortality were aggregated, no statistically signifi-
cant reduction in mortality was found (RR 0.99, 95 %, CI 0.99, 1.08, P
= 0.75, I2 = 0 %). In addition, there was no significant effect of paren-
teral selenium on infections (P = 0.15). There was no effect of IV sel-
enium therapy on ICU LOS, hospital LOS, and ventilator days. Result
of subgroup analysis is found in Table 41.
Conclusions
Parenteral selenium as monotherapy or in combination with other
antioxidant micronutrients has no effect on overall mortality, in-
fections, as well as on ICU LOS, hospital LOS, and ventilator days in
critically ill patients.Table 41 (Abstract P294). Subgroup analysis.
Subgroup analysis Mortality Infections
Monotherapy RR 0.91 (95% CI 0.80, 1.04; P
= 0.18)




RR 1.08 (95% CI 0.93, 1.25; P
= 0.33)
RR 0.90 (95% CI 0.78, 1.05; P
= 0.18)
High dose RR 0.98 (95% CI 0.87, 1.11; P
= 0.78)
RR 0.97 (95% CI 0.89, 1.05; P
= 0.46)
Daily dose = 500
mcg
RR 0.88 (95% CI 0.57, 1.34; P
= 0.54)
RR 0.87 (95% CI 0.64, 1.19; P
= 0.39)
Low dose RR 0.94 (95% CI 0.67, 1.33; P
= 0.75)
RR 0.87 (95% CI 0.72, 1.05; P
= 0.15)
Loading dose RR 0.91 (95% CI 0.76, 1.09; P
= 0.30)
RR 0.99 (95% CI 0.90, 1.09; P
= 0.84)
No loading dose RR 1.01 (95% CI 0.90, 1.14; P
= 0.83)
RR 0.87 (95% CI 0.77, 0.99; P
= 0.03)
Fig. 76 (Abstract P295). Effects of probiotics on infections.P295
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Critical illness is characterized by changes in the microbiology of the
intestinal tract, leading to a loss of commensal flora and an over-
growth of pathogenic bacteria. Probiotics are living non-pathogenic
bacteria colonizing intestine and providing benefits to the host. In
2012, we demonstrated that probiotics may be able to reduce infec-
tions and may influence intensive care unit (ICU) mortality1. Over the
last three years different randomized controlled trials (RCTs) have
been published. Therefore, the aim of this systematic review is to up-
date our previous data on probiotics in the critically ill.
Methods
We included RCTs enrolling critically ill adults, which evaluated pro-
biotics compared to a placebo and reported clinically important out-
comes. According to eligibility criteria, original studies were
abstracted in duplicate by two reviewers. Overall infections was the
primary outcome; secondary outcomes were overall mortality,
ventilator-associated pneumonia (VAP), diarrhea, ICU length of stay
(LOS), and hospital LOS.
Results
A total of 29 RCTs (n = 2737) met inclusion criteria, including 6 new
trials since our last update. When the results of trials reporting infec-
tions were aggregated, probiotics were associated with a significant
reduction in infections (RR 0.82, 95 % CI 0.69, 0.97, P = 0.02; hetero-
geneity I2 = 41 %), and particularly among patients with higher risk
of death (RR 0.75, 95 % CI 0.61, 0.99, P = 0.04; I2 = 58 %; Fig. 76).
Moreover, probiotics were associated with a significant reduction in
the incidence of VAP (RR 0.74, 95 % CI 0.58, 0.96, P = 0.02, I2 = 29 %).
Finally, probiotics had no effect on mortality, diarrhea, and hospital
LOS
Conclusions
Probiotics are associated with a significant reduction in overall infec-
tions, as well as a reduction in the incidence of VAP.
Reference
1. Petrof EO, et al. Probiotics in the critically ill: a systematic review of the
trial evidence. Crit Care Med. 2012; 40: 3290-3292.P296
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Introduction
The relationship between diabetes and pancreatic cancer has been
discussed. However, the effects of diabetes with poor control on
pancreatic cancer have never been evaluated. We address the
strength of association for relationship between diabetes and pan-
creatic cancer.
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The data from 1,000,000 National Health Insurance beneficiaries were
utilized. The study cohort consisted of 42,581 diabetic patients and
672,750 unexposed subjects. Among patients with diabetes, 1082
have been admitted with hyperglycemic crisis episodes. All adult
beneficiaries were followed from 1 January 2005 to 31 December
2012 to evaluate if pancreatic cancer was diagnosed. Cox regression
models were applied to compare the hazards adjusted for potential
confounders.
Results
After controlling for age, gender, urbanization level, socioeconomic
status, liver cirrhosis, hypertension, coronary artery disease, hy-
perlipidemia, malignancy, smoking, chronic obstructive pulmonary
disease, obesity, history of alcohol intoxication, chronic renal insuffi-
ciency, biliary tract disease, chronic pancreatitis and Charlson Comor-
bidity Index score, the adjusted hazard ratio of pancreatic cancer was
2.48 (95 % confidence interval, 1.84¡X3.34) in patients with diabetes.
In patients with history of hyperglycemic crisis episodes, the haz-
ard ratio of pancreatic cancer was significant higher. (hazard ra-
tio, 3.60; 95 % confidence interval, 1.15¡X11.25)
Conclusions
The cohort study provided evidence for the relationship between
diabetes and pancreatic cancer. Moreover, diabetes with hyper-
glycemic crisis episodes is associated with higher risk of pancreatic
cancer.
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Introduction
Hypoglycemia is associated with increased mortality in critically ill pa-
tients. The aim of this study was to assess glucose control in an in-
tensive care unit and the incidence of hypoglycemia depending on
insulin protocol.
Methods
Single-center prospective observational study. All patients admitted
to 2 ICUs between January and April of 2014 for more than five days,
were enrolled. Data on demographics and clinical characteristics of
patients were collected at baseline. All blood glucose measurements
during the first 5 days were recorded. Three insulin protocols were
used, two using subcutaneous actrapid insulin depending if the pa-
tient is diabetic (DP) or not (NDP), and an intensive protocol (IP)
using IV insulin depending solely on the glycemic value using a tar-
get value of 180 mg/dL. A glucose value of 70 mg/dL or less was
considered moderate hypoglycemia and 40 mg/dL or less as severe
hypoglycemia. SPSS was used for statistical analysis.
Results
106 patients were included, 66 (66,26 %) were men, with an average
age of 62,53 ± 15,61 years, mortality rate was 20,75 %. 50 (47,17 %)
patients were non-surgical. 34 were diabetic (32,08 %). On aver-
age 6.1 glucose measurements were performed per patient/day.
The average value of blood glucose levels over the first five days
was 168,18 +/- 46,93 mg/dL (diabetic - 182,65 +/- 46,91 mg/dL;
nondiabetic - 161,18 +/- 46,93 mg/dL). Depending on protocol the
average value of blood glucose was 190,76 +/- 52,20 mg/deal for
DP, 158,12 +/- 39,65 mg/dl for the NDP and 175,12 +/- 47,03 mg/dl
(IP). The glycemic variability was 103,45 +/- 71,06 mg/dl for DP,
64,41 +/- 55,14 mg/dl for NDP and 113,50 +/- 67,76 mg/dl for IP. 17
patients (16,04 %) had at least 1 episode of moderate hypoglycemia
and 7 patients (6,6 %) had severe hypoglycemia. In diabetic patients
19/886 (2,14 %) determinations were under 70 mg/dL and 4/886
(0,45 %) were under 40 mg/dL, as for non-diabetic 15/1720 (0,87 %)
were under 70 mg/dL and 5/1720 (0,29 %) were under 40 mg/dL.
Depending on insulin protocol, the incidence of moderate
hypoglycemia was 2,88 % in DP, 0,98 % in NDP and 0,96 % in IP;
and in severe hypoglycemia was 0,89 % in DP, 0,25 % in NDP and
0,21 % in IP.Conclusions
As usually the incidence of hypoglycemia was higher in the diabetic
population. With the new target for glycemic control in intensive
therapy, the incidence of hypoglycemia is now very low in this group.
In contrast the protocol for NDP had a better glycemic control than the
Intensive Protocol.
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Introduction
Elucidation of the relationship between severity of the diseases and
blood glucose(BG), including BG variability, is considered to be signi-
ficant for determining BG targets. The purpose of this study is to ana-
lyze the relationship because that analysis has not been fully performed.
Methods
One hundred and forty nine patients with glucose intolerance were ana-
lyzed during 1 week after ICU admission. Studied items were, 1) maximum
value of SOFA score(SOFAmax), 2)mean of BG(BGm) and 3)standard devi-
ation of BG(BGsd). BG was measured basically every 6 hours and insulin
was used when BG was above 140 mg/dL. Correlation between SOFAmax
and BG(BGm, BGsd) was analyzed according to the SOFAmax levels.
Results
1)Mortality of the patients with SOFAmax of 0-3(n = 60), 4(n = 26),
5(n = 21), 6(n = 13), 7-8(n = 12), 9-10(n = 8), 11-19(n = 9) was 0 %, 8 %,
14 %, 23 %, 25 %, 50 % and 78 %, respectively. 2)BGsd was linearly
correlated to BGm(correlation coefficient r = 0.79). 3)SOFAmax was
two-dimensionally correlated to both BGm and BGsd. Range of BGm
and BGsd with SOFAmax less than 4, calculated from the two-
dimensional, or quadratic, equation, was 121-178 and 24-44 mg/dL,
respectively. 4)Two-dimensional correlation coefficient(R) between
SOFAmax and BGm according to SOFAmax above 0(n = 149), 2(n =
121), 4(n = 89), 6(n = 42), 8(n = 21) and 10(n = 11) was 0.38, 0.41, 0.37,
0.49, 0.66 and 0.54, respectively. 5)R between SOFAmax and BGsd ac-
cording to SOFAmax above 0, 2, 4, 6, 8 and 10 was 0.43, 0.46, 0.45,
0.54, 0.62 and 0.70, respectively.
Conclusions
1)BG control to hyperglycemia is one of the measures which bring
the reduction of BG variability. 2)BG targets were considered to be
obtained by the analysis of two-dimensional relationship between se-
verity of the diseases and BG. 3)There is a possibility that strict BG
control is more effective to severer(moderate to severe) patients,
considering the results indicating higher correlation coefficient (R) in
severer patients. 4)Glucose administration for increasing BG and BG
variability might bring beneficial effect not only for hypoglycemic pa-
tients but also for a part of normoglycemic patients, judging from BG
targets listed above. 5)Low BG variability in a part of severe patients
may be related to lower variability of physiologic activity. 6)Analysis
of the relationship between severity of the diseases and BG based
on the fine BG control, including by the use of artificial pancreas,
was considered to link to better BG control and outcomes.
P299
A study of glycemic control by subcutaneous glargine injection
transition from continuous regular insulin infusion in critically ill
patients
T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit
Prince of Songkla University, Hat Yai City, Songkhla province, Thailand
Critical Care 2016, 20(Suppl 2):P299
Introduction
Vary Insulin protocols were applied to control blood glucose(BG) in
critical patients, mostly based on short acting insulin, which consumed
lots of manpower and resources. By previous study yielded 66.7 %
Critical Care 2016, Volume 20 Suppl 2 Page 122 of 182success rate of glycemic control with 80 % dose conversion from short
acting insulin dose with mean of differences of 26.5 mg/dL. The aim of
this study was to determine whether a single subcutaneous glargine in-
jection with 100 % dose transition is not inferior to the continuous
regular insulin (RI) infusion for BG control in critically ill patients (inferior
margin acquired from 85 % of the mean of differences from previous
study =22.525 mg/dL).
Methods
All eligible participants admitted Critical care unit which required
constant rate of continuous RI infusion per standard MICU insulin in-
fusion protocol for 24 consecutive hours were switched to receive
single dose of glargine insulin subcutaneously by 100 % of their total
daily insulin requirement calculated by cumulative dose of RI require-
ment in the previous 24 hours. The continuous insulin infusion was dis-
continued 2 hours after the transition. BG were monitored every
2 hours for the following 24 hours or until the study termination or
discontinuation
Results
Of 20 cases included, 12 cases achieved a good glycemic control.
Among success subgroup, there were no BG level higher than mean
glucose during RI more than 22.525 mg/dl. Only a mild hypoglycemia
event was observed with spontaneously resolved. Otherwise among 8
participants in failure subgroup, half of them developed hypergly-
cemia at 8th hour. This research also found that median RI dose
was different as 1.8 mg/dL among success cases and 2.5 mg/dL
among failure cases.
Conclusions
A single subcutaneous Glargine injection with 100 % dose transition
was not inferior to the continuous RI infusion for BG control in critic-
ally ill patients with 60 % success rate. Higher pre-treatment RI dose
was related to failure and success outcome.Fig. 77 (Abstract P299).P300
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Target levels of glycemia in critically ill patients have fluctuated since
2001, as evidence initially indicated that tight glycemic control (80-
110 mg/dl) leaded to the lowest morbidity and mortality, however
subsequent studies have demonstrated minimal clinical benefit com-
bined with greater morbidity and mortality, so nowadays the target
glucose level approaches 150-180 mg/DL. The aim of this study was to
assess glucose control in critically ill patients in Portuguese ICUs and
evaluate the incidence of hyperglycemia and hypoglycemia.
Methods
Prospective observational study conducted in eleven ICUs in nine
Portuguese hospitals for six months. Included participants were pa-
tients who were expected to have a length of stay (LOS) in the ICU
of 7 days or more. Data on demographics and clinical characteris-
tics of patients were collected at baseline. All patients were assigned a
target glucose of 180 mg/dL or less. All blood glucose measurements
during the first 7 days were recorded. A glucose value of <40 mg/dL
was considered as severe hypoglycemia.
Results
155 patients were included, where 60.6 % were men, with an aver-
age age of 62. ± 17, ICU LOS was 15.2 ± 6.4 days and mortality rate
was 25.2 %. 70 % of patients were non-surgical. 49 were diabetic.
1085 days of hospitalization were evaluated and 6563 glucose
measurements were performed, with an average of 6,0 +/- 2,5 per pa-
tient/day. The average value of blood glucose levels over the first
seven days was 155,8 +/- 40,6 mg/DL (diabetic (D) - 175,2 +/-
82,8 mg/DL; nondiabetic (ND) -147,1 +/- 82,8 mg/dL). 71/6563 de-
terminations were below 70 mg/dL and 11/6563 were below
70 mg/DL and 11/6563 were below 40 mg/DL (per patient D -
2,0 %; ND - 0.9 %). 2302/6563 (26 %) were above 180 mg/dL (D
- 63.5 %; ND - 22.9 %).
Conclusions
Using a target glucose level of 180 mg/DL, uncontrolled hyperglycemia
was avoided over 72 %, with fewer hypoglycemic episodes. As dia-
betics had more hyperglycemic and hypoglycemic events, may be dia-
betic patients should have different targets.P301
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short-term outcome of cardiac surgery patients
D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou,
G. Drossos
Department of Cardiothoracic Surgery, George Papanikolaou General
Hospital , Thessaloniki, Greece
Critical Care 2016, 20(Suppl 2):P301
Introduction
Aim of this study was to investigate whether hyperglycemia duration
(hours/24 hour cycle) intraoperative and on first ICU day, has any im-
pact on postoperative outcome after cardiac surgery
Methods
This long-range observational study, carried in our department, from
January 2013 until June 2014 and consisted of data from 615 cardiac
surgery patients. Based on glucose levels on the operation day
(24 hours), patients were divided in 5 groups depending on the
hours of hyperglycemia. We investigated the possible relationship
between duration of hyperglycemia and the following postoperative
complications: Deep sternal wound infection, acute kidney injury,
need of intravenous drip infusion of a diuretic solution and renal re-
placement therapy requirement in ICU. The study was conducted by
an independent investigator and the results were processed by stat-
istician with the statistical program SPSS 20.
Results
Results are showed in Table 42.
Conclusions
Hyperglycemia has statistical significant relationship with AKI, need
of IV diuretics and RRT requirement. In our study, hyperglycemia has
no impact on postoperative sternal wound infections.
Table 42 (Abstract P301).
Hyp/mia hours Pts AKI DIURETIC RRT DSWI
0 55 12.7% 16.4% 0 1
1-6 116 12.6 % 8.6% 0 5
7-12 162 13.6% 16% 2 8
13-18 197 18.3% 24.9% 4 8
19-24 85 23.5% 40% 7 4
616 (p = 0.03) (p = 0.00) (p = 0.01) (p = 1)
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Introduction
Diabetic ketoacidosis (DKA) is a life-threatening acute complication
of diabetes that presents with high-anion-gap metabolic acidosis,
hyperglycemia and ketonemia (1). The aim of this study is to deter-
mine lactate levels and its clinical outcomes in DKA patients admit-
ted to the medical Intensive Care Unit (ICU).
Methods
A total of thirty-one (31) patients who admitted to our medical ICU
of tertiary care university hospital with DKA in last thirty (30) months
was included in the study retrospectively. Hyperlactatemia was de-
fined as serum lactate >2.5 mmol/L.
Results
The mean age of patients with DKA was 50.4 ± 24.1 and 45.2 % (n =
14) of them were men and 54.8 % (n = 17) were women. Twelve
(38.7 %) of patients had type 1 diabetes and 19 (61.3 %) had type 2.
The mean serum lactate was 2.93 ± 1.81 mmol/L (0.89–9.20). Of 31
patients, 14 (45.2 %) had elevated serum lactate levels (>2.5 mmol/
L), and 6 (19.4 %) had high lactate levels (>4 mmol/L). No correlation
was found between serum lactate levels and mortality, length of ICU
and hospital stay. Besides, lactate levels were not correlated with
Acute Physiology and Chronic Health Evaluation II (APACHE II) score,
blood pressure, serum glucose and HbA1C levels.
Conclusions
Elevated lactate level is commonly found in DKA patients (2). However,
this is not associated with worse clinical outcomes and disease severity
(3). Thus, elevated lactate levels determined in DKA patients should not
to be appreciated by clinicians to define a high-risk population.
References
1. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in
adult patients with diabetes: a consensus statement from the American
Diabetes Association. Diabetes Care. 2006; 29(12):2739–2748.
2. Fulop M, Hoberman H, Rascoff J, et al. Lactic acidosis in diabetic patients.
Arch Intern Med. 1976; 136(9):987-990.
3. Cox K, Cocchi MN, Salciccioli JD, et al. Prevalence and significance of lactic
acidosis in diabetic ketoacidosis. J Crit Care. 2012 April ; 27(2): 132–137.
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Introduction
The London Chest Hospital and The Heart Hospital merged with St
Bartholomew’s Hospital to become the Bart’s Heart Centre, receiving all
Heart Attack Centre (HAC) Activations in the North Central and North
East London areas. This created the largest Cardiac Intensive Care Unit
in Europe with 42 beds currently (and expanding to 58 next year.) We
are reporting the changes that have occurred following the merger oftwo HAC services in adjacent regions. Data was collected from the In-
tensive Care National Audit and Research Centre (ICNARC) database as
well as the Myocardial Ischaemia National Audit Programme (MINAP).
Methods
The ICNARC and MINAP databases were interrogated to identify
numbers for:
 HAC activation
 pPCI (primary percutaneous coronary intervention)
 Admissions to Level 3 Intensive Care.
We compared data from the five months following the merger
(May – September 2015) with the same months in 2014. High de-
pendency and coronary care admissions were excluded. The in-unit
mortality and length of stay were examined. Results are expressed as
median and interquartile range (IQR) for non-normal distribution data.
Ethics approval was sought but deemed not necessary.
Results
Between May and September 2014 there were 628 HAC activation pa-
tients admitted to the legacy sites of the London Chest Hospital and
Heart Hospital. Following the merger there was an increase of 246 pa-
tients (39 %). Of the HAC activations at the legacy sites from May-
September 2014, 282 (45 %) patients underwent primary percutaneous
coronary intervention, pPCI, compared to 254 (29 %) patients in the five
months post-merger. ICNARC data was not collected at the Heart Hos-
pital and therefore data is only available from one legacy site. The ITU
admission rate at the London Chest was observed as 4.9 % compared
to 6.4 % in the new Centre. The length of stay on Intensive Care in-
creased following the merger from a median 3.9 days (IQR 2.1-8.0) to a
median 2.9 days (IQR 1.6-7.0). The in-unit mortality decreased in May-
September 2015 to 41.1 % from 45.2 % the previous year.
Conclusions
To our knowledge this is a unique situation where three specialised
London hospitals have merged to produce one large cardiac centre.
The rise in patient numbers yet fall in pPCI rate is interesting and fur-
ther analysis is needed to understand this trend.P304
Special characteristics of in-hospital cardiac arrests
M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos,
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Introduction
In-hospital cardiac arrests (CAs) are not a sudden event but in most
of the cases the result of a slow and progressive deterioration of the
patient. The aim of this study was the systematic analysis of CA inci-
dence, primary causes and initial rhythm with regard to its location
in the hospital in order to identify potential obstacles and to under-
take preventive measures to enhance outcome.
Methods
177 in-hospital CAs, in which resuscitation was attempted, were in-
cluded in the study and data were recorded according to the Utstein
Style template for in-hospital CA. Age and gender of patients, pri-
mary causes, initial rhythm and location of CA were recorded and
reviewed.
Results
Results are depicted on Tables 1 & 2.
Conclusions
The vast majority of CAs (42.3 %) occurred in areas supervised by the
cardiology department. Together with the “cardio surgical” CAs, car-
diology related CAs percentage arises to 58.2 %. Number of CAs in
the ED and in the RIU was also significant. Mean age of CAs patients
was similar in all locations, whereas there were significant differences
as far as primary causes and initial rhythm analysis are concerned.
These interesting results merit further study, larger number of pa-
tients and detailed analysis of all related parameters in order to con-
duct safe conclusions and to be able to undertake preventive
measures.
Fig. 78 (Abstract P304). Demographic data, causes and initial
rhythm of CAs.
Fig. 79 (Abstract P304). Location of CAs and correlation with all
recorded parameters.
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Introduction
Patients with nosocomial cardiopulmonary arrest (CPA) have aggra-
vated clinical signs before CPA occurs. The early recognition of these
signs and quick treatment may reduce the death rate in these patients.
We examined the background factors and various biomarkers of the
patients who were resuscitated in the general medicine ward.
Methods
Eighteen patients who were admitted to the ICU after resuscitation
in the general medicine ward were studied. Patients were classified
as gfair prognosis h (FP-group: 12 persons) if the patient survived
more than 28 days or gpoor prognosis h (PP-group: 6 persons) if the
patient died within 28 days. Blood samples were drawn for mea-
suring blood chemistry and sepsis-related biomarkers (procalcitonin,
presepsin, endotoxin activity assay) immediately after ICU admission.
Statistical analysis was performed with the Mann-Whitney U-test and
Chi square test or Fisher’s test. A value of p < 0.05 indicated statistical
significance.
Results
The underlying diseases were as follows: sepsis (5), acute respiratory
distress syndrome (3), lethal arrhythmia (2), ileus (1), suffocation (1),
amyotrophic lateral sclerosis (1), sudden unexpected death in epi-
lepsy (1), unknown (4). The SOFA scores of the FP-group and PP-
group were 10}3 (10) and 14}3 (14), respectively; the differencebetween the groups was statistically significant (p < 0.05). APACHE2
scores of the FP-group and PP-group were 34}7 (35) and 40}8 (44),
respectively; however, there was no significant difference between
the groups. Procalcitonin levels of the FP-group and PP-group were
9}13 (6) and 22}26 (15), respectively; again there was no significant
difference between the groups. IL-6 levels of the FP-group and PP-
group were 1096}2851 (98.8) and 19,475}24,603 (11,305), respectively;
the difference between the groups was statistically significant (p <
0.05). The EAA level of the FF-group was 0.41}0.16 (0.46), whereas
the PP-group was 0.54}0.26 (0.49); however, there was no significant
difference in EAA levels between the groups.
Conclusions
In our institute, the 28-day survival rate of the patients who were re-
suscitated in the general medicine ward was 66.7 %. The factors
which affect patient outcome were SOFA score and IL-6. However,
we could not evaluate the duration of CPA; therefore, it will be ne-
cessary to examine this further in the future.P306
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Introduction
Teaching basic life support (BLS) to secondary school students has
been proved feasible, but not much evaluated. We conducted a
study to evaluate the efficacy of a one-hour BLS training course for
secondary school students.
Methods
From September 2014 to June 2015, six secondary schools were in-
cluded in the study. Two of them received a one-hour BLS session
conducted by an intensivist assisted by 3 medical students. Sessions
contained: a theoretical lecture and a practical simulation-based
training using low-fidelity manikins (MiniAnnePlus®, Laerdal). Between 2
and 3 months later, both trained and non-trained students were
assessed using a serious game reproducing real-life cardiac arrest
situation (3D real-time simulation software, Stayingalive®, ILUMENS-
Dassault system). Primary outcome was the time spent to complete the
serious game (from onset of cardiac arrest to shock delivery and re-
covery). Secondary outcomes included knowledge of emergency call,
hand placement during chest compressions and electrodes placement
of automated external defibrillator.
Results
Among 199 students assessed on the serious game, 72 had received
the one-hour BLS session. Children’s ages did not differ between the
2 groups (12 [11-12] vs 12 [11-12] years old, p = 0.7).
The total game completion time was 169 (+/-28) seconds in the
trained group versus 185 (+/-32) seconds in the non-trained group
(p = 0.0006) (Fig. 80).
Knowledge of emergency call did not differ between the two groups
(92 % in trained group vs 86 % in non-trained group, p = 0.2). Hands
were more often properly placed during chest compression in the
trained-group (92 % vs 73 %, p = 0.002). Electrodes of automated ex-
ternal defibrillator were more often properly placed in the trained-
group (44 % vs 10 %, p = 0.0001).
Conclusions
A one-hour BLS training session with low-fidelity manikin improved
significantly young students’ performance during a 3D-real life simu-
lation session.
Fig. 80 (Abstract P306). Game completion time.
Fig. 81 (Abstract P307). shows the predicted survival rates of initial
CPR (staff v public).
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Introduction
People have unrealistic expectations of the outcomes of inpatient
adult cardiopulmonary resuscitation (CPR). We conducted a survey
looking at clinical staff and the general public perceptions and know-
ledge of CPR compared to local and national data.
Methods
276 public and staff were surveyed at 2 hospitals and a GP surgery
in South East London.
Results
75.2 % of the public knew what CPR was and 29.5 % felt they had
enough CPR knowledge. Knowledge did not appear to be influenced
by attending university.
Compared to the national figure of 45.6 % for initial CPR survival, the
public predicted the correct survival range more accurately (see Fig. 81)
[1]. Staff results were more comparable to their local hospital data. Hos-
pital A’s initial survival rate was 33 %: 15 % of staff compared to 6.6 %
of public chose the correct survival range. In hospital B, every doctor
underestimated the initial CPR survival figure (55 %). Nurses were closer
to the figure with the most popular response range being 30-40 %
compared to 10-20 % for doctors. GPs were most pessimistic at predict-
ing general CPR survival rates and nurses were most optimistic.
87 % of staff wanted CPR if they were healthy, this dropped to 29 %
if they were to have a chronic illness that affected them daily. Public
figures were 62 % and 48.8 % respectively. People of African origin
were less likely to want CPR if they had a chronic illness, compared
to Caucasians. Those who went to university were more likely to
want to discuss CPR with a doctor. Less than 3 % surveyed had a do
not attempt resuscitation (DNAR) in place.
Conclusions
Staff are not better at predicting initial CPR survival rates. The public
felt that they need more knowledge about CPR; the most popular
learning modality was online learning. Staff opinions on whether
they would want CPR are strongly influenced by the presence of a
chronic disease causing a daily impact.
Reference
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Introduction
Pediatric out-of-hospital cardiac arrest (OHCA) is a devastating event
with low survival rates, partly due to lack of bystander cardiopulmo-
nary resuscitation (CPR) (1). While telephone dispatcher-assisted CPR
instructions (T-CPR) improve the frequency and quality of bystander
CPR for OHCA in adults (2), this support remains undeveloped in
pediatry. We aim to assess the effectiveness of a new pediatric T-CPR
protocol in both previously trained and untrained bystanders, and
secondarily, the utility of the ventilations.
Methods
Adults with no CPR experience were recruited in a public movie cen-
ter and among bachelor nursing students in Liège district. Volun-
teers were randomly assigned either to «T-CPR» or to «no T-CPR» and
were submitted to a 6 minutes infant OHCA scenario. CPR perform-
ance data were extracted from video and infant manikin using Laerdal
Simpad® SkillReporter.
Results
161 volunteers were recruited and 115 met the inclusion criteria.
They were distributed in 4 groups : trained unguided group (U-NG, n
= 27), untrained guided group (U-G, n = 32), trained unguided group
(T-NG, n = 26), trained guided group (T-G, n = 30).
T-CPR increased significantly CPR attempts (74.1 % of U-NG group
performed chest compressions, compared to 100 % of other groups;
p = 0,0007) and overall CPR performance, but median time to first
chest compression was longer in guided groups (p < 0,0001).
The proportion of volunteers who managed to deliver ventilation
during CPR was higher (p < 0,0001) in guided groups (81,2 % for U-G
group and 83,3 % for T-G group) than in unguided groups (0 % for
U-NG group and 46,1 % for T-NG group). While the tidal volume de-
livered was too high for each group, the fraction of time required to
give ventilations was significant higher for guided groups.
Conclusions
T-CPR instructions have the potential to increase the number and
the performance of bystander CPR in trained or untrained volunteers
(3). Mouth to mouth ventilations was responsible for major inter-
ruptions in chest compressions. Moreover, we identified an overall
tendency to hyperventilation.
References
1. Atkins DL et al. Improving outcomes from out-of-hospital cardiac arrest
in young children and adolescents. Pediatr Cardiol. 2012; 33(3): 474–483.
2. Stipulante S et al. Implementation of the ALERT algorithm, a new
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1 1 Death 0 3 2 2 7
2 1 Survive 0 0 1 0 1
3 1 Survive 0 1 1 1 3
4 1 Survive 0 0 0 0 0
5 1 Survive 0 0 0 0 0
6 1 Survive 0 0 0 0 0
7 2 Survive 1 3 2 2 8
8 2 Death 10 9 4 3 26
9 2 Survive 0 0 0 0 0
10 3 Death 4 9 4 3 20
11 3 Death 8 9 4 3 24
12 3 Death 9 9 4 3 25
13 3 Survive 0 3 2 3 8
14 3 Survive 0 0 0 0 0
15 3 Survive 2 2 1 3 8
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Introduction
Dantrolene is a therapeutic drug for patients with malignant hyper-
thermia. Interestingly, dantrolene has antiarrhythmic characteristics
and might be an alternative for patients with VTs (ventricular tachy-
cardia) or VF (ventricular fibrillation). However, experimental resusci-
tation studies comparing dantrolene and amiodarone are still
missing. Aim of this study was to evaluate ROSC (return of spontaneous
circulation) rates for dantrolene versus amiodarone in a pig model of
sustained cardiac arrest (8 min) under VF.
Methods
Ventricular fibrillation was induced in anesthetized pigs (dantrolene,
n = 14 and amiodarone, n = 14 or saline, n = 10). After 8 min of un-
treated VF, chest compressions and ventilation were started and one
of the drugs (amiodarone 5 mg kg -1, dantrolene 2.5 mg kg -1 or sa-
line (sham)) was applied in a blinded fashion. After 4 min of CPR
without epinephrine or other drugs, defibrillation with 200 J was per-
formed. Standardized resuscitation including mechanical cpr and de-
fibrillation according to protocol was applied in all animals. ROSC
rates and cardiovascular as well as blood gas analysis and cerebral
oximetry and perfusion measurements were calculated during the
experiments.
Results
Initial ROSC rates were 10 of 14 animals in the dantrolene group vs.
5 of 14 animals in the amiodarone group (3 of 10 for saline group).
However, persistence of ROSC until 120 min follow-up was shown in
6 animals of the dantrolene group, 4 animals in the amiodarone
group and 2 animals of the saline (sham) group. However, results
were not statistically significant between groups. Hemodynamic data
and cerebral perfusion as well as cerebral oximetry were comparable
between survivor animals.
Conclusions
Pharmacological effect of dantrolene is comparable to amiodarone
regarding ROSC in our experimental model. Hemodynamic parame-
ter did not show any relevant significance between both groups.
Future studies should evaluate dantrolene for CPR in a bundle ap-
proach including epinephrine and post-ROSC therapy protocol.
References
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Introduction
Therapeutic hypothermia(TH) improves short term physical neuro-
logical outcome and survival in post-arrest patients. However, there
are limited data of long term survival and functional neurological
outcome in the survivors.Methods
We reviewed database of post arrest patients undergoing TH who
survived to discharge with consciousness (Glasgow-Pittsburgh Cere-
bral Performance: CPC 1-3) in our hospital from 2006 to 2014. All
hospital survivors were evaluated life or death status and death date
on January 31st , 2015 by checking death certificates from national
registry system. We contacted the survivors or their relatives by
phone or mail and scheduled a follow-up visit to evaluate their abil-
ity. The patients who were unable to visit were assessed the func-
tional disability by phone interview or using recorded follow-up data.
The functional neurological outcome was scored on a disability rat-
ing scale.[1] This scale consisted of 1) arousability awareness and
responsivity, 2) cognitive ability for self-care activities, 3) dependence
on others and 4) psychosocial adaptability. The level of disability
was defined as the followings: 0 – none; 1 – mild; 2 to 3.5– partial;
4 to 6 – moderate; 7 to 11 – moderately severe; 12 to 16 – severe;
17 to 21 – extremely severe; 22 to 24 – vegetative state and 25 to
29 – extreme vegetative state. In addition, survival rates at
6 months, 1 and 2 years after discharge were analyzed.
Results
Of 51 patients treated with TH, 27 patients survived to hospital
discharge. Seventeen of the hospital survivors were conscious: 6,
3 and 8 patients with CPC at discharge 1, 2 and 3, respectively.
Five of them passed away later. Approximately 78.6 %, 76.9 %
and 75 % of awake patients survived at 6 months, 1 and 2 years
after discharge, respectively. The majority (3/5) of dead cases
died within 6 months with severe functional disability (score 24-
26). The patients’ disability scores were shown in table. One-third
of awake patients with CPC 2 and 3 who still survived at
6 months after discharge finally recovered to normal physical and
cognitive function, while most of patients with CPC1 returned to
normal function or minimal disability.
Conclusions
Long term survival rate of conscious survivors with TH was high.
Most of hospital survivors alive longer than 6 months after discharge
had good functional capability.
Reference
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Introduction
Kidney disease after out-of-hospital cardiac arrest (OHCA) is previ-
ously incompletely described. We examined the occurrence of
chronic kidney disease (CKD) and acute kidney injury (AKI) in OHCA
patients, and the impact of AKI on six-months mortality and neu-
rological outcome in patients with our without renal replacement
therapy (RRT).
Methods
Prospective cohort study at Oslo University Hospital, Oslo, Norway,
between September 8, 2010, and January 13, 2014. Resuscitated co-
matose OHCA patients admitted to an intensive care unit were in-
cluded. Patients were treated according to a standardized treat-
ment protocol including therapeutic hypothermia to 33 °C for
24 hours. CKD and AKI were classified according to the Kidney Dis-
ease Improving Global Outcomes (KDIGO) guidelines. Patients with
previously known CKD were excluded from further detailed analyses.
Main outcomes were six-months mortality and good neurological
outcome defined as Cerebral Performance Category 1-2.
Results
Among 245 included patients (84 % males, mean age 61 years),
4 % had previously known CKD and 46 % developed AKI. The
AKI patients consisted of 58 (52 %) AKI stage 1, 30 (27 %) AKI
stage 2, and 24 (21 %) AKI stage 3. Overall six-months outcome
revealed that 46 % died and 50 % had good neurological out-
come. Compared with no kidney disease, AKI patients had signifi-
cantly increased mortality (odds ratio (OR) 3.17, 95 % confidence
interval (CI) 1.95-5.43, p < 0.01) and worsened neurological out-
come (OR 0.29, 95 % CI 0.17-0.50, p < 0.01). AKI patients with and
without RRT had comparable six-month mortality (50 versus (vs.)
61 %, p = 0.40) and good neurological outcome (44 vs. 35 %, p =
0.42), also after excluding patients where RRT was withheld due
to futility.
Conclusions
Kidney disease occurred in about half of patients successfully resus-
citated from OHCA. AKI was associated with unfavorable six-month
mortality and neurological outcome; however, RRT in these patients
was not.
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Introduction
Available clinical evidences indicate early PCI improves outcome for non
STEMI out of hospital cardiac arrest (OHCA) patients with suspected car-
diac cause [1,2]. Adoption of this approach will increase ICU admission
at the regional PPCI centers. In this observational cohort study we ana-
lysed the ICU service dependency of the PPCI patients following OHCA.
Methods
All adult patients admitted to our intensive care unit between April
2014 and March 2015 were analysed. Patients admitted from the
PPCI pathway following OHCA were compared with all other un-
planned admissions during the study period. Data regarding outcome
and dependency was collected from the ICNARC (Intensive Care Na-
tional Audit Research Council, UK) database. Paired t-test & Chi square
test were performed to estimate statistical significance levels.
Results
The number of OHCA-PPCI and unplanned admissions during the
study period were 51 and 630 respectively. Median length of ICU staywere significantly high for the PPCI patients (4.25 vs 3.70 days, P =
0.02). Furthermore, PPCI patients had higher ICNARC severity scores
(29.3 vs 20; p < 0.0001). PPCI patients had significantly higher levels
of dependency, evidenced by higher levels of organ support (3.2 vs
2 organs; p < 0.0001), greater level 3 care (4.1 vs 2.6 days; p = 0.012),
more days ventilated (4 vs 2.4 days; p = 0.005), and higher require-
ments for advanced CVS support (1.6 vs 0.6 days; p < 0.0001). There
were no significant differences between dialysis requirement or hos-
pital length of stay. Overall ICU mortality rates were higher in the
PPCI group (46.9 % vs 30.7 %, p = 0.02). Despite representing only
8 % of the total number of patients admitted during the study
period, PPCI patients accounted for 12 % of total ICU level 3 bed
days, 13 % of ventilated days and 19 % of advanced CVS days.
Conclusions
Overall, patients undergoing PPCI post OHCA had significantly greater
levels of dependence than other patients admitted to the ICU. The high
level of dependency need to be considered when contemplating ex-
pansion of PCI services for non STEMI, OHCA patients with suspected
cardiac causes.
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Introduction
We established a multi-center, prospective cohort that included
Utstein data in prehospital and treatment contents and data after
hospital arrival. The purpose of this study was to determine the
most important indicators of prognosis in patients with return of
spontaneous circulation (ROSC) following out-of-hospital cardio-
pulmonary arrest (OHCA) and to develop a best outcome predic-
tion model.
Methods
All consecutive patients who were suffering from OHCA and who
were then transported to institutions participating in this registry
were prospectively recorded in July 2012 to December 2013. Criteria
for inclusion of this study were a witnessed cardiac arrest, age
greater than 17 years, presumed cardiac origin of the arrest, and suc-
cessful ROSC. Multivariate logistic regression (MLR) analysis was used
to develop the best prediction model. The dependent variables were
favorable outcome (cerebral-performance category: CPC 1-2) and
poor outcome (CPC 3-5) at 1 month after the event. The explanatory
variables were used concerning patient characteristics and
resuscitation.
Results
Subjects comprised 147 patients in VF and 177 patients with pulse-
less electrical activity (PEA)/asystole. The percentage of favorable out-
comes was 42.2 % (62/147) in VF and 11.3 % (20/177) in PEA/asys-
tole. The most important prognostic indicators of favorable outcome
founded by MLR were age (p < 0.01), time from collapse to ROSC
(TROSC) (p < 0.01), base deficit (p = 0.06), presence of by-stander car-
diopulmonary resuscitation (p = 0.09) for VF and age (p = 0.05),
TROSC (p < 0.01), and base deficit (p < 0.05) for PEA/asystole. Areas
under the receiver-operating characteristic curve were 0.866 for VF
and 0.896 for PEA/asystole respectively.
Conclusions
A model based on four selected indicators showed a high predictive
value for favorable outcome in OHCA patients with ROSC.
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Introduction
Near infrared spectrometry (NIRS) could be a useful non-invasive
monitoring of cerebral perfusion during cardiopulmonary resuscita-
tion (CPR). The aim of our study was to investigate and evaluate NIRS
during CPR in a porcine model of cardiac arrest (CA).
Methods
24 pigs under general anesthesia and mechanical ventilation were in-
cluded in this study. In all study animals ventricular fibrillation was
induced with application of electrical current via a pacing wire. After
7 min of CA, CPR was initiated with the use of LUCAS mechanical de-
vice and after 5 more min, initial CA-rhythm was analyzed and ad-
vanced life support interventions were provided according to the
2015 ERC guidelines. Regional cerebral oxygenation (rSO2) was re-
corded before and after resuscitation in 1 min intervals by INVOS OX-
IMETER via a Somasensor electrode placed on pigs heads. Pigs were
divided into two groups depending on return of spontaneous circula-
tion or not, G-A: no ROSC (n = 15) & G-B: ROSC (n = 9). G-A & G-B
were compared at 6 Phases: P0 (baseline), P1 (7 min after CA-no
flow), P2 (5 min after CPR initiation) and thereafter every 5 min
(P3-P5). For the statistical analysis repeated measures ANOVA was
used (SPSS21).
Results
Duration of CPR was 40 min for G-A and until ROSC for G-B. Directly
after CA, a rSO2 decrease was recorded, which remained for the
whole resuscitation attempt (Table). There weren’t any statistical dif-
ferences between the study groups. After ROSC, rSO2 remained de-
creased and increased gradually over time.
Conclusions
According to our study results, rSO2 alterations are useful in iden-
tifying CA immediately but do not provide any other useful information
during CPR.Fig. 82 (Abstract P314). rSO2 alterations over time.P315
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Introduction
While a new 2015 AHA guideline of cardiopulmonary resuscitation
recommends cardiac compression should be performed on the ster-
nal bone at a level of bust point, there is individual difference in the
heart position. The ratio of real-time low-oxygenized cerebral blood
circulation represented by rSO2 (regional cerebral oxygen saturation)
can be non-invasively and quantitatively measured using a near
infrared-red spectroscopy (NIRS) sensor placed at the forehead in
which higher absorption of near infrared-red ray occurs in low-
oxygenized blood. Therefore, rSO2 potentially enables us to monitor
the effective cardiopulmonary resuscitation. The purpose of thisstudy was to validate rSO2 monitoring on effectiveness of chest com-
pression by investigation of relationship between arterial blood pres-
sure and rSO2 in patients with out-of-hospital cardiac arrest (OHCA).
Methods
This study was a prospective observational study conducted at a ter-
tiary emergency medical care center in Japan. Systolic arterial pres-
sure (SAP) and mean arterial pressure (MAP) through invasive arterial
pressure monitoring, and rSO2 were measured at every 3 minutes
during the cardiopulmonary resuscitation of OHCA patients, and the re-
lationships between absolute values in the measurements were com-
pared using the two types of coefficient of correlation, within and
between patients in order to perform the statistical analysis considering
repeated measurement taken from a single patient.
Results
There were 38 patients out of total 169 patients with OHCA who ful-
filled the inclusion criteria of the study and 16 patients were finally
included. Total measurement points of these patients were 29 points.
Median value of the patient age was 82 years old (IQR 71-87). Male
patient number was 14 (88 %), and 81 % patients had witnesses at
the time of cardiopulmonary arrest. Two types of coefficient of cor-
relation between arterial pressure and rSO2 showed that the within
patients f coefficient of correlation between MAP and rSO2 was 0.20
(95 % CI:-1.8-0.53), but the coefficient of correlation between patients
was 0.82 (95 % CI:0.14-0.72).
Conclusions
There was correlation between rSO2 and MAP during sternal chest
compression in patients with OHCA indicating that rSO2 may be use-
ful to monitor cerebral blood flow during the chest compression. Our
results suggest that sternal chest compression under rSO2 monitor-
ing improves outcome of the patients with OHCA.P316
EEG reactivity in patients after cardiac arrest: a close look at
stimuli
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Introduction
Testing EEG reactivity is a standard procedure during EEG regis-
tration in unconscious ICU patients. It is suggested to use EEG re-
activity as a marker for poor outcome after cardiac arrest [1]. How-
ever, there is no clearly defined protocol how to test reactivity. In
this study we investigated which stimulus type most effectively
evokes a cortical response in cardiac arrest patients.
Methods
Prospective cohort study in patients monitored with continuous EEG
after cardiac arrest in two Dutch ICUs. Twice a day a very strict stimu-
lus protocol including five stimulus types (in this order: clapping, yell-
ing patients name, passive eye opening, nasal tickle and sternal rub)
was executed. Each stimulus was applied 3 times for 5 s with an
interval of 30s. Each stimulus response was individually scored react-
ive, non-reactive, doubtful or unscorable (e.g. too much noise) by
three independent, blinded raters (JH, MvP, MT-C). Reactivity was de-
fined as a change in the amplitude or frequency in the EEG upon
stimulation, excluding muscle artifacts. Iso-electric EEGs were ex-
cluded beforehand. Stimulus responses on which two out of three
raters agreed were included in the analysis.
Results
The stimulation protocol was executed 72 times in 29 patients,
resulting in 1050 independently rated stimulus responses. 42 stimuli
were excluded because of disagreement between raters. The intra-
class correlation coefficient was 0.38. The response to 91 stimuli in
19 patients was found reactive. The stimulus inducing EEG reactivity
most often was clapping, 29 %. Passive eye opening least often in-
duced EEG reactivity, 16 %.
Fig. 84 (Abstract P317). NSE distribution in poor outcome patients.
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A sudden loud noise stimulus such as clapping seems to most effect-
ively evoke a cortical response in patients after cardiac arrest. We
suggest integrating this stimulus in the standard set of stimuli for
testing EEG reactivity. More studies are needed to determine the
relevance for prognostication.
Reference
1. Sandroni C, et al. Prognostication in comatose survivors of cardiac arrest:
An advisory statement from the European Resuscitation Council and the
European Society of Intensive Care Medicine. Intensive Care Med. 2014;
40(12):1816–1831.
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Introduction
The serum concentration of neuron-specific enolase (NSE) has been
established as a highly specific predictor of poor outcome after car-
diac arrest but no clear cut-off has been identified.
Methods
We prospectively included all out-of-hospital cardiac arrest patients
admitted in our intensive care unit (ICU) from 2011 to 2014. They
were submitted to target temperature management (34 °C) for
24 hours. Outcome was assessed according to the Cerebral Perform-
ance Category (CPC) at ICU discharge. CPC 1 to 3 was considered as
good outcome and CPC 4 to 5 as poor outcome. Recent guideline
suggest to sample NSE at 72 hours after cardiac arrest.
Results
132 patients were admitted from 2011 to 2014. 54 patients pre-
sented good outcome while 78 patients presented poor outcome ac-
cording to CPC. The NSE serum concentration was sampled at the
3rd days after cardiac arrest.
In the first group NSE value was 22.3 mcg/l. In the second group NSE
value was 74,5 mcg/l.
Nevertheless 8 patients presented poor outcome and NSE serum
concentration < 40 mcg/l and 3 patients presented good outcome
and NSE > 60 mcg/l (Fig. 83).
We observed great variability of NSE value in patients with poor out-
come (Fig. 84).
Conclusions
NSE could be an important biomarker of poor outcome after cardiac
arrest. Further investigation is necessary to clarify timing for sample
and cut off.
Reference
Jerry P. Nolan, et al. European Resuscitation Council and European Society of
Intensive Care Medicine Guidelines for Post-resuscitation Care 2015.
Section 5 of the European Resuscitation Council Guidelines for
Resuscitation 2015. Resuscitation. 2015; 95 L 202–222Fig. 83 (Abstract P317). NSE distribution in good outcome patients.P318
Correlation between electroencephalographic findings and serum
neuron specific enolase with outcome of post cardiac arrest
patients
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Introduction
Anoxic–ischemic encephalopathy after cardiac arrest is a common
cause of coma requiring intensive care of survivors. Certain ma-
lignant electroencephalographic (EEG) patterns have been shown to
correlate with poor prognosis. Neuron specific enolase (NSE) released
after cardiac arrest is regarded as a severity indicator of postanoxic
neuronal injury. We investigated the EEG findings in post-cardiac
arrest patients and correlated these findings with NSE levels and out-
come scales.
Methods
34 Egyptian patients after resuscitation from cardiac arrest were sub-
jected to, EEG, NSE measurement, and Glasgow outcome scale (GOS).
EEG data EEG monitoring was done within the first day of admission
for about 30 minutes and repeated on the seventh days after cardiac
arrest. EEG classification on days 1 and 7 post-arrest according to
Young et al. (1)
I. Delta/theta > 50 % of recording
II. Triphasic waves
III. Burst-suppression pattern: with or without epileptiform activity
IV. Alpha/theta/spindle pattern coma (no reactivity).
V. Suppression (generalized) : <20 microvolts.
NSE will be sampled at both day 1 and 3 after cardiac arrest. Serum
concentrations of NSE will be measured using ELISA technique.
Results
There was statistically significant negative correlation between EEG
coma scale on day 1 and 7 with GOS ( p > 0.001). There was statis-
tically significant negative correlation between NSE on day 1 and 3
with GOS (p > 0.001) (Table 44).
There was statistically significant positive correlation between EEG
scale on day 1 and 7 with neuron specific enolase on day 1 and 3
(Table 45).
Conclusions
In post-cardiopulmonary arrest patients, there is significant correl-
ation between EEG coma scale and Glasgow outcome scale, as cer-
tain malignant EEG patterns are correlated with high serum levels of
NSE and they are good predictors of poor outcome of these patients.
Reference
1. Young GB, McLachlan RS, Kreeft JH, Demelo JD. An
electroencephalographic classification for coma. Can J Neurol Sci. 1997;
24(4): 320–325.
Table 44 (Abstract P318).
GOS (r) GOS (p)
EEG SCALE 1ST DAY -0.670 <0.001
EEG SCALE 7TH DAY -0.722 <0.001
NSE 1ST DAY -0.624 <0.001
NSE 3RD DAY -0.673 <0.001
Table 45 (Abstract P318).
NSE 1ST DAY (P) NSE 3RD DAY (P) EEG SCALE 1ST DAY
0.002 <0.001 EEG SCALE 7TH DAY
<0.001 <0.001
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Introduction
We report the experience of a 10-bed intensive care unit (ICU) intro-
ducing a targeted temperature management (TTM) strategy follow-
ing cardiac arrest based on the TTM trial investigation protocol [1],
including pre- and post-intervention data. Our unit averages 4 car-
diac arrest cases a month; at this low frequency, and given recent
updates to TTM evidence, we were concerned that our temperature
management practice could be inconsistent or outdated.
Methods
Cases were identified retrospectively from the Scottish national ICU
audit database. All patients with a diagnosis of cardiac or respiratory
arrest were selected for full case note review. Baseline survey from
May-November 2014 yielded 21 cases of which 3 sets of notes were
unobtainable. Data collected included documented target tempe-
rature (TT), use of active cooling, hourly temperature data over the
first 24 hours in ICU, and eventual outcome.
A new TTM strategy, based on the TTM study protocol, was then in-
troduced in February 2015. This was presented at the local ICU meet-
ing and copies made available at each bed space for staff to refer to.
Subsequently, all cases from March-September 2015 were identified
by the same method and the same data set collected, totalling 20
cases of which 1 set of notes was unobtainable.
Results
Baseline data indicated no consistent TTM strategy with documented
TT ranging from 35 to 37 °C, with no target documented in 50 %.
Only 28 % were actively cooled, while 50 % were pyrexial (defined as
>37.5 °C) and all but one patient (94 %) exceeded the TTM target of
36 °C by at least 0.5 °C. Prior to intervention, the average time spent
above 37.5 °C was 5.8 hours and the average time above 36.5 °C was
11.8 hours.
Following the intervention, TTs ranged from 36-36.5 °C with an in-
creased proportion of patients (12, 63 %) having the desired TT of
36 °C. A decreased proportion, 26 % regrettably still had no docu-
mented TT, however significantly more patients (13, 68 %) were ac-
tively cooled. Only 4 patients (21 %) were pyrexial, while 12 still
exceeded 36.5 °C (63 %). Encouragingly, after the introduction of the
protocol, the average time spent above 37.5 °C was 1.15 hours (80 %
reduction) and the average time above 36.5 °C was 4.2 hours (64 %
reduction).
Conclusions
Following changes to TTM in recent years, our promising initial data
show that introduction of a TTM strategy in a small unit with infre-
quent cases is achievable, and compliance with targets can be sig-
nificantly improved with a simple intervention protocol.Reference
1. Nielsen N, et al. Targeted Temperature Management at 33 °C versus
36 °C after Cardiac Arrest. N Eng J Med. 2013; 369: 2197-2206.
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Introduction
Regardless of the recent advances in cardiopulmonary resuscitation
and post-resuscitation care, most patients who die during their hos-
pital stay after out-of-hospital cardiac arrest (OHCA) decease due to
post-anoxic neurological injury. Near infrared spectroscopy (NIRS)
provides information on regional brain oxygenation by measuring
the regional cerebral oxygen saturation (SctO2) and offers the possi-
bility to determine changes in the balance between oxygen delivery
and uptake in the frontal lobe of the brain. The aim of the study was
to monitor SctO2 for 48 hours in OHCA patients during targeted
temperature management (TTM).
Methods
A prospective, observational study was performed during therapeutic
hypothermia (TH; 24 hours at 33 °C, followed by rewarming at 0.3 °C/h
over 12 hours) in 107 successfully resuscitated OHCA patients. SctO2
was continuously monitored with NIRS for 48 hours using the FORE-
SIGHTTM (CAS Medical systems, Branford, CT, USA). The Cerebral Per-
formance Category (CPC) scale was used to define patient’s outcome at
180 days after OHCA, where CPC 1-2 and CPC 3-5 represented a good
and poor outcome, respectively. Data are reported as mean ± SD. A stu-
dent t-test was performed as appropriate and a mixed model was cre-
ated to analyze continuous SctO2 data over time.
Results
While 50 patients (47 %) survived with a good neurological outcome,
57 patients (53 %) corresponded to a CPC score of 5. The mean
SctO2 at ICU admission was 64 % ± 7 for survivors compared to
66 % ± 6 for non-survivors (p = 0.184). After initiation of TH, an im-
portant decrease was observed in both groups with a lowest SctO2
of 62 % at hour 3 for survivors and 61 % at hour 5 for non-survivors
(p = 0.432). This was followed by a progressive increase towards
baseline values. With respect to non-survivors who regained baseline
SctO2-values at 22 hours (66 % ± 6), survivors already reached base-
line values within 12 hours (65 % ± 6). All SctO2-values were fitted in
a linear mixed model and a significant time effect was observed
during the course of SctO2 after adjustment for age and gender
(p < 0.001). We found that SctO2-values of non-survivors followed
a linear course over time, whereas SctO2-values of survivors could be
fitted in a logarithmic curve.
Conclusions
TTM following OHCA is accompanied by fluctuations in the balance
between oxygen delivery and supply to the brain as reflected by
changes in SctO2. Moreover, the course of SctO2 over time is signifi-
cantly different as SctO2-values of survivors follow a logarithmic
course compared to a linear one for non-survivors.
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hypothermia in comatose survivors from cardiac arrest : 8-year
single center experience
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Introduction
Therapeutic hypothermia(TH) improves neurological outcome and
survival in comatose patients with ROSC after cardiac arrest [1]. Our
institute has developed hypothermia protocol and used it as a stand-
ard practice for 8 years. We aimed to evaluate clinical outcomes of
patients undergoing TH and analyze factors associated with these
outcomes.
Fig. 85 (Abstract P322).
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We retrospectively reviewed baseline characteristics, cooling practice
and clinical outcomes of post-arrest patients treated with TH in our insti-
tute from 2006 to 2014. Neurological status measured by the Cerebral
Performance Categories Scale (CPC) and survival rate were evaluated.
Prognostic factors for good neurological recovery and survival were ana-
lyzed. Continuous data were reported as medians and percentage. Chi-
square and Mann- Whitney U test were used to compare data of pa-
tients with favorable outcomes and those with unfavorable outcomes.
Results
TH was applied in 51 comatose survivors, including 40 survivors
(78.4 %) from out-of-hospital arrest. The primary cardiac rhythm for
the majority (40/51, 78.4 %) was non-shockable rhythm. The median
age of patients was 59 years. Overall, 52.9 %(27/51) of patients sur-
vived. The median hospital LOS was 13 days. Nine of 27 survivors at
discharge had good recovery (CPC1 = 6 and CPC2 = 3) Eight patients
had severe disability(CPC3) and 10 patients were in a vegetative state
(CPC4). Free of vasopressor was the only prognostic factor for good
neurological recovery (p = 0.012) and survival (p < 0.001), while the
shorter time from collapse to ROSC was associated with favorable
outcome (p = 0.044). Additionally, duration of less than 6 hours from
ROSC to achieved temperature and protocol completion were associ-
ated with survival (p = 0.038 and p = 0.027, respectively). Cardiac
rhythm, location of arrest, target temperature attainment, rebound
hyperthermia and age were not associated with any clinical outcome.
Conclusions
Regardless of cardiac rhythm and arrest location, approximately 53 %
of post arrest patients with TH survived and 33 % of survivors had fa-
vorable neurological outcome. The factors associated with the good
recovery were free of vasopressor and time from collapse to ROSC,
while factors associated with survival were free of vasopressor after
successful resuscitation, time to target temperature of less than
6 hours and protocol completion.
Reference
1. Alzaga A, Cerden M, Varon J. Therapeutic hypothermia. Resuscitation.
2006; 70(3): 369-380.
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Introduction
Targeted temperature management after out of hospital cardiac arrest
remains a recommended therapeutic approach by the Australian Resus-
citation Council. As one of the top five reasons for admission to our
major tertiary Australian Intensive Care Unit, we aimed to audit our
current practice with regards to time to target temperature, time at tar-
get temperature and rewarming practices.
Methods
We conducted a retrospective review of 54 patients admitted to our
Intensive Care Unit after return of spontaneous circulation (ROSC)
from out of hospital cardiac arrest, collecting data from our electronic
medical records system ‘Metavision’ and analysed using SPSS v22.0.
Ethics approval was obtained.
Results
Only 16 % of patients achieved target temperature within 4 hours,
with 25 % still not achieving target within 16 hours of ROSC and
44 % were maintained at the target for 12-24 hours. The target was
chosen as 32-24 degrees in 73 % of patients. Rewarming occurred at
a a rate of <0.5 degrees per hour in less than 50 % of the patients.
Despite these findings there was no correlation between neurological
outcome and adherence or not to the current evidence based
recommendations.
Conclusions
This data shows that our unit has been unable to consistently apply
targeted temperature management in “real world practice” accordingto evidence based guidelines, however this has not resulted in ad-
verse outcomes for our patient population.
References
Nielsen N, et al. Targeted temperature management at 33 °C versus 36 °C
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Introduction
Mild therapeutic hypothermia (MTH) improves neurological outcome
and survival after out-of-hospital cardiac arrest (OOH-CA) from TV/FV
[1]. However, this technique is not universally accepted, partially due
to technical difficulties related with the implementation of practice
protocols [2]. We present our experience over one year since the
introduction of an institutional MTH protocol, testing its feasibility.
Methods
We cooled comatose patients (unable to respond to verbal commands)
survived to OOH-CA from TV/FV since the implementation of a MTH
protocol between May 2014 and May 2015 at Pescara Spirito Santo
Hospital, a second-level hospital serving 300000 people. MTH was in-
duced after ROSC by intravenous 70 ml/Kg Ringer’s Lactate over 30′
and maintained, after ICU admission, by a temperature-regulated sur-
face device (Arctic Sun®, Medival, Padova, Italy; target temperature
33 °C, 0.5 °C/hours). Rewarming started 24 hours from induction
(target 36.5 °C, 0.5 °C/hours); device pads were left on site for
24 hours after normothermia was achieved. Neurological sequelae
were investigated before ICU discharging (clinical evaluation, CT
scan and EEG) and 3 months after, by telephonic interview.
Results
6 patients met protocol inclusion criteria (5 males, mean age 51.7).
Mean GCS value at ROSC was 4/15. MTH was started in ED (4 pa-
tients) or in ambulance (2). 4 patients underwent emergency coronar-
ography. Mean core temperature at ICU admission was 35.3 °C. Mean
time to target temperature was 320′, bradycardia was common in this
phase (6/6), as were hypokalemia (4/6) and metabolic acidosis (4/6).
Mean active rewarming time was 375′. Mild hyperkalemia occurred in 2
cases, while a case of hyperthermia (38 °C) needed pads repositioning.
All patients were discharged alive, 4 of them free from apparent neuro-
logical sequelae (1 agitation, 1 confusion and amnesia). Mean ICU stay
Critical Care 2016, Volume 20 Suppl 2 Page 132 of 182was 7.2 days. At 3 months, all patients were at home and free from
neurological alterations.
Conclusions
The study points out feasibility of a MTH protocol implementation in
this particular hospital setting. We overcame difficulty to rapidly in-
duce and safely maintain MTH mixing two cooling techniques: times
of induction and rewarming were acceptable, maintenance phase
was characterized by temperature stability and lack of life threaten-
ing events, and clinical outcome was encouraging.
References
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Introduction
Out of hospital cardiac arrest (OHCA) patients treated with targeted
temperature management (TTM) may have substantial difficulty in
ventilator weaning due to multiple organ failure, including post-TTM
neurologic injury. Ability to predict the clinical course of TTM patients
regarding duration of ventilation is important for clinical decision-
making for both safer extubation and planning early tracheostomy.
However, predictive factors of ventilator weaning after TTM remain
unclear. Hypothesizing that weaning difficulty is associated with ad-
mission resuscitation conditions, we explore whether failure to wean
may also be predicted at admission. The purpose of this study is to
examine which factors predict ventilator weaning difficulty.
Methods
We performed a retrospective cohort study of OHCA patients brought
to the emergency room at St. Luke fs International Hospital in Tokyo,
Japan, who underwent TTM between January 2006 and July 2015. Pri-
mary outcome was days to weaning from admission to the intensive
care unit. Using the electronic medical record, we collected patient
characteristics, resuscitation conditions, and examination data at
admission. After characterizing weaning success using descriptive
statistics, the relationship between ventilator weaning during
hospitalization and resuscitation conditions were assessed with Cox
regression.
Results
Of 115 OHCA patients who completed TTM, median time to weaning
from ventilation was 6 days (4-8: IQR). 98 patients (85 %) were weaned
within 2 weeks after admission. Earlier weaning was significantly associ-
ated with age (HR, 0.96; 95 % CI, 0.94 to 0.97) and motor response on
admission (HR, 1.56; 95 % CI, 1.01 to 2.41). Though not significantly as-
sociated with weaning, ventricular fibrillation and asystole showed a
trend towards early and later weaning, respectively, compared to Pulse-
less Electrical Activity.
Conclusions
A large majority of TTM patients can be weaned from ventilation
within 2 weeks. Older age and absence of motor response at ad-
mission are related with prolonged mechanical ventilation. Early
tracheostomy planning should be considered for patients after
achievement of TTM who are older and does not show motor re-
sponse in ER.
Reference
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Differential activation of c-fos in paraventricular nuclei of the
hypothalamus and thalamus of the rat following myocardial
infarction
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Introduction
c-Fos is well used to detect a pathogenesis in CNS disorders. We ex-
amined changes in c-Fos immunoreactivity in the paraventricular nu-
cleus of the hypothalamus (PVNT) and paraventricular nucleus of the
thalamus-(PVNT) after myocardial infarction (MI) in rats.
Methods
Infarction in the left ventricle was examine by Massoni’s trichrome
staining. Neuronal degeneration (damage/death) was examined for
56 days after MI using cresyl violet (CV) and Fluoro-Jade B (F-J B) his-
tofluorescence staining. Changes in C-Fos immunoreactivity were ex-
amined by immunohistochemistry for c-Fos.
Results
The average infarct size of the left ventricle circumference was about
44 % after MI. Neuronal damage/death was not detected in both
PVNH and PVNT after MI. c-Fos immunoreactive (+) cells were hardly
found in both nuclei of the sham-group. However, c-Fos + cells were
increased in both nuclei after MI and peaked in the PVNH and PVNT
3 days and 14 days, respectively, after MI. At 56 days after MI, c-Fos
+ cells were barely found in both nuclei.
Conclusions
These results show that MI dramatically induced c-Fos immunoreac-
tivity in the PVNT and PVNT and suggest that the increase of c-Fos
expression may be associated with brain stress associated with MI.
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Introduction
Cerebrovascular diseases are leading cause of morbidity, mortality
and disability [1]. Elevated troponin levels after AIS are common and
are associated with increased risk of death and cardiac complications
[2]. The aim of these study was to investigate if elevated levels of
serum cTnI in acute Ischemic stroke patients are able to predict
higher inhospital mortality.
Methods
We retrospectively investigated 218 patient between 11.2012 and 11.
2014. They were admitted in ICU and diagnosed as (AIS) according
to the TOAST classification. They were 8.51 % of total 2561 patients
hospitalized in the ICU in the same period. Brain CT or MRI were
used on admission. The severity of neurological deficit were scoring
based on NIHSS. The functional condition of patients was assessed
on discharge by modified Rankin scale (mRS). Troponin I was mo-
nitored on the 1st, 3rd and 5th day. Inclusion criteria were age over
18,AIS less than 24 hours, CT/MRT on admission and Troponin I on
1st, 3rd and 5th day. Exclusion criteria were SAH or ICH renal failure,
Acute coronary syndrome, Acute PE.
Results
Patients were divided into two groups-discharged alive and died in
hospital. The average age of patients was 75,27 ± 12,6 (SD) years.
Men’s age was 72,64 ± 13.50(SD)years, and women’s 75,27 ± 12,67
(SD) years. In hospital mortality among patients were 43.6 % (95/218).
The patients discharged alive were 56.4 %(123/218).The cTnI was
investigated on the 1st, 3rd and 5th day. According to the labora-
tory test results established upper limit of cTnI is 0.06 mg/l. We
found higher levels on admission in 47.2 % (103/218), on the 3rd
day in 54,6 % (119/218) and on the 5th day in (93/218). Among all
patients with high cTnI in hospital mortality was 70.9 %(73/103)on
admission, on the 3rd day 76.5 % (91/119), and 82.8 % (77/93). We
used nonparametric method for comparing the medians of two
Critical Care 2016, Volume 20 Suppl 2 Page 133 of 182variables. Statistically significant differences in the levels of cTnI
were found in group died in hospital. About the first and fifth days
the cut off points established by ROC analysis were 0,075 mg/l,
while about the third was 0,085 mg/l (Area = 0.771,CI = 0.704-0.837).
The sensitivity of the method was 74.16 % and specificity 76.42 %
for the first measurement, 86.52 % and 78.05 % for the third and
for the fifth day 77.53 % and 88.62 %.
Conclusions
The study showed increased levels of cTnI in patients with AIS died
inhospital. Those results gave us the grounds to offer routine moni-
toring of cTnI for early stratification of high risk patients.
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damage in the gerbil ischemic hippocampal dentate gyrus via
decreasing sods expressions
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Introduction
It is well known that neurons in the dentate gyrus (DG) of the hippo-
campus are resistant to short period of ischemia. Hyperthermia is a
proven risk factor for cerebral ischemia and can produce more exten-
sive brain damage and related with mortality rates. The aim of this
study was to examine the effect of hyperthermic conditioning (H) on
neuronal death, gliosis and expressions of SODs as anti-oxidative en-
zymes in the gerbil DG following 5 min-transient cerebral ischemia.
Methods
The animals were randomly assigned to 4 groups: 1) (N + sham)-
group was given sham-operation with normothermia (N); 2) (N + is-
chemia)-group was given 5 min-transient ischemia with N; 3) (H +
sham)-group was given sham-operation with H; 4) (H + ischemia)-
group was given 5 min-transient cerebral ischemia with H. H (39 ¡¾
0.5¨¬C) was induced by subjecting the animals to a heating pad for
30 min before and during the operation.
Results
In the (N + ischemia)-groups, a significant neuronal death was observed
in the polymorphic layer (PL) from 1 day after ischemia-reperfusion. In
the (H + ischemia)-groups, neuronal death was also observed in the PL
from 1 day post-ischemia; the degree of the neuronal death was se-
verer than that in the (N + ischemia)-groups. In addition, we examined
the gliosis of astrocytes and microglia using anti-glial fibrillary acidic
protein (GFAP) and anti- ionized calcium-binding adapter molecule 1
(Iba-1). GFAP+ and Iba-1+ glial cells were much more activated in the
(H + ischemia)-groups than those in the (N + ischemia)-groups. On the
other hand, immunoreactivities and levels of SOD1 rather than SOD2
were significantly lower in the (H + ischemia)-groups than those in the
(N + ischemia)-groups.
Conclusions
In brief, on the basis of our findings, we suggest that cerebral ischemic
insult with hyperthermic conditioning brings up severer neuronal dam-
age and gliosis in the polymorphic layer through reducing SOD1 ex-
pression rather than SDOD2 expression in the DG.
P328
Failure in neuroprotection of remote limb ischemic post
conditioning in the hippocampus of a gerbil model of transient
cerebral ischemia
J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin
Kangwon National University, Chuncheonsi, South Korea
Critical Care 2016, 20(Suppl 2):P328Introduction
Remote ischemic post conditioning (RIPoC) has been proven to pro-
vide potent protection of the heart and brain against ischemia-
reperfusion injury. However, despite the evidence of cerebral pro-
tection with RIPoC is compelling, RIPoC-mediated neuroprotection
against transient cerebral ischemic damage insult is still mired in
controversy. In this study, we examined the effect of RIPoC induced
by sublethal transient hind limb ischemia neuronal death in the
hippocampus following 5 min of transient cerebral ischemia in
gerbils.
Methods
Animals were randomly assigned to sham-, ischemia-, sham plus (+)
RIPoC- and ischemia + RIPoC-groups. RIPoC was induced by three cy-
cles of 5 min and 10 min occlusion-reperfusion of both femoral arter-
ies at predetermined points in time ( 0, 1, 3, 6, 12 and 24 h after
transient cerebral ischemia). CV staining, F-J B histofluorescence
staining and NeuN immunohistochemistry were carried out to exam-
ine neuroprotection in the RIPoC-mediated hippocampus 5 days after
ischemia-reperfusion.
Results
In the ischemia-group, we found a significant loss of pyramidal neu-
rons in the stratum pyramidale (SP) of the hippocampal CA1 region
at 5 days post-ischemia compared with the sham-group. In all of the
ischemia + RIPoC-groups, the loss of pyramidal neurons in the CA1
region at 5 days post-ischemia was not different from that in the
ischemia-group.
Conclusions
Our present findings indicate that RIPoC does not prevent hippo-
campal CA1 pyramidal neurons from neuronal death induced by
transient cerebral ischemia.P329
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Introduction
Aim of the study is to evaluate which acute brain injury (ABI)
was correlated with brain death (BD) in our neurologic intensive
care unit (NICU).
Methods
All dead patients for ABI in the NICU of the Modena Hospital were in-
cluded from January 1st 2009 to November 30th 2015. Data were
collected from the transplant register DONOR ACTION of National
Transplant Service.
Results
465 dead patients with ABI were included in the study. Age, sex, admis-
sion GCS and diagnosis, cause of death were recorded. The mean age
was 68.8 ± 14.9 standard deviation (SD) with a progressive increase dur-
ing the period observed from 60.3 ± 14.4 (2009) to 69.1 ± 14.4 (2015) in
the BD group (p < 0.05). Males were 236 (50.8 %). The mean GCS at ad-
mission was 4.4 ± 2.5. Among all patients, 245(52.7 %) have met criteria
for brain death according with Italian law. Admission diagnoses were
cerebral haemorrhage for 241 patients (51.8 %), anoxic coma for
91(19.6 %), brain trauma for 71(15.3 %), ischemic stroke for 46 (9.9 %),
brain cancers for 9 (1.9 %) and other reasons for 7 (1.5 %). 155 (63,3 %)
patients with brain haemorrhage developed brain death (p < 0.01)
(Fig. 86), while only 20 (21,9 %) anoxic brain injury patients experienced
brain death (p = 0.052) (Fig. 87).
Conclusions
The incidence of brain death was higher for patients admitted in the
NICU with cerebral haemorrhage than for patients with anoxic brain
injury.
Fig. 86 (Abstract P329). Brain death in cerebral hemorrhage.
Fig. 87 (Abstract P329). Brain death in anoxic coma.
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Introduction
The imaging of the brain of septic shock patients showing alterations
in their neurological status are unremarkable most of the time. The
current study provided findings from magnetic resonance imaging of
the brain in septic shock.
Methods
Twenty patients with septic shock and brain dysfunction symptoms
(acute alterations in mental status, delirium, coma, seizures and focal
neurological deficits) [median age 54 years (26 to 65), APACHE II: 21
(15 to 29), SOFA: 8(1 to 15)] underwent brain magnetic resonance
imaging (MRI) including gradient echo T1-weighted, fluid-attenuated
inversion recovery (FLAIR), T2-weighted and diffusion isotropic images,
and mapping of apparent diffusion coefficient. MRI findings were classi-
fied based on lesion types and localizations. Blood was withdrawn sim-
ultaneously for biomarker analysis. Neurological recovery of all patients
were evaluated using Glasgow Outcome Scale (GOS) during discharge.Results
None of the patients’ brain imaging was normal at the time of the
diagnosis of neurological alterations including mostly delirium. Twelve
patients showed white matter hyperintensity (leukoencephalopathy),
three patients showed ischemic lesions and posterior reversible en-
cephalopathy syndrome findings were evident in three patients. Un-
expected findings of cerebral atrophy not relating to age were seen in
seven patients. The lesions were correlated with disease severity and
GOS. No unexpected events were encountered during transport and
MRI scan.
Conclusions
Our study indicates the importance of brain imaging in severe sepsis
and septic shock. MRI can be an important imaging method in these
patients, where lesions were associated with disease severity and
poor outcome.
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Introduction
Valproic acid (VPA) is widely used as antiepileptic drug, which is known
to induce hepatotoxicity and hyperammonemia encephalopathy. These
toxic side effects are produced by a decrease in the carnitine blood-
levels, of which the valproic acid is directly responsible. The aim of this
report is to demonstrate the benefits of L-carnitine supplementation in
patients with acute valproic acid intoxication. Patients who are chronic-
ally treated with VPA show low levels of carnitine by depletion of its de-
posits, therefore L-carnitine addition proves to be appropriate.
Methods
This was a randomized controlled trial conducted in the Intensive
Care-Toxicology Unit of the Clinical Emergency Hospital in Bucharest,
that included all patients admitted for acute VPA poisoning (VPA
>150 μg/l), in 2014. The patients were randomly allocated in 2
groups to receive standard therapy or 1800 mg of L-carnitine/ day
together with standard therapy for 3 days. Plasma levels of valproic
acid and ammonemia were determined every six hours. Data was
statistically analyzed and the results were considered statistically sig-
nificant at p < 0.05.
Results
A total of 62 patients (34 in the standard group and 28 in the
L-carnitine group) accomplished the inclusion criteria. L-Carnitine
supplementation resulted in significant reductions in ammonemia
(47.9 ± 6 vs. 61.9 ± 11.39 μ mol/L), determined after 24 hours, levels
compared with baseline (P < 0.001), whereas this parameter re-
mained still high in standard group. The trend was similar for plasma
VPA levels (p < 0.05). Studied parameters were not influenced by
gender, but were correlated with age (p = 0.01).
Conclusions
The use of L-carnitine in the treatment of VPA poisoning accelerates
the elimination of VPA and facilitates the decrease in ammoniac
plasma levels, therefore reducing systemic toxicity and encephalopathy
risk. Further controlled, extented trials are required to better elucidate
the therapeutic and prophylactic roles of L-carnitine in the manage-
ment of VPA toxicity.
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Introduction
EEG reactivity has been reported as a predictor of outcome in coma-
tose patients with post-anoxic encephalopathy [1,2]. However, visual
analysis of EEG reactivity has a high inter-rater variability and is time
Critical Care 2016, Volume 20 Suppl 2 Page 135 of 182consuming [3,4]. Therefore, analysis of EEG reactivity may benefit
from a quantitative approach enabling automatic interpretation.
Methods
Prospective cohort study in comatose ICU patients with continuous
EEG background patterns in two Dutch ICUs. Reactivity to auditory,
visual and sensory stimuli was tested following a strict protocol. Vis-
ual analysis was regarded as the gold standard. Reactivity was de-
fined as a change in amplitude or frequency in the EEG after
stimulation, excluding muscle activity. Stimulus responses were
scored by three independent experts (JH, MvP, MT-C), responses on
which all three experts agreed were used. Data was separated in an
independent training and validation set. Spectral characteristics of
the EEG before and after each stimulus were compared. These were
determined by both parametric and non-parametric methods.
Epochs of 2, 5 and 10 seconds before and after the start of the
stimulus were analyzed and averaged over 1, 3, 5 and 7 channel.
Results
In the training set and validation set, 190 and 163 stimuli of 13 and 7
patients, respectively, were included. The prevalence of a reactive re-
sponse is 8.3 % in the training set and 3.1 % in the validation set.
The non-parametric power spectral density with a difference of 30 %,
in 5 second epochs, averaged over 5 channels was found to be the
optimal method for automatic analysis. This resulted in a sensitivity
of 92.9 % (95%CI 87.6-96.2) and a specificity of 94.8 % (95%CI 90.0-
97.7) in the training set. In the validation set a sensitivity of 40.0 %
(95%CI 32.5-48.0) and a specificity of 78.5 % (95%CI 71.2-84.4) were
found.
Conclusions
Automatic analysis of EEG reactivity based on the differences in spec-
tral characteristics detects reactivity. With further research we will
optimize this method to increase objectivity of EEG reactivity testing.
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Introduction
Accurate prognostic models, including common intensive care severity
scores such as APACHE II (acute physiology and chronic health
evaluation II), SAPS II (simplified acute physiology score) and SOFA (se-
quential organ failure assessment) are of high importance for quality
assurance and research in intensive care [1-3]. The aim of our study
was to investigate the usefulness of these in predicting mid-term mor-
tality after spontaneous intracerebral hemorrhage (ICH), and whether
the scores are of any extra value compared to a basic model compris-
ing of only age and level of consciousness.
Methods
We included adult patients with spontaneous ICH, treated in Finnish
intensive care units (ICU) in 2003-2012 from a nationwide ICU data-
base. Logistic regression was used to customize APACHE II, SAPS II
and SOFA for six-month mortality prediction. We created a reference
model based on age and Glasgow Coma Scale (GCS) score for com-
parison. We used a temporal split-sample technique for internal val-
idation. We tested model performance by assessing discrimination
(area under the curve [AUC]) and calibration (Hosmer-Lemeshow
&#264; and GiViTI calibration tests).Results
Totally 3,218 patients were included (1,238 in the development and
1,980 in the validation cohort). Both APACHE II and SAPS II showed
good discrimination (AUC 0.84, AUC 0.85, respectively) but did not
outperform the reference model (AUC 0.85; compared to APACHE II,
p = 0.133; compared to SAPS II, p = 0.141). SOFA, however, displayed
significantly poorer performance compared to the other models
(AUC of 0.76). All models showed poor calibration (p < 0.05). Age was
found to be a particularly strong predictor of death in patients with
GCS 9-12, as the mortality for patients aged <40 was only 8 %, yet
being as high as 43 % for patients aged >79.
Conclusions
Both APACHE II and SAPS II-based models showed good discrimin-
ation, but poor calibration for predicting six-month mortality in pa-
tients with spontaneous ICH treated in the ICU. The performance of a
simple prognostic model composed of only age and GCS, was com-
parable to the more complex scoring systems and based on our re-
sults, could replace these in this patient group.
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Introduction
The commonest symptom of non-traumatic subarachnoid haemor-
rhage (SAH) is sudden onset severe headache. The Emergency Phys-
ician is faced with a significant diagnostic challenge by this condition
as headache represents 1-2 % of ED attendances while SAH only ac-
counts for 1-3 % of these headaches [1,2]. Conventional practice re-
mains lumbar puncture (LP) sample analysis in patients with a negative
CT scan [1]. Recent series in Europe and the United States have demon-
strated wide variation in practice as whether an LP is undertaken with
no clear guidance on LP omission [2]. We propose a clinical decision
tool integrating recent evidence on this patient group.
Methods
Our search strategy included Medline, Embase, Google Scholar, inter-
national guidelines and reference searches as well as the authors’ col-
lection on the subject. The following search strings were applied:
[Subarachnoid haemorrhage exp OR subarachnoid hemorrhage exp
OR SAH.mp OR berry aneurysm.mp OR perimesencephalic OR arterio-
venous malformation.mp] AND [Lumbar puncture.mp OR cerebro-
spinal fluid exp OR spinal tap.mp OR spinal OR LP.mp OR CSF.mp]
AND [Computed Tomography exp OR CT.mp]. Studies using < 4 de-
tector technology CT-scanners were excluded.
Results
Multiple risk factors have been identified for SAH including: Loss of
consciousness, family history, hypertension, polycystic kidneys, exces-
sive alcohol intake and smoking. The aetiology of SAH in the majority
(>85 %) of patients is an aneurysm in the “Circle of Willis” [2]. CT sen-
sitivity within eligible studies ranged from 91-100 % [2], the largest
study was of a prospective design and included 3132 patients and
reported 100 % sensitivity if CT is performed within 6 hours of symp-
tom onset [1]. Recent work in the UK including 2248 patients who
underwent an LP concluded that an LP to be of low diagnostic yield
with the investigation of choice in patients equivocal LP findings or
recurrent symptoms was CT Angiography [2].
Conclusions
The majority of patients presenting with acute severe headache can
have a SAH excluded with a negative CT scan if seen with 6 hours of
onset and the images are reported by a Radiologist. A number of pa-
tients with delayed presentation or risk factors for SAH benefit from
CT Angiography unless contra-indicated. Our findings will be pre-
sented as an evidence based clinical decision tool.
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Introduction
Aneurismal subarachnoid haemorrhage (aSAH) is a significant
cause of morbidity and mortality throughout the world. The pri-
mary goal of the treatment is the occlusion of the ruptured
aneurysm preventing a rebleeding. To reduce the rate of this ad-
verse event current guidelines recommend that surgical clipping or
endovascular coiling should be performed as early as feasible. However,
this strategy may be associated with several disadvantages and timing
of procedure remains controversial. The aim of this study was to evalu-
ate the effect of timing of invasive treatment for aSAH on clinical
outcomes.
Methods
We performed a prospective, observational cohort study at a tertiary
university 750-bed hospital including patients with severe aSAH ad-
mitted to the Intensive (ICU) or Intermediate Post-operative Care Unit
(IMCU) after trying early endovascular coiling or surgical clipping
over a 1-year period (November 2014 to October 2015). We analysed
demographic, comorbidities, APACHE II score, Fisher and Hunt-Hess
grade, aneurysm characteristic, type of treatment, time interval be-
tween ICU or IMCU admission and invasive procedure, ICU, IMCU and
hospital length of stay, and outcomes variables. The study outcomes
were mortality, readmissions and re-operations.
Results
A total of 31 patients were included aged 56.5 ± 9.8 years old, with
22 (71 %) females and APACHE II score on admission 15.9 ± 8.4.
Endovascular coiling was performed in 27 (87 %) and surgical clip-
ping 4 (13 %) patients. Twenty-three (74.2 %) patients were admitted
to the ICU and eight (25.8 %) to the IMCU. Aneurysms were mainly
on anterior location (71 %), with saccular morphology (64.5 %) and
medium size (7.8 ± 3.4 mm). Fisher and Hunt-Hess grade 4 occurred
most frequently. A total of 7 (22.6 %) patients (5 coiling, 2 clipping)
died during ICU stay. The mean time from ICU admission to proced-
ure performed was shorter in this group than in the survivor group
(0.8 days [95 % CI 0.2 to 1.5]) versus 2.2 days (95 % [CI 1.4 to 2.9]); P
= 0.03). There was no correlation between time from admission to
procedure and ICU, IMCU or hospital length of stay. Only one patient
was readmitted to the ICU and in three was necessary repeat a new
invasive procedure.
Conclusions
In our cohort of aSAH patients treated with endovascular and surgical
methods and requiring intensive care we found a high mortality rate
mainly related to early procedure. Furthermore, we speculate that these
findings could have a significant impact on organizational strategies
and cost saving of healthcare organizations in some countries.
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Restrictive red blood cell transfusion (RBCTx) strategies are advo-
cated in most critical care populations. Whether this is standard
practice and applies to an aneurysmal subarachnoid hemorrhage
(aSAH) patient population is unclear. We aimed to describe transfusion
practices in an aSAH population in Canadian hospitals, including
hemoglobin (Hb) triggers and predictors of RBCTx in preparation for a
transfusion trial.
Methods
This is a multi-centre retrospective cohort study conducted at four
Canadian academic tertiary care centres. Population: All adult aSAH
patients admitted to the study hospitals from January 1, 2012 to
December 31, 2013. Patients were identified from hospital admi-
nistrative discharge records and existing local SAH databases. The
diagnosis was confirmed by reported presence of blood in the sub-
arachnoid space (on either imaging or lumbar puncture) due to a
ruptured cerebral aneurysm (as demonstrated on angiography,
neuro-imaging or autopsy). Data Collection: Trained abstractors col-
lected demographic data, aSAH characteristics, administration of RBC
transfusion, daily hemoglobin concentrations, other major aSAH co-
interventions, and outcomes using a pre-tested case report form in
reference to a standardized operations manual.
Results
From 886 screened patients, a total of 527 (59.5 %) with aSAH were
included in our study. Mean (±SD) age was 57 ± 13 years; 357
(67.7 %) were female. Median presenting Fisher Grade was 4 (IQR
3-4). Aneurysms were secured in 90.1 % of patients (52.2 % by en-
dovascular coiling, and 39.7 % by surgical clipping). Mean nadir
hemoglobin was 98 ± 20 g/L and occurred on median post-
admission day (PAD) 4 (IQR 2-11). RBCTx occurred in 100 patients
(19.0 %). RBCTx rates varied across centres (12.1-27.4 %, p = 0.02). A
median 1 unit of RBCs (IQR 1-2) was administered per transfusion
episode and patients received a median total of 2 units (IQR 1-4).
Median pre-transfusion hemoglobin for first transfusion was 79 g/L
(IQR 74-93) and did not vary substantially across centres (78-82 g/L,
p = 0.37). Of patients with nadir Hb < 80 g/L, 65.8 % received an
RBCTx compared to 7.0 % with Hb nadir > =100 g/L (p < 0.0001). Uni-
variate predictors of RBCTx were increasing age, anterior circulation
aneurysm, lower presenting GCS, advanced Fisher Grade, neurosurgi-
cal clipping and lower Hb.
Conclusions
In our retrospective study of aSAH patients, we observed that RBCTx
was uncommon (19.2 % of patients), and mostly reserved for patients
with significant anemia (Hb <80 g/L).
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Introduction
Little is published about anemia in aneurysmal subarachnoid
hemorrhage (aSAH). We aimed to describe the disease burden of
an aSAH population in Canadian hospitals, and the prevalence and
incidence of moderate anemia (hemoglobin <100 g/L) in preparation
for a transfusion trial.
Methods
This is a multi-centre retrospective cohort study conducted at four
Canadian academic tertiary care centres. Population: All adult aSAH
patients admitted to the study hospitals from January 1, 2012 to
December 31, 2013. Patients were identified from hospital adminis-
trative discharge records and existing local SAH databases. The diag-
nosis was confirmed by presence of blood in the subarachnoid space
(on either imaging or lumbar puncture) due to a ruptured cerebral
Critical Care 2016, Volume 20 Suppl 2 Page 137 of 182aneurysm (as demonstrated on any of angiography, neuro-imaging
or autopsy). Data Collection: Trained abstractors collected demo-
graphic data, aSAH characteristics, daily hemoglobin concentrations
and nadir hemoglobin, other major aSAH co-interventions, and out-
comes using a pre-tested case report form in reference to a stan-
dardized operations manual.
Results
A total of 527 patients (59.5 %) with aSAH met study eligibility cri-
teria. Mean (±SD) age was 57 ± 13 years; 357 (67.7 %) were female.
The most common prior medical history was presence of hyper-
tension (44.2 %) and active tobacco smokers (35.1 %). Mean
aneurysm size was 7 ± 4 mm with 62.0 % occurring in the anterior
circulation. Median presenting Glasgow Coma Scale score and Fisher
Grade was 14 (IQR 11-15) and 4 (IQR 3-4) respectively. Aneurysms
were secured in 90.1 % of patients (52.2 % by endovascular coiling,
and 39.7 % by surgical clipping). Moderate anemia was prevalent in
29 patients (5.5 %) at admission and occurred in an additional 259
(52.0 %) during hospitalization. Nadir hemoglobin occurred on me-
dian post-admission day (PAD) 4 (IQR 2-11). Mean admission and
nadir hemoglobin were 130 ± 17 g/L and 98 ± 20 g/L, respectively.
Within the first 21 days of admission, moderate anemia occurred in
273 (51.8 %) of patients by median PAD 2 (1-4). RBC transfusion oc-
curred in 100 (19.0 %) of patients. In-hospital mortality was 17.7 %;
35.3 % of the survivors were discharged from hospital with moderate
to severe disability.
Conclusions
Moderate anemia (hemoglobin <100 g/L) is common in patients ad-
mitted with aneurysmal subarachnoid hemorrhage. Less than 20 %
of aSAH patients receive a RBC transfusion. Acute aSAH is associated
with significant mortality, and morbidity in survivors.
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Introduction
NLR has been investigated as a biomarker of poor outcome in
various conditions. The prognostic value of NLR and of C-reactive
protein (CRP) was investigated in patients with SAH. Our hypoth-
esis was that the profile of NLR from admission to the 5th
hospital day could predict the development of symptomatic vaso-
spasm or DCI.
Methods
We retrospectively reviewed data from consecutive SAH patients
(Jan 1, 2004 - Jan 1, 2015) and recorded demographics, neuro-
logical examination, radiological and transcranial Doppler find-
ings, length of stay (LOS) in the ICU, and mortality. NLR values
were calculated from admission to the 5th hospital day. Medians
were compared between groups using Mann Whitney U test.
Multivariate logistic regression analysis using stepwise backward
method was generated to predict the occurrence of symptom-
atic vasospasm and DCI. Receiver operating characteristic (ROC)
curves were generated to assess the accuracy of NLR to predict
complications.
Results
The cohort included 123 patients (71 % F, median age 53). Severity
was high, with 40.7 and 50.4 % of the patients having respectively a
Fisher grade 3 or 4 SAH. The mortality rate was 23.6 %. The median
ICU LOS was 12 days (IQR:15-40). Asymptomatic vasospasm was no-
ticed in 9.8 % of the patients, and symptomatic vasospasm in 36 %.
DCI was demonstrated in 62 %. Early infection (within the first fivedays) was noticed in 15.4 %. The median NLR at ICU admission was
9.2 (IQR:5-12.7) for the entire cohort and NLR decreased over time
with a median NLR at 6.4 on day 5 (IQR:4.6-9.6). The median NLR
was different in patients with or without symptomatic vasospasm
(7.8 vs 6.7,p = 0.045), but only on day 3. CRP values were differ-
ent on day 1 and 4 in patients with early infection but showed
no difference between patients with or without DCI. Univariate
analysis found that younger age and Fisher grade were associ-
ated with DCI. Neither NLR nor CRP could predict the onset of
DCI. Lower NLR at day 5 was associated with symptomatic vaso-
spasm (OR:0.89[95%CI:0.79-0.98]) in univariate analysis. Following
multivariate analysis, a younger age (OR:0.96[95%CI:0.93-0.99])
and a lower NLR at day 5 (OR:0.89[95%CI: 0.80-0.99]) were identi-
fied as risk factors for symptomatic vasospasm.
Conclusions
NLR from day 0 to 5 did not vary with the presence of vasospasm or
DCI. NLR at day 3 was slightly lower in patients with vasospasm. A
lower NLR at day 5 was associated with an increased risk of symp-
tomatic cerebral vasospasm.P339
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Introduction
Patients with aneurismal subarachnoid hemorrhage (aSAH) have in-
creased risk to develop nosocomial infections, associated with poor
outcome.
Aim of our study was to describe infections incidence and features in
aSAH patients and evaluate the impact on ICU and hospital length of
stay (LOS).
Methods
We retrospectively analyzed data from a observational trial on aSAH. All
patients with aSAH admitted to our ICU were included. Demographic,
clinical, radiological and microbiological data were recorded. Infections
were diagnosed according to current guidelines. Patients who died
within 72 hours from admission were excluded from analysis. Statistical
analysis was performed using Prism. Significance was set at a p
value < = 0.05.
Results
159 patients were included: median age was 59 years old, 30 % was
male. Aneurysm was located in anterior circulation in 139 patients
and secured through coiling in 76 %.
74 patients (47 %) experienced 98 septic episodes: incidence was
low (31 %) in less severe (World Federation of Neurosurgeons grade
(WFNS) 1 to 3) and higher in more severe aSAH (WFNS 4-5 78 %,
p < 0.001). Diagnosis was made at 4 ± 1 days from admission. VAP
(79 %) and urinary tract infections (10 %) were the most prevalent in-
fection. 1 patients had septic shock. Most common pathogens were
Haemophilus influenzae, Escherichia coli and Pseudomonas aeruginosa,
accounting for 37 % of infections, while multidrug resistant bacteria
were less than 5 %.
ICU and hospital LOS were significantly higher in septic compared to
non-septic patients, independently of WFNS category, as shown in
Fig. 88.
Conclusions
ICU-acquired infections are common especially in severe aSAH pa-
tients, predominantly VAP caused by Gram negative bacteria. Infec-
tions cause longer ICU and hospital LOS.
Fig. 88 (Abstract P339).
Fig. 89 (Abstract P340). Box-plots illustrating CMD concentrations
in normoxic and hyperoxic conditions.
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Cerebral metabolic effects of normobaric hyperoxia during the
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Introduction
Mechanical ventilation is often necessary in patients with poor-
grade subarachnoid hemorrhage (SAH) and supra-normal oxygen
levels are frequently achieved in the acute phase both in prehos-
pital setting or in the intensive care unit. However the exact
cerebral physiologic effects of normobaric hyperoxia have not
been investigated in this setting in humans. Cerebral microdialy-
sis (CMD) is a unique technique that allows the chemistry of the
extracellular brain interstitial fluid to be monitored continuously
at patient bedside.
Methods
Retrospective analysis of a prospective database of comatose pa-
tients after SAH monitored with CMD as part of standard care.
The relationship of hyperoxia (defined as a supra-normal PaO2 >
150 mmHg for at least 1 hour) with brain extracellular bio-
markers (including CMD lactate, lactate/pyruvate ratio [LPR] and
glutamate) was examined during the acute phase (first 48 hours)
following SAH. Comparisons between groups were explored
using non-parametric Mann-Whitney U test. Significance was set
at p < 0.05. Approval for the study was obtained from our local
Ethical Committee.
Results
A total of 460 matched PaO2/CMD samples from 28 consecutive
mechanically ventilated poor-grade SAH patients (median age 58
[10th-90th percentiles 42-68] years, median WFNS 5 [3-5]) were ana-
lyzed. Compared to non-hyperoxic samples (n = 366), those with
hyperoxia (n = 94) were associated with higher CMD levels of lactate
(3.5 [2-7.5] vs. 4.7 [2.3-9.1] mmol/L), LPR (30 [19-54] vs. 36 [23-53])
and glutamate (12.1 [2.2-61.2] vs. 27.2 [1.9-68.6] μmol/L) (all p < 0.01),
while main cerebral (PbtO2, ICP, CPP) and systemic (PaCO2, MAP)
variables were within normal ranges and did not differ between the
two conditions.
Conclusions
Our findings in comatose patients with SAH monitored with intra-
cerebral microdialysis suggest that hyperoxia was associated with in-
creased secondary cerebral damage. Our study indicates that the use
of supra-normal oxygen levels (PaO2 > 150 mmHg) may be harmful
in the acute ICU phase following SAH.P341
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Introduction
Admission to intensive care unit (ICU) is a routine practice following
elective craniotomy for brain surgery. The rationale for this practice is
the high risk of surgery on this vital organ and that ICU allows the early
detection of serious complications. However, several studies have
shown that many of these patients require minimal ICU interventions
[1]. In addition, ICU resources are scarce and costly. Intermediate care
units provide more monitoring than general wards and less than ICU
with evidence to support the benefits on cost and patient outcomes
[2]. The aim of this study was to compare outcomes of patients under-
went elective craniotomy who were admitted to the intensive or inter-
mediate post-operative care unit (IMCU) settings postoperatively.
Methods
We conducted a prospective observational study during a year
period (November 2014 to October 2015) with patients who had
undergone elective craniotomy for brain surgery admitted post-
operatively to ICU or IMCU of a tertiary 750-bed hospital. Main vari-
ables analyzed included demographic, comorbidities, ASA, APACHE II
score, duration of anesthesia and surgery, surgical procedure and
diagnosis, ICU and IMCU length of stay. Study outcomes were mortal-
ity, readmissions to ICU and re-operation rates.
Results
One hundred and fourteen patients were included in the study
(mean age 53.8 ± 14.2 years, 61 (63.5 %) males). Sixty-five (57 %) patients
were ASA II and 29 (24.4 %) class III. Mean APACHE II score was 10.1 ±
8.3. Duration of anesthesia and surgery were 241 ± 99.6 min and 208 ±
87.6 min, respectively. Eighty-two patients were admitted to ICU and 32
to IMCU. Main diagnoses were supratentorial meningioma (n = 27) and
glioma (n = 20), infratentorial tumor (n = 21) and transsphenoidal resec-
tion of pituitary tumours (n = 21). Duration of stay was 24.3 (95 % CI [7
to 24.9]) hours in ICU and 16.2 (95 CI [13.8 to 18.5]) hours in IMCU group,
respectively (P < 0.001). Two patients admitted to the ICU died. Four pa-
tients from the ICU and two from the IMCU group were readmitted. Five
patients in ICU and two in IMCU patients were re-operated.
Conclusions
In our setting, patients undergoing elective craniotomy for brain surgery
received proper postoperative care in both units. Length of stay was
shorter in the IMCU than in the ICU group. Mortality, readmissions and
re-operations were similar. Cost could be reduced when postoperative
care for this surgery is provided in intermediate care unit.
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Introduction
Every realized donor counts, because they can all save or improve
somebody’s life. The aim of this study was to analyse patients after
receiving organs from donors from our neurocritical care.
Methods
We performed a 5-year prospective follow-up study on patients from
the Transplant Center after transplantation of organs donated by 14
stroke patients with a diagnosis of brain death in our adult neurocri-
tical care unit (subarachnoid haemorrhage 7, intracerebral haemor-
rhage 4, ischemic stroke 3). Overall 29 organs (27 kidneys, 2 livers)
were retrieved and transplanted to 29 patients with mean age
55.3 ± 9.76 years.
Results
Of the 27 patients who underwent a kidney transplant, 21 (78 %) pa-
tients lived 5 years, of those 17 (63 %) patients with functional graft.
One patient (4 %) had primary afunctional graft and in three patients
(11 %) rejection occurred (3, 15 and 41 months). Six patients (22 %)
died after their kidney transplants, 1 patient with functional graft, 1
patient had primary afunctional graft and 4 (15 %) patients had re-
jection (1, 12, 44 and 56 months). The two patients with liver trans-
plants lived 5 years with functional graft.
Conclusions
14 neurocritical care organ donors helped patients live 5 years with
functional graft,17 patients after kidney transplants and 2 patients
after liver transplants.P343
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Introduction
Traumatic brain injury (TBI) may affect the pharmacokinetics of
anti-epileptic drugs (AEDs) leading to the potential for ineffective
post-traumatic seizure (PTS) prophylaxis. Levetiracetam (LEV) is in-
creasingly utilized for the prophylaxis of PTS. Recent studies sug-
gest that neurocritical care patients may require higher LEV doses
to achieve therapeutic trough levels of 12-20mcg/mL [1,2]. The
aim of this study is to describe the pharmacokinetics of LEV in the early
(less than or equal to 7 days after injury) post-TBI period and evaluate
the incidence of seizures.
Methods
This retrospective chart review included adult patients with a diagno-
sis of severe TBI who had at least one LEV level drawn during an in-
tensive care unit (ICU) admission from January 2010 to October 2015.
Patients were evaluated for the following outcomes: LEV trough
levels (drawn at steady state), LEV dosing regimen, % of patients
reaching LEV trough goal, LEV duration of therapy, diagnosis of seiz-
ure during hospital admission, hospital and ICU length of stay (LOS),
and in-hospital mortality.
Results
Evaluation of 26 patients resulted in a median LEV trough of 9.7mcg/
mL (IQR 6.75-18.8) with only 19.2 % of patients within trough goal
(57.6 % below goal, 23.1 % above goal). A subset of 15 patients had
two consecutive LEV levels, which allowed for pharmacokinetic
evaluation, resulting in median maximum concentration (Cmax) =
32.2mcg/mL, minimum concentration (Cmin) = 8.1mcg/mL, volume ofdistribution = 28.5 L, and half-life = 7.4 hours. The most common
maintenance dose was 1 g twice daily (57.6 % of patients), followed
by 1.5 g twice daily (23.1 %). Median duration of LEV therapy was
7 days. Seizures occurred in 7 patients during admission (26.9 %),
with the majority of seizures occurring in the first 24 hours of admis-
sion. Median ICU and hospital LOS were 11 and 15 days, respectively,
with an in-hospital mortality rate of 11.5 %.
Conclusions
The majority of LEV trough levels were subtherapeutic during the
early post-TBI period despite more aggressive initial dosing com-
pared to previous studies. Linear regression suggests that the op-
timal dose of LEV for patients with normal renal function is 1.5 g
every 8 hours. Further research is necessary to determine the im-
pact of augmented renal clearance on LEV levels in patients with
severe TBI.
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Introduction
The BrainIT database contains the physiological and outcome data
of 261 TBI patients [1]. We aimed to identify distinct patient groups
distinguishable by the trajectory of their physiology over time using
cluster analysis, a form of data mining [2]. We hypothesised that
the resulting groups would have a good or poor outcome, mea-
sured by the extended Glasgow outcome score (eGOS). This would
indicate physiological trajectories associated with a good or poor
prognosis.
Methods
The MREC for Scotland approved the use of BrainIT data for scientific
purposes in 2002, and need for informed consent was waived. We
first cleaned the database, which left 155 patients. These patients
were then clustered based on 24-hour trajectories of CPP, ICP, HR,
SaO2, and mean BP. To do this, we applied the general linear mixed
model, a form of cluster analysis [2], to the data to create three algo-
rithms: Algorithm 1 clustered patients on minute-by-minute physio-
logical data, Algorithm 2 used the same data with six outlying
patients removed, and Algorithm 3 used hour-by-hour data, with the
same six outlying patients removed as in Algorithm 2. Each algo-
rithm’s resulting clusters were paired to admissions data such as first
GCS and outcome data as measured by eGOS.
Results
Algorithm 1 identified six outliers with distinct and extreme physio-
logical trajectories and eGOS. (n = 149, eGOS 5; n = 3, eGOS 7; n = 2,
eGOS 1; n = 1, eGOS 1). The patients in Algorithm 2 did not separate
into clusters (n = 149, eGOS = 5). Algorithm 3 revealed three clusters
(n = 65, eGOS 5; n = 58, eGOS 5; n = 26, eGOS 6) with similar phy-
siological trajectories and outcomes. However, as well as having a
slightly better outcome, the cluster with an eGOS of 6 was older than
the other two clusters and had a higher CPP and mean BP.
Conclusions
Clustering TBI patients based on physiological trajectories is possible.
We identified outliers with distinct eGOS based on minute-by-minute
physiology. The model is not able to identify groups of patients with
distinct outcomes based on hour-by-hour clustering with outliers
removed.
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Introduction
Changes of pressure inside cranium occur only when compartment in-
side has reached the compliance limit and changes below that point
are not monitored. Second weakness of ICP is that local changes may
have gone wrong long before ICP has reached the alarming value. Use
of electrical BI is real-time and has high sensitivity to minor changes of
volume shifts related to metabolism or HS infusion (1).
Methods
We used four electrode BI catheter connected to multi-frequency bioim-
pedance measurement device (Smartimplant Ltd.) (2). BI measurement
provided continuously from frequencies 100 Hz to 100 Khz. All data have
been recorded simultaneously with ICP and arterial pressure (AP) values.
Results
In ischemic tissue extravascular volume will decrease and we have
cytotoxic edema. In case of microvascular and trauma damage we will
have vasogenic edema and extracellular space will expand (Fig. 90).
By administrating HS we can monitor changes of intracellular and
extracellular volumes.
Conclusions
BI is fast and rapid indicator to any volume changes in tissue level
and is useful method to measure brain tissue status in icu as indica-
tor of HS administration resultativity and rebound effect.
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Introduction
We aimed to evaluate RBC transfusion frequency, their determinants
and associated clinical outcomes.
Methods
We conducted a retrospective multicenter cohort study using data
from the National Trauma Registry of Canada. All patients admitted
with a moderate or severe traumatic brain injury to one of the 114
participating centers from 2005 to 2013 were eligible. The registry
contains information on age, gender, trauma severity, discharge sta-
tus and discharge disposition. Data from the Discharge Abstract
Database containing information on blood products, comorbidities,
interventions and complications were linked to NTR observations. We
conducted multivariate robust Poisson regression with a random ef-
fect at the center level. Missing data were handled through multiple
imputation techniques.
Results
Over the course of their hospital stay, 1991 patients (28.19 %; 95%CI
27.16 to 29.25)) received RBC transfusions among 7062 patients suf-
fering from traumatic brain injury, with frequencies varying from 0 to
43 % between centers. Female gender, age 55-65 (in reference to pa-
tients aged < 55), anemia, coagulopathy, sepsis, bleeding, hypovol-
emic shock, presence of multiple other comorbidities, face, thoracic
and abdominal, spine, lower extremities and skin injuries, as well as
invasive interventions were associated with higher frequency of RBC
transfusions. Trauma severity and invasive interventions explained
76 % of the observed variation. Mortality, complications and dis-
charge elsewhere than home were increased in patients who re-
ceived RBC transfusions. ICU length of stay and hospital length of
stay were also longer in patients who received RBC transfusions.
When stratified, patients who were anemic on admission showed
neither benefit nor disadvantage on any outcome relative to RBC
transfusions. Similar results were obtained for stratum of patients
who were diagnosed with sepsis on admission.
Conclusions
RBC transfusion is common in patients with traumatic brain injury
and is potentially associated with unfavourable outcomes. Important
variation between centers was observed, and highlights the need
for stronger evidence over optimal transfusion practices in this
population. Considering the potential impact of RBC on brain oxy-
genation in this population, rigorous trials evaluating Hb triggers for
transfusion are needed.P347
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In general intensive care units (ICU), the non-inferiority of restrictive
transfusion strategies has been observed. Due to the risk of second-
ary cerebral lesions in traumatic brain injury, concerns have been
raised regarding the impact of low hemoglobin and hypoxia in this
population. Data remain scarce and clinical equipoise persists.
Methods
We conducted a cohort study of patients with moderate/severe trau-
matic brain injury admitted to the ICU of a level I trauma center
(Halifax). Data related to pre-transfusion hemoglobin levels and red
blood cells were collected. The association between hemoglobin
level, red blood cell transfusion and mortality was evaluated using a
robust Poisson model. We also constructed proportional hazard
models with time-dependant variables (hemoglobin and transfusion)
to evaluate survival. Neurological and non-neurological trauma com-
plications as well as length of stay (LOS) in ICU or hospital were con-
sidered as secondary outcomes.
Results
We included 215 patients (78 % male; mean age: 45 years). A third of
patients were transfused over their ICU stay (n = 66)). The median
pre-transfusion hemoglobin levels in patients who were transfused
were 81 g/L (IQR 67 to 100); and 110 g/L (IQR 93 to 123) in patients
who did not receive red blood cells. Worse outcomes were signifi-
cantly more frequent in patients who were transfused in adjusted
models (mortality RR: 2.25 [95%CI 1.41 to 3.59]; neurological compli-
cations RR: 3.45 [1.43 to 8.32]; trauma complications RR: 1.64 [1.29 to
2.07]; ICU LOS geometrical ratio: 1.99 [1.45 to 2.73]; hospital LOS geo-
metrical mean ratio: 2.38 [1.51 to 3.75]). A non-statistically significant
trend toward higher risk ratios for unfavorable outcomes following
transfusions in strata of patients with higher hemoglobin levels was
observed. No significant modification of transfusion effect by age, pres-
ence of comorbidities, or traumatic brain injury severity was observed.
Conclusions
In our cohort, red blood cell transfusions were associated with worse
outcomes in patients with traumatic brain injury, an association that
tend to increase with hemoglobin levels. However, residual confoun-
ding from comorbidities and traumatic brain injury severity is possible.
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Introduction
Penetrating gunshot wounds to the head (PGWH) are associated with
high mortality and morbidity. Getulio Vargas Hospital is a public
trauma center in Rio de Janeiro with a high volume of neurocritical
patients and an unusual number of civil patients admitted with PGWH.
The aim of this study was to describe patients with PGWH admitted
in Intensive Care Unit (ICU), investigating clinical characteristics, com-
plications and management that could be related to a better out-
come in this setting.
Methods
We retrospectively assessed the hospital records of every patient with
PGWH admitted to the ICU from October 1st, 2014 to September 30th,
2015. Exploratory analysis of clinical data, image results, treatment,
complication and outcomes was made. The primary end point was the
modified Rankin scale at hospital discharge.
Results
In the period of the study, 1789 patients were admitted to the ICU
and 13 PGWH patients were included. There were 10 male patients
(77 %) and 3 female (23 %), with a mean age of 30 years (range 14-
64). There were no self-inflicted lesions (all PGWH were results of ag-
gression). Glasgow Coma Scale at admission was 8 or less in 10 pa-
tients. On admission, 7 patients were anisocoric, 8 presenting shock,
5 had associated body lesions from another gunshot wound (such as
limbs or in the thorax). Mean SAPS 3 was 67 (range 35-94) and mean
Apache II, 26 (range 8-37). The CT scan findings were: midline shift in8 patients, 7 single lobe haemorrhages (such as frontal or parietal
lobe), and 6 patients with bleeding in more than one lobe. Six pa-
tients had subarachnoid and 3 had intraventricular hemorrhage. Early
surgical procedure was made to 10 patients (mainly decompressive
craniectomy). The mean hospital length of stay was 21 days (range 2
to 136 days). Six patients had wound infection, and three, infection in
other sites. The mortality rate for the entire group was 54 % (7 out 13).
4 patients progressed to brain death. Of the six patients discharged
from the hospital, four had good outcome (defined as modified Rankin
scores of 0-3), and two, bad outcome (modified Rankin of 4).
Conclusions
In agreement with previous reports, our results showed that the sur-
viving group was mostly of hemodynamically stable patients, in-
cluded all with GCS above 8, and had lower SAPS3 and APACHE 2
scores. Patients with multiple gunshot wounds, even on non-vital or-
gans, had worse outcome.
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Introduction
According to the advanced trauma life support; vital signs, mental
status, base excess (BE), and serum lactate are valuable parameters
to evaluate the hemodynamic status of the trauma patients. Only
few studies have examined the role of admission BE in blunt trauma
patients. To evaluate the value of admission BE in blunt trauma pa-
tients with respect to intensive care unit (ICU) admission rate and
length of hospital stay.
Methods
From January 2014 to October 2014, 293 patients visited emergency
room of our hospital due to the traumatic injury. In triage, Vital signs,
Glasgow coma scale (GCS), BE, and SL were checked as initial param-
eters. Also study database included admission BE, length of hospital
stay, mechanism of injury, injury severity score (ISS), and ICU admis-
sion. Admission BE drawn within 20 minute of arrival emer-
gency room. The patients with intracranial hemorrhage, penetrating
injury, age under 16 years old, and death on arrival were excluded.
The patients were grouped by the Injury severity score: group I (<8),
II (9 - 15), III (16 - 25), and IV (>26).
Results
A total of 293 patients were enrolled in our study. Among them 96
patients were admitted to ICU. Most common cause of ICU ad-
mission was driver traffic accident (n = 25, 26 %). Admission BE asso-
ciated with significantly ICU admission (p < 0.000). The area under
the curve of the receiver operating characteristic curve of admission
BE for predicting ICU admission was 0.63. Also admission BE (odds ra-
tio [OR], 0.904; 95 % confidence interval [CI], 0.823-0.992; P = 0.033)
and ISS (OR, 1.146; 95 % CI, 1.100-1.194; P < 0.000) were determined
to be predictors of ICU admission. BE seemed to show a weak correl-
ation for the ISS (R Spearman = -0.30). Admission BE was significantly
lower in the group IV than the remaining groups.
Conclusions
Admission BE in triage may be predicted injury severity and ICU ad-
mission in blunt trauma patients.
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Previous studies have found Proadrenomedullin (ProADM), an in-
flammatory blood marker, to provide additional prognostic infor-
mation for risk stratification. We aimed to translate ProADM cut-off
levels into an easy-to-use emergency department (ED) triage algo-
rithm to improve current risk assessments and clinical outcome pre-
diction of medical patients.
Methods
In this large multi-national, prospective, observational study from
Switzerland, France and the United States [1], we combined two
ProADM cut-off values with a five-level ED risk assessment tool
(Manchester Triage System, MTS) to further risk-stratify medical ED
patients [2]. The performance of this algorithm was tested to predict
adverse clinical outcome.
Results
Using data from 7132 consecutive ED patients (median age 62 years,
53.3 % male), the risk for 30 day mortality showed a stepwise in-
crease from low (0.64 % [95 % CI 0.37-0.92]) in patients with a
ProADM value of <0.75 nmol/L, to intermediate (4.38 % [95 % CI
3.58-5.18]) with a ProADM value >0.75 nmol/L and <1.5 nmol/L, to
high (15.5 % [95 % CI 13.5-17.5]) with a ProADM value of >1.5 nmol/L
(ANOVA, p < 0.0001). Combining initial ED triage (MTS) and ProADM re-
veals an observed risk for 30 day mortality of 0.5 % (14/2780 patients)
in case of low priority initial triage and a ProADM value of
<0.75 nmol/L until 23.1 % (96/416) in case of high priority initial
triage and a ProADM value of >1.5 nmol/L. In low priority patients
the overall 30 day mortality was 2.95 % (164/5550). Adding
ProADM values of <0.75 nmol/L the relative risk reduction was
-83 %, whereas adding ProADM values of >1.5 nmol/L increased
the risk for mortality four times. In high priority patients (11.56 %
overall 30 day mortality) relative risk reduction was -86 % adding
ProADM values of <0.75 nmol/L, and doubled in patients with ProADM
values of >1.5 nmol/L.
Conclusions
The proposed ProADM based triage algorithm allows a more accurate
prediction for adverse clinical outcome in medical ED patients at high
risk. To proof safety and efficacy of this new ED triage algorithm, an
intervention study involving a rapid ProADM point-of-care measure-
ment is mandatory.
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Introduction
Simulation training within Emergency Medicine is growing with vari-
ous peer-reviewed journals promoting simulation as a valuable edu-
cational tool [1,2]. High-fidelity mannequins are commonly used but
considerable barriers remain, particularly a lack of human interaction.
We suggest that a live patient during a point-of-care simulation
teaching series could both create more realistic scenarios, and de-
velop non-technical skills between the multi-disciplinary team. In
addition, studies have shown that curriculum mapping optimises
teaching in medical education and results in improved student satis-
faction [3]. Thus, we set out to develop an innovative Emergency
Medicine point-of-care simulation programme using live patients
with an associated curriculum map.
Methods
We developed and implemented a six-month point-of-care simula-
tion programme within the Royal Cornwall Hospital Emergency De-
partment covering critical illness, paediatric, and major trauma
presentations. A live clinically trained actor, rather than a high-fidelity
mannequin, acted as the patient in suitable weekly simulations. A
curriculum map was designed for each session detailing specificcurriculum topics covered. Feedback was collected from 12 Emer-
gency Medicine doctors using visual analogue scale questionnaires.
Results
Using a curriculum map, doctors’ knowledge of specific curriculum
learning increased from 42 % to 88 %, an increase of 46 percentage
points. 100 % stated that a curriculum map was useful/very useful.
100 % found interacting with a live patient a positive learning experi-
ence. 92 % stated it improved realism and the learning experience
compared to a high-fidelity mannequin. 100 % felt a live patient was
superior for non-technical skills.
Conclusions
Our research suggests that interaction with a live, simulated patient
creates a realistic emergency medicine simulation providing the op-
portunity to develop non-technical skills within the multi-disciplinary
team. We appreciate that particular scenarios may not be suitable for
this approach. A comprehensive curriculum map in this context is val-
ued by trainees, and improves trainee familiarity with their curriculum.
Further work will involve evaluating any clinical/patient outcome im-
provements from participating in this simulation programme.
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Introduction
In situ simulation is increasingly recognised as an effective means of
delivering education to clinicians within their own work environment
[1,2]. We have developed the InSIM program, a novel in situ simu-
lation program aimed at junior trainees within our ICU. The program
focuses on developing both the clinical and non-clinical skills of
trainees, improving multi-disciplinary teamwork and identifying areas
for logistical improvement within our unit.
Methods
The simulation team developed three simulation scenarios: Alarming
Ventilator; Massive Haemorrhage; and Tracheostomy Emergency.
Each scenario has learning points addressing both clinical and non-
technical skills and involves a structured debrief following the sce-
nario. The initial program objective was to deliver a total of 15 simu-
lations, including junior medical and nursing staff within each
scenario.
Results
A total of eight out of 15 planned sessions were delivered. Feedback
on the scenarios indicate that participants ‘Strongly Agree’ (72 %) or
‘Agree’ (18 %) that the scenarios were useful and improved their un-
derstanding of the clinical subject (Strongly Agree 60 %, Agree
40 %). They also ‘Strongly Agree’ (50 %) or ‘Agree’ (50 %) that discus-
sion of the non-clinical aspects of the scenarios was useful. When
asked to identify one thing they learnt from each scenario, multiple
respondents identified non-technical aspects such as the importance
of communication within the team, situational awareness and closed
loop feedback.
A number of important logistical issues were identified through the
simulation program. These included a lack of knowledge on the con-
tents of the difficult airway trolley and a lack of familiarity on the cor-
rect procedure for activating the hospital’s Massive Haemorrhage
Protocol.
Conclusions
We have been able to develop and deliver an in situ simulation pro-
gram to our junior trainees within our ICU. The program has been
well received and has increased junior trainees’ understanding and
confidence in dealing with a number of emergent scenarios. It has
also helped to develop and increase their awareness of key non-
Critical Care 2016, Volume 20 Suppl 2 Page 143 of 182technical skills in these situations. Finally, it has identified a number
of logistical issues within our intensive care unit, which are being ad-
dressed through quality improvement projects.
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Introduction
The cardiac Troponin test has a key role in the diagnosis, prognosis
and risk stratification of acute coronary syndrome (ACS). Over
utilization and inappropriate requests for it have created a heavy
workload for laboratory staff, increased costs to the health care sys-
tem, and unnecessarily increased the length of stay and costs for pa-
tients. The aim of this study was to make and standardize all
requests of Troponin more accurate and scientific without causing
any burden to the patients, doctors or laboratory section.
Methods
A total number of 1073 requested serum Troponin-T Tests in the
Emergency department)ED) of Hamad General hospital were
reviewed retrospectively during the period from start of October/
2014 to end of December /2014, then a data analysis was done in-
cluding sex, race, age, a proper history taking and physical examin-
ation in addition to electrocardiographic (ECG) records and any
necessary aid can be helpful before making any decision for Tropo-
nin request, then our results were compared to other studies and
international results.
Results
Out of 1073 involved cases, there were only 208 patients with ele-
vated serum Troponin-T levels, representing about 19.38 %, those
whom were proved to have acute coronary syndrome were only 83,
representing 7.7 % from the whole studied cases, (having a cardiac
cause for their chest pain). Although patients who describe chest
pain to the emergency physician represent an immediate challenge,
but still we conclude that there is over utilization of Troponin test
which increases workload and costs.
Conclusions
The majority of chest pain complaints are not due to (ACS). Non-
cardiac chest pain is the second most common reason presentation
to the ED and accounts for approximately 2 to 5 percent of all visits
worldwide. Unnecessary and inappropriate requests for serum tropo-
nin should be reduced. The reduction in these requests eases the
workload, cuts test and labor costs. Reducing unnecessary testing
can lead to shortening stay times also beneficial for patients.
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Examination time at emergency department (ED) could have in-
fluence for patient Ls prognosis. Door to balloon time is one of the
most famous quality indicators related to patient Ls outcome. How-
ever, there have not been a lot of time quality indicators at ED ex-
cept door to needle time and door to antibiotics time. Other door to
examination or intervention time could be a quality indicator at ED.
It will be used evaluation, improvement, and maintenance of ED. Our
aim was to develop a real time monitor to register and manage pa-
tient Ls flow and time. We will make new time quality indicators at
ED with this monitor. It will lead to hospital automation.
Methods
We developed the monitor system to track patient Ls flow and to
show it in real time on a big display at ED in such a way of logistics
system, which is connected with electronic health record (EHR). It
can show time components such as door to intervention time. We
named it Time Tracking Monitor (TTM) at ED.
Results
Our TTM system had three big appeals. First, it showed time data per
examination or per intervention in real time. It helped to share pa-
tient Ls flow within medical staff. It would prevent to mistake. Sec-
ond, this time data was being compared with a world standard time
period based quality indicators such as door to balloon time in real
time. It was also alerted if that time ran past the time limit. Moreover,
we can analyze the relationship between diseases and time data be-
cause TTM has capability as database. Data analysis is used quality
comparison among patients L individuals, within a hospital setting,
among hospitals.
Conclusions
It has been still hard to manage patient Ls flow because there were
variety of patients and diseases at ED although we used many auto-
matic data accumulation with EHR. However, this monitor could
bring medical staff to their attention of examination time and its
importance.
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Introduction
Syncope remains a common Emergency Department (ED) pre-
sentation [1]. Almost 50 % of syncope cases are likely caused by a re-
flex response with excellent prognosis [1,2]. Unfortunately, up to
33 % of patients with syncope will be discharged with no clear diag-
nosis and are known to have an elevated risk of morbidity and mor-
tality from cardiac causes [1-3]. We set out to develop a focused-
echocardiography based algorithm to risk stratify this patient group.
Methods
Literature searches were carried out by the authors using Medline
1946-2015, Google Scholar, Cochrane Collection and international
guidelines as well as reference searches. Our search converged on
the role of comprehensive echocardiography in evaluation of syn-
cope in parallel to utility of focused echocardiography in detecting
structural cardiac disease.
Results
In patients with syncope, echocardiography is an imaging modality
with high sensitivity and specificity for clinically significant structural
disease [3]. Current guidelines only recommend formal echocardio-
graphic evaluation in patients with clinically suspected structural car-
diac disease [3]. Clinical assessment tools including composite risk
scores have repeatedly been demonstrated to be poor at identifying
structural heart disease [3]. Syncopal events in such context are asso-
ciated with significant increase in mortality [1-3]. Studies have dem-
onstrated that emergency physicians can attain a high level of
proficiency in echocardiography allowing diagnostic evaluation of
complex systolic and diastolic dysfunction and in operators with >
250 examinations, accurate identification of structural disease [3].
Focused-echocardiography can be safely integrated into the clinical
Critical Care 2016, Volume 20 Suppl 2 Page 144 of 182assessment process in the presence of an experienced operator and
yields findings superior to clinical assessment alone [3].
Conclusions
Clinical evaluation, laboratory investigations, and electrocardiography
continue to be core investigations for patients with syncope. In the co-
hort of patients with no clear diagnosis, focussed-echocardiography by
an appropriately trained operator offers additional safety-net for pa-
tients who are discharged without a clear diagnosis. Our paper assimi-
lates these findings into a novel focused-echocardiography based
algorithm for ED evaluation of syncope.
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Introduction
This real-time ultrasound (US) guided study aimed to determine the
rate of pneumothorax progression after 14-gauge (G) cannula inser-
tion in a self-ventilating swine model. Standard treatment of sus-
pected tension pneumothorax includes emergent insertion of a large
bore catheter into the pleural cavity [1]. Widely accepted practice in-
cludes a catheter is left in-situ, open-ended and not capped based
on a quoted dictum that air will only significantly be entrained into
the pleural space via a wound > ¨ø the diameter of the trachea [2].
Methods
Three swine were consecutively anaesthetised using total intra-
venous anaesthesia and remained self-ventilating without endo-
tracheal intubation at all times. A single 14G cannula (BD Venflon)
was inserted sequentially into the second intercostal space of each
hemithorax under US guidance. Real-time US was used to identify
the development of pneumothorax. Lung-point shift was used to
track pneumothorax expansion within pre-mapped numeric chest
wall segments. In the event of respiratory distress, air was aspirated
through the cannula.
Results
Insertion of an uncapped 14G cannula resulted in a significant pneu-
mothorax developing in <2 minutes. Each insertion (n = 3) resulted in
the lung-point moving laterally by >10 cm in <2 minutes in all cases.
At 2 minutes, swine were observed to develop a significant tachyp-
noea (respiratory rate >50/min) and showed signs of respiratory dis-
tress. Upon aspiration of 800 ml-1200ml of air, normal physiology
was restored. During aspiration, the lung-point was observed to shift
medially and apically over time, confirming lung re-inflation. Upon
replacement of caps and monitoring over 5 mins, no subsequent
pneumothorax or physiological distress were observed, suggesting
that the expanding pneumothorax resulted from air entrained via
the open ended catheter.
Conclusions
In this self-ventilating swine model, insertion of an uncapped, open-
ended 14G catheter into the pleural space resulted in the rapid de-
velopment of a large pneumothorax. If these data are transferable to
humans, questions must be raised about leaving an open-ended
catheter in the pleural space of a spontaneously breathing patient
and this warrants further study.
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Introduction
EZ-IO® ‘tea trolley’ training aimed to provide emergency intraosseous
(IO) access teaching for time pressured hospital practitioners. Recent
guidelines advocate the use of emergency IO access when in-
travenous access is difficult [1], as battery powered devices like the
EZ-IO® allow IO access within 49 seconds [2]. Despite introductory
training few use IO devices on a regular basis. There is increasing
recognition that lifesaving technical skills used in emergencies but
required infrequently, need regular practise to prevent ‘psychomotor
skill fatigue’ [3,4].
Methods
We adopted a novel technique for technical skill training, used ini-
tially for difficult airway training [4], to train anaesthetic and ICU staff
for EZ-IO® access. A theatre trolley is converted into a mobile training
trolley with EZ-IO® training devices, tea and cakes. The trolley is oper-
ated by two anaesthetists and visits theatres during normal working
hours: one anaesthetist takes over the care of a stable patient in the-
atre while the second delivers a 15 minute training session in the an-
aesthetic room to the listed anaesthetist and nurse/operating
department practitioner (ODP). Training includes EZ-IO® device loca-
tions, all practical aspects of their use, and is followed by tea, cake
and a questionnaire.
Results
The EZ-IO® tea trolley was used to train a mixture of 36 consultants,
juniors, nurses and ODPs. 97 % reported an increase in their confi-
dence using the EZ-IO® system and 100 % found the ‘tea trolley’ a
useful teaching method (mean Linkert 4.9, 5 =most useful). Follow-
ing training 100 % of participants were correctly able to identify the
locations of EZ-IO® devices for their clinical areas and identify the
correct anatomical sites for IO insertion.
Conclusions
We have utilised the ‘tea trolley’ to improve EZ-IO® awareness and
skills, and to provide mobile training sessions requiring minimal man-
power and time commitments from participants who ordinarily have
little time to practice. It is a transferable training approach which
could be applied to many resuscitation skills and utilised in many
departments.
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Introduction
Latrodectus is a genus of spider, which is the widely known black
widow. It is characterised by neurotoxic venom. It has a worldwide
distribution. The purpose of this study is to describe patients’
Fig. 91 (Abstract P359).
Critical Care 2016, Volume 20 Suppl 2 Page 145 of 182presentation, clinical manifestations and management course of pa-
tients with envenomations by black widow spiders in southern re-
gion of Saudi Arabia.
Methods
A Prospective observational case series study was performed at a ter-
tiary hospital in southern region of Saudi Arabia over one year period
.All adult patients with history of envenomations by black widow spi-
ders included. We recorded the symptoms, physical signs, laboratory
workup, management course and disposition of patients who came
with envenomations by black widow spiders.
Results
A total of 8 subjects participated in the study. All of the patients
were males with an age range of 25–58 years (median: 47 years). In
all eight cases the black widow spider identification was made via a
description of the spider. The time of onset of pain ranged from
30 minutes after the sting to 4 hours (median: 1 hour).Of the eight
patients, three were asymptomatic , three had leg pain and two pa-
tients had abdominal pain. One patient had nausea and vomiting
(12 %); the same patient had ptosis and sweating with neck rigidity
and back pain (12 %).Upon examination, most of the symptomatic
patients had redness over the sting location with no signs of com-
partment or swelling. Patients with abdominal pain had a rigid abdo-
men and guarding that mimicked an acute abdomen. blood test
includes white blood count, kidney function test, coagulation profile,
and creatine kinase. The results were normal in seven patients; only
one patient developed acute kidney injury although his kidney function
returned to normal upon discharge. In the treatment, all symptomatic
patients received analgesia depending on the physician’s discretion.
Three patients received calcium gluconate intravenously and reported
no improvement in their symptoms. In addition, all patients received
tetanus toxoid vaccine. Four of the patients required admission (50 %),
but they were all discharged with a mean hospital of stay of 3.75 days.
Conclusions
Envenomation by black widow is a complex syndrome that manifests
itself in various ways and results in various outcomes. The syndrome
is generally self-limited and antivenom treatment is rarely necessary.
Patients with significant pain that does not improve should be ad-
mitted for observation and possible treatment with antivenom.
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Introduction
Patients with an overdose or intoxication are admitted to the ICU for
hemodynamic or respiratory monitoring. It was our impression that
many patients who are monitored do not need interventions. The
objective of this study was to estimate the incidence of mechanical
ventilation within 24 hours after ICU admission in intoxicated pa-
tients who were not already ventilated on admission to the ICU.
Methods
The study was done in ICUs of the Reinier de Graaf Hospital in Delft
and the HagaHospital in the Hague, both in the Netherlands. The
study is a retrospective cohort study of all consecutive patients ad-
mitted to either ICU between 2010 and 2014 with a diagnosis of in-
toxication or overdose who were not mechanically ventilated or
intubated on admission. The need for ethical approval was waived
by the local ethical committee. All patient data are collected regularly in
the databases of both units for administrative and quality improvement
purposes. The study endpoint was mechanical ventilation within the first
24 hours after ICU admission.
Results
During the study period a total of 403 patients were admitted with
an overdose or intoxication. Of these 403 patients, 91 patients were
excluded since they were intubated and ventilated on admission.
Characteristics of the study population of 312 patients are presented
in the Table.Conclusions
Our results show that only a small minority of patients (18/312 =
5.8 %) admitted with intoxication or overdose that are not ventilated
on ICU admission develop the need for intubation and mechanical
ventilation in the next 24 hours. A quarter of patients admitted with
a GCS < 8 was subsequently intubated and ventilated in the first
24 hrs, whereas only 2.6 % of patients admitted with a GCS > =8
needed tracheal intubation and ventilation in the first 24 hrs after
ICU admission. Our study shows that the GCS on admission is a sig-
nificant predictor for the need of mechanical ventilation.P360
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Introduction
The objective of the present survey was to identify the ventilator-
associated pneumonia (VAP) risk and prognostic factors among poi-
soned patients, who admitted to Toxicological ICU (TICU), especially
in CNS depressants due to its prevalence and importance. VAP is a
main cause of nosocomial infection in intensive care units (ICUs)
which causes high mortality and morbidity.
Methods
A case- control study was conducted at Loghman Hakim Hospital be-
tween March 2013 and March 2014. Among 300 poisoned patients
with mechanical ventilator > =48 hours, 150 patients who developed
microbiologically-confirmed VAP were considered as VAP group and
150 without VAP were defined as control group. The data were col-
lected by age, sex, type of poisoning, GCS, APACHE II score, length of
hospital stay, previous antibiotic use, microbial culture of the trachea,
body temperature, leukocyte count, and patients’ outcome. Based on
the type of poisoning, patients were divided in 3 groups that in-
cluded opioid (opium, heroin and methadone), CNS depressants
(Antidepressant, Benzodiazepine and anti-convulsive) and other
such as pesticide, methanol, 3, 4-methylenedioxy-methamphetamine
(MDMA) and multi drugs. All data were expressed as mean (SD) for con-
tinuous variable and frequency for categorical variables. Logistic re-
gression was used to determine the relationship between risk factors
and VAP.
Results
Mean age of the patients was 33.9 ± 14.3 years. The probable VAP in-
cidence and mortality were 22 % and 18.6 %, respectively. CNS de-
pressant versus opioid (odds ratio, 3.74; p < .027), APACHE II (odds
ratio, 1.28; p < .000) and Hospital length of stay (odds ratio, 2.15;
p < .000) were the independent risk factor for VAP. While, APACHE II
score (odds ratio, 1.12; p < .044) and Hospital length of stay (odds ra-
tio, 2.15; p < .000) were the independent predictors of VAP mortality
among these patients. The most common microorganisms in VAP
cases were methicillin-resistant staphylococcus aureus (MRSA), and
Acinetobacter sp in order to 56.7 % and 12.7.
Conclusions
CNS depressant was an important risk factor for VAP among poi-
soned patients. Hypoventilation due to CNS depression can lead to
VAP. APACHE II and Hospital length of stay were shown as independ-
ent predictors of VAP and mortality among these patients. It seems
that patients’ short turn over and hospitalization would be resulted
in patients’ outcome.
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Introduction
Soluble Barium salts poisoning is a rare and potentially fatal cause of
severe hypokalemic paralysis. There is no agreement on adequate
management, particularly on the use of renal support. We present a
case of barium intoxication successfully treated with hemodiafiltration,




A 21-year-old male with a history of depression was admitted to our
hospital emergency department two hours after the voluntary inges-
tion of a non-quantified amount of barium chloride, which the pa-
tient had procured and purchased online as a means for a suicide
attempt. The clinical picture consisted of vomiting, diarrhea, and pro-
gressive generalized muscle weakness requiring tracheal intubation
and mechanical ventilation, with subsequent ICU admission. Severe
hypokalemia was documented (minimum K+ 1.2 mmol/L), compli-
cated by frequent ventricular premature beats with prolonged QT
interval (corrected value was 640 ms). Magnesium sulfate and a K+
infusion were administered, but serum K+ remained low. Serum K+
was then 2.2 mmol/L and barium levels were 0.04 mmol/L (toxic
range). Continuous veno-venous hemodiafiltration (CVVHDF) was
started. This resulted in a rapid decrease in barium levels and
normalization of serum K+. Clinical improvement ensued with the
correction of hypokalemia and restored muscular function, allowing
spontaneous ventilation and extubation 6 hours later. Barium was
persistently undetectable from 12 hours after the beginning of
CVVHDF (<0.006 mmol/L). The patient was later transferred to the
Psychiatry department, with an uneventful hospital stay.
Conclusions
There is very limited published data on the use of renal replacement
techniques in acute barium intoxication, which is associated with a
quicker barium half-life reduction and clinical improvement. A trans-
cellular K+ shift and the barium concentration itself impact muscle
weakness, implicating a possible direct effect of barium on either
skeletal muscle or neuromuscular transmission. This patient pre-
sented with symptoms typical of severe barium intoxication, non-
responsive to K+ supplementation. Clinicians in the ICU should re-
main aware of the potential ingestion of unusual chemicals such as
barium chloride in the appropriate clinical context, as the risk of
availability through internet purchases may continue to rise in the fu-
ture. With this unique case we add on to the scanty existing evi-
dence in the literature and strongly advocate the use of dyalisis,
targeting both barium removal and the correction of hypokalemia.
Consent to publish
Written informed consent was obtained from the patient for publica-
tion of this abstract.P362
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Introduction
The Central Statistics Office Ireland (CSO) reported following the
2011 census that there was a 9.6 % increase in the number of people
cycling to work compared with 2006. This leads to a higher preva-
lence of injuries and hospital attendances. The Road Safety Authority
(RSA) conclude from their most recent research that there were 639
cycling associated collisions in 2012. We hypothesise that both the
true number of cycling injuries and the major trauma that results
from cycling collisions is being under-reported and this is placing asignificant demand on Emergency Departments (EDs) and Intensive
Care Units (ICUs) in Ireland.
Methods
This is a retrospective review of patients with a cycling-related injury
presenting to Saint Vincent¡¯s University Hospital (SVUH) from 1st of
January to 31st of December 2014. Subjects were identified by inter-
rogating the Maxims Clinical© patient information system in use at
the ED. Triage records were searched for the keywords; “bike”, “cyc-
ling”, “cyclist”, “pushbike”, “bicycle”. SVUH participates in the Trauma
Audit and Research Network (TARN) and data was extracted from this
database, e.g. the injury severity score (ISS) for patients who fulfilled
the criteria for TARN.
Results
The total number of cycling associated injuries that attended our ED
in 2014 was 534, accounting for just over 1.0 % of attendances in
2014. 380 (71.2 %) occurred in males. The mean age of the patients
was 36.6. 79 cyclists (14.8 %) presented following a road traffic colli-
sion involving at least one vehicle. There was a wide spectrum of in-
juries with upper limb injuries sustained in 43 % (n = 243), head
injuries in 16 % (n = 89) and facial injuries in 11 % (n = 84). 11 (2.1 %)
patients were included in TARN with ISS varying from 4 to 24. An ISS
¡Ý15 is defined as major trauma and in our cohort, 5 patients fulfilled
this criteria including 2 mortalities. These injuries included pneumo-
thoraces, haemothoraces, spinal fractures, intracranial haemorrhage
and skull fractures. All of these patients required intensive care re-
view with 3 patients being admitted to the ICU.
Conclusions
Cycling injuries result in significant ISS with 5 patients in our cohort
sustaining major trauma. There is significant demand placed on EDs
by these injuries regarding trauma resuscitation procedures, use of
specialised radiology and intensive care involvement. Cycling injuries
are being under-reported in Ireland and studies such as this may
help to guide injury prevention strategies in the future.
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Introduction
Burns in combat usually represent 5-20 % of injuries [1]. The purpose
of the study was to describe epidemiological characteristics and the
management of burns during French military operations.
Methods
A retrospective observational study was performed of French cas-
ualties with burns, transported to Percy Burn Center (R4 Medical
Treatment Facility) between January 1, 2001, and December 31,
2014.
Results
46 patients were included. 76 % of burns analyzed were non-battle
injuries, mainly due to mishaps occurring with the burning of waste
and the use of fuel. Combat burns (n = 11/46) were all explosions re-
lated (improvised explosive devices). The median total body surface
area burned was 15 % [9;27]. Major anatomical regions affected were
upper limbs (91 %), head/neck (78 %) and hands (70 %). Battle-
related burns resulted in higher median Injured Severity Score, more
patients under mechanical ventilation, more blood transfusions and
surgeries, respectively 16 [6;23] vs 4 [1;8], 64 % vs 17 %, 8 [0;17] vs 0
and 3 [0;4] vs 0 (p <0.05). The combination of burn injury and mul-
tiple trauma occurred in 20 % (n = 9/46). The case fatality rate was
2 % (n = 1/46).
Conclusions
Majority of burns are non-battle injuries, small in size and accessible
to prevention [2]. For battle-related burn injuries, the anatomical top-
ography can be explained by the personal protective equipment and
Critical Care 2016, Volume 20 Suppl 2 Page 147 of 182the higher severity score due to the associated trauma and mechan-
ism. The initial management of burns with multiple trauma remains
attention to the priorities of circulation, airway and breathing. The
treatment of either the burn or the associated injuries may be com-
promised by their combined presence, and a team approach is es-
sential to their optimal management [3]. Only patients with major
burns that required hospitalizations have been included. So, this
study is the visible tip of the iceberg. All military care providers
should be familiar with the assessment and treatment of burns in
military settings.
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Introduction
Burn injuries are amongst the most severe physical and psycho-
logical insults a patient can experience and morbidity is extensive
with variable mortality [1]. Studies have repeatedly confirmed factors
associated with high mortality, which include increasing age, extent
of burn and presence or absence of inhalational injury [2]. Predicting
mortality from burns is useful in identifying those that may benefit
from treatment or those in whom initiation of treatment is futile and
not in the best interests of the patient. The objective of this surveil-
lance study was to evaluate and compare the predictive value of
Baux [3], Modified Baux (m-Baux) [4], and the Intensive Care National
Audit and Research Centre (ICNARC) scores for overall outcome in
our cohort of burns patients admitted to the ICU over the last
5 years.
Methods
A single centre, retrospective surveillance study was carried out on
all patients with a total body surface area burn (TBSA) > =15 % ad-
mitted to the ICU between February 2011 and February 2015.
The Baux, m-Baux, and ICNARC scoring systems were compared with
data analysis performed using logistic regression models. The fitness
of each model was assessed using the Hosmer-Lemeshow, the Cox-
Snell, and the Nagelkerke R2 statistics.
Results
45 patients were admitted to the ICU with burn injuries > =15 %
TBSA, none were excluded from this study. 17 patients died resulting
in a mortality rate of 37.7 %. On all three measurements, the Baux
score had the highest R2 value (0.21, 0.25, 0.33).
We found that the odds ratio for survival changes by 0.96 (95 % c.i.
0.92 to 0.98) for each increase in Baux score by one unit.
Conclusions
Our data suggests that the Baux score is most useful for predicting
overall mortality in patients with Burns versus the m-Baux and
ICNARC scoring systems but all tests utilised have good discrimin-
ation and calibration for mortality prediction.
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Introduction
Treatment in an Intensive Care Unit (ICU) often necessitates un-
comfortable and painful procedures for patients throughout their ad-
mission. There is growing evidence to suggest that chronic pain is
becoming increasingly recognised as a long term problem for pa-
tients following an ICU admission [1]. Intensive Care Syndrome: Pro-
moting Independence and Return to Employment (InS:PIRE) is a five
week rehabilitation programme for patients and their caregivers after
ICU discharge at Glasgow Royal Infirmary. This study investigated the
incidence and location of chronic pain in patients discharged from ICU
and classified the analgesics prescribed according to the World Health
Organization analgesic
Methods
The InS:PIRE programme involved individual sessions for patients and
their caregivers with a physiotherapist and a pharmacist along with
interventions from medical, nursing, psychology and community ser-
vices. The physiotherapist documented the incidence and pain location
during the assessment. The pharmacist recorded all analgesic medica-
tions prescribed prior to admission and at their clinic visit. The patient’s
analgesic medication was classified according to the WHO pain ladder
from zero to three, zero being no pain medication and three being
treatment with a strong opioid. Data collected was part of an evalu-
ation of a quality improvement initiative, therefore ethics approval was
waived.
Results
Data was collected from 47 of the 48 patients who attended the re-
habilitation clinic (median age was 52 (IQR, 44-57) median ICU LOS
was 15 (IQR 9-25), median APACHE II was 23 (IQR 18-27) and 32 of
the patients were men (67 %)). Prior to admission to ICU 43 % of pa-
tients were taking analgesics and this increased to 81 % at the time
of their clinic visit. The number of patients at step two and above on
the WHO pain ladder also increased from 34 % to 56 %.
Conclusions
Of the patients seen at the InS:PIRE clinic two-thirds stated that they
had new pain since their ICU admission. Despite the increase in the
number and strength of analgesics prescribed, almost a quarter of
patients still complained of pain at their clinic visit. These results con-
firm that pain continues to be a significant problem in this patient
group. Raising awareness in primary care of the incidence of chronic
pain and improving its management is essential to the recovery
process following an ICU admission.
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Introduction
Despite the development and availability of effective analgesic pro-
cedures, pain is still underestimated and poorly managed, especially
in the critical areas. Nurses’ knowledge about pain plays a significant
role in effective clinical decision making for pain management. The
Critical Care 2016, Volume 20 Suppl 2 Page 148 of 182objective of the study is describing the level of knowledge and prac-
tice of nurses in pain management as well as highlighting the pos-
sible barriers that nurses face in assessing and managing acute pain
in the critical areas ICU and ER.
Methods
This study a cross-sectional study. A semi-structured questionnaire
was distributed to the nurses in the critical care areas in tertiary care
hospital. These nurses have direct contact with patient care in clinical
settings and must provide pain assessment and management to
their patients. Measurement investigated like the demographic data,
work ranking, level of education and years of experience. As well their
actual level of knowledge and practice and the perceived barriers
about pain assessment and management during their clinical work.
Results
A total of 600 nurses participates in the study with a response rate of
70 %, 14.3 % male, 85.7 % female. 81 % of the nurse participants re-
ported that they are documenting pain on a routinely bases as they
document more than 75 % of the assessments while 2 % of them
document rarely . 62 % of nurse participants always agree with pa-
tient statements about their pain. 83 % of the nurse participants indi-
cate that they have adequate knowledge and 17 % are none. 75 %
only of nurse participants have read the guidelines about pain man-
agement. Out of the 14 reasons the majority of nurses identifies
working load (70 %) as a barrier against adequate pain management
while (65 %) identify the use of sedation & language issues by (2 %).
Conclusions
Although the critical care nurses who participated in this study have
good exposure to different critical specialties, but still the inadequate
pain management is significant. The level of knowledge and the per-
ceived barriers are playing a major role in the adequacy of pain man-
agement practiced in the hospital and those needs to improve.
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Introduction
Critical-Care Pain Observation Tool (CPOT) and The Behavioral Pain
Scale (BPS) are behavioral pain assessments for unconscious intensive
care unit (ICU) patients. The aim is to determine the validation and reli-
ability of the CPOT in Turkish in mechanically ventilated adult ICU
patients.
Methods
This prospective observational cohort study included 50 mecha-
nically ventilated mixed ICU patients who were unable to report pain.
The study was conducted in a tertiary ICU in a university hospital in
Turkey.
After obtaining permission from the author of the original study (1),
CPOT was translated into Turkish and language validity was per-
formed according to the reports obtained from 10 senior intensivists.
Pain was assessed before and during non-painful and painful routine
care procedures (touching with wet towel and suctioning respect-
ively) using the CPOT and the BPS performed by a resident and an
intensivist concomitantly. Tests reliability, interrater reliability, and
validity of the CPOT and the BPS were evaluated.
Results
Thirty three of the patients (66 %) was male. The mean age was 57.4
and the mean APACHE II score was 18.7. Glasgow Coma Score was
equal or less than 8 in 66 % of all patients. A total of 100 as-
sessments performed by a resident and an intensivist were recordedfrom 50 patients using the CPOT and the BPS. Scores of the CPOT
and the BPS during the painful procedures were both significantly
higher than those during the nonpainful procedures. The agreement
between CPOT and BPS during painful and nonpainful stimuli was
ranged as; sensitivity 66.7 % - 90.3 %; specificity 89.7 % - 97.9 %;
kappa value 0.712 - 0.892. The agreement between resident and
intensivist during painful and non-painful stimuli was ranged from
97 % to 100 % and the kappa value was between 0.904 - 1.0.
Conclusions
The Turkish version of the CPOT showed good correlation with the BPS.
Inter-rater reliability between resident and intensivist was good. The
study showed that the Turkish version of BPS and CPOT are reliable
and valid tools to assess pain in intubated and unconscious mechanic-
ally ventilated critically ill patients for use in daily clinical practice.
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Introduction
Assessing and managing pain and sedation levels in patients who
are mechanically ventilated in the intensive care unit is often challen-
ging but essential in order to provide holistic patient-centred critical
care [1,2].
The aim of this audit was to evaluate the assessment of pain and
sedation in the intensive care unit at Milton Keynes University Hos-
pital NHS Foundation Trust, by examining current clinical practice
and highlighting areas for improvement.
Methods
Guidelines were utilised to formulate audit criteria and standards. A
proforma was developed for use in 50 adult patient cases who were
mechanically ventilated in the intensive care unit over a 3 month
period between August and October 2015. All data were coded and
entered into a spreadsheet for analysis. Initial recommendations for
change have been made.
Results
90 % of patient cases had a pain assessment documented within
6 hours of admission, scored utilising the VAS. 73 % of initial pain as-
sessments were scored by nursing staff, with self-reporting occurring
in the remaining 27 %. When pain scores were subsequently evalu-
ated over a following 24 hour period, the mean number of scores
documented was n = 5.
When sedation scores were evaluated utilising the RASS over the same
24 hour period, the mean number of scores documented was n = 6
(ranging from -5 to +2). Of note, 60 % of patients did not have a formal
sedation hold, with 66 % having no reason for this documented. In
addition, only 46 % of patients had a goal RASS documented on the
daily ward round, and of these 39 % met their target RASS.
Conclusions
This audit has raised awareness of the need for improvement in the
assessment of pain and sedation in the intensive care unit. As a re-
sult, a new clinical guideline has been developed and an educational
intervention will be designed to integrate this into daily clinical prac-
tice. A second audit cycle will take place in 2016.
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Introduction
As underlying diseases and causes of agitation are varied in different
patients, a selection of sedative agents should be made individually.
Currently, there is a lack of guideline for the sedative use in the med-
ical intensive care unit (ICU), Ramathibodi Hospital. A prescription of
sedative agents performed by critical care pharmacists during patient
care rounds, based on appropriate guidelines and patient data would
shorten the ICU length of stay (LOS). This study was set out to investi-
gate the impact of pharmacist interventions on ICU LOS, hospital LOS,
ventilator days and mortality in Medical Intensive Care patients at
Ramathibodi Hospital.
Methods
A before-after study at the medical ICU (total of 8 beds) of the uni-
versity hospital was conducted on mechanical ventilated patients re-
ceiving sedative agents. Baseline characteristics, active problems and
APACHE II were used as the criteria to match the patients between
two groups, the retrospective group (no pharmacist interventions)
and the prospective group (pharmacist interventions). Medical chart
reviews were performed and data were collected over a 2-year
period in the retrospective group. In the prospective group, pharma-
cists made interventions with the team to select sedative agents to
individual patients based on underlying disease, active problems,
renal and hepatic function, and causes of patient agitation.
Results
There were 156 mechanically ventilated patients prescribed sedative
agents, 66 and 90 patients in the prospective and retrospective
group, respectively. The median duration of ICU LOS was reduced
from 10.0 days in the retrospective group to 6.5 days in the pros-
pective group (p = 0.002). The median hospital stay and ventilators
days were significantly different between two groups. The median
hospital stay was reduced from 30.50 days in the retrospective group
to 17.50 days in the prospective group(p = 0.000). The ventilator days
were 14 days and 8.5 days in retrospective and prospective group,
respectively (p = 0.008). Mortality remained unchanged, 53.03 % in
the prospective group compared to 46.67 % in the retrospective
group (p = 0.432).
Conclusions
The pharmacist participations in critical care team resulted in a sig-
nificant reduction in the duration of ICU stay, hospital LOS and venti-
lator days, but not mortality in mechanically ventilated patients
receiving sedation.
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Introduction
Agitation is a syndrome characterized by the acute onset of central
nervous system dysfunction identified by the several features including
a change or fluctuation in baseline mental status, and either disor-ganized thinking or an altered level of consciousness. Agitation occurs
frequently in critically ill patients and intensive care unit (ICU).
Methods
A retrospective study with waiver of consent was conducted in one
of the trauma intensive care unit (ICU) for one year. ICU patients
were enrolled in the study and classified based on their agitation sta-
tus. The depth of sedation along with the Ramsey Sedation Scale
(RS), Glasgow Coma Scale (GCS), type of injury and observation of
vital signs were clinically evaluated.
Results
One hundred and two patients (n = 102) were enrolled during the
period of the study. Among those patients, forty six patients (n = 46)
were agitated. Comparing the two groups of patient, agitated pa-
tients had higher incidence of infection (p < 0.02) compared to the
non-agitated patients. In addition, there was a significant difference
type of sedation used (p < 0.001), ventilators free days (p < 0.001)
and length of stay.
Conclusions
Agitation in ICU patients is associated with several adverse outcomes
including prolonged stay, nosocomial infections, and unplanned
extubations.
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Introduction
The aim of our observation retrospective study was to test the hy-
pothesis that a correlation exists between percentages of ventilated pa-
tients developed VAP (% VP) and the use of main sedative and
neuromuscular blockage agents indexes in our both medical and surgi-
cal ICU served in community hospital.
Methods
From January 2008 to December 2012 admitted to our ICU 384 pa-
tients. From our database we looked for percentage of ventilated pa-
tients developed VAP as well as the use of the following agents as
items per ventilation day per ventilated patient: Midazolame (amp
50 mg), Propofol (vial 2 % 50 ml), Sisatracurium (amp 5 ml/10mg)
per year from 2008 to 2012. Using linear correlation method, we looked
for linear slope, correlation coefficient (r), and coefficient of determin-
ation (r2), and by linear regression method using ANOVA test we
looked for p value, according percentage of ventilated patients devel-




According to our data, there was no statistically significant correl-
ation detected between percentages of ventilated patients devel-
oped VAP and use of Midazolam, Propofol and Cisatracurium. On the
other hand, not all but some patients had increased demand for
more sedative agents. Our data suggest that the percentages of ven-
tilated patients developed VAP is independent from the use of main
sedative and neuromuscular blockage agents in all ICU ventilated
patients.
Table 46 (Abstract P371). Correlation between % VP and use of
sedative and neuromuscular blockage agents.
Slope St. Error r r2 L. CI U.CI p value
Midazolam 0.072 0.088 0.425 0.161 -0.210 0.354 0.4750
Propofol 0.282 0.222 0.591 0.349 -0.424 0.989 0.2934
Cisatracurium 0.012 0.007 0.694 0.481 -0.011 0.036 0.1904
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Department: The implementation of the SIVA International
Taskforce adverse event reporting tool for procedural sedation
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Introduction
Sedation is routine in UK emergency departments (EDs); to maintain
and improve our quality of care, and compare local practice with na-
tional and international standards, a standardised and sensitive tool
is needed to detect and report adverse events (AE). The World SIVA
International Sedation Taskforce tool [1] incorporates phy-
siological thresholds, clinical interventions, and overall outcome to
grade AE as minimal to sentinel. We incorporated this tool into our
sedation documentation, and report its effect on the detection and
documentation of AEs.
Methods
All notes from patients undergoing sedation in our ED between 1/1/14
and 30/4/14 were retrospectively reviewed for documentation of AE, as
well as evidence of adverse events where not formally recorded. After
implementation of a new sedation proforma incorporating the SIVA
tool [1], the data collection process was repeated retrospectively be-




The SIVA tool highlights AEs within our ED have gone unreported. Its
incorporation improved awareness and documentation of AE, but
further education is needed to improve the accuracy of reporting.
Utilising this tool should facilitate more sensitive and standardised
data collection, allowing regular review and improvement of practice,
as well as comparison with national and international standards.
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AE (as % of
total AE)
Minimal 0 0 0 4 6 2 (33%)
Minor 0 7 7 (100%) 2 14 12 (86%)
Moderate 0 1 1 (100%) 0 0 0
Fig. 92 (Abstract P373).P373
Impact of sedative drug use on the length of mechanical
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Sedation of invasive mechanically ventilated (MV) Intensive Care Unit
(ICU) patients is common. However, recent studies found increased
sedation delivery can adversely affect MV patient outcomes. A retro-
spective audit of length of MV (LoMV) and sedation delivery in the
Christchurch Hospital ICU over 3 calendar years (2012-2014) was car-
ried out.
Methods
Data on sedative drug (Dexmedetomidine, Fentanyl and Propofol)
usage and LoMV were collected from hospital records. Total sedative
drug use and LoMV were assessed monthly and compared between
years using a Wilcoxon Ranksum and Kruskal-Wallis test. Zero-lag
cross correlations were used to assess the relationship between
month-to-month trends in LoMV and sedation use. A Monte-Carlo
simulation was performed to assess the impact of potential outlier
months on the results (4 of 36 months were removed without re-
placement and the analysis repeated 10,000 times). Standardised
Mortality Rate (SMR) was calculated each year to account for changes
in cohort.
Results
In 2012, the median [Interquartile range (IQR)] of LoMV hours was 92
[IQR: 77-101] while 2013 was 86 [IQR: 75-103] and 2014 was 107 [IQR:
80-121]. The median LoMV per patient for 2013 and 2014 were sig-
nificantly higher than 2012 (p < 0.05) (92 and 107 hours vs 86 hours).
Median [IQR] for total sedative drug usage was 13 [IQR: 12-16] mg/
hour LoMV in 2012, 15 [IQR: 13-18] in 2013 and 16 [IQR: 14-18] 2014.
Usage in 2013 and 2014 were significantly higher than 2012 (p <
0.05). The zero-lag cross-correlation between LoMV and sedation
usage per month over the 3 years was 0.76 indicating that these ris-
ing trends are well mirrored, as additionally shown in Fig. 92. Monte
Carlo simulation shows that the trend of increasing sedation usage
associated with increasing LoMV is robust, with 98 % of the simula-
tion indicating an increasing trend.
Over the study period, the SMR was 0.71 (2012), 0.58 (2013) and 0.61
(2014) for MV patients suggesting that increased LoMV was not due
to a significantly more ill MV cohort.
Conclusions
Sedative drug use per ventilated hour is strongly associated with
LoMV and the increase of these metrics over the last 3 years is sig-
nificant and strongly associated.P374
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Introduction
Sedation in ICU using sevoflurane via Anaconda enables desirable
sedation level with numerous advantages over propofol/midazolam
based sedation. In patient with severe ARDS inhaled nitric oxide (NO)
improves oxygenation and reduces right heart afterload. Both ther-
apies are simultaneously used in our ICU with ARDS patients and pa-
tients with right heart failure being ventilated for various reasons.
Since sevoflurane can interact with certain gas monitoring (eg. Quark
rmr indirect calorimetry) we examined potential gas readings inter-
action with NO.
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NO circuit (Carefusion) and Anaconda were connected to ventilator
tubing and gas concentrations was measured at different circuit out-
lets. Ventilator (NPB 840) was set to V-AC, 450 mL and 16 BPM. Two
sevoflurane concentrations (5 mL/h and 8 mL/h) and three FiO2 (air,
50 % and 100 % oxygen) were tested against constant NO flow
(20 ppm).
Results
At constant V-AC ventilation and constant NO flow, inspiratory con-
centration NO readings showed minimal (NS) variations during dif-
ferent FiO2 or sevoflurane concentration administered. Similarly,
administering constant NO and 2 different sevoflurane concentration
did not affect sevoflurane concentration readings.
Conclusions
Co-administration of NO and sevoflurane via Anaconda does not
affect gas analysis and can be safely used as a sedation and ARDS
salvage therapy.
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A retrospective study of the use of Dexmedetomidine in an
oncological critical care setting
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Introduction
Dexmedetomidine (DEX) may spare other sedative use, reduce delir-
ium incidence, facilitate earlier extubation, and thereby prevent the
need for a tracheostomy as well as reduce hospital expenses. There
is however a paucity of data in patients with cancer. We sought to
evaluate the clinical and cost-effectiveness of the drug in this setting.
Methods
A retrospective review of electronic records between February 2014
and March 2015 was conducted. Sedative use, ventilator weaning,
extubation rates and tracheostomy requirement were assessed. In
addition, a cost-analysis per patient was determined.
Results
Twenty-nine patients (19 male) received DEX in the study period
(age range 19-82 years). The median length of stay was 19.6 days
(interquartile range (IQR) 13.0-26.3) as a result of prolongedmechanical ventilation (median 15.8 days (IQR 8.0-23.0). Nineteen pa-
tients survived to ICU discharge. Eighteen patients (61.1 %) required
a tracheostomy, with a median duration of 18 days (IQR 10.5-19.77).
DEX was used to facilitate sedation reduction in those patients who
were difficult to wean, manage agitation and delirium and to ex-
pedite extubation/decannulation. It was utilised for a median of
79 hours (IQR 144-47) with a median dose of 0.91 micrograms/kg/hr
(IQR 0.57-1.13). It was deemed to have improved the defined out-
comes for 12 patients (41 %). Bradycardia and/or hypotension was
observed in 17 patients within 4-hr of DEX treatment, almost half re-
quired support. The mean cost of DEX treatment was £630 per pa-
tient. This approximates to £1500 per patient with clinical benefit.
This cost was offset by the reduction of sedation (11 patients) in
those patients with difficult to manage agitation with other agents,
as well as ventilator weaning, earlier extubation and avoidance of
tracheostomy (10 patients).
Conclusions
This cohort of patients belonged to a group with high mortality and
high length of stay as a result of prolonged ventilation, associated
with difficult to manage sedation and/or delirium. Further studies
should evaluate the optimal duration of treatment, to facilitate de-
escalation in those patients not obtaining benefit.
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Dexmedetomidine and posttraumatic stress disorder incidence in
alcohol withdrawal icu patients
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Introduction
Alcohol withdrawal patients have the increased risk of PTSD [1], es-
pecially when treated at intensive care unit (ICU) with high BZD
doses. We hypothesized that dexmedetomidine addition to BZD for
AWS patients’ sedation in the ICU will decrease PTSD incidence.
Methods
Prospective cohort study was conducted in the mixed ICU during
July 2014 - July 2015. AWS patients were assigned in 2 groups:
group D (dexmedetomidine) and group C (Control). In group D
dexmedetomidine infusion at dose 0.2-1.4 μ g/kg/h prescribed for
sedation and AWS symptoms control. BZD (diazepam 10 mg) and
antipsychotics (haloperidol 5 mg) were prescribed in both groups
with similar symptom-triggered local protocol. Posttraumatic
stress disorder was diagnosed according to the Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition criteria by a
psychiatrist using a clinical interview within 1, 3 and 6 months
after hospital discharge.
Results
98 patients were included in the study. 8 % of the patients in the Gr.
D and 26 % of pateints in gr.C had a posttraumatic stress disorder
diagnosis 1 month after hospital discharge (p = 0.03). At 3-month
follow-up 17 % of patients in gr.D and 36 % in gr.C were diagnosed
PTSD (p = 0,04), after 6 months – 15 % and 30 %, respectively (0,03).
Conclusions
Dexmedetomidine addition to basic AWS therapy with benzodia-
zepines and antipsychotics, may decrease risk of PTSD for alcohol
withdrawal patients in ICU.
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1 month, n (%) 4/48 (8) 13/50 (26) 4 [1, 06-17] 0,031
3 month, n (%) 8/48 (17) 18/50 (36) 2,8 [1-8] 0,04
6 month, n (%) 7/48 (15) 15/50 (30) 3 [1,03-10] 0,03
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Hemodynamic effects of dexmedetomidine in a porcine model of
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Introduction
Dexmedetomidine is a selective a2-adrenoreceptor agonist and due to
its unique actions on central nervous system it has been widely used as
a sedative agent in the Intensive Care Unit and in the operating theatre.
The aim of our study was to investigate if dexmedetomidine can be
used effectively and safely as a sedative agent in a porcine model of
septic shock.
Methods
32 pigs under general anesthesia and mechanical ventilation were in-
cluded in this study and were randomly assigned into one of the
4study groups (G-A, G-B, G-C, G-D-each group consisted of 8 ani-
mals). All pigs received continuous infusion of propofol and ro-
curonium. In G-A, no other intervention was performed, in G-B
dexmedetomidine was administered in a dose of 0.8mcg/kg/hr, in
G-C sepsis was induced by intravenous administration of LPS and in
G-D both dexmedetomidine infusion and sepsis induction were per-
formed in a similar manner like in G-B and G-C respectively. Study
parameters included heart rate-HR, mean systemic-mSAP and pul-
monary artery blood pressure-mPAP, central venous pressure-CVP
and pulmonary artery occlusion pressure-PAOP. Parameters were re-
corded at baseline (phase-P0) and every 30 min for 3 hrs (P1-6). For
the statistical analysis, repeated measures ANOVA was used (SPSS21).
Results
HR, mSAP and mPAP values are depicted on the following Table. CVP
and PAOP did not show any significant alterations.
Conclusions
According to our study results, dexmedetomidine has positive effects
both on HR and on sepsis induced pulmonary hypertension. The de-
crease of mSAP was similar in all study animals, both in the septic
and the non-septic ones.Fig. 95 (Abstract P377). HR, mSAP, mPAP alterations over time in
groups & comparison between groups.P378
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Introduction
Evidence from experimental studies suggests that ketamine may
be beneficial for analgosedation in acute respiratory failure dueto bronchospasmolytic and immunomodulatory effects. However,
limited data exist whether analgosedation with ketamine is safe
to use and whether it decreases the requirements for respiratory
support.
Methods
Over a 6-year period we retrospectively identified patients who re-
ceived ketamine for hypoxic respiratory failure after admission to
critical care. Ketamine dose, mean arterial pressure, heart rate,
blood biochemistry, ventilator settings, and sedation score were re-
corded over the first 5 days of ketamine treatment. Complications
(delirium, arrhythmias, malabsorption of feed) were documented.
Chest X-ray findings were documented on the day ketamine was
commenced.
Results
27 patients (11 males, 16 females) were included. Mean age was
54.2 ± 13.4 years. The mean APACHE II score was 14.9 ± 4.1. 37.0 %
died while on Intensive Care. The underlying diagnosis of respiratory
failure included COPD in 14 and severe asthma in 13 patients. The
mean length of stay in critical care was 10.9 ± 8.7 days. All patients
were intubated on admission and 26 patients (96.3 %) were recei-
ving controlled ventilation. By Day 5, 17 patients were still ventilated,
with 10 patients on controlled ventilation, 8 were weaned to ASB,
CPAP, or SIMV. Ketamine was given for 3.9 ± 1.9 days. On day 1 of
ketamine treatment the Peak Inspiratory Pressure-max was 30.0 ±
3.4 mmHg and PEEP-max was 8.0 ± 3.7 mmHg. 25 patients received
intravenous aminophylline (92.6 %), 20 salbutamol (74.1 %) and 22
MgSO4 (81.5 %). The total dose on days 1 to 5 was 73.9 ± 64.9,
130.7 ± 76.7, 127.1 ± 56.4, 101.0 ± 73.8 and 124.7 ± 84.2 mg. pCO2-
max decreased from 15.5 ± 6.1 kPa to 8.8 ± 3.5 kPa, lactate-max
decreased from 3.5 ± 2.6 mmol/L to 1.6 ± 1.0 mmol/L, whereas
pH-min increased from 7.06 ± 0.15 to 7.34 ± 0.11. Abdominal dis-
tension was observed in 5 patients and 13 failed to absorb enteral
feeds. Delirium requiring treatment with haloperidol was seen in 5
patients. 14 patients (51.9 %) had X-ray changes consistent with
infection and 19 patients (70.4 %) had positive microbiology re-
sults within the first 7 days of ketamine administration. 2 patients
(7.4 %) developed new onset AF and 22 patients (81.5 %) had epi-
sodes of tachycardia.
Conclusions
Ketamine is safe for analgosedation in severe hypoxic respiratory failure
caused by COPD or asthma. Chest infection was a common trigger.
Common complications of critical care (constipation, delayed gastric
transport, abdominal distension, delirium, atrial fibrillation) were not
more frequently observed than reported for critically ill patients.
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on the intensive care unit
S. Berhane, C. Arrowsmith, C. Peters, S. Robert
Homerton University Hospital, London, UK
Critical Care 2016, 20(Suppl 2):P379
Introduction
Many Health professionals believe that the lunar cycle influences the
incidence of psychiatric presentation to hospitals [1,2]. Research has
shown that the circa-lunar cycle can influence the objective quality
of sleep [3]. However more robust research largely involving the ef-
fect of the full moon on emergency psychiatric presentations has
failed to find any correlation [4]. The aim of this novel study was to
examine whether the incidence of delirium in intensive care patients
was influenced by the lunar cycle.
Methods
The study was conducted over six months in a general intensive care
unit. Data was collected on the day of the full moon and new moon
of each month and 24 hours before and after). Delirium was assessed
using the confusion assessment method – intensive care (CAM-ICU).
Patients who were too sedated to be assessed by CAM- ICU were
excluded.
Results
Data on 92 patients was collected. There was no significant dif-
ference in these baseline characteristics and interventions known to
Critical Care 2016, Volume 20 Suppl 2 Page 153 of 182increase the risk of delirium. Sedative drugs used in the two groups
were similar apart from the fact that patients in the full moon group
received more benzodiazepines (0 % vs. 10 %) and more haloperidol
(0 % vs. 12 %).
There was no statistical difference between the incidence of delirium
during the new moon (CAM-ICU positive 20 %) and the full moon
groups (CAM-ICU positive 14 %).
Conclusions
Our study found no association between the incidence of delirium
and the full moon in intensive care patients. We hypothesise that
the reason for the persistence of the belief that the full moon is
associated with increased psychiatric morbidity is due to confirma-
tion bias. This may explain why patients received more sedative drugs
during the full moon when compared to the new moon.
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Fig. 97 (Abstract P380). Mean values of the autoregulation index
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Introduction
Cardiac surgery is associated with a high incidence of neurological
complications, including stroke, delirium and cognitive impairment.
Involved mechanisms include embolism and reduced brain flow dur-
ing bypass. There are no data evaluating the impact of cardiac sur-
gery in cerebral autoregulation and its potential relation to
neurological outcomes. The aim of this prospective observational
single-centre study was to evaluate the impact of cardiac surgery on
dynamic cerebral autoregulation (dCA) and assess its potential asso-
ciation with postoperative delirium.
Methods
Adult with a EuroSCORE > 6 or left ventricular ejection fraction <
40 % undergoing coronary artery bypass graft (CABG) surgery with
bypass were included. Cerebral blood flow velocity (CBFV, trans-
cranial Doppler, middle cerebral artery), end-tidal PaCO2 (EtCO2, in-
frared capnograph), and blood pressure (BP, Finapres or intra-arterial)
were continuously recorded supine during 5 minutes at rest pre-
operatively (T1),after 24 h (T2) and 7 days after surgery (T3). Diagno-
sis of delirium was performed using the confusion assessment
method for ICU (CAM-ICU). Autoregulation index (ARI) was estimated
from CBFV response to a step change in BP derived by transfer func-
tion analysis using standard template curves. Changes in ARI at T1,
T2 and T3 were assessed with repeated measures ANOVA.
Results
Thirty-three (23 male) patients, mean age 64.5 (SD10.9) years had
data with acceptable quality.CBFV step responses at T2 were mark-
edly different from T1 and T3 (Fig. 96) with corresponding values of
ARI (Fig. 97) significantly reduced at T2 (3.9 ± 1.4), compared to
T1(5.7 ± 1.4) and T3 (5.4 ± 1.6) (p < 0.001). We defined impaired dCA
< 4. Of a total of 33 patients, 19 (57 %) had impaired CA at T2 and
7 patients (21 %) at T3.Delirium was diagnosed in 8 patients; of
these, 6 (31 %) had impaired dCA, compared to 2 (14 %) with nor-
mal dCA (Fisher p = 0.31). At T3, 71 % of patients with impaireddCA had delirium compared to 8 % with normal dCA (Fisher p =
0.0175).
Conclusions
Dynamic cerebral autoregulation is impaired after CABG surgery and
possibly associated with occurrence of postoperative delirium. Fur-
ther work is needed to elucidate the underlying mechanisms of dCA
and to establish the adequate therapy.P381
Risk factors predicting prolonged intensive care unit length of stay
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Critical Care 2016, Volume 20 Suppl 2 Page 154 of 182Introduction: This study investigated risk factors for prolonged inten-
sive care unit (ICU) length of stay (LOS) in an elective surgical patient
cohort. LOS is an important outcome as a marker of ICU resource
consumption, and there is increasing pressure to use beds more effi-
ciently. If we can estimate the common LOS for common ICU patient
groups, such as elective procedure patients, and identify risk factors
for prolonged LOS in these groups, then beds can be booked in a
more prospective way. This could help improve the flow efficiency of
these patients through intensive care beds.
Methods: Retrospective cohort study of 1288 elective surgical patients
who stayed on an ICU at King’s College Hospital between the period
1/4/2014 to 31/3/2015. Data was collected for patients including pre-
operative and immediate (within 6 hours) post-operative physiology
and comorbidities. A Charlson comorbidity index (CCI) was calculated
for each patient using an ICD-10 specific algorithm. The main outcome,
prolonged LOS, was defined as an LOS greater than or equal to the
75th percentile. Multivariate logistic regression was used to identify var-
iables significantly associated with prolonged length of stay.
Results: With multivariate logistic regression, patients with prolonged
LOS were characterised by renal disease (OR 5.564 CI 95 % 1.166-
26.546 p = 0.031), high post-operative sodium (OR 1.342 CI 95 %
1.115-1.615 p = 0.002), high pre-operative c-reactive protein (OR
1.036 CI 95 % 1.003-1.070 p = 0.033) and low post-operative c-
reactive protein (OR 0.963 CI 95 % 0.929-0.998 p = 0.041), with a c-
index of 0.756 (CI 95 % 0.655-0.856 p < 0.0004). Analysing the univari-
ate relationship between each factor and LOS additionally identified
the presence of anaemia, malignancy, low albumin and high CCI as
significantly associated with a prolonged stay, but these were not
validated as significant at the multivariate stage. Age, chronic pul-
monary disease and heart failure were not found to be significantly
associated with an increased LOS in our cohort.
Conclusions: Prolonged LOS is significantly associated with several
measurable patient characteristics. Further work would be required
to more accurately characterise risk factors, but validation of similar
risk factors could facilitate prospective bed booking in a dedicated
post anaesthetic care unit, with those patients who have risk factors
for prolonged LOS instead being admitted directly to the general ICU
post-operatively.P382
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Introduction: Introduction: Criteria for Systemic Inflammatory Response
Syndrome (SIRS) are frequently used to identify patients at higher risk
of death. However, the utility of SIRS has recently been questioned. The
objective of this study was to evaluate if SIRS criteria might predict hos-
pital mortality in a Brazilian cohort of critically ill patients.
Methods: Methods: This is a retrospective cohort study conducted at
a private tertiary hospital (Hospital Sirio-Libanes) at São Paulo, Brazil.
We extracted relevant information from the adult intensive care unit
database (sistema Epimed™). A comparison was performed between
SAPS 3 score model and SIRS model both as a dichotomous variable
(> = 2 criteria - “SIRS positive” versus 0-1 criterion - “SIRS negative”)
and as an ordinal variable from 0 to 4 (according to the number of
SIRS criteria met) for predicting hospital mortality. Models discrimina-
tions were compared using area under the ROC curves.
Results: Results: Between January to December 2012, we studied 932
patients (60.4 % were classified as “SIRS positive”). Patients “SIRS
positive” were more severily ill compared to patients “SIRS negative”
(SAPS 3 of 45 [34 – 56] versus 39 [31 – 50] respectively; p < 0.001)
and had higher hospital mortality rates (16.9 % vs 8.1 % respectively;
p < 0.001). However, area under ROC curve for SAPS 3 was higher
(0.81 [95 % CI 0.78 – 0.85]) than for SIRS criteria both as a dicho-
tomous variable (0.60 [95 % IC 0.55 – 0.65]) as an ordinal variable
(0.62 [95 % IC 0.57 – 0.68]; p < 0.001 for comparisons between SAPS
3 and SIRS criteria).Conclusions: Conclusion: The utility of SIRS criteria to recognize severity
of illness and predict mortality in our cohort could not be observed.
P383
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Introduction: This study aims to evaluate the efficacy of pre-defined
clinical and biochemical criteria in predicting deterioration following
hospital admission via the Emergency Department (ED), and to evalu-
ate their utility as triggers for involvement of the iMobile Critical Care
Outreach service within the hospital.
Methods: 113 patients were randomly selected from King’s College
Hospital emergency admissions. Notes were screened for the presence
of: a National Early Warning Score (NEWS) > =5 or respiratory rate > =24
at transfer from the ED to the ward, sepsis with hypotension at any
point, new acute kidney injury (AKI), lactate > =4 or metabolic acidosis
on blood gas analysis and need for high flow oxygen at transfer from
the ED to the ward. Primary outcome measures were mortality, Intensive
Care Unit (ICU) admission, and length of stay. Associations between pro-
posed criteria and patient outcomes were statistically evaluated.
Results: Results calculated based on 14-day outcome data suggest that
likelihood of ICU admission is significantly increased by NEWS > =5 (chi-
squared = 5.029, p = 0.025), new AKI (chi-squared = 9.099, p = 0.003)
and need for high flow oxygen at transfer (chi-squared = 16.634, p <
0.0001). Patient mortality was significantly increased by NEWS > =5
(chi-squared = 6.391, p = 0.011), respiratory rate > =24 (chi-squared =
5.417, p = 0.020), need for high flow oxygen at transfer (chi-squared =
19.394, p < 0.00001), detection of metabolic acidosis on blood gas ana-
lysis (chi-squared = 4.764, p = 0.030) and new AKI (chi-squared = 5.056,
p = 0.025). Additionally, new AKI significantly increases length of stay
(+5.785 days, p = 0.003). Patients will be followed up for a period of
3 months and current preliminary results will be reassessed with 3-
month outcome data in this ongoing study.
Conclusions: NEWS > =5, new AKI, elevated respiratory rate, meta-
bolic acidosis and a high inspired oxygen fraction requirement are
significant predictors of inpatient stay morbidity and could potentially
be used as triggers for early Critical Care input. A study based on a lar-
ger patient sample is underway.
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general ward
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Introduction: In 2014, admissions following elective surgery occupied
26 % of admissions to the Critical Care Unit (CCU) at Ipswich Hospital. A
retrospective study showed 75 % of these admissions did not result in
Level 2 or 3 intervention.
Depending on CCU bed pressures, patients booked for elective post-
operative admission are assessed in the recovery room for suitability
to return to a general ward. The purpose of this study is to compare
the outcomes of all patients who were identified as high risk, thus
being booked for post-operative CCU admission, thereby identifying
those who do benefit from CCU admission and those safe for care
on the ward.
Methods: A retrospective analysis of all CCU bed requests was under-
taken between November 2013 - April 2014. Patient demographics, co-
morbidities, nature of surgery and post-operative progress were re-
corded. A comparison was made between those admitted to CCU and
those returning to a general ward.
Results: Of 149 CCU bed requests made, 100 cases were admitted to
CCU, 49 cases returned to the ward following anaesthetist or intensivist
assessment. There was no significant difference in age between the
Critical Care 2016, Volume 20 Suppl 2 Page 155 of 182two groups (mean 72.9 vs 75.6 years, p = 0.16). There was no significant
difference in comorbid state, quantified using the Charlson Comor-
bidity Index (mean score 2.55 vs 2.31, p = 0.24). Of all surgical spe-
cialities, colorectal patients were most likely to be admitted to CCU.
Overall length of stay was significantly longer in those admitted to
CCU compared to ward, (mean 11 vs 5 days, p = 0.00006). There were
also more post-operative complications; 64 events in 42 patients vs 12
events in 11 patients. 6 of 100 patients admitted to CCU required sub-
sequent readmission. 1 of 49 patients returned to the ward was admit-
ted to CCU day 1 post-operatively. Thus, only 26 of 149 CCU bed
requests resulted in admission with Level 2 or 3 interventions.
Conclusions: This study suggests that patient demographics and co-
morbid state have little influence on the eventual post-operative care
pathway in this patient cohort. Rather, an objective assessment in
the recovery room effectively identified patients with a shorter
length of stay and fewer post-operative complications.
We recommend routine assessment of high risk patients in the re-
covery room to determine suitability for admission to CCU. We have
introduced a proforma outlining peri-operative risk factors to allow
consistent assessment of suitability for ward-based care.P385
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Introduction: Obesity is one of the major risk factor for a number of
chronic diseases including diabetes, cardiovascular diseases and can-
cer. While obesity itself is a chronic inflammatory condition, pre-
vious studies showed that the obese patient with severe infection
was found associated with significantly lower mortality compared to
the septic patients with normal BMI [1]. In surgical critically ill pa-
tients whether obesity confers a “protective” effect is not clearly de-
fined. We hypothesized that surgical critically ill patients, which their
disease pathologies differ from septic medical patients, may also
have “protective” effect from obesity.
Methods: We conducted a retrospective cohort analysis using the
THAI-SICU study databases, which recruited 4652 Thai patients who
admitted to the surgical intensive care units of nine university-based
hospitals in Thailand [2]. All 4579 patients whose body mass index
(BMI) and mortality at 28 days were available, were included in this
analysis. The patients were categorized into 4 groups based on their
BMI i.e., underweight (BMI <18.5), normal BMI (BMI 18.5-24.9), over-
weight (BMI 25-29.9), and obesity (BMI >30). Primary outcome was
28-day mortality, and secondary outcome was the incidence of sys-
temic inflammatory response syndrome (SIRS).
Results: Of 4579 patients, 768 (16.8 %), 2624 (57.3 %), 858 (18.7 %),
and 329 (7.2 %) patients were classified as underweight, normal BMI,
overweight, and obese, respectively. Obese patients had the lowest
APACHE II score (8, interquartile range (IQR) 5-12), followed by over-
weight (10, IQR 7-15), normal BMI (10, IQR 7-16), and underweight
(12, IQR 8-16) (p < 0.001). Among these four patient groups, obese
patients had the lowest 28-day mortality (6.7 %), followed by over-
weight (9.6 %), normal BMI (14.7 %), and underweight patient groups
(18.5 %) (p < 0.001). Obese patients also had the lowest incidence of
SIRS (29.5 %), followed by overweight (34.5 %), normal BMI (35.6 %),
and underweight patients (41.1 %) (p = 0.001). In multivariate ana-
lysis, we found that every one unit increasing of BMI associated with
lower risk of hospital mortality, adjusted odds ratio = 0.96 (95%CI:
0.94-0.98, p < 0.0001) after adjusted for age, gender, and APACHE II
severity score.
Conclusions: We demonstrated that, compared to surgical critically ill
patients with lower BMI, surgical patients with higher BMI had sig-
nificantly lower risk of mortality.
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The national early warning score (news) reliably improves adverse
clinical outcome prediction in community-acquired pneumonia -
results from a 6 year follow-up
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Introduction: Clinical scores such as pneumonia severity index (PSI)
and CURB-65 are recommended for risk assessment in community-
acquired pneumonia (CAP). We investigated the prognostic potential
of the National Early Warning Score (NEWS) in a large and well de-
fined cohort of CAP patients with a 6 years follow-up.
Methods: We prospectively followed 925 CAP patients from a previ-
ous Swiss multicentre trial. Our primary outcome was all-cause mor-
tality within 6 years of follow-up. Secondary outcomes were adverse
clinical outcome defined as intensive care unit (ICU) admission, com-
plications (empyema) and unplanned hospital readmission all within
30 days. We used logistic regression models and area under the re-
ceiver operating characteristics curve (AUC) to compare NEWS with
PSI and CURB-65.
Results: Six-year overall mortality was 45.1 % (n = 417) with a step-
wise increase with higher NEWS categories. For 30-days and 6-year
mortality prediction, NEWS showed only moderate discrimination
(AUC 0.65 and 0.60) inferior compared to PSI and CURB-65. For pre-
diction of ICU admission, NEWS showed high discrimination (AUC
0.73) and improved the prognostic accuracy of PSI (AUC from 0.66 to
0.74, p = 0.001) and CURB-65 (AUC from 0.64 to 0.73, p = 0.015).
NEWS was also superior to PSI and CURB-65 for prediction of compli-
cations, but did not well predict rehospitalisation.
Conclusions: NEWS provides additional prognostic information in re-
gard to risk of ICU admission and complications thereby improves
traditional clinical risk scores in the management of CAP patients in
the emergency department setting.
P387
Clinical usefulness of the charlson¡¯s weighted index of
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Introduction: Concurrent comorbidities increase the risk of severe in-
fections and greatly influence the patient outcome. Our study evalu-
ated the clinical utility of Charlson¡¯s weighted index of comor-
bities (WIC) as a prognostic factor in patients with prolonged acute
mechanical ventilation (PAMV, ventilator care ¡Ã 96 hrs).
Methods: We retrospectively enrolled 311 PAMV patients who were
admitted to the mechanical intensive care unit (ICU) of Pusan Na-
tional University Hospital between 2008 and 2013. Survivors were
defined as patients who survived for 28 days after their ICU
admission.
Results: The median age of the subjects was 67 years (range: 18-93),
and 71.7 % of them were male. The median lengths of their stay in
the ICU and the hospital were 15 (range: 4-129) and 26 (range:
5-430) days, respectively. The ICU and hospital mortality rates were
43.7 and 44.4 %, respectively, and the 28-day mortality rate after the
ICU admission was 34.7 %. The median WIC was 2 (range: 0-11), and
there was a significant difference in the WICs of the non-survivors
and survivors (p < 0.05). The linear regression analysis revealed a sig-
nificant positive relationship between the WIC and the Acute Physi-
ology and Chronic Health Evaluation II and Sequential Organ Failure
Assessment scores on the admission day (p < 0.05). The receiver op-
erating characteristics curve indicated a WIC of 3 as the cut-off value
[area under the curve, 0.593; 95 % confidence interval (CI), 0.525-
0.661; and p < 0.05], and the subjects with a WIC greater than 3 had
a higher mortality rate (44.5 % vs. 28.6 %, p < 0.05). The univariate lo-
gistic regression analysis showed that a WIC ¡Ã 3 was independently
associated with 28-day mortality in our population (odds ratio, 2.0;
95 % CI, 1.240-3.226; and p < 0.05).
Critical Care 2016, Volume 20 Suppl 2 Page 156 of 182Conclusions: In our study, WIC was the useful prognostic indicator
for 28-day mortality in patients with PAMV.
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Introduction: Mortality of patients with cirrhosis admitted to the in-
tensive care unit (ICU) has been reported to be as high as 60 %. Re-
cently, a number of scoring systems have been developed in order
to predict mortality in tertiary liver units, including CLIF-SOFA-based
scoring systems and Royal Free Hospital (RFH) tool, however, none of
them has been validated in patients admitted to general ICU [1]. The
aim of the study is to validate the new measures and compare with
established prediction models.
Methods: Data on patients with confirmed cirrhosis admitted to a
general ICU at a major university hospital between 2008 and 2014
were retrospectively collected from medical records. Scores were cal-
culated for CLIF-Consortium Organ Failure score (CLIF-C OF, a short-
ened version of CLIF-SOFA), CLIF-C ACLF (includes age and white cell
count), RFH, Model for End-Stage Liver Disease (MELD) and Acute
Physiology and Chronic Health Evaluation (APACHE II). The main out-
come was mortality in ICU. Predictive accuracy and calibration was
assessed using area under the receiver operator curve (AUROC) and
goodness-of-fit χ statistic.
Results: 118 patients were identified (mean age 50.6 years, 66.9 %
male). ICU mortality was 54.2 %. Alcoholic liver disease was the main
aetiological factor present in 91.5 % of the patients. 56 % of patients
were admitted to ICU with gastrointestinal bleeding. All measures
were well calibrated (χ >0.2, p > 0.05), particularly CLIF-OF (χ =1.3,
p = 0.93). Accuracy of the novel models was generally not super-
ior to the established scores (AUROC values: CLIF-OF 0.68; CLIF-
ACLF 0.68; RFH 0.72 vs. APACHEII 0.65; MELD 0.71). Bilirubin, cre-
atinine and platelets were found to be independent predictors of
mortality in a multivariate logistic model. The accuracy of creatin-
ine alone was higher than any of the prediction models (AUROC
0.85, χ =8.4, p = 0.35).
Conclusions: RHF and MELD scores have the best predictive accuracy.
However, complex and specialised measures do not offer advantage in
predicting mortality over MELD and routinely available APACHEII score
in cirrhotic patients admitted to general ICU. Creatinine alone is a ro-
bust prognostic indicator of mortality. Simplified scores encom-
passing few variables may offer similar accuracy, but higher utility.
Reference
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Introduction: Admission source and time of admission could play a
role on the outcome of Pediatric Intensive Care Unit (PICU) patients
(pts). The aim of the present study is to investigate admission charac-
teristics in a Greek multidisciplinary 8 bed PICU and their relationship
with mortality at discharge.
Methods: Retrospective 15 years study (1/6/1999-31/12/2014). Data
collected: Demographics, reason for admission, emergency admis-
sions, readmissions, co-morbidities, source of admission (internal
pediatric, internal surgical, other in city hospital, remote peripheralhospital), season of admission (spring, summer, autumn, winter), time
of admission (in or out-of-hours), length of stay (LOS) and the outcome.
Statistics: t-test for independent samples, chi-square test, p < 0.05.
Results: 1977 pts, 57.5 % male, aged 55.51 ± 50.28 mo (mean ± SD,
median 40) were recorded. The main reasons for admission were re-
spiratory failure (26 %), postoperative care (15.7 %), seisures (11.5 %),
head trauma (11.2 %), coma (8 %), polytrauma (6.5 %), sepsis (4.7 %),
cardiovascular (4.5 %), accidents (3.9 %), MODS (3.7 %), miscellaneous
(2.9 %) and metabolic (1.5 %). LOS was 11.35 ± 26.64 days (median 5)
and mortality at discharge 14.36 %. Age (p = 0,742), infancy (p = 0.204),
readmissions (p = 0.793), co-morbidities (p = 0.969), season of admission
(p = 0.560) and time of admission (p = 0.353) did not play a role on the
mortality. On the contrary, mortality was significantly related to sex
(male 12.1 % vs. female 17.6 %, p = 0.003), emergency admissions
(16.7 % vs. 3.1 %, p = 0.000), source of admission (p = 0.000), and reason
for admission (p = 0.003). Internal pediatric pts had the highest mor-
tality (25.7 %), followed by other in city hospital (11.5 %), remote per-
ipheral hospital (12.2 %) and internal surgical (8.6 %). Moreover,
outcome was worse for MODS (mortality 65.3 %), cardiovascular
(43.2 %), sepsis (27.5 %), coma (24.2 %) and metabolic (21.4 %) pts. Non
survivors stayed significantly longer (16.38 ± 36.52 vs. 9.97 ± 13.92 days,
p = 0.000).
Conclusions: Our results are in accordance with data that attribute
higher mortality in internal pts, which is partially expected in tertiary
care hospitals like ours. Season and time of admission did not have a
significant impact on the outcome, indicating a high level of care
even under suboptimal conditions where resources are restricted, as
happened during holidays and out-of-hours admissions.
P390
Heart rate variability and outcomes prediction in critical illness
N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M.
Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Critical Care 2016, 20(Suppl 2):P390
Introduction: Heart Rate Variability (HRV) is an indicator of the dy-
namic equilibrium between the sympathetic and parasympathetic di-
visions of the autonomic nervous system. We hypothesized that
baseline HRV variables and changes during resuscitation, may predict
outcomes from critical illness.
Methods: A prospective, observational study was performed on inpa-
tients that required a Rapid Response Team (RRT) consultation. 24-
hour holter monitoring and serial measurements of physiological and
biochemical data were made. Heart rate variability was measured as
time domains measured over 24 hours (SDNN, ASDNN, rMSSD,
pNN50%, SDANN, mean NN) and frequency domains measured
hourly (Very Low Frequency VLF, Low Frequency LF, High Frequency
HF, Low/High ratio). The Research Ethics Committee approved the
study protocol (RAC No. 2151069).
Results: Fifty-three patients were enrolled, mean APACHE II score
was 23.5 ± 6.3, age 52 ± 24.3 years. Day 1 SOFA score was 8.9 (range
1, 23). Forty patients (75.5 %) required ICU admission; ICU mortality
rate was 27.5 %.
HRV was significantly higher in RRT consultations who stabilized and
did not require ICU admission; time domains; ASDNN [33(IQR21) vs
18(IQR21), p = 0.024], rMSDD [23(IQR19) vs 15(IQR18), p = 0.036] and
frequency domains; meanVLF [16.6(IQR7.3) vs 9.3(IQR10), p = 0.018],
meanLF [12.4(IQR11) vs 5.4(IQR7), p = 0.009], meanHF [9.3(IQR12) vs
4.8(IQR7), p = 0.011].
Baseline HRV was significantly higher in survivors; ASDNN [31.5(IQR24)
vs 12(IQR9),p = 0.002],rMSDD [25(IQR19) vs 11.5(IQR10), p = 0.012],
pNN50% [6(IQR9.5) vs 0.75(IQR2.5),p = 0.002], meanNN[732.5(IQR291) vs
570(IQR87),p = 0.006], mean VLF [12.1(IQR11.8) vs 5.3(IQR4), p = 0.002],
meanLF [8.5(IQR10.2) vs 3.4(IQR4.6), p = 0.009], meanHF [7.5(IQR6) vs
3.3(IQR3.9), p = 0.005].
Survivors also demonstrated a significantly larger increase in HRV
over 24 hours of resuscitation; deltaVLF [3(IQR8.1) vs -0.6(IQR8), p =
0.015], deltaLF [3.2(IQR5.9) vs -0.3(IQR7.6), p = 0.017].
Conclusions: HRV analysis appears to be a powerful identifier of out-
comes in critical illness. Baseline values and changes over the first
Critical Care 2016, Volume 20 Suppl 2 Page 157 of 18224 hours of resuscitation accurately predicted both the need for ICU
admission and survival.
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Introduction: Critically ill patients often develop hyperlactatemia,
and elevated serum lactate levels are associated with increased hos-
pital mortality. However, the epidemiology of hyperlactatemia in pa-
tients admitted to the post anaesthesia care unit (PACU) has never
been studied previously.
Methods: This retrospective observational study was conducted in
the PACU of a university hospital in Tokyo, Japan from 1 January
2010 to 31 December 2014. Adult PACU patients who were mo-
nitored with the arterial catheter after elective surgery were included,
except for patients with no lactate measured within 3 hours after PACU
admission. We measured serum lactate levels in arterial blood samples
using a point-of-care device. Study patients were divided to three
groups according to maximum lactate levels in the first 24 hours of the
PACU stay; normal lactate (<2 mmol/L), moderate hyperlactatemia (2-
3.9 mmol/L) and severe hyperlactatemia (> = 4 mmol/L). The primary
outcome was the composite outcome consisted of in-hospital mortality,
re-admission to the PACU or admission to the ICU, and emergency re-
operation during the same hospital stay.
Results: A total of 5362 patients were included in the study. Among
these patients, 3421 (63.8 %) patients had normal lactate, 1642
(30.6 %) had moderate and 299 (5.6 %) had severe hyperlactatemia.
The composite outcome occurred in 333 (6.2 %) of all patients. The
incidence rate of the composite outcome increased as serum lactate
levels elevated (normal: 4.7 %, moderate: 7.9 %, severe: 14.1 %, normal
vs. moderate: [i]p[/i] <0.001, moderate vs. severe: [i]p[/i] <0.001). In-
hospital mortality, re-admission to the PACU or admission to the ICU,
and emergency reoperation occurred in 71 (1.3 %), 190 (3.5 %), and
168 (3.1 %) for all patients, respectively. Each primary outcome tended
to increase with elevated serum lactate levels. Multivariable logistic re-
gression analysis revealed that moderate and severe hyperlactatemia
were risk factors for the composite outcome, odds ratio: 1.56 (1.20 -
2.01) for moderate hyperlactatemia, 1.57 (1.01 - 2.43) for severe hyper-
lactatemia referred to normal lactate.
Conclusions: The incidence of hyperlactatemia in the PACU was
36.2 % after elective surgery. Although hyperlactatemia was indepen-
dently associated with poor outcome, severe hyperlactatemia was
only similarly associated with poor outcome compared with mo-
derate hyperlactatemia. Further studies, especially for causes of
hyperlactatemia in the PACU, will be clarified.
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Introduction: Severe sepsis is a life-threatening multisystem process
that can result in significant morbidity or mortality. In most patients,
severe sepsis and shock septic is preceded by a period of physio-
logical deterioration; but evidence suggests that the early signs of
this are frequently missed. An arterial blood gas (ABG) analysis is in-
dispensable tool to assess and monitor critically ill patients in the ICU
or other critical care settings.
Methods: In this cross-sectional study, the medical data of all critic-
ally septic patients admitted to the Albert Schweitzer Hospital were
reviewed between January 2013 and September 2015. Data including
age, gender, SAPS III score upon admission, SOFA score, arrival and
24 hour ABG and arterial lactate levels, as well as length of stay and
in-hospital mortality rate were collected. A logistic regression modelwas used to determine the association between acid-base disturb-
ance and lactate levels with in-hospital mortality after adjustment for
potential confounding factors.
Results: Of the 2974 patients, 54 % were male; mean age of 62 years
old, mean SAPS III score of 63 points, SOFA score of 9 and 37,9 % of
them died in the hospital. Univariate analysis showed a significantly
higher risk of mortality in patients who developed metabolic acidosis
plus hyperlactatemia (OR = 2,98, p-value 0.01). Multiple logistic re-
gression analysis demonstrated that mixed metabolic acidosis plus
respiratory acidosis (OR = 3.19, 95 % CI = 1.48-9.32, p-value = 0.001)
and hyperlactatemia (OR = 1.78, 95 % CI = 0.49-4.56, p-value 0.02), pa-
tients with acidoses had very higher mortality (pH less then 7,2
44,1 % died and pH less then 7,05 95,5 % died; p 0.01 and p < 0,001
respectively), patients with hyperlactatemia had higher mortality (ar-
terial lactate over 2,5x regular levels 23,2,% died and arterial lactate
over 5x regular levels 63,4,% died; p 0.05 and p 0,01 respectively)
were two significant predictors of mortality, regardless of other con-
founding variables.
Conclusions: The results show that in critically septic patients initial
metabolic acidosis and hyperlactatemia are significant predictors of
mortality, reinforcing the significance of early action to restore tissue
perfusion and minimizing damage.
Reference
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Introduction: To validate the SAPS 3 and MPM-III scores in a large
contemporary cohort of patients admitted to Brazilian ICUs.
Methods: Retrospective multicenter cohort study in 48,816 adult pa-
tients consecutively admitted to 72 ICUs in 51 hospitals during 2013.
We excluded patients who underwent cardiac surgeries or invasive
cardiac procedures, readmissions, and those admitted for acute cor-
onary syndromes and burns. We retrieved clinical and out-
come data from an electronic ICU quality registry (Epimed Monitor
System), including the estimates for the MPM-III and SAPS 3 scores.
For the SAPS 3 score, we estimated predicted mortality using both
standard (SE) and Latin-American (LA) customized equations. We
evaluated models’ discrimination using the area under the receiver
operating characteristic curve (AUROC). We applied the calibration
belt to evaluate the agreement between observed and expected
mortality rates (calibration). We also calculated standardized mortality
ratios (SMR) for each model.
Results: Median age was 65 (48-79) years. Main reasons for ICU ad-
mission were postoperative care (26 %), sepsis (22 %), cardiovascular
(11 %) and neurological (11 %) complications. Mechanical ventilation
was used in 16 % of admitted patients, vasopressors in 13 %, and
dialysis in 3 %. ICU and hospital mortality rates were 11 % and 17 %.
Mean SAPS 3 score was 44 ± 15 points. Predicted mortality rates were
16 ± 19 % (SAPS 3 SE), 22 ± 23 % (SAPS LA) and 14 ± 14 % (MPM-III).
SMRs were 1.00 (95 % CI, 0.98-.102) for the SAPS 3 SE, 0.76 (0.74-
0.77) for the SAPS 3 LA and 1.15 (1.13-1.18) for the MPM-III. Discrim-
ination was better for SAPS 3 models (AUROC = 0.85) than for MPM-
III (AUROC = 0.80) (p < 0.001). In the calibration belt analyses, the
SAPS 3 LA overestimated mortality throughout all risk classes while
the MPM-III underestimated it uniformly. The SAPS 3 SE did not show
relevant deviations from ideal calibration.
Table 49 (Abstract P395). Combined mortality data.




Critical Care 2016, Volume 20 Suppl 2 Page 158 of 182Conclusions: In a contemporary large cohort, the SAPS 3 SE was ac-
curate in predicting outcomes for Brazilian patients.
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Introduction: While previous studies have assessed the relationship
of preadmission functional status (FS) to mortality in critically ill pa-
tients, none has assessed the impact of FS on the results of mortality
prediction models (MPM). We hypothesized that FS would confound
predictions of severity adjusted mortality.
Methods: This is a retrospective review of prospectively collected
data, and includes all 10,149 patients admitted to the 16 bed inten-
sive care unit of our university-affiliated hospital between 10/1/05
and 9/30/15. We abstracted information from the ICU’s database,
including diagnoses, APACHE II scores (APII), APACHE IV predic-
tions of mortality (APIVM) and hospital discharge status. We pro-
spectively characterized patients as FS1 (fully independent,
n = 8,146), FS2 (partly dependent, living at home, n = 1,026) and
FS3 (not living at home, n = 977). We stratified by severity of ill-
ness, compared observed:expected mortality ratios (O:E) and cre-
ated a multivariable model to assess the independent effect of
FS on mortality.
Results: FS1 were younger than FS2 and FS3, were more likely to be
admitted to the ICU after surgery and had lower APII, APIVM and
mortality than did FS2 or FS3 (p < 0.0001 all comparisons).
The impact of FS on confounding predictions of mortality was in-
versely related to severity of illness:
O:E mortality ratios, based on hospital discharge status and APIVM
and stratified by severity of illness for FS1, FS2, FS3:
APIVM <10 % - 0.33, 0.72, 1.02
APIVM 10-25 % - 0.49, 1.03, 0.88
APIVM 25-50 % - 0.60, 0.76, 0.98
APIVM >50 % - 0.87, 0.93, 0.94
Multivariable analysis demonstrated that FS2 and FS3 were inde-
pendently associated with increased risk of mortality when compared
to FS1: OR (95 % CI) 1.93 (1.57-2.37) and 2.29 (1.87-2.79), respectively,
(p < 0.0001 for both comparisons).
Conclusions: Preadmission functional status is independently asso-
ciated with risk of mortality in critically ill patients and confounds the
results of mortality prediction models, especially in patients with less
severe illness. Future mortality prediction models should incorporate
functional status in their design.
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Introduction: Studies have identified an increase in mortality and
critical care readmissions in those patients discharged from critical
care out of hours (22:00-06:59) [1].
Methods: Wardwatcher© provided mortality and readmission data
of patients discharged from two district hospital ITU’s in a year. Dis-
charges were split into night, weekday and weekend. Chi squared was
used to calculate the significance of mortality data. Rate of delayed dis-
charge (>240 minutes) and reason for delay were recorded.
Results: In hospital 1, 15 % were night discharges. 65 % weekday
and 20 % weekend. Night discharge mortality was 9 %, 8 % week-
day and 7 % weekends. 84 % of weekend discharges were delayed,77 % at night and 70 % during the week. In hospital 2 6.7 % were
night discharges. 74 % weekdays and 19 % weekends. Night dis-
charge mortality was 18 %, 9 % on weekdays and 8 % at weekends.
68 % of daytime discharges were delayed, 53 % at weekends and
62 % at night. The combined mortality data (Table 49) has a p value
of 0.089, using Chi-squared. In all groups >50 % of discharges were
delayed over four hours. Across both sites, >80 % of delays were
due to a lack of ward beds. Readmission rates were <5 %.
Conclusions: An increase in mortality for night discharges was
noted. Hospital 1 had a higher rate of night discharges and a
higher rate of delayed discharges. Hospital 2 has a lower rate of
both. Possibly demonstrating that prompt discharge of patients
leads to fewer night discharges. With the increase in mortality in
those discharged at night, it highlights the importance of avoiding
delayed discharges. Although a causal relationship between de-
layed discharge, night discharge and mortality cannot be proved;
this data adds to the evidence. Demonstrating a higher mortality
associated with night discharges and that delaying discharges con-
tributes to a higher rate of night discharges. More research is re-
quired to explore this.
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Introduction: Our objective was to identify factors associated with
high mortality on admission to a mixed ICU in a resource-cons-
trained environment, and to examine the impact of high-risk admis-
sions. Currently we admit around 1200 patients per year to our
mixed general university hospital ICU. Our predicted mortality is
higher than the national average (ICNARC).
Methods: This was a retrospective review of 6570 consecutive admis-
sions from 2009-14. We analysed our existing ICNARC dataset, to-
gether with referring specialty, lead time bias and CPR prior to
admission. Logistic regression was used to describe predicted hos-
pital mortality using age, Apache II score, referring specialty and pre-
admission CPR. The subset admitted post-CPR were further analysed.
These models were then fit-tested using ROC curves. Cost of ICU stay
was estimated using mean duration of stay and our current mean
ICU cost.
Results: Mean age was 61 (range 16-95), median APACHE II score
was 20 (IQR 15-26). Median time between hospital and ICU admission
was 2 days (IQR 2-5), ICU LOS 2.1 days (1-4.9), post-ICU LOS 8 days
(1-19).
The logistic regression model used is shown in Fig. 98. Factors
strongly associated with mortality were referral from haematology
(OR 2.64), oncology (OR 2.40) or admission after CPR (OR 3.14). Area
under the ROC was 0.8.
366 patients were admitted after CPR. Overall ICU mortality in this
group was 50 %. Logistic regression (Fig. 99) demonstrated a
strong association between mortality and admission from a med-
ical ward (OR 2.97) or A&E (OR 6.76). Area under the ROC was
0.81. Estimated ICU costs per survival to hospital discharge were
£75,091 if admitted with an APACHE II predicted mortality >90 %,
Critical Care 2016, Volume 20 Suppl 2 Page 159 of 182£48,000 for admission post-CPR, and £56,000 if referred from
haematology.
Conclusions: Referral from haematology, oncology, and post-CPR are
independently associated with poor outcome and a high cost per
survivor. These results suggest a need to review our admissions pol-
icy in view of the severe resource constraint and bed shortages cur-
rently experienced.Fig. 98 (Abstract P396). Predicting survival in all admissions; logistic
regression model.
Fig. 99 (Abstract P396). Predicting survival after CPR; logistic
regression model.P397
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Introduction: Mortality is one of the most used outcome indicator
among critical care patients. It depends on several variables like co-
morbidities, reason for admission and severity of the disease. Less at-
tention has been directed to how the timing of admission and
discharge from Intensive Care Unit (ICU) may influence hospital
mortality.
The aim of this study was to determine the impact on ICU and hos-
pital mortality of the moment of admission to and discharge from
the Intensive Care Unit.
Methods: To this end we developed a prospective observational
study, which included patients admitted between April and Novem-
ber 2014 in the ICU of the Maciel Hospital of Montevideo-Uruguay.
We consider weekdays between monday to thursday, and weekend
friday to sunday. Nocturnal admission was defined between 8:00 PM
to 7:59 AM.
Results: We analyzed 325 patients with a median age of 55 (36-71)
years and SAPS II of 43 (29-58) value points. No differences in mortal-
ity in ICU were found when comparing the time of admission (35 %
on weekends vs 31 % on weekdays, p = ns) nor the time of entry
(nocturnal 35 % vs diurnal 31 % , p = ns). The discharge day was as-
sociated with higher hospital mortality (57 % in the weekend vs.
14 % on weekdays, p = 0.000).Factors associated with hospital mortal-
ity by uni variate analisys were: age less than 50 years (43 % vs 17 %;
p = 0.000); SAPS II higher than 35 points (36 % vs 21; p = 0.017),
weekend discharge from ICU (57 % vs 14 %, p = 0.000), COPD (46 %
vs 26 %, p = 0,031), cardiovascular comorbidity (46 % vs 25 %,
p=,005) , and tracheostomised patients (42 % vs 25 %, p = 0,019).
Factors independently associated with hospital mortality after dis-
charge from the ICU were patients older than 50 years (OR 2.4; 95 %CI, 1.1 to 5.4) and discharge during the weekend (OR 7.7 95 % CI, 3.8
to 15.6).
Conclusions: This study shows that the moment of discharge was in-
dependently associated with hospital mortality.
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Introduction: To investigate the impact of organizational factors on
the outcomes and resource use in cancer patients admitted to a
large sample of Brazilian ICUs.
Methods: Retrospective cohort study of 9,946 cancer patients
(solid = 8,956; hematological = 990) (surgical = 4,929; medical = 5,017)
admitted to 70 ICUs (51 located in general hospitals and 19 in cancer
centers) during 2013. We retrieved clinical and outcome data from
an electronic ICU quality registry (Epimed Monitor System). We sur-
veyed ICUs regarding hospital and ICU structure, organization, staff-
ing patterns and process of care. We used multilevel logistic
regression analysis to identify characteristics associated with hos-
pital mortality. We evaluated efficiency in resource use using stan-
dardized mortality rates (SMR) and resource use (SRU) based on the
SAPS 3 score.
Results: ICUs were mostly medical or medical-surgical (n = 60, 86 %)
and located in private hospitals (n = 66, 94 %). Median number of
cancer patients per center was 110 (IQR 58-154), corresponding to
16 % (9 %-25%) of all ICU admissions. Median SAPS 3 score was 47
(36-59) points; mechanical ventilation (MV) was used in 21 % of the
patients. ICU and hospital mortality rates were 15.9 % and 25.4 %, re-
spectively. Adjusting for relevant patients’ characteristics (age, MV
use, admission diagnosis, cancer type, performance status, comor-
bidities, neutropenia), the presence of clinical pharmacist in the ICU
(OR = 0.67 (95 % CI, 0.49-0.90), the number of protocols (OR = 0.92
(0.87-0.98)) and daily meetings between oncologists and ICU team
(OR = 0.69 (0.52-0.91)) were associated with lower mortality. Con-
versely, mortality was higher in ICU holding training programs in crit-
ical care (OR = 1.38 (1.05-1.81)). The number of protocols (OR = 1.52
(1.11-2.07)) and meetings between oncologists and ICU team (OR =
4.70 (1.15-19.22)) were also independently associated with a more ef-
ficient resource use (both low SMR and SRU). Admission to ICUs in
cancer centers compared to general hospitals and annual case-
volume had no impact on mortality or resource use.
Conclusions: Organizational aspects, namely the implementation of
protocols and presence of clinical pharmacists in the ICU, and close
collaboration between oncologists and ICU team are targets to im-
prove mortality and resource use in critically ill cancer patients.
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Introduction: Cancer has grown steadily in ICU. The cancer patients
are gradually improving the treatment of the underlying disease,
both the earlier diagnosis, as most effective treatment, this lead to a
better prognosis. And the prospect is that these numbers reach
higher proportions over the years. But when you have to decide how
much admission or not in a ICU? Based on this question we decided
Critical Care 2016, Volume 20 Suppl 2 Page 160 of 182to retrospectively (nearly two years) evaluate the results of hos-
pitalization of patient with or without cancer, and compare their
major clinical outcomes. This study aimed to improve the knowledge
of the main clinical outcomes of cancer patients in the ICU of a large
private hospital. Can we break the paradigm that cancer patients
may have a non-significantly different evolution of a patient without
cancer admitted to the ICU?
Methods: We evaluated 2341 patients admitted in ICU during the
period from Jan 2014 to Oct 2015. It was an observational study
which was assessed retrospectively, the data of all adults patients ad-
mitted in ICU (excluding terminals). We separated in two groups: (1)
With some oncologic disease (2) Without oncologic disease. After the
division of the groups they were analyzed in comparison to each
other in age, sex, SAPS3 severity score, ICU and hospital length stay,
final outcome in the ICU and hospital. Data were collected from
Epimed System and the MV system, tabulated in Excel and studied
statistically.
Results: The group (1) with 2077 patients (56 % male) had a mean
age of 60.0 ± 18.9; SAPS3 41.1 ± 13.3; ICU stay 6.8d ± 10.3; hospi-
talization 19.2d ± 35.6 while group (2) with 264 (58 % male) had a
mean age of 62.4y ± 15.9; SAPS3 42.2 ± 12.9; ICU stay 6.9d ± 9.6; hos-
pitalization 20.4d ± 27.4. None of these values showed significance
with the Student-t.
Mortality for the group (1) in the ICU and hospital was 7.5 % and
10.3 % respectively an the group (2) was 10.6 % and 18.6 %. The ex-
pected mortality by SAPS3 to group (1) was 12.3 % ± 15.4 and (2)
13.4 % ± 15.2. The Z test was evaluated for two proportions and
there was no difference in mortality in the ICU for both groups, there
were differences for in-hospital mortality, was more significant for
cancer patients.
Conclusions: Oncology patients have the same outcome as in the
ICU, so the fact of the presence of the tumor can not be an obstacle
in the hospital in ICU.
Reference
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Introduction: Palliative oncology patients are admitted to critical care
not uncommonly, outcomes are variable and often difficult to pre-
dict. We sought to observe Intensive care unit (ICU) and hospital out-
comes of palliative oncology patients, in relation to demographic,
disease and organ failure criteria.
Methods: Retrospective review of the electronic database and notes
of patients admitted to ICU between January 2012 and October
2014 was undertaken. Patients without a formal palliative diagnosis
or with a diagnosis of haematological malignancy, were excluded.
Demographics, functional status, current cancer treatment, inter-
ventions received, and palliative care team involvement were
amongst parameters collected. SAPS II, APACHE II scores and ICU
outcome were recorded. STATA 14.1 was used for Logistic regression
analyses.
Results: 31 patients were identified, median (IQR) age was 68 (62-76)
years, 14 (45.2 %) were male, median (IQR) SAPS II score was 56
(53-71). Of 28 patients, where information was available, 18 (64.3 %)
had metastatic disease; 16 (61.5 %) were undergoing palliative
chemotherapy and/or radiotherapy, 5 (19.2 %) palliative surgical
intervention. Median (IQR) LOS was 3.25 (1.3-5.1) days and 6 (19.4 %)
patients had died at CC discharge. Hospital mortality was 29.6 %. Me-
dian survival was 7 days in hospital patients and 143 days in patients
discharged home. At logistic regression analysis, adjusted for age
and gender, the only factor associated with mortality at ICUdischarge was SAPS II score (OR 0.9, 95%CI 0.8-1, p = 0.046), while
length of stay (LOS), type of palliative treatment received prior to ICU
admission, metastatic spread, neutropenia, smoking and diabetic sta-
tus and highest recorded lactate in the 24 hours prior to ICU admis-
sion seemed to not be associated with ICU outcome. The lack of
statistical significance for these correlations may be related to the
small sample size.
Conclusions: A high SAPS II score may confer accurate prognostic in-
formation in the context of critically unwell palliative cancer patients.
Overall ICU mortality was lower than those documented by previous
works (47-70 %), [1][2][3] this may be related to strict triage by both
the ICU and oncology teams. Median survival of palliative oncology pa-
tients admitted to critical care remains poor.
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Introduction: Hemato-oncological patients with neutropenic sepsis
or septic shock are a growing concern in oncological Intensive Care
Units (ICU). Acute Physiology and Chronic Health Evaluation II
(APACHE II) and Simplified Acute Physiology Score II (SAPS II) are
used to predict prognosis in critical patients based in clinical and
analytic criteria obtained in the first 24 hours after admission.
Through this study we aim to analyse which factors predict mortality
in a cohort of febrile neutropenic (FN) patients with haematological
malignancies.
Methods: We carried out a retrospective study which evaluated all
hemato-oncological patients with FN admitted to an ICU in a com-
prehensive cancer center between January, 2011 and December,
2014. Baseline clinical and demographic information was described
using descriptive statistics. Factors predicting in-ICU mortality were
identified using univariate logistic regression. Variables with a p
value <0.20 were included in a multivariate analysis.
Results: A total of 54 patients were included for analysis. The me-
dian age at admission was 48 years and 51.9 % were male (N =
28). The baseline cause of immunosuppression was Alogeneic
Stem Cell Transplant (N = 20) and recent Chemotherapy (N = 34).
The SAPS II and APACHE II scores had a median of 64 and 28.5,
respectively. Multiple organ dysfunction was observed in 79.63 %
of cases (N = 43). The single more frequent dysfunctions were re-
spiratory, in 94.44 % (N = 51), renal, in 62.96 % (N = 34), and car-
diovascular dysfunction, in 57.40 % of patients (N = 31). Renal
replacement therapy was required in 11 cases. Invasive ventila-
tion was performed in 81.48 % of patients (N = 44), with median
duration of 168 hours. The median ICU length of stay was 8 days.
In-ICU mortality was 31.48 % (N = 17). In univariate analysis, the
APACHE II (OR 1.279, p value <0.01), SAPS II (OR 1.082, p value
<0.01), renal dysfunction (OR 3.403, p value <0.05) and invasive
ventilation (IV) (OR 8.7, p value <0.20) were associated with in-
ICU mortality. In a multivariate analysis, APACHE II remained sta-
tistically significant (OR 1.546, p value 0.018, AUC 0.84) as IV in
an exact logistic analysis.
Conclusions: A high APACHE II score and IV seems to predict an
elevated mortality risk in ICU patients with FN and haemato-
logical malignancies. SAPS II appears to be a less important pre-
dictor of mortality in this setting. However, it should be noted
that the scores shouldn’t be used to ascertain prognosis in indi-
vidual cases.
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Introduction: Acute respiratory failure may complicate the course of
patients with hematological malignancies and has historically been
associated with poor prognosis. This study evaluated the characte-
ristics, outcomes and predictors of mortality of patients with hema-
tologic malignancies who required intubation.
Methods: This was a retrospective study of all patients with hema-
tological malignancies who were admitted to the intensive care unit
(ICU) of King Abdulaziz Medical City-Riyadh from 01/01/2008 to
31/12/2013 and required intubation. We noted their baseline clin-
ical characteristics, treatments received in the ICU and different
outcomes. Multivariate logistic regression analysis was performed
to evaluate predictors of hospital mortality. Variables entered in
the model were gender, APACHE II score, PO2:FiO2 on admission,
admission serum lactate and INR, septic shock, noninvasive venti-
lation before intubation, renal replacement therapy and chemo-
therapy administration in the ICU.
Results: In the 6-year period, 190 patients with hematological malig-
nancies were admitted to the ICU and 123 (64.7 %) required intub-
ation for acute respiratory failure. These patients had mean age =
56.9 ± 19.6 years and APACHE II score = 27.9 ± 7.9 and were predom-
inantly males (63.4 %). Lymphomas (43.9 %) were the most common
hematologic malignancy followed by acute leukemias (39.0 %). Only
4 patients had bone marrow transplantation. Septic shock was pre-
sent in most (62.6 %) patients on ICU admission. Noninvasive ventila-
tion was tried in 23 (18.7 %) but failed. Chemotherapy was provided
in 19 (15.4 %) patients during ICU stay. New renal replacement ther-
apy for acute kidney injury was used in 18 (14.6 %) patients. Hospital
mortality was 69.1 % (64.6 % for acute leukemias and 70.4 % for
lymphomas, p = 0.68). Most deaths (82.4 %) occurred in the ICU. On
multivariate analysis, male gender (odds ratio, 4.81; 95 % confidence
interval, 1.69-13.72), septic shock (odds ratio, 5.67; 95 % confidence
interval, 1.92-16.75) and new renal replacement therapy (odds ratio,
13.59; 95 % confidence interval, 1.14-161.93) were independent mor-
tality predictors. Neither noninvasive ventilation failure nor chemo-
therapy during ICU stay was associated with mortality.
Conclusions: Patients with hematologic malignancies requiring intu-
bation had high mortality (69 %). Male gender, septic shock and
renal replacement therapy were independent predictors of mortality.
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Introduction: Intensivists’ clinical decision-making should pursue two
main goals for patients: to decrease mortality and improve patient-
centered outcomes such as quality of life and functional status in
survivors.We sought to investigate how published randomized con-
trolled trials (RCTs) explore these patient-important outcomes in crit-
ically ill patients.
Methods: Literature searches were conducted in Medline (via
Pubmed®) to identifiy eligible articles indexed from January 2013 to
December 2013.Articles were eligible if they reported an RCT in-
volving critically ill adult patients and were written in English. Data
extraction was conducted by 2 independent senior intensivists on a
standardized, pre-tested extract form. We assessed patients and
study characteristics. All outcomes (primary and secondary) were col-
lected, described and classified using 6 categories of outcomes in-
cluding patient-important outcomes. Patient-important outcomes
were represented by 2 entities: mortality at any time and patient-centered outcomes assessed after ICU discharge (such as quality of
life and functional status).
Results: Of the 716 articles retrieved, 152 RCTs met the inclusion cri-
teria and were assessed. These totaled 142,252 patients (age: 61 [54-
66] years, male sex: 62 %). Most common topics were mechanical
ventilation (31 %), sepsis (20 %) and nutrition (14 %).
Among the 152 primary outcomes 31 (20 %) were patient-important
outcomes (mainly mortality, 25/31) but only 6 (4 %) were patient-
centered outcomes assessed after ICU discharge (functional disability =
4; quality of life = 2). Among the 801 secondary outcomes, 169 (21 %)
were patient-important outcomes (mainly mortality, 117/169) but only
52 (6 %) were patient-centered outcomes assessed after ICU discharge
(quality of life = 22, functional disability = 19; neurological/cogni-
tive performance = 7; handicap = 2; post-traumatic stress = 1; pa-
tient satisfaction = 1).
Ninety-six (63 %) RCTs reported at least one patient-important out-
come (either primary or secondary outcomes) but only 17 (11 %) re-
ported at least one patient-centered outcome assessed after ICU
discharge. In a multivariate analysis, sepsis as topic (OR, 7.6; 95 % CI,
2.2-25.5) and RCTs with Jadad score > 3 (OR, 4.8; 95 % CI, 2.1-10.7)
were more likely to assess at least one patient-important outcome.
Conclusions: A small percentage of outcomes used in RCTs in critic-
ally ill patients published in 2013 were patient-important outcomes
and a large majority of them was mortality outcome.
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Introduction: Alopecia in adult survivors of critical illness has not
been previously well researched. During acute critical illness, alopecia
is of minimal concern to an ICU team, as survival is the primary aim.
In the recovery phase of illness however alopecia can prove distressing.
(1) The aim of this study was to investigate the incidence and nature of
patient-reported alopecia in a cohort of critical illness survivors.
Methods: This was a single centre, qualitative survey study com-
pleted in the ICU Follow-up Clinic of a teaching hospital in Wales. All
patients who had been discharged home for at least 12 weeks, fol-
lowing an ICU stay of three or more days and attending the Follow-
Up Clinic, were invited to complete the survey. The survey was
adapted from one used in a previous study and included questions
regarding patient demographics and alopecia.(2) Statistical analysis
included numbers (%) and medians (IQR). Comparisons between pa-
tients with and without alopecia were made using Fisher’s Exact test
and Mann Whitney U test. Due to the anonymity of the surveys the
Wales REC 6 confirmed ethical approval was not needed for this
study.
Results: The survey was completed by 75 patients attending the
clinic between July and December 2014. Median age was 65 years
and 35 % of patients were male. Alopecia was reported in 13 (17 %)
patients and the hair loss was gradual in 12 (92 %) of the 13 patients.
The severity of hair loss in this cohort ranged between less than
10 % to over 50 %, with the location of hair loss varying bet-
ween the patients. In all but one of the patients hair loss occurred
gradually at between one and six weeks post-ICU discharge and
lasted for between one and seven months. On analysis, no significant
differences were found between the patients with and without alo-
pecia in the demographic variables.
Conclusions: Limited research exists examining the incidence and
nature of patient-reported alopecia in adult survivors of critical ill-
ness. The type, amount and location of the hair loss varied between
patients in this study. The main limitation of this study is the survey
design resulting in a lack of information regarding potential predic-
tors of alopecia. The incidence reported in this study however sug-
gests that further research is warranted.
References
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Introduction: South Wales is an area of relative socio-economic
deprivation, with a myriad of well-recognised associated mental
health problems. Patients with mental health disorders are com-
monly admitted to an ICU as a direct consequence of their illness,
such as a suicide attempt, or due to indirect consequences, such as
an intravenous drug overdose in drug addicts. As a result of these
findings we set out to ascertain the effect of pre-existing mental
health issues including addiction on ICU admission.
Methods: A prospective study design was used in which data was col-
lected on all admissions to the general ICU of a large teaching hospital
in South Wales, over a two month period. All adult patients were
screened for the following questions; Was the admission a direct conse-
quence of a mental health disorder or recreational/ illicit psychoactive
substance use? Is there a co-existing mental health diagnosis present
prior to admission? ICD-10 codes were used to define mental health
disorders. Outcomes studied included in-hospital mortality, ventilator
days and length of ICU stay. Data analysis included Fisher Exact and
Mann Whitney U tests. Statistical significance was set at p < 0.05.
Ethical approval was waived for this service evaluation.
Results: A total of 192 patients were screened with 51 (27 %) pa-
tients admitted with a mental health disorder (15 patients as a direct
consequence and 36 patients with an existing mental health prob-
lem). The patients with a mental health disorder were signifi-
cantly younger than the controls (p < 0.05) however there was no dif-
ference in APACHE II scores. There were no significant differences in
mortality, mechanical ventilation days or ICU length of stay between
the two groups. There was a significant difference in the mortality
rate between the patients admitted as a direct conse-
quence of a mental health disorder and the control group (p < 0.05)
Conclusions: Patients with mental health problems appear to have
worse outcomes than those without. The mortality of those admitted
to ICU as a direct consequence of their mental health problems is
significantly higher than controls. The reasons for this are unclear
and likely multi-factorial. A future multi-centre prospective study is
planned in Wales to investigate the national impact of mental health
disorders on ICU resources.
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Introduction: Survivors of critical illness often have an incapacitating
form of cognitive, psychological and functional impairment but the
potential reversibility of these clinical conditions 5 years after inten-
sive care unit (ICU) discharge remains inadequately understood. Our
aim is to evaluate long-term cognitive impairment, psychological
morbidity and quality of life 5 years after ICU discharge.
Methods: Prospective cohort study of survivors, admitted to a mixed ICU
between January and September 2010. Clinical evaluation was performed
at 6 months and 5 years after hospital discharge and it included the De-
mentia Rating Scale-2 (DRS-2), Hospital Anxiety and Depression Scale
(HADS), Post-traumatic stress syndrome 14-questions inventory (PTSS-
14), Medical Outcomes Study 36-Item Short Form (SF-36) and the
Euro Quality of Life 5 Dimensions (EQ-5-D) in both two moments.
Results: During the study period, 26 patients were evaluated in the
outpatient clinic 6 months after ICU discharge, with a mean age of
63 ± 16 years; of these, 18 were re-evaluated 5 years after ICU
discharge. Twelve (46 %) patients presented cognitive impairment
(DRS-2 < 10 percentile) in the first evaluation and 3 (17 %) at 5 years(p = 0.063). Anxiety and depression at 6 months was present in 5
(19 %) and 4 (15 %), at 5 years only 2 patients reported anxiety and
none had depression. Evaluation with SF-36 did not show significant
differences in the physical function [53 (39-75) vs 64 (43-94), p =
0.619], physical pain [78 (39-90) vs 58 (35-100), p = 0.810], general
health [59 (39-68) vs 62 (42-71), p = 0.845], vitality [63 (38-80) vs
56 (22-78), p = 0.276], social function [50 (38-63) vs 100 (25-100),
p = 0.179], emotional performance [100 (0-100) vs 100 (67-100),
p = 0.091] and mental health [66 (54-86) vs 67 (29-79), p = 0.098];
differences were found in physical performance [100 (0-100) vs
89 (41-100), p = 0.010] and in health status change for worse: 4
(15 %) vs. 6 (33 %) patients (p = 0.018). Evaluation with EQ-5-D
showed that 27 % vs. 50 % (p = 0.031) had some problems in
self-care, 46 % vs. 58 % (p = 0.549) in usual activities, 62 % vs.
62 % (p = 1.000) reported pain/discomfort, 58 % vs. 65 % (p = 0.727)
some problems in motility and 50 % vs. 50 % (p = 1.000) anxiety/
depression; visual analogue scale was 80 (50-80) at 6 months vs. 60
(50-82)points at 5 years (p = 0.599).
Conclusions: In our cohort, patients did not show an increase in cog-
nitive deterioration, nor in anxiety or depression. There was a deteri-
oration in physical function and a higher proportion of patients
reported a health change for worse during the previous year, but
that did not translate in worse quality of life.
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Introduction: ICU illness severity scores are used in the ICUs for out-
come prediction and guidance to human and financial resources use.
Applicability of severity illness scores to octagenerians in medical ICU
remains unclear.
Methods: Retrospective analysis of 244 consecutive octogenarians
admitted to our MICU in 2014 was performed calculating APACHE II
and IV. Predicted mortality was compared to actual mortality. Actual
and predicted length of stay were compared.
Results: Out of 1075 admitted patients, there were 244 octagenerians
(23 %) with 28 % ICU mortality. ICU mortality in younger patients was
19 % (p < .005). Both APACHE II and IV predicted 50 % mortality thus
overestimating it by nearly 45 %. Actual LOS (3 days) was statistically
shorter then predicted (6 days), p < 0.005.
Conclusions: APACHE II and APACHE IV correlate poorly with observed
mortality when applied to octagenerians in MICU. There is discrepancy
between predicted and actual LOS.
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Fig. 101 (Abstract P407). Mortality rates.
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Introduction: Advanced age is associated with increased illness se-
verity leading to an increased mortality when critical care is required.
Although the average life expectancy in India is 68 years, and only
0.9 % of the population is above 80 years of age, ICUs in major cities
like ours admit a substantial proportion of octagenarians. Since the
ICU outcomes of octagenarians in the Indian setting is not known,
we conducted this retrospective review.
Methods: This retrospective review was conducted in a 19 bedded
multidisciplinary ICU (mixed medical, surgical and coronary care) in
the state of Tamilnadu in south India. Data was extracted from our
ICU patient database for a one year period from Sept 2014 to Aug
2015. There were 470 admissions during this period, of which 53 pa-
tients were octagenarians making it 11.3 % of the total admissions.
The demographics and outcomes of octagenarians were compared
with the rest of the ICU admissions with full available APACHE 4 dur-
ing this period.
Results: The average age of octagenarians admitted to our ICU was
84 years. Unlike the rest of the admissions, there were more females
(55 %) amongst the octagenarians. Their average APACHE 4 score
was 57.6 with a predicted mortality of 13.9 %. This correlated well
with the actual mortality of 11.3 %. There was no statistically significant
difference between the length of ICU stay or mortality between the
octagenarians and the rest of the admissions. The number of cardiac
patients between the two groups was also comparable.
Conclusions: 11.3 % of all our ICU admissions were octagenarians.
Compared to the western population, octagenarians admitted to our
ICU seem to have a lower predicted and actual mortality indicating
less illness severeity. This could be due to a combination of patient
factors, healthcare factors, healthcare delivery location and cultural
factors. Published western data may not be helpful for discussing the
outcomes with the patient and the family or decision making, before
or after ICU admission.
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Introduction: The brazilian population is ageing and this is affecting
trends in the percentage of hospital and intensive care unit (ICU) ad-
missions attributable to patients aged 80 years or older, the very eld-
erly. In 2050 the population elderly will be a quarter of the total
population. Advanced age is associated with increased severity of
acute critical illnesses and admission to ICU. They have a high risk of
death.
Methods: We evaluated age-specific 2329 subjects > = 15y old and
retrospectively admitted to the ICU from Jan 2014 to Oct 2015. We
analyzed the clinical data of the subjects and divided into two
groups: less than 80 (L80) and greater than or equal to 80 years
(G80). We evaluated the major clinical outcomes and compared the
two groups.
Results: We had 56.2 % male. The average length of stay in ICU
(L80 = 6.5d ± 10.2; G80 = 8.2 ± 10.5) and hospital (L80 = 18.7 ± 35.9;
G80 = 23.0 ± 28.7) showed no significant difference between the
two groups. Mean SAPS 3 was 41.2 ± 13.3, with differences between
the L80 group (38.8 ± 12.5) and G80 (53.0 ± 10.8) as well as the prob-
ability of death L80 = 9.8 % ± 13.6 and G80 = 24.8 % ± 17.3, respectively.
As might be expected mortality, both in ICU or hospital were higher in
the older group with significance according to the Z test for two
proportions.
Conclusions: Age did not affect the length stay in ICU and hospital.
The elderly subjects (> = 80y) admitted to the ICU had a higher mor-
tality rate compared with subjects of other ages. These findings raise
questions about the use of critical care at the end of life for the very
elderly.
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Introduction: Compared to younger patients, octagenerians exper-
ience higer shor- and long-term mortality rates, and their admission
rates over the last decade is increasing. The purpose of this study
was to evaluate ICU and hospital mortality and mortality associated
with ICU readmission.
Methods: Single center retrospective study in tertiary center acade-
mic hospital. Charts of 244 octagenerians consecutively admitted to
medical ICU were analyzed. Pre -ICU performance was assesed, ICU
mortality (APACHE IV), rate of remissions and hospital mortality was
analyzed.
Results: In 2014, 1075 patients were admitted to our MICU, 244 aged
80 or more, oldest being 98. ICU mortality among octagenerians was
28 % and was significantly higher compared to the younger patients
(19 % mortality; p <0.0005). None of the patients aged 80 or more di-
agnosed with sepsis survived ICU. In-hospital mortality of octagener-
ians was 43 %. 10 patients (4 %) were readmitted to ICU, none of
whom survived. Pre-admission performance status was not predictive
considering ICU or hospital mortality.
Critical Care 2016, Volume 20 Suppl 2 Page 164 of 182Conclusions: Octagenerians have higher ICU mortality rates com-
pared to younger patients and their in-hospital mortality doubles. Re-
admission to ICU in analyzed period was associated with 100 % mor-
tality. Pre ICU performance status was independent risk factor for
mortality. Careful evaluation is warranted before readmitting elderly
patient to MICU. We encourage making clear therapeutic plan after
ICU discharge with clear recommendations considering potential ICU
readmission, re-introducing invasive or non-invasive mechanical ven-
tilation, vasopressor or commencing renal replacement therapy and
antibiotic treatment.
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Male 101 29 (29%) 42 (42%) 4 (4%) 4 (100%!
Female 143 40 (28%) 64 (46%) 6 (6%) 6 (100%)
All 244 69 (29%) 106 (43%) 10 (5%) 10 (100%)
Fig. 102 (Abstract P412). Survival curves by admission group over
24 months.P411
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Introduction: Many elderly patients are admitted to intensive care
units (ICUs) despite known poor outcomes and frequent patient pref-
erence to avoid unnecessary prolongation of life. The REALISTIC-80
(Realities, Expectations and Attitudes to LIfe Support Technologies in
Intensive Care for Octogenarians) trial studied the outcomes of very
elderly patients admitted to ICUs in Canada. Not only was mortality
high, but long-term physical and functional recovery was also poor,
raising questions about the appropriateness of ICU admission in this
group. These findings also carry significant economic implications.
Using data from REALISTIC-80 trial, we examined the cost of ICU ad-
mission for the very elderly, factors affecting this cost, and the poten-
tial savings of reducing admissions that are either undesired by the
patient or medically futile.
Methods: This multicentre, prospective, observational cohort study
included patients > =80 years old admitted to 22 Canadian ICUs from
2009-2013. Overall cost of care per patient was determined by length
of stay and direct-variable costs for ICU admission. Using both uni-
variate and logistic regression models, we investigated potentially
predictive factors influencing cost, including patient outcome (death
vs. survival), frailty, residence in a nursing home, as well as the pres-
ence of advance directives. An exploratory analysis was performed to
illustrate the potential cost savings of reducing the number of ICU
admissions in this population.
Results: In total, 3,064 patients > =80 years old were admitted to ICU,
of which 1,917 were eligible, and 610 were enrolled in the study. The
average age was 84 years; median length of stay was 5 days in ICU
and 21 days in hospital. Mortality was 14% in ICU, 26% in hospital
and 41% at 12 months. For non-survivors, the median time from
admission to death was 12 days. Of enrolled patients, 240 (39%)
remained in ICU for 7 days or more; 99 (41%) of these died inhospital. At 1 year, 28% of patients had meaningful recovery
measured by the Short Form-36, a survey of general health status
that includes both physical and mental health component scales.
The results of the cost analysis are pending and will be presented at
the conference.
Conclusions: In this study, we will demonstrate the significant eco-
nomic costs of critical care in very elderly patients admitted to
ICU—a population for whom this level of care is often unwanted or
futile. More importantly, we expect to illustrate the potential cost
savings of reducing these admissions, which will be crucial for
informing clinical and policymaking decisions.P412
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A. G. Murchison1, K. Swalwell2, J. Mandeville3, D. Stott3
1Milton Keynes Hospital, Milton Keynes, UK; 2Imperial College, London,
UK; 3Buckinghamshire Healthcare NHS Trust, Aylesbury, UK
Critical Care 2016, 20(Suppl 2):P412
Introduction: The purpose of this study was to determine the rela-
tionship between acuity of illness on ICU and two-year mortality for
patients aged 85 or older. Few data exist about this association.
Methods: Patients aged 85 or older who were admitted to ICU at
Stoke Mandeville and Wycombe Hospitals between Oct 2012 and
Oct 2013 were identified. 24 month mortality was evaluated accor-
ding to category of admission, organ support during ICU stay and
APACHE III scores.
Results: 78 patients were included with a median age of 87 (range
85-96). 22 patients (28%) died during their ICU stay, and a further 12
(15%) died on the ward before discharge, giving a total of 34 (44%)
hospital deaths. 6- and 24- month mortality were 54% and 60%
respectively.
Medical patients had the highest acuity scores and highest mortality
at all end-points (Fig. 102). High APACHE III scores (Fig. 103) and in-
creasing numbers of organs supported correlated with shorter time
from ICU admission to death (p < 0.0001 in both cases). Of those
who required support of 4-5 organs (8 patients), none survived their
hospital admission.
Conclusions: Almost half of patients aged over 85 admitted to ICU
died before discharge from hospital, but a large proportion of pa-
tients who survived 6 months were still alive at two years. High APA-
CHE III scores and organ support were associated with higher
mortality. These results suggest that intensive care is of benefit to se-
lected patients aged over 85, and that acuity of illness is a useful in-
dicator of long-term survival.
Fig. 103 (Abstract P412). Association between number of organs
supported and mortality (means with SEM).
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Acquired weakness in an oncological intensive care unit
I. Guerreiro
IPO -Porto, Porto, Portugal
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Introduction: Intensive Care Unit–acquired weakness (ICU-AW) is a
frequent complication of critically ill patients with an approximately
incidence of 25%-50%. The diagnosis is clinical and consists in asses-
sing the strength of various muscles groups in the upper and lower
extremities. This problem represents one of the greatest burdens pa-
tients face after surviving ICU care. Objectives: To assess the inci-
dence and identify clinical factors associated with ICU-AW in an
Oncology Center.
Methods: Retrospectively collected data on patients admitted to the
ICU between January 2013 and December 2014 were reviewed. Pa-
tients admitted to the ICU, aged > = 18 years, mechanically ven-
tilated for > = 48 hours and with the final diagnosis of ICU-acquired
weakness were selected. Predictive factors of ICU-AW were identified
using multivariate logistic regression analysis.
Results: From the 177 patients included, 20,3% developed ICU-AW.
The mean age was 57,3 years and 58,3% were female. The median
time of mechanical ventilation was 343,5 hours. 55,6% of patients
had solid tumors and 44,4% had hematological malignancies. Gluco-
corticoids and neuromuscular blocking agents were administered in
88,9% and 38,9% of patients, respectively. Septic shock developed in
72,2% of patients and was found to be a predictive factor for devel-
oping ICU-AW (OR 4,15, pvalue 0,018). 66,7% of patients started or
continued physical rehabilitation during the hospital length of stay
approximately 12 days after admission in the ICU. 44,4% of patients
with ICU-AW died 37 days after admission in the ICU. 8 patients (22,2%)
with ICU-AW were re-evaluated by physical and rehabilitation medicine
144 days after hospital discharge. Significant improvement was noted
in their physical status while in the program of physical therapy.
Conclusions: ICU-AW is a relatively frequent problem and septic
shock was found to be a predictive factor for the development of
this entity. Early mobilization is an important intervention to de-
crease the weakness and physical deconditioning in the critically ill
patients.References
-Kress J,Hall J.ICU-AW and recovery from Critical Illness.NEJM 2014,370:1626-35
-Lipshutz A,Gropper M.Acquired Neuromuscular Weakness and Early
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Musculoskeletal problems in intensive care unit (ICU) patients
post-discharge
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Introduction: The aim of this study was to examine the incidence of
musculoskeletal problems (i.e. pain, weakness, decreased joint range
of movement) in critical care patients post discharge. Post intensive
care syndrome (PICS) is now a widely used term to describe the col-
lection of problems patients develop due to their stay in intensive
care. ICU survivors have been found to have a high risk of de-
veloping not only psychological problems but physical problems
such as Intensive Care Unit Acquired Weakness (ICUAW) and chronic
pain [1, 2].
Methods: Discharged patients from ICU attended a 5 week mul-
tidisciplinary rehabilitation programme as part of a quality improve-
ment initiative within Glasgow Royal Infirmary ICU. Participants com-
pleted a one-one musculoskeletal assessment with an ICU phy-
siotherapist. Ethics approval was waived as the programme was part
of a quality improvement initiative.
Results: Data was collected from 47 of the 48 patients who attended
the programme (median age was 52 (IQR, 44-57), 67% of the patients
were men, median ICU length of stay (LOS) was 15 days (IQR 9-25)
and median APACHE II was 23 (IQR 18-27). 66% of participants
(n = 47) reported a new incidence of pain since discharge from ICU,
28% reporting lower limb (LL) pain and 25% reporting shoulder pain.
Bilateral symptoms were reported in 84% of those who complained
of lower limb pain in contrast to 25% of those with shoulder pain. In
relation to muscle weakness, 74% of participants presented with LL
weakness compared with 51% in the upper limb (UL). UL joint range
of movement was reduced in 40% of participants and a 19% reduc-
tion for the LL. 23% of all participants reported numbness in UL/LL
or both.
Conclusions: Musculoskeletal problems especially shoulder pain and
bilateral LL pain and weakness remain a significant problem for survi-
vors of critical illness. This may have implications regarding falls risks,
exercise capacity and reduce the likelihood of patients retur-
ning to work. Shoulder pain was found to be one of the most com-
mon complaints of pain supporting other research [1] with contribut-
ing factors such as the position of ventilator tubing, dialysis lines or
central lines hypothesised. Collecting this data has helped raise
awareness of these problems and may strengthen the case for more
equipment for active mobilisation in ICU and herald a need for in-
creased understanding in downstream wards on ICUAW.
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induced muscle wasting and weakness
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Introduction: The ‘obesity paradox’ of critical illness refers to better
survival with a higher BMI. We hypothesized that fat mobilized from
excess adipose tissue during critical illness provides energy more effi-
ciently than exogenous macronutrients and could prevent lean tissue
wasting.
Methods: In a centrally-catheterized mouse model of cecal ligation
and puncture (CLP)-induced prolonged septic critical illness, body
weight and composition, and muscle wasting were assessed in lean
and premorbidly obese mice, each with fasting and parenteral
Critical Care 2016, Volume 20 Suppl 2 Page 166 of 182feeding [healthy mice: lean n = 8, obese n = 9; fed CLP mice: lean n =
7, obese n = 10; fasted CLP mice: lean n = 9, obese n = 9]. Muscle
weakness was assessed in a second mice experiment examining
ex vivo muscle force [healthy mice: lean n = 17, obese n = 15; fed CLP
mice: lean n = 15, obese n = 15]. Mice were generated by providing
12-week old male C57BL/6J mice with ad libitum 10% fat chow or
45% fat chow for 12 weeks prior to the septic insult. Also, in matched
lean (BMI < =25 kg/m2) and overweight/obese (BMI >25 kg/m2) pro-
longed critically ill patients and healthy controls, we compared
markers of muscle wasting (m. vastus lateralis biopsies (n = 102) and
m. rectus abdominis biopsies (n = 86)) as well as muscle weakness,
quantified by Medical Research Council sum scores (n = 278).
Results: Five days of sepsis reduced body weight similarly in lean
and obese mice, with more fat loss in the obese (p < =0.03). Lean
CLP mice, but not the obese, showed reduced muscle mass (p < =0.04),
muscle protein content (p < =0.06), myofiber size (p < 0.01), and muscle
and hepatic triglyceride content (p < =0.06), irrespective of adminis-
tered feeding. Obese CLP mice maintained normal maximal muscle
force, whereas in lean CLP mice, maximal muscle force decreased (p <
0.01) and recovered less from fatigue (p < 0.01). These differences be-
tween lean and obese CLP mice coincided with signs of more effective
hepatic fatty acid and glycerol metabolism, and ketogenesis in the
obese. Also overweight/obese critically ill patients showed pre-
served myofiber size, while myofiber size reduced in lean patients (p =
0.02 in m. vastus lateralis biopsies, p = 0.01 in m. rectus abdominis biop-
sies). Furthermore, fewer overweight/obese patients suffered from
muscle weakness, assessed 8 days post-ICU admission (p < 0.01).
Conclusions: In conclusion, during critical illness premorbid obesity,
but not nutrition, facilitated utilization of stored lipids and attenua-
ted muscle wasting and weakness.P416
Physical outcome measures for critical care patients following
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Introduction: The aim of this study was to evaluate the most suitable
physical outcome measures to be used with critical care patients fol-
lowing discharge. ICU survivors experience physical prob-
lems such as reduced exercise capacity and intensive care acquired
weakness. NICE guideline ‘Rehabilitation after critical illness’ (1) rec-
ommends the use of outcome measures however does not provide
any specific guidance. A recent Cochrane review noted wide variabil-
ity in measures used following ICU discharge (2).
Methods: Discharged ICU patients attended a five week multidis-
ciplinary programme. Patients’ physical function was assessed during
the programme, at 6 months and 12 months post discharge. Three
outcome measures were included in the initial two cohorts. The Six
Minute Walk Test (6MWT) and the Incremental Shuttle Walk test
(ISWT) were chosen as they have been used within the critical care
follow up setting (2). The Chester Step Test (CST) is widely thought
to be a good indicator of ability to return to work (one of the pro-
grammes primary aims). Ethics approval was waived as the
programme was part of a quality improvement initiative.
Results: Data was collected for the initial patients attending the
programme (n = 13), median age was 52 (IQR = 38-72), median ICU
LOS was 19 days (IQR = 4-91), median APACHE II was 23 (IQR = 19-41)
and 11 were men. One patient was so physically debilitated that the
CST or ISWT could not be completed however a score was achieved
using the 6MWT. Another patient almost failed to achieve level 1 of
the ISWT. Subsequent patients for this project (total n = 47) have all
therefore been tested using the 6MWT. Good inter-rater and intra-
rater reliability and validity have been reported for the 6MWT (3).
Conclusions: Exercise capacity measurement is not achievable for
some patients with either the ISWT or the CST due to the severity of
their physical debilitation. Anxiety, post-traumatic stress disorder and
depression are common psychological problems post discharge (4),
therefore using a test with a bleep is not appropriate. Therefore, the6MWT is the most appropriate physical outcome measure to be used
with critical care patients post discharge.
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Introduction: We aimed to improve the active mobilisation of Inten-
sive Care (ICU) patients through a quality improvement (QI) project.
Only 50% of ICU patients return to work within one year of discharge
[1]: there are ongoing physical, psychological and cognitive problems
after ICU discharge [1, 2]. Active mobilisation shortens hospital stay,
increases return to independent function [3] and reduces delirium
[3]. UK ICU standards, introduced in 2013, direct 45 minutes/day of
active mobilisation in suitable patients.
Methods: Our ICU selected a multidisciplinary (MD) team in January
2014 to lead the mobilisation QI project and a commitment was
made to the weekly collection and presentation of data. We used the
ADEPT (aim, data, evidence, process, team) format. Our initial aim
was 20 minutes of active mobilisation daily in 95% of suitable ICU
patients. Patients had to be able to obey commands, to have
achieved a degree of cardiovascular stability and must have no mus-
culoskeletal injuries precluding mobilisation. Vasopressor use and in-
vasive ventilation per se were not barriers to active mobi-
lisation. Agreed forms of active mobilisation were active limb exer-
cises (a booklet of exercises was developed), bed edge sit (dangle),
sitting out of bed in a chair, standing and walking. Baseline data was
collected and serial Plan, Do, Study, Act (PDSA) cycles were carried
out.
Results: Baseline data (March – April 2014) showed 34% daily mo-
bilisation in the target group. Performance improved to a median of
95% by November 2014 and has been maintained from January to
November 2015 at 94%. Our daily mobilisation aim was increased
to 30 minutes in June 2015 and to 45 minutes in October 2015.
We saw a reduction of 1.2 days in our ventilator length of stay
September 2014 as better reliability in active mobilisation was
achieved.
Conclusions: The results of this QI project show that a MD approach
to mobilisation can achieve results. The weekly data collection and
discussion proved essential in advancing success. We had no extra
resources or new funding to help us increase mobilisation time and
we used our data and successive PDSA cycles to achieve success.
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Introduction: Recent studies show that ICU survivors who needed
mechanical ventilation often presents with neuromuscular weakness
and functional impairment. ICU Acquired Weakness may develop
even in critical patients who are immobilized for only a few days
Critical Care 2016, Volume 20 Suppl 2 Page 167 of 182despite receiving supportive care and physiotherapy. Such weakness
contributes for poor outcome. Early mobilization may enhance func-
tional recovery, reduce days in mechanical ventilation, shorten ICU
and hospital length of stay, decrease the incidence of delirium and
improve survival. A great part of ICU patients are on vasoactive drug
therapy, but there are few data in literature about the safety of
mobilization in this group. Therefore our study aimed to prove that
early mobilization even of patients using low dose of vasoactive
drugs is safe and feasible.
Methods: Whe assigned patients who were using or not low dose of
vasoactive drugs to receive 2 daily sessions of physiotherapy during
their ICU length of stay and analyzed their tolerance. The exercises
consisted in 3 levels of mobilization: level 1 were passive exercises,
level 2 were active exercises and level 3 were orthostatic position
and walking. Hearth rate, respiratory rate, peripheral oxygen saturation
and MAP were evaluated in 3 moments: before the physiotherapy ses-
sion, immediately after and 30 minutes after.
Results: 154 patients were followed from November 3, 2015 to No-
vember 20, 2015. 50.6% of patients were men. Mean age was 71.1 in
vasoactive group and 73.4 in control group. Mean SAPS 3 score was
73.6 in vasoactive group and 62.7 in control group (p < 0.05). The
types of vasoactive drugs were 53.5% norepinephrine, 45.1% nitro-
prusside and 1.4% nitroglycerine. We removed from bed and putted
on the seating position 34.7% of patients in the vasoactive group
and 57.3% in the other group. There weren’t complications statisti-
cally significant. During the exercises there were changes on MAP,
but with no major event associated, though increase in dose of vaso-
active drug (p > 0.05). The only statistically significant difference be-
tween the two groups was increase in MAP in the vasoactive group
immediately after mobilization (from mean MAP of 84.02 to 87.0).
The mean dosage in mcg/kg/min of norepinephrine was 0.0117, ni-
troprusside 0.098 and nitroglycerin 0.278.
Conclusions: Our study showed that mobilization of patients on low
dose of vasoactive drugs therapy may be possible and safe, with lit-
tle complications and no major changes in MAP. These data are very
important to encourage early mobilization of patients in ICU and to
ameliorate their outcomes.
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Introduction: During an intensive care stay, patients often have their
chronic medications withheld for a variety of reasons and new drugs
commenced [1]. As patients are often under the care of a number of
different medical teams during their admission there is potential for
these changes to be inadvertently continued [2]. Intensive Care Syn-
drome: Promoting Independence and Return to Employment (In-
S:PIRE) is a five week rehabilitation programme for patients and their
caregivers after ICU (Intensive Care Unit) discharge at Glasgow Royal
Infirmary. Within this programme a medication review by the critical
care pharmacist provided an opportunity to identify and resolve any
pharmaceutical care issues and also an opportunity to educate patients
and their caregivers about changes to their medication.
Methods: During the medication review we identified ongoing
pharmaceutical care issues which were communicated to the patient’s
primary care physician (GP) by letter or a telephone call. The patients
were also encouraged to discuss any issues raised with their GP. The
significance of the interventions was classified from those not likely to
be of clinical benefit to the patient, to those which prevented serious
therapeutic failure.
Results: Data was collected from 47 of the 48 patients who attended
the clinic (median age was 52 (IQR, 44-57) median ICU LOS was 15
(IQR 9-25), median APACHE II was 23 (IQR 18-27) and 32 of the pa-
tients were men (67%). The pharmacist made 69 recommendations;
including 20 relating to drugs which had been withheld and not
restarted, dose adjustments were suggested on 13 occasions and
new drug recommendations were made for 10 patients. Duration oftreatment for new medications started during hospital admission
was clarified on 12 occasions. Lastly adverse drug effects were re-
ported on 4 occasions and the incorrect drug was prescribed on 2
occasions. Of the interventions made 58% were considered to be of
moderate to high impact.
Conclusions: The pharmacist identified pharmaceutical care issues
with 18.6% of the prescribed medications. Just over half of the pa-
tients reported that they were not made aware of any alterations to
their prescribed medication on discharge. Therefore a pharmacy
intervention is an essential part of an intensive care rehabilitation
programme to address any medication related problems, provide
education and to ensure patients gain optimal benefit from their
medication.
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Introduction: Light sedation has gained attention as part of standard
daily care in the intensive care unit (ICU). Particularly early mobi-
lization is associated with shorter time on the ventilator, shorter ICU
length of stay and better survival. Interactive gaming may be a chal-
lenging way of engaging the patient in his own rehabilitation pro-
gram. Few data are available for the use of these interactive games
in the ICU envirnoment as part of daily routine physiotherapy, al-
though one study showed that it was safe [1].
Methods: We developed a trolley with a Wii device that can be easily
used when the patient is mobilized in a chair. In addition, we used
the Mile™ device with a bedcycle and hypothesized that this would
be associated with increased motivation to use the bedcycle by our
patients.
Results: Patients liked to use the Wii device, particularly because a
choice in games made it more interesting to use. Tennis, bowling
and boxing were most frequently used. The use of the Wii was pro-
grammed in the daily mobilization schedule together with a physio-
therapist, or just with the attending ICU nurse.
The mile™ bed-cycle device was used routinely since October 2015 with
interesting results. Patients could choose the environment where they
wanted to cycle around, e.g. “slot Zeist”, in the woods or using a water-
cycle in the colourful village of Giethoorn. In parallel to the observation
with the Wii device, patients liked the variety in scenes best. A study is
in progress evaluating safety, as well as effects on motivation of pa-
tients using these interactive games in the ICU.
Conclusions: The use of interactive video games as part of routine
rehabilitation programs in the ICU environment is feasible and ap-
pears safe in this short observation period. Interactive game ther-
apy may complement existing rehabilitation techniques and
increase motivation for ICU patients to be engaged in their own
rehabilitation program.
Reference
Feasibility and observed safety of interactive video games for physical
rehabilitation in the intensive care unit: a case series. Kho ME, Damluji A,
Zanni JM, Needham DM. J Crit Care. 2012 Apr;27(2):219.e1-6
P421
Simulation-based design of a robust stopping rule to ensure
patient safety
Y. S. Chiew1, P. Docherty1, J. Dickson1, E. Moltchanova1, C. Scarrot1,
C. Pretty1, G. M. Shaw2, J. G. Chase1
1University of Canterbury, Christchurch, New Zealand; 2Christchurch
Hospital, Christchurch, New Zealand
Critical Care 2016, 20(Suppl 2):P421
Critical Care 2016, Volume 20 Suppl 2 Page 168 of 182Introduction: Stopping rules instigate early clinical trial termination
when interim analysis shows statistically significant effects of treat-
ment as part of a randomised controlled trial (RCT). This study aims
to develop a stopping rule based on observing a powered and sig-
nificant difference in mortality across RCT arms in a study.
Methods: The stopping rule was developed using a Monte-Carlo
simulation approach with predetermined control group mortality rate
(MC) and intervention group mortality rate (MI). This stopping rule is
determined as the bias in mortality required to achieve a statistical
significance of p < 0.05 with 80% power.
Results: The stopping rule determined is as shown in the Fig. 104.
The y-axis is the mortality difference (MDiff) between MC and MI.
Each line denotes a stopping rule for a different MC. For example, if
MC is observed at 20% at sample size per arm of 100, the MDiff re-
quired to terminate the trials is 19%. Thus, the MI threshold for trig-
gering the stopping rule is 39%. In practice, this means that if
interim analysis of 100 patients per trial arm includes 20 deaths in
the control group, the intervention group must observe 39 deaths or
more to stop the trial (MI > = 39%).
For MC = 30% at sample size per arm of 430 patients, the MDiff from
the Figure is approximately 9%. This mortality difference is similar to
the result found in the ARDSnet trial when comparing lower and
traditional tidal volume ventilation [1]. The ARDSnet trial found a
mortality difference of 31.0% versus 39.8% was significant when
~430 patients per arm were recruited to the trial, and the early ter-
mination of the trial was triggered. This result further validates this
stopping rule design method presented in this study.
Conclusions: This stopping rule design method can be adapted for any
two-arm RCT that monitors probabilistic and binary outcomes. This ap-
proach in designing a RCT stopping rule can be adjusted to the partici-
pating cohort using local data and based on the desired study characte-
ristics, and fulfills ethical needs for a statistically justifiable stopping rule.
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Are daily blood tests on the intensive care unit necessary?
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Critical Care 2016, 20(Suppl 2):P422Introduction: Daily blood tests are a long running feature of ICU
care, and are regarded as an essential diagnostic tool by medical
staff, however the risk of iatrogenic anaemia is a very real one and
there are significant costs involved.1
Methods: Existing guidelines are intended to limit excessive testing
in stable patients. We audited adherence to these and also recorded
trends in haematocrit and haemoglobin to identify cases of iatrogenic
anaemia on the unit. In order to establish trends and to exclude stable
post surgical patients, we limited eligible patients to those who were
on the unit for 3 days or more. On six randomly assigned days over a 2
month period, all eligible patients on the unit had a proforma filled
retrospectively for all days up until their admission to the unit, or up to
seven days previously, whichever sooner. Presence of arterial or central
access was also noted, as these facilitate obtaining samples.
Results: We obtained 101 patient days worth of data across 20 pa-
tients who were considered eligible. Our results demonstrated that
54% of tests done were required but more importantly, 46% of tests
carried out were deemed clinically unnecessary by a panel of three
ICU physicians, and 48% were ordered despite the unit guidelines
stating otherwise. The inpatient cost of carrying out the unnecessary
blood tests added up to £842 and the amount of blood wasted to-
talled 1052 ml. Based on these figures, the average volume of un-
necessary blood taken from a patient per week is 73 ml. Only 2
patients selected had no central or arterial line for part of their
inspected days, and this had no effect as they had tests taken daily
anyway.
Conclusions: Stopping short of suggesting an opt in approach to lab
tests as other units have done2, we are recommending a period of
education for existing nursing and medical staff, and also new
trainees on the Intensive Care Unit. We are also recommending re-
moval or alteration of the “Critical Care” test set that is currently
available from our electronic requesting system in the hope that it
will encourage more critical thinking about which tests are appropri-
ate for the patient they are caring for.
References
1. Goddard K, Austin SJ. Appropriate regulation of routine laboratory testing
can reduce the costs of associated with patient stay in the intensive care
unit. Critical Care 2011;15:P133
2. R Gray* and F Baldwin. Targeting blood tests in the ICU may lead to a
significant cost reduction. Critical Care 2014, 18:P15 doi:10.1186/cc13205
P423
Measuring urine output in ward patients : is it helpful?
B. Avard1, A. Pavli1, X. Gee2
1The Canberra Hospital, Hughes, ACT, Australia; 2ANU Medical School,
Canberra, Australia
Critical Care 2016, 20(Suppl 2):P423
Introduction: The significance of tracking urine output as a marker
for patient deterioration on general wards remains unclear. We aimed to
explore the utility of measurement of urine output in patients including
those who deteriorated and required Intensive Care support and a cohort
who did not, from both medical and surgical wards in a large metropol-
itan hospital in Australia. Of note this hospital had a program to recog-
nise and respond to deteriorating patients well embedded, which
included a modified early warning score and track & trigger response.
Methods: A retrospective cross sectional analysis was performed on
440 patients admitted to our hospital over a six month time period.
We excluded patients with premorbid renal insufficiency or requiring
dialysis prior to admission as these patients would have skewed re-
sults. We collected data on urine output, modified early warning
scores, when patients were admitted to ICU the timing of deterior-
ation being recognised and responded to, patient length of stay and
mortality.All data was subsequently analysed using SPSS software.
Ethics approval was obtained for this research.
Results: Only 9% of the ward patients had urine output measures
performed, irrespective of whether they deteriorated to the point of
ICU admission or remained on the ward. Despite this, those patients
who had a low urine output recorded on the ward and who were
subsequently admitted to ICU continued to have a lower mean
Critical Care 2016, Volume 20 Suppl 2 Page 169 of 182output in the first 24 hours of their ICU stay. A statistically significant
association was found between reduction in urine output and in-
creased hospital mortality with a mortality rate of 7.9% in those with
reduced output compared with 1.3% with normal output for those
patients who were not subsequently admitted to ICU, with an even
more pronounced correlation in those who deteriorated to the point
of requiring ICU admission. 25% of those patients who received a
medical review in response to deterioration may not have elicited a
review if the urine output had not been monitored and included in
the activation criteria.
Conclusions: This research suggests that urine output remains a vital
component of our recognition of deteriorating patients and our focus
should be on improving routine measurement of this parameter rather
than removing this from modified early warning scores.More reliable
measurement may allow further investigation as to whether earlier
intervention based on this parameter may improve patient outcome.
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Introduction: Pressure Ulcers (PU) are common and serious com-
plications in critically ill patients. This study aims to evaluate the inci-
dence and risk factors that are associated with PU development in
an adult mixed intensive care unit (ICU) in Turkey.
Methods: Ethics approval was obtained prior to start of the study. A
prospective cohort study was performed from December 2013 to
July 2014. Patients were screened daily until discharge or death, over
a consecutive 28-day period. We collected data on demographic and
baseline variables, co-existing diseases, serum albumin level, reposi-
tioning frequency, presence of mechanical ventilation, Acute Physi-
ology and Chronic Health Evaluation II (APACHE II) score, Sequential
Organ Failure Assessment (SOFA) score, Glasgow Coma Score (GCS)
and vasoactive medications.
Results: A total of 194 patients were examined in the study, 30
(15,4 %) of them developed a PU. The factors associated with PU de-
velopment were: serum albumin level (p =0,0004), generalized
edema (p = 0,004), mechanical ventilation use (p = 0,0007), sedation
(p = 0,01) and GCS (p = 0.00001). Age, gender, body mass index, APA-
CHE II and SOFA scores, and repositioning were not different be-
tween patients with and without PU.
Conclusions: Pressure ulcers are common complications in adult mixed
intensive care unit, with potentially severe consequences. The incidence
of pressure ulcers were related with state of consciousness, sedation,
mechanical ventilatory support and presence of generalized edema.
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Critical Care 2016, 20(Suppl 2):P425Introduction: There has been an increase in the number and size of
closed ICUs in Alexandria, Egypt that has not been met by a compar-
able increase in the number of intensivists. Consequently, leading to
work overload and negative impact on both patients and intensivists.
Methods: Using an in-person questionnaire of Consultants and In-
house physicians in 27 closed ICUs in Alexandria, Egypt, obtaining in-
formation about their demographic data, patient workload, other
hospital and medical duties and perception of the workplace and
teaching environment.
Results: 254 Physicians responded. The average daily (SD) census of
patients was 7.96 ± 6.24 patients, and the average (SD) maximum ser-
vice size was 10.46 ± 6.75 patients. The median of consultant/patient
ratio was (1:8), which classified 8 ICUs into Unfavourable ratio ICUs
(>1:8), and 19 ICUs into Favourable ratio ICUs (<1:8). The median of
In-house physician/patient ratio was (1:4.5), which classified 16 ICUs
into Unfavourable ratio units (>1:4.5), and 11 ICUs Favourable ratio
units (<1:4.5). Respondents from Unfavourable ratio ICUs perceived
significantly more time constraints, teaching difficulties, burnout, and
negative impact on patients.
Conclusions: Intensivists working in Unfavourable ratio ICUs fre-
quently perceived being overburdened in comparison with those
working in low ratio units. Also high physician/patient ratios may
have a negative impact on teaching, patient care, and workforce
stability.
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Introduction: Reduction in ALOS is an important efficiency indicator
in any ICU [1]. We hypothesized whether eICU can create an impact
on quality of service and financial implication thereof.
Methods: This retrospective study was done at a tier 2 city hospital
with eICU support comprising of 36 ICU beds to assess the impact of
eICU on ALOS for a period of 6months before and after inception.
The study period was October 2014 to April 2015 and April to Octo-
ber 2015 respectively. The eICU had complete access 24*7 to pa-
tient’s real-time vitals, imaging, lab values, audiovisual and alerts.
eICU support was pertaining to patient management, clinical proto-
col implementation, bundles compliance and did not involve any
change in discharge policies or administrative policies. Patient base
line demographics, including risk factors, severity score and all-cause
mortality at 30 days were recorded. Descriptive analysis was done.
Between groups comparison was performed by applying student’s T
test, significance was assumed at a value of p < 0.05. Financial impli-
cation was derived based on average cost per ICU bed per day.
Results: Total of 2053 and 2432 patients were admitted with ICU
days being 6460 and 6193 pre and post eICU respectively. Baseline
demographics and patient profile in two groups did not show sta-
tistically significant difference. Mean APACHE II was 16.48 ± 6.81
[SMR (standardized mortality ratio) 0.71 ± 0.14] vs 16.82 ± 7.12 (SMR
0.49 ± 0.16). ALOS was 3.14 ± 2.39 vs 2.55 ± 2.45 days pre and post
eICU respectively indicating a reduction of ~ 19% which is signifi-
cant (p < 0.01). Nosocomial infection incidence per thousand device
days post eICU came down from 16.4 to 6.31 (decrease of ~ 62%).
Financial impact from reduced ALOS was INR 28.7 million which is
Fig. 105 (Abstract P428). Trends in hospital outcomes.
Critical Care 2016, Volume 20 Suppl 2 Page 170 of 182significant compared to the eICU cost borne by the unit of INR 2.4
million.
Conclusions: eICU has been judged as a cost centre by most admin-
istrators but if we look at the above case study then it’s clear that in
developing country like India not only it’s cost effective but also
made a significant decrease in ALOS along with mortality and noso-
comial infection. This leads to a direct impact of financials on pa-
tients and the hospital. By mobilizing shorter turnovers we can help
in treating more patients without escalating cost by building new
beds which will never have adequate manpower and resources.
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Introduction: Deterioration of patients in hospitals is typically pre-
ceded by changes in vital signs. Deterioration detection based on
changes of a single vital sign can result in missed deterioration
events and high false alarm rates. Multi- parameter systems such as
the modified and national early warning system (MEWS and NEWS)
use look up tables to score data from multiple vital signs and specify
actions based on the score. These systems offer improved perfor-
mance compared to single-parameter systems, but were created
through physician consensus and may not be making optimal use of
the available data. Here we explore use of modern data mining tech-
niques to derive a high performance multi- parameter deterioration
detection algorithm, the Early Deterioration Indicator (EDI).
Methods: EDI was created by producing risk curves for every input
feature. Every feature value is mapped to a risk score which are
added together to get the final score. Input features for EDI were:
heart rate, systolic blood pressure, respiration rate, oxygen satu-
ration, temperature and age. To derive and validate EDI, we collected
data from 14282 general ward stays. 11864 stays were used to de-
velop the algorithm. We tested the algorithm on the other 2418
stays. EDI, MEWS and NEWS were calculated in the middle of gen-
eral ward stay for non- deteriorating stays. For patients who deteri-
orated, middle values in the last 6 hours before deterioration were
used to calculate the scores. We computed sensitivity, speci-
ficity values and the area under the curve (AUC) for the receiver op-
erator characteristic curve for the 3 scores and compared their
performance.
Results: We tested the ability of EDI, MEWS and NEWS to predict de-
terioration which was defined as patient death or transfer to a higher
level of care such as ICU. The training dataset comprised of 882 dete-
riorations (7.4% prevalence). In the training data, the AUC values
were- EDI: 0.7793, NEWS: 0.6764, MEWS: 0.6404. The test dataset
comprised of 184 deteriorations (7.6% prevalence). AUC values were-
EDI: 0.7655, NEWS: 0.6569, MEWS: 0.6487.
Conclusions: EDI was developed using a data-driven approach to
discover patterns in vital sign values that are predictive of
imminent patient deterioration. It is based on continuous-value
risk curves that are sensitive to subtle variations in vital signs,
and may be automated for real- time risk assessment. EDI signifi-
cantly improves performance over commonly deployed systems
(MEWS and NEWS) while making use of the same input parame-
ters, offering the possibility of a drop-in solution to reduce alarm
fatigue.
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Critical Care 2016, 20(Suppl 2):P428Introduction: King’s College Hospital is one of the largest acute and
tertiary referral hospitals in the UK and plays a pivotal role in King’s
Health Partners, an AHSC.
In 2013, the hospital set up a multi-disciplinary 24/7 enhanced critical
care outreach service to support patients, relatives and staff provid-
ing: Rapid response & stabilisation; critical care follow-up; outreach
education; and delivering virtual critical care beds when critical care
flows exceed capacity.
Methods: Process and hospital outcome data was collated by our
business intelligence unit and the National Cardiac Arrest Audit
(NCAA). Trends in hospital outcomes & cardiac arrests were analysed
using linear regression and contingency tables.
Results: The service saw 6046 patients in its first year which repre-
sented 12.2 % of the hospital admissions. The mean number of re-
views per patient ranged from 3.25 for discharges to 13.5 for
patients undergoing critical care interventions making 24,000 clinical
episodes annually. The ‘dose’ was 82/1000 admissions, with only
8.8 % of calls inappropriate, and this exceeds the minimum dose rec-
ommended by the Institute for Healthcare Improvement.
The median time to review after activation was 14 minutes.
Hospital admissions and acuity rose during the study period by
11.2 % as measured by nationally set metrics and there was a reduc-
tion in the actual cardiac arrest rate as against the forecast cardiac
arrest rate based on local historical NCAA data (P < 0.021).
There was a significant difference in the trends for expected vs. ob-
served deaths pre and post the introduction of the iMobile service
(p < 0.043).
Conclusions: High impact, high dose, critical care outreach services
can deliver the changes in outcomes that are difficult to evaluate in
healthcare socio-cultural interventions.P429
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Introduction: ICU bed scarcity is associated with reduced probability
of ICU admission, but it is not clear if decisions to admit are sub-
jected to heuristics and biases and to the impact of greater cognitive
load.
Methods: Physicians were electronically invited to respond an online
questionnaire. The study was a factorial 2x2 trial and each respon-
dent was randomized to increased or no increased cognitive load






Mean value (±SD) on
ED discharge to ICU
Mean value (±SD) at 24
hrs after ICU admission
SOFA 2.29 (±2.62) 2.55 (±2.67) 3.52 (±3.07)
APACHE II 12.49 (±7.50) 13.65 (±8.03) 15.88 (±8.63)
SAPS II N/A 30.92 (±13.78) 35.87 (±17.44)
Table 52 (Abstract P430). p-values from comparison of illness severity
scores over early hospital course.
Initial vs. ED
discharge
ED discharge vs. ICU 24
hr
Initial vs. ICU 24
hrs
SOFA
0.54 0.031 0.006 APACHE
II
0.30 0.075 0.007 SAPS II
N/A 0.045 N/A
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lated by distracting videos, sounds and time-limit for response.
Clinical vignettes were based on real patients for whom ICU admis-
sion was requested. Archetypical vignettes for ICU admission or re-
fusal were defined based on experts opinion. Six groups of vignettes
were constructed: 1)single archetypical for admission; 2)two simul-
taneous archetypical for admission; 3)single archetypical for refusal;
4)two simultaneous archetypical for refusal; 5)single non-archetypical
vignette. Each of these groups were randomly presented in an ICU
scarcity (last bed available) or non-scarcity setting. Group 6 vignettes
were randomly presented in two versions: 6.1 consisted in a “mul-
tiple choice” vignette in which the respondent was presented with
the decision to admit an archetypical case for ICU admission or an
elective surgery patient; 6.2 consisted in a “status quo” vignette, in
which the last ICU bed was already reserved for an elective surgery
patient and the respondent was presented with two simultaneous
ICU requests for archetypical cases for ICU admission.
Results: 159 physicians logged in and were randomized and 106
(67%) had complete data. Completion rate was lower for the cogni-
tive load group (56% vs 79%, p < 0.05), but there were no differences
on demographic characteristics. Cognitive load had no impact on the
proportion of cases admitted or refused in each group. Group 3 vi-
gnettes were more often refused admission in ICU scarcity setting
(68% vs 45%, p < 0.05). Archetypical vignettes for admission were
more often refused in group 6.1 (multiple-choice) than group 6.2
(status quo): 20.4% vs 1.8%, p < 0.05.
Conclusions: There was no impact of cognitive load on the responses,
but the results may have been hampered by the differential dropout
rate. ICU scarcity was associated with increased refusal of patients for
whom ICU admission was deemed inappropriate, but not with refusal
of patients for whom ICU admission was deemed appropriate. Multiple-
choice bias had more impact than status quo bias in the inappropriate
refusal of ICU admission.
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Introduction: Patients admitted through the emergency department
(ED) to intensive care units (ICU) represent a unique population with
varying etiologies of illness, for which existing descriptive analysis of
severity and early prognosis of disease is lacking. Our study com-
pares several ICU illness severity scores (Acute Physiology and
Chronic Health Evaluation (APACHE)II, Simplified Acute Physiology
Score (SAPS)II, Sequential Organ Failure Assessment (SOFA) score)
within this cohort of patients during their early ED and ICU course to
describe illness progression.
Methods: Retrospective review of consecutive patients admitted
from the ED to the ICU in an academic referral center between Janu-
ary and February of 2014. Clinical and demographic data were col-
lected to calculate APACHE II, SAPSII, SOFA scores on initial ED arrival
(with exception of SAPSII), ED discharge, and after first 24 hours in
the ICU. t-test used to evaluate differences between scores at each
time interval, with p < 0.05 representing significance.
Results: We enrolled 82 patients, who averaged 62 years of age, 53%
were female. 43% were admitted to medical, 39% to surgical, 17% to
neurologic ICUs. Mortality rate was 13%. SOFA, APACHE II, SAPS II re-
sults summarized in Table 51. Comparison of scores by t-test showed
significant increase in illness severity between ED arrival and end of
first 24 hours in ICU (Table 52).
Conclusions: Illness scores (SOFA, APACHEII, and SAPSII) significantly
increased at 24 hours after ICU admission compared to ED arrival.
While a preliminary investigation, our data provides insight on ex-
pected progression of illness for ICU-bound patients admitted fromthe ED. Further work is needed in elucidating prognostic indicators
and patient-care factors.P431
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Introduction: Critical Care (CC) services are in increasing demand but
published guidance for triaging admissions may no longer reflect
current practice [1-2]. Exercise tolerance and clinical frailty assess-
ment may have a role in assessing patients (pts) referred to CC [3].
We aimed to establish the impact of frailty and other factors on this
decision making process.
Methods: Referrals to CC were prospectively enrolled in a review co-
hort. Data included patient demographics, a measure of acute
physiological derangement (early warning score, EWS), prior hospital
length of stay (LOS), exercise tolerance (ET), functional and depen-
dence status, Canadian Clinical Frailty Scale (CCFS) and comorbidities.
Logistic regression analysis was used to assess factors influencing ad-
mission, using STATA 14.1. Results are expressed as median
(interquartile range) and odds ratios (OR) for admission with 95%
confidence intervals (CI).
Results: Data was collected on 617 pts referred to CC between No-
vember 2013 and October 2014, of whom 344 (55.8%) were made
out of hours, 279 (45.2%) were admitted. Median age was 65 (50-74)
years, 311 (50.4%) were male and the median LOS prior to referral
was 2 (0-2) days. The median CCFS, MET grading and EWS were 4 (3-
6), 4 (0-6) and 4 (2-6) respectively. The majority of referrals came
from the medical specialties (246 pts, 39.9%), directly from the emer-
gency department (190 pts, 30.8%) and the surgical specialties (129,
20.9%). The most common comorbidities were cardiovascular (238
pts, 38.6%) diseases, respiratory (141 pts, 22.9%) and diabetes (108
pts, 17.5%). The most common referral reason was sepsis (140 pts,
22.7%), with post-operative monitoring accounting for 61 referrals
(10%). At age and gender adjusted logistic regression analysis the
EWS (OR per point 1.12, CI 1-1.25, p = 0.04), the CCFS (OR per point
0.79, CI 0.69-0.91, p = 0.001), ET > 30 yards (OR 2.5, CI 1.6-3.98, p <
0.001), self-caring status (OR 2.5, CI 1.6-3.97, p < 0.001) and house-
bound status (OR 0.38, CI 0.24-0.58, p < 0.001) influenced admission.
The number of CC beds available, the LOS prior to referral and the
MET grading did not.
Conclusions: Frailty, level of dependence and exercise tolerance ap-
pear to be major factors in decision making regarding admission to CC,
Critical Care 2016, Volume 20 Suppl 2 Page 172 of 182even after adjusting for age. These factors may support decision mak-
ing by allowing objective quantification of functional reserve.
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Introduction: Demand for Critical Care (CC) is increasing but admis-
sion may be inappropriate if the patient is unlikely to survive. Conse-
quently, published guidance may no longer reflect current practice
[1-2]. Clinical frailty evaluation scores have recently been shown to
be associated with increased mortality in patients already admitted
to CC [3]. We aimed to establish the impact of frailty and other fac-
tors on the decision whether to admit a deteriorating hospital pa-
tient to CC.
Methods: Unplanned patient referrals were prospectively enrolled in
a review cohort. Data included patient demographics, acute physio-
logical parameters, prior hospital length of stay (LOS), Canadian Clin-
ical Frailty Scale (CCFS) and comorbidities. Logistic regression analysis
was used to assess factors influencing admission, using STATA 14.1.
Results are expressed as median (interquartile range) and odds ratios
(OR) with confidence intervals (CI).
Results: Between June and October 2015 data was collected on 220
patients referred to CC, of whom 87 (39.5%) were admitted. Median
age was 66.5 (50-77) years, 134 (60.9%) were male and the median
LOS prior to referral was 2 (0-7) days. The median SOFA score, CCFS
and Charlson age-adjusted comorbidity index (CACI) was 5 (4-7), 4
(3-5) and 4 (2-6), respectively. At unadjusted logistic regression ana-
lysis age (p = 0.86), gender (p = 0.72), LOS (p = 0.34) and SOFA score
(p = 0.42) did not impact on likelihood of admission to CC. Con-
versely, each unit increase in the CACI (OR 0.78, 95% CI 0.66-0.91,
p = 0.002) and in the CCFS (OR 0.69, 95% CI 0.56-0.85, p < 0.001)
caused a decrease of approximately 22% and 31% in the odds of ad-
mission, respectively. On age and gender adjusted multivariate logis-
tic regression analysis CCFS retained its ability to predict admission
to critical care (OR 0.65 per unit increase, 95% CI 0.49-0.85, p =
0.002), whilst CACI did not (OR 0.85, 95% CI 0.70-1.03, p = 0.09).
Conclusions: Frailty appears to be a major factor in decision making
regarding admission to CC, even after adjusting for age, gender and
other known comorbidities. Quantification of frailty using the CCFS
may be a valuable tool in risk stratification and resource allocation,
and merits further investigation in this context.
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Introduction: Intensive care unit (ICU) admission triage is performed
routinely in ICUs of developed and developing countries and is often
based solely on clinical judgement, which could mask unethical
prejudice or bias. Therefore, development of an objective triage
score and of guidelines applying to individual patients has beendiscussed in the literature. To help triage decisions for ICU admission,
a critical care team was assembled to come up with an instrument to
aid triage decisions, based on the Society of Critical Care Medicine’s
(SCCM) guidelines. We sought to evaluate the validity and reliability
of this instrument.
Methods: An algorithm based on responses to an ICU request form
was developed to classify patients in each of four SCCM’s priority
strata. Nine physicians with experience in critical care or emergency
medicine evaluated forty clinical vignettes for reliability analyzes. The
correlation of algorithm-based priorities with surrogate gold stan-
dards, defined by a panel of specialists, was evaluated in a validity
analysis. Validity was further evaluated by applying this algorithm to
a retrospective sample of 603 patients with requests for ICU admis-
sion, for association with outcomes.
Results: Overall agreement was substantial, with a weighted kappa
of 0.61 (95% CI 0.57-0.65). Algorithm-based priorities were also corre-
lated with the priorities ascribed by specialists, with a weighted
kappa of 0.67 (95% CI 0.60-0.74) and with subjective assessments of
appropriateness of ICU admission. Algorithm-based priorities were
also associated with ICU admission and hospital mortality (priorities
1,2, 3 and 4 had hospital mortality rates of 35.5%, 27.6%, 46.1% and
66.1%, respectively, P < 0.05). However, in an unadjusted analysis,
there was no differential mortality benefit of ICU admission in each
priority stratum.
Conclusions: This ICU admission triage tool demonstrated good reli-
ability, validity and predictive characteristics. However, it may not be
suitable to standard practice, yet, since it was not properly evaluated
to demonstrate a difference in benefit of ICU admission, justifying
the admission of one priority stratum over the others. Further pro-
spective studies with additional collected variables should be imple-
mented to address its limitations.
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Introduction: SSRI/SNRIs are among the most commonly prescribed
drugs in patients admitted to critical care. We reviewed the literature
for evidence of benefit/harm from chronic use, continued use or
withdrawal - to guide clinicians considering whether to continue,
stop, or restart these medications on critical care.
Methods: Data Sources
4298 studies through November 2014 were identified using pres-
pecified search terms in Medline, Embase and the Cochrane Central
Register of Controlled Trials.
Study Selection
Abstracts were screened by predefined criteria, then 289 full-text arti-
cles assessed for eligibility. After applying prespecified exclusion cri-
teria, only 14 studies were included in the systematic review (total
20048 patients - 14709 from one large study).
Data Extraction
Studies were analysed according to published quality criteria – co-
hort studies were awarded a Newcastle-Ottawa Score.
Data Synthesis
The low number of studies reviewed and their heterogeneity did not
allow meta-analysis, so a narrative review was presented.
Results: We found few papers presenting useful evidence – five co-
hort studies, one case series and seven case reports. We found no
evidence for benefit from use of SSRI/SNRIs in critical care. We found
some evidence of increased morbidity in patients using SSRI/SNRIs
on admission to critical care. However due to inadequate adminis-
Critical Care 2016, Volume 20 Suppl 2 Page 173 of 182tration reporting it was often unclear if they were actually continued,
and therefore whether harm was due to chronic effects, ongoing
use, or drug withdrawal.
Conclusions: Overall there were inadequate data to draw firm con-
clusions. We feel there is sufficient uncertainty regarding the safety
and utility of SSRI/SNRIs in critical care to warrant a randomized
interventional study into continuing/withholding them on critical
care admission.
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Introduction: The literature lacks a brief, specific, and validated
instrument for measuring and monitoring adaptive coping of hos-
pitalized patients with a severe medical condition. Hence, we
introduce the Sickness Insight in Coping Questionnaire (SICQ) and
examined its validity and patient-proxy agreement.
Methods: Study 1 (n = 103 hospitalized patients) addressed the in-
ternal consistency, initial factor structure, and construct validity, of
the SICQ. Coping subscales of the BRIEF COPE, Illness Cognition
Questionnaire, and Utrecht Coping List, were used as comparator
measures in testing the construct validity of the SICQ-subscales
(fighting spirit, toughness, redefinition, positivism, non-acceptance).
Study 2 (n = 100 ICU-patients and close family members of ICU-
patients as proxies) addressed the structural validity of the SICQ with
confirmatory factor analyses, and examined patient-close proxy
agreement with correlation and Bland-Altman Plot analyses.
Results: Study 1 showed that the SICQ has adequate internal con-
sistency (0.64 [<=] α [<=] 0.79), a clear initial factor structure, and ad-
equate convergent (0.24 [<=] r [<=] 0.50) and divergent (r [<=] 0.12)
construct validity. Study 2 showed that the SICQ has good structural
validity, and moderate (r = 0.37; non-acceptance) to strong (r > 0.50;
fighting spirit, toughness, redefinition, and positivism) patient-close
proxy agreement.
Conclusions: Overall, the SICQ has good psychometric properties.
ICUs can use the SICQ to gain insight in adaptive coping style of pa-
tients through ratings of close family members.
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Introduction: In Portugal training in intensive care is done after the
achievement of a primary specialty. This is about to change with a
proposal to create a primary intensive care medicine (ICM) specialty.
A national survey was done to determine intensive care practitioners’
opinion on how to train in ICM.
Methods: Questionnaires were sent to all intensive care practitioners.
Models of intensive care training were described as: primary specialty
with direct entry following primary medical qualification; sub-
specialty of another discipline; supra-specialty permitting multidiscip-
linary access from a range of base specialties.
Results: The team sent 391 questionnaires and obtained 240 answers
(61%). Responders had 46 ± 10 years, 52% are male and worked in
intensive care for 10(4-19) years, 86% worked in full time, of thoseworking in shared schedule (n = 33) only 16 dedicated < 50 % of their
time to ICM. Primary specialty of the responders was: Internal Medi-
cine (67%), Anaesthesiology (24%) and other (9%). Most of them
(73%) had previous experience in their primary specialty before initi-
ating Intensive Care practice, during 2(1-5) years. When ques-
tioned about the ideal model 45% (n = 106) choose a “primary speci-
ality” and of those: 69% thinks that training should be 5 years; 90%
consider important a common core with Internal Medicine (92%), An-
aesthesiology (92%), Emergency Medicine (89%), Cardiology (83%) and
others (7,4%); for 81% the remaining training should be entirely in
ICM and of these 95 % think that training in a dedicated ICU should
be considered, mainly in neuro-ICU (93%) and RED-ICU (61%). For
those who support ICM as a supra-specialty (51%,n = 121) or sub-
specialty (28%,n = 65) the main reasons pointed were: previous spe-
cialty facilitates acquisition of ICM knowledge (97%), increases clin-
ical autonomy (97%), provides a higher capacity in clinical judgment
and medical decisions (90%) and allows more firm bioethics know-
ledge (80%); it is an advantage having a multidisciplinary team
(95%). Regarding the training program: 77% knows the CoBatriCE
project; 89% knows the PACT and 95% finds it usefull. Technical
competencies found to be desirable in the ICM training were: Echo-
cardiogram (97%), Bronchoscopy (97%), Fast Eco (97%) and others
(30%). Undergraduate teaching was reported as desirable by 83%
(n = 193).
Conclusions: Good response rate, less than half of the responders
think that ICM should be a primary specialty, the vast majority thinks
that an intensive care team should be composed by consultants from
different specialties.
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Introduction: Work-related stress with the accompanying emotions
provoked specifically in the Intensive Care Unit (ICU) is well docu-
mented over the previous years. The high-stakes, high stress envi-
ronment that ICU health care professionals (HCP) practice in, are
demanding intellectually, physically, and emotionally. Work engage-
ment has been operationalized as a positive work-related state of
mind and characterized by vigor, dedication, and absorption. The
aim of the study is to explore the influence of personal resources,
e.g. empathic ability on work engagement among the ICU HCP.
Methods: The design of the study was a cross-sectional survey study
among ICU HCP (i.e. intensivists and nurses) of Erasmus MC, a univer-
sity hospital in the Netherlands. A digital link to the questionnaire
was sent in October 2015 to a given e-mail address of 163 nurses in
a mixed ICU, 45 nurses in a thoracic ICU, 54 nurses in a cardiac ICU
and 53 intensivists. Two reminders were sent. Work engagement was
measured with the Utrecht Work Engagement Scale, which includes
17 items five point Likert items about how a person feels at work.
Additionally, 14 items based on the Jefferson Scale of Physician
Empathy measured emphatic ability.
Results: The overall response rate was 66%, with a male-female ratio
of .47. The mean age of the respondents was 43.4 years, mean work-
ing hours/weeks rated 33.6, and 54% finished A-levels in education.
ICU HCP scored the same on vigor, higher on dedication (p < .05),
and lower on absorption (p < .05) compared to the average Dutch
employee. They reported no more stress related symptoms such as
mental distance and sleeping disorders. Although only 2.8% of the
ICU HCP assessed workload as high, compared to 3.6%, the emo-
tional burden scored higher (3.1 and 1.8 in respective, p < .05). Gen-
eral HCP acted as benchmark in empathic ability. ICU HCP showed
an equal score on the cognitive component (3.9 compared to 4.0)
and a lower score on the emotional component (3.0 compared to
3.8, p < .05). Mean cognitive empathy is positively correlated with
vigor (r = .21) although both cognitive and emotional empathy did
not correlate with work engagement.
Fig. 106 (Abstract P439). Data are presented as median (IQR).
Critical Care 2016, Volume 20 Suppl 2 Page 174 of 182Conclusions: Workload at the ICU may be high, but seemed not too
hard for the respondents. It is assumable that workload, with the
emotional high burden, is acknowledged as an integral part of ICU
work. ICU HCP understand the patients and relatives, but remain at a
certain distance emotionally. The results of this study suggested no
influence on work engagement by empathic ability.
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Introduction: Burnout is a rapid resurgent worldwide problem; inten-
sive care unit (ICU) practitioners are particularly at risk. Leader-
empowering behavior could reduce the encountered job tension and
enhancement of work effectiveness [1]. We aim to assess the role of
empowerment on ICU practitioners’ burnout.
Methods: Mixed qualitative and quantitative methodology was used
in a cross-sectional descriptive survey. The case study focused on
Qatari ICU where anonymous questionnaire survey was presented to
the staff members including physicians, nurses and respiratory thera-
pists who work as full time. We used two main instruments, Maslasch
Burnout scale (MBI-HSS), and Empowerment scale (ES). High burnout
is considered when MBI-HSS is scores of 27 and more [2].
Results: Two-hundred healthcare practitioners were enrolled in
mixed medical and surgical ICUs. Fifty-one ICU practitioners showed
high prevalence association (25.5%). Physicians, nurses, and re-
spiratory therapists were equally presented at burnout association
(p = 0.19). Age was associated with high burnout (p = 0.000), while
gender was not. Empowerment was significantly associated with
burnout by two-tailed test (p = 0.006). Positive empowerment had
a negative effect on burnout variance (3.8%) when speculating
practitioners’ burnout.
Conclusions: Empowerment components could reduce burnout
within ICU. Particular attention should be given to the high burnout
in ICU settings.
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Introduction: Circadian rhythm has a profound role in harmonising
the function of organs and cells of the human body, while disruption
of this rhythm (i.e. chronodisruption) is accompanied with a wide
spectrum of pathological conditions. This rhythm in healthy subjects
is mainly orchestrated by the daily cycles of light and darkness, as
shown by the elevation of melatonin (MEL) levels peaking at dawn
[1]. The aim of our prospective clinical study was to examine the
rhythm of MEL release in ICU patients suffering from continuous light
pollution.
Methods: Mechanically ventilated patients over 18 years, without
brain injury were enrolled into the study in January 2015. Illu-
minance was measured by a lux meter over the patients&#8217;
body and serum MEL levels were determined from blood samples.
Measurements took place after admission starting with the closest
time point of the regular sampling period of 01:00, 07:00, 13:00 and
19:00 hours with a precision of &#177;10 min. for 4 days. Blood sam-
ples were kept in total darkness until clotting before beingcentrifuged 8 min. at 3000 rpm, then serum samples were placed
into -80 °C until MEL measurement was performed.
Results: 15 patients were enrolled on a multidisciplinary ICU, with
age of 63&#177;9 years, male/female ratio was 9/6. Out of the 16
measurements/patient, 240 MEL samples were analysed. MEL and il-
luminance levels are summarised in Fig. 106. Although illuminance
was the lowest at 01:00, but levels were still a lot higher than phy-
siologically required. Furthermore, at 01:00 a MEL peak should occur
[1], which was also missing. A repeated correlation analysis between
MEL serum concentration and illuminance levels showed a weak
within-subject correlation (r = -0.097, P = 0.152), and a still non-
significant between-subject correlation (r = 0.438, P = 0.103).
Conclusions: Our results indicate that circadian rhythm is desyn-
chronized in ICU patients, as indicated by a) the missing MEL peak
during the night; b) by the poor correlation between illumination
and MEL levels c) the absence of the normal 24h rhythm of MEL re-
lease. Future trials are hence warranted to test whether providing
physiological light/dark conditions could resynchronise circadian
rhythm and if it has any effect on patient outcomes.
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Introduction: Noise is an underestimated problem in the ICU that
can attribute to sleep disturbance and delirium with an adverse ef-
fect on morbidity and mortality in critically ill patients.
WHO recommendations of average sound levels below 35 dBA are
not achievable in an ICU, where 50% of the time average sound
levels exceeding 52 dBA are reported [1].
Since noise is also in our ICU considered a problem, we investigated
sound levels and its causes and tried to implement a bundle of mea-
sures for noise reduction.
Methods: We placed a sound level meter (Amptec 10EaZy RT) at two
places in the ICU: one bedside in a two-bed room and one at the
nursing station. Recordings were performed at each location continu-
ously for a 24 hrs period.
Simultaneously, structured observations were performed to identify
the causes of elevated sound levels.
After identifying the mean causes of noise and implementing a bun-
dle of measures for noise reduction, the recordings and obser-
vations were repeated.
Results: Average sound levels were comparable both bedside and at
the nursing station before and after the noise reduction measures
(Bedside: 52.8 dBA vs 52.9 dBA at night and 54.6 dBA vs 53.7 dBA at
daytime – Nursing station: 52.6 dBA vs 52.2 at night and 53.9 dBA vs
53.2 dBA at daytime).
There was also no difference in the incidence of sound level peaks
(Bedside: 14 vs 16 - Nursing station: 11 vs 10).
However, the maximum sound level peak bedside was significantly
reduced (101.1 dBA vs 91.6 dBA).
Further, observations showed that operational sounds and not struc-
tural sounds are the main cause for noise in the ICU. In particular,
the ICU-team (nurses, doctors, …) seemed to be the main contribut-
ing factor.
Conclusions: Reduction of noise in the ICU is complex and mul-
timodal. Reaching WHO levels seems not feasible in a ICU setting
Critical Care 2016, Volume 20 Suppl 2 Page 175 of 182since measures for noise reduction can temper peaks but not the
average sound level.
Since the ICU-team is the main contributing factor, behavioural
guidelines play an important role in noise reduction.
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Introduction: In the humanized care in the critical patient, the bed-
washing is an internalized activity with impact over the risk involved
for the accidental removal of invasive devices, and our intensive care
unit it is not exempt from this.
It was modified the bed-washing protocol, in order to measure the
impact of direct supervision and professionalized nursing interven-
tion during the bad-washing in relation with the incidence of acci-
dental removal of invasive devices.
Methods: The incidence of accidental removal of invasive devices
(orotracheal tube, arterial catheter, central venous access, surgical
drainage and indwelling urinary catheter) were reviewed of the in-
tensive care unit (ICU) of the Hospital Clínico Universidad de Chile
doing the difference between the totals events of those into the
bed-washing in our patients. It was coordinated a continuous me-
dical education to nursing team (emergency and intensive nurses,
technicians of nurses and auxiliaries) modifying the bed-washing
protocol, including the direct supervision and nursing intervention in
critical patients with invasive devices. It was defined two periods for
comparison (2003-2005 and 2012-2014). The incidents rates were an-
alyzed for the study period by Kwallis nonparametric test. Signifi-
cance level of p < 0.05.
Results: The incidents rates of accidental removal of invasive devices
were reviewed of ICU through the database nursing department of
our hospital. The period of diagnostic described 76 events of ac-
cidental removal of invasive devices; 13 into the bad-washing (rate:
1.18 adjusted events per year). In the evaluation period, 60 events
are reported and 7 during the bed-washing (rate: 0.64 adjusted
events per year). The rates showed significant differences in the to-
tals events (p = 0.02). To compare rates of bed-washing events, a
significant difference was observed in relation to the change of
protocol (p = 0.04).
Conclusions: A decrease was evident in the overall incidence of the
accidental removal of invasive devices in liaison to continuous med-
ical education (p = 0.02). The same is observed on the incidence dur-
ing the bed-washing, between the period of diagnostic and
evaluation of the intervention (p = 0.04).
The presence of nursing into the bed-washing decreases significantly
the rates of the accidental removal of invasive devices. We believe
these data validate the implementation of our bed-washing protocol.
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Introduction: The aim of this audit is to investigate the compliance
of a critical care unit (CCU) with the application of Deprivation of lib-
erty safeguards (DoLS) authorisations. DoLS form part of the UK’s
Mental Capacity Act and are intended to safeguard the rights of pa-
tients who lack mental capacity, and whose freedom to leave a
healthcare environment is potentially limited.[1] They require written
application to the local authority in order to gain permission for the
patients on going care. However, because of the fact that thissituation potentially applies to some patients in the CCU, an unin-
tended consequence of the legislation is that it is increasingly being
applied to critically ill patients. This can result in a significant work-
load for both the critical care team and the local council.
Methods: A search was made on the Phillips ICIP electronic record
over a 10-month period (19th Dec 2014 - 8th Sept 2015) for the
number of patients who had a mental health assessment form com-
pleted, declaring them as lacking capacity. A detailed search of their
notes on the electronic patient record (EPR) was made in order to
look retrospectively at the number of DoLS applications made in
comparison to the number required.
Results: Out of a total of 994 admissions, 34 patients lacked capacity at
some point during their stay. These were divided into emergency med-
ical (56%), elective surgical (35%) and emergency surgical ad-
missions (9%) respectively. Of 31 patients who were retrospectively
deemed eligible for a DoLS, 7 (23%) had an application submitted to
the local council. The reasons why authorisations were necessary were
divided in to tracheostomy related (45%), chemical/physical restraint
for delirium (39%) and other best interest decision (16%). On average a
DoLS authorisation was necessary for 4.5 days. The local authority de-
nied no applications. The average time between identifying a lack of
capacity and completion of DoLS application was 5.2 days.
Conclusions: A significant number of patients admitted to CCU who
lack mental capacity may be at risk of having their liberty deprived.
A compliance rate of 23% may be a reflection of the way DoLS can
now be applied to CCUs. Local interventions, such as routine pre-
consent and streamlining of the DoLS application process are being
implemented with the intention of reducing work load and improv-
ing the rate of compliance with the law.
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Introduction: The CriSTAL checklist1 is a tool to identify the elderly,
dying patient in hospital, aiming to help avoid aggressive, futile
treatments and initiate appropriate plans for end of life care. We
aimed to assess whether a version, modified for our department and
institution, would help identify those elderly patients who may bene-
fit from critical care.
Methods: Unplanned critical care admissions in patients aged over
70 years between January and March 2014 were retrospectively ana-
lysed. Validated predictors of short and medium term death chosen
from the CriSTAL checklist were assigned a score of 1(present) or 0(ab-
sent) with a maximum of 15:
Chronic kidney disease (CKD [>=]3), Previous myocardial infarction,
Abnormal ECG at presentation, Congestive cardiac failure, Chronic
pulmonary disease, Cerebrovascular disease, Dementia/cognitive im-
pairment, Long term institutionalised mental health, Chronic liver dis-
ease, Solid tumours, Hospital stay >5days before critical care review,
Previous hospitalisation in past year, Previous ICU admissions, Marked
weight loss in last 12 months and Frailty (Rockwood scale [>=]4)2.
The sum score for survivors and non-survivors was compared. Statis-
tical analysis was performed via Mann-Whitney U test(SPSS) and
values expressed as median(range).
Results: Of 125 patients with a median age of 79 (70-93), 42 (34%)
were female, 83 (66%) male and 56 (45%) received level 3 and 69
(55%) level 2 care.
Median modified CriSTAL scores were higher in non-survivors (3.0)
compared with survivors (2.0) with a p-value of 0.001.
This difference was maintained in the subgroups of level 3 (survivors
2.5, non-survivors 3.0; p-value 0.024) and level 2 patients (survivors
2.0, non-survivors 3.5; p-value 0.041).
Conclusions: Absolute CriSTAL score values, as assessed with our
simplified tool, were low across all groups. The signal for increased
Critical Care 2016, Volume 20 Suppl 2 Page 176 of 182mortality with higher scores may suggest use in informing treatment
stratifications in elderly critically ill patients. Identification of the most
appropriate individual parameters and their relative contributions to-
wards an overall score merits further evaluation.
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Introduction: There is increasing evidence that a well-structured pal-
liative care initiative in the form of an integrative or consultative or a
combination of both into standard ICU care can provide benefits for
patients and families.
Recent systemic reviews suggest that proactive palliative care in the
ICU decrease hospital and ICU length of stay.
Methods: We embarked on a first of a kind ICU-Palliative Collabor-
ation and Project in Singapore. The aim was to improve referral rate
to palliative care for patients wih poor prognosis in Neurosurgical In-
tensive Care (NICU).
Poor Prognosis was defined as patients with at least one of the fol-
lowing referral criteria:
1. Hypoxic Ischaemic Encephalopathy
2. Severe Head Injury with poor neurological prognosis
3. Extensive Intracerebral/Subarachnoid Haemorrhage
4. Low presenting Glasgow Coma Scale (GCS) of less than 6
A multi-disciplinary team, consisting of intensivists, neurosurgeons,
medical social workers,nurses and palliative care medicine physicians
formed the core team to lead this project in NICU.
Interventions include
1. A structured screening tool that is easily available to the nurses
2. A referral criteria that is agreed upon by all involved in care of
patient
3. Communication workshop conducted for all nurses and
physicians in NICU to broach end of life care issues with family
4. Weekly palliative rounds in NICU to discuss current cases and
to debrief previous patients referred.
Results: 1. The number of pallaitive care referrals, increased from a
baseline of 30% to 85%.
2. Patients relatives when interviewed, had a higher level of satis-
faction with overall medical care in hospital.
3. There was a 1.3 day reduction of ICU stay for patients referred to
palliative care, with its attendant cost savings.
Conclusions: Palliative care in the ICU is an important part of man-
agement of patients with poor prognosis. It improves family emo-
tional outcomes abd reduces ICU length of stay
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medico-surgical intermediate care unit, and outcome of patients
with lsc limitation: a monocentric, six-month study.
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Critical Care 2016, 20(Suppl 2):P445Introduction: Limitations of Life Supporting Care (LSC) and With-
drawal of LSC are scarcely studied in Intermediate Care Units (IdtCUs).
We report prevalence of LSC limited patients in a medico-surgical Inter-
mediate Care Unit over a six month period, with description, outcomes,
and patterns of LSC Limitation and Withdrawal for such patients.
Methods: Monocentric, retrospective observational study in the IdtCU
of a 500-bed general hospital. Data were extracted from patients’ files
and included age, gender, admission diagnoses, Knaus index, Charlson
comorbidity score, severity scores (SAPS2 and SOFA), LSC treatments,
IdtCU and hospital mortality / length of stay, LSC withdrawal.Factors as-
sociated with LSC limitation of LSC were determined through univariate
and multivariate analysis.
Results: Out of 405 patients, 79 (19,5%) patients were admitted with
LSC limitation in the IdtCU. They presented with higher chronic and
acute severity scores than unlimited patients. The most frequent ad-
mission diagnosis of LSC limited patients was acute respiratory failure
(51,8% of patients). Non Invasive Ventilation (NIV) use was frequent
within this population (39%). Hospital mortality for LSC limited patients
was high (53%) and associated with growing age -OR = 1,09 (1.02 -
1.15), preexisting organ failures or comorbidities -OR 7,34 (1.94 - 27.81)-
elevated SOFA score -OR 1,36 (1.03 - 1.8)- and hypoxemic respiratory
failure –OR 24,8 (3.52 – 175.3). Withdrawal of LSC was proceeded in 19,
5% of cases, with frequent terminal sedation with or without NIV re-
trieval (43, 8%).
Conclusions: Patients with limitations of LSC are frequently admitted
in IdtCU. Hospital mortality is high and associated with age, acute
and preexisting organ failures, and hypoxemic respiratory failure. Life
support withdrawal includes NIV terminal weaning and palliative sed-
ation. LSC limited hypercapnic patients appear to be safely treated with
NIV. The very high mortality of most severe patients raises questions on
appropriateness of care and use of acute care resources.
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Introduction: It has been suggested that clinical deterioration during
hospitalization could be seen as a trigger for palliative care (PC) con-
sultation. The co-occurrence of urgent intensive care unit (ICU) ad-
mission request and PC consultation request was analyzed in
hospitalized patients.
Methods: All urgent ICU admission and palliative care consultation
requests at an academic tertiary hospital from May, 2014 to May,
2015 were evaluated. Patients were analyzed in four different groups:
1) ICU request without palliative care consultation (ICUnoPAL), 2) ICU
request and palliative care consultation (ICUandPAL), comprising those
patients with 3) palliative care consultation before ICU admission re-
quest (PALbefICU) and those with 4) palliative care consultation after
ICU admission request (PALaftICU).
Results: There were 2476 ICU admission requests and 949 palliative
care consultation requests. Of the formers, 179 (7%) were ICU and
PAL. These patients, when compared to ICUnoPAL, were older (65 vs
54 years, p < 0.05), with more severe disease, as measured by MPMII0
score (0,40 vs 0,26, p < 0.05), less likely to be admitted to the ICU
(49% vs 64%, p < 0.05) and had higher adjusted hospital mortality
(83% vs 37%; OR [95%CI]: 7,2 [4,6-11,4]). There were 29 (16%) pa-
Critical Care 2016, Volume 20 Suppl 2 Page 177 of 182tients PALbefICU and 150 (84%) PALaftICU. When comparing
these two groups, there were no differences in MPMII0 score, organ
dysfunctions or use of artificial life support at the moment of ICU
request. PALbefICU patients were hospitalized for fewer days before
PC consultation request (8 vs 29 days, p < 0.05), were more likely to
have no diagnosis at the moment of consultation (10% vs 0%, p <
0.05) and presented less frequently with palliative perfor-
mance scale (PPS) lower than 30 (56% vs 85%, p < 0.05). More pa-
tients had PC consultations discontinued in the PALbefICU group
(41% vs 20%, p < 0.05) and the main reason for discontinuation was
the absence of indication for exclusive palliative care (31% vs 6%,
p < 0.05). However, PALbefICU patients were less likely to be ad-
mitted in the ICU (31% vs 53%, p < 0.05) and hospital mortality was
similar in both groups (88% vs 82%, p < 0.05), both adjusted for se-
verity of illness.
Conclusions: Co-occurrence of ICU admission request and PC con-
sultation in the same hospitalization was frequent and PC consult-
ation before ICU request was associated with a lower chance of ICU
admission. These patients had extremely high hospital mortality, des-
pite differences in timing of consultation, diagnosis, PPS and defin-
ition of life support limitation. This data seems to support the notion
that clinical deterioration during hospitalization may be seen as an
opportunity to discuss end of life goals.
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Introduction: End-of-life (EOL) decision making in acute care is com-
plex, involving difficult decision, such as whether to initiate or discon-
tinue life support, place a feeding tube or a tracheostomy, or initiate
cardiopulmonary resuscitation (CPR) in the event of a cardiac arrest.
Methods: our critical care nurses suffer when they think they are per-
forming procedures that are harmful or of low efficacy and when
their advocacy is ineffective. Prolonged, unrecognized suffering can
be detrimental and can lead to disengagement and silence. Habitual
silence or silencing in the face of perceived wrongs can result in per-
manent, deleterous changes in ethical values (1).
In recent studies researchers suggested that false optimism is associ-
ated with medical activism or a strong need for control over death,
which is prevalent in the western world.. or ignorance or some emo-
tional anesthesia present in us.
Results: Narratives enable those involved in the ICU to negotiate the
meaning of critical care for the patient. Narrative functions as an inter-
pretive procedure that allows diverse persons- we- nurses-patient, and
patient’s families- to make sense of critical care.... and supplies a theory
and instrument for negotiating meaning throughout the process that
respects the realities and limitations of such care.
Conclusions: the effective practice of medicine requires “narrative
competence.. the ability to acknowledge, absorb, interpret, and act
on the stories and plights of others”.
The nurses that working with us every day are often caught in the
middle-an ethically untenable position- as they attempt to comply
with our medical directives and simultaneously protect and advocate
for their patient.
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Critical Care 2016, 20(Suppl 2):P448Introduction: to evaluate end of life practise in 20 bedded ’icu with
neuro intensive care.
Methods: a prospective observational study of end of life decisions
made by medical professionals and whether the patient, family, or
legal representative were involved in the end of life decisions.
Results: 240 patients were admitted in ICU for a 3 month period of
which 42 patients died in ICU (17.5%) 2 patients died in the ward fol-
lowing withdrawal of care.29(65.9%) of whom had died followed
withdrawal or withholding of care.11(18% of the dead)had spon-
taneous cardiac arrest or `Brain Dead.all patients who had limitation
of therapy had family consensus,of which 2 were autonomous deci-
sion of the patients.
Conclusions: the reasons for withdrawal of care was either unres-
ponsive to maximal therapy or irreversible neurologic status,The opti-
mal use of resources and the good practise of optimal care in ICU re-
mains a challenge .Consnsus with the family remains a challenge
despite good communication and well educated clientele.There is still
scope for improvement in these areas.
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Introduction: Around 50% of deaths in the UK occur in hospital, giv-
ing a total of around 250 000 in 2013 [1]. The responsibility of con-
firmation and documentation of these deaths rests across all
specialties of hospital doctor. The Academy of Medical Royal Colleges
(AMRC) released a consensus guideline in 2008 aiming to standardise
this process [2]. Guidance is available for the diagnosis of death fol-
lowing cardiorespiratory arrest and death following cessa-
tion of brainstem function. The diagnosis should be transparent, con-
sistent and instil public confidence in the process. This audit took a
retrospective look at current practice and adherence to these
guidelines.
Methods: A retrospective case notes examination was carried out be-
tween February and August 2015. 98 deaths were observed on Whis-
ton ICU during this period. Doctors carrying out the reviews were
not involved in the process of diagnosing death in order not to bias
the study findings. Data was collected from entries made in the pa-
tient’s case notes and compared with recommended standards set
out within AMRC guidelines. These include absence of heart and
breath sounds, central pulse and corneal reflex. The patient should
have been observed for 5 minutes and the time and date entered in
the patient record, along with the name/grade of doctor.
Results: Of the 98 verifications of death examined, the % compliance
was as follows:
Heart sounds 89.7, central pulse 82.6, respiratory effort 92.8, ob-
served 5 minutes 9.1 (absent in 35 cases), pain response 72.1,
pupillary response 89.7, corneal reflex 6.1, time correct 74.4, date cor-
rect 80.6, signed 97.9, printed name 97.9, grade 81.6. In the 63 cases
where duration of observation was documented, mean time of was
2.1 minutes. There was only 1 instance of practice falling in line with
current guidelines.
Conclusions: Despite AMRC consensus guidelines being available for
best practice in diagnosis of death, there remains a great deal of vari-
ation in practice for this common procedure. Only 1% of the case
notes examined met the guidelines, with the majority not observing
the patient for long enough or documenting a corneal reflex. Fur-
thermore, 20% of cases were found to have documented the time/
date of death incorrectly. We propose that these wide varia-
tions in practice can easily be addressed with the introduction of a
Critical Care 2016, Volume 20 Suppl 2 Page 178 of 182standardised proforma to be completed and signed by the clinician
at the time of verification.
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Introduction: Human deceased skin donor allografts represent a suit-
able and much used temporizing option for skin cover following any
kind of skin injury. The main advantages for its use include dermo-
protection while disadvantages of its use include the limited abun-
dance of donors and availability of surgical retrival team. This paper
will explore the role of skin procurement performed by intensive care
physicians.
Methods: Data from skin procurement performed in Modena hospital
were analyzed from 2006 to 2014. After attending Burn Care Unit in
Cesena and a short training with a plastic surgeon who usually per-
fermed this kind of procedure, two intensive care physicians were
able to perform skin retrival since 2011. Electric dermatome was used
to remove skin. After the retrival skin grafts are sent to bank tissue.
The activities of skin and tissues banks currently involve their recov-
ery, processing, storage and distribution.
Results: Human skin allografts were obtained from multi organ and
tissue donors after both brain and cardiac death. During these nine
years, 84 deceased donor skin allograft donations were performed. A
significant improvement of numbers of skin procurement was ob-
served from 2011 after the introduction of intensive care physicians
as surgical team (Fig. 107). Quality and quantity of human skin allo-
grafts procured by intensivists were comparable to those pro-
cured by plastic surgeons.
Conclusions: The skin performs a variety of important functions for
the human body. Deceased donor skin allografts is a feasible option
for saving life of patient with extensive skin injury. Intensivists trained
in human allografts procurement can implement donor pool.
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Introduction: Mode of death in Pediatric Intensive Care Unit (PICU)
could differ in different population and institutional setting. The aim
of the present study is to investigate the mode of death in a single
center.
Methods: Retrospective death analysis from 1/1/2012 to 31/12/2013
in a multidisciplinary PICU of Northern Greece. All deaths happened
in pts stayed for > 4hours were recorded. Data collected: Demo-
graphics, reason for and severity score at admission, treatment char-
acteristics, and laboratory data. Appropriateness of antibiotics was
defined as pathogen susceptibility to at least one drug, given at least
24 hours before death. The mode of death was classified as death
due to MODS, brain death (BD), and limitation of care (DL). P <
0.05.
Results: Twenty seven deaths (13 male/14 female), mean (±SD) age
53.12 ± 50.27 mo, were recorded in 231 admissions (11.68%). Eight-
een pts died from MODS (66.66%), six from BD (22.22%) and three
due to DL (11.11%). Pts died from MODS were significantly younger.
All pts died due to DL were readmissions that suffered from co-
morbidities. Severity score and lactate levels admission, and LOS
didn’t differ significantly according to the mode of death. Although
not significant, at the time surrounding death or after death, 10
positive blood cultures were revealed in 9 pts (8 in MODS); 4 acine-
tobacter b., 2 enterobacter c., 1 pseudomonas aer., 1 klebsiella p., 1
enterococcus f., 1 candida non al. Appropriate antibiotics were pre-
scribed in 3 of them (33.33%).
Conclusions: We found that MODS were the main mode of death,
following by BD and DL. Pts dying of MODS were more likely to be
younger and suffer from co-morbidities. As the majority of pts died
from MODS were under inadequate treatment, and the results ar-
rived quite late, we could speculate that timely processing and
handling of blood culture results, and better antibiotic coverage
could lead to better infection control and less progress to MODS
and death.
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Introduction: Organ donation after euthanasia has been performed
at least 30 times in Belgium and the Netherlands, often at an ICU.
Thousands undergo euthanasia each year, but it is unclear what the
potential of this procedure can be for the donor pool.
Methods: It was not possible to obtain detailed euthanasia data from
Dutch authorities. All Belgian euthanasia reports of 2013 were ana-
lyzed. The primary outcome was the number of patients which could
donate at least 1 organ. Subgroup analysis was performed to evalu-
ate the number of potential donors per organ.
Exclusion was based on the contraindications for donation within the
Eurotransplant region. Cancer was an exclusion criterion as the majority
of malignancies are a contra-indication for organ donation. Patients
with “Multiple pathologies” were excluded, because they would be un-
likely to be accepted as an organ donor. Patients with “Other patholo-
gies” were excluded, because many mentioned contra-indications for
donation or details about the pathology were lacking. For subgroup
Critical Care 2016, Volume 20 Suppl 2 Page 179 of 182analysis, patients with renal disease were excluded as potential kidney
donors and patients with lung disease as potential lung donors.
Within the Eurotransplant region, 75 years is the maximum age for
donation of kidneys, lungs and pancreas islet isolation in Maastricht
category 3 deceased donors. For potential liver donors, a maximum
age of 60 years was used and for whole pancreas donors 50 years.
Results: Of 1811 obtained Belgian reports, a total of 186 potential
donors with at least 1 suitable organ for donation remained. 6 pa-
tients with a history of kidney disease were excluded, leading to 360
potential kidney donations. For lung donation 31 patients were ex-
cluded leaving a potential of 155 lung donors. 113 patients between
60-79 years old were excluded, leaving 73 potential liver donors. For
whole pancreas donation, the age group of 50-79 years was ex-
cluded, resulting in 30 potential pancreas donors.
Conclusions: In this first analysis of Belgian data on euthanasia in
order to explore the potential of organ donation after euthanasia,
10,3% of all euthanasia cases are potentially suitable patients for do-
nation. Whether they are willing to donate is unclear and should be
studied. If only a small percentage of these patients would consider do-
nation, this could mean an increase in donation in Belgium and the
Netherlands.
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Introduction: The ability to communicate well with patients and their
relatives is a fundamental clinical skill in intensive care me-
dicine and central to good medical practice. Communication at the
bedside, even when the patient is unconscious or sedated, may often
be recalled by critical care survivors and can impact upon long-term
psychological outcomes[1].The Intensive Care Society released guide-
lines for the provision of intensive care services and one area which
was highlighted was the patient and relative perspective, the import-
ance of effective communication with relatives and patients and
valuable time spent talking to the patient[2].The aim of this audit
was to assess the communication skills on the daily ward rounds be-
tween the team leader, normally the on call Consultant, and the pa-
tient at the bedside.
Methods: An observational study comprising of 32 daily ward rounds
on the 14 bedded Critical Care Unit (CCU) at Whiston hospital between
October and November 2015. An average of 11 patients per ward
round were recorded including non-ventilated and ventilated patients.
A data collection tool was used which assessed whether the Consultant
leading the ward round introduced themselves, explained what their
role was and introduced the rest of the team.
Results: Out of the 348 patients who were on the CCU within this
time period, the majority of these patients were not ventilated. Say-
ing that it was found that only 53% of Consultants introduced them-
selves, 52% explained their role and 45% introduced the rest of the
team. There seemed to be a significant difference in the com-
munication between Consultants and ventilated patients, showing
that only 16% introduced themselves, 14% explained their role and
11% introduced the rest of the team.
Conclusions: The communication between patients and doctors
within the CCU calls for vast improvement. Given the evidence as
mentioned, it is imperative that strategies are put in place to help
improve the results which were found. This would include a simple
adjunct next to the bedside to help remind the Consultant about the
importance of effective communication. It is worthwhile re-auditing
once this implementation has been put in place to see whether com-
munication has improved.
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Introduction: Communication with patients and families in critical
care medicine (CCM) can be complex and challenging. Physicians
benefit from dedicated communication teaching, although the ideal
model has not been established. Our purpose was to develop and as-
sess the impact of a communication skills curriculum for CCM fellows.
Methods: Surveys including multiple choice and free-text questions
were sent to all CCM fellows, staff physicians, nurses and social
workers at our institution. The results informed the design of a longitu-
dinal communication skills curriculum for CCM fellows. The effective-
ness of the curriculum is being assessed through trends in clinician
feedback.
Results: The survey response rate was 7/7 fellows, 15/29 staff phy-
sicians, 56/404 nurses, and 1/5 social workers. More than 50% of
non-fellow respondents identified that fellows ranked below expecta-
tions in counseling about the emotional impact of emergency situa-
tions; fellows reported they had the least amount of training in this
area and were least comfortable addressing patient and family emo-
tional issues. Staff physicians were least comfortable teaching and
assessing fellows’ capacity to address emotion, and had received the
least amount of training in this area themselves. All non-trainee
groups described fellows’ focus on giving information over building
rapport; fellows indicated their challenges may be related to the
absence of a prior relationship with patients and families, and their
own discomfort in talking about death and dying. Despite chal-
lenges in the relational aspects of communication, topics of great-
est interest to fellows included organ donation, adverse events,
conflict, and family meetings. Preferred learning methods included
simulation and feedback in clinical practice. This data guided the
development of a communication skills curriculum involving 5 for-
mal sessions over a year, and structured feedback during CCM rota-
tions. Each formal session consisted of a didactic presentation and
simulated practice. One formal session was dedicated to basic prin-
ciples of communication, which were incorporated into each of the
topic-based sessions. A form to guide multidisciplinary preceptors
in providing feedback to fellows in clinical practice was also devel-
oped and implemented. Preliminary data indicate that fellows value
the curriculum and feedback; more objective curricular evaluation
is ongoing.
Conclusions: Kern’s model has been valuable in developing a blended
communication skills curriculum tailored to CCM fellows’ needs. The
curriculum has been received favorably.
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Introduction: Conflicts between healthcare professionals and patients’
relatives are rather common in the intensive care unit (ICU). As a result
of societies’ increased ethnic diversity these conflicts more often in-
volve actors with a different ethno-cultural background. However few is
known about the specific nature of staff-family conflicts in a multi-
ethnic ICU environment. In this study, we give an overview of some
characteristics of conflicts between family members from ethnic-
minority groups and staff members and compare them to characteris-
tics of staff-family conflict in general.
Methods: Ethnographic fieldwork was done in 1 ICU of a multi-
ethnic urban hospital in Belgium. During 6 months, data were collected
through negotiated interactive observation, in-depth-interviews with
staff, from patients’ medical records, and by making notes in a logbook.
Critical Care 2016, Volume 20 Suppl 2 Page 180 of 182Data were analyzed via grounded theory and compared to the litera-
ture on staff-family conflict in general.
Results: It is known that, in general, physicians identify a situation
less often as conflict-loaded than relatives, suggesting the presence
of hidden conflicts during critical care [1-2]. However, in our studied
multi-ethnic ICU conflicts were found to be explicitly recognized by
both relatives as well as healthcare professionals, and to be very vis-
ible and auditable on the ward. Moreover where in general relative-
staff conflict tend to be centered around crisis moments (end-of-life
decision making, patients’ death) [3], we found that in a multi-ethnic
ICU conflicts tend to be present during various care phases (curative
phase, end-of-life decision making, non-curative phase, patients’
death) and concern a broad spectrum of care aspects ( e.g. bedside
care activities, seeking a second opinion), easily assaulting the core
of actors’ identity. Consequently, end-of-life decisions, often a difficult
assignment in ICUs, might be even more problematical in a multi-
ethnic context than in general, as tensions in the pre-end of life deci-
sion making phase might worsen conflicts in the end-of-life decision
making phase.
Conclusions: In ICUs, staff-family conflicts tend to be more severe
and overtly present in a multi-ethnic context than in general. There-
fore we urge for the development of specific and effective staff-
family conflict prevention strategies in a multi-ethnic ICU.
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Introduction: The management of critically ill patients is often chal-
lenging for clinicians with most being sedated or too unwell to be
actively involved in aspects of their care.
The quality of care received by patients can also vary between hos-
pital locations, which in turn influences family perceptions of care
provision. Family members are surrogates for patients and monitoring
their experiences positively influences patient outcomes [1].
The aim of this study was to identify whether the source of admis-
sion to critical care had any impact family satisfaction.
Methods: This prospective study was conducted over a period of
eight weeks on our critical care unit. Up to four relatives per patient
prior to discharge from the unit, or after initiation of end of life care,
were requested to fill in a modified (Family satisfaction Survey (FSS)-
ICU questionnaire. The qualitative responses obtained using a Likert
scale were transformed into numerical data for analysis.
Results: 34 completed surveys were analysed with majority of the re-
spondents being female (65%).
46% of the patients were admitted from the emergency resuscitation
department and whilst admissions from the inpatient wards ac-
counted for 34%.
Of the patients admitted from the emergency department the level
of satisfaction was excellent (56%) or very good (54%) in all aspects
of the patient care, as opposed to 36% of patients from the ward
Conclusions: The results show that relatives are more likely to be sat-
isfied when admitted from the emergency department than the from
an inpatient ward. There is a correlation between inclusion in the
decision-making process and overall satisfaction. The timely manner
in which patients are admitted from the emergency department
(RESUS) as well as the levels of staffing on initial management may
account for the results seen.
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Introduction: We sought to evaluate whether the succinct Critical
Care Family Needs Inventory (CCFNI) [1], a validated survey, may
serve as a suitable alternative to the FS-ICU. Undertaking relative ex-
perience surveys annually was outlined as a quality indicator by the
Scottish Intensive Care Society Quality Improvement Group in 2012.
Over the past 5 years we have completed the FS-ICU annually. This is
a lengthy survey covering aspects of care & decision making. The
FSS has been previously validated in large US/Canadian studies [2].
More recently the Family Reported Experiences Evaluation (FREE) vali-
dated the FS-ICU in the UK, employing the survey across 20 different
ICUs with approximately 7000 forms completed.
Methods: The audit was conducted across both hospitals in the trust.
Over 4 weeks we distributed the CCFNI to relatives of patients on
ITU/HDU once decision to step down to a ward was made. We inclu-
ded a section for open comments at the end of the survey.
Results: Over 4 weeks a total of 44 surveys were completed. Selected
results are detailed below with comparison to results from similar
questions in the FS-ICU survey.
Quality of care: CCFNI: 77% of relatives felt that the best possible
care was being given to the patient almost all the time. FS-ICU: 72%
felt the care received from doctors was excellent & 71% felt the care
received from nurses was excellent.
Communication: CCFNI: 73% felt that explanations about the pa-
tient’s condition were given in terms that they could understand al-
most all of the time & the remaining 27% felt explanations were
understandable most of the time. FS-ICU: 69% felt staff provided
understandable explanations excellently, 31% described this informa-
tion as very good.
Empathy: CCFNI: 84% stated that staff members showed an interest
in how relatives were feeling almost all of the time and most of the
time. FS-ICU: 72% stated that ICU staff were excellent in showing
interest & consideration to relative needs, and 28% said staff were
very good.
Conclusions: Results suggest that relatives are satisfied with the care
that their relatives received at the trust. The results appear to cor-
relate well with those from the FS-ICU in several domains such as
care, communication and empathy. We therefore propose that the
CCFNI can be used as an alternative annual survey to measure rela-
tives experience on ICU.
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Introduction: ICU survivors suffer persistent physical, psychological
and social problems in the months and years after discharge from
critical care (1). Caregivers of these patients also suffer similar prob-
lems (2). As a result, an innovative, peer supported rehabilita-
tion programme- Intensive Care Syndrome: Promoting Independence
and Return to Employment (InS:PIRE) was created in Glasgow Royal In-
firmary. This 5 week multi disciplinary programme, which is co facili-
tated by patient and family volunteers further along the recovery
trajectory, aims to empower patients and caregivers to take control of
their health and wellbeing. The objective of this study was to explore
the experiences of the volunteers who participated in InS:PIRE. It also
Critical Care 2016, Volume 20 Suppl 2 Page 181 of 182sought to identify the support required by volunteers from healthcare
professionals involved in the project.
Methods: Six in depth semi structured interviews were undertaken
with volunteers (both patients and family members) involved in the
InS:PIRE clinic by an assistant psychologist. A predetermined topic
guide was utilised to guide interviews. Interviews were audio recor-
ded and transcribed verbatim. Interpretative Phenomenological
Analysis was used to analyse the transcripts (3). Peer Review was
undertaken to ensure credibility of the findings.
Results: Findings: Six key themes were identified from these interviews:
the social impact of volunteering, shared experiences; supporting
others; personal boundaries; support needs and personal gain. The im-
portance of peer support and having a shared understanding of partici-
pants needs were key themes for the volunteers. Volunteers described
the need for further support in areas such as: confidentiality; listening
skills and understanding boundaries.
Conclusions: The use of peer volunteers in this ICU rehabilitation ser-
vice has been successful within this local context. Further, larger scale
research studies, which explore further the impact of volunteering for
ICU survivors are required.
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Introduction: Intensive care unit is one of the most stressful places
in a Hospital. Relatives are exposed to many factors that may cause
symptoms of anxiety and depression.
The aim of this study was to determine the prevalence of anxiety
and depression symptoms 72 hour and 90 days after ICU adimssion,
and identify factors associated with this symptoms.
Methods: Relatives of Patients admitted to the National Burn Center
in Montevideo between february and october 2015 were invited to
participate in this study.
72 hours and ninety days after ICU admission, family members com-
pleted a survey that included the Hospital Anxiety and Depression
Scale.
Results: 95 and 45 relatives reponded the survey at 72 hours and 90
days after ICU admission repectively.
The prevalence of Anxiety symptoms were 60% and 28% 72 hours
and 90 days after ICU admission respectively.
Symptoms of depression were present in 47% of relatives at the third
day and 18% at 90 days after ICU admission.
72 hous after ICU admission, a longer time lived with the patient was
associated with anxiety 18 (3-26) years vs 2 (0-23) years (p = 0,02),
and with depression 18 (7-26) years vs 4(0-23) (p = 0,02). At this mo-
ment, a higher total burn area 27% (18-37) vs 19% (10-27) (p = 0,02)
was associated with depression.
Factors associated with anxiety 90 days after ICU admission were: felt
that treatment information was incomplete (80% vs 22%,p = 0,02),
and not being able to return to work (80% vs 22%p = 0,02).The only factor associated with depression symptoms 90 days afetr
ICU admission was not being able to return to work (38% vs 11%,
p = 0,04).
Conclusions: Prevalence of Anxiety and Depression among relatives
was very important after 72 hours of ICU admission, and remained el-
evated 3 months later. This study shows factors associated with the
apearence of anxiety and depression.P460
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Introduction: St Elisabeth Hospital has a 30 bed ICU for critically ill
adult patients. We facilitate family centred care, but in earlier years
children were not allowed to visit family members in our ICU. The
objective of our project was to facilitate paediatric visitation and to
provide support related to the distress and needs of children with a
relative in our ICU.
Methods: Practical aids were developed for our caregivers. An infor-
mation leaflet was made with practical information for parents. This
was subdivided in developmental stages. Furthermore we created a
book in which a child visits his father at our ICU. Pictures show what
children can expect, which helps prepare the child for visiting. An in-
struction box is included with ICU materials (Fig. 108). These materials
are used to give children a more tactile experience of the ICU. Guid-
ance materials for when a patient may die were developed in-
cluded. For example: there are little boxes that can be decorated by
the children to put in a memory or a token of grief. Pedagogical staff
are available to support parents, children and staff. If there are more
profound problems there will be referral to our children’s psychologist.
Our hospital photographers can be called upon to commemorate the
last moments (Fig. 109). We instructed our nurses and doctors on how
to use these materials and how to guide children. We held a survey
among our staff to inquire if this met their needs.
Results: There’s an increasing awareness to the needs of children
among our staff. Children and parents are welcomed and guided by
our staff. Our survey amongst our staff showed a great appreciation
for the materials we developed. When relatives of children die, chil-
dren can be included in the farewell visit.
Conclusions: When a child is confronted with a sick or dying parent,
loss and sorrow are inevitable. We, as care givers, can be more than by-
standers and can help parents guide their children in difficult times.
Fig. 109 (Abstract P460). Last moments: hands of the family,
including patient’s 14 and 16 year old siblings.
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Introduction: In 2007 we found a clear tendency in Italian PICUs to
apply restrictive visiting policies [1]. However, we also pointed out
that a formal process of revision of the ward’s visiting policies was
underway in roughly half of the units. Therefore, we carried out a
new national survey to evaluate this issue in Italian PICUs.
Methods: An email questionnaire was sent to the heads of all 30 Ital-
ian PICUs asking about their visiting policies.
Results: The response rate was 100%. Median daily visiting time was
7 hours. Twenty per cent of surveyed PICUs (6/30) had unrestricted
policies where one parent is allowed to be present both day and
night, while 59% of units (17/30) do not allow constant presence of a
parent even during the day.
Children were not permitted to visit in 64% (19/30) of PICUs. In the
case of a dying patient, 53% of PICUs (16/30) extended visiting hours,
77% (23/30) increased the number of slots, and 77% (23/30) allowed
more visitors.
A gowning procedure was compulsory for visitors in 70% (21/30) of
PICUs. No waiting room for family members and visitors was pro-
vided by 13% of units (4/30). Thirteen PICUs out of thirty (43%) re-
cently revised the ward’s visiting policies.
Conclusions: Although in Italian PICUs persists a tendency to apply
restrictive visiting policies, these findings suggests that a revision of
current policies is underway and that over the last eight years there
has been perceptible change in favour of the liberalization of visiting
in the Italian pediatric critical care setting. Despite the many ob-
jections considered valid in the past, there is conclusively no scientific
basis for limiting family presence in ICU [2].
Our survey could contribute towards liberalizing visiting policies in
Italian PICUs and promoting more attentive care for the patient and
his/her family.
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